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MOVING AWAY FROM TIGHT GLUCOSE CONTROL. WHAT IS THE IMPACT
ON PATIENTS IN A DISTRICT GENERAL HOSPITAL INTENSIVE CARE UNIT?
R. J. P. Jose1, J. Preller1, J. Durcan1.
1Broomfield Hospital, Intensive Care Medicine, Chelmsford, UK
INTRODUCTION. The question of optimum serum glucose levels in the critically ill, and
the effect on outcome continues to be keenly debated. A recent large trial has shown that
intensive glucose control increased ICU mortality among adults in ICU [1].
OBJECTIVES. To compare two protocols with different triggers for starting insulin sliding
scales for glucose control, in a district general hospital ICU in the UK and to observe the
effects on our patient outcomes.
METHODS. In May 2007 our ICU protocol trigger for starting insulin sliding scales for
glucose control changed from glucose level greater than 8 mmol/l (group 1) to 10 mmol/l
(group 2). No other policies were changed during this period. We compared 208 patients in
group 1 to 659 patients in group 2. Only patients on an insulin sliding scale were included. A
severe hypoglycaemic patient day was defined as a day in which a patient had at least one
blood glucose reading \2.1 mmol/l.
RESULTS. In Group 1, 39.9% of patients were female versus 42.9% in group 2 (p = 0.47).
In group 1 and group 2, 15.4 versus 20.8% were admitted from A&E, 52.9 versus 50.1%
admitted from theatre and 31.7 versus 29.1% admitted from other locations, respectively
(p = 0.23). The mean age was 67 versus 64 years (p = 0.02) in group 1 and group 2,
respectively.
There was no significant difference between the two groups regarding all cause mortality
within 28 days (p = 0.44), 90 day mortality (p = 0.20), ICU mortality (p = 0.16) or length
of stay in ICU (0.21). There was no significant difference in the number of severe hypo-
glycaemic patient days (p = 0.86) or in the number of patients having severe hypoglycaemic
days (p = 1.00).
The ICU and hospital mortality (p = 0.00) was significantly greater in the group of patients
who had severe hypoglycaemic patient days.
The odds ratio for a patient who had a severe hypoglycaemic patient day dying in hospital was
8.978 (95% CI 3.640–22.145) and for dying in ICU was 14.728 (95%CI 6.622–32.760)
greater than those for those who did not. The relative risk of those who did not have a severe
hypoglycaemic patient day dying in ICU and hospital was 80 and 61% less, respectively, than
in those with severe hypoglycaemic patient days.
CONCLUSIONS. Changing our policy on glucose control from a treatment trigger of [8 to
[10 mmol/l had no significant difference on the incidence of severe hypoglycaemic patient
days or ICU mortality but the group of patients with severe hypoglycaemic patient days had
higher mortality.
REFERENCE. 1. The NICE-SUGAR Study Investigators (2009) Intensive versus conven-
tional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297.
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ENHANCED MODEL PREDICTIVE CONTROL (EMPC) ALGORITHM IS A SAFE
AND RELIABLE TOOL FOR THE ESTABLISHMENT OF GLYCAEMIC CON-
TROL IN SERIOUSLY ILL MEDICAL ICU PATIENTS—RESULTS OF ALDEA 01
K. Amrein1, M. Ellmerer1, R. Hovorka2, K. H. Smolle1, N. Kachel3, D. Parcz1, S. Korsatko1,
G. Bock1, G. Ko¨hler1, T. R. Pieber1,4, J. Plank1.
1Medical University of Graz, Department of Internal Medicine, Graz, Austria, 2University of
Cambridge, Institute of Metabolic Science, Cambridge, UK, 3BBraun, Melsungen, Germany,
4Joanneum Research Forschungsgesellschaft mbH, Graz, Austria
INTRODUCTION. Several trials investigating the effects of tight glycaemic control failed to
establish glycaemia within the target range. In contrast, the eMPC algorithm has demonstrated to
be effective and safe in critically ill medical and surgical patients for a period of up to 5 days.
OBJECTIVES. To investigate the performance of the eMPC algorithm for glycaemic control
in mechanically ventilated medical ICU patients for the whole length of stay. The primary
endpoint was defined as time within target range (80–110 mg/dl).
METHODS. PatientswithanexpectedICUstay[5 dayswererecruitedinthissingle-centre,open,
non-controlled trial.44nursesweretrainedtorunalaptop-basedbedsideversionoftheeMPC.
RESULTS. 20 patients (age 69 ± 11, BMI 27.4 ± 4.5, APACHE II 25.5 ± 5.2, 16 male, 6 dia-
betic)wereincludedforaperiodof7.8 ± 4.1 days.Thepercentageoftimespentwithinpredefined
glucose level ranges isdisplayed inTable 1. Mean arterial bloodglucose was105.7 ± 8.9 mg/dl.
Threesinglehypoglycaemicepisodesoccurredduringthetrial,correspondingtoarateof0.018per
treatmentday.NomalfunctionsoftheeMPCalgorithmwereobserved.































CONCLUSIONS. From a clinical point of view, performance of the eMPC algorithm was
excellent. The eMPC algorithm is a safe and reliable method to control blood glucose in
critically ill patients in the medical ICU.
GRANT ACKNOWLEDGEMENT. The study was sponsored by BBraun, Melsungen,
Germany.
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LOW INCIDENCE OF HYPOGLYCAEMIA WITH COMPUTER-ASSISTED GLU-
COSE CONTROL IN INTENSIVE CARE PATIENTS
M. Hoekstra1, M. Vogelzang2, I. C. C. van der Horst2, F. Zijlstra2, M. W. N. Nijsten3
1University Medical Center Groningen, Department of Cardiology and Anesthesiology,
Groningen, Netherlands, 2University Medical Center Groningen, Department of Cardiology,
Groningen, Netherlands, 3University Medical Center Groningen, Department of Intensive
Care, Groningen, Netherlands
INTRODUCTION. Insulin administration is associated with the risk of iatrogenic hypo-
glycaemia. To improve patient safety and optimize glucose control (GC) we implemented a
nurse-driven computerized glucose regulation program in our intensive care unit (ICU) [1].
OBJECTIVES. To evaluate the safety and efficiency of computerized GC after being part of
routine workflow for over 4 years.
METHODS. In this observational cohort study we collected data of consecutive patients
admitted in our mixed ICU (45 beds) of a university teaching hospital. All patients were
glucose regulated with a computer-assisted glucose regulation protocol called Glucose
Regulation for Intensive care Patients (GRIP). Effectiveness was determined in terms of
achieved glucose control and incidence of hypoglycaemia, which we compared with other
published computerized glucose regulation programs.
RESULTS. We analyzed 162,884 BG samples of 5,898 consecutive ICU patients (55%
surgical). Mean ± SD age was 60 ± 16 and 3,771 patients (64%) were male. Of all mea-
surements, 0.5% were below 3.5 mmol/L (mild hypoglycaemia) and 0.05% below 2.2 mmol/
L (severe hypoglycaemia). 58 patients (1.0%) experienced at least one episode of severe
hypoglycaemia during their entire length of stay at the ICU. Of the severe hypoglycaemic
episodes, 55% was iatrogenic. The remaining episodes occurred after withdrawal of medical
treatment or severe hypoglycaemia was a reason of ICU admission. Mortality was 8.3% (ICU)
and 11.5% (hospital). Glucose control with the computer-assisted GRIP program was efficient
with glucose values within the predefined target range (4.0–7.5 mmol/L) in 75% of the time.
The mean number of blood glucose measurements was 5.6 per patient per day.
CONCLUSION. In a large cohort covering all sorts of ICU patients, glucose control was
efficient with a low number of hypoglycaemic episodes. In comparison with other published
computerized protocols, this was achieved with considerably less blood glucose
measurements.
REFERENCE. 1. Vogelzang M, Loef BG, Regtien JG (2008) Computer-assisted glucose
control in critically ill patients. Intensive Care Med 34:1421–1427.
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THE PROGNOSTIC VALUE OF ADMISSION BLOOD GLUCOSE LEVELS
H. M. Soliman1, J. L. Vincent1
1Universite´ Libre de Bruxelles, Erasme Hospital, Department of Intensive Care, Brussels,
Belgium
INTRODUCTION. Admission blood glucose levels are known to have a prognostic value in
ICU patients. We wondered whether the addition of blood glucose to severity indexes may
increase their prognostic value.
OBJECTIVE. To study the relation between admission blood glucose levels and morbidity
and mortality in critically ill patients.
METHODS. We reviewed all 420 adult patients (stayed [1 day) consecutively admitted to
our 35 bed medico surgical Intensive Care Department over a 3-month period. After exclusion
of four patients who had severe hypoglycemia (less than 60 mg/dl), admission blood glucose
levels were classified in four groups: Group A, less than 110 mg/dl. Group B, between 110
and 149 mg/dl. Group C, between 150 and 180 mg/dl. Group D, greater than180 mg/dl.
RESULTS. Patients in group B had lower APACHE II, admission and Maximum SOFA
scores than group D (P \ 0.01). They also had a shorter length of stay (LOS) than group D
(P \ 0.05). Mortality rate was lower in group B than C and D [Table 1 (mean ± SD)].
Compared to group B, risk of mortality increased to four times in group C and D [OR 3.96 (CI
95% 1.71–9.20) and OR 4.17 (CI 95% 1.87–9.29), both p \ 0.01]. A receiver-operating
characteristic (ROC) curve to predict mortality showed that increasing admission blood
glucose levels were associated with increasing mortality (AUC 0.64, CI 95% 0.56–0.72, P\
0.01) but the AUC was smaller than for APACHE II (AUC 0.84, CI 95% 0.79–0.89, P \
0.001), admission SOFA (AUC 0.83, CI 95% 0.78–0.89, P \ 0.001) and maximum SOFA
(AUC 0.88, CI 95% 0.83–0.93, P\0.001) scores. Adding admission glucose levels to either
APACHE II or admission SOFA scores AUC models did not add any significant information
to their predictive values on mortality (AUC 0.85, CI 95% 0.80–0.90 and AUC 0.85, CI 95%





















Age (years) 57 ± 20* 58 ± 18* 61 ± 17 64 ± 15
Sex, M/F (n) 35/22 96/50 61/31 66/55
Medical/surgical (n) 25/32 65/81 36/56 53/68
APACHEII score 10.7 ± 7.5 9.8 ± 5.3** 12.0 ± 6.1 13.2 ± 6.0
Admission SOFA score 3.9 ± 4.1 3.6 ± 2.5** 4.3 ± 2.7 5.1 ± 3.1
Maximum SOFA score 4.5 ± 4.1* 4.3 ± 3.1** 5.2 ± 3.5 6.1 ± 4.1
LOS (days) 3.4 ± 6.1 3.1 ± 4.0* 3.3 ± 5.7 5.4 ± 9.2
Mortality,n (%) 7/57 (12) 9/146(6)** 19/92 (21) 26/121(21)
* p \ 0.05, **p \ 0.01 versus group D. p \ 0.01 versus group C
CONCLUSION. Admission blood glucose levels between 110 and 149 mg/dl is associated
with better outcome, less morbidity severity scores, and shorter length of stay. Adding blood
glucose values to severity scores do not add to their predictive value.
S120 22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009
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TIGHT GLYCEMIC CONTROL: A SYSTEMATIC REVIEW ON THE REASON
FOR SUCCESS OR FAILURE
P. Marik1, P. Wiesen2, J.-C. Preiser2
1Thomas Jefferson University, Philadelphia, USA, 2University Hospital of Liege, Liege,
Belgium
INTRODUCTION. Following publication of the ‘‘Leuven Intensive Insulin Therapy Trial’’
[1] in 2001, tight glycemic control became the standard of care in ICU’s. The recent NICE-
SUGAR [2] study and others suggest that this approach may be flawed.
OBJECTIVES. The goal of this systematic review was to determine the benefits and risks of
tight glycemic control in ICU patients and to explain the differences in outcomes between
reported trials.
METHODS. Prospective, randomized, controlled clinical trials (RCT’s) that studied the
impact of tight glycemic control (blood glucose 80–110 mg/dl) on mortality in ICU patients
were searched in MEDLINE, Embase, the Cochrane Database of Systematic Reviews and
citation review of relevant primary and review articles. Data were abstracted on study design,
study size, patient characteristics as well as mean blood glucose level, mean daily dose of
insulin administered, average daily caloric intake, use of parenteral nutrition, incidence of
hypoglycemia, need for dialysis and 28 day/hospital mortality. Meta-analytic techniques were
used to analyze the data; meta-regression was used to explain difference in the treatment
effect.
RESULTS. We identified 7 RCT’s studies that included 11,425 patients. Overall, tight
glycemic control did not reduce the 28 day mortality (OR 0.95; 95% CI 0.87–1.05), the
incidence of blood stream infections (OR 1.04; 95% CI 0.93–1.17) nor the requirement for
renal replacement therapy (OR 1.01; 95% CI 0.89–1.13). The incidence of hypoglycemia was
significantly higher in patients randomized to tight glycemic control (OR 7.7; 95% CI 6.0–9.9,
p \ 0.001). Meta-regression demonstrated a significant relationship between the treatment
effect (28 day mortality) and the proportion of calories provided parenterally (p = 0.005).
The difference in outcome between the two ‘‘Leuven Intensive Insulin Therapy Trials’’ and
the subsequent trials could be related to the use of parenteral nutrition.
CONCLUSIONS. There is no evidence to support the use of intensive insulin therapy in
general medical-surgical ICU patients who are fed mostly enterally. Tight glycemic control is
associated with a high incidence of hypoglycemia with an increased risk of death.
REFERENCES. 1. N Engl J Med 2001;345:1359.
2. N Engl J Med 2009;360:1346.
GRANT ACKNOWLEDGEMENT. None.
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ACCURACY OF CONTINUOUS GLUCOSE MEASUREMENTS DURING HYPOX-
EMIA IN CRITICALLY ILL PATIENTS
P. Singer1, I. Kagan1, I. Ben David1, M. Grunev1, J. Singer2, A. Kononenko3, E. Gabis3,
A. Weinstein3, J. D. Cohen1
1Rabin Medical Center, Beilinson Hospital and Sackler School of Medicine, Tel Avi Uni-
versity, General Intensive Care Department, Petach Tiqva, Israel, 2Rabin Medical Center,
Beilinson Hospital, Endocrinology Institute, Diabetes Services, Petach Tiqva, Israel, 3Orsense
Ltd, Nes Ziona, Israel
INTRODUCTION. Control of hyperglycemia is proposed in the critically ill patient for
decreasing morbidity and mortality. However, concerns about hypoglycemia mainly in the
most severely ill patients have been raised. A new device utilizing an enhanced optical signal
resulting from a temporary over-systolic occlusion produced by a finger-based pneumatic has
become available. This study assessed for the first time the accuracy of this non-invasive
continuous glucose monitoring in hypoxemic severely ill patients.
MATERIAL AND METHODS. A NBM-200 device (Orsense Ltd) was placed at the base of
a finger in 9 patients (aged 27–74 years) with SpO2 below 90%. Red/near infrared occlusion
spectroscopy detected blood glucose. NBM measured continuously glucose for 2–10 h with
reading every 15 min. These results were compared to blood gas machine (ABL 700,
Radiometer, Copenhagen, Denmark). A prospective analysis based on an uniform model with
personal paramagnetic adjustments was performed for 180 readings. A Clarke Error Grid
analysis was performed.
RESULTS. Calibration phase lasted 2 h. No adverse effect was identified. SpO2 varied from
90 to 60% The blood glucose ranged from 48 to 234 mg/dL. The resulting Median Relative
Absolute Error was 10.8 mg/dL, and the Median Absolute Error was 9.1%. The Clarke error
grid analysis showed that 93.3% of the measurements fell within zones A (73.9%) and B
(19.4%). The overall accuracy during hypoxemia was similar to nonhypoxemic periods.
These results require larger studies.
CONCLUSION. NBM-200 seems to be a continual, accurate, safe and easy to use blood
glucose evaluation in hypoxemic patients. This noninvasive method could improve the safety
of patient care, and is promising in trend analysis and detection of hypoglycemia in the most
at risk patients.
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GLUCOSE CONTROL IN RESPIRATORY ICU
A. Samokhvalov1, N. Makhoul1
1Western Galilee Hospital, Respiratory Intensive Care Unit, Nahariya, Israel
INTRODUCTION. Hyperglycemia is common among patients admitted to ICU. It is known
that tight glucose control by insulin infusion may reduce mortality in this population but the
optimal target for blood glucose range is unclear. Our objective was to assess the effec-
tiveness of intensive insulin therapy among critically ill respiratory patients in achievement
glucose control.
METHODS. Within 24 h after admission to the respiratory intensive care unit, patients were
treated by insulin infusion for target glucose at 110–140 mg/dl. Patients treated less than 48 h
were excluded. Patients with mean glucose [140 mg/dl throughout insulin therapy were
classified as glycemic control failure (GCF). Mortality rate was compared among patients
with/without GCF. To determine the impact of GCF on mortality, ICU survivors and non-
survivors were compared using univariate analysis.
RESULTS. Total 89 patients were enrolled including 44 patients with COPD/Asthma
exacerbation and/or Pneumonia, which were on mechanical ventilation C3 days and received
predominantly enteral nutrition. Most of them were treated with corticosteroids. The main
blood glucose was 138 mg/dl under insulin treatment. The glucose control failed in 22
patients (50%). Patients with/without GCF had similar characteristic at baseline. ICU mor-
tality rate was 38.6% (17 patients). Hypoglycemia (23 episodes) was recorded in 14 patients
(32%). All hypoglycemic episodes were resolved without significant adverse events. The
mean number of glucose measurements was 8 per patient per day. The GCF group showed a
tendency to higher mortality, but statistically it was not significant. Time to reach target
glucose was longer in this group. Comparison between ICU survivors and non-survivors
revealed that length of ICU stay, hypoglycemia rate, daily insulin dose and time for reaching
target glucose had negative influence on mortality rate.
CONCLUSION. The glucose target achievement is difficult among critically ill respiratory
patients despite intensive insulin therapy and above-normal target range. GCF has a tendency
to higher mortality rate. To improve glucose control we should reduce the time for reaching
target glucose and apply more accurate insulin dose adjustment to avoid hypoglycemia.
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THE IMPACT OF MEMBRANE LENGTH AND DIALYSIS PUMP VELOCITY ON
ACCURACY DURING INTRAVENOUS MICRODIALYSIS
P. Mattsson1, O. Rooyackers1, J. Wernerman1
1Karolinska University Hospital Hudinge, Stockholm, Sweden
BACKGROUND AND AIM. To achieve blood-sugar control, accurate on-line real-time
measurements are desired. We have investigated the feasibility of intravenous microdialysis
for this purpose. In earlier studies we have demonstrated that the intravascular membrane has
an unaltered function for 3–5 days in critically ill subjects, but also that a minimum diameter
of the vein with the membrane is needed. Here we elucidated the length of the membrane and
the velocity of the microdialysis fluid pump in order to optimise the accuracy of measure-
ments using healthy volunteers with blood-sugars in the normal range.
METHODS. In study I, 30 healthy volunteers were randomised to receive membranes of 10
or 20 mm length or to be controls. Plasma glucose concentration was used as standard. A
study period of 60 min was used after a 60 min run-in period.
In study II, 15 healthy volunteers were studied using a 30 mm membrane, but with a
microdialysis fluid pump velocity of 0.5, 1.0 or 2.0 lL/min in random order. Study periods of
60 min were used with run-in and wash-out periods of 60 min in between. Microdialysis
samples were collected over six 10 min periods and plasma samples taken every tenth minute
for comparison. Differences (delta) between microdialysis and plasma were calculated and
median values for every sampling period (60 min) were compared using ANOVA.
RESULTS. The results are given as medians (quartiles) of the differences between plasma
glucose concentration and microdialysis glucose concentration for the 60 min study periods,
including six plasma values and six collection periods. In study I, the percentage differences
were 22% (20–45), 7% (5–21), and 2% (0–4) for the 10, 20 mm and plasma controls,
respectively. Comparisons showed that 20 mm and controls were different from 10 mm
(P \ 0.0005, Kruskal-Wallis). In study II the percentage differences were 5%(3–10), 23%(7–
38) and 45%(10–58) for 0.5, 1.0 and 2.0 uL/min, respectively. Comparisons showed that
0.5 lL/min was different from 1.0 and 2.0 lL/min (P \ 0.00001, Friedman).
CONCLUSION. It is concluded that in intravenous microdialysis a comparatively long
membrane and a low velocity of the microdialysis fluid pump resulted in better concordance
to plasma glucose concentrations.
22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009 S121
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SUBCUTANEOUS INSULIN THERAPY REDUCES BLOOD GLUCOSE VARIABIL-
ITY IN THE CRITICALLY ILL PATIENT WITH ORAL INTAKE
P. Zeidler1, B. Steinlechner1, H. Koinig1, M. J. Hiesmayr1
1Medical University of Vienna, General Hospital, Division of Cardiothoracic and Vascular
Anaesthesia and Intensive Care, Vienna, Austria
INTRODUCTION. High glycemic variability is an independent predictor of mortality in the
critically ill [1]. Glycemic control decreases with transition from continuous parenteral or
enteral nutrition to oral intake in patients on continuous insulin therapy. Insulin therapy may
need to be modified with the onset of oral nutrition.
The objective of this study was to determine whether continuous intravenous insulin therapy,
the current standard in ICU or intermitted subcutaneous insulin therapy allows a better gly-
cemic control in ICU patients after initiation of oral intake.
METHODS. In this prospective, randomised study we included 30 ICU patients after initi-
ation of oral intake, who had undergone elective cardiac surgery. 14 patients were administered
IV insulin with an infusion pump and 16 patients SC insulin with a PEN. Blood glucose
concentration was measured every 4 h and in addition before, 1 and 2 h after each meal.
The coefficient of variability (COV) [2], variability index (VI) [3], glycemic lability index
(GLI) [4] and mean amplitude of glycemic excursions (MAGE) [4] were calculated to
compare blood glucose variability between the groups.
RESULTS. Patients administered SC insulin had less variability of glucose concentrations in
all calculations (p \ 0.05)
Expressions of glucose variability
CONCLUSION. Oral intake of the critically ill should be combined with SC insulin therapy.
REFERENCE(S). 1. Krinsley JS (2008) Crit Care Med.
2. Egi M (2006) Anesthesiology.
3. Wintergerst KA (2006) Pediatrics.
4. Ali NA (2008) Crit Care Med
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CHANGE OF STANDARD INFUSION FLUID FROM GLUCOSE INTO GLUCOSE/
SALINE INCREASES HYPERNATREMIA WITHOUT IMPROVING GLUCOSE
CONTROL
C. W. Spruijt1, M. Hoekstra2, M. W. Nijsten1
1University Medical Center Groningen, Critical Care, Groningen, Netherlands, 2University
Medical Center Groningen, Anesthesiology, Cardiology, Groningen, Netherlands
INTRODUCTION. Both hypernatremia [1] and hyperglycemia are associated with increased
mortality. In order to improve glucose regulation by reducing glucose load, we changed the
basic infusion of glucose 5% into glucose 2.5%/saline 0.45%.
OBJECTIVE. Evaluate the effect of a protocol-change that was specifically intended to
improve glucose control.
METHODS. In a 14-bed thoracic ICU, we prospectively analyzed two consecutive patient
groups. All patients were managed with the glucose regulation for intensive care patients (GRIP)-
computer system. Over the whole study period, GRIP aimed at the same glucose-target range of
4.0–7.5 mmol/L. The basic infusion in all patients consisted of 1,000 ml/day of isotonic glucose
5% (G-group) or 1,000 ml/day of isotonic glucose 2.5% with sodium chloride 0.45% (GS-group).
This is equivalent to a net change in the daily administration of 25 g of glucose (100 kCal) into
4.5 g of NaCl. All additional infusions were either colloids of crystalloids that did not contain
glucose, and were not changed. Blood glucose and sodium levels were recorded daily for up to the
first 14 ICU-days. The incidence of mild hypernatremia (sodium[150 mmol/L) and pronounced
hypernatremia (sodium/155 mmol/L) during the first 14 ICU days was also recorded.
RESULTS. The G-group consisted of 751 patients (25%) and the GS-group consisted of 2296
patients (75%). The overall impact on glucose control was limited. Initial mean glucose was
8.4 ± 1.6 mmol/L in the G-group and 8.2 ± 1.8 mmol/L in the G/S-group. Glucose levels on the
first day post-surgery were 6.8 ± 0.9 and 6.9 ± 1.0, respectively. Also in the subsequent days
glucose was not improved with in the G/S-group. The impact of the change in standard infusion on
mean sodium levels during the first days was also limited: Initial sodium levels were 139 ± 3 and
139 ± 4 mmol, respectively. On the first day post-surgery these levels were 138 ± 3 and
139 ± 3 mmol/L for the G-group and GS-group. Later on this difference did not increase.
However, the incidence of mild hypernatremia was significantly lower in the G-group
compared to the G/S group: 0.9 versus 1.9%; as was the incidence of pronounced hyper-
natremia 0.1 versus 0.6% (P = 0.003).
CONCLUSIONS. In the context of computer-guided glucose regulation substituting a
modest amount of intravenous glucose with NaCl had no benefit on glucose regulation and
hardly affected overall sodium levels.
However, the incidence of mild and severe hypernatremia sharply increased. Since both
hypernatremia and hyperglycemia are probably undesirable, future studies should evaluate
the feasibility of integrating adjustment of infusion fluids with glucose control in order to
improve both sodium and glucose homeostasis.
REFERENCES. 1. Stelfox HT et al (2008) The epidemiology of intensive care unit
acquired hyponatremia and hypernatremia in medical-surgical intensive care units. Crit Care
12:R162.
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AVOIDING GLUCOSE DYSREGULATION BY COMPUTERIZED GLYCEMIC
CONTROL DURING RAPIDLY INCREASED PARENTERAL NUTRITION IN
CRITICALLY ILL PATIENTS
M. A. Schoorl1, M. Hoekstra2, I. C. C. van der Horst3, F. Zijlstra3, M. W. N. Nijsten1
1University Medical Center Groningen, Critical Care, Groningen, Netherlands, 2University
Medical Center Groningen, Cardiology, Anesthesiology, Groningen, Netherlands, 3University
Medical Center Groningen, Cardiology, Groningen, Netherlands
INTRODUCTION. Early delivery of calories is important in critically ill patients. In many
patients it may take several days to achieve adequate enteral caloric intake, some patients even
cannotbeenterally fed forprolongedperiods.Whenoptimalcaloricdelivery isdesiredunder such
circumstances, parenteral nutrition (PN) is required. A disadvantage of PN is that it increases
glucose levels and thus may interfere with glycemic control, an accepted goal in critical care.
OBJECTIVES. We hypothesized that initiation of PN using a rapid step-up approach,
coupled with computerized insulin dosing, will result in a desirable caloric intake within 24 h
without creating unacceptable glucose levels.
METHODS. In our ICU we have been using a computerized nurse-centered glucose regu-
lation program (GRIP) for the past 5 years [1]. GRIP was programmed to aim at glucose
levels between 4.0 and 7.5 mmol/L. The desired full TPN goal was divided in six steps, to be
taken every 4 h. TPN was thus increased with steps of 0.16 kCal/kg per hour (equivalent to
10 ml/h). In the meantime GRIP could adjust the continuous insulin infusion rate when
appropriate. In case glucose levels became C10 mmol/L, TPN was not increased until GRIP
had regulated glucose levels\10 mmol/L. Both insulin and TPN were administered by nurses
according to GRIP and the step-up protocol. Physicians were only consulted when extreme
glucose levels (\4 or[15 mmol/L) developed. We analysed all glucose-related data over the
first 24 h for 23 consecutive patients who were started on TPN in our ICU.
RESULTS. 23 consecutive patients aged 51 ± 19 years with an mean APACHE-II admis-
sion score of 18 ± 5 were studied. Within 24 h mean caloric intake was 1 kCal/kg per hour
(Fig. 1). During the 552 h patient observation period, 132 glucose samples with a mean
glucose level of 7.4 ± 1.4 mmol/L were taken. There were no glucose levels outside the 4–
15 mmol/L range. Only six samples (5%) had a glucose level C10 mmol/L. Mean insulin
infusion rate was more than doubled by GRIP from 1.1 ± 1.5 to 2.9 ± 2.5 U/h.
CONCLUSION. This proof of concept study shows that a nurse-centered rapid initiation of TPN
using a step-up approach and simultaneous computerized insulin therapy resulted in adequate
caloric intake within 24 h without inducing hyperglycaemia or hypoglycemia (Table 1)
TABLE 1 PATIENT CHARACTERISTICS
Patients N; mean ± SD; (range)
Males/females 18/5
Age (years) 51 ± 18.6
Apache II 17.9 ± 5.3
Diabetes 1 (4%)
Receiving steroids 7 (30%)
Mechanical ventilation 17 (74%)
Body Mass Index 25 ± 6
Hopital mortality 4 (17)
Insulin requirements (U/day) 46 ± 37 (0–159)
REFERENCE(S). 1. Vogelzang M, Loef BG, Regtien JG et al (2008) Computer-assisted
glucose control in critically ill patients. Intensive Care Med 34:1421–1427.
GRANT ACKNOWLEDGEMENT. None.
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HYPERGLYCEMIA DURING HEPATIC RESECTION WITH PRINGLE MANEU-
VER: CONTINUOUS MONITORING OF BLOOD GLUCOSE CONCENTRATION
H. Maeda1, T. Okabayashi1, I. Nishimori2, T. Kohsaki2, T. Sugimoto1, M. Kobayashi1,
K. Hanazaki1, K. Yamashita3
1Kochi Medical School, Department of Surgery, Nankoku, Japan, 2Kochi Medical School,
Department of Gastroenterology and Hepatology, Nankoku, Japan, 3Kochi Medical School,
Department of Anesthesiology and Critical Care Medicine, Nankoku, Japan
INTRODUCTION. Hepatocytes contribute to blood glucose homeostasis under physiolog-
ical conditions by storing or releasing glucose [1]. Therefore, hepatic surgery is often
associated with deterioration of glucose homeostasis. However, the trends of blood glucose
concentrations during hepatic resection have not been clearly defined.
OBJECTIVE. We previously demonstrated the postoperative hyperglycemia after hepatic
resection (Okabayashi et al. 20th ESICM). This is the further study of continuous monitor of
the blood glucose concentrations during hepatic resection involving Pringle maneuver.
METHOD. 30 patients undergoing hepatic surgery in our institute were enrolled. The ethics
committee of our institution approved all study protocols, and informed consent was obtained.
Blood glucose concentration during hepatic resection was continuously measured by an
artificial endocrine pancreas system, STG-22. Values are expressed as mean ± standard error.
Statistical analysis of blood glucose concentration was performed by paired t tests and non-
repeated ANOVA. The relationship between changes in glucose concentration and clinical
parameters was analyzed using the Mann–Whitney U test or correlation. A value of P \ 0.05
was considered significant.
RESULT. Glucose concentrations followed a similar up-and-down pattern in all patients
during surgery. From baseline levels at the start of surgery (102.4 ± 14.4 mg/dl), glucose
concentrations gradually and significantly increased until the start of liver resection
(140.3 ± 23.8 mg/dl) (P \ 0.01, paired t test). The glucose levels decrease during clamping
of the hepatoduodenal ligament and immediately and profoundly increased after unclamping.
This trend of decrease and increase was repeated with the second round of clamping and
unclamping, and so on. After the last Pringle maneuver, glucose concentrations gradually
declined in 27 cases and increased in 3 cases. Patients with pathologically confirmed liver
cirrhosis showed smaller elevations in glucose concentration after the first unclamping
compared to patients without liver cirrhosis (P \ 0.05). However, there was no statistically
significant relationship between glucose elevation after the first unclamping and a panel of
other clinical parameters reflecting hepatic function, diabetes status, and surgery.
CONCLUSION. The present study revealed, for the first time, a rapid and profound tran-
sition in glucose concentration during hepatic resection. This rapid increase in blood glucose
concentration might involve glycogen breakdown due to hypoxia from the ligament clamping
[2], although further study is necessary to reveal the underlying mechanism.
REFERENCES. 1. Klover PJ, Mooney RA (2004) Hepatocytes: critical for glucose
homeostasis. Int J Biochem Cell Biol 36:753–758. 2. Vandebroeck A, Uyttenhove K, Bollen
M, Stalmans W (1988) The hepatic glycogenolysis induced by reversible ischaemia or KCN is
exclusively catalysed by phosphorylase a. Biochem J 256:685–688.
TPN and insulin dose during study period
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COMBINATION OF CONTINUOUS GLYCAEMIA MONITORING WITH COM-
PUTERIZED MODEL PREDICTIVE ALGORITHM WITH VARIABLE SAMPLING
INTERVAL (EMPC) FOR THE INTENSIVE INSULIN THERAPY IN CARDIAC
SURGERY PATIENTS
P. Kopecky1, M. Mraz2, J. Blaha1, J. Kremen2, M. Stritesky1, M. Haluzik2
1Charles University in Prague, General Faculty Hospital, Anaesthesiology, Resuscitation and
Intensive Care Medicine, Prague, Czech Republic, 2Charles University in Prague, General
Faculty Hospital, 3rd Department of Internal Medicine, Prague, Czech Republic
INTRODUCTION. Increased blood glucose levels are frequently observed in patients
undergoing cardiac surgery procedures, with or without diabetes. Glycaemia control is one of
the factors decreasing mortality, length of hospitalization and number of complications as it
has been shown in previously published studies. Many protocols have been developed to
implement glycaemic control. The aim of this study was to assess the effectivity of the system
which is combination of continuous glycaemia monitoring (CGM) with computerized model
predictive algorithm with variable sampling interval (eMPC) in the postoperative period in
cardiac surgery patients.
METHOD. Twenty patients undergoing elective cardiac surgery were enrolled into the study.
10 patients were randomized into the group eMPC-CGM, 10 patients into the standard group. In
the eMPC-CGM group the eMPC algorithm was managed by the glycaemia obtained every
15 min from continual glycaemia system (Guardian RT CGMS). The accuracy of CGM was
under consideration every 1 h through the use of referential arterial blood glycaemia and Clark
Error-Grid Analysis (C-EGA). In the case of clinically non-acceptable values the referential
glycaemia was used as input information for eMPC and simultaneously for recalibration of
CGMS. Control group (n = 10) was treated by the routine paper insulin protocol used in
postoperative ICU. Duration of the study was 24 h. Continuous insulin infusion was adminis-
trated to maintain glycaemia in a target range of 4.4–6.1 mmol/l. Statistical analysis—the
patients from different groups were compared using ANOVA followed by Holm–Sidak test,
Student t test or Mann–Whitney U test as appropriate. The significance level was set at p = 0.05.
RESULTS. Total amount of paired glycaemic values was 231. 227 values (97%) were found in
the clinically acceptable zone C-EGA and only 7 values (3%) were found in the clinically non-
acceptable zone D. Only two patients required more than one additional recalibration by the
referential glycaemia. Mean blood glucose was significantly lower in the eMPC-CGM group
versus control group (6.1 ± 0.1 vs. 6.6 ± 0.1 mmol/l, p \ 0.05) and also percentage of time
above the target range was shorter in the eMPC-CGM group versus control group (37.2 ± 2.6
vs. 52.8 ± 5.6%, p \ 0.05). Percentage of time in the target range was significantly higher in
eMPC-CGM group versus control group (49.6 ± 5.9 vs. 41.9 ± 2.6%, p \ 0.05). No severe
hypoglycaemia (defined as a blood glucose level of 2.9 mmol/l or less) in the eMPC-CGM
group occurred during the study compared to five episodes in the control group.
CONCLUSION. In our study, the eMPC-CGM combination demonstrated sufficient accu-
racy and reliability for the future testing in a larger group of patients. Above mentioned
combination could be a promising step to develop fully automated closed system for the
continuous insulin infusion.
GRANT ACKNOWLEDGEMENT. This study was supported by grant of Charles Uni-
versity in Prague—GAUK 44407.
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EFFECT OF TIGHT GLUCOSE CONTROL ON HYPERLACTATEMIA AFTER
CARDIAC SURGERY
M. Tani1, Y. Kusume1, H. Irie2, M. Kosaka3, S. Hatakenaka1
1Chikamori Hospital, Department of Anesthesiology, Kochi, Japan, 2Chikamori Hospital,
Department of Cardiovascular Surgery, Kochi, Japan, 3Syowa University Northern Yoko-
hama Hospital, Department of Anesthesiology, Kanagawa, Japan
INTRODUCTION AND OBJECTIVES. Hyperlactatemia after cardiac surgery is associ-
ated with high mortality and hyperglycemia is a risk factor. Tight glucose control (TGC) with
continuous insulin infusion has been performed after cardiac surgery to improve mortality and
morbidity. The aim of this study is to determine the effect of TGC on hyperlactatemia and
outcome.
METHODS. By retrospective chart review, we evaluated 157 nondiabetic adult patients
undergoing elective valvular surgeries with cardiopulmonary bypass (CPB). The each blood
glucose level was maintained within a target range below: 80–130 mg/dl in TGC group and
100–200 mg/dl in conventional glucose control (CGC) group. We collected the data on
perioperative clinical variables including patient demographics, duration of CPB, time to
extubation, length of ICU stay and hospital stay. In addition, we recorded postoperative
laboratory data of arterial blood gas analysis, serum glucose and serum lactate. We compared
postoperative changes in glucose and lactate and postoperative outcome between the two
groups. The groups were compared by t test, v2test, or Mann–Whitney U test, as appropriate.
And change of glucose and lactate over time were assessed by calculating area under the
variable-time curve. Data were expressed as mean ± SD or proportions. P \ 0.05 was
considered significant.
RESULTS. Postoperative glucose levels (Graph 1, P \ 0.01) and lactate levels (Graph 2,
P \ 0.01) were significantly lower in TGC group. Length of ICU stay was shorter in TGC
group (P \ 0.05), however, duration of postoperative ventilation and length of postoperative
ward stay were similar in both group.
CONCLUSIONS. TGC using continuous insulin infusion was related to lower lactate levels.
The length of ICU stay was shorter in TGC group
Glucose level in TGC group and CGC group
Lactate level in TGC group and CGC group
REFERENCES. 1. Maillet J-M et al (2003) Chest 123:1361–1366
GRANT ACKNOWLEDGEMENT. This work was not supported by any organizations.
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HIGH FREQUENCY OSCILLATION AND TRACHEAL GAS INSUFFLATION
VERSUS STANDARD HIGH FREQUENCY OSCILLATION: COMPARISON OF
GAS EXCHANGE AT TWO LEVELS OF TRACHEAL PRESSURE
S. Kokkoris1, S. Malachias1, M. Theodoridi2, A. Papaioannou2, E. Kostopoulos2, S. Zakyn-
thinos1, S. Mentzelopoulos1
1University of Athens, Department of Intensive Care Medicine, Athens, Greece, 2Evagge-
lismos Hospital, Department of Anesthesiology, Athens, Greece
INTRODUCTION. In acute respiratory distress syndrome (ARDS), combined high-fre-
quency oscillation (HFO) and tracheal gas insufflation (TGI) may improve oxygenation
through a TGI-induced increase in tracheal pressure. We compared standard HFO and HFO–
TGI matched for tracheal pressure. To further elucidate the mechanism of TGI action, we also
compared HFO and HFO–TGI matched for mean esophageal pressure (Pes), used as lung
volume indicator.
METHODS. In our 37-bed, university intensive care unit, we conducted a prospective,
randomized, crossover, main and complementary study. In the main study, we enrolled 22
patients with early acute lung injury or ARDS. In the complementary study, we enrolled
another 10 patients fulfilling main study’s enrolment criteria.
INTERVENTIONS OF MAIN STUDY: On day 1, patients were ventilated with HFO, without
(60 min) and combined with TGI (60 min) in random order. HFO/HFO–TGI sessions were
repeated in inverse order within 7 h. HFO/HFO–TGI mean tracheal pressure was equal to or 3 cm
H2O higher than preceding conventional mechanical ventilation (CMV) tracheal pressure. On
day 2, the protocol was repeated at the alternative tracheal pressure level relative to Day 1.
INTERVENTIONS OF COMPLEMENTARY STUDY: Two sets of HFO/HFO-TGI ses-
sions separated by 7 h of CMV were performed, initially in random and then in inverse order.
HFO/HFO–TGI were matched for preceding CMV mean Pes.
RESULTS. Gas-exchange and hemodynamics were determined before, during, and after
HFO-sessions.
MAIN STUDY: At both tracheal pressure levels, HFO-TGI versus HFO improved average
PaO2/inspired O2 fraction (FiO2) by 42–58% (P \ 0.001), and average PaCO2 by 13–16%
(P = 0.037–0.09). Preliminary Pes measurements suggested that TGI increased lung volume.
COMPLEMENTARY STUDY: At equal mean Pes, HFO–TGI versus HFO resulted in 15%
higher average PaO2/FiO2 (P = 0.67). In both studies, hemodynamics and CMV respiratory
mechanics remained unchanged.
CONCLUSIONS. At the same tracheal pressure level, HFO–TGI results in superior gas
exchange compared to HFO. This is mainly due to a TGI-induced increase in lung volume.
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HFOV USED AS A RESCUE STRATEGY FOR CO2 CLEARANCE AFTER FAILURE
OF CONVENTIONAL VENTILATION IN PATIENTS WITH VARIOUS CLINICAL
ENTITIES DUE TO ACUTE RESPIRATORY FAILURE
J. Krassler1, A. Rolle2, G. Ho¨ffken3, D. Koschel3
1Centre of Pulmonary and Critical Care, Department of Thoracic and Vascular Surgery,
Affiliated to the Carl Gustav Carus University of Dresden, Anaesthesiology and Intensive
Care Medicine, Coswig, Germany, 2Centre of Pulmonary and Critical Care, Thoracic and
Vascular Surgery, Department of Thoracic Surgery, Coswig, Germany, 3Centre of Pulmonary
and Critical Care, Thoracic and Vascular Surgery, Department of Pneumology, Coswig,
Germany
INTRODUCTION. High-frequency oscillatory ventilation (HFOV) can provide adequate
gas exchange, sustaining protective lung ventilation by using only very small tidal volumes.
We initiated HFOV in cases of ARF when it was impossible to achieve sufficient CO2
elimination with low tidal volume ventilation.
METHODS. Between 6/07 and 03/09 14 patients (4 females, 10 males), mean age 55 years
(range 26–73), suffering from ARF were treated with HFOV. The reasons for ARF demon-
strated the wide range of pulmonary diseases that can lead to life threatening organ
dysfunction. After performing lung recruitment manoeuvres in all patients, the standard
setting for HFOV were 6 Hz, a PIP 5 cm H2O over the Pmean and the I:E ratio of 40%. The
medial HFOV treatment was 3,9 days (range 1–8 days).Routine measurements of oxygena-
tion were done under conventional ventilation (conv), immediately after beginning HFOV
(HFOV1), after stabilisation of patients (HFOV2\8 h), during HFOV (HFOV3), immediately
before stopping HFOV (HFOV7) and shortly after resuming conventional pressure controlled
ventilation (MV). Statistical analysis was performed using the Mann–Whitney test.
RESULTS. In all cases the failure of CO2 elimination could be stopped and gas exchange was
initially improved.
Figure 1 shows the mean pCO2 values and standard deviation at each measurement point.
*: p = 0.009
After resuming conventional ventilation (MV) there was a significantly lower mean pCO2
(p = 0.009) compared with initial lung protective ventilation (conv) in all patients (9 sur-
vivors, 5 nonsurvivors). Also during HFOV mean pH levels returned to normal, without any
statistically differences between survivors and nonsurvivors.
CONCLUSIONS. HFOV can provide adequate CO2 clearance in some patients with ARF
due to various etiologies. In cases where conventional lung ventilation cannot provide ade-
quate gas exchange, HFOV can improve oxygenation and in these patients HFOV also
achieved sufficient CO2 elimination.
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HIGH-FREQUENCY OSCILLATORY VENTILATION (HFOV) IN ADULTS WITH
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) AS A RESCUE THERAPY
TO CONVENTIONAL MECHANICAL VENTILATION (CMV)
R. Leon-Lopez1, N. M. Mun˜oz Guillen1, J. M. Duen˜as-Jurado1, M. J. Ferrer-Higueras1,
F. Caballero-Gueto1, A. Mula-Gomez2, J. M. Serrano-Simo´n1
1H. U. Reina Sofia, Intensive Care Medicine, Cordoba, Spain, 2Hospital Universitario Reina
Sofı´a, Intensive Care Medicine, Cordoba, Spain
OBJECTIVES. Evaluate the effectiveness and safety of the HFOV in adults with severe
Acute Respiratory Distress Syndrome (ARDS) when fails the conventional mechanical
ventilation (CMV).
METHODS. Observational pilot study. We included 64 patients, [18 years (47 male/17
female), with ARDS (Conference consensus 1994), admitted to ICU from August 2003-
November 2008; when failed CMV, defined by one of the following criteria: FiO2 C 0.70
with a PaO2 B 60, plateau pressure C35 cmH2O or PEEP C10 cmH2O. Baseline APACHE II
score was 24 (19–30) and ARDS Lung Injury Score C2.5. We considered HFOV failure
when: (1) PaO2/FiO2 ratio \50 after 24 h treatment—despite increased Airway Pressure
(Paw) 40 cmH2O and FiO21—or (2) ventilation failed (PaCO2 C 80 mmHg, pH \ 7.20). 32
patients had multiple-organ failure, and 31 required continuous venovenous hemofiltration.
INTERVENTIONS: The HFO Sensormedics 3100B was used. The initial Paw was 2–
3 cmH2O higher than Paw in CMV, defined to maintain SatO2 C 88% or PaO2[55 mmHg. If
SatO2 was C88–90%, then FiO2 was reduced to a FiO2 target B0.60. If SatO2 was B88%,
then Paw was increased by 1–2 cmH2O to maximum Paw of 40 cmH2O. The PaCO2 targeted
range was 35–80 mmHg, with a pH C 7.25. PaCO2 was adjusted increasing DP. If hyper-
capnia persisted despite a DP [ 100 cmH2O, oscillatory frequency was reduced in steps of
0.5 Hz to a lower limit of 3 Hz. After HFOV, we made a recruitment manoeuver (RM):
maintaining 40–45 cmH2O for 40–45 s. Patients requiring a FiO2 B 0.40 and
Paw B 22 cmH2O were weaned to CMV.
STATISTIC: Base-line and outcome variables are expressed in means or medians. Com-
parisons of measured variables over time in individuals was made by a paired t test.
Comparisons between survivors and nonsurvivors were determined by two-tailed Mann–
Whitney U rank sum test. All calculations were performed by SPSS15.0.
MEASUREMENT AND RESULTS. Gasometrical, hemodynamic and oscillator parameters
were monitored during transition from CMV to HFOV and 30 min, 4, 12, 24 and 48 h after
oscillator. During the first 24 h, the Paw was reduced to the one used in CMV. HFOV
increased PaO2/FiO2 ratio, as early as 30 min, and showed a PCO2 decreased with regard to
the basal values during the CMV; as well as in the systemic pressure. 38 patients (59.37%)
were responders to the rescue therapy. Complications observed during HFOV: seven episodes
of Pneumotorax (11.9%) and in four of these cases required removal due to hypotension
(6.8%). 30-day mortality: 40 patients (62.5%) 89% due to multisystemic failure. A signifi-
cantly higher 30-day mortality was observed in patients on CMV C4 days prior to HFOV.
CONCLUSIONS. Our results suggest that HFOV proves to be beneficial in the rescue of
patients with severe ARDS, regarding its safety and effectiveness in gas interchange. Pro-
longed CMV previous to HFOV was associated with higher mortality. Mortality can be
related to the multisystemic failure.
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COMPARISON OF DIFFERENT GAS HUMIDIFICATION DEVICES DURING HFO.
A BENCH STUDY
F. Lellouche1, P.-A. Bouchard2, S. Delisles3
1Universite´ Laval, IUCPQ, Centre de recherche, Service de soins intensifs de chirurgie car-
diaque, Que´bec, Canada, 2Institut Universitaire de Cardiologie et de Pneumologie de Que´bec,
Centre de Recherche, Que´bec, Canada, 3Hoˆpital Sacre´-Coeur, Service de Soins Intensifs,
Montreal, Canada
INTRODUCTION. Few data are available for gas humidification during HFO. Currently,
only active humidification is used for this purpose, considering that additional dead space may
be an issue in this specific situation. Also, the HFO circuitry only allows the use of active
humidification. We assessed the performances of different humidification device during HFO,
including HME and a newly available unclassified system (Hydrate).
METHODS. We measured on bench gas humidity (with psychrometric method) of different
humidification devices (MR 730, MR 850, HC 200, Hydrate, Hygrobac S and Hygrobac)
using previously described methods [1, 2]. The devices were connected to a HFO ventilator
set as per Oscillate study recommendations : Flow 40 L/min, Amplitude 90 cmH2O, Ti 33%,
Mean pressure 30 cmH2O, at two different oscillation frequencies: 4 and 10 Hz. Two dif-
ferent ambient temperature were used: 23 and 29C. Three measurements were performed at
steady state.
RESULTS. Preliminary results are presented on the Fig. 1. Absolute Humidity at 23C of
ambient temperature.
CONCLUSIONS. Both heated humidifiers performed well within the tested conditions.
The small HME tested performed reasonably well. Impact of dead space on alveolar venti-
lation and of HME’s resistive properties remains to be assessed.
REFERENCES. 1. Lellouche F et al (2009) Humidification performance of 48 passive
airway humidifiers: comparison with manufacturer data. Chest 135(2):276–286. 2. Lellouche
L et al (2004) Influence of ambient air and ventilator output temperature on performances of
heated-wire humidifiers. Am J Respir Crit Care Med 170:1073–1079
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BIOLOGICAL MARKERS OF LUNG INJURY BEFORE AND AFTER THE INSTI-
TUTION OF HIGH FREQUENCY PERCUSSIVE VENTILATION IN
SPONTANEOUSLY BREATHING SURGICAL ICU PATIENTS
P. Reper1, K. vanLoey1
1Queen Astrid Hospital, Critical Care Department, Brussels, Belgium
INTRODUCTION. Several biological markers of lung injury are predictors of morbidity and
mortality in patients with acute lung injury (ALI). The low tidal volume lung-protective
ventilation strategy is associated with a significant decrease in plasma biomarker levels
compared to the high tidal volume ventilation strategy. The primary objective of this study
was to test whether the institution of high frequency percussive ventilation in spontaneously
ventilating patients after surgery admitted in the ICU could be responsible for lung injury by
using measurements of biomarkers of lung injury before and after starting HFPV.
METHOD. A prospective observational cohort study was conducted in the intensive care
unit. Fourteen spontaneously breathing patients admitted in the ICU after surgery were
enrolled. Physiologic data and serum samples were collected on admission before starting
HFPV and at two different time points within the first 24 post operative hours after starting
physiotherapy with HFPV to measure the concentration of interleukin (IL)-6, IL-8 and
TNFalpha. The differences in biomarker levels before and after HFPV were analyzed using
repeated measures analysis of variance and a paired t test with correction for multiple
comparisons.
RESULTS. On admission in the ICU after surgery, all of the biological markers (IL-8, IL-6
and TNFalpha) were normal in these spontaneously breathing patients suggesting no signif-
icant postoperative lung injury. After the institution of HFPV with face mask or nose piece,
none of the biological markers was significantly increased at either an early (3 ± 2 h) or later
(20 ± 3.5 h) time point. During the 24-h period with HFPV, the PaO2/FiO2 (partial pressure
of arterial oxygen/fraction of the inspired oxygen) ratio significantly increased without side
effects.
CONCLUSION. Levels of IL-8, IL-6, and TNF are not elevated in spontaneously ventilating
patients receiving HFPV for postoperative physiotherapy. The institution of HFPV does not
increase the levels of biological markers of lung injury. These results suggest that the insti-
tution of HFPV does not worsen the pre-existing lung status in most patients admitted in the
ICU after surgery and could enhance blood oxygenation during this critical period.
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INFLUENCE OF LOW TIDAL VOLUME VENTILATION WITH AND WITHOUT
PERIODIC RECRUITMENT MANOEUVRES ON CYTOKINE AND AMPHIREGU-
LIN RELEASE IN ALI/ARDS PATIENTS
T. Meier1, A. Lange1, H. Papenberg1, C. Stamme1, S. Uhlig2
1University of Lu¨beck, Department of Anaesthesiology, Lu¨beck, Germany, 2RWTH Aachen,
Institute of Pharmacology, Aachen, Germany
INTRODUCTION. Patients suffering from ARDS benefit from low tidal volume ventilation
(LV) [1]. Increase of alveolar pressure can induce pro-inflammatory cytokines which may
lead to the development of ventilator induced lung injury (VILI) [2]. The effect of routinely
performed recruitment manoeuvres (RM) on cytokine and amphiregulin release, a most
recently identified indicator of mechanical alveolar stress [3], is not known.
OBJECTIVE. The aim of the present study was to compare LV ventilation with an open lung
approach (OLA) via periodic RM in ARDS patients in terms of pulmonary and systemic
cytokine and amphiregulin release.
METHODS. After approval of the local ethic committee 11 ALI/ARDS patients were ran-
domized to the LV (n = 6) or the OLA group (n = 5). The ventilator setting was based on the
ARDSnet protocol [1], i.e. pressure control ventilation, VT 6–8 ml/kg/KG. In the OLA group
periodic RM (PEEP 25 cmH2O, inspiratory pressure elevated stepwise to 40, 50, 60 cmH20)
were performed routinely every 8 h, after bronchoalveolar lavage (BAL) and in cases of a
decrease (20%) of oxygenation or an increase (20%) in pCO2. If a therapeutic RM was
performed the PEEP level was increased by 2 cmH2O. During the study (T0, T1, T2, T3;
24 h frequency of measurements; 72 h evaluation period) cytokines (IL-6, IL-8, IP-10) and
amphiregulin were analyzed in BAL fluids and serum samples. A repeated mixed-model-
analysis was performed for statistical purposes with T0 as a covariate.
RESULTS. BAL cytokine concentrations (IL-6, IL-8, IP-10) showed no differences between
the study groups. In contrast, amphiregulin concentrations were elevated in the BAL of the
OLA group (p = 0.007). Serum concentrations of IL-6 (0.0019) and IL-8 (0.006) were sig-
nificantly reduced in OLA patients compared to T0, which was paralleled by a reduction of
the APACHE-II Score.
CONCLUSION. Periodic recruitment manoeuvres increase pulmonary mechanical stress
indicated by higher alveolar amphiregulin concentrations. Patients treated with an OLA
showed a tendency towards reduced systemic inflammatory responses and the severity of
critical illness.
REFERENCES. 1. N Engl J Med (2000) 342:1301–1308.
2. Am J Respir Crit Care Med (1999) 160:109–116. 3. Physiol Genomics (2006) 26:68–75.
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FEASIBILITY OF PROPORTIONAL ASSIST VENTILATION AS ROUTINE VEN-
TILATORY SUPPORT IN INTENSIVE CARE PATIENTS
M. Delgado1, E. Zavala2, R. Toma´s Puig3, R. Fernandez1,4
1Sant Joan de Deu Hospital, Xarxa Althaia, Intesive Care Unit, Manresa, Spain, 2Clinic
Hospital of Barcelona, Intensive Care Unit, Barcelona, Spain, 3General de Catalun˜a Hospital,
Intensive Care Unit, Sant Cugat, Spain, 4CIBERES, Mallorca, Spain
RATIONALE. Proportional Assist Ventilation (PAV) is an assisted ventilatory mode that
applies pressure in proportion to patient inspiratory effort. Caregivers decide gain level in
order to unload work of breathing. High assistance of PAV could be comparable with control
ventilatory modes. However, this mode has not spread as daily mode in routine practise
OBJECTIVE. To asses PAV feasibility as routine ventilatory support in the acute phase of
critically ill patients, where high assistance is needed.
METHODS. Inclusion criteria: patients under assist control ventilation (ACV), hemody-
namically stable and suitable for triggering ventilator. PAV? was initially set at 90% in order
to get the highest assistance. FiO2 and PEEP were managed according to routine practise.
Breathing pattern, respiratory mechanics and blood gas analysis were recorded daily until
weaning or PAV failure, based on attending physician decision.
RESULTS. We screened 110 patients, but only 19 fulfilled the criteria. PAV failed in 7
patients due to hemodynamic instability [1], metabolic acidosis [2], hypercapnia [2], high
respiratory rate [1] and high airway pressure [1]. Failure patients showed worse respiratory
mechanics (see Table 1), mainly Paw, Resistance and WOB.
TABLE 1 MEAN VENTILATORY PARAMETERS DURING ICU STAY
PAV success n = 12 PAV failure n = 7 p
Vt (mL) 528.5 ± 117.3 599.3 ± 15 0.2
RR (min-1) 22 ± 6 23 ± 8 0.6
Vmin (L) 10.3 ± 3 11.7 ± 5 0.4
PEEP (cmH2O) 7.3 ± 2.3 7.2 ± 1.5 0.9
PaO2/FiO2(mmHg) 279.4 ± 100 224.5 ± 46 0.2
pH 7.41 ± 0.04 7.36 ± 0.09 0.1
PaCO2(mmHg) 38 ± 5.7 41 ± 8 0.2
% PAV 79 ± 0.1 83 ± 0.1 0.3
CONCLUSION. PAV was easily performed in 63% of cases, whereas interruption was
associated with clinical events related to basal illness. PAV failure also seems related to worse
mechanical characteristics (Table 2)






Peak Paw (cmH2O) 21.1 ± 5 28 ± 4.6 0.01
ComplianceRS (mL/
cmH2O)
57 ± 22 51 ± 20.2 0.5
Resistanceaw (cmH2O/L/
seg)
6.3 ± 1.7 8.4 ± 2.2 0.001
WOB (J/L) 1.08 ± 0.3 1.6 ± 0.2 0.0004
MV length (days) 10.6 ± 8.4 9.6 ± 4 0.8
PAV length (days) 4.4 ± 3.7 3.6 ± 2.3 0.6
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INTERVENTIONAL LUNG ASSIST CAN ATTENUATE THE INVASIVENESS OF
MECHANICAL VENTILATION IN ARDS
A. Nierhaus1, D. P. Frings1, B. Wittenburg1, H.-J. Baumann2, C. G. Schneider3, S. Kluge1
1University Medical Center Hamburg-Eppendorf, Department of Critical Care, Hamburg,
Germany, 2University Medical Center Hamburg-Eppendorf, Department of Pulmology,
Hamburg, Germany, 3St. Elisabeth Hospital, Department of General Surgery, Neuwied,
Germany
BACKGROUND. To describe the clinical usability of a new pumpless extracorporeal
membrane ventilator (Novalung) in an ICU population with severe respiratory insufficiency.
METHODS. Retrospective report of a mixed cohort of 13 consecutive patients from oper-
ative and medical ICUs at a university hospital with established ARDS. Management
consisted of transcutaneous placement of femoral arteriovenous pumpless extracorporeal lung
assist device (pECLA) to allow lung-protective ventilation by the immediate and sustained
reduction of tidal volume, inspiratory pressure and respiratory frequency.
RESULTS. Mean SAPS II score was 49.5 ± 6.6, ICU mortality was 53% (7/13). Mean
length of ICU stay was 55.7 ± 20.9 days for survivors (S) and 30.1 ± 9.4 days for nonsur-
vivors (NS). Total time on pECLA was 26 ± 16 days (S) and 9 ± 2.1 days (NS), total time
on mechanical ventilation was 42.5 ± 14.5 (S) and 29.9 ± 7.6 days (NS). pECLA was fol-
lowed by a significant increase in oxygenation index from 107 ± 15 to 200 ± 28 mmHg.
Hypercapnia was sharply reduced from 80.9 ± 5.1 (pre pECLA) to 55 ± 4 mmHg (day 1),
while minute volume, respiratory rate and inspiratory pressure could be markedly decreased.
Complications consisted of one minor bleeding event and two inadvertent decannulations.
CONCLUSION. pECLA is an efficient technique with a low complication rate to support gas
exchange in ARDS patients widening the therapeutic options towards prolonged periods of
effective protective ventilation.
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HEMODYNAMIC EFFECTS OF INTERVENTIONAL LUNG ASSIST IN ACUTE
RESPIRATORY DISTRESS AND SEPTIC INFLAMMATORY RESPONSE
SYNDROMES
G. Zick1, G. Elke1, D. Scha¨dler1, S. Pulletz1, I. Frerichs1, J. Scholz1, N. Weiler1
1University Medical Center Schleswig-Holstein, Campus Kiel, Department of Anesthesiology
and Intensive Care Medicine, Kiel, Germany
INTRODUCTION. Therapy with a pumpless arteriovenous membrane oxygenator [inter-
ventional lung assist (ILA)] has been used in the treatment of the acute respiratory distress
syndrome (ARDS) to facilitate a lung protective ventilation strategy. A systemic inflamma-
tory response syndrome (SIRS) may be present as the cause or accompanying the ARDS. The
characteristics of the hemodynamic pathology of SIRS include hyperdynamic circulation and
intravascular volume depletion. The use of ILA creates and requires an arteriovenous shunt
that might cause hemodynamic problems by reducing the afterload. The aim of our study was
to examine the consequences of this shunt on the cardiac function.
METHODS. The study was designed as a prospective experimental study. 6 pigs (43–58 kg
body weight) were anesthetized and mechanically ventilated. ARDS was induced by repeated
bronchoalveolar lavages. Volume substitution was performed with Ringer’s lactate and hy-
doxy-ethyl-starch solutions until pulmonary artery occlusion pressure (PAOP) was above
20 cm H2O. ILA was set up using one 17 Fr venous and two 13 Fr arterial cannulae. Cardiac
output, PAOP, arterial pressure and the echocardiographic parameters of left ventricular end
diastolic area and fractional area contraction were measured (vivid 7 pro, GE Healthcare,
Mu¨nchen, Germany). The hemodynamic changes before and after the opening of the ILA
shunt were examined. A paired, two-tailed t test was performed using GraphPad Prism
(Version 5 for Windows, GraphPad Software, San Diego, USA) and significance was
accepted at P values \0.05. The data is given as mean ± SD.
RESULTS. The ILA shunt of 1.5 (±0.4) L/min altered the studied parameters before and
after opening the ILA, respectively, as follows: cardiac output 11.7 (±2.3) to 11.6 (3.3) L/
min, PAOP 21.2 (±1.5) to 19.2 (4.8) cmH2O, mean arterial pressure 83 (±13.0) to 69 (±19.5)
mmHg, enddiastolic area of the left ventricle 9.4 (±1.8) to 10.0 (±2.7) cm2 and the fractional
area contraction from 82 (±9.0) to 85 (±9.0)%. Only the change in cardiac output was
significantly different (P = 0.013).
CONCLUSIONS. The mean arterial pressure fell moderately but significantly when ILA was
applied. Other hemodynamic parameters exhibited only minimum and mostly insignificant
changes after the ILA use was initiated. We conclude that, with the usual monitoring, these
hemodynamic changes should easily be accounted for and they should not prevent the use of
ILA if its use in ARDS is indicated.
The study was partially supported by Novalung, Hechingen, Germany.
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EFFECT OF PRONE POSITIONING (PP) ON LUNG VOLUME AND
OXYGENATION
J. Dellamonica1,2, H. Hafidi2, L. Bornard2, H. Hyvernat2, L. Brochard1, G. Bernardin2
1Henri Mondor Hospital, Universite´ Paris 12, INSERM U955, Creteil, France, 2MICU and
Universite´ Nice Sophia Antipolis, Nice, France
RATIONALE. Prone position may contribute to the reduction of aerated lung volume of
patients with ARDS. We looked for a relationship between change in lung volume and
oxygenation during this manoeuvre. An automated measurement of end expiratory lung
volume (EELV) using nitrogen (N2) washout/washin is available in an ICU ventilator
(Engstrom, GE).
PATIENTS AND METHODS. 9 patients with severe ARDS (PaO2/
FiO2 = 118 ± 27 mmHg) were studied. Patients were ventilated in volume controlled (Vt
6 mL/kg PBW and flow = 60 L/min). We evaluated prolonged (10–12 h) PP sessions.
Arterial blood gas, EELV, and static compliance were measured before PP and after 30 min,
3, 6 and 10–12 h of prone positioning; another measure was realised 30 min after back to
supine position. Responders were defined as PaO2/FiO2 ratio increase under 30% of base line
after 30 min PP.
RESULTS. Increase in PaO2/FiO2 ratio (159 ± 66%, p = 0.02) was observed from 30 min
and last until the end of PP session. PaCO2 decreased all along study (p = 0.01). PaO2/FiO2
ratio decreased when patient went back to supine. PaO2/FiO2 ratio of nonresponders (n = 4)
remained low during whole PP session. EELV of responders was lower (p = 0.01) before PP,
and increased significantly at 3 and 6 h (Fig. 1).
EELV during PP
Changes in position (prone to supine and supine to prone) were associated with mild and
transient variations of compliance (p \ 0.05 for compliance at 30 min after PP and after
return to supine position). No correlation was found between EELV and compliance. Cor-
relation between variations of EELV and of PaO2/FiO2 ratio after 30 min PP was not
significant (p = 0.08).
CONCLUSION. Preliminary data on nine patients showed prone positioning of patients with
ARDS may increase PaO2/FiO2 ratio and EELV. Association between lung volume and
oxygenation has to be confirmed.
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COMPARISON OF POTENTIALLY RECRUITABLE LUNG (PRL) IN SUPINE
VERSUS PRONE POSITION. PRELIMINARY DATA
R. Cornejo1, J. C. Diaz2, C. Repetto1, P. Sua´rez1, D. Arellano1, K. Rouliez1, G. Dı´az1, C.
Romero1, E. Mezzano2, A. B. Riquelme2, C. Ramos2
1Universidad de Chile, Hospital Clı´nico, Unidad de Pacientes Crı´ticos, Santiago, Chile,
2Universidad de Chile, Hospital Clı´nico, Centro de Imagenologı´a, Santiago, Chile
INTRODUCTION. In ALI/ARDS patients, the percentage of potentially recruitable lung is
highly variable. Considering the proposed pathophysiological mechanisms by which prone
position (PP) improves oxygenation, and its probable protective effect on mechanical ven-
tilation, we thought that PRL from patients with early ARDS may be higher when it is
measured in PP. Similarly, the response to PEEP could be better in prone, reflecting an
improvement in the distribution of the different compartments in the ARDS lung, obtaining
better aeration without unnecessary exposure to increased stress and strain. The aim of this
study was to compare the PRL, as well as the changes in the distribution of lung compart-
ments in supine versus prone, according to density detected by CT.
METHODS. 9 ARDS patients with \72 h of MV and PaO2/FiO2 persistently below 200,
underwent whole-lung CT during breath-holding sessions at consecutive airway pressures of
5, 45, and 15 cmH2O, in both supine and prone position (position was applied in random
order). All patients were sedated and paralyzed. The percentage of potentially recruitable lung
was defined as previously described Gattinoni et al. [1], Non aerated tissue (NAT) at 5–
45 cmH2O)/total weigh. A recruitment manoeuver (RM) was performed before CT session at
45 cm of water (Pressure-controlled mode with inspiratory pressure of 25 cmH2O, and PEEP
20 cmH2O, I/E ratio 1:1, RR 159 min, during 1 min). The TV was performed at 6 ml/kg, and
FiO2 and RR were adjusted to maintain O2 sat C93%, and PaCO2 \55 mmHg. CTscan
images were obtained for each position, and level of PEEP. t test was used to compare results,
with a p \ 0.05 as significant.
RESULTS. We analyzed 9 ARDS patients, mean age 60 ± 21 years (3 male), 5 medical–4
surgical admissions, APACHE II 22 ± 6, SOFA 11 ± 3, SAPS II 46 ± 10, MV time
50 ± 18 h, PaO2/FiO2 168 ± 52, plateau pressure 25 ± 2, compliance 34 ± 5 ml/cmH2O,
and mean IAP was 11 ± 5 mmHg. Lung weight was 1233 ± 377 g. Non aerated tissue was
reduced from 471 ± 236 to 293.3 ± 182 g in supine, and from 441.9 ± 230 to 232 ± 190 g
in PP. Only in PP the reduction of NAT was significant (p = 0.065 for supine, and p = 0.05
for PP). PRL was 14.4 ± 8% in supine, and 18 ± 8% in PP (p = 0.26). At PEEP 15 cmH2O,
after RM, the percentage of well aerated tissue (WAT) was higher in prone than supine
position (54 ± 13 vs. 60 ± 11%, p = 0.038), and Hyperinflated tissue (HIT) and NAT were
lower in PP than supine, but these difference were not significant (p = 0.41, and p = 0.28,
respectively).
CONCLUSIONS. Our preliminary data suggest that PP provide a better distribution of the
lung regions, increasing WAT, and reducing NAT and HIT in comparison with supine
position for the same level of PEEP after RM. PRL has a trend to increase in PP, but this
needs to be confirmed by larger series.
REFERENCES. 1. Gattinoni et al (2006) NEJM 354:1775–1786
GRANT ACKNOWLEDGEMENT. FONDECYT 11070156.
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PRONE POSITION FOR ACUTE RESPIRATORY DISTRESS SYNDROME IN
CARDIAC INTENSIVE CARE
A.-O. Ghenu1, D. Filipescu1, M. Luchian1, A. Prodea1, S. Marin1, A. Calugareanu1, I.
Marinica1
1Emergency Institute of Cardiovascular Diseases ‘C. C. Iliescu’, Cardiac Intensive Care and
Anesthesia, Bucharest, Romania
INTRODUCTION. Although prone positioning has been shown to be a useful adjunct for the
treatment of severe hypoxia in respiratory failure, it does not improve survival.
OBJECTIVES. The aim of this study was to assess the safety and efficiency of prone
position ventilation (PP) in patients with adult respiratory distress syndrome (ARDS) in
patients admitted in cardiac intensive care.
METHOD. We analyzed retrospectively ARDS patients ventilated in prone position, between
Jan 2003 and Dec 2008. Demographic data were recorded. The turning maneuver followed an
established protocol. Parameters registered were: oxygenation index (PaO2/FIO2) and paCO2
before, during PP and in the fist 12 h after returning to dorsal recumbent position (DP). The
incidence of complications related to the turning episodes and the outcome were also reg-
istered. Statistical values are expressed as the median, mean ± standard deviation. Student t
test was used to compare values. P \ 0.05 was considered significant.
RESULTS. 41 patients (19 male, 22 female, mean age 57 ± 15 years) were ventilated in PP
for a mean duration of 11.5 ± 3.7 (range 5–20) h. There were 35 (85.4%) cardiac surgical
patients with drainage tubes, and 8 of them (22.8%) associated intra-aortic balloon pump
(IABP). Six patients (14.6%) had beyond PP simultaneous IABP, renal replacement therapy
(CRRT) and chest drainage. For the entire group, median PaO2/FIO2 rises from 106 (range
61–200) before PP to 259 (range 157–478, p \ 0.05) after it. The PaO2/FIO2 ratio improved
in 40 (97.5%) patients (responders). After returning to DP, PaO2/FIO2 declined to 197 (range
67–507, not significant). Median PaCO2 had decreased from 41.5 to 38.5 mmHg in PP and to
38 mmHg in DP. No death or severe complications associated with PP. There were no CRRT
(16/41), IABP (8/41) or tracheostomy tubes (13/41) malfunctions. There were no inadvertent
extubation, central line displacement; no brachial plexus stretch injuries, or ocular injury. 18
patients (44%) developed facial pressure sores but no necrosis. The in-hospital mortality in
our patients was 41.6%.
CONCLUSION. The results obtained suggest that PP is safe and effective to improve
oxygenation in cardiac patients with severe ARDS when it is carried out by a trained staff and
within an established protocol. The poor outcome was related to the severity of illness and
number of organ failure.
REFERENCE. Guerin C, Gaillard S (2004) Effects of systematic prone positioning in
hypoxemic acute respiratory failure: a randomized controlled trial JAMA 292(19): 2379–
2387.
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EFFECT OF BODY POSITION ON LUNG REGIONAL STRESS/STRAIN RELA-
TION: TOMOGRAPHIC STUDY ON ANIMAL
G. Perchiazzi1, C. Rylander2, A. Vena3, S. Derosa1, D. Polieri1, A. P. Tannoia1, R. Giuliani1,
G. Hedenstierna4
1Bari University, Emergency and Organ Transplant, Bari, Italy, 2Sahlgrenska University
Hospital, Anaesthesia and Intensive Care Medicine, Go¨teborg, Sweden, 3SS Annunziata
Hospital, Anesthesia and Intensive Care, Taranto, Italy, 4Uppsala University, Medical Sci-
ences, Clinical Physiology, Uppsala, Sweden
INTRODUCTION. Lung strain is the deformation of parenchyma from its resting position
(Functional Residual Capacity, FRC) when subjected to an applied force called stress, cor-
responding to transpulmonary pressure (PTP).
OBJECTIVES. Aim of the study was to evaluate the Stress versus Strain (S/S) relation of
five lung regions of interests (ROI) in supine and prone mechanically ventilated animals by
using computed tomography (CT).
METHODS. During general anesthesia in four mechanically ventilated pigs we recorded
continuously flow, volume and pressure at airways opening as well as esophageal pressure;
PTP was calculated. Twelve End-Inspiratory Hold Maneuvers (EIHM) at increasing delivered
volumes and one expiratory hold maneuver (EEHM) at zero end expiratory pressure were
performed, interposed with tidal ventilation. During each EIHM and the EEHM we made
synchronized CT scans at a fixed level between heart and diaphragm. The sequence was
repeated in supine and prone position. We analysed five ROIs comprising the entire lung slice
and four regions: upper (nondependent), medium (intermediate), lower (dependent) and center
(under the heart projection). The ROI strain was computed from the gas content during the
EIHM and the gas content at EEHM (corresponding to FRC). Simultaneously, stress was
estimated by PTP. Exponential regression of the single S/S curves was performed, tested for
statistical significance and compared by Fisher test.
RESULTS. S/S tracings obeyed statistically significant exponential regressions which were
statistically different. Dependent ROIs showed, at the same applied stress, a higher strain than
the nondependent ROI, both in supine and in prone position. However, the difference between
the more strained and the less strained ROI decreased in the prone position.
CONCLUSIONS. At the same stress, strain is inhomogeneously distributed throughout the
lung. Prone compared to supine position, attenuates the differences in strain between
dependent and nondependent lung regions.
GRANT. The Swedish Medical Research Council (5315); the Italian Ministry of University
and Scientific Research.
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EFFECTS OF A NEW ROTATIONAL DEVICE ON COMPLICATION RATE DUR-
ING PRONE VENTILATION IN PATIENTS WITH ACUTE RESPIRATORY
DISTRESS SYNDROME: A RETROSPECTIVE ANALYSIS
P. Taccone1, F. Polli1, C. Mietto2, L. Gattinoni1,2, for the Prone-Supine II Study Group
1Fondazione IRCCS, ‘‘Ospedale Maggiore Policlinico, Mangiagalli, Regina Elena’’ di Mi-
lano, Dipartimento di Anestesia e Rianimazione, Milan, Italy, 2Universita` degli Studi di
Milano, Istituto di Anestesiologia e Rianimazione, Milan, Italy
INTRODUCTION. Prone positioning is currently suggested for the treatment of patients with
Acute Respiratory Distress Syndrome (ARDS) in whom mechanical ventilation is potentially
dangerous [1]. The RotoProne (KCI Medical Products, San Antonio, TX, USA) is a
new electrical medical bed which allows to perform automatically the positional changes during
prone ventilation. Potential advantages of this new device are the reduction of staff workload
and the standardization of the treatment across different centers. On the other hand, the Roto-
Prone may have some effects on the rate of adverse events related to prone positioning.
OBJECTIVES. The aim of this study is to assess the impact of Rotoprone bed on the
incidence of complications during prone ventilation.
METHODS. We retrospectively analyzed the database of a multi-centers, randomized con-
trolled trial on prone positioning in ARDS patients, that has been recently terminated (Prone-
Supine II study). In this clinical trial, RotoProne was available in 20/25 participating cen-
tres. 168 patients with ARDS were enrolled in the treatment arm, and were kept in prone
position for a total of 1,397 study days. In 1140 of these study days, prone positioning was
performed with the use of RotoProne bed, while in 257 days the treatment was manually
executed (mainly because of RotoProne unavailability). We compared the incidence of adverse
events between the days of treatment with Rotoprone and the days of manual treatment.
RESULTS. The overall incidence of complications was similar between the two groups. Use
of RotoProne bed was retrospectively associated to a statistically significant decrease in the
use of sedation and muscle relaxant, and to a decrease in rate of pressure sores.
CONCLUSION. Despite the potential limitations of this retrospective analysis, our
results suggest that RotoProne bed is at least equivalent to the manual execution of
prone positioning. Prone ventilation may be performed with this new rotational device
without any increased in incidence of clinically relevant complications.
REFERENCE. 1. Dellinger RP et al (2008) Surviving Sepsis Campaign: international
guidelines for management of severe sepsis and septic shock. Crit Care Med 36(1):296–327.
GRANT ACKNOWLEDGEMENT. We thanks KCI medical products, that freely provided
RotoProne beds to the ICUs participating to the Prone-Supine II study. The main trial and this
secondary analysis were conducted independently from KCI company (Table 1)











Need for increased sedation/muscle relaxants 27.3 38.1 \0.001
Airway obstruction 13.0 16.3 0.16
Transient Transient desaturation 22.7 21.4 0.64
Hypotension/arrhytmias/increased vasopressors 23.2 26.5 0.27
Loss of venous access 2.02 1.95 0.94
Displacement of the endotracheal tube 1.47 0.39 0.22
Displacement of a thoracotomy tube 0.07 0.03 1.00
Pressure sores 30.0 34.6 0.04
Facial edema 62.5 62.4 0.77
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NON-INVASIVE PREDICTORS IN ACUTE EXACERBATION OF CHRONIC
OBSTRUCTIVE PULMONARY DISEASE (AECOPD)
A. S. Omar1, M. S. Abdelazim2, A. Abdelrazek2, A. Kamal2, M. A. Geddawy3
1Beni-Sweif University, Critical Care Medicine, Beni-Swief, Egypt, 2Cairo University,
Critical Care Medicine, Cairo, Egypt, 3South Valley University, Anaethesia and ICU, Kenna,
Egypt
INTRODUCTION. Accurate prediction for prognosis is important for hospitalized patients
with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) requiring
mechanical ventilation (MV) and for their family members to make end-of-life issues.
AIM OF THE PRESENT STUDY. To determine if non invasive parameters including
APACHE II score, bedside echocardiography could guide the plan of management in patients
with AECOPD either ventilatory or conservatively, and if it could predict patient outcome.
PATIENTS AND METHODS. The study was conducted on 60 adult patients with AE-
COPD, with mean age 60.1 ± 6.2 were admitted to intensive care unite (ICU). All patients
were subjected to arterial blood gases (ABGs), APACHE II score and Doppler echocardi-
ography study.
RESULTS. Patients were divided into two groups according to ventilatory requirement
invasive or non invasive into group I (34 patients) with need of MV and group II (26 patients)
with success of conservative treatment. Our data showed high predictive value for MV
necessity for APACHE II score 19.17 ± 3.4 in group I versus 11.46 ± 4.42 in group II
(P \ 0.0001), pH 7.22 ± 0.07 in group I versus 7.33 ± 0.06 in group II (P \ 0.05), and
Doppler evidence of pulmonary hypertension (PH) at a cut off 36.6 mmHg, the accuracy was
85% and can predict the need for MV in 82% of patients in the group I. Increase in the
APACHE II score and increase in the mean pulmonary artery pressure (PAPm) 38.73 ± 7.27
versus 45.40 ± 5.53 mmHg (P \ 0.01), and pulmonary artery systolic pressure (PASP)
42.20 ± 6.87 versus 57.68 ± 5.97 mmHg (P \ 0.0001) were significantly more in patients
who died in comparison to survivors in the failure group.
CONCLUSION. Increased APACHE II score, PaCO2 on and PAP on admission are pre-
dictors of the need of MV invasive or non-invasive, also high APACHE II score and PAP
could predict mortality.
KEY WORDS. COPD, APACHE II score, mortality
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THE USE OF NONINVASIVE MECHANICAL VENTILATION IN COPD PATIENTS
WITH SEVERE HYPERCAPNIC ACIDOSIS
P. Cimen1, C. Kirakli1, O. Edipoglu1, S. Bilaceroglu1, K. A. Cirak1, H. Halilcolar1
1Izmir Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey
OBJECTIVE. To compare the effect of noninvasive mechanical ventilation (NIV) in acute
hypercapnic chronic obstructive lung disease (COPD) with severely acidotic and mildly
acidotic patients
METHOD. Patients who were admitted to intensive care unit with acute hypercapnic COPD
were analysed in two groups: mild (pH 7.25–7.35) or severe (pH \ 7.25) acidosis. Com-
parison of NIV in consecutively enrolled patients on time to normalise pH and improve
PaCO2, duration of NIV treatment, length of stay in hospital and the survey in 28th of the
treatment.
RESULTS. 70 COPD patients who were admitted to intensive care unit were included to our
study. Thirty-eight patients were severely acidotic and 32 were mildly acidotic. Compared
with the mildly acidotic group, the length of time for pH to normalise was significantly high in
severely acidotic group (respectively, 32 (7–78) h, 20 (1–76) h, p\ 0.01). Full face masks
were used mostly in severely acidotic group (p \ 0.01). 14 patients in acidotic group and one
patient in mildly acidotic group were needed endotracheal intubation (p \ 0.01). At the end of
the 28th of treatment, 7 patients were died in severely acidotic group, no patient was died in
mildly acidotic group. No statistical difference between the length of hospital and intensive
care unit stay in both groups.
CONCLUSION. NIV can be tried in some severely acidotic COPD patients, but it can not be
as effective and safe as in mildly acidotic COPD patients. To determine the effectivity and
safety of NIV in severely acidotic COPD needs further investigations.
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EFFECT OF MECHANICAL VENTILATION WITH PEEP ON THE BRONCHODI-
LATOR TREATMENT IN PATIENTS WITH ACUTE ON CHRONIC
RESPIRATORY FAILURE
A. Tejero Pedregosa1, F. Ruiz Ferro´n1, M. I. Ruiz Garcı´a1, J. Pe´rez Valenzuela2, A´. Ferre-
zuelo Mata1, R. Quiro´s Barrera1, L. Rucabado Aguilar1
1Hospital Universitario Ciudad de Jae´n, Unidad de Cuidados Intensivos, Jae´n, Spain, 2Hos-
pital Universitario Ciudad de Jae´n, Jae´n, Spain
INTRODUCTION. The inhaled bronchodilators are the main therapeutic measure in patients
with Acute On Chronic Respiratory Failure (ACRF). However, the optimal ventilator
parameters to achieve the best bronchodilator effect are not defined. It is known that con-
trolled mechanical ventilation with PEEP improves flow distribution in these patients, because
of that it may improve the drug effectiveness.
Objectives. to measure, in controlled mechanically ventilated patients receiving inhaled
salbutamol, if a PEEP level lower than PEEPi can additionally reduce airway resistance.
METHODS. 8 patients with clinical criteria of ACRF by different causes and receiving
controlled mechanical ventilation were included. Salbutamol is administered through aero-
chamber (between 6 and 10 inhalations according weight). Patients were haemodinamically
stable and deeply sedated (Ramsay V–VI). We calculate respiratory mechanics by means of
the constant flow occlusion technique, using the ventilator curves (Plateau pressure, Peak
inspiratory pressure, PEEPi, V0, Vt, Static compliance, Total resistances). The measurements
were registered in 4 phases: with 0 PEEP before the administration of salbutamol and after the
treatment. Later a PEEP level equal to 80% of PEEPi was set and after 6 h measurements pre
and post-treatment were repeated. Results were analyzed with non-parametrical tests, using a
statistical significance level of p \ 0.05.
RESULTS. Mean age was 60 ± 17 years. 4 patients needed mechanical ventilation (MV)
because of respiratory infection, 2 were postsurgical patients and 2 needed MV after a cardiac
arrest. The ventilator parameters were: FiO2: 0.5 ± 0.07, Vt: 568 ± 82 cc, FR: 15 ± 3 bpm,
V0: 0.75 ± 0.12 l/s, PEEPi: 9 ± 3 cmH2O. Total resistances (tR) on basal state were 25 ± 7
cmH2O/l/s, those decreased to 22 ± 7 (13 ± 9%),after adding PEEP the value of tR was
20 ± 6 cmH2O/l/s and decreased to 16 ± 6 cmH2O/l/s (22 ± 15%). Those changes were not
statistically significant (p = 0.2) and showed a wide variability between patients.
CONCLUSIONS. In a basal state the effect of salbutamol on resistances is similar to that
previously known (15%). With the limitation of the number of patients included, our data
reflects that in some cases mechanical ventilation with PEEP has bronchodilator effect ‘‘per
se’’ and increase the action of bronchodilators.
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MECHANICAL VENTILATION IN LIFE-THREATENING ASTHMA
H. Quiroz Martı´nez1, F. Frutos Vivar2,3, N. Nin2,3, A. Anzueto4, P. Desmery5, M. Gonza´lez6,
M. Jibaja7, A. Esteban2,3, N. D. Ferguson1, VENTILA Study Group
1University of Toronto, Interdepartmental Division of Critical Care Medicine, Toronto,
Canada, 2Hospital Universitario de Getafe, Madrid, Spain, 3CIBER Enfermedades Respira-
torios, Madrid, Spain, 4University of Texas San Antonio, San Antonio, USA, 5Sanatorio
Mitre, Buenos Aires, Argentina, 6Universidad Pontificia Bolivariana, Medellı´n, Colombia,
7Hospital Militar de Quito, Quito, Ecuador
RATIONALE. Little is known about real-world mechanical ventilation (MV) practices for
patients with life-threatening asthma. We used data from two international prospective util-
isation reviews to determine: (1) the characteristics, ventilatory practices, and outcomes of
these patients; (2) whether practice had changed over time; and (3) whether asthmatics are
ventilated differently than other patients.
METHODS. We performed a secondary analysis of data from 10,051 patients who received
MV for more than 12 h and were enrolled in two international observational studies con-
ducted in 1998 and 2004. Patients were followed prospectively for the duration of ventilation.
We analysed patients whose primary indication to begin MV was asthma; comparing them to
each other between 1998 and 2004, and to patients with other causes of acute respiratory
failure.
RESULTS. Comparing asthmatics from 1998 (n = 79) to those from 2004 (n = 63), the
mean (SD) baseline characteristics [Age 51 (18) vs. 49 (16), p = 0.47; female sex 63 vs. 51%,
p = 0.09; SAPS II 35 (13) vs. 34 (17) p = 0.72] were similar in both cohorts. Choice of MV
mode [CMV 71 vs. 59%, p = 0.93], and those with tidal volume\8 ml/kg ABW (61 vs. 70%,
p = 0.26) or ZEEP (76 vs. 65%, p = 0.16) were also unchanged. Barotrauma (6.3 vs. 4.8%,
p = 0.49), and outcomes [duration of MV 5.1(6.1) vs. 4.0 (4.6) days, p = 0.23; ICU LOS 7.0
vs. 6.2 days, p = 0.56; ICU mortality 11.4 vs. 9.5%, p = 0.44] were similar between 1998
and 2004. Comparing all asthmatics with patients ventilated for other conditions, asthmatics
were significantly younger [51 (17) vs. 59 (17) years, p \ 0.001], were predominantly women
(58 vs. 39%, p \ 0.001), and had lower SAPS II scores [35 (15) vs. 44 (17), p \ 0.001). More
asthmatics received CMV as the initial mode of MV (65 vs. 52%, p = 0.004], and more were
paralysed (25 vs. 12%, p \ 0.001). The proportion of patients receiving tidal volumes below
8 ml/kg ABW (65 vs. 41%) or ZEEP (71 vs. 35%) was higher in asthmatics (p \ 0.001 for
both). Peek pressures were higher in asthmatics [35 (13) vs. 28 (8), p \ 0.001], while plateau
pressures were similar [23 (8) vs. 21 (5), p = 0.92]. Mean PaCO2 was higher in asthmatics
[52 (17) vs. 40 (12), p \ 0.001]. Rates of barotrauma were similar (6 vs. 4%, p = 0.16) but
complications of ALI or sepsis were less frequent in asthmatics. Duration of ventilation [4.3
(4) vs. 6.0 (7)], ICU LOS [7.6 (8) vs. 11.5 (13)], and ICU mortality (11 vs. 31%) were all
significantly lower in asthmatics (p \ 0.001 for all).
CONCLUSIONS. MV practices did not change significantly in asthmatics from 1998 to
2004. In asthmatics there were significantly different MV parameters compared with other
causes of respiratory failure, and they had significantly better outcomes.
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INFLUENCE OF INSPIRED OXYGEN CONCENTRATION ON ARTERIAL PAR-
TIAL PRESSURE OF CARBON DIOXIDE DURING NONINVASIVE VENTILATION
IN PATIENTS WITH ACUTE EXACERBATION OF COPD
R. P. Oliveira1,2, C. Teixeira1,2, A. Savi2, J. G. Maccari2, T. F. Tonietto2, M. M. Rieder1, E. C.
Zignani1, E. B. Silva1, P. Z. Teixeira1, N. B. Silva2
1Complexo Hospitalar Santa Casa, Porto Alegre, Brazil, 2Hospital Moinhos de Vento, Porto
Alegre, Brazil
INTRODUCTION. The administration of a high fraction of inspired oxygen concentration
(FIO2) to chronic obstructive pulmonary disease (COPD) patients breathing spontaneously
may result in hypercapnia; this fact may be due to the reversal of preexisting regional hypoxic
pulmonary vasoconstriction resulting in a greater dead space. To date this issue was not
studied during noninvasive ventilation (NIV).
OBJECTIVE. To investigate the response of the arterial partial pressure of carbon dioxide
(PaCO2) to a high inspired FIO2 during NIV.
METHODS. Experimental prospective study in an 18-bed medical-ICU in a university
teaching hospital.
MEASUREMENTS AND MAIN RESULTS. Seventeen NIV-ventilated CO2-retaining
COPD patients were studied both at their baseline FIO2 (0.25–0.50), and following a 40
minutes period of exposure to an FIO2 of 1.0. No other parameter was changed. Following 40
minutes at an FIO2 of 1.0, the VT, RR, VE, ABG, and SaO2 were again recorded, as well as
changes in mental status (evaluating Glasgow coma score [GCS]). The patients were then
returned to their baseline FIO2. They were not aware of the changes made to their FIO2. Mean
(±SD) baseline findings were: PaO2 of 101.4 ± 21.7 mmHg, PaCO2 of 52.6 ± 10.4 mmHg,
respiratory rate (RR) of 17.8 ± 3.7 breaths/min, tidal volume (VT) of 601 ± 8 mL, and
Glasgow coma scale (GCS) of 14.8 ± 0.3. Statistical analysis using the paired Student’s t test
showed that the PaO2 (290.5 ± 35.7 mmHg; p \ 0.001) increased significantly when the
FIO2 was increased to 1.0, but there was no significant change in PaCO2
(51.5 ± 12.3 mmHg), RR (17.5 ± 2.8 breaths/min), VT (608 ± 8 mL) and GCS
(14.8 ± 0.3).
CONCLUSION. These results show that during noninvasive ventilation with an FIO2 suf-
ficient to maintain a normal PaO2, a further increase in FIO2 for forty minutes does not result
in an increased PaCO2 in this group of CO2-retaining COPD patients.
REFERENCES. 1. Calverley PM (2005) Chronic obstructive pulmonary disease. In: Fink
MP, Abrahan E, Vincent JL, Kochanek PM. Textbook of Critical Care, 5th edn. Elsevier
Sauders, Philadelphia, pp 599–608. 2. Ciang LL, Hung TC, Ho SC, Lin HC, Yu CT, Wang
CH, Kuo HP (2002) Respiratory response to carbon dioxide stimulation during low flow
supplemental oxygen therapy in chronic obstructive pulmonary disease. J Formos Med Assoc
9:607–615
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NON-INVASIVE VENTILATION—A ONE YEAR COHORT STUDY COMPARED
TO A PREVIOUS COHORT STUDY IN AN ICU
D. Høen-Beck1, K. Marcussen1, H.-H. Bu¨low1
1Holbæk Hospital, Department of Anaesthesia, Holbæk, Denmark
INTRODUCTION. Non-invasive ventilation (NIV) has been used increasingly for more than
20 years, but little is known about outcome when used extensively on daily basis in an ICU.
OBJECTIVE. To compare NIV-treatment in a 2007 cohort with a 2002/2003 cohort
regarding patient characteristics, procedures and outcome. In the 2007 cohort arterial blood
gasses were analyzed, in order to evaluate if it was possible to treat patients with pH below
7.25 with NIV.
METHOD. Prospective, consecutive, strictly observational cohort study of all patients
treated with NIV without any specific interventions.
RESULTS. 142 patients in 2007 were compared to 100 patients in 2003 and 58 patients in
2002. There were eight different diagnostic groups: COPD, cardiac disease, pneumo-
nia, postoperative, septicemia, intoxication, cancer, and others. There were no difference in
patient categories with regard to admission diagnosis during the study periods.
Hours of NIV-treatment decreased each year (from 22 to 15 to 14).
Hours in ICU decreased significantly (from 92 in 2002 to 40 in 2003 to 49 in 2007).
APACHE-score increased each year significantly (from 19.4 to 20.1 to 21.8).
Median age of patients each year were not different, but the proportion of patients older than
79 years increased each year (from 16 to 24 to 25%).
When NIV failed time-to-intubation decreased each year (from 19.5 to 7 to 5.3 h) and at the
same time surviving rate increased each year (from 33 to 52 to 57%).
Overall mortality rates during the 3 years were 31, 41 and 39%, respectively.
Arterial blood gases were evaluated only in the 2007 cohort. Out of 81 patients with a
pH \ 7.25, there were 59 patients only treated with NIV and 42 (71%) survived. Out of 58
patients with a pH [ 7.24 there were 44 patients only treated with NIV and 27 (61%)
survived.
CONCLUSIONS.
1. With increased experience in treating NIV-patients we found that:
– we were able to decrease hours of NIV-treatment and time in the ICU
– we were able to treat more patients older than 79 years with unchanged mortality rate
– we were able to treat patients with higher APACHE-scores with unchanged mortality
rate
– the staff reacted faster when NIV failed and intubated the patients, and when
intubated faster surviving rate increased
2. In the 2007 cohort we found that in patients treated exclusively with NIV, the surviving
rate was greater for patients with a pH below 7.25, as compared to patients with a pH
above 7.24.
REFERENCES. 1. Bu¨low HH, Thorsager B, Hoejberg J (2007) Experiences from intro-
ducing non-invasive ventilation in the intensive care unit: a 2-year prospective consecutive
cohort study. Acta Anaesthesiol Scand 51:165–170. 2. Carlucci A, Delmastro M, Rubini F,
Fracchia C, Nava S (2003) Changes in the practice of noninvasive ventilation in treating
COPD patients over 8 years. Intensive Care Med 29:419–425
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COMPARATIVE EVALUATION OF A NEW HELMET FOR DELIVERING NON-
INVASIVE VENTILATION (NIV)
C. Olivieri1, R. Costa2, G. Cammarota1, F. Della Corte1, G. Conti2, P. Navalesi1
1University of Eastern Piedmont, Anesthesiology and Intensive Care Medicine, Novara, Italy,
2Universita` Cattolica del Sacro Cuore, Anesthesiology and Intensive Care Medicine, Roma,
Italy
INTRODUCTION. NIV is an effective means to provide ventilatory assistance to patients
with acute respiratory failure (ARF) of various aetiology. Compared to the facial mask (FM),
which is the gold standard, the helmet is an alternative interface that allows longer periods of
continuous NIV. On the one hand, the helmet eliminates the risk of facial skin breakdown by
removing the need for sealing around the nose and the mouth, but exposes the patient to the
risk of bruises under the armpits because of the anchoring braces. On the other hand, in
contrast to FM, it remarkably deteriorates patient-ventilator interaction (PVI), because of the
soft wall and the cranio-caudal oscillation of its soft collar. We thus designed a new helmet
aimed to improve PVI, by reducing the inspiratory trigger delay (Delaytrinsp) and increasing
the rate of airway pressurization, while eliminating the need for the armpit braces.
OBJECTIVES. Purpose of this bench study is to evaluate the performance of this new helmet
(NH) in delivering NIV, compared to the standard helmet (SH) and the FM.
METHODS. The three interfaces were tested on a mannequin connected to a lung model at
respiratory rates of 20 (RR20) and 30 (RR30) breaths/min. NIV was applied through a
mechanical ventilator set in pressure support (PS) with positive end-expiratory pressure of
8 cmH2O and inspiratory support of 12 cmH2O. Inspiratory trigger delay (Delaytrinsp),
pressure-time product 300 and 500 ms after the onset of the inspiratory effort (PTP300 and
PTP500, respectively), and pressure–time product 200 ms after the onset of ventilator assis-
tance (PTP200) were determined.
RESULTS. Delaytrinsp were 0.14, 0.11 and 0.08 ms at RR20, and 0.17, 0.13 and 0.09 ms at
RR30, for SH, NH, and FM, respectively. NH resulted to be significantly different (p \ 0.05),
compared to either SH and FM, at both RR20 and RR30.
PTP300 values for NH (1.08 and 0.85 cmH2O/s at RR20 and RR30, respectively) were sig-
nificantly (p \ 0.001) higher than for SH (0.8 and 0.27 cmH2O/s at RR20 and RR30,
respectively), and lower than for FM (1.66 and 1.62 cmH2O/s at RR20 and RR30,
respectively).
PTP500 values for NH (3.21 and 2.70 cmH2O/s at RR20 and RR30, respectively) were sig-
nificantly (p \ 0.05) higher than for SH (3.04 and 2.48 cmH2O/s at RR20 and RR30,
respectively), and lower than for FM (3.67 and 3.78 cmH2O/s at RR20 and RR30,
respectively).
PTP 200 values for NH (0.90 and 0.85 cmH2O/s at RR20 and RR30, respectively) were sig-
nificantly (p \ 0.001) higher than for SH (0.61 and 0.57 cmH2O/s at RR20 and RR30,
respectively), and lower than for FM (1.31 and 1.40 cmH2O/s at RR20 and RR30,
respectively).
CONCLUSIONS. Although less efficient than FM, compared to SH, NH significantly
improved PVI, while eliminating the need for the armpit braces.
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CLINICAL PERFORMANCE OF NON-INVASIVE VENTILATION (NIV) MODES
ON ICU VENTILATORS DURING PRESSURE SUPPORT : PRELIMINARY
RESULTS
L. Vignaux1, J. Roeseler2, D. Tassaux1, P. Jolliet1
1University Hospital, Intensive Care Unit, Geneva, Switzerland, 2Saint Luc University Hos-
pital, Intensive Care Unit, Brussels, Belgium
INTRODUCTION. 43% of patients undergoing NIV exhibit severe asynchrony, mainly
associated with leaks [1]. Specific NIV modes to decrease the impact of leaks have been
designed, but remain untested in clinical conditions.
PURPOSE. To evaluate in the clinical setting the effect of NIV modes on the incidence and
severity of asynchrony.
METHOD. Prospective multicenter observational study of pts. with ARF receiving clinician-
set pressure support NIV. Two 30 min periods of continuous recordings were performed,
without (NIV0) and with (NIV?) NIV mode. Respiratory rate, pt. neural inspiratory time
(tin), duration of ventilator pressurisation (tiv), excess pressurization duration (tiex-
cess = tiv - tin/tin 9 100), n asynchrony events (AE) and Asynchrony Index [AI = n
asynchrony events/(triggered ? non-triggered breaths)] were measured. Results are given in
mean ± SD. p is considered significant if \0.05.
RESULTS. (mean ± SD): 10 pts (4F/6 M); age = 66 ± 16 years; BMI = 27.3 ± 5.3 kg
m-2, PSL = 12.5 ± 3.7 cmH2O, PEEP = 6.8 ± 1.8 cmH2O. Table 1, 4 patients without NIV
mode had an AI[10%. No patient with NIV mode had severe asynchrony (Table 2)
TABLE 1
Parameters NIV0 NIV?
Leaks (L/min) 4.4 ± 3 3 ± 2 *
VTe (ml) 660 ± 241 712 ± 214
Respiratory rate (n/min) 22.4 ± 4.4 22.3 ± 4.5
Tin (s) 793 ± 120 808 ± 144
Tiexcess (s) 34.5 ± 8.0 23.7 ± 9.0 *
* p = 0.05 versus NIV0
TABLE 1
Asynchronies NIV0 NIV?
Double triggering (n/min) 0.2 ± 0.3 0.1 ± 0.01
Auto-triggering (n/min) 0.4 ± 0.2 0.2 ± 0.2*
Non-triggered breaths (n/min) 0.14 ± 0.1 0.07 ± 0.1*
Premature cycling (n/min) 0.05 ± 0.04 0.2 ± 0.27
Delayed cycling (n/min) 2.4 ± 0.5 0.2 ± 0.2*
Asynchrony index (%) 14.2 ± 5 3 ± 2.3*
* p = 0.05 versus NIV0
CONCLUSION. During NIV with leaks, asynchronies can be partly corrected by NIV mode,
mainly delayed cycling and auto-triggering. The present ongoing trial should provide further
insight as to the clinical relevance of specific NIV modes in patients with ARF.
1) Vignaux et al (2009) Intensive Care Med 2009. doi:10.1007/s00134-009-1416-5
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NON INVASIVE MECHANICAL VENTILATION (NIMV) USE IN RESPIRATORY
FAILURE AFTER EXTUBATION—PRELIMINARY RESULTS
A. Belenguer-Muncharaz1, M. L. Mico´-Go´mez1, E. Moreno-Cları´1, A. Ferra´ndiz-Selle´s1,
M. L. Mateu-Campos1, S. Mas-Font1, F. Sa´nchez-Mora´n1, L. Albert-Rodrigo1
1General Hospital of Castello´n, Intensive Care Unit, Castello´n de la Plana, Spain
OBJECTIVES. Our aim has been to assess the benefit of the use of NIMV in patients with
respiratory failure appeared after removing tracheal intubation.
PATIENTS AND METHODS. Since December 2007 to October 2008 we analyzed 70
patients undergoing mechanical ventilation (MV) for more than 24 h and admitted in a 19 bed
medical/surgical ICU in a university hospital. Patients with neurological disease or COPD
were not included (because of the argued added benefit of NIMV in this group). We identified
those patients who developed respiratory failure during the 48 immediate hours after
extubation.
Type of study. Randomized comparison of treatment with conventional oxygen therapy
versus NIMV.
Analyzed variables. Reduction of the reintubated number of cases, incidence of nosocomial
infection, ICU length of stay, and need for tracheotomy. Statistical analysis was performed
using SPSS 12.0, with a significance level of p \ 0.05.
RESULTS. Out of the 70 patients included in the study, 15 patients (21%) failed after
extubation. Two of them required urgent intubation due to decreased level of consciousness.
Of the remaining 13, 8 were randomized to NIMV and 5 to oxygen (control group). The
comparison between the NIMV and the control group only showed differences in the values
of bicarbonate (26 vs. 23 meq/l, p = 0.03). There was a lower rate of reintubation in NIMV
group (2 vs. 5, p = 0.028), incidence of nosocomial pneumonia and mortality were similar.
The average stay was higher in the oxygen group (18 vs. 11 days, p = 0.21).
CONCLUSION. Our preliminary results on respiratory failure after removing OT tube show
a satisfactory result in the use of NIMV with less need for reintubation and shorter stay in ICU
than in the control group, but with very similar mortality rates.
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NON-INVASIVE VENTILATION IN ACUTE CARE - EXPERIENCE IN AN INDIAN
ICU
A. Gurnani1
1Kailash Hospital and Heart Institute, Noida, Critical Care, DELHI, India
INTRODUCTION. Acute hypoxic respiratory failure with ALI/ARDS is a common
accompaniment of many illnesses, such as pancreatitis, sepsis, trauma, in an ICU.
There is growing evidence that, besides the traditional use of non-invasive ventilation (NIV)
in COPD, it is equally efficacious in hypoxic respiratory failure when used early. It improves
the PO2 and optimises the PO2/FiO2 ratio in this group of patients. The prospective study was
done to evaluate the efficacy of non-invasive ventilation (NIV) in acute hypoxic respiratory
failure in ICU in developing countries like India.
METHODS. 50 adult patients of both sexes admitted in ICU over a period of 1 year,
requiring respiratory support were studied. NIV was initiated using a bilevel ventilator
(Knight Star 330, PB) with O2 supplementation @ 4–6 lpm. Haemodynamic and respiratory
monitoring (invasive and noninvasive) was done. Patients who were obtunded, haemody-
namically unstable or having facial injuries or bilateral chest trauma were excluded. NIV was
discontinued when PO2/FiO2 was[300 mmHg or when there was failure of NIV (due to non
improvement). Statistical analysis was done using Wilcoxon Signed Ranks Test and Chi-
Square Test.
RESULTS. 40 males and 10 females, mean (±SD) age 38 ± 16 were studied. Patient
population comprised of unilateral # ribs (40%), pancreatitis (34%), pneumonitis (16%), fat
embolism (8%) and postoperative respiratory failure (2%). Mean length of stay on NIV was
4.61 ± 0.5 days. Mean length of stay in ICU was 8 ± 2 days. Mean PO2 on initiation of NIV
was 65 ± 5 mmHg and on termination was 154 ± 12 mmHg (p \ 0.001, significant). Mean
PO2/FiO2 on initiation of NIV was 129 ± 15 mmHg and on termination improved to
319 ± 8 mmHg, which was significant (p \ 0.001). 4 out of 50 patients required intubation
and invasive ventilation which was not significant (p [ 0.05). 46 out of 50 patients could
easily be managed on NIV (p \ 0.001).
CONCLUSIONS. Early and judicious use of non-invasive ventilation in selected patients
with ALI/ARDS is an efficient alternative in ICU settings in the third world countries. Patients
with haemodynamic instability and extensive bilateral chest injuries are exception.
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NON-INVASIVE VENTILATION IN THE POST-ANESTHESIA CARE UNIT FOR
POST-OPERATIVE RESPIRATORY FAILURE: PROSPECTIVE ANALYSIS OF 14
CASES
J. M. Alonso-In˜igo1, M. J. Fas1, A. Herranz1, D. Pardo2, R. Castera´2, E. Grafia2, L. Vidagany2,
J. E. Llopis1
1Hospital Universitario de la Ribera, Anaesthesia, Critical Care and Pain Therapy, Alzira,
Spain, 2Hospital Universitario de la Ribera, Post-Anaesthesia Care Nursing Unit, Alzira,
Spain
INTRODUCTION. Non-invasive ventilation (NIV) has become an effective treatment to
reduce morbidity and mortality in patients with acute respiratory failure. Its application has
been restricted to critical care o intermediate care areas, and little data is available on its
usefulness in the post-anaesthesia care units (PACU). The aim of this study is to evaluate the
effectiveness of NIV after implementing a treatment protocol.
METHODS. We undertook a prospective analysis of patients treated with NIV between
September 2008 and February 2009. The need for NIV was established in the recovery room, if
patients met the following criteria: hypoxemia with arterial partial pressure of oxygen/inspired
oxygen fraction ratio (PaO2/FIO2) \300, and/or arterial partial pressure of carbon dioxide
(PaCO2) [50 mmHg. Data of age, ASA physical status, surgical procedure, anaesthesia
modality, type of respiratory failure, ventilatory mode, side effects related to NIV application,
and time of NIV were recorded. We also recorded arterial blood gas analysis at two points: (1)
before NIV and (2) after discontinuation of NIV. Descriptive statistical analysis was used. Data
are presented as means and standard deviations (SD). Comparison of variables was performed
with paired sample t test. Statistical significance was assumed at P = 0.05.
RESULTS. Fourteen patients were included. The mean age was 67 ± 14 (SD) years. Seven
patients were classified as ASA 2 (50%), six as ASA 3 (42.9%), and one as ASA 4 (7.1%).
General and regional anaesthesia were employed in 13 and 1 cases, respectively. Type of
surgery was abdominal (56.1), thoracic (21.4%), vascular (14.3), and urologic (7.1). Type of
respiratory failure was hypoxemic (43%), hypercapnic (21.3%), and global (35.7%). Venti-
latory mode was BIPAP (50%), and CPAP (50%). The mean time of NIV was 75.37 ± 20.78
(SD) min. PaO2/FiO2 was significantly higher after NIV compared with basal data
(143.62 ± 63.27 vs. 253.90 ± 88.69; P = 0.01). PaCO2 values were significantly lower after
NIV (52.77 ± 9.54 vs. 45.62 ± 6.71 mm Hg; P = 0.01). No complications related to NIV
occurred. Although two patients were transferred to de ICU, no patient required intubation.
The rest of them were transferred to the surgical wards the same day.
CONCLUSIONS. NIV can be safely applied to selected patients in the PACU, to treat
respiratory failure after either general or regional anaesthesia. It improves gas exchange and is
an effective method to avoid intubation and ICU stays, with minimal side effects.
REFERENCES. Battisti A et al (2005) Non-invasive ventilation in the recovery room for
post-operative failure: a feasibility study. Swiss Med Wkly 135:339–343
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WHEN THE NON INVASIVE VENTILATION FAILS
E. Gonza´lez- Higueras1, J. M. An˜o´n1, V. Go´mez-Tello2, J. J. On˜oro2, V. Co´rcoles3, C. Martı´n-
Delgado4, M. Quintana5, F. Gordo6, L. Marina7, J. Lo´pez8, A. Garcı´a de Lorenzo9
1Hospital Virgen de la Luz, Intensive Care Medicine, Cuenca, Spain, 2Clı´nica Moncloa,
Intensive Care Medicine, Madrid, Spain, 3C. H. U. Albacete, Albacete, Spain, 4H. Mancha
Centro., Intensive Care Medicine, Alcazar de San Juan, Spain, 5H. Ntra. Sra. del Prado,
Intensive Care Medicine, Talavera de la Reina, Spain, 6F. H. Alcorco´n, Intensive Care
Medicine, Madrid, Spain, 7H. Virgen de la Salud, Intensive Care Medicine, Toledo, Spain,
8H. Severo Ochoa, Intensive Care Medicine, Legane´s, Spain, 9H. U. La Paz, Intesive Care
Medicine, Madrid, Spain
OBJECTIVES. To evaluate the influence of the non invasive ventilation (NIV) failure on a
heterogeneous sample of critically ill patients.
METHODS. Sub-analysis from an observational, prospective, multicenter, cohort study
carried out in thirteen Spanish ICU during 2 years. Inclusion criteria: adult critically ill
patients mechanically ventilated more than 24 h. Exclusion criteria: patients \18 years old
and thermally injured patients.
RESULTS. One thousand forty-nine critical medical patients mechanically ventilated more
than 24 h were recruited. One hundred seventy-five patients received NIV during (median)
12 h (r: 1–216) whose failure led to endothracheal intubation and invasive mechanical
ventilation (IMV). Diagnosis and results are showed in the Tables 1, 2 and 3.
TABLE 1 ADMISSION DIAGNOSIS
Diagnosis IMVafter NIV
failure (N = 175)
IMV without
NIV (N = 874)
Pneumonia 72 (41.2%) 150 (17.2%)
COPD 30 (17.1%) 75 (8.6%)
Sepsis 11 (6.2%) 94 (10.8%)
Pancreatitis 6 (3.4%) 16 (1.8%)
ALI/ARDS 10 (5.7%) 13 (1.5%)
Admission diagnosis
TABLE 2 ADMISSION DIAGNOSIS
Diagnosis IMVafter NIV
failure (N = 175)
IMV without
NIV (N = 874)
ACS 2 (1.1%) 6 (0.7%)
Heart failure 12 (6.9%) 42 (4.8%)
Cardiogenic shock 8 (4.6%) 22 (2.5%)
Stroke 4 (2.4%) 102 (11.7%)




failure (N = 175)
IMV without previous
NIV (N = 874)
p
Age 63.3 ± 13.7 62.3 ± 15.3 0.3
APACHE II 21.8 ± 7.03 21.4 ± 7.6 0.4
SOFA respiratory 3.25 ± 0.85 2.7 ± 1.07 0.000
SOFA Glasgow 0.88 ± 1.1 1.8 ± 1.5 0.000
Total SOFA 8.3 ± 3.3 8.8 ± 3.5 0.04
IMV (days) 15.8 ± 15 12.3 ± 15.3 0.005
Tracheostomy 59 (33.7%) 216 (24.7%) 0.03
UCI mortality 63 (36%) 240 (27.5%) 0.02
CONCLUSIONS. NIV failure leads to: (1) A delayed endothracheal intubation. (2) Longer
duration of IMV. (3) Higher mortality in ICU. Therefore, we should be strict whit this
technique and its use should be restricted to those pathologies where clear benefits have been
demonstrated.
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PREDICTING FAILURE OF NON-INVASIVE VENTILATION: AN ASSESSMENT
OF THE USEFULNESS OF POTENTIAL PREDICTORS IN A UK TEACHING
HOSPITAL POPULATION
E. Dawe1, A. J. D. Parry-Jones2
1University Hospital of Wales, Cardiff, UK, 2Royal Gwent Hospital, Newport, UK
INTRODUCTION. Non-invasive ventilation (NIV) has many potential benefits, however,
careful patient selection and monitoring are important to its success. Many factors have been
related to NIV failure (either due to intubation or death). These include age, ARDS, pneu-
monia, a non-COPD background, high illness severity, low GCS, low pH, high PaCO2,
hypoxia, high respiratory rate and hypotension.
OBJECTIVES. This retrospective study aimed to assess the applicability of potential pre-
dictors of NIV failure to a standard mixed ICU population and to quantify the influence of
each of these factors by means of odds ratios.
METHODS. In a large UK teaching hospital all patients who had received NIV in the ICU
over 1 year (April 2007–April 2008) were retrospectively reviewed. Their diagnoses,
potential predictors, NIV use and success or failure were recorded. Predictors were examined
overall and separately in COPD and non-COPD patient groups.
RESULTS. Ninety-eight patients initiated a trial of NIV on the ICU in 1 year. Of these 55%
were successful, 28% resulted in intubation and 17% of patients died without intubation.
Survival was 80% to ICU and 72% to hospital discharge. The main diagnoses were ‘chest
infection’ (42%), pneumonia (19%) and pulmonary oedema/heart failure (18%). COPD was a
factor in 33% of patients. Extubation failure was a reason for NIV in 20% of patients. Surgical
patients made up 21% of the total.
Factors associated with failure were a non-COPD diagnosis (OR 5.53), age [40 (OR 6.13),
hypotension (OR 5.00), immune suppression (OR 2.48), pneumonia (OR 1.70) and extubation
failure (OR 1.76). Factors associated with success were surgical (vs. medical) conditions (OR
0.37) and pulmonary oedema/heart failure (OR 0.33). In the COPD group (81% success with
NIV) no factors strongly predicted failure. In the non-COPD group (44% success with NIV)
failure was associated with age [40 (OR 7.5), hypotension (OR 2.80) and immune sup-
pression (OR 3.15). Success was associated with pulmonary oedema/heart failure (OR 0.38)
and surgical conditions (OR 0.37).
CONCLUSIONS. In this mixed group of patients NIV failure was associated with: age[40,
diagnoses other than COPD or pulmonary oedema/heart failure, hypotension, immune sup-
pression, medical conditions, extubation failure and pneumonia. Therefore, NIV use in these
patients needs to be considered carefully.
REFERENCES. 1. Confalonieri et al (2005) A chart of failure risk for noninvasive venti-
lation in patients with COPD exacerbation. Eur Respir J 25:348–365. 2. Phua et al (2005)
Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive
respiratory disease versus other conditions: effectiveness and predictors of failure. Int Care
Med 31:533–539. 3. Antonelli et al (2001) Predictors of failure of noninvasive positive
pressure ventilation in patients with acute hypoxaemic respiratory failure: a multi-center
study. Int Care Med 27:1718–1728.
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EFFECTS OF NON-INVASIVE MECHANICAL VENTILATION ON HEMODY-
NAMICS AND GAS EXCHANGES PARAMETERS AFTER CARDIAC SURGERY IN
PATIENTS WITH RELATIVE HYPOXEMIA
A. Preisig1, V. B. Lagni2, V. L. Almeida3, E. A. Lucio3, S. R.R. Vieira4
1Irmandade Santa Casa de Misericordia de Porto Alegre, Intensive Care Unit, Sao Francisco
Hospital, Porto Alegre, Brazil, 2Instituto Porto Alegre, IPA, Porto Alegre, Brazil, 3Irmandade
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil, 4Hospital de Clinicas de
Porto Alegre, Porto Alegre, Brazil
INTRODUCTION. Non-invasive mechanical ventilation (NIV) has been used in hypoxic
post-operative cardiac patients but more studies are necessary to clarify its respiratory and
hemodynamic effects. Therefore, our objective was to study its effects in the oxygenation
index (PaO2/FiO2) and in hemodynamic variables in this group of patients.
METHODS. This is a randomized trial in which all post-operative cardiac patients since
April 2008, having a Swan–Ganz catheter and showing a PaO2/FiO2 between 150 and 300
(with FIO2 0.31), 1 h after extubation, were included. Intervention group used NIV with a bi-
level positive airway pressure (an inspiratory pressure to generate a tidal volume of 6 ml/kg
and an expiratory pressure of 7cmH2O) with a FIO2 0.4. Control group used oxygen by
Venturi mask in order to keep a good oxygenation. In both groups measurements were done in
basal situation and 1 h after beginning the treatment. Variables studied included: PaO2/FiO2,
PaO2, heart rate (HR), mean arterial pressure (MAP), pulmonary capillary wedge pressure
(PCWP) and cardiac output (CO) (Table 1)
TABLE 1 GAS EXCHANGE AND HEMODYNAMIC PARAMETERS
(*P\0.05)
Control group
(n = 19; mean age 63.6 ± 9.5)
NIV group (n = 17;
ean age 70.4 ± 7.4)
Basal 1 h p Basal 1 h p
PaO2/FIO2 245.7 ± 28.7 235.1 ± 45.2 0.320 252.2 ± 29.8 292.3 ± 55.5* 0.012
PaO2 77.2 ± 8.1 96.2 ± 17.2 \0.001 79.3 ± 8 118.1 ± 20.5* \0.001
HR 90.8 ± 12.3 93 ± 9.9 0.221 85.2 ± 12.3 82.2 ± 14.1* 0.146
MAP 77.6 ± 8.5 80.6 ± 7.8 0.288 81.4 ± 12.3 82.8 ± 11 0.583
PCWP 11.3 ± 4.9 11.1 ± 5.7 0.686 9.1 ± 4.1 10.9 ± 4.1 \0.001
CO 5.5 ± 1.7 5.6 ± 1.9 0.772 4.6 ± 1.9 4.4 ± 1.3* 0.268
RESULTS. Until now, 36 patients were included (20 male and 16 female). The most
important results are shown in the table below.
CONCLUSIONS. These preliminary results showed that NIV with bi-level pressure
improves oxygenation without significant hemodynamic changes, except a small increase in
PCWP and a trend to decrease in HR.
Poster Sessions
General perioperative care: 0495–0508
0495
THE USE OF INDOCYANINE GREEN IN THE EVALUATION OF HEPATIC
FUNCTION BEFORE AND AFTER HEPATIC RESECTION SURGERY
S. Afonso1, I. Miranda1, R. Matos1, R. Moreno1, P. Amado2, F. Oliveira Martins2
1UCIP, Hospital de Sto. Anto´nio dos Capuchos, CHLC EPE, Lisbon, Portugal, 2S. Cirurgia 2-
1, Hospital de Sto. Anto´nio dos Capuchos, CHLC EPE, Lisbon, Portugal
INTRODUCTION. Inadequate functional reserve of the remaining hepatic parenchyma after
surgical resection, is associated with progression of liver failure. A non-invasive liver func-
tion monitoring system, the LiMON (Pulsion) has been developed to measure indocyanine
green (ICG) elimination by pulse spectrophotometry. The ICG retention rate at 15 min (R15)
and ICG plasma disappearance rate (PDR) have both been used as predictors of postoperative
liver failure and mortality, in particular in patients with mild to moderate liver dysfunction
prior to surgery.The aim of this study is to evaluate the use of this method in patients
submitted to hepatic resection and admitted to the ICU.
METHODS. From July 2008 to March 2009, we evaluated 21 patients that have been
submitted to hepatic resection surgery and have been admitted to the ICU postoperatively.
The administration of ICG in a dose weight-adjusted was performed before and after the
surgery (1–2nd day). ICGPDR and ICGR15 were measured and their values were registered.
RESULTS. From the 21 patients, 6 were excluded from analysis due to incomplete infor-
mation. 15 patients were evaluated, mostly female (11 vs. 4), with a mean age of 57.5 years.
The majority (10 patients) had liver metastasis secondary to breast cancer or from gastro-
intestinal tract cancer, 2 patients had a primary neoplasm of the liver and the others had
benign disease (cysts, adenoma). The assessment of liver function by the conventional tests
(total bilirubin, albumin, INR) was within the normal range or presented just slightly changes.
All patients were included in the Child-Pugh Class A. In the group of patients with secondary
liver cancer, 2 had ICG values outside the normal range. One patient with low PDR (14.4%/
min) and high R15 (11.5%) preoperatively and with postoperative normalization of the value
of R15. Another patient with only PDR altered preoperatively (16.5%/min) that normalised in
the post-surgery determination. These two patients had 70 and 74 years old and both had
rectum cancer, with previous removal of the primary location and liver metastasis.In the
group of patients with primary tumour of the liver and with benign disease the values of PDR
and R15 were within normal limits. All patients were discharged alive from the hospital.
CONCLUSIONS. ICG PDR and R15 measured by pulse spectrophotometry is a quick, non-
invasive and reliable liver function test that helps the surgeon to estimate liver reserve and to
plan the surgery according to this data. The performance of hepatic surgery, monitored in the
pre-operative stage by this technique, presented a good outcome in this group of patients.
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LIVER TRANSPLANTATION WITH GRAFTS FROM DONOR ASISTOLIA VER-
SUS DONOR BRAIN DEATH—PRELIMINARY RESULTS
C. Pe´rez Castan˜o1, E. Regidor Sanz1, J. C. Montejo Gonzale´z1, C. G. Mercedes1, J. C. Meneu
Diaz1, E. Moreno Gonzalez1
1Hospital Doce de Octubre, Madrid, Spain
INTRODUCTION. The possibility of using donor liver grafts asistolia (DA) increases the
availability of organs for liver transplantation (WR). In donor asistolia there may be an
increase in the immediate postoperative complications of graft preservation injury and sub-
sequent dysfunction of the same.
OBJECTIVE. To evaluate differences in the immediate postoperative period with grafts
from DA (TXHDA) compared to donor brain death (DME) (TxHDME).
MATERIAL AND METHODS. A prospective case-control in adult patients with WR.
Study period: 3 years. Patients were divided into two groups according to type of graft: The
study group: TxHDA; Control group: TxHDME. Both were treated with the same protocol.
We analyzed parameters of the postoperative donor and recipient. Statistical analysis was
performed with SPSSv11.
RESULTS. We included 54 patients: TxHDME: 26; TxHDA: 28. The DA had the highest
figures of cytolysis, amylase, rhabdomyolysis, metabolic acidosis and hyperglycemia that
DME. There were differences in the severity of Child-Pugh (C 42 vs. 53.6%, B 32.1 vs. 50%,
8 vs. 14.3%) and MELD 14 ± 4.7 pre-WR. The mean age was higher TxHDA (56.63 ± 9.42
vs. 52 ± 11 years). There was no difference in ischemic stroke. The incidence of immediate
postoperative complications in the ICU was higher in group TxHDA (69.94% vs. 55%). A
greater incidence of reperfusion syndrome (78.57 vs. 31%), graft dysfunction (35.7 vs. 15%)
and degree of coagulopathy during the first 72 h post-WR in TxHDA. TxHDA Six patients
required retransplantation and none TxHDME. The ICU and hospital stay was also higher in
TxHDA 7.09 ± 4.11 versus 10.74 ± 4.63 days and 21.94 ± 19.77 versus
20.43 ± 11.12 days, respectively. In this group the mortality in the ICU was 17.86%. No
patient died in TxHDME.
CONCLUSIONS.
1. TxHDA the higher incidence of reperfusion syndrome, graft dysfunction and that the
coagulopathy TxHDME, indicating greater amount of blood during surgery and the
postoperative period.
2. TxHDA the higher incidence of immediate postoperative complications
3. There is increased hospital mortality in group TxHDA related characteristics of recipients
and graft.
4. The data should be confirmed with more cases.
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BLOOD LACTATE AND APACHE IIAND MODS SCORE IN SEVERE SEPSIS
WITH LIVER TRANSPLANTATION
S.-W. Huang1, X.-D. Guan1
1The First Affiliated Hospital of Sun-Yat Sen University (SUMS), Surgical Intensive Care
Unit (SICU), Guangzhou, China
OBJECTIVES. Lactate levels are a useful tool in monitoring septic patients. However, blood
lactate levels often changes when liver dysfunction. The prognostic significance of blood
lactate in severe sepsis with or without orthotopic liver transplantation (OLT) was investi-
gated in this study.
METHODS. 30 septic patients in non-OLT group and 26 septic patients in OLT group. Blood
lactate and APACHE II and MODS score were checked in 1, 3 and 7 day, respectively.
RESULTS. There was significant difference in 28 days survival rate between non-OLT group
and OLT group (70 vs.43.4%, P \ 0.05) and blood lactate in 1 day (2.1 ± 1.1 vs.
6.1 ± 2.1 mmol/L, P \ 0.05). Blood lactate in OLT group was constant higher than that in
non-OLT group in 7 day (2.9 ± 1.6 vs.1.5 ± 1.1 mmol/L, P \ 0.05). The MODS score in
OLT group was higher than that in non-OLT group in 7 day (7.1 ± 2.9 vs.11.1 ± 3.4,
P \ 0.05), but not in APACHE II.
CONCLUSIONS. Failure to improve blood lactate in 1 day is a strong predictor of mortality
in severe sepsis patients with liver transplantation. To assess failure organs in severe sepsis
patients with liver transplantation, MODS score is better than APACHE II.
KEYWORDS: Orthotopic liver transplantation (OLT); Sepsis; Blood lactate
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CORRELATION BETWEEN ELECTROCARDIOGRAPHY SIGNS OF MYOCAR-
DIAL ISCHEMIA AND VALUES OF CARDIO SPECIFIC ENZYMES
G. Gazivoda1, N. Kovacevic Kostic2, L. Soskic2, B. Milicic3, I. Divac3
1Institute for Cardiovascular Diseases Clinical Centar Serbia, Intensive Care, Belgrade,
Serbia, 2Institute for Cardiovascular Diseases Clinical Centar Serbia, Belgrade, Serbia,
3Institute of Cardiovascular Diseases Clinical Centar Serbia, Belgrade, Serbia
OBJECTIVE. Diagnosis of perioperative myocardial infarction after cardiosurgical proce-
dures rely on a combination of electrocardiography (ECG) changes and postoperative values
of cardio specific enzymes. As in this conditions myocardial ischemia is the most often global,
ECG changes are unspecific. In this study we correlate ECG changes with the values of cardio
specific enzymes.
METHODS. In the study were enrolled 112 patients scheduled for elective aorto-coronary
bypass or heart valve surgery. ECG was recorded preoperatively and the first postoperative
day and the presence of ischemic changes were followed. Criteria of myocardial damage
were: new appearance of Q wave, ST elevation more than 0.2 mV and ST depression more
than 0.1 mV. Values of cardiac troponin I (cTnI) were measured before the operation, 6 and
24 h after the operation. Incidence of ECG changes were correlated with values of cTnI. Data
were analyzed using Mann–Whitney U test and Wilcoxon test.
RESULTS. Presence of ECG ischemic changes did not represent statistically significant
correlation with the postoperative values of cTnI.
CONCLUSION. As the presence of ischemic ECG changes after elective cardio surgical
procedures did not correlates with the values of cTnI it can be concluded that after extra-
corporeal circulation ECG is not specific marker of myocardial ischemia. In this conditions
ischemia is the most often global, and the clinicians can not rely just on ECG changes in the
diagnosis of perioperative myocardial infarction.
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CENTRAL VENOUS OXYGEN SATURATION VALUES ARE RELATED TO THE
NUMBER OF COMPLICATIONS IN POSTOPERATIVE PATIENTS
E. Agustin1, J. I. Go´mez-Herreras1
1Rio Hortega University Hospital, Valladolid, Spain
INTRODUCTION AND OBJECTIVES. Several studies have stablished the use of central
venous oxygen saturation values as a guide for the treatment in critically ill patients [1, 2].
The aim of our study has been to analyze the relationship between the central venous oxygen
saturation (ScvO2) values and the number of complications in postoperative abdominal sur-
gical patients.
MATERIAL AND METHODS. ScvO2 were assesed every 4 h since the patients get into the
Unit and during the first 24 h from the central lines of 307 postoperative patients. We
included ASA I–IV patients who were sent to the Critical Care Unit (33.5% females, 66.5%
males). Complications in the Critical Care Unit were registered. A t Student test for non-
dependent samples with a type error of 5% was used.
RESULTS. The mean value of ScvO2 was the only one related with the number of com-
plications in the Critical Care Unit. Data (ScvO2 values in patients with 1, 2 or C3
complications) are shown in the Graph.
CONCLUSIONS. Patients with higher number of complications (C3 complications) in the
Critical Care Unit had lower ScvO2 values than those with less number of complications.
Mean ScvO2 and number of complications
REFERENCE(S). 1. Reinhart K, Kuhn HJ, Hartog C, Bredle DL (2004) Continuous central
venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care
Med 30:1572–1578.
2. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al (2004) Surviving




ADMINISTRATION OF HIGH-DOSE TRANEXAMIC ACID IN OPEN HEART
PROCEDURES MIGHT BE ASSOCIATED WITH INCREASED RISK OF DEATH
M. Sander1, C. D. Spies1, V. Martiny1, C. von Heymann1
1Charite´-Universitaetsmedizin Berlin, Department of Anaesthesiology and Intensive Care
Medicine, Berlin, Germany
AIMS. Antifibrinolytic agents are commonly used during cardiac surgery to minimize
bleeding. In 2006, retrospective data from the Mc SPI database seemed to show that the use of
aprotinin was associated with an increased risk of complications after cardiac surgery and
even with an increased mortality [1, 2]. In 2007 data from the BART trial was published [3],
showing a higher rate of deaths in patients receiving aprotinin. In 2008 data from a retro-
spective study liked the use of tranexamic acid (TXA) to an increased rate of seizures after
open heart procedures [4].
So still the question about safety of aprotinin and TXA is not solved. Therefore, the aim of
this study was to evaluate the efficiency and the safety profile of TXA compared to aprotinin
in open heart procedures by this prospective observatory study.
METHODS. After publication of the first Mangano paper raising concerns about the safety
profile of aprotinin we changed our routine adminstration of antifibrinolytics to 50 mg/kg
TXA prior CPB and 50 mg/kg into the priming fluid of the CPB. Prior to this paper all
patients received aprotinin after sternotomy in a dose of 1.5 9 106 KIU. After consent for this
retrospective observatory study we included 320 consecutive patients undergoing open heart
procedures (105 receiving TXA and 215 receiving aprotinin) into our final analysis. Effi-
ciency was evaluated by the need for transfusion of blood products and total postoperative
blood loss. Safety was evaluated by mortality, routinely monitored biomarkers and the
diagnosis of myocardial infarction, ischemic stroke, convulsive seizures, acute renal failure
and pericardial tamponade during ICU and IMCU stay. Data is provided as mean and standard
deviation or percentage of patients in the respective groups.
RESULTS. Patients receiving TXA had increased in hospital mortality (16.2 vs. 7.5%;
p = 0.01). The rate of convulsive seizures was increased in patients receiving TXA (6.7 vs.
1.9%; p = 0.03). Patients receiving TXA had increased total postoperative blood loss during
first 48 h ICU stay [845 mL (1065) vs. 508 mL (507); p \ 0.01], increased rate of surgical
reexploration (14.3 vs. 3.3%; p \ 0.01) and 50.9 vs. 37.3% patients received red blood cell
transfusion (p \ 0.01). Patients receiving aprotinin showed a tendency for increased stroke
(4.2 vs. 1.0%; p = 0.12) and had increased neurologic disabilities (7.0 vs. 1.0%; p = 0.02).
No difference regarding biomarkers, myocardial infarction, acute renal failure and pericardial
tamponade was observed.
DISCUSSION. The minor efficiency of TXA and the increased in hospital mortality and rate
of transfusion, surgical reexploration and a higher rate of con-vulsive seizures warrant critical
reconsideration of routine administration of high dose TXA. Further prospective studies
evaluating the efficacy and safety profile of TXA are urgently needed.
REFERENCES. 1. Mangano D (2007) JAMA. 2. Mangano D (2003) N Engl J Med. 3.
Fergusson DA (2008) N Engl J Med. 4. Martin K (2008) Anesth Analg.
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RELATIVE IMPACT OF ADULT CARDIAC SURGERY RELATED ACUTE RENAL
FAILURE (ACS-ARF) AND ORGAN DYSFUNCTION OR FAILURE ON OUTCOME.
A PROSPECTIVE COHORT STUDY
R. Ceriani1, M. Mazzoni1, C. Solinas1, G. Villa1, M. Gabuda1, M. Cortinovis1, R. De Maria2,
M. Parolini2, V. Arena3, F. Bortone1
1Humanitas Gavazzeni, Anesthesia and ICU, Bergamo, Italy, 2CNR Clinical Physiology
Institute, Section of Milano, Ospedale Ca’ Granda, Milano, Italy, 3Humanitas Gavazzeni,
Cardiac Surgery, Bergamo, Italy
INTRODUCTION. ACS-ARF is a frequent complication which impacts on postoperative
length of stay (LOS) and mortality. Its relationship with occurrence of organ dysfunction or
failure has not been evidenced by prior studies.
OBJECTIVES. To evaluate relationship between ACS-ARF and organ failure on outcome in
cardiac surgery patients
METHODS. Single center, prospective cohort study on consecutive cardiac surgery patients.
ARF was classified according to international consensus classification of RIFLE. Prospec-
tively collected clinical and laboratory data were used for assessing organ dysfunction and
outcome.
RESULTS. Among 700 subjects the incidence of ARF was 17%. ARF Risk occurred in 59
(48%), ARF Injury in 43 (36%) and ARF Failure in 19 (16%). Renal Replacement Therapy
was performed in 13 (11%) ARF subjects. Compared to those without ARF, patients with
ARF had longer ICU stay (median days 2 [interquartile range 2–3] vs. 5 [3–7]) and hospital
stay (8 [7–11] vs. 12 [9–15]). In the overall cohort, in-hospital mortality rate was 1.7%. In
subjects without ARF, mortality was 0.2%, in those with ARF Risk 5%, with ARF Injury 2%
and in those with ARF Failure 37%. After univariable and multivariable logistic regression
analysis, age (OR 1.04 [1.02–1.07 95% CI]), additive EUROScore (OR 1.09 [1.01–1.18 95%
CI]) and total SOFA score on postoperative day 1 (OR 1.32 [1.20–1.44 95% CI]) were
independent predictors of ARF development. In the multivariable logistic regression model,
besides ARF (4.87 [2.88–8.23 95% CI]), additive EuroSCORE (OR 1.27 [1.17–1.38 95%
CI]), cardiovascular SOFA score (OR 1.39 [1.07–1.80 95% CI]) and Total SOFA score on day
1 OR 1.27 ([1.10–1.4895% CI]) were associated with prolonged ICU LOS. Furthermore,
independent predictors of a longer hospital LOS were additive EuroSCORE (OR 1.20 [1.126–
1.284 95% CI]), ARF (OR 1.973 [1.239–3.141 95% CI]), and total SOFA score on day 1 (OR
1.133 [1.033–1.243 95% CI]). At univariable logistic regression analysis, respiratory, platelet,
liver, renal and total SOFA score were associated with outcome. At multivariate logistic
regression analysis total SOFA score on day 1 (OR 1.813 [1.222–2.691 95% CI]) and multi
organ failure (OR 5.515 [1.014–29.980]) were predictive of mortality.
CONCLUSIONS. ACS ARF is a risk factor for prolonged ICU and hospital stay, it is
aggravated by high mortality rates and it parallels organ dysfunction and failure in the
postoperative setting.
REFERENCE. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis
Quality Initiative Workgroup (2004) Acute renal failure—definition, outcome measures,
animal models, fluid therapy and information technology needs: the Second International
Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care
8(4):R204–R212
0502
PLATELET REACTIVITY DURING CARDIOPULMONARY BYPASS - MARKED
REDUCTION FOLLOWED BY EARLY RESTITUTION
G. Ehnsio¨1, J. Norderfeldt1, J. Alfredsson2, S. Berg1
1University Hospital, Linko¨ping, Heart Centre, Department of Cardiothoracic Anaesthesia
and Intensive care, Linko¨ping, Sweden, 2University Hospital, Linko¨ping, Heart Centre, Dep.
of Cardiology, Linko¨ping, Sweden
INTRODUCTION. Cardiopulmonary bypass (CPB) affects platelets, and platelet dysfunc-
tion is considered to be an important risk factor for post-operative bleeding after coronary
artery bypass graft (CABG) surgery. Monitoring platelet function in the peri-operative period
therefore is of importance to reduce morbidity due to both bleeding and post-operative graft
occlusion. Our aim was to study platelet reactivity in CABG patients in the peri-operative
period.
METHODS. Platelet function in 30 patients undergoing CABG was analyzed using an
impedance aggregometry point-of-care (POC) instrument (Multiplate). Platelet reactivity
was measured preoperatively at induction of anaesthesia, preoperatively immediately before
CPB, after 30 minutes of CPB, after end of CPB, postoperatively at arrival to the ICU and
finally at 3 and 18 h after surgery. Whole blood platelet aggregation was measured after
activation with ADP (adenosin diphosphate), TRAP (thrombin receptor activating peptide),
AA (arachidonic acid) and collagen. Platelet count was measured, and circulating platelet
pool was assessed by correcting for hemodilution by indexing to hemoglobin. Non-parametric
statistics were used, results are presented as median and 25–75%-percentiles.
RESULTS. Reactivity to ADP, TRAP and AA agonists was significantly reduced at 30 min
of CPB and at the end of CPB, followed by a rapid increase after CPB to preoperative values.
Collagen showed a similar, but not significant, decrease during CPB followed by a post-CPB
increase to values above baseline (p \ 0.001). Platelet count dropped after 30 min of CPB
from 240 (204–301) preoperatively to 150 (132–189) after 30 min of CPB and further to 134
(120–151) 9 109/L at the end of CPB (p \ 0.001). Corrected for blood loss and hemodilution
there was a reduced platelet pool at the end of CPB and at arrival at the ICU (p \ 0.001)
CONCLUSION. There is an early decrease in platelet reactivity during CPB followed by a
rapid post-CPB restitution of platelet function, despite low preoperative aggregometry values
and lower post-CPB platelet count. The rapid preoperative changes in aggregometry points to
a possible role for POC analysis of hemostatic function. The post-CPB increase in platelet
reactivity simultaneously to the decrease in platelet count could imply increased aggregating
tendency for remaining platelets, with possible implications for early graft failure and post-
operative anti-platelet therapy.
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CRITICAL RHABDOMYOLYSIS AFTER SURGERY FOR ACUTE AORTIC
DISSECTION
H. Murayama1, H. Kito1, S. Asano1
1Chiba Prefectural Cardiovascular Center, Chiba, Japan
BACKGROUND. Rhabdomyolysis is an important cause of acute renal failure and poten-
tially life threatening especially after aggressive operation such as acute aortic dissection
surgery. Our experience are showed and analysis of the factors resulting in rhabdomyolysis
are presented.
METHODS. We retrospectively analysed 50 patients who underwent emergent acute aortic
dissection operation over past 3 years. Among them, five patients (10%) presented critical
rhabdomyolysus (myoglobin [ 10,000 ng/ml) postoperatively without significant findings of
limb ischemia.
RESULTS. Among 5 cases, mean extracorporeal circulation (ECC) time was 418 min,
cardiac arrest time was 169 min, open distal anastomosis time was 107 min. Rhabdomyolysis
occured immediately after operation and maximum serum myoglobin level was 56,530 ng/ml
(mean) on the postoperative day of 1or2. Continuous veno-venous hemodiafiltration (CVVH)
was performed in 3 cases for 3.5 days. One case with mesenteric malperfusion died of
multiple organ failure. Factors influencing onset of rhabdomyolysis were ECCtime
(p = 0.003) and operation time (P = 0.002) . ECCtime and CPK level on the 1st operative
day correlated significantly (rs = 0.62 p \ 0.01) in total 50 cases.
CONCLUSION. 10% of cases after emergent operation for acute aortic dissection showed
critical rhabdomyolysis. With intensive treatment including CVVH, rhabdomyolysis was
treated successfully in four patients.
0504
RISK FACTORS FOR VOCAL CORD PARALYSIS IN PATIENTS UNDERGOING
CARDIOVASCULAR SURGERY
R. Seo1, H. Mima1, H. Seo1, M. Tanaka1, K. Sato1, S. Maekawa1, H. Yamashita1, N. Hi-
gashibeppu1, S. Okazaki1, I. Miyawaki1, K. Yamazaki1
1Kobe City Medical Center General Hospital, Department of Anesthesia and Critical Care,
Kobe, Japan
INTRODUCTION. Vocal cord paralysis is known as a complication of cardiovascular
surgery. But its risk factors are unknown.
OBJECTIVES. We examined postoperative risk factors for vocal cord paralysis after car-
diovascular surgery.
METHODS. A prospective observational study. 113 patients (female, 46; male, 67) who
underwent coronary artery bypass graft, valve, and/or aortic operations were enrolled.
Flexible laryngoscopy was performed on all patients to evaluate vocal cord function within
24 h after extubation. Sex, age, tracheal tube cuff pressure after operation, emergent opera-
tion, body mass index (BMI), chronic renal failure on hemodialysis, hypertension, diabetes
mellitus (DM), chronic obstructive lung disease, history of smoking, history of cerebral
infarction, history of coronary artery disease and operation time were evaluated as risk factors
using Pearson’s chi-square test. Multivariate analysis was performed among parameters with
a p value less than 0.20.
RESULTS. 33 patients (29.2%) had ipsilateral or bilateral vocal cord paralysis. Left vocal
cord paralysis occurred more frequently (26 patients) than right (6 patients) or bilateral (1
patient). Multivariate analysis revealed that incidence of vocal cord paralysis significantly
increased with DM (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.2–8.7), operation
time greater than 8 h (OR, 3.2; 95% CI, 1.1–9.1) and BMI less than 25 (OR, 3.6; 95% CI, 1.2–
13.0).
CONCLUSIONS. DM, operation time greater than 8 h and BMI less than 25 were significant
risk factors for vocal cord paralysis after cardiovascular surgery.
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PERIOPERATIVE MANAGMENT OF PATIENT WITH CHRONIC OBSTRUCTIVE
PULMONARY DISEASE (COPD)
M. L. De Prisco1, R. Sicilia1, A. D’Agostino1, R. Naimoli1, A. Mignone1, C. Candurro1,
F. Chiumiento1
1P. O. ‘‘S. Francesco d’Assisi ASL Salerno, U. O. di Anestesia e Rianimazione Dip. Area
Critica, Oliveto Citra, Italy
INTRODUCTION. There is lack of studies investigating procedures aiming at a decrease in
perioperative mortality in patients with COPD. Perioperative attention should be focused on a
secure airway and the duration of monitoring that is necessary regarding severity of COPD,
surgical stress and respiratory function. Postoperatively, residual neuromuscular blockade and
a supine position have to be avoided. CPAP or NIPPV should be administered as soon as
feasible after surgery.
METHODS. 8 postoperative abdominal surgery patients with COPD (6 m, 2 f), age
72.5 ± 5.5, were studied (elective sigmoid resection four patients; elective right hemicol-
ectomy four patients, emergency right hemicolectomy four patients). All patients receive
balanced anaesthesia (remifentanyl ? sevoflurane), postoperative continuos epidural anal-
gesia (bupivacaine 0.5% 10 ml/h for 3 days) ? tramadol i.v. and BIPAP with mask (2
patients, IPAP/EPAP 10–12/4–5 cmH20; Fr = 10–12) or CPAP with mask and Boussignac
valve (6 patients PEEP = 4–6 cmH2O), in postoperative.
RESULTS. No adverse respiratory events were observed in all patients. Epidural bupivacaine
plus tramadol resulting in excellent pain relief. The patients were discharged home
5 ± 2 days after surgery.
CONCLUSIONS. Perioperative administration of BiPAP or CPAP, excellent pain control by
continuous epidural infusion of local anesthetic may have contributed to these patient’s
uncomplicated postoperative course.
REFERENCES. 1. Licher M et al (2007) Perioperative medical management of patients with
COPD. Int J Chron Obstruct Pulmon Dis 2(4):493–515. 2. Maddali MM (2008) Chronic
obstructive lung disease: perioperative management. Middle East J Anesthesiol 19(6):1219–
1239. 3. Slinger P (2008) Perioperative lung injury. Best Pract Res Clin Anaesthesiol
22(1):177–191. 4. Wolthuis EK et al (2008) Mechanical ventilation with lower tidal volumes
and positive end-expiratory pressure prevents pulmonary inflammation in patients without
preexisting lung injury. Anesthesiology 108(1):46–54
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NO SAD (DAILY NOTIFICATION OF SLUMBER OR SEDATION, ANALGESIA,
ABSTINENCE, AND DELIRIUM)
A. Vanzan1, M. Knibel1, E. Guimara˜es1, C. Roderjan1, E. Neto1, L. R. Silva1, A. Affonso1,
M. Murta1, P. Azambuja1
1Hospital Sa˜o Lucas, Rio de Janeiro, Brazil
OBJECTIVE. To evaluate the introduction of a new protocol called NO SAD (daily noti-
fication of slumber or sedation, analgesia, abstinence, and delirium). In other words, it is a
daily-collected evaluation and notification of alterations in slumber, degree of sedation, and
analgesia as well as symptoms and signs of abstinence and delirium. The protocol encom-
passes the four evaluations above once they share some characteristics as to their its
manifestations, treatments and success in ICU release.
METHODS. All the patients would be evaluated in the morning by the team of medical and
nursing professionals, followed by the listing of guidelines based on the protocols of sedation,
analgesia, abstinence, and delirium, aiming at an uniform guideline making.
Patients would be evaluated at any moment and the guidelines changed accordingly in case
the clinical profile showed any alterations.
Slumber evaluation would be carried out through simple patient questioning. Sedation levels
would be checked by means of the Ramsay scale and Richmond’s agitation and sedation
scales (RASS).
Pain would be classified in relation to intensity with the numeric scale from (0) absence of
pain to (10) unimaginable pain.
Tobacco abstinence would be prevented by using nicotine pads.
The use of alcohol, opioids, and benzodiazepinics would be registered and abstinence
symptoms looked for during daily evaluation.
Delirium would be evaluated through CAM-ICU, a confusion assessment method for ICU-
committed sensitive and 95% specificity patients.
RESULTS. The introduction of such protocol has been carried out during a 2-week training
period attended by the physicians and nursing teams.
After training the evaluation of sedation and analgesia quality as well as abstinence signs and
delirium happened on regular and systematic basis with guidelines made according to
established protocols.
CONCLUSION. The introduction of a protocol that joins the evaluation of slumber and
sedation quality and the occurrence of pain, delirium and abstinence enabled the standardi-
zation of treatment by a trained team improving the assistance quality.
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ELECTRIC NEUROMUSCULAR STIMULATION FOR PREVENTION OF ICU
ACQUIRED PARESIS IN PATIENTS WITH SEVERE SEPSIS
P. Rodriguez1, I. Bonelli1, M. Setten1, S. Attie1, P. Maskin1, S. Kozima2, R. Valentini1
1CEMIC, Centro de Educacio´n Me´dica e Investigaciones Clı´nicas, Terapia Intensiva, Buenos
Aires, Argentina, 2CEMIC, Centro de Educacio´n Me´dica e Investigaciones Clı´nicas, Diag-
no´stico por Ima´genes, Buenos Aires, Argentina
INTRODUCTION. Muscle weakness is frequently recognized in septic patients requiring
mechanical ventilation (MV) after awakening. This acquired paresis has prognostic impli-
cations. However, no specific preventive or therapeutic treatment has been described.
OBJECTIVE. To evaluate the potential protective effect of transcutaneous electric neuro-
muscular stimulation (TENS) on muscle strength, in patients on MV suffering from severe
sepsis.
METHODS. Patients were included in the first 48 h following ICU admission when sepsis
requiring MV and organ failure, other than respiratory dysfunction (SOFA score C3), were
present. Those with previous neurological or orthopaedic diseases, prolonged immobilization
or marked alteration of performance status were not included.
TENS on biceps and quadriceps of one side of the body was performed twice a day (30 min)
with a Multiplex Classic device (Meditea, Argentina) in LP mode from inclusion until MV
withdrawal. Stimulation side was randomised on inclusion according with cerebral
dominance.
Measurements were performed by blinded operators (physiotherapist and radiologist). Arm
and thigh circumference and biceps thickness measured by echography were registered every
72 h. Biceps and quadriceps strength was evaluated with the Medical Research Council
(MRC) grading system (0 paralysis to 5 normal force) before MV withdrawal.
Continuous data are expressed as median (25–75th percentiles). Wilcoxon signed ranks test
was used for comparisons.
RESULTS. Twelve patients were included. APACHE II and SOFA at inclusion were 19 (17–
27) and 10 (9–12). Length of stay in the ICU was 23 days (12–43). TENS was applied for
14 days (6–36). Three patients died before muscle strength evaluation was possible.
Changes in arm (DArm) and thigh (DThigh) circumference and biceps thickness (DBiceps)
from baseline to MV withdrawal and muscle force performance are shown in the Table 1.
TABLE 1
Stimulated side Non stimulated side P
DArm (cm) -1.0 (-2.5–0.0) -0.5 (-2.5–0.0) 0.919
DThigh (cm) 1.0 (-0.5–4.1) 1.7 (0.0–3.5) 0.202
DBiceps (mm) 0.0 (-2.5–1.8) -1.0 (-1.6–1.0) 0.838
Biceps forcea 4.0 (3.0–4.0) 3.0 (2.0–4.0) 0.025
Quadriceps forcea 3.0 (3.0–4.0) 3.0 (2.0–3.5) 0.180
aMRC score, n = 9
CONCLUSIONS. We observed a clinically significant increase in muscle strength in stim-
ulated biceps. However, no change in circumference and biceps thickness was found,
suggesting that force preservation was not related to less muscle mass loss.
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ELECTRICAL MUSCLE STIMULATION PREVENTS CRITICAL ILLNESS POLY-
NEUROMYOPATHY IN ICU PATIENTS - A RANDOMIZED PARALLEL
INTERVENTION TRIAL
C. Routsi1, V. Gerovasili1, D. Zervakis1, E. Karatzanos1, E. Papadopoulos1, T. Pitsolis1, E.
Tripodaki1, C. Manetos1, V. Markaki1, S. Nanas1
1National Kapodistrian University of Athens, First Critical Care Medicine Department,
Evaggelismos Hospital, Athens, Greece
INTRODUCTION. Critical illness polyneuromyopathy (CIPNM) is a common consequence
of critical illness presenting with limb weakness and delayed weaning, resulting in extended
ICU and hospital stay and increased health cost. No effective method of prevention or
treatment has been suggested. Electrical muscle stimulation (EMS) has been used effectively
in patients with severe COPD or advanced CHF in improving muscle strength and exercise
tolerance. This study was aimed at investigating the role of EMS in preventing the appearance
of CIPNM.
METHOD. One hundred twenty-six consecutive patients (82 male and 44 female, age:
59 ± 19 years) admitted to the ICU were evaluated using the APACHE II (18 ± 5). Patients
with APACHE II score C 13 at admission were assigned, after stratified randomization (age,
gender), to an EMS intervention and a control (CON) group. Exclusion criteria were pre-
existing neuromuscular disease, terminal disease, BMI [ 35 kg/m2, age \ 18 years,
pregnancy, connective tissue disease, bone fractures, skin lesions that did not allow the use of
EMS, pacemakers, readmission, length of stay\48 h. EMS (45 Hz, 400 ls, 12 s on–6 s off,
at intensities able to cause visible contractions) was applied to the vastus lateralis, vastus
medialis and peroneus longus of both lower limbs 7 days/week, 45 min/session, once daily.
The CIPNM diagnosis was based on the MRC scale for muscle strength, which requires
patient’s cooperation. Grading was conducted by two independent investigators within 24 h,
on 12 muscle groups of the upper and lower limbs. MRC score \48 (out of 60) was the
diagnostic criterion for CIPNM. Statistical analysis employed chi-square and Kaplan–Meier
analysis.
RESULTS. CIPNM evaluation was feasible in 50 patients (EMS group: 23, CON group: 27)
out of 126 (44 died, 32 had poor cooperation). Three patients of the EMS group (13%) and 11
of the CON group (41%) were diagnosed with CIPNM. A chi-square test showed significant
between-group difference (p \ 0.05). Based on Kaplan-Meier analysis, a difference
(p = 0.07) between the EMS group (mean ± SD: 13 ± 9 days, median: 9, range: 4–33) and
the CON group (mean ± SD: 21 ± 19 days, median: 15, range: 3–90) was observed in length
of stay, while similar results were obtained in weaning from mechanical ventilation. Fur-
thermore, Kaplan–Meier analysis confirmed a significant difference (p \ 0.05) between those
with and those without CIPNM, irrespective of EMS application, in terms of length of stay
and weaning.
CONCLUSION. These results show that EMS prevents development of CIPNM. Further
research is necessary to explore the pathophysiological mechanisms that are involved in the
prevention of CIPNM with the use of EMS as well as the EMS characteristics that yield the
maximum benefit on CIPNM prevention.
This research project is co-financed by EU, European Social Fund (75%) and the Greek
Ministry of Development, General Secretariat for Research and Technology (25%).
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THE EFFECT OF 6% HYDROXYETHYLSTARCH 130/0.4 AND 4% GELATIN ON
COAGULATION AND BLOOD TRANSFUSION REQUIREMENTS AFTER CAR-
DIAC SURGERY
A. Von Metz1, A. Lo¨ckinger2, I. Lorenz1, B. Friesenecker1, C. Velik-Salchner2, E. Oswald2,
P. Innerhofer2, D. Fries1
1Medical University Innsbruck, General and Surgical Critical Care Medicine, Innsbruck,
Austria, 2Medical University Innsbruck, University Hospital for Anaesthesia and Intensive
Care Medicine, Innsbruck, Austria
BACKGROUND. The question as to the optimal volume replacement for compensating
intravascular blood loss is subject of ongoing controversy. Gelatin preparations impair fibrin
polymerization and disturb the network of the fibrin monomers in addition to their dilutional
effects. Moreover, reduced clot elasticity and clot weight have been reported because of
gelatin based volume replacement. Hydroxyethyl starch (HES) is associated with an increased
tendency for bleeding, especially when using high molecular weight solutions with high
replacement degree. HES solutions cause a von Willebrand type 1-like syndrome charac-
terized by diminished FVIII activity, diminished vWF plasma levels and impaired fibrin
polymerization. 6% HES 130/0.4 (Voluven, Fresenius, Pharma Austria GmbH), a modern,
medium molecular weight and low substitution degree starch preparation was hypothesized to
affect the coagulation system less strong than older HES preparations.
Until now, no clinical data are available comparing the effects of 6% HES 130/0.4 (Volu-
ven) and gelatin on coagulation parameters and transfusion of blood products in patients
following cardiac surgery.
MATERIALS AND METHODS. 1.050 patients were analysed retrospectively after cardiac
surgery between January 2005 and December 2006. They either received gelatin (n = 633) or
gelatine in combination with 6% HES 130/0.4 (Voluven, Fresenius). Coagulation parameters
and blood transfusion requirements were evaluated immediately after ICU admission and on
the first postoperative day. Differences in laboratory parameters between time of ICU
admission and the first postoperative day between these groups (gelatine vs. gelatine/HES)
were analyzed using a t test for independent groups. Differences in blood products usage were
analyzed using a Mann–Whitney U test, since assumption of normality were not attained. P
values \ 0.05 were assumed statistically significant.
RESULTS AND DISCUSSION. Upon admission to the ICU and on the first day after
surgery, patients who received 6% HES 130/0.4 showed a significantly smaller increase in
plasma fibrinogen concentrations (60 ± 61 vs. 71 ± 63 mg/dl; p = 0.006) when compared to
patients treated with gelatin alone after cardiac surgery. This effect of 6% HES 130/0.4 on
plasma fibrinogen levels was dose dependent. Furthermore, platelet count in the patients
treated with 6% HES 130/0.4 decreased, while platelets in the patients who received gelatin
alone increased after admission at the ICU (p = 0.004). 6% HES 130/0.4 treated patients also
showed a higher need for transfusion of packed red blood cell concentrates (median trans-
fusion rate of 0.81 vs. 0.65 unit of packed red cells; p \ 0.05) during the observation period.
CONCLUSION. Our clinical data correspond well with several experimental trials, showing
that impairment of the coagulation system after 6% HES 130/0.4 is significantly more pro-
nounced when compared to the use of gelatine alone after cardiac surgery.
0510
EFFECTS OF HYPERTONIC SALINE (HTS) ON EX VIVO WHOLE BLOOD
PEPTIDOGLYCAN (PEPG) OR LIPOPLYSACCHARIDE (LPS)-STIMULATED
CYTOKINE RESPONSE
Y. Gundersen1, T. E. Ruud1, C. D. Krohn1, O. Sveen1, A. O. Aasen1
1Institute for Surgical Research, Rikshospitalet University Hospital, Oslo, Norway
INTRODUCTION. Infusion of HTS rapidly expands plasma volume in shock therapy. The
physical and physiological effects last for a relatively short period of time, and it has been a
commonly held view that they cannot not fully account for the increased survival rates seen
after HTS treatment. Subsequently, specific immunomodulating qualities have been revealed.
The clinical utility value after common dosing, however, has been questioned [1]. In the
present study we have measured how increasing osmolalities caused by HTS influence the
values of selected cytokines after stimulation with PepG or LPS.
METHODS. Freshly drawn blood from ten healthy donors was exposed to osmolalities
ranging from 295 to 480 mOsm/kg. In a whole blood model, the samples were stimulated
with PepG 1 lg/ml or LPS 10 ng/ml for 6 h at 37C. We evaluated the leukocyte response
according to the concentrations of selected cytokines in the supernatant. Cellular viability, as
tested by trypan blue straining, was strongly reduced at 480 mOsm/kg. Therefore, only results
from tonicities B375 mOsm/kg were included.
RESULTS. Increasing extracellular osmolality diminished TNF-a, IL-1 b, and IL-6 values in
an osmolality-dependent way in samples stimulated with PepG. Statistical significance was
reached at 315 mOsm/kg (IL-6) and 335 mOsm/kg (TNF-a and IL-1 b). In cells stimulated
with LPS this effect of HTS was absent. The PepG or LPS-stimulated concentrations of IL-1
ra, IL-10, and IL-12 were only moderately affected; IL-8, MCP-1, and RANTES hardly. For
the latter six variables, the choice of immune stimulator was of minor importance.
CONCLUSIONS. Osmolalities not exceeding commonly encountered clinical values, i.e.
B315 mOsm/kg, in general had insignificant effects on the selected cytokine concentrations.
These observations may explain some of the conflicting, and often disappointing, results
obtained from clinical trials.
REFERENCES. Kølsen-Petersen JA (2004) Immune effects of hypertonic saline: fact or
fiction? Acta Anaesthesiol Scand 48:667–678
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RESPIRATORY VARIATIONS IN THE PULSE OXIMETER WAVEFORM AMPLI-
TUDE AS INDICATOR OF FLUID RESPONSIVENESS
E. Robin1, A. Derichard2, M. Fleyfel3, M. Costecalde3, G. Lebuffe3, B. Vallet3
1University Hospital of Lille, Anesthesiology and Intensive Care Medicine, Lille, France,
2University Hospital of Lille, Anesthesiology and intensive care medicine, Lille, France,
3University Hospital of Lille, Lille, France
INTRODUCTION. Dynamic preload-dependency index as respiratory pulse pressure vari-
ations are useful to predict fluid responsiveness during a surgical procedure. However,
invasive arterial catheter is necessary to measure such a parameter. The aim of this study was
to validate the respiratory variations in the pulse oximeter waveform amplitude as a nonin-
vasive index of fluid responsiveness.
Patient and method: Eleven patients undergoing digestive or vascular surgery were inclu-
ded. Cardiac output was evaluated by oesophageal Doppler (Hemosonic 100, Arrow). Arterial
pressure and plethysmographic waveform was recorded using an arterial catheter and a pulse
oximeter connected to the Intellivue monitor (Philips) allowing to calculate pulse pressure
(PPV) and plethysmographic (Pleth) respiratory variations. A fluid challenge (250 ml of
hydroxyethyl starch) was realized whenever a 20% decrease in systolic blood pressure and/or
a 20% increase in heart rate were observed. Responders to fluid challenge were defined by a
10% increase in stroke volume. The capability of these indexes to predict fluid responsiveness
was analysed by a Receiver Operating Characteristic (ROC) curve. Correlations between
PPV, Pleth and stroke volume variation during fluid challenge were evaluated by a Rho
Spearman test.
RESULT. Area under ROC curve for PPV and Pleth were 0.93 and 0.69, respectively with
threshold values of 13% (sensitivity: 88%; specificity: 94%) and 18% (sensitivity: 57%;
specificity: 80%). Correlation coefficient between PPV and Pleth was 0.5. Correlation
between the stroke volume variations during fluid challenge and PPV or Pleth were 0.7 and
0.27, respectively.
DISCUSSION. In our study, respiratory pulse oximeter plethysmographic variations were not
a valuable index of preload-dependency during digestive or vascular surgery. These results
are not in agreement with former studies.
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ANALYSIS OF PROGNOSTIC FACTORS FOR PULMONARY COMPLICATIONS
FOLLOWING MAJOR THORACOTOMY FOR LUNG CANCER
N. Barbetakis1, C. Asteriou1, M. Vassiliadis2, E. Mavroudi2, K. Lyriti2, G. Samanidis1, A.
Kleontas1, Z. Tzimorota1, C. Tsilikas1
1Theagenio Cancer Hospital, Thoracic Surgery Department, Thessaloniki, Greece, 2Theage-
nio Cancer Hospital, Intensive Care Unit, Thessaloniki, Greece
INTRODUCTION. Patients undergoing thoracotomy associated with lung resection are
thought to be at high risk for the development of postoperative pulmonary complications
(PPCs) during the perioperative period. Aim of this study was to analyse risk profile, outcome
and identify predictors of postoperative pulmonary complications following major thoracot-
omy for lung cancer.
OBJECTIVES. All patients underwent lung resection during a 9-year period (2000–2008)
were reviewed.
METHODS. The following information was recorded: age, sex, body mass index, smoking
history (pack-year history), comorbid cardiovascular conditions (preexisting history of
myocardial infarction, angina pectoris, hypertension, arrhythmia, stroke), preoperative pul-
monary function tests, ASA class, preoperative chemotherapy, type and duration of
pulmonary resection, quantification of blood loss during the perioperative period (perioper-
ative period and during the first 24 h after the end of surgery) and postoperative analgesic
therapies. PPCs (Nosocomial pneumonia, lobar or whole-lung atelectasis, acute respiratory
failure, prolonged air leak, pulmonary embolism, ARDS, bronchospasm) were defined as
those occurring within 30 days of thoracotomy. Death was analyzed as a separate compli-
cation. The risk of PPCs associated with selected factors was evaluated using multiple logistic
regression analysis to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS. Ninety-nine patients (67 M/32F, mean age: 65.6 years) out of 1,056 experienced
PPCs and were studied. Eleven patients (11.1%) died during the 30 days following the
surgical procedure. An American Society of Anesthesiology (ASA) score 3 (OR, 2.35; 95%
CI 1.23–4.26; p \ 0.05), an operating time[80 min (OR, 2.68; 95% CI 1.32–3.26; p \ 0.05),
the need for postoperative mechanical ventilation [48 h (OR, 1.72; 95% CI 1.27–3.96;
p \ 0.05) and pneumonectomy (OR, 2.16; 95% CI 1.42–4.93; p \ 0.05) were independent
factors associated with the development of PPCs, which was in turn associated with an
increased mortality rate and the length of ICU or surgical ward stay.
CONCLUSIONS. The major predictors for PPCs were ASA physical status, operation time,
duration of postoperative mechanical ventilation and pneumonectomy. Pulmonary compli-
cations are mainly responsible for mortality of patients undergoing thoracotomy. Surgeons
and anesthesiologists must actively participate in the development of more effective pre-
ventive strategies.
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EFFECT OF IMPLEMENTING ROUTINE OESOPHAGEAL DOPPLER MONITOR-
ING IN COLORECTAL AND ORTHOPAEDIC SURGERY
D. Antcliffe1, L. Calopez1, M. Ledbury1, C. Charalambides1, H. Mukhtar1, A. Oshowo1, S.
Gold2, D. Conway3, M. Kuper1
1Whittington Hospital, London, UK, 2Derby Royal Infirmary, Derby, UK, 3Manchester Royal
Infirmary, Manchester, UK
INTRODUCTION. During major colorectal and orthopaedic surgery, guidelines [1] rec-
ommend that intraoperative fluid should be titrated to optimize stroke volume, as this reduced
morbidity and shortened length of stay by 2 days in randomized trials using the Deltex
Oesophageal Doppler (Doppler). However, in practice implementation has been patchy. We
present data from phase 1 of a National Technology Adoption Centre [2] project exploring
barriers to technology adoption. There are two hypotheses: (1) that barriers to Doppler
implementation can be overcome by targeted education. (2) That the benefits suggested by
clinical trials will be seen in practice.
METHODS. This prospective audit was conducted at the Whittington Hospital, a university
associated general hospital in London. An educational campaign promoted Doppler use in
four groups; elective and emergency colorectal surgery and elective hip replacement and
emergency hip fracture surgery. Prospective data was collected regarding Doppler use, length
of hospital stay and day 5 Post-Operative Morbidity Survey (POMS) score [3] for three
periods in 2008. Period 1, February to May inclusive, prior to the project launch. During
Period 2, June to August inclusive, Doppler use was encouraged and training provided. Period
3, September and October, once training was completed.
RESULTS. 202 patients underwent surgery, of which 74 (44 elective, 30 urgent) had colo-
rectal and 127 (67 elective, 61 urgent) hip surgery. Following the educational campaign,
Doppler use increased significantly; from 20% in phase 1, to 54% in phase 2, to 62% in phase
3 (p \ 0.01 by chi squared).The percentage of patients with morbidity on day 5 was sig-
nificantly reduced in elective colorectal (91–67% p = 0.04) and urgent hip surgery (93–25%
p = 0.02) and trended downward in the other groups. Mean length of stay fell in all four
groups by between 1 and 13 days, though the reductions did not attain statistical significance.
CONCLUSION. Phase one of this National Technology Adoption Hub project supports the
hypothesis that targeted education can significantly increase Doppler utilisation. The second
hypothesis, that trial benefits are realisable in practice, is supported by significant reductions
in morbidity in two groups and trends to reduced morbidity and length of stay in all patients.
In the next phase of the project, ongoing data collection from the Whittington will be sup-
plemented by additional sites at Derby and Manchester Royal Infirmaries. This will provide
data on the practical effect of implementing Doppler monitoring in over 1,000 patients, a
dataset larger than the current meta-analysis population [2].
REFERENCES. 1. GIFTASUP (2008) British consensus guidelines on intravenous fluid
therapy for adult surgical patients.
2. Phan T et al (2008) Improving perioperative outcomes. JACS 6:935–941.
3. NHS National Technology Adoption Centre. http://www.technologyadoptionhub.nhs.uk.
4. Grocott M et al (2007) The postoperative morbidity survey. J Clin Epidemiol 60:919–928.
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HOW IS PYREXIA TREATED WITHIN UK INTENSIVE CARE UNITS?
A. Frigyik1, G. C. Fisher1
1Russells Hall Hospital, Anaesthetic, Dudley, UK
INTRODUCTION. Fever is strongly associated with mortality in critical illness, particularly
in head injury and post stroke conditions, but this is not a proven cause and effect relationship.
Efforts to reduce fever are widely practiced although the evidence base is largely absent. The
one randomised controlled trial known in literature associated aggressive treatment with
higher mortality rate. Some of the applied interventions are potentially harmful. There is no
concensus on treating fever in U.K. critical care units, and we suspect that cooling measures
are being used routinely but not always appropriately
OBJECTIVE. We designed a telephone survey to find out the current practise of treating
pyrexia on ITUs around the country
METHODS. We asked the lead nurse of the units to tell us about their practise. We asked
about the number of active beds, the profile of the unit, the temperature at which treatment is
started, about who makes the decision, and about the actual treatment given.
RESULTS. Complete answers were obtained from 45 units. Seven were specialised units, the
remainder general ITUs. Only ten had a protocol for treating pyrexia. In 28 units, the decision
was made by either the medical or the nursing staff, with only eight units requiring a medical
decision for initiating treatment. The threshold for starting treatment was 37C in two units,
38C in 25, and ten only treating temperatures above 39C. Eight had variable limits to
starting treatment. Both physical and pharmacological means were used no special instruc-
tions regarding sequence. Ice packs, forced cool air blankets, wet sheets and cold infusions
were the most used physical measures. All units use paracetamol and two also use ibuprofen.
CONCLUSION. Our survey showed considerable variation in practice reflecting the lack of
agreement on the need to treat fever. While the benefits and harmful effects may not be of
major importance, their widespread use affects many thousands of patients each year in the
UK. We would suggest antipyretic measures should not be left to nursing routine.
0515
USE OF HALOPERIDOL FOR PREVENTING AND TREATING SUBSYNDROMAL
DELIRIUM AND CLINICAL DELIRIUM IN THE FIRST 24 H AFTER ENDO-
SCOPIC UROLOGICAL SURGERY
G. M. Valcoreanu Zbaganu1, L. Olteanu1
1Spitalul CF No 2 Bucarest, ATI, Bucarest, Romania
INTRODUCTION. Delirium (defined in APA and DSM-IV terms) is a seriously problem for
the first postoperative 24 h in elderly patients submitted to urological surgery.
OBJECTIVE. We propose that delirium in the first 24 h after endoscopic urological surgery
is correlated with the number of risk factors hosted by the patient over 65 years and that it will
be diminished by systematically used of oral haloperidol.
METHODS. 150 patients older than 65 years (Table 1) scheduled for urological surgery
(males and females) were recruited. They were evaluated for delirium hosted risk factors
(alcoholism, cognitive impairment, depression, hypertension, smoking, vision/hearing
impairment) and cognitive status (ICDSC score)
TABLE 1 THE PATIENTS (150)
Age (years) Femeales Meales Total
65–69 5 27 32
70–74 3 30 33
75–79 2 22 24
80–84 1 32 33
[85 6 22 28
After premedication (midazolam 0.02 mg/kg and pentazocine 0.45 mg/kg) we performed
subarachnoidian anesthesia with bupivacaine (0.15 mg/kg) and, then the urological procedure
was performed.
The first evaluation of ICDSC score after surgery was at 4 h then we check ICDSC every 3 h
for the first 24 h. All patient with three or more risk factor received 2 mg haloperidol per os in
the first hour after surgery. All patient received 2 mg haldoperidol if ICDSC score was 4 or
more (maximum 6 mg).
RESULTS. Table 2 describes the number of mental disorders at the first evaluation moment.
Table 3 describes ICDSC score at the same moment.
TABLE 1 NUMBER OF RISK FACTORS AND COGNITIVE ALTERATION












Number of risk factors and cognitive alteration






Delirium (18) 6.53 ± 1.72 5.13 ± 2.18* 6.92 ± 1.18* 0.01
Subsyndromal
delirium (55)
2.58 ± 0.26 2.06 ± 1.18 2.88 ± 0.58 0.05
ICDSC score at 4 hours
CONCLUSIONS. The severity of mental impairment in elderly patients after urological
surgery may be correlated with the number of hosted risk factors. Systematically adminis-
tration of oral haloperidol is an available and cheep method to tempt to reduce the delirium
and subsydromal delirium incidence and severity.
REFERENCES. 1. Girard TD et al (2008) Delirium in the intensive care unit. Crit Care
12(Suppl 3):S3. doi:10.1189/cc6149. 2. Pisani MA (2008) Delirium assessment in the
intensive care unit: patient population materes. Crit Care 12:131. doi:10.1186/cc6847. 3.
Ahlers SJGM et al (2008) Comparation of different pain scoring system in critically ill
patients in general ICU. Crit Care 12:R15. doi:10.1186/cc6789. 4. Carrasco G (2000)
Instruments for monitoring intensive care unit sedation. Crit Care 4:217–225.
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ANEMIA AND BLOOD TRANSFUSION IN A SURGICAL INTENSIVE CARE UNIT
S. Knuepfer1, S. Lobo1, E. Esser1, M. Bauer1, U. Settmacher2, D. Barz3, K. Reinhart1, Y.
Sakr1
1Friedrich Schiller University, Department of Anesthesiology and Intensive Care, Jena,
Germany, 2Friedrich Schiller University, Department of General and Vascular Surgery, Jena,
Germany, 3Friedrich Schiller University, Institution of Transfusion Medicine, Jena, Germany
INTRODUCTION. Anemia and blood transfusion can influence morbidity and mortality in
critically ill patients.
OBJECTIVES. To investigate the epidemiology of anemia and blood transfusion in a large
cohort of surgical intensive care patients.
METHODS. We included all adult patients ([18 years old) admitted to the intensive care unit
between 1 March 2004 and 30 July 2006. Data recorded prospectively on admission included
age, gender, referring facility, primary and secondary admission diagnoses, and surgical pro-
cedures. A priori subgroups were defined arbitrarily according to admission characteristics and
included age (18–50, 51–65, 66–80 and more than 80 years old), SAPS II score (\24, 25–50, 51–
75 and[75), SOFA score (0–4, 5–8, 9–12 and more than 12), surgical procedures (cardiovas-
cular vs. non-cardiovascular surgery), and the occurrence of severe sepsis.
RESULTS. Of 5,925 patients, 1,833 (30.9%) received a blood transfusion in the intensive care
unit. Hemoglobin concentrations were\9 g/dl on at least one occasion in 57.6% of patients.
Lower hemoglobin concentrations during the intensive care unit stay were associated with
higher Simplified Acute Physiology II scores and Sequential Organ Failure Assessment scores,
greater mortality rates, and longer intensive care unit and hospital lengths of stay. Transfused
patients had higher intensive care unit and hospital mortality rates (12.5 vs. 3.2 and 18.3 vs.
6.5%, respectively, p \ 0.001 pairwise) and longer intensive care unit and hospital lengths of
stay than non-transfused patients. In multivariable analysis, higher hemoglobin concentrations
(RR 0.97, 95% CI: 0.95–0.98, per 1 g/dl, p \ 0.001) and blood transfusion (RR 0.96, 95% CI
0.92–0.99, p = 0.031) were independently associated with a lower risk of in-hospital death.
CONCLUSIONS. In this group of surgical ICU patients, anemia was common and was
associated with higher morbidity and mortality. Higher hemoglobin concentrations and
receipt of a blood transfusion were independently associated with a lower risk of in-hospital
death. The groups that were more likely to benefit from blood transfusion were elderly
patients and patients with a higher severity of illness and more organ dysfunction.
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PREDICTORS OF HOMOLOGUE BLOOD TRANSFUSION IN THE ICU AFTER
MAJOR ORTHOPAEDIC SURGERY: A RETROSPECTIVE COHORT STUDY
J. Liesmons1, K. Brabants2, P. Mertens2, S. Engelen1, D. Himpe1
1Middelheim General Hospital, Departments of Anaesthesia, Antwerp, Belgium, 2Middel-
heim General Hospital, Departments of Orthopaedic Surgery, Antwerp, Belgium
INTRODUCTION. Homologue blood transfusion is not without risk and always has a high
cost [1]. This study was designed to detect patients prone to receive homologous blood transfusion
after major orthopaedic surgery in order to optimize our perioperative management.
METHODS. Following institutional guidelines a retrospective cohort study reviewing 100
consecutive files of hip and knee arthroplasty was conducted using stepwise logistic regression
with transfusion as the outcome measure. Preoperative Hb level (Hb_preop), age, BMI, gender,
type of surgery, revision or not, application of acute normovolemic hemodilution (ANH) entered
as the independent variables. Additionally, the best cut-off value for Hb_preop to predict trans-
fusion was sought by analysis of the Receiver Operating Characteristics (ROC).
RESULTS. Logistic regression revealed repeat surgery as an increased risk (OR: 24; 95% CI:
2.5–5.3; p = 0.006) and higher preoperative Hb levels as a reduced risk (OR: 0.59; 95% CI:
0.32–0.91; p = 0.047). ROC analysis (AUC = 0.650, p = 0.028) indicated a Hb_preop of
11.2 g/L as a fair cut-off value predicting homologous transfusion with sensitivity 29% and
specificity 95% (Fig. 1).
Fig. 1 ROC
DISCUSSION. Exposure to repeat surgery was a major determinant of homologous trans-
fusion in this study population. High-normal preoperative Hb levels significantly reduce
transfusion risks and make these patients also more eligible for ANH. None of the ANH
patients received homologous blood, which is in accordance with previous studies [2]. By
contrast, transfusion risks for aenemic patients are rather unclear and indefinable as evidenced
by the low sensitivity (29%). Therefore and, in conclusion, low Hb patients and especially
those scheduled for repeat surgery deserve a more meticulous approach. They may benefit
from induced preoperative Hb increases using exogenous erythropoetin combined with a high
commitment towards red blood cell saving techniques peroperatively.
REFERENCES. 1. Kleinman S, Chiavetta J, Hindieh F, Pi D, Ricketts M, Robillard P, Sher
G, Chan P. The Surveillance and Epidemiology of Transfusions Working Group Final Report
(1999) Ottawa. 2. Bryson GL, Laupacis A, Wells GA (1998) Does acute normovolemic
hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International
Study of Perioperative Transfusion. Anesth Analg 86:9–15
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THE USE OF BLOOD PRODUCTS IN MASSIVE BLEEDING: A PRELIMINARY
REPORT
E. Giuliani1, S. Braccini1, C. Cantaroni1, G. Semeraro1, E. Bertellini2, M. De Palma3, M.
Marietta4, G. Pinelli5, M. Rambaldi6, M. Girardis1
1Azienda Ospedaliera-Universitaria di Modena, Cattedra di Anestesia e Rianimazione, Mo-
dena, Italy, 2Ospedale di Carpi, Servizio di Anestesia e Rianimazione, Carpi, Italy, 3Azienda
Ospedaliera-Universitaria di Modena, Servizio di Medicina Trasfusionale, Modena, Italy,
4Azienda Ospedaliera-Universitaria di Modena, Cattedra di Ematologia, Modena, Italy,
5NOCSE di Modena, Unita` Operativa di Medicina d’Urgenza, Modena, Italy, 6NOCSE di
Modena, Servizio Di Anestesia e Rianimazione, Modena, Italy
BACKGROUND. In patients with severe bleeding, the appropriate use of packed red blood
cells (PRBC), fresh frozen plasma (FFP) and platelet concentrate (PLT) has been hypothe-
sized to be correlated with a better survival rate [1], but so far data available on this issue are
limited. A 2-year multi-centre observational study was conducted to evaluate the relationship
between the use of blood products in massive transfusion and outcome.
METHODS. Patients admitted in three hospitals of the Modena district in two consecutive
years and receiving more than seven units of PRBCs in 24 h were included in the study. The
cause of bleeding (i.e. trauma, surgery, gastrointestinal and other causes), the number of
PRBCs, FFP and PLT units infused in a 24 h-period after the first PRBC unit and the hospital
mortality were recorded for each patient. To evaluate the effect of an appropriate use of blood
components, we normalized the FFP and PLT units used according to PRBCs units transfused
in each patient.
RESULTS. 134 patients were included in the study (24.2% females; age 59 ± 20 years;
34.07% trauma, 44.44% surgery, 5.93% gastrointestinal and 15.56% other causes). The
overall hospital mortality rate was 41%. The PRBC (11.3 ± 5.4 units), FFP (7.3 ± 5.4) PLT
(3.6 ± 5.9) units infused in survivors were slightly lower than those infused in non-survivors
(PRBC 12.9 ± 6.1, PLT 5.6 ± 7.7, FFP 9.9 ± 6.8. The normalized ratios of FFP
(0.60 ± 0.38) and PLT (0.26 ± 0.44) units to PRBCs units were also lower (p \ 0.05) in
survivors than in non-survivors (FFP 0.75 ± 0.40 and PLT 0.39 ± 0.58).
CONCLUSION. The above preliminary data indicate that in massive bleeding the amount of
blood products infused, regardless of the type, is directly related to mortality and that an
increased use of FFP and PLT per unit of PRBC infused does not seem to modify the patient
outcome.
REFERENCE. 1. Johansson PI, Hansen MB, Sørensen H (2005) Transfusion practice in
massively bleeding patients: time for a change? Vox Sang 89:92–96
0519
INTRAVENOUS PARACETAMOL REDUCED THE USE OF OPIOIDS AND EXTU-
BATION TIME AFTER MAJOR SURGERY IN INTENSIVE CARE UNIT
D. Memis1, M. T. Inal1, G. Kavalci1, A. Sezer1, N. Sut1
1Trakya University, Edirne, Turkey
AIM. This study assessed the analgesic efficacy, side effects and time to extubation of
intravenous paracetamol when administered as an adjuvant to intravenous mepheridine after
major surgery in intensive care unit.
METHODS. Patients were randomized post-operatively into two groups in ICU. Patients
received either 100 mL serum saline IV every 6 h and IV mepheridine (n = 20 Group M) or
IV paracetamol 1 g every 6 h and IV mepheridine (n = 20, Group MP) into a peripheral vein
over a 24 h. Behavioral Pain Scale (BPS) is used until extubation and visual analogue score is
(VAS) used after extubation. When BPS and VAS values were [4, meperidin 1 mg/kg i.v.
was administered and noted in two groups. Pain scores, total meperidine consumption, side
effects, time to extubation are 24 h postoperatively noted.
RESULTS. Postoperative mepheridine consumption, extubation time, BPS and VAS scores
significiantly lower in group paracetamol–mepheridine (p \ 0.05). In addition to, postoper-
ative nausea–vomiting were significantly lower in group paracetamol–mepheridine when
compared with alone mepheridine (p \ 0.05).
CONCLUSION. We have demonstrated important clinical benefits by the addition of 4 g/day
paracetamol to mepheridine after major surgery. This benefit has been shown in a range of
patients under routine clinical conditions and therefore has important practical consequances
in ICU. These data suggest that intravenous paracetamol is a useful component of the mul-
timodal analgesia model, especially after major surgery
0520
WHICH ARE THE QUANTITATIVE VARIABLES THAT MAY IMPACT ON
PATIENTS UNDERGOING CABG SURGERY?
F. Cislaghi1, A. M. Condemi1, A. Corona1
1Luigi Sacco Hospital, Milano, Italy
INTRODUCTION. The mortality of CABG surgery is ranging from 2 to 5% although
continuously decreasing, in relation to better surgical and anaesthetic practice.
TYPE OF STUDY. Prospective observational cohort study.
STUDY AIM. To assess if the following selected quantitative variables (1) age, (2) car-
diopulmonary by-pass (CPB) time, (3) aortic cross clamp (ACC) time, (4) duration of
mechanical ventilation (MV), (5) red blood cells (RBC) transfusion units, (6) fresh frozen
plasma (FFP) transfusion units, (7) ICU length of stay (LOS), may impact on patient hospital
outcome.
METHODS. On all the patient undergoing CABG surgery admitted to our ICU, since 1997
through June 2004 we collected the above quantitative variables and put them into an elec-
tronic database. ROC curve analysis was performed in a view to assess which one of the
variables was the best predictor of patient hospital outcome. Statistic analyses were performed
using SPSS Software. P values \ 0.05 were considered statistically significant.
RESULTS. We considered a total of 3,269 patients undergoing CABG surgery, with a









MV length C 11.5 h 0.844 75 70 0.001 (0.765–0.923)
ICU-LOS C 36 h 0.732 74 70 0.001 (0.616–0.848)
Age C 68.5 years 0.569 61 59 0.230 (0.452–0.685)
CPB-time C 90 min 0.682 79 73 0.001 (0.580–0.785)
ACC-time C 60 min 0.523 58 55 0.682 (0.415–0.631)
RBC transfusions
C 2.5 units
0.882 79 78 0.001 (0.823–0.942)
FFP transfusions
C 3.5 units
0.813 75 80 0.001 (0.723–0.904)
CONCLUSIONS. We found that the best quantitative variables predicting patient hospital
outcome are MV length C11.5 h, RBC transfusions C2.5 units and FFP transfusions C3.5
units; CPB and ACC time together with patient age and ICU LOS are likely to impact less
importantly on patient outcome.
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OUTCOME AND USE OF CRITICAL CARE RESOURCES, FOLLOWING EMER-
GENCY LAPAROTOMY, AT A LARGE DISTRICT GENERAL HOSPITAL IN THE
UNITED KINGDOM
G. Devanaboina1, A. G. H. Stone2
1Southend University Hospital NHS Foundation Trust, Department of Surgery, Southend on
Sea, UK, 2Southend University Hospital NHS Foundation Trust, Department of Anaesthesia
and Critical Care, Southend on Sea, UK
INTRODUCTION. It is becoming increasingly recognised that there is a population of non-
cardiac surgical patients at high risk of complications and death [1, 2]. The emergency
laparotomy represents one such group of patients with a high overall mortality and long length
of hospital stay. It has recently been suggested that outcome could be improved in high-risk
general surgical patients by adequate provision and more effective utilisation of critical care
resources [1]. At Southend Hospital, the outcomes, lengths of stay and postoperative path-
ways following emergency laparotomy have not been defined in recent years.
OBJECTIVES. The aim of the study was to determine the number of emergency laparot-
omies performed over a 12-month period, to determine basic patient demographics in-hospital
mortality, length of stay and use of critical care resources.
METHODS. A list of all emergency operations was obtained from the electronic theatre
system. The list was filtered to select only primary laparotomies. Basic patient demographics
were extracted from this list. Using the patient administration system, the patient in-hospital
pathway, length of stay and mortality was determined.
RESULTS. There were 288 primary laparotomies. The mean patient age was 67 years. There
were 52% male and 48% female patients. The overall in-hospital mortality rate was 12.8%
(n = 37). The mean length of stay was 22 days (median: 15 days). Primary postoperative
destinations were as follows: Ward 57%; HDU 15%; ICU 28%. The overall in-hospital
mortality by post-op destination was as follows: Ward 6%, HDU 9%, and ICU 23%. Of the 37
deaths, one died on table. Of the remaining 36 deaths, 75% (n = 27) went to ICU or HDU
immediately after operation. 25% (n = 9) went straight to the ward following surgery. Of the
patients that went straight to the ward, 13 (7.9%) had to be sent to ICU or HDU after-
wards. The overall mean length of stay by destination was as follows: ward 17 days, HDU
26 days and ICU 30 days.
CONCLUSIONS. The results suggest that for this group of patients Southend Hospital’s
performance compares favourably with recently published figures [1]. It is a concern that
amongst patients that die, 25% are not admitted to either Critical Care or the Surgical HDU
immediately post operatively. We acknowledge the relatively small number of patients (288)
within this study is its principle limitation, and that further work looking at other high-risk
surgical groups, for both elective and emergency groups is warranted.
REFERENCES. 1. Jhanji S, Thomas S et al (2008) Mortality and utilisation of critical care
resources amongst high-risk surgical patients in a large NHS trust. Anaesthesia 63:695–700.
2. Goldhill DR, Down JF (2008) Are we operating as well as we can? Critical care to
minimise postoperative mortality and morbidity. Anaesthesia 63(7):689–692.
3. Pearse RM, Harrison DA et al (2006) Identification and characterisation of the high-risk
surgical population in the UK. Crit Care 10:R81
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INTRACRANIAL VENOUS THROMBOSIS IN PERIPARTUM: CASE REPORT
G. La Rocca1, D. Canzio1, S. M. Raineri1, S. Salemi1, N. D. Cascio1, G. Mineo1, A.
Giarratano1
1University of Palermo, Anesthesiology and Intensive Care, Palermo, Italy
INTRODUCTION. Intracranial venous thrombosis is a rare but potentially fatal complica-
tion of pregnancy and postpartum period. The presenting symptoms mimic those of a postural
puncture headache (PDPH) in a parturient who has undergone regional anesthesia and cae-
sarian section.
CASE REPORT. A 36-years-old pregnant woman affected by hypertension, diabetes, and
obesity in first day after third caesarian delivery, had positional headache treated as PDPH
without benefit. In second postoperative day blindness and loss of consciousness occurred; the
patient was admitted in ICU and we managed oro-tracheal intubation. CT scan showed a sub-
dural left temporal-phronto-parietal haemorrhage, edema, and moderate median line shift.
Angio-RM showed thrombosis of anterior side of sagittal sinus (Fig. 1). The patient was
treated with UFH in continuous endovenous infusion, keeping aPTT-ratio [1.5 \ 2. After
12 h, CT scan showed a slight reduction of haemorrhage and median line shift. During
hospitalization, the patient was always conscious and treated for the intracranial hypertension.
In fifth day of hospitalization, she was discharged.
DISCUSSION. Due to risk factors and coagulation abnormalities absence (normal values of
PT/INR, aPTT, fibrinogen, ATIII, platelet count), her symptoms were underestimated, with
delay of diagnosis. In ICU we found a hyper-coagulation pattern (TEG-CI 7, FVII 148%,
FVIII 246%, PAI-1 0 U/ml), even if genetic anomalies were absent. At the discharge, the
coagulation parameters returned to normal value.
CONCLUSION. In our experience, an early differential diagnosis between PDPH and
intracranial venous thrombosis is the most important goal for a good prognosis and an easy
and fast screening, as TEG, could be useful. In suspected clinical cases, a second level test of
coagulation pattern is recommended.




CRITICAL ILLNESS MYOPATHY (CIM): EARLY DETECTION AND OUTCOME
J. Sarmiento1, H. Perez-Molto´1, J. Coll2, S. Vitoria1, M. J. Dura`3, J. Klamburg1, R. Alvarez2
1Hospital Universitari Germans Trias i Pujol de Badalona, Medicina Intensiva, Badalona,
Spain, 2Hospital Universitari Germans Trias i Pujol de Badalona, Neurologia, Badalona,
Spain, 3Hospital Universitari Germans Trias i Pujol de Badalona, Rehabilitacio´, Badalona,
Spain
OBJECTIVES. To investigate a method for early detection of myopathy in critically ill
patients, following their outcome.
METHODS. A prospective study of 35 patients admitted to ICU with a SOFA C6. Each
patient underwent a weekly electromyography. When EMG alterations were detected a
muscle biopsy was performed. After ICU discharge the patients were controlled periodically
measuring the muscle strength using the MCR scale.
RESULTS. In 22 patients, the first detected EMG alteration was the presence of fibrillation
potentials. After electromicroscopic study of the muscle specimen, all of them showed a
selective loss of thick (myosin) filaments. Fibrillation appeared within 32 days (average 13).
11 of these 22 patients died. No patient had muscle membrane inexcitability.
Mechanical ventilation average time in the myopathy group was 32 days, in contrast to
13 days among the nonmyopathy group. At ICU discharge all patients with myopathy
detected by EMG and biopsy had muscle weakness. The average time to reach full muscle
strength was 20 days. Five patients with myopathy who also developed polyneuropathy
(identified by loss of all sensory potentials) eventually died.
CONCLUSION. Fibrillation in the EMG is the best method for early and easy detection of
CIM. This is directly related to typical pathological changes of CIM. Its onset of change is
within the first 2 weeks of illness, and its presence is associated with a prolonged mechanical
ventilation time. Full muscle strength is recovered sooner than previously reported.
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CRITICAL ILLNESS POLYNEUROPATHY—INCIDENCE, RISK FACTORS,
LONG-TERM OUTCOME AND QUALITY OF LIFE
B. Meyer1, A. Unger1, M. Nikfardjam1, D. Moertl1, G. Delle Karth1, M. Huelsmann1,
C. Woeber1, G. Heinz1
1Medical University of Vienna, General Hospital, Vienna, Austria
INTRODUCTION. Critical illness polyneuropathy (CIP) is an axional peripheral neuropathy
that leads to severe motorical dysfunction and weakness. CIP is increasingly diagnosed in
ICU patients. The incidence of CIP is essentially unknown, as are the risk factors and the
outcome of patients with CIP.
OBJECTIVES. We aimed to assess the incidence of CIP and to define potential risk factors
for CIP. Moreover, we aimed to assess the long-term outcome of patients with CIP and to
assess their quality of life.
METHODS. A database analysis was performed on 1,450 patients admitted to the ICU of a
tertiary care hospital within 4.7 years. Diagnosis of CIP was based on clinical judgement and
confirmed by electrophysiologic evaluation. Various clinical, laboratory and haemodynamic
variables were analysed for prediction of CIP. Outcome and quality of life were assessed in a
follow up evaluation by use of structured interview, standardised quality of life scores and
clinical neurological examination.
RESULTS. The overall CIP incidence was 3.3% (48 patients) with a continuous annual
increase (1.4% in the first year and 5.5% in the fifth year analysed). CIP patients had higher
SAPS II scores (53 ± 16 vs. 44 ± 22, p = 0.01), were more often mechanically ventilated
(48/48 vs. 1,000/1,402, p = 0.0001), had a longer duration of mechanical ventilation (median
4 vs. 30 days, p = 0.0001), needed more often renal replacement therapy (22/48 vs. 266/1402
patients, p = 0.0001) and for a longer period of time (median 4 vs. 11 days, p = 0.0001).
Moreover, patients with CIP had higher bicarbonate levels on ICU admission and had a
longer ICU length of stay (median 5 vs. 36 days, p = 0.0001). Evaluating factors associated
with CIP in a multivariate model, only high bicarbonate (p = 0.0016), duration of renal
replacement therapy (p = 0.043) and duration of ICU stay (p = 0.0001) were independently
associated with CIP.
After a median follow up time, 16 of 48 CIP patients underwent follow up evaluation using
clinical neurological examination and standardised interview assessing quality of life. All
patients had abnormalities in strength, tendon reflexes and sensibility, predominantly
affecting the distal parts of the limbs (lower leg in 4/11, arms in 3/11). The deficits were rated
at least medium severity. Objective deficits assessed by neurological examination, how-
ever, were subjectively noted in only 7 of 11 patients. Moreover, almost half of the patients
(7/16) reported on subjective recovery despite persistence of objective signs.
CONCLUSIONS. CIP is diagnosed in approximately 5% of ICU patients. The incidence of
CIP is rising, as are severity of the disease and length of the ICU stay, which are associated
with the diagnosis of CIP. CIP is characterised by long-term persisting abnormalities in
muscle strength. A striking difference, however, is observed between objective assessable
clinical deficits and subjective recovery in most patients.
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PREHOSPITAL STROKE MEDICAL ACTIVATION: IMPACT ON TIMES
RESPONSE AND OUTCOME IN PATIENTS WITH ISCHEMIC STROKE TREATED
WITH INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR.
PRELIMINARY DATA
N. Bacelar1, M. Martinez1, D. Canovas2, A. Carvajal3
1Hospital of Sabadell, Critical Care Centre, CIBER Enfermedades Respiratorias, Sabadell,
Spain, 2Hospital of Sabadell, Neurology, Sabadell, Spain, 3UDIAT., Neuroradiology, Saba-
dell, Spain
INTRODUCTION. The most important factor in successful thrombolytic treatment of acute
ischemic stroke is early treatment. Stroke protocols may have the effect of reducing treatment
delays. The aim of this study was to analyse the effect of a prehospital activation protocol in
our stroke patients treated with rt-PA.
METHODS. Observational prospective study of all patients with acute ischemic stroke
admitted in our ICU and treated with rt-PA (2004–2008). We compare two groups: patients
activated by a prehospital care protocol (medicalized ambulance that notified the intensive
care team of a thrombolysis candidate and directly transfer patient to the CT scan room) with
patients arrived without medical care. We analysed epidemiological data, stroke severity, CT
scan findings, treatment timeline (door to interpretation of CT scan and door-to-needle), early
clinical improvement and neurological outcome at 3 months using a modified Rankin scale
(mRS). Results are expressed as mean or percentage, using a p \ 0.05 as a significance level.
We applied SPSS 15 with ‘‘t’’ test for the continuous variables and Chi-square for categorical
ones.
RESULTS. We have treated 79 patients, 14 of them with the prehospital protocol activation.
No baseline clinical differences were observed between two groups. Times to response were
significantly better in the prehospital group. There were no differences in the neurological
outcome (early improvement and Rankin at 3 months).The most relevant findings are shown
in the following (Table 1).
TABLE 1 PRELIMINARY DATA: PREHOSPITAL MEDICAL ACTIVATION
Prehospital
medical





Age (years) 64.4 ± 8.8 65.1 ± 13.5 0.84
Diabetes (%) 0 23 0.06
Baseline NIHSS 14.2 ± 5.8 13.4 ± 4.6 0.57
Early signs on CT (%) 21 30 0.74
Door-to-CT informed (min) 11.7 ± 4.8 39.3 ± 15.34 \0.001
Door-to-neddle (min) 54.4 ± 27.1 69.1 ± 24.4 0.04
Early improvement (\ 4p NIHSS 48 h) (%) 43 47 0.7
Rankin 3 months (0–2) (%) 50 46 0.41
CONCLUSION. In our series of acute stroke patients treated with rt-PA, a prehospital
activation protocol with medicalized care allows a significant reduction in the treatment
timeline, mainly door-to-CT scan informed. Despite that our preliminary data show a mild
trend in the early signs on CT scan also on mRS, we did not find any statistics significant
differences. Additional data will be necessary to confirm the neurological improvement.
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PREDICTORS OF BETTER EARLY OUTCOME IN THROMBOLYSED CASES OF
ACUTE ISCHEMIC STROKE AT A TERTIARY CARE HOSPITAL
Y. Javeri1, D. Juneja1, P. Agarwal1, J. D. Mukherji1, R. Reddi1, C. Gupta1, D. Makkar1, O.
Singh1
1Max Super Speciality Hospital, New Delhi, India
OBJECTIVES. To analyze the predictors of clinical outcome in thrombolysed cases of acute
ischemic stroke in a tertiary care centre.
METHODS. Open, nonrandomized, observational study of 295 patients of stroke admitted
from July 2006 to May 2008. Out of these, 205 patients were ischemic, 55 were hemorrhagic
and 35 were transient ischemic attack (TIA). Thirty-three (15.6%) patients were thrombol-
ysed, out of which 21 (63.63%) were thrombolysed with intravenous recombinant tissue
plasminogen activator (r-tPA), 8 (24.24%) underwent sonothrombolysis (continuous trans-
cranial Doppler and r-tPA) and 4 (12.12%) patients underwent intra-arterial thrombolysis.
Patients were classified using TOAST criteria (large artery atherosclerotic = 10; cardioem-
bolic = 5; small vessel occlusion = 14; other determined etiology = one, undetermined
etiology = three). The age ranged from 35 to 75 years (55 ± 18.6). The mean time to reach
hospital was 110 min (70–210), the mean door to MRI brain time 16 min (10–30) and mean
door to needle time 22.5 min (18–35). Fourteen (42.4%) patients had time to treat less than
two h. The mean NIHSS scores were 15.5 ± 6.5 (range 8–22).
RESULTS. Twenty-two patients (66.66%) significantly improved on NIHSS (4 points) (mean
change = 8; range = 4–20) at 48 h and seventh day. There was significant recovery
(p \ 0.05) in NIHSS score in patients who had time to treat less than 2 h, sonothrombolysed,
age \60 years, better blood pressure, sugar control and NIHSS score \15. One each devel-
oped small parietal lobe hemorrhage and recurrent stroke and five (15.2%) showed no
improvement. There was no mortality.
CONCLUSIONS. Outcome in thrombolysed patients can be improved by reducing the time
to treat, better control of blood pressure, sugar and sonothrombolysis.
0527
OUTCOME OF PATIENTS WITH STATUS EPILEPTICUS TREATED WITH
INTRAVENOUS LEVETIRACETAM
K. E. Wartenberg1, C. Blume2, V. Pu¨tz2, I. Dzialowski2, A. Kunz2, U. Becker2, H. Hentschel2
1Carl Gustav Carus University Hospital Dresden, Neurology/Neurocritical Care, Dresden,
Germany, 2Carl Gustav Carus University Hospital Dresden, Dresden, Germany
INTRODUCTION. Status epilepticus carries a mortality rate up to 77% depending on
underlying cause, age, and time to treatment success. Benzodiazepines and phenytoin as first
and second line agents are effective in terminating status epilepticus in only 31–56%. Newer
antiepileptic agents with less side effects might be powerful adjunctive therapies. We would
like to report our experiences with IV levetiracetam as second line agent in a treatment
protocol for a prospective patient cohort with status epilepticus.
METHODS. We treated 17 patients with convulsive status epilepticus between January 2007
and April 2008 with an institutional treatment protocol consisting of IV lorazepam as first line
agent, IV phenytoin as second line agent, followed by IV levetiracetam as third line agent or
second line agent if there were contraindications for IV phenytoin. If the status epilepticus
could not be terminated by IV levetiracetam, IV propofol and/or midazolam were applied as
continuous infusion under EEG monitoring. Primary outcome was treatment success of IV
levetiracetam. Secondary outcome measures were time to treatment success defined as ter-
mination of clinical and electrographic status epilepticus, modified Rankin Scale (mRS) at 6
and 12 months, and complications.
RESULTS. Of the 17 patients 13 (76%) had cerebral structural abnormalities such as remote
or acute infarction, hemorrhage, brain tumor, hippocampal sclerosis, neonatal hypoxic brain
injury as underlying etiology for status epilepticus, the cause was infection in 3 (18%)
patients, and hyponatremia in 1 patient (1%). Median age was 72 (range 33–88) years. IV
levetiracetam resulted in successful in termination of status epilepticus in 2 (12%) patients.
The treatment was continued with midazolam and/or propofol infusions in 15 (88%) patients.
Median time to treatment success was 373.5 (24–16337) min in all patients, 5 and 16,337 min
in the 2 patients successfully treated with IV levetiracetam. One patient died while still in
status epilepticus. At 6 months, 5 (29%) patients had died, support had been actively with-
drawn in 1 patient. The mRS was 0 in 2 patients, 1 in 4 patients, 2 in 1 patient, 3 in 2 patients,
4 in 2 patients and 5 in 1 patient. At 12 months, 1 patient with an mRS of 3 had progressed to
4, the other patients had remained in the same functional state. The most common compli-
cations included hyperglycemia (71%), hypotension (71%), acute renal failure (29%),
pulmonary edema (29%) and anemia (29%), thrombocytopenia (24%), pneumonia (24%),
seizure recurrence (24%), urinary tract infection (18%), septic shock (12%), and cardiac arrest
(2%).
CONCLUSION. Levetiracetam offers a feasible alternative strategy to break status epilep-
ticus as adjunctive third line therapy in a paucity of patients before administration of sedatives
with a broad spectrum of adverse effects and needs to be studied in a standardized trial.
0528
USE AND OUTCOMES OF ELECTROENCEPHALOGRAPHY IN AN ADULT
GENERAL INTENSIVE CARE UNIT. A 6 YEAR EXPERIENCE
C. Patvardhan1, R. Greer1
1Manchester Royal Infirmary, Critical Care Unit, Manchester, UK
INTRODUCTION. EEG is rapid and safe test, which assesses the thalamocortical function
in comatose patients [1]. However, EEG patterns can be nonspecific and their interpretation
can be hampered with artifacts or use of sedation. Our aim was to assess the diagnostic yield
and outcomes of EEG in critically ill population in our intensive care unit.
METHODS. We audited all EEG results generated between January 2003–December 2008.
Clinical, demographic and mortality data was collected.
RESULTS. A total of 96 EEG reports were generated from 74 patients admitted over a 6 year
period. Mean age of patient was 49 ± 31 years. 29.7% (n = 22) were female. 44.5% patients
(n = 33) had a preceding cardiorespiratory arrest. 12.1% (n = 9) had a history of traumatic
brain injury. 40.5% (n = 30) patients were not on any sedation. The most common diagnostic
indication was to diagnose seizures (n = 38), followed by HIE (n = 26), and encephalopathy
(n = 15). Other indications for requesting EEG included assessment of coma (n = 6), delay
in waking up (n = 4), encephalitis (n = 7), confusion (n = 4), follow up (n = 5), abnormal
movements (n = 1). Many EEG requests had multiple indications. Only 3.1% (n = 3) EEG’s
were normal. 24% (n = 25) were inconclusive because of effect of sedation or machine/
muscle artifacts. The overall diagnostic yield of EEG in this population was 73.95%
Table 1 The incidence of HIE was 14.5%. 8.1% (n = 6) EEG’s, performed on 5 patients with
no history of cardio respiratory arrest had features of HIE. P value was 0.0099 using Fischer0s
extract test. (See Table 2)
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TABLE 2
HIE NO HIE
EEG with h/o CPR 14 27
EEG with no h/o CPR 6 49
38 EEG’s were requested to diagnose seizures of which 28.1% (n = 11) had the diagnosis
confirmed. Incidence of epileptiform activity on EEG was 11.4%. 6.7% (n = 5) patients had
no history of epilepsy documented but had evidence of nonconvulsive status epilepticus on
their EEG. Diagnosis of encephalopathy was made in 28.12% (n = 27) EEG’s of which 15
EEG’s had a coincidental diagnosis. Thirty day mortality of patients who had an EEG was
54.05% (n = 40).
CONCLUSION. EEG had a high diagnostic yield (73.95%) in our population. A statistically
significant finding was an 8.1% incidence of hypoxic ischaemic encephalopathy in patients
with no history of preceding cardiorespiratory arrest. There was a high incidence of incon-
clusive EEG’s (24%) due to sedation or muscle/machine artefacts.
REFERENCE. 1. Young GB (2000) The EEG in Coma. J Clin Neurophysiol 17(5):473–485
GRANT ACKNOWLEDGEMENT. This audit was carried out without the aid of grant.
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PREDICTION OF OUTCOME AFTER CARDIAC ARREST AND INDUCED
HYPOTHERMIA
M. Rundgren1, T. Cronberg2, H. Friberg1
1Lund University Hospital, Intensive and Perioperative Care, Lund, Sweden, 2Lund Univer-
sity Hospital, Neurology, Lund, Sweden
INTRODUCTION. Prediction of outcome in comatose survivors after cardiac arrest (CA) is
difficult and is further complicated with the introduction of hypothermia as a treatment option,
since sedation and intermittent use of muscle relaxants are mandated. Other means of
prognostication, unaffected by pharmaceuticals, are warranted. We present data from a coma
project, where the aim was to evaluate prognostic means by themselves or in combination.
METHODS. A retrospective analysis of all patients in the Intensive Care Unit at Lund
University Hospital included to hypothermia treatment after CA, 2004–2008. Hypothermia
treatment was performed regardless of initial rhythm or location of arrest. A standardised
protocol for monitoring and evaluation of neurological function and outcome was used. All
patients were monitored with continuous amplitude integrated EEG (aEEG) during hypo-
thermia until recovery of consciousness, death or maximum 120 h after the
CA. Serum samples of NSE were collected at 24, 48 and 72 h after the CA. Patients were
assessed neurologically and an SSEP was performed at 72 h after normothermia. A decision
on level of care was based upon the result of the neurological examination and SSEP.
RESULTS. During a 4-year period, 106 consecutive patients were included; 19 were
excluded because of death prior to evaluation (15), protocol violation (3) and intracerebral
bleeding (1). Of the remaining 87 patients, 50 patients regained consciousness within 72 h
after normothermia and 37 patients were still in coma (GCS B 7). Among these 37 patients, 8
patients eventually regained consciousness, whereas 29 did not. Our 8 patients with a late
recovery had a positive profile regarding aEEG (continuous pattern), NSE (\28 lg/L at 48 h)
and SSEP (cortical response), whereas 27 of 29 patients with persisting coma had at least one
other strong marker for a poor outcome.
CONCLUSION. A decision on level of care after cardiac arrest should be based on a
neurological examination (GCS B 7) and at least one other prognostic tool. This should be
performed no earlier than 72 h after normothermia.
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AN AUDIT OF THE OUTCOMES FOR THERAPEUTIC HYPOTHERMIA FOL-
LOWING CARDIAC ARREST
A. Lowe1, R. Campbell1, R. Breeze1
1University Hospital Lewisham, Anaesthesia and Intensive Care, London, UK
AIMS. Therapeutic hypothermia as a protective strategy for brain injury has been known
since the 1950. Recently, it re-emerged following two prospective randomized controlled
trials published in 2002 [1, 2]. They highlighted the potential benefit in patients who suffered
out of hospital cardiac arrest with a presenting rhythm of either ventricular fibrillation (VF) or
ventricular tachycardia (VT). The benefit was generally in neurological outcome. Therapeutic
hypothermia is now provided at University Hospital Lewisham, London for all patients post
cardiac arrest, regardless of rhythm. Therefore, a retrospective audit of our practice, outcomes
and complications was carried out.
METHOD. We retrospectively identified patients who underwent therapeutic hypothermia
post cardiac arrest from August 2007 to January 2009. The notes were analysed and data
collected using a proforma. The information collected was: patient demographics; presenting
rhythm; time to cardio-pulmonary resuscitation (CPR); duration of CPR; resuscitation drugs
administered; time to initiate cooling; time to target temperature; time at target temperature;
peak temperature following re-warming; complications and outcome in terms of morbidity
and mortality.
RESULTS. 21 patients underwent therapeutic hypothermia post cardiac arrest, of whom 8
patients survived to hospital discharge. Over half the cardiac arrests occurred in hospital. The
average time to initiation of CPR was 2 min. The most common rhythm was pulseless
electrical activity (PEA) at 43%. The mean CPR time was 15 min with a mean number of DC
shocks of 1.3. The mean time to target temperature was 490 min with an average of 22 h
spent at this temperature. There was no significant bleeding. 36% of patients required renal
support, 21% became septic post arrest, 36% developed pneumonia and 21% developed an
arrhythmia requiring treatment.
DISCUSSION. 38% of patients, who had a return of spontaneous circulation following
cardiac arrest that underwent therapeutic hypothermia, survived to hospital discharge. Nor-
mal survival rates from ITU are between 25 and 35% [3]. Interestingly, this was despite its
application to all comers and the seemingly prolonged time to initiate cooling and subse-
quently the time to attain target temperature. This highlighted an area for development in our
practice. Our results are encouraging for the wider implementation of therapeutic
hypothermia.
REFERENCES. 1. The Hypothermia After Cardiac Arrest Study Group (2002) Mild ther-
apeutic hypothermia to improve the neurological outcome after cardiac arrest. N Engl J Med
346:549–556. 2. Bernard SA, Gray TW, Buist MD et al (2002) Treatment of comatose
survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557–
563. 3. Denton R, Thomas AN (1997) Cardiopulmonary resuscitation: a retrospective review.
Anaesthesia 52:324–327
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ONE YEAR REVIEW OF IN-HOSPITAL CARDIAC ARRESTS IN AN ACADEMIC
HOSPITAL IN BELGIUM
A. Goubella1, M. Van Nuffelen1, J.-L. Vincent1
1Erasme University Hospital, Intensive Care Medicine, Brussels, Belgium
INTRODUCTION. The outcome from in-hospital cardiac arrests is variable but some
physiological alterations may be recognized in the hours preceding the arrest and serve as
criteria for early warning.
MATERIAL AND METHODS. Review over a 1-year period of 246 emergency calls in a
858 bed academic hospital.
RESULTS. A total of 54 patients (22%) had cardiorespiratory arrest: CPR was performed in
46 of them (85%) of whom 19 could be resuscitated (41%): 13 were resuscitated, but died in
hospital within 48 h (28%) so that only 6 (13%) were discharged from hospital. One or more
significant physiological changes were detected in 68% of cases. By univariable logistic
regression, significant predictors of cardiac arrest were abnormal breathing (OR:4.53–
p = 0.01), a decrease in SpO2 (OR: 5.68, p:0.015), a change in heart rate (OR: 4.83, p: 0.004),
a change in systolic blood pressure (OR: 3.15, p:0.01), occurrence of chest pain (OR:11.79, p:
0.02) and altered consciousness (OR: 4.26, p: 0.008).
CONCLUSION. Outcome from in-hospital cardiac arrest is poor. A better recognition of
some physiological changes in the preceding hours could prevent the cardiac arrest.
0532
THE GAMMA ISOFORM OF ENOLASE (NSE) IS PREDICTIVE OF MORTALITY
AFTER CARDIOPULMONARY RESUSCITATION (CPR): COMPARISON WITH
CLINICAL NEUROLOGIC EXAMINATION AND CT SCAN OF THE BRAIN
J. Sonne1, O. Grebe1, N. A. Cicco1, E. G. Vester1, K. Magnusson1
1Evangelisches Krankenhaus Du¨sseldorf, Kardiologie, Du¨sseldorf, Germany
OBJECTIVE. To assess the prognostic value of neuron-specific enolase (NSE) for early
prediction of outcome in patients at risk for anoxic encephalopathy after cardiopulmonary
resuscitation (CPR) and to compare NSE with conventional risk indicators—neurological
examination and computed tomography of the brain (CT).
DESIGN. Prospective study. Patients: 31 patients (age 63.7 ? 16.7 years [SD]) after CPR
due to different reasons.
METHODS. Blood sample on the third day after CPR, CT, neurological examination and
documentation of myoclonia. Patients were categorized into four groups (A = those who
died, B = survivors, C = those with a neurologic deficit and/or those who died, D = sur-
vivors without any neurologic deficit).
RESULTS. NSE-plasma levels of group D differed significantly from group A and C. (D:
15.66 ? 8.79 ng/ml versus A: 75.11 ? 65.3; p = 0.02; versus C: 72.82 ? 67.16; p = 0.01).
There were no significant differences concerning neurologic examination and the findings of
CT. NSE measurements reached a sensitivity of 0.95 and a specificity of 0.5 to predict
hypoxic ischaemic brain damage. CT scan could be performed in only 51.6%. The neurologic
examination showed that no patient was without neurologic deficit 3 days after successful
resuscitation.
CONCLUSION. Non-elevated NSE-levels mean a complete neurologic restitution whereas
elevated NSE-levels do not exclude a restitution. Determination of NSE is ideal as a reliable
and convenient parameter for estimation the neurologic outcome after CPR in comparison to
CT, neurologic examination and the existence of myclonia and can make the process of
individual decision easier because of its simplicity in daily routine of intensive care.
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THE USE OF LIPID EMULSION IN THE MANAGEMENT OF CARDIAC ARREST
SECONDARY TO LOCAL ANAESTHETIC TOXICITY: AN ONLINE QUESTION-
NAIRE SURVEY OF RESUSCITATION OFFICERS OF THE UK
A. Syed Mohammad1, N. Zafar1, M. Malik2, G. Eyre3, L. Dale3, N. U. Din4
1Nottingham University Hospitals NHS Trust, Intensive Care, Nottingham, UK, 2Nottingham
University Hospitals NHS Trust, Anaesthesia, Nottingham, UK, 3Nottingham University
Hospitals NHS Trust, Resuscitation Training, Nottingham, UK, 4Cardiff University, Primary
Care and Public Health, Cardiff, UK
INTRODUCTION. Local anaesthetic (LA) toxicity can lead to resistant cardiac arrest. The
use of lipid emulsion, when added to standard resuscitation protocols or procedures, can result
in improved outcome. Guidelines by Association of Anaesthetists of Great Britain and Ireland
and a statement from the Resuscitation Council (UK) have been issued in this regard. In this
survey, we asked resuscitation officers about their awareness of local anaesthetic toxicity and
the use of lipid emulsion to treat it. Resuscitation officers (ROs) have a vital role in teaching
and training resuscitation techniques, and are therefore well placed to cascade information
about management of LA toxicity.
OBJECTIVES. Explore the awareness and involvement of ROs in the implementation and
dissemination of guidelines for management of LA toxicity.
METHODS. The electronic survey was carried out by sending the survey link to the web site
(http://www.surveymethods.com) by email to all the ROs registered with Council for Pro-
fessionals as Resuscitation Officers (CPRO) UK. Three reminders at intervals of
approximately 3 weeks were sent to non-responders.
RESULTS. Survey was sent to 423 addresses and a 60% response rate was obtained.
• *35% participants were not aware of any guidelines
• *57% followed AAGBI or local guidelines.
• *40% were not sure about the use of lipid emulsion in LA toxicity
• *58% would use lipid emulsion in LA toxicity.
• *60% were not aware of the whereabouts of Lipid emulsion in their clinical areas.
• 57.2% reported either not having or not knowing of a system in place for making lipid
emulsion available in high risk areas in their trust.
• Cardio pulmonary bypass (CPB) was available and considered an option by only 7.8%
respondents.
• [80% participants were of the view that RC (UK) should produce guidance to deal with
LA induced cardiac arrest.
CONCLUSIONS. There is a need to increase awareness of the use of lipid emulsion
(especially amongst non-anaesthetists) and its availability for emergency use.
RECOMMENDATIONS.
1. Increase awareness, especially amongst non-anaesthetists, of the role of lipid emulsion in
the management of LA toxicity and cases of resistant cardiac arrest from overdose of
lipid soluble drugs.
2. More widespread availability of lipid emulsion - including in emergency departments.
3. A multi disciplinary team approach to tackle this issue jointly by hospital pharmacy and
departments of anaesthesia and resuscitation training.
4. Recommendation to Resuscitation Council, UK to add lipid emulsion to the special
circumstances workshop for poisoning on resuscitation courses.
REFERENCES. 1. Association of Anaesthetists of Great Britain and Ireland (2007)
Guidelines for the management of severe local anaesthetic toxicity. http://www.aagbi.org/
publications/guidelines/docs/latoxicity07.pdf. 2. http://www.resus.org.uk/pages/caLocalA.
htm. 3. Picard J et al (2009) Lipid emulsion to treat drug overdose: past, present and
future. Anaesthesia
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CHECKING OF PUPILS FROM THE HEAD END OF PATIENT DURING A LAND
AMBULANCE TRANSFER
A. Syed Mohammad1, N. Zafar1, H. Jlala2, B. Winter1
1Nottingham University Hospitals NHS trust, Anaesthesia and Intensive Care, Nottingham,
UK, 2Nottingham University, Academic Department of Anaesthesia, Nottingham, UK
BACKGROUND. Referral of an acute traumatic brain injured patient to a tertiary neuro-
science centre is one of the most common indications for inter hospital transfer in the UK.
With no facility available for ICP monitoring during the ambulance transfer, the only indi-
cator of critically high intracranial tension is pupillary signs as most patients are
pharmacologically paralysed. National guidelines recommend checking pupils during such a
transfer [1]. Ambulance trolleys designed to transport critically ill patients are higher than
standard trolleys because of monitors and ventilators housed under them and the head end is
additionally raised 20 to facilitate cerebral venous drainage. Standing up in a moving
ambulance increases risk to and invalidates the insurance cover of the transferring personnel.
OBJECTIVE. To determine whether it is possible to check a patient’s pupils while sitting at
the head end during a land ambulance transfer.
MATERIALS AND METHODS. After ethics approval 26 volunteers were recruited in a
transfer course organised by the Mid Trent Critical Care Network, UK. Participants were
invited to check the pupils of a manikin strapped to a trolley using a standard ICU pen torch,
by sitting on the head side of the trolley without removing their seat belt. The trolley used was
Falcon 6 [Ferno (UK) Ltd] modified to critical care transfer specification. Participants and
two trained observers were asked to separately assess the difficulty of seeing the pupils using
three point scale (1 = impossible, 2 = with difficulty, 3 = easy). Descriptive analysis was
done of the observations. Height and gender were compared using Chi-square test.
RESULTS. All 26 subjects (12 male and 14 female) completed the task. Average height of
the participants was 168.2 cm (±9.6). Participants’ subjective assessment were well corre-
lated to the observer assessment (R2 = 0.9, P \ 0.01). 13 (50%) participants found the task
impossible to perform, compared to only 6 (23%) who found it easy. Height and gender had
no influence on the ability to check the pupils (P \ 0.05).
CONCLUSIONS. Height did not statistically correlate with the ability to check pupils whilst
seated. However, there was a trend that taller participants found the task easier. Although half
of the participants could not perform the task it was possible for some to check pupils while
seated with the seat belt on. Amalgamating these facts with the importance of assessing pupils
raises the question whether training in pupil assessment whilst restrained during transfer
might make a difference. Although this was a pilot study, our results may suggest reviewing
the current guidelines, so paramedics, who are covered to work in a moving vehicle unre-
strained, should check patients’ pupils instead, or make an issue for change of ambulance
design.
REFERENCE. 1. AAGBI (2006) Recommendations for the safe transfer of patients with
brain injury. http://www.aagbi.org/publications/guidelines/docs/braininjury.pdf.
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FATAL HYPOGLYCEMIA; CT AND MR FINDINGS OF THE BRAIN
L. Keeris1, A. Postma2, E. Machiels3, J. H. Zwaveling3, W. van Mook3
1Elkerliek Hospital, Intensive Care, Helmond, Netherlands, 2Maastricht Universitair Medisch
Centrum?, Radiology, Maastricht, Netherlands, 3Maastricht Universitair Medisch Centrum?,
Intensive Care, Maastricht, Netherlands
INTRODUCTION. Changes in the human brain due to after severe hypoglycemia are rel-
atively unknown since few reports on imaging studies are available in the literature. In this
case report, we describe both the CT scan and MR findings in a patient with severe hypo-
glycaemic coma, illustrating the unique changes in the brain. Knowledge of possible findings
is important, because of their substantial prognostic impact.
METHODS. Case report.
RESULTS. A 22-year-old woman with borderline personality disorder, was admitted to our
hospital after being found at home in an unresponsive state. Paramedics measured a glucose level
\1.0 mmol/L and administered 50 ml glucose 50% intravenously, without improvement of
consciousness. On arrival in hospital, the patient was comatose; Glasgow Coma Score E1M2V1.
Blood pressure was 100/60 mmHg and heart rate 60/min. Respiration was regular with a
peripheral saturation of 100% with a non-rebreathing mask. The temperature was 35.7C. Ini-
tially, patient showed mid-sized isocore pupils, both reactive to light. Glucose level at admission
was 11.9 mmol/L. Physical examination revealed several small skin lesions in the abdominal
wall, compatible the suspicion of multiple insulin injections. This was evidenced by an insulin
level of 14.3 with a C-peptide level\0.03. To antagonise a potential opoid or benzodiazepine
intoxication, flumazenil and naloxon were given intravenously, but without any effect. Toxi-
cology screening proved negative, apart from a very low urine concentration of benzodiazepines.
Patient was intubated. Thirty minutes after admission to the ICU patient showed anisocore pupils
developed. A CT scan of the brain showed low attenuation of the brain with loss of gray-white
matter differentiation and swelling, most pronounced in the frontotemporal lobes. A bright
cerebellaiir sign was noted. In spite of continuous glucose monitoring, hypoglycemia re-
occurred three times during first 12 h. Twenty-four hours after admission, the Glasgow Coma
Scale remained unchanged, and had developed bilateral wide, unresponsive pupils. Subsequent
MR revealed pronounced symmetric bilateral hyperintensity of the basal ganglia, hippocampus
and parts of the thalamus with restricted diffusion. Also hyperintensity of the cerebral cortex,
with diffuse swelling of the brain was noted, with compression of the brainstem, consistent with
herniation. Because prognosis was considered dismal, therapy was subsequently withdrawn.
CONCLUSION. Our patient suffered severe brain injury due to severe hypoglycemia after
insulin overdose. MR findings after severe hypoglycemicia can serve as a prognostic factor and
assist in clinical decision-making. Only cortical changes and swelling of the brain have a relative
good outcome, whereas involvement of basal ganglia and hippocampus, as present in our patient,
is indicative of poor outcome, resulting in death or survival in a persistent vegetative state.
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SUICIDAL HANGING: IS IT THE END OF THE ROAD? AN INDIAN EXPERIENCE
T. P. Nisheeth1, A. S. Arun Kumar2, SS. Prabhu2, M. Vakamudi2
1Sri Ramachandra University, Department of Anesthesiology and Critical Care, Chennai,
India, 2Sri Ramachandra University, Chennai, India
AIM. To analyse incidence of mortality and identify predictors of mortality in patients
admitted with suicidal hanging.
METHODS. We performed a retrospective analysis of all patients with suicidal hanging admitted
to our ICU from January 2006 to February 2009. Primary outcome was in hospital mortality.
Secondary outcomes—ICU Length of stay (LOS), Hospital LOS, ICU free days, Ventilator days and
Ventilator free days. Admission data included demographics, mode of hanging, lead time to ER
admission, clinical presentation including vital parameters, ABG and relevant imaging studies.
Admission APACHE II, GCS, SOFA, 48 h SOFA, and need for vasopressors were documented.
Statistical analysis: Fischer’s exact test, students t test and logistic regression. p\ 0.05 significant.
RESULTS. Of the 44 patients included, 25 were females and 19 males. Mean age was
28.8 ± 11.6 years (Mean ± SD). Lead time to ER admission was 2.22 ± 3.92 h. Mortality was
17% (n = 7). Observations at admission were loss of consciousness 93%, seizures 23%, rest-
lessness 30% and vomiting in 9%. 43% had systolic BP B 90 and 20% required inotropic support
within first 24 h. Admission Lactate (n = 23) was 2.6 ± 1.1 mmol/L. Intubation was required
in 84% (n = 37). CT brain abnormalities (23%) included diffuse cerebral edema, subarachnoid
hemorrhage, petecheal hemorrhage and fracture occiput. None had spinal injuries. Clinical and
radiological evidence of pulmonary edema was present in 23% (n = 10) in whom mortality was
43% (n = 3). Stress cardiomyopathy diagnosed by echocardiogram was seen in four patients.
80% presented with GCS\ 8. GCS normalised in 2.2 ± 4.1 days, while in 54% this took less than
24 h.
CONCLUSION. Suicidal hanging is associated with significant mortality. Predictors of poor
outcome in our study were admission GCS and SOFA at 48 h. Survivors stayed shorter in ICU
and on the ventilator (Tables 1, 2, 3)
TABLE 1 SEVERITY OF ILLNESS SCORE AND BASE DEFICIT
Study group






APACHE II admission 19.68 ± 7.42 18.49 ± 7.17 26.00 ± 5.47 0.01
SOFA admission 5.86 ± 2.59 5.58 ± 2.61 7.29 ± 1.89 0.10
SOFA 48 h 1.47 ± 2.53 0.78 ± 1.39 5.67 ± 3.93 0.00
GCS admission 6.27 ± 3.89 6.76 ± 4.05 3.71 ± 1.11 0.05
Base Deficit admission -6.45 ± 4.62 -5.79 ± 4.46 -9.90 ± 4.41 0.02
Base Deficit after 24 h -1.60 ± 4.82 -0.98 ± 4.04 -5.33 ± 7.56 0.03
Severity of illness score and base deficit
TABLE 2 SECONDARY OUTCOMES
Study group






Hospital stay (days) 6.50 ± 5.27 6.43 ± 5.27 6.86 ± 5.69 0.8
ICU LOS (days) 4.10 ± 3.67 3.58 ± 2.99 6.86 ± 5.69 0.02
ICU free days 2.38 ± 2.59 2.82 ± 2.59 0.0 0.007
Ventilator days 2.64 ± 3.41 1.86 ± 2.09 6.81 ± 5.75 0.000
Ventilator free days 3.44 ± 3.79 4.64 ± 3.94 0.0 0.004
Secondary outcomes
TABLE 3 MULTIVARIATE ANALYSIS
P value 95% CI
GCS admission 0.046 1.09–46.5
APACHE II 0.08 0.44–1.05
SOFA admission 0.74 0.37–2.04
Base Deficit admission 0.055 0.99–1.51
Base Deficit after 24 h 0.79 0.97–1.50
SOFA 48 h 0.74 0.26–0.80
ICU LOS 0.04 0.67–0.99
Ventilator days 0.007 0.56–0.91
Multivariate analysis
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ICP MONITORING DURING HYPOTHERMIA AFTER CARDIOPULMONARY
RESUSCITATION
E. Isotani1, K. Ohno2, Y. Otomo1
1Tokyo Medical and Dental University, Acute Critical Care Medicine, Tokyo, Japan, 2Tokyo
Medical and Dental University, Neurosurgery, Tokyo, Japan
INTRODUCTION. Two randomized clinical trials explored that induced hypothermia
improved outcomes in adults with coma after resuscitation from ventricular fibrillation. In this
study, we will present the usefulness of intracranial pressure (ICP) monitoring to predict the
patient’s outcome after induced hypothermia
METHODS. Hypothermia (34C, 48 h) was induced in patients after the recovery of
spontaneous circulation. The indication was as follows: motor response of GCS2 5, intact at
least one of brain stem reflexes and age 15–80 years. ICP and SjO2 monitoring were per-
formed during hypothermia.
RESULTS. Hypothermia was induced in 23 patient’s (55%) after resuscitation. The outcome
of nine patients (39%) were modified Rankin Scale 0–2, 11 (48%) were 3–5 and 3 (13%) were
dead. ICP during hypothermia did not increase beyond 10 mmHg in neurologically good
outcome patients (Fig. 1). SjO2 tended to be less than 80% in neurologically good outcome
patients (Fig. 2).
CONCLUSIONS. ICP monitoring during hypothermia was extremely useful to predict the
patient’s outcome. SjO2 monitoring during hypothermia was also predictable about the
patient’s outcome.
REFERENCES. 1. Bernard SA et al (2002) N Engl J Med 346:557–563. 2. Dixon SR, et al
(2002) J Am Coll Cardiol 40:1928–1934
0538
AUDIT OF OUTCOME OF PATIENTS ADMITTED TO ITU FOLLOWING EITHER
IN OR OUT OF HOSPITAL CARDIAC ARREST
T. C. Meekings1, A. Temple1, A. Girolami1, J. Garrod1
1Sheffield Teaching Hospitals NHS Foundation Trust, Critical Care Department, Sheffield,
UK
INTRODUCTION. Therapeutic hypothermia has been demonstrated to improve outcome
when instituted in patients following cardiac arrest. Previously this has only been recom-
mended for pulseless VT or VF cardiac arrests occurring in the community. Guidelines for the
use of therapeutic hypothermia at Sheffield Teaching Hospitals (STH) were introduced in
January 2008. Inclusion criteria for these guidelines incorporate all patients following cardiac
arrest, regardless of initial rhythm or location of arrest.
OBJECTIVES.
• To review the case mix of post-arrest patients admitted to the ITU at the Northern General
Hospital, STH.
• To assess how often therapeutic hypothermia is being instituted when indicated.
• To record patient outcomes following ITU admission.
• To assess the utility of the PAR score in predicting outcome in patients admitted to ITU
following cardiac arrest.
METHODS. For all patients admitted to the ITU following cardiac arrest from May 2006–
May 2008 the following was recorded:
• Location of cardiac arrest.
• Did patient fulfil criteria for therapeutic hypothermia?
• Was therapeutic hypothermia initiated?
• Prognosis after resuscitation (PAR) score.
• Outcome at hospital discharge.
RESULTS. 66 patients were admitted to ITU following cardiac arrest from May 2006 until
2008. 29 of 66 patients (44%) had their cardiac arrest in the community. The three most
common locations for in-patient cardiac arrests were renal wards (8 patients), A&E (6
patients) and the Medical Assessment Unit (5 patients).
41 patients fulfilled criteria for therapeutic hypothermia, 23 (56%) received this therapy. The
proportion of patients fulfilling criteria treated with therapeutic hypothermia improved from
2006 (30%) to 2008 (56%).
30 patients in total (45%) survived to hospital discharge. Survival was the same for cardiac
arrests occurring in the community and in-hospital. Only one patient with a PAR score of 6 or
greater survived.
CONCLUSIONS. 45% of the patients admitted to the ITU following cardiac arrest survived
to hospital discharge. This has improved compared to data collected locally for 2001–2005
(survival 30%). The appropriate use of therapeutic hypothermia improved following intro-
duction of trust guidelines. The PAR score appears to be a useful predictor of non-survival in
patients admitted to ITU following cardiac arrest.
PAR score and hospital outcome
REFERENCES. Ebell MH (1992) Prearrest predictors of survival following in-hospital
cardiopulmonary resuscitation: a meta-analysis. J Fam Pract 34:551–558.
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THERAPEUTIC HYPOTHERMIA AFTER OUT OF HOSPITAL CARDIAC
ARREST: A RETROSPECTIVE AUDIT OF PRACTICE AFTER INTRODUCTION
OF A PROTOCOL
B. Harris1, D. Pogson1
1Portsmouth Hospitals NHS Trust, Department of Critical Care, Portsmouth, UK
INTRODUCTION. Therapeutic hypothermia is recommended for prevention of brain injury
in out of hospital VF cardiac arrest. It should be started as soon as possible and continued for
at least 12–24 h at 32–34C [1]. Local audit in 2006 led to the introduction of a protocol for
this therapy [2].
OBJECTIVES. To audit the protocol effectiveness.
METHODS. A retrospective audit was conducted of all admissions after cardiac arrest to
critical care in 12 months in 2008. Data regarding cooling, cardiac arrest and outcome was
recorded.
RESULTS. 73 people were admitted after cardiac arrest. 41 were out of hospital arrests and
32 in-hospital.
28 patients underwent therapeutic hypothermia after an out of hospital cardiac arrest. Cooling
methods included wet towels, ice packs, cold intravenous fluids and fans. The intravascular
cooling device was not yet purchased. 100% of eligible out of hospital VF/VT cardiac arrests
underwent attempted therapeutic hypothermia. 35% of out of hospital PEA or Asystole
cardiac arrests underwent therapeutic hypothermia.
Only 8 patients (28%) were within the target temperature range (32–34C) for at least 12 h.
15 patients (53%) had rebound hyperthermia within 48 h. 11 patients had clearly recorded
commencement of therapeutic hypothermia. Of these, 45% had therapeutic hypothermia
initiated in the emergency department (ED).
Overall survival to leave hospital was 37.9% of all patients treated with therapeutic hypo-
thermia. In the VF/VT group survival was 52.3% (n = 11). Survival in the non-VF/VT group
was 12.5% (n = 1).
CONCLUSIONS. In the 2006 audit [2] only 60% of eligible out of hospital VF/VT arrests
underwent therapeutic hypothermia. Introduction of a protocol has improved this to 100%.
Survival in 2006 [2] in the VF/VT group who underwent therapeutic hypothermia was 50%
and remains similar in this audit. Survival of PEA and Asystole is consistently poor and
consideration should be made only to cool under exceptional circumstances. Cooling should
be initiated in ED and the protocol needs more successful implementation here.
Achieving target temperature for at least 12 h is difficult using surface methods and rebound
hyperthermia is common. A protocol can ensure eligible patients undergo therapeutic
hypothermia but new equipment is needed to optimise cooling. We have recently purchased a
new intravascular cooling device to address these problems and are conducting a prospective
audit of its use (Table 1)




Number admitted 20 21
Number admitted who underwent
attempted therapeutic hypothermia.
7 21
REFERENCES. 1. Nolan JP et al (2003) Therapeutic hypothermia after cardiac arrest. An
advisory statement by The International Liaison Committee on Resuscitation. Resuscitation
57:231–235. 2. Noble et al (2007) The use of therapeutic hypothermia in portsmouth critical
care unit post cardiac arrest. Abstract Number 0878 presented ESICM Berlin meeting 2007
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MOTOR RESPONSE TO PAIN AS AN OUTCOME PREDICTIVE FACTOR AFTER
CARDIAC ARREST
S. Alongi1, M. Panigada1, S. De Chiara1, N. Bottino1, M. L. Caspani1, L. Gattinoni1
1Istituto di Anestesia e Rianimazione, Universita` degli Studi di Milano Rianimazione
Generale ‘‘Emma Vecla’’ Fondazione IRCCS ‘‘Ospedale Maggiore Policlinico, Mangiagalli e
Regina Elena’’, Milan, Italy
INTRODUCTION. Some patient do not regain consciousness despite return of spontaneous
circulation (ROSC) after cardiac arrest (CA). In these patients prognosis can be predicted
after 2–3 days (1–2).
OBJECTIVES. To evaluate GCS [ 3 at day 3 as an outcome predictive factor in patients
admitted to our Intensive Care Unit (ICU) after CA.
METHODS. We enrolled all patient to be admitted to the ICU after CA. We recorded time
(in minutes) from CA to the beginning of Basic Life Support (time CA-BLS) and time from
CA to ROSC (time CA-ROSC). Neurological examination was performed for 3 days to
evaluate the pupillary response to light and the motor response to pain (GCSm). Survival at
ICU discharge and at 6 months was recorded. Favorable neurologic outcome was evaluated
with the Pittsburgh Cerebral Performance Category (CPC). Good outcome was defined as
good cerebral performance (CPC 1) or moderate cerebral disability (CPC 2).
RESULTS. From January 2005 to October 2008 we enrolled 58 patients (age 62 ± 15, F/
M = 24/34), 27 out-of-hospital CA (OHCA) e 31 inhospital Cardiac Arrest (IHCA). Eight
patients died within 24 h after admission. In two patients CPC was not recorded. At day 3: 27
patients had a GCSm B3 (group 1). 21 patients had a GCSm[3 (group 2). Z-test was used to
compare proportions between group 1 and 2. More results are shown in the Table 1 below.
TABLE 1
GCSm B 3 (Group 1) GCSm [ 3 (Group 2)
Number of patients 27 (11 IHCA) 21 (14 IHCA)
Pupillary response to light 21 (78%) 21 (100%)
Survival to ICU discharge 8 (29.6%) 21 (100%)*
Survival to 6 months 2 (7.4%) 18 (85%)*
CPC 1–2 2 (8%) 18 (86%)*
Time ACC-BLS 4.8 min 0.7 min
Time ACC ROSC 22.6 min 13 min
* p \ 0.001
CONCLUSION. Our result confirms that the motor response to pain at day 3 after CA is a
strong outcome predictive factor of death or poor neurological outcome. Also, patients
showing GCSm [3 had shorter no-flow time compared to patients showing GCSm B3.
REFERENCES. 1. Attia J et al (1998) Crit Care Clin 14:497–511. 2. Booth CM et al (2004)
Jama 291:870–879.
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USE OF A STANDARDIZED ORDER SET FOR MILD THERAPEUTIC HYPOTHER-
MIA AFTER CARDIAC ARREST: AN EASY AND INEXPENSIVE TECHNIQUE
T. Shiga1, K. Ando1, Y. Sakurada2, T. Tajima2, N. Sodeyama2, T. Horinouchi3, H. Fudeta2
1Sendai City Hospital, Emergency and Critical Care Center, Sendai, Japan, 2Sendai City
Hospital, Anesthesiology, Sendai, Japan, 3Senen Genetal Hospital, Anesthesiology, Tagajo,
Japan
INTRODUCTION. Mild therapeutic hypothermia (MTH) has become a standard of care in
comatose survivors of out-of-hospital cardiac arrest (OHCA) [1, 2]. However, those processes
are cumbersome and needed of special technique. Moreover, the special cooling resources are
expensive.
OBJECTIVES. We made the standardized order set for MTH using easily available, low-cost
Intensive Care Unit (ICU) resources. We consider the neurological outcome and cost to give
an assessment of our order set.
METHODS. We retrospectively studied 19 OHCA survivors that were treated with MTH in
our ICU from 2006 to 2008 with regard to cerebral performance category (CPC) at hospital
discharge. 19 comatose post-cardiac arrest/post-anoxic event patients were cooled to a target
temperature range of 32–34C and maintained in target range for 24–36 h with traditional
water circulating cooling blankets. Cooling was begun immediately upon arrival to the
emergency room by rapid intravenous infusion of 40 ml/kg 4C bicarbonated Ringer’s
solution. Favorable outcome was defined as good cerebral performance (CPC1) and moderate
cerebral disability (CPC2).
RESULTS. There were 19 patients (12 male, 7 female) in coma after cardiac arrest or anoxia
event with an average age of 56.5 years. Time to reach target range after induction of cooling
modalities averaged 144 min. Time to reach target range from resumption of spontaneous
circulation (ROSC) averaged 241 min. Neurological outcomes were 9 cases in CPC1
(47.5%), 2 cases in CPC2 (10.5%), 2 cases in CPC3 (10.5%), 1 case in CPC4 (5.3%), and 5
cases in CPC5 (26.5%). Favorable outcome was 11 cases (57.9%). Cost of materials was
approximately 100 Euros per patient.
CONCLUSIONS. Our standardized order set can be induced with easily available and low-
cost ICU resources. We reported favorable outcomes which were almost same as already
reported [1]. These results suggest that MTH will potentially become widespread even at
small ICU by our standardized order set.
REFERENCES. 1. Bernard SA, Gray TW, Buist MD, Jones BM et al (2002) Treatment of
comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med
346:557–563. 2. Hypothermia after Cardiac Arrest Study Group (2002) Mild therapeutic
hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549–
556.
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SOMATOSENSORY EVOKED POTENTIALS IN PREDICTION OF INDIVIDUAL
OUTCOME IN UNCONSCIOUS CARDIAC ARREST SURVIVORS
R. Kitzberger1, E. Doberer1, G. C. Funk1, U. Holzinger1, V. Fuhrmann1, M. Wewalka1,
C. Madl1
1Medical University of Vienna, General Hospital, Dep. of Internal Medicine III, ICU 13H1,
Vienna, Austria
INTRODUCTION. Somatosensory evoked potentials (SEP) is the method with the highest
prognostic reliability in unconscious cardiac arrest survivors. Whereas bilaterally absent N20
peak predicts bad outcome with a specificity of 100%, the sensitivity of the N20 peak is low.
Additional recording of the N70 peak increases prognostic accuracy. In this study we assessed
the prognostic accuracy for the N20 peak and for different cut-off points of the N70 peak.
METHODS. SEP were recorded within 24 and 72 h after cardiac arrest. We included 448
unconscious patients after successful cardiopulmonary resuscitation. One year after cardiac
arrest, final outcome was assessed and severe disability, persistent vegetative state or death,
were defined as bad outcome. Sensitivity (good outcome which has classified correctly)
specificity (bad outcome which was classified correctly) and negative predictive value (NPV)
and positive predictive value (PPV) of the N20 and N70 peak latency were calculated.
RESULTS. One year after cardiac arrest, 322 (72%) patients were classified as bad outcome.
All patients with bilaterally absent N20 peak (n = 129; 29%) had bad outcome. The pre-
dictive accuracy of an absent N20 peak and of different cut-off points for the N70 peak in
predicting bad outcome are shown in the Table 1.
TABLE 1
Specificity Sensitivity PPV NPV
N20 absent 1 0.40 1 0.33
N70 cut-off 148 ms 0.98 0.70 0.97 0.69
N70 cut-off 127 ms 0.77 0.84 0.79 0.83
N70 cut-off 110 ms 0.33 0.97 0.35 0.96
CONCLUSIONS. Recording of SEP N20 peak predicted correct outcome only in 29% of
cardiac arrest survivors. Additional recording of the N70 peak increased the predictive
accuracy of SEP. A N70 peak[148 ms or absent predicted bad outcome with a specificity of
98%, whereas a N70 peak\110 ms predicted favourable outcome with a sensitivity of 97%.
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BARRIERS TO RESEARCH TRANSLATION. A QUALITATIVE STUDY INTO THE
INTRODUCTION OF THERAPEUTIC HYPOTHERMIA FOR POST RESUSCITA-
TION CARE IN A DISTRICT GENERAL HOSPITAL
A. K. Swinson1, L. Keating2, O. Johnson2, P. Thomas3
1Royal Berkshire NHS Foundation Trust, Department of Anaesthesia, Reading, UK, 2John
Radcliffe Hospital, Department of Intensive Care, Oxford, UK, 3Milton Keynes Hospital,
Department of Emergency Medicine, Milton Keynes, UK
INTRODUCTION. The International Liaison Committee on Resuscitation (ILCOR) has
recommended the use of therapeutic hypothermia (TH) after cardiac arrest since 2002. Evi-
dence for the use of TH in patients with a return of spontaneous circulation after cardiac arrest
is based on two prospective randomised control trials and one meta-analysis [1-3]. The
uptake of TH has been variable [4]. ILCOR has called for research into the barriers to an
effective approach the implementation of TH [5, 6].
OBJECTIVE. To identify the barriers to the implementation of the uptake of TH for post-
resuscitation care of cardiac arrest patients.
METHODS. Semi-structured qualitative interviews of 16 doctors, nurses and managers in all
departments with a stake in post resuscitation care in a 500 bedded acute general hospital in
the UK. Purposeful sampling was used and interviews continued until data saturation was
achieved. Transcripts of interviews were analysed in themes based on the principles of
grounded theory.
RESULTS. Whilst some participants were highly motivated, many clinicians expected the
outcome of patients in this group to be poor. The overwhelming attitude was not conducive to
change. The decision making surrounding treatment decisions for these patients was per-
ceived to be influenced by capacity in ICU, relatives’ wishes and different consultants
attitudes. The inter-departmental working patterns could be improved by greater transparency
over decisions. The evidence for TH was challenged and the logistics perceived to be too
great. There was no consensus from the ICU and the organisational structure could be
improved.
CONCLUSION. Barriers to the implementation of TH are clearly linked to the management
of post-cardiac arrest patients. Areas for improvement have been highlighted including the
need for better communication between the teams and a more efficient organisational
structure to facilitate better patient care.
REFERENCES. 1. Holzer M, Bernard SA, Hachimi-Idrissi S, Roine RO, Sterz F, Mullner M
(2005) Hypothermia for neuroprotection after cardiac arrest: systematic review and individual
patient data meta-analysis. Crit Care Med 33(2):414–418.
2. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G et al (2002)
Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.
N Engl J Med 346(8):557–563.
3. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest
(2002) N Engl J Med 346(8):549–556.
4. Soar J, Nolan JP (2007) Mild hypothermia for post cardiac arrest syndrome. BMJ
335(7618):459–460.
5. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW et al (2008) Post-cardiac
arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication Circulation.
118(23):2452–2483.
6. Intensive Care Society (2008) Standards for the management of patients after cardiac arrest
2008:1–38.
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ICPR: NEW SOFTWARE FOR CARDIOPULMONARY RESUSCITATION
TRAINING
F. Semeraro1, L. Marchetti2, F. Taggi1, G. Tammaro1, G. Imbriaco1, E. L. Cerchiari1
1Maggiore Hospital, Anaesthesia and Intensive Care, Bologna, Italy, 2D-sign, Bologna, Italy
PURPOSE OF THE STUDY. The consolidated importance of cardiopulmonary resuscita-
tion (CPR) for survival of cardiac arrest patients has been integrated with the role of good-
quality CPR to significantly improve outcome. When tested on mannequins, CPR quality
performed by lay rescuers and health care professionals tends to deteriorate significantly
within a few months after training. iCPR is a software for iPod and iPhone downloadable from
Apple Store built specifically to help CPR retention and ameliorate feedback about quality
CPR training.
MATERIALS AND METHODS. We built a software specifically dedicated to self-directed
CPR training through a tutorial including a simple feedback module dedicated to guide
training in relation to the quality of CPR. The software can be used with iPod and iPhone on
armbands commonly used for running. The accelerometer mounted inside iPod and iPhone
measures the rate and the depth of compressions and gives audio-visual feedback to the
operator of performance to reach the guideline target (100 compressions per minute and 4–
5 cm depth). The tutorial is based on ILCOR (AHA and ERC guidelines) and periodically can
be used to easily refresh the CPR algorithm through a slideshow inside iPod and iPhone.
RESULTS PRESENTED IN SUFFICIENT DETAIL TO SUPPORT THE CONCLU-
SION. Our preliminary tests on iCPR were performed on a group of 50 healthcare
professionals to validate the comfort, the user-friendliness and the accelerometer precision
compared to other quality CPR devices.
CONCLUSIONS. iCPR can become a easy and cheap software to help rescuers maintain
retention of CPR skills.
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COMPARISON OF EXTERNAL JUGULAR CANNULATION WITH MORE
PERIPHERAL VEINS AS AN ACCESS ROUTE IN CARDIAC ARREST SITUATION
A. Kaushal1, Y. Javeri1, D. Juneja1, M. Gupta1, G. Singh1, R. Kaushik1, R. Pandey1, O. Singh1
1Max Super Speciality Hospital, New Delhi, India
INTRODUCTION. Even under best of circumstances obtaining peripheral venous access is
challenging and time consuming in cardiac arrest situation. Significant delay in delivery of
drugs to the heart is seen when peripheral access is used. Thus better route will be a peripheral
vein, large in size, easy to cannulate and offering quick access to central circulation. External
jugular vein (EJV) has all these attributes.
OBJECTIVES. To determine the success rates with EJV versus more peripheral veins in out
of ICU cardiac arrest scenarios.
METHODS. All patients developing cardiac arrest out of ICU, during the period from June
2006 to December 2008, were randomized to have peripheral or EJV cannulation. Data were
collected regarding time required for cannulation, number of attempts and failure rates, with
time required for cannulation being the primary outcome measure.
RESULTS. A total of 82 patients were included in the study with 40 (48.8%) receiving
peripheral cannula and 42 (51.2%) receiving EJV cannula. 15/40 and 30/42 veins could be
cannulated in less than one minute in peripheral and EJV groups, respectively (p = 0.01).
Mean time to cannulate EJV was 66 seconds versus 133 seconds for more peripheral vein
cannulations (p = 0.002). Overall, 21/40 and 35/42 cannulations could be achieved in first
attempt in peripheral and EJV groups, respectively (p = 0.028). In three patients, peripheral
vein could not be cannulated and hence EJV or a central vein was cannulated. In the EJV
group, all patients had successful cannulations (Table 1).









\1 min 15 (37.5%) 30 (71.4%) 0.01
1–5 min 19 (47.5%) 12 (28.6%)
[5 min 3 (7.5%) 0
Mean time taken (s) 133.1 ? 122.7 66.1 ? 47.8 0.002
No. of attempts
1 21 (52.5%) 35 (83.3%) 0.028
2 9 (22.5%) 5 (11.9%)
3 or more 7 (17.5%) 2 (4.8%)
Failure rates 3 (7.5%) 0
CONCLUSIONS. EJV in comparison to more peripheral veins takes significantly lesser time
to cannulate in cardiac arrest victims with lesser number of attempts required and lesser
failure rates. Thus it is an easy, faster and reliable venous access route in cardiac arrest
scenarios.
REFERENCES. 1. Jacobs LM, Panic S (1994) Out-of-hospital care: what works, what does
not. Adv Trauma Crit Care 9(1).




COMPARISON OF IN HOSPITAL CARDIAC ARRESTS IN TWO CONSECUTIVE
PERIODS
R. de la Chica Ruiz-Ruano1, G. Tuero1, V. Mun˜oz Marina1, M. Colmenero Ruiz1
1Hospital Virgen de las Nieves, Granada, Spain
OBJECTIVES. To determine the evolution of the survival and main characteristics of the
cardiac arrests in a hospital when comparing two consecutive periods.
METHODS. A prospective cohort study of all the resuscitation attempts occurred in the
general center in the university hospital ‘‘Virgen de las Nieves’’ (Granada, Spain). Used in-
hospital Utstein style, collecting only the first episode per patient. We excluded resuscitation
efforts made during surgical interventions and any other not attended by the hospital resus-
citation team. Too excluded those resuscitation when efforts initiated prior to emergency
room. We compared data from two consecutive period: July/2003–December/2005 and
January/2006–December/2008. We analyzed survival to hospital discharge and the main
characteristics of the patients in both periods. Results were expressed as means, medians, and
both series were compared using the Yates’ test when the dependent variable was qualitative
and the t Student for independent samples for quantitative.
RESULTS. We collected in the first period a total of 203 arrest (6.76 arrest/month) and 260 in
the second (7.2 arrest/month). The median age of patients was also similar in both groups:
63.1 ± 14 years versus 64.8 ± 12.7 years (ns) as well as by gender (males 60 and 59%,
respectively, in first and second series). There was a significant decrease in the proportion of
arrest of cardiac origin in the first period (62%) over the second (49%) (19.6, p \ 0.001) but
not in the proportion of shockable rhythm (ns). The proportion of cardiac arrests occurred in
the intensive care unit compared to the total (48.7% vs. 42.3%) presented no statistical
differences. The hospital survival in both series (23.1% and 23.2%) were similar (ns).
CONCLUSIONS. There have been no improvements in survival between the two periods
examined in our hospital and patient characteristics remained similar, except for a decrease in
cardiogenic etiology.
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A RANDOMIZED CONTROLLED TRIAL OF PHARYNGEAL COOLING SYSTEM
DURING CARDIOPULMONARY RESUSCITATION
Y. Takeda1, K. Shiraishi1, H. Naito2, N. Morimoto2, K. Morita1
1Okayama University Medical School, Anesthesiology and Resuscitology, Okayama, Japan,
2Tsuyama Central Hospital, Emergency and Critical Care Center, Tsuyama, Japan
INTRODUCTION. The development of a technique that enables brain temperature to be
immediately and selectively reduced without affecting systemic circulation is needed to
perform resuscitative hypothermia in a clinical situation. Since bilateral common carotid
arteries exist at 1 cm from the pharynx, cooling the pharyngeal region decreases the carotid
arterial temperature first and subsequently decreases brain temperature before lowering car-
diac temperature. A multi-center (12 of emergency critical care centers in Japan)
prospectively randomized controlled trial of pharyngeal cooling system during cardiopul-
monary resuscitation will start in June 2009.
PURPOSE. This study will be performed to elucidate the effects of pharyngeal cooling initiated




1. Patients (16–89 years) with witnessed cardiogenic cardiac arrest or witnessed non-
cardiogenic cardiac arrest except posttraumatic cardiac arrest.
2. Patients who have been resuscitated by medical services within 15 min after the onset of
cardiac arrest.
TREATMENTS. Patients in the treatment group will undergo pharyngeal cooling during
resuscitationorwithin30 minafter theonsetofspontaneouscirculation.Aftertracheal intubation,
pharyngeal cooling cuff is inserted into the pharynx. Physiological saline (5C) circulates into the
pharyngeal cooling cuff at the rate of 500 ml/min for 2 h. Intra cuff pressure is controlled at 50
cmH2O.
PRIMARY ENDPOINT AND POWER ANALYSIS. Lowering tympanic temperature
greater than 1 degree centigrade.According to the power analysis, 300 cases will be needed.
SECONDARY ENDPOINTS
1. Glasgow Coma Scale at 2 weeks after resuscitation.
2. Glasgow Pittsburgh cerebral performance and overall performance categories at 1 month
and 6 months after resuscitation.
3. Mortality rates at 1 month, 3 months and 6 months after resuscitation.
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ANALYSIS AND LONG-TERM MONITORING OF IN-HOSPITAL CARDIOPUL-
MONARY RESUSCITATION
R. de la Chica Ruiz-Ruano1, V. Mun˜oz Marina1, G. Tuero Leon1, M. Colmenero Ruiz1
1Hospital Universitario Virgen de las Nieves, Granada, Spain
OBJECTIVES. To establish the main features, results and long-term evolution (5 years) of
patients who suffered a cardiac arrest according to the in-hospital Utstein style.
METHODS. Prospective study of all cardiac arrests occurred in a university hospital during a
period of 2.5 years (Julio/2000–Diciembre/2002) according to the Utstein style. Exclusion
criteria were the PCR occurring in the operating rooms, not attended by the hospital resus-
citation team and those when life support maneuvers were initiated before hospital admission.
Subsequently conducted a follow-up of all survivors identified until 5 years. We collected all
the key variables considered in the Utstein style. To assess the patient’s controls were used in
these scales of brain function categories Glasgow–Pittsburgh (CPC) for neurological function
and level of overall function of Glasgow–Pittsburgh (OPC) for the overall situation. The
deceased were collected the interval too.
RESULTS. A total of 203 patients were treated by cardiac arrest during the period of which 47
survived (hospital survival 23.15%) and were included in the follow-up. The 60.6% were male and
mean age 63.2 (±14.92) years. The most common location was the ICU (48%) and 62% there was
a cardiac origin. The first shockable rhythm was detected in 62 patients. The initial rate of
successful resuscitation (ROSC [ 24 h) was 17.3%. The vast majority of them were discharged in
excellent neurological and general functional status (75% in the optimum). After 5 years of
follow-up of these patients, 31 were still alive (69.9% hospital survivors and 15.3% of all the
patients cared for by cardiac arrest in hospital) and 2 could not be located. The distribution of
deaths was heterogeneous along the track with a backlog of cases in the first few months. All
patients except one were contacted in the best position both neurological (CPC 1) and general
(OPC 1). We found a statistically significant association between the degree CPC/OPC 1 when the
hospital discharge and the probability of being alive at 5 years later (Fisher test 5.65, P = 0.029).
CONCLUSIONS. Patients surviving a cardiac arrest in hospital remain alive and most of
them in good neurological and functional status. The good functional status at discharge is
associated with long-term survival.
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PREDICTIVE VALUE OF NEUROLOGICAL EXAMINATION FOR RESULTS OF
SOMATOSENSORY EVOKED POTENTIALS IN PATIENTS AFTER CARDIAC
ARREST
B. Verbaan1, A. Bouwes1, J. Binnenkade1, E. Zandbergen1, A. Hijdra1, J. Horn1
1Academical Medical Centre, Intensive Care, Amsterdam, Netherlands
INTRODUCTION. To determine the prognosis of postanoxic coma after cardiopulmonary
resuscitation (CPR), somatosensory evoked potentials (SSEP) of the nervus medianus can be
used [1]. Bilateral absence of the cortical responses (N20) of this SSEP invariably correlates
with a poor neurological outcome. However, bilateral presence of the N20 responses does not
predict awakening. Patients are examined neurologically before a SSEP is requested. The
results of this examination might lead to the decision not to perform a SSEP, as the cortical
responses are expected to present.
OBJECTIVES. Aim of this study was to determine the characteristics of neurological
examination, always yielding a positive SSEP.
METHODS. Data from the PROPAC study [2], in which patients who remained in coma
24 h after CPR were included, were used. Neurological examination, consisting of Glasgow
Coma Score (GCS) and brainstem reflexes, and SSEP were performed 24, 48 and 72 h after
admission. The neurological examination (pupillary reaction, corneal reflexes, eye and motor
scores) and SSEP (positive when N20 bilaterally present) were correlated with a 2 9 2 table
to determine sensitivity, specificity and positive (PPV) and negative predictive values (NPV).
RESULTS. Data of 407 patients were included, 67% male, mean age 63 (range 18–92). 764
SSEPs were performed in this group, 471 were positive. No correlation predicting SSEP
results was found for pupillary reaction, corneal reflexes and GCS eye scores. Only motor
score of 5 or 6 (localizes painful stimuli or obeys to commands) predicted a positive SSEP:
specificity 1.0 (95% CI 0.98–0.99) and a PPV of 0.9 (95% CI 0.8–1.0).
CONCLUSION. This study shows that the cortical N20 responses of median nerve SSEP are
always present in patients who localize painful stimuli or obey to commands. Lower motor
scores and brainstem reflexes do not predict SSEP results and therefore cannot be used to
decide whether or not to do this test. Surprisingly, other items investigated with clinical
neurological examination did not predict SSEP results reliably. The PROPAC study was
performed before treatment with therapeutic hypothermia was routinely used. This might
limit the usefulness of the results found, as neurological examination is hampered by sedative
medication administered during hypothermia. Another limitation is that neurological exam-
ination in the PROPAC study was also performed by other physicians than neurologists.
REFERENCES. 1. Wijdicks EFM, Hijdra A et al (2006) Practice parameter: prediction of
outcome in comatose survivors after cardiopulmonary resuscitation (an evidence based
review). Neurology 67:203–210.
2. Zandbergen EGJ, Hijdra A et al (2006) Prediction of poor outcome within the first 3 days
of postanoxic coma. Neurology 66:62–68
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IDENTIFICATION OF THE ETIOLOGY OF 314 SERIAL NON-CARDIAC CAR-
DIOPULMONARY ARREST USING US AND/OR US
Y. Moriwaki1, Y. Tahara1, S. Arata1, H. Toyoda1, M. Iwashita1, T. Kosuge1, N. Harunari1, N.
Suzuki1
1Yokohama City University Medical Center, Critical Care and Emergency Center, Yoko-
hama, Japan
INTRODUCTION. Most of out-of-hospital cardiopulmonary arrest (OH-CPA) patients are
thought to be cardiac origin in the world, and most of them are thought to show VF as an
initial cardiac rhythm. However, the term ‘‘cardiac origin’’ is defined as CPA derived from
clear cardiac disease such as acute myocardial infarction or exception from clear non-cardiac
origin. It is defined as following in Utstein template; ‘‘an arrest is presumed to be of cardiac
etiology unless it is known or likely to have been caused by trauma, submersion, drug
overdose, asphyxia, exsanguination, or any other noncardiac cause as best determined by
rescuers.’’ However, we can only guess the etiology of OH-CPA using very restricted
methods during advanced resuscitation in the hospital. The accurate etiology of OHCA is not
clear and well established even today. In this study, we evaluate the etiology of OHCA of
population based data using US and/or CT.
METHODS. We treated serial 849 OH-CPA patients in our emergency department for the
past 2 years. OH-CPAs occurred after contact of EMS and occurred in the hospital are
excluded. We examined the etiology of these patients during resuscitation using blood
examination including blood sugar, troponine and CK, arterial blood gas analysis, plane chest
x-ray, US and CT. We reviewed medical records of these patients and evaluate the etiology of
cardiac events from performed examinations and patients’ history. If we could found lethal
and clear etiology easily by their history such as trauma, neck hanging, terminal stage of
malignancy, or distinct airway obstruction, we diagnosed the etiology of CPA without any
other special examinations. In other cases we performed CT, US, and/or trans-esophageal US.
RESULTS. In all 849 patients, 102 were due to trauma and 49 were neck hanging, whom we
did not perform any special examination to determine their etiology. In other 698 patients, we
perform brain CT in 293 patients and body CT in 58 patients, and chest and abdominal US in
all patients. We determine etiology of the 314 patients as non-cardiac origin including trauma
and neck hanging, in which 52 (17%) were great vascular disease origin, 7 (2%) pulmonary
embolism, 39 (12%) cerebrovascular disease, 19 (6%) renal failure, 12 (4%) gastrointestinal
disease, 67 (21%) airway obstruction by malswallowing, 24 (8%) hypoxia due to pneumonia,
20 (6%) worsening of COPD, 7 (2%) attack of asthma, 74 (24%) submersion in bath tab.
CONCLUSIONS. The population of OH-CPA from cardiac origin is not so high (63%). The
population of OH-CPA from cardiac origin is probably decreasing according to aggressive
examinations such as US and CT. The etiology of OH-CPA of non-cardiac origin is thought to
be various and different among countries.
Neurointensive care: 0551–0564
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PRONE POSITION IN BRAIN INJURED PATIENTS WITH ACUTE RESPIRATORY
FAILURE
A.-M. Domı´nguez-Berrot1, F.-J. Diaz-Dominguez1, M. Riesco-Crespo1
1Complejo Asistencial de Leon, Intensive Care Unit, Leon, Spain
INTRODUCTION. Prone position (PP) may improve gas exchange in severe acute respi-
ratory failure (ARF). Its potential deleterious effect on ICP precludes its use in brain injured
patients (BIP). We present four cases of BIP with severe ARF who were placed in PP for
lowering FiO2 to B0.6, providing ICP B 20 and CPP C 65. In case 4 PTiO2 was monitored.
CASE 1: 17-year-old #. Severe TBI. Epidural haematoma and hemorrhagic petechia in
lamina quadrigemina. On 6th day, he shows ARF. Diagnosis of ventilator-associated pneu-
monia (VAP) was made. On 9th day he was placed in PP for 16 h. The patient made a good
recovery. Upon discharge from ICU, he was awake and showed left brachial weakness that
eventually disappeared (Table 1)












ICP 15 28 20 30 17 19 13
MAP 82 94 89 93 92 104 106
CPP 67 66 69 63 75 85 93
PaO2 60 92 92 93.7 93.7 91.2 89
FiO2/
PEEP
1/10 0.8/10 0.8/10 0.7/9 0.7/9 0.6/8 0.6/8
PaO2/
FiO2
60 115 115 133.8 133.8 152 148.3
CASE 2. 69-year-old #. Moderate TBI. Initial high ICP responsive to sedation, analgesia,
muscle relaxation. On 9th day he shows VAP and severe ARF. On day 10th PP was tried for
6 h. A favourable course was observed. He was discharged from ICU awake and with tra-
cheotomy. On discharge from hospital, normal neurological examination (Table 2)
TABLE 2 CASE 2
Before PP PP After Manitol 3 h in PP 6 h in PP SP
ICP 19 25 17 18 19 16
MAP 84 87 83 83 84 82
CPP 65 62 66 65 65 66
PaO2 66 66 72 97 96 97.6
FiO2/PEEP 1/14 1/14 0.8/14 0.7/14 0.6/13 0.6/13
PaO2/FiO2 66 66 90 138.5 160 162.66
CASE 3. 36-year-old#. Intracerebral hemorrhage opened to ventricles. Surgical treatment was
ruled out. High ICP was pharmacologically controlled. On 3rd day, ARF ensues from neurogenic
pulmonary edema. PP was adopted for 12 h. A rapid improvement was obtained. Clinical course
was favorable. On discharge from ICU: awake and with mild left weakness (Table 3)
TABLE 3 CASE 3 AND 4
Before PP PP After
Manitol









Case 3 Case 3 Case 4 Case 3 Case 4
ICP 18 20 16 22 16 14 18 14 13
MAP 85 85 88 93 92 92 100 85 90
CPP 70 65 72 71 66 78 82 71 75
PaO2 57 63.9 92 195 143 118 177 159 85
FiO2/
PEEP
1/10 1/15 1/10 1/16 0.5/15 0.4/9 0.5/12 0.4/9 0.5/14
PaO2/
FiO2
87 63.9 92 195 286 295 354 397.5 170
PTiO2 8 13 24.4 22.2 16
CASE 4. 40-year-old #. Intracerebral haemorrhage due to aneurysmal rupture. Urgent sur-
gery (evacuation, decompressive craniectomy, blood transfusion). On day 3rd ARF was
observed, related to ARDS. PP was tried for 24 h. Slow favorable recovery (tab 03). No need
for tracheotomy. On discharge from ICU: awake, aphasic, right paresia.
CONCLUSIONS. No conclusions for general practice. PP could be CAUTIOUSLY CON-
SIDERED as an option for BIP with severe ARF.
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ALTERATION OF CARDIOPULMONARY FUNCTION AFTER SEVERE HEAD
INJURY
E. Isotani1, K. Ohno2, Y. Otomo1
1Tokyo Medical and Dental University, Acute Critical Care Medicine, Tokyo, Japan, 2Tokyo
Meical and Dental University, Neurosurgery, Tokyo, Japan
INTRODUCTION. It is very hard to achieve optimal water balance in severe head injury
(SHI) patient (GCS2 8). Cardiopulmonary complications are common after SHI: neurogenic
pulmonary edema, cardiac failure, and so on. In this study we will present the alteration of
cardiopulmonary function on PiCCO plus monitoring after SHI.
METHODS. Plasma catecholamines, natriuretic polypeptides, thrombomodulin and D-dimer
of nine patients were measured immediately after SHI. The cardiopulmonary functions of nine
consecutive patients were monitored by PiCCO plus daily during a week after SHI.
RESULTS. Noradrenalin (NOR), dopamine (DOA) and BNP concentrations were signifi-
cantly high during the entire study period. Significantly, higher elevations of plasma
thrombomodulin and D-dimer concentrations were also observed after SHI. Intrathoracic
blood volume was maintained in spite of systemic hypovolemia, and this fluid redistribution
caused hydrostatic fluid retention in lung tissues on PiCCO plus monitoring after SHI.
CONCLUSIONS. Persistent catecholamine release and the different sensitivity of blood
vessels to catecholamine cause the blood volume redistribution: systemic hypovolemia and
hydrostatic pulmonary edema. The excess cardiac preload due to catecholamine release leads
to BNP release resulting in natriuresis.
REFERENCES. 1. Isotani E et al (1994) Stroke 25(11):2198–2203. 2. Isotani E et al (1996) J
Cardiovasc Pharmacol 28(5):639–644. 3. Kubota Y et al (2007) Vascul Pharmacol
47(2–3):90–98. 4. Mizuno Y et al (2008) Vascul Pharmacol 48(1):21–31
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FUNCTION SKILL IMPACT AFTER DECOMPRESSIVE CRANIECTOMY AS A
SECOND LEVEL THERAPY IN PATIENTS SUFFERING INTRACRANIAL
HYPERTENSION
M. D. Arias Verdu´1, M. J. Chaparro Sa´nchez1, M. A. Prieto Palomino1, M. J. Ruı´z de Elvira1,
P. De Rojas Roma´n2, J. Mun˜oz Bono1
1Hospital Universitario Carlos Haya, Intensive Care Unit, Ma´laga, Spain, 2Hospital Comarcal
Antequera, Intensive Care Unit, Antequera, Spain
INTRODUCTION. The aim of this study is to report the function skill impact after des-
compressive craniectomy (DC) included as a therapy in the control of intracranial
hypertension (IH) in patients admitted to an Intensive Care Unit (ICU) in a tertiary reference
hospital, with the help of the Glasgow Outcome Scale (GOS) and the Barthel Index (BI) at
discharge and the changes after 6 and 12 months.
METHODOLOGY. We recorded all adult patients (18 years old or more) data, admitted to
our ICU in the interval time period going from 01/01/2007 up to 31/12/2008, who underwent
a DC due to uncontrolled high intracranial pressure (ICP) after medical therapy failure.
Epidemiologic data, cause leading to DC, Glasgow Coma Scale (GCS) at admission, GCS
before and immediately after DC, previous and post DC computer tomography (CT) reports,
ICP monitoring prior to and after DC, from admission to DC surgery time interval, destination
on discharge, and GCS, GOS and BI on discharge from hospital were registered.
RESULTS. From a total of 165 patients admitted to ICU with high ICP, we reported 10
patients (70% men, 30% women) with refractory high ICP. In seven patients raised ICP was
secondary to traumatic brain injury; rupture of a cerebral aneurysm was the cause in two
patients and in one patient a malignant middle cerebral artery (MCA) infarction was present.
Mean GCS at admission was 7. Stage II diffuse axonal injury (DAI) was the most frequently
CT report (6 patients) while stage III DAI was present in 2 patients and stage I DAI in one
patient. Surgical injury was appreciated in one patient. After DC surgery the CT reports found
stage III DAI (5 patients), stage II DAI (2 patients), surgical injury (2 patients) and malignant
MCA infarction (1 patient). Mean first ICP measurement was 21 while just before DC became
33. The mean time to accomplish DC surgery was 79 h, and ICP mean measurement just after
DC was 20. Fronto-temporal-parietal DC was conducted in eight patients while Frontal
bilateral craniotomy approach was done in two patients. Mean ICU length of stay was
22 days. Two patients died. Severe disability (GOS 3) was present in five patients, persistent
vegetative state (GOS 2) in three patients, and death (GOS 1) in two patients. Six months
later, severe disability (GOS 3) appeared in two patients, moderate disability (GOS 4) in three
patients, there were three deaths (GOS 1) and good outcome (GOS 5) was present in one
patient. Mean Barthel Index at discharge was 21, rising to 46 after 6 months and up to 51 in
12 months.
CONCLUSION. In our short experience, we feel DC is a useful technique, especially if done
early after brain injury, for refractory ICP control in patients with IH. This may improve




HIGH PLATELET COUNT MAY CORRELATE WITH POOR NEUROLOGICAL
OUTCOME AFTER MODERATE TO SEVERE TBI
A. Taha1, A. Omar1, S. Qadri1
1Mafraq Hospital, ICU, Abu Dhabi, United Arab Emirates
INTRODUCTION. The pathophysiological mechanisms of traumatic brain injury (TBI) are
complex and known to involve both hemodynamics and metabolism [1].
OBJECTIVES. To find out if there is any correlation between high platelet counts and poor
early neurologic outcome (within 30 days) in patients with moderate to severe TBI.
METHODS. Retrospective observational study on 50 patients admitted with isolated mod-
erate to severe TBI who survived for more than 1 month after injury. Patients who died before
completing 1 month, who required multiple resuscitative transfusions, who had sepsis
induced thrombocytopenia or heparin induced thrombocytopenia (HIT), and those who
received antiplatelet agents prior to or after injury were excluded from the study. All patients
were treated according to brain trauma foundation guidelines. Determination of consciousness
was based on Glasgow coma score (GCS) that had been recorded on Day 1, 8, 15, 22, and 30.
Platelet counts were also recorded in the same days. Patients were classified according to GCS
into three groups. Group 1 had GCS of C9, Group 2 had GCS of 7–8, and Group 3 had GCS
of B6. Patients were allowed to swap between groups if there GCS showed improvement or
deterioration.
RESULTS. Thirty sex male and 14 females were included in the study with a mean age of
29 years (±24). Thirteen out of 50 were involved in road traffic accidents, 23 had direct
trauma to the head, and 14 had falls from height. Seven out of them had extradural or subdural
hematoma, 10 had brain edema, and 19 had brain contusions, and diffuse axonal injury (DAI).
The platelet counts did not show any statistically significant differences between the three
groups on admission and on day 8. Although it was statistically insignificant, patients in group
3 had a trend of high platelet counts compared with group 1 on days 15 and 22 (P 0.092 and
0.051, respectively). On day 30, patients in group 3 had a significantly higher platelet counts
compared to group 1 (P 0.003). Moreover, patients in group 2 had less significant higher
platelet counts compared to group 1 (P 0.02).
CONCLUSIONS. We concluded that higher platelet counts in patients with moderate to
severe TBI strongly correlate with early poor neurologic outcome. The exact cause and
mechanism of this pathophysiologic pattern is not yet clear and still need more research to
define it properly.
REFERENCES. Bouma GJ, Muizelaar JP, Choi SC et al (1991) Cerebral circulation and
metabolism after severe traumatic brain injury: the elusive role of ischemia. J Neurosurg
75:685–693
KEY WORDS. Traumatic brain injury, high platelets.
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GUILLAIN-BARRE SYNDROM:PROGNOSIS AND RISK FACTOR DIFFERENCES
BETWEEN CHILDREN AND ADULTS IN INTENSIVE CARE UNIT
K. Baccar1, N. Baffoun1, M. Ben Salah1, C. Kaddour1
1National Institute of Neurology, Anesthesia and Intensive Care Medicine, Tunis, Tunisia
INTRODUCTION. One-third of patients with Guillain-Barre´ syndrome (GBS) require
admission to the intensive care unit (ICU) associated significant risk of morbidity, mortality
and incomplete recovery [1]. A many studies describe the outcome of GBS is more favorable
in children than in adults [2].This study this is meant to analyse risks factors that children/
adults.
METHODS. Retrospective study from January 1999–December 2008. Analysis of all
patients admitted in ICU for confirmed GBS (clinic, electromyography and lumbar) and
subject to intra venous immunoglobulin with or without plasmapheresis exchange.
We compared the events and outcomes both two subgroups (children and adults)
RESULTS. During 10 years, 94 patients [22(23.4%) children and 72(76.6) adults] were
admitted in our ICU. The average age of children was 8 years (range 2–15) that of adult was
41 years (range 16–75).
80% of children were admitted during precocity deficit ascending phase 20% during plateau
phase. Where as 88% of adults were admitted during plateau phase. 5 patients (1 child and 4
adults) were admitted after cardiac arrest.
8 (36) of children and 54 (75%) of adults requiring artificial ventilation. Hospitalisation
period in the icu was 10 days (range 4–28) for children versus 17 days (range 6–80)
We recorded 3 (13.6) children versus 18 (25%) adults death: 1 child and 14 adults presented
autonomic disturbances before the death. 2 children and 2 adults developed a fatal acute
respiratory distress syndrome. Septic shock caused the death of 2 adults.
The association GBS and acquired critically neuromyopathy were the causes of weaning and
long ICU bed-stay for 12 adults.
CONCLUSION. Late diagnosis GBS and late hospitalisation in the ICU, autonomic dis-
turbances, immunosuppression and association acquired critically neuromuscular are death
factors more present with adults then with children.
REFERENCES. 1. Dhar R et al (2008) J Neurol Sci 121:8.
2. Tseng BS, Markowitz J (2008) Cuillain-Barre in Childhood. http://emedecine.
medscape.com.
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MONITORING OF CEREBROVASCULAR PRESSURE REACTIVITY (PRX) IN
NEUROSURGICAL PATIENTS
P. G. Papanikolaou1, E. Papadopoulos1, A. Mavrommatis2, F. Moraitou2, V. Dionysopoulou2,
G. Leptidis2, T. S. Paleologos1, S. Stamatiou1, A. Markelos1, A. Venetikidis1, K. Kazdaglis1
1General Nikaia Piraeus Hospital, Neurosurgical Department, Athens, Greece, 2General Ni-
kaia Piraeus Hospital, Intensive Care Unit, Athens, Greece
INTRODUCTION. Cerebrovascular pressure reactivity is the ability of cerebral vessels to
respond to transmural pressure changes. Cerebrovacular pressure reactivity index (PRx) is
determined as the moving correlation coefficient of mean intracranial pressure (ICP) and
mean arterial blood pressure (MAP).
METHODS. We present data of 40 critical patients harboring severe brain trauma or
spontaneous intracranial hemorrhage, who underwent monitoring of cerebrovascular pressure
reactivity. All patients were monitored for brain tissue oxygenation (PtiO2–LICOX), while
five patients also underwent regional cerebral blood flow (CBF) monitoring with a thermo-
diffusion probe (Hemedex). Patient outcome was assessed with modified Glasgow Outcome
Scale (GOS). We compared the results of PRx monitoring with the PtiO2 and CBF
monitoring.
RESULTS. There was a correlation of PRx with PtO2 and CBF monitoring. Cerebrovascular
pressure reactivity index seems to correlate positively with patient outcome. In addition to
that it is a sufficient index of successful treatment as it shows improvement when patient’s
management is adequate.
CONCLUSIONS. PRx is a secondary index derived from ICP and MAP changes. It can be
used complementary for the assessment of brain damage severity as well as successful
treatment management, but there is still time needed to evaluate the best use of it in
neurosurgery.
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BRAIN TISSUE OXYGENATION PRESSURE (PTIO2) MONITORING IN HEAD
INJURED PATIENTS: USEFULNESS FOR OPTIMIZING MEAN ARTERIAL
PRESSURE AND CEREBRAL PERFUSION PRESSURE
J.-M. Dominguez-Roldan1, F. Murillo-Cabezas1, A. Marin-Caballos1, J. Marquez-Rivas2, J.-
M. Almarcha-Bethancourt2, C. Garcia-Alfaro1, J.-J. Egea-Guerrero1
1Hospital Virgen del Rocio, UCI-HRT, Sevilla, Spain, 2Hospital Virgen del Rocio, Neuro-
surgery Department, Sevilla, Spain
INTRODUCTION AND OBJECTIVES. Low arterial pressure and low cerebral perfusion
pressure in head injury are frequently associated to cerebral ischemia. In head injured adults,
it is recommended to maintain cerebral perfusion pressure (CPP) higher than 60 mmHg to
assure cerebral perfusion. The main objective of this research was to establish if the con-
tinuous monitoring of tissular cerebral oxygen pressure (ptiO2) is useful for the identification
of the lower mean arterial pressure and CPP associated to a normal and stable cerebral blood
flow and consequently a normal oxygen delivery.
METHODS. In 29 severe head injured patients (GCS at admission\9; mean age 35.5 years)
the continuous recording of Intracranial Pressure (ICP), ptiO2 (brain tissue oxygen pressure)
and Mean Arterial Pressure (MAP) during the 72 first hours was analyzed. Patients with
Diffuse Injury (traumatic Coma Data Bank) type II (41%) and III (34%) were the more
frequent in this series. Cerebral hypoxia episodes (defined as ptiO2 lower than 20 mmHg)
were classified according Siggaard–Andersen classification. The diagnosis of Ischemic
Cerebral Hypoxia due to absolute/relative Hypotension was established when: a decrease of
MAP was associated to a parallel decrease of ptiO2 (non attributable to primary increase of
ICP or low extractivity cerebral hypoxia) with return to normal values after increasing MAP.
The incidence of ischemic cerebral hypoxia due to hypotension was analyzed in the whole
group. The efficacy of maintaining a CPP over 60 mmHg that assured a normal ptiO2 was also
evaluated.
RESULTS. Cerebral hypoxia episodes of several mechanisms was observed in 23 patients
(79.3% of the whole group). Ischemic Cerebral Hypoxia due to Hypotension was present in 19
patients (65.5%). In this subgroup, 18 patients suffered more than 1 these episodes and 3 more
than 3 episodes. In 10 patients Ischemic Cerebral Hypoxia due to absolute/relative Hypo-
tension was detected even maintaining a CPP over 60 mmHg. In this group the average lower
value of CPP for maintaining ptiO2 normal was 73 mmHg. In two episodes a value of CPP
higher 80 mmHg was needed to ptiO2 over 20 mmHg.
CONCLUSIONS. In head injured patients, continuous monitoring of brain ptiO2 can fre-
quently detect cerebral hypoxia episodes no due to increase of ICP. Systemic hypotension is
often related with brain hypoxia episodes. The maintenance of CPP over 60 mmHg does not
assure a normal oxygenation of the brain. The simultaneous monitoring of ICP, CPP and ptiO2
is useful for detection and treatment of cerebral hypoxia due to systemic hypotension.
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AN AUDIT OF FINDINGS ON CT SCANS OF THE BRAIN PERFORMED
CRITICAL CARE IS ‘‘NOT WAKING UP’’ A VALID INDICATION?
A. Foulkes1, P. Jeanrenaud1, N. Bhuiyan1
1University Hospital Aintree, Critical Care Unit, Liverpool, UK
BACKGROUND. Transferring ventilated patients from critical care to CT scan entails risk,
from transfer [1] and arguably from radiation dosing. In our practice we often request CT
scans of the brain to exclude intracranial pathology if a patients’ neurological recovery is slow
or absent after stopping sedation.
SETTING. A 19 bed Critical Care Unit in a University Hospital where the Picture Archiving
and Communication System (PACS) was installed in late 2006.
AIMS. Our aim was to assess the value of CT brain scans on patients with slow or absent
neurological recovery from critical illness (excluding brain injury). By analysing the indi-
cations for all CT Brain scans and the rate of positive findings we aimed to draw conclusions
regarding validity of requests looking for intracranial pathology when a patient was not
waking up as might be expected, or their Glasgow Coma Score (GCS) remained unexpectedly
low.
METHODS. Using PACS we identified all CT scans performed from 1/1/2007 to 31/3/2009.
Reports for all brain scans were analysed; each showed reasons for requesting the scan, and
the radiologists’ final report.
The reason for requesting each scan was categorised, and the result classified as positive or
negative. A positive result was one which showed definite intracranial pathology, or signif-
icant new changes since a previous scan.
The following were excluded from the main analysis: scans taken at admission or first scans at
\24 h, scans after neurosurgery or as routine follow up for known traumatic brain injury
(TBI), and those indicated by focal neurological signs, an acute fall in GCS, or raised Intra-
cranial pressure (ICP) on an invasive monitor.
Paper records were checked when electronic data was incomplete.
Focal neurology was defined as: Unexplained change in pupil reactivity, reduced limb/facial
muscle movements, dysphasia, aphasia, or decerebrate/decorticate posturing.
RESULTS. A total of scans 250 CT brain scans were identified; 140 were post-admission, of
which 52 were carried out purely for failure to wake appropriately.
• One (1.9%) of these 52 showed a new finding.
• 10 out of 14 (71%) scans requested for follow-up after neurosurgical intervention were
positive.
• 8 out of 15 (53%) post-admission scans requested for focal neurological signs were
positive.
• 4 out of 10 (40%) scans requested for raised ICP were positive.
CONCLUSIONS. CT brain performed for reasons of failure to wake appropriately, in the
absence of focal neurology, known TBI, raised ICP or recent neurosurgery had a sensitivity of
1.9%. We suggest this indication should not be used in routine practice.
DISCUSSION. This audit did not attempt to identify whether a negative result from a CT
brain affected patient management. Preliminary analysis while planning this audit suggested
this would require prospective study. This may require [2 years to complete.
REFERENCES. 1. Waydhas C (1999) Intrahospital transport of critically ill patients. Crit
Care 3:R83–R89. doi:10.1186/cc362.
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EFFECT OF DIFFERENT FLUID RESUSCITATION ON BRAIN TISSUE OXYGEN
DEPTH IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY
T. Molnar1, E. Czeiter1, D. Palinkas1, L. Pisztrai1, A. Buki1
1University of Pecs, Pecs, Hungary
INTRODUCTION. Severe head injury is associated with high morbidity and mortality due
to secondary brain injury. Invasively measured parameters are used in the therapeutic algo-
rithm as a guide to reduce the ischemic complications. The LICOX microelectrode is able to
measure the parenchymal brain tissue oxygen depth (PbrO2) and brain temperature (Tbr).
OBJECTIVES. We investigated the change in invasively measured parameters (SBP, DBP,
MAP, ICP, CPP, PbrO2, Tbr) following different fluid management.
METHODS. Patients with GCS B 8 were recruited for this study who were fully and
invasively monitored within 12 h after hospital admission and were treated with a standard
therapy. If CPP B 65 mmHg and/or PbrO2 B 15 mmHg, all patients were treated with either
cristalloid (Salsol) or colloid (Voluven) infusion. Glasgow Outcome Scale (GOS) at discharge
from hospital or death were used as measures of clinical outcome. Statistics: Student t test [2],
Spearman correlation and Mann–Whitney U test were used.
RESULTS. A total of 15 patients were examined. Eight patients with poor outcome
(GOS B 2) had a significantly higher first measured ICP (median: 15.5, IQR: 8.5–30.5 vs. 6,
1–8.5, p = 0.037). In the first 24 h, PbrO2 was above 15 mmHg in 8 patients, in whom Tbr
was significantly higher (mean: 37.6, 95% CI: 37.1–38.0 vs. 35.7, 34.5–37.0, p = 0.015).
Volume resuscitation with colloid infusion resulted in significant improvement in hemody-
namic parameters (SBP, MAP, CPP) and reduced ICP. In patients treated with only
crystalloids, no significant changes were observed. There was no difference in mortality
between the groups, but there were significant differences not only in hemodynamics but also
in brain tissue oxygen tension, favoring the colloid treated group.
CONCLUSIONS. The higher ICP in the early stage predicts a higher mortality and worsens
the secondary hyperthermic brain injury. Voluven infusions have beneficial effects on both
systemic and cerebral circulation indicating improvement in cerebral perfusion pressure and
brain tissue oxygen depth.
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EFFECTS OF VOLUME THERAPY ON CEREBRAL OXYGENATION AND
METABOLISM
S. S. Petrikov1, U. V. Titova1, A. A. Solodov1, H. T. Guseinova1, V. V. Krylov2
1Sklifosovsky Research Institute, Neurosurgical ICU, Moscow, Russian Federation, 2Sklifo-
sovsky Research Institute, Neurosurgery Department, Moscow, Russian Federation
INTRODUCTION. Hypovolemia treatment of is one of the main goals of intensive care of
neurosurgical patients. But effects of hypovolemia and volume therapy on cerebral oxygen-
ation and metabolism are still unknown. The purpose of our study was to investigate the
dynamics of brain oxygen tension (PbrO2) and cerebral metabolism during hypovolemia
correction in patients with intracranial hemorrhage.
METHODS. We analyzed 41 episodes of hypovolemia correction with HES 130/0.4/9:1 in 8
patients with intracranial hemorrhage and GCS 4–8 (3 with aneurismal SAH, 5 with severe
TBI). Monitoring of systemic hemodynamics and cerebral microdialysis was used in all
patients. PbrO2 was investigated in 4 patients. Microdialysis and PbrO2 catheters were placed
into ‘‘lesioned’’ and ‘‘intact’’ brain tissue. Decrease of global end-diastolic volume index
(GEDVI) below 680 ml/m2 was the indication for HES infusion. The average amount of
infused HES was 500 ml (6–8 ml/kg of body weight).
RESULTS. FiO2, Hb, PaO2, PaCO2, PaO2/FiO2, blood temperature and serum glucose
concentration were stable during the study. GEDVI, cardiac index (CI) and cerebral perfusion
pressure (CPP) significantly improved after HES administration [before infusion: GEDVI
604 ± 67 ml/m2, CI 4.1 ± 0.8 l/min/m2, CPP 77 ± 16 mmHg; after infusion: GEDVI
720 ± 79 ml/m2 (p \ 0.05), CI 5 ± 1 l/min/m2 (p \ 0.05), CPP 85 ± 16 mmHg
(p \ 0.05)]. PbrO2 and cerebral metabolites concentrations remained unchanged [before
infusion: PbrO2(lesioned) 28.1 (19.8;33.6) mmHg, PbrO2(intact) 26.7 (19.1;38.1), lactate/pyruvate
ratio(intact) 26 (20;32), lactate/pyruvate ratio(lesioned) 29.5 (24;43.1); after infusion: PbrO2(le-
sioned) 27.5 (22.1;32.1) mmHg, PbrO2(intact) 30 (22.8;36.1), lactate/pyruvate ratio(intact)
26.7(21.6;31.2), lactate/pyruvate ratio(lesioned) 28.1 (25;34.9)]. Subgroup analysis showed, that
in case of initial lactate/pyruvate ratio(lesioned) more than 30 and less than 100 HES infusion
was accompanied by increase in pyruvate concentration from 76.5 (58.3;136.8) lmol/l to 99.5
(62.8;139.3) lmol/l (p \ 0.05) and decrease of lactate/pyruvate ratio from 42.2 (35.6;64.3) to
33 (28.4;56) (p \ 0.05) in ‘‘lesioned’’ brain tissue.
CONCLUSION. In case of impaired cerebral metabolism hypovolemia correction with HES
130/0.4/9:1 can improve glycolysis and oxidative phosphorylation in lesioned brain tissue.
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EARLY HYPERGLYCEMIA IN THE NATURAL HISTORY OF SEVERE TRAUMA
PATIENTS IS A PROGNOSTIC FACTOR
N. Saito1
1Nippon Medical School Chiba-Hokuso Hospital, Emergency and Critical Care Medicine,
Chib, Japan
BACKGROUND. Intensive insulin therapy (IIT) may lead to a better outcome in severe
trauma patients [1], but it should not be performed for a long period without a specific object
because of the risk of hypoglycemia. The optimal target blood glucose (BG) level for IIT is
unknown, and it remains to be determined that how long IIT should be continued. The
purpose of this study was to determine the optimal target BG level and period for IIT.
MATERIALS AND METHODS. We retrospectively reviewed 404 cases with an injury
severity score (ISS) of more than 15 that have been treated for more than 48 h between
January 2004 and December 2007, and we divided the cases into a survival group and a non-
survival group. We reviewed age, ISS, history of diabetes, nosocomial infection (NI), mor-
tality, admission blood glucose (BG) level (mg/dl) and BG change during the first 7 days after
admission. We did not adopt any insulin therapy protocol in this period, and the treatment of
insulin was determined by attending staff. Univariate analysis by the paired t test was used
and multivariate analysis by the stepwise method and likelihood ratios were used to identify
prognostic factors.
RESULTS. 94% of the 404 trauma patients were victims of blunt trauma.
Mean (±SD) age and ISS were 46 ± 21.6 years, 25.1 ± 10.2, respectively, and 6.6% was a
history of diabetes. The NI rate was 27.4%. Mortality was 8.1%. There were 371 cases in the
survival group and 33 in the non-survival group. The non-survival group had a higher ISS and
admission BG level (survival group vs. non-survival group: 24.1 ± 9 vs. 36.5 ± 15.1, p\
0.001; 174.8 ± 72.5 vs. 211.67 ± 61.6, p = 0.002). The mean BG level during the first
3 days after admission was lower in the survival group. (147.2 ± 39.5 vs. 170.9 ± 42.2,
p = 0.004). The cutoff value for the mean BG level during the first 3 days after admission
according to the sensitivity specificity curve in relation the mortality was 150. We defined
early hyperglycemia (EH) as a mean BG level during the first 3 days after admission of more
than 150 mg/dl. The AUC of the ROC curve for mortality in EH was 0.661 (p = 0.002).
EH was significantly correlated with NI (p = 0.015). The independent prognostic factors for
death were ISS (OR 1.05 [p = 0.002; 95% CI: 1.01–1.08]), GCS (OR 0.78 [p \ 0.001; 95%
CI: 0.7–0.87]), and EH (OR 3.13 [p = 0.008; 95% CI: 1.34–7.31])
CONCLUSION. IIT with a target BG level of less than 150 mg/dl should be performed for at
least the first 3 days after admission of severe trauma patients.
REFERENCE. 1. The NICE-SUGAR Study Investigators (2009) Intensive versus conven-
tional glucose control in critically ill patients. NEJM 360:1283–1297.
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SURVIVE AND MORTALITY IN SEVERITY BRAIN TRAUMA (CLINIC
EXPERIENCE)
M. Kerci1, T. Zhurda1, M. Bajraktari1, D. Muzha1, N. Baftiu2, S. Horeshka1
1Military University Hospital, National Trauma Center, Anaesthesia and ICU Department,
Tirana, Albania, 2Clinical Center Kosova, Anaesthesia and ICU Department, Prishtina, Serbia
BACKGROUND AND GOAL OF THE STUDY. Brain injury is an important part of
overall injuries. The goal of the study was to assess the dynamic of head injury of B8 GCS
during 2006 in our department.
MATERIALS AND METHODS. 112 patients were attended to our Critical Care Depart-
ment for brain injury during 1 year. F/M ratio was 30/82, age 33.12 ± 8.42. Related to their
GCS assessment they were presented as GCS 3–4 pts 36 patients, as GCS 5–6 pts 28 patients
and as 7–8 pts 48 patients.
RESULTS AND DISCUSSION. Most of them were road casualties (90 patients). 38 of them
had other important damages. 17 of the patients were operated for traumatic brain hematomas.
Immediately after the attendance the patients were intubated, sedated and mechanically
ventilated with Tidal volume 6–8 ml/body weight. CT-scans performed at the attendance
showed 69% hemorrhagic contusion, 26% were massive hematomas and 5% only pronounced
hypoxemic brain swelling. 26% of the patients were presented to the hospital in shock status.
In 32 patients, Diclofenac was used as antiflogistic agent. Overall mortality was 54% (61 from
112). Mortality rate in-patients with GCS 3–4 pts was 94%, in-patients with 5–6 GCS was
53% and in the group with 7–8 GCS 25%.
CONCLUSION. The most frequent cause of brain injury in our patients was road casualties.
The overall mortality was over 50%. In the patient, we use Diclofenac showed better recovery
to other patients.
REFERENCE. Marini JJ, Wheeler AP (2006) Crit Care Med (the essentials-third edition)
568–573, 576–578
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THE CHANGES OF CEREBRAL HEMISPHERE PRESSURE GRADIENT IN
PATIENTS WITH SINGULAR HEMISPHERE INJURY
W. Qiu1,2, C. Guo1, Q. Jiang1
1Hangzhou Normal University, Department of Neurosurgery, Hangzhou, China, 2Brain
Medicine Institute, College of Medicine, Zhejiang University, Hangzhou, China
OBJECT. We investigate the changes of cerebral hemisphere pressure gradient after brain
injury and the effects of craniotomy on the pressure gradient.
METHODS. Twenty-four patients with traumatic brain injury were included in this study.
All patients received brain parenchyma pressure (BPP) monitoring. Each optic fibro sensor
was introduced into each cerebral hemisphere via the frontal lobe. All patients underwent
surgical craniotomy for evacuation of space occupying lesions such as cerebral hemisphere
contusion, subdural, and/or intracerebral hematoma. Preoperative and postoperative BPP data
at different time point were recorded and analyzed.
RESULTS. Before craniotomy, the BPP value of the injured hemisphere was significantly
higher than that of the contrary hemisphere (25.7 ± 5.7 mmHg vs. 23.5 ± 5.4 mmHg,
t = 11.675, P = 0.0001). After craniotomy, the mean BPP values of the patients who
underwent craniotomy were similar to those of the contrary hemisphere (9.6 ± 4.9,
10.2 ± 4.6 and 13.5 ± 5.3 mmHg vs. 9.7 ± 4.5, 10.2 ± 4.5, and 13.3 ± 5.4 mmHg,
respectively, t = 0, P = 1).The Postoperative hemisphere BPP values were lower than the
preoperative ones.
CONCLUSIONS. BPP monitoring sensors should be introduced into the injured hemisphere,
so that the valuable information can be timely showed. When the cerebral hemisphere has
lesions such as injury and bleeding, such lesions become the source of elevated intracranial
pressure and can result in the bilateral hemispheres pressure gradient. Craniotomy cannot only
effectively lower the intracranial pressure, but also eliminate the BPP gradient; therefore, the
oppressed brain tissue can be reposited.
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HEMODYNAMIC MONITORING DURING OPERATIONS ON POSTERIOR BRAIN
FOSSA TUMORS
R. Nazarov1, V. Novikov1, A. Kondratiev1
1Russian Neurosurgical Institute of Prof. A. L. Polenov, Anaesthesiology and Intensive Care
Unit, St. Petersburg, Russian Federation
Direct, multifactorial influence upon brain tissue during neurosurgical operations on posterior
fossa tumors causes the development of centrogenuous reactions. The potential danger of
them brings us about the necessity of current control over intraoperative hemodynamic.
AIM. To form a correct estimate of diagnostic value of PICCO monitoring in neurosurgical
operations.
MATERIALS AND METHODS. In our investigation we enrolled 11 patients aged from 20
to 60 years? who had undergone neurosurgical operation on posterior brain fossa tumors.
Total intravenous anesthesia was maintained with fentanyl, clonidin, propofol.
In all patients we carried out the monitoring of central hemodynamic and extra vascular lung
water with PiCCOplus (Pulsion Medical System, Munich).
RESULTS. In 9 patients we observed centrogenuous reactions of the first type, manifestated
as bradycardia and increase of arterial blood pressure. At that time we observed increase of
cardiac output to 8.34 ± 0.77 l/min, cardiac index to 3.31 ± 0.14 l/min and decrease of
peripheral resistance to 370 ± 42 din s cm-5. All the indexes returned to the base line in 4–
5 min after cessation of surgical activity. Extra vascular lung water stayed stable
4.6 ± 0.4 ml/kg.
In 2 cases we observed centrogenuous reactions of the second type. Hemodynamic changes
had a lot in common with manifestations of the first type reactions. But the alterations were
more prolonged and were accompanied with the increase of extra vascular lung water to
8.7 ± 2.1 ml/kg.
Those reactions could be caused by the direct irritation of diencephalon structures. The
sympatic nerves irritation caused spasm of lung arterioles and increased pulmonary capillary
wedge pressure which led to lung edema.
CONCLUSIONS.
1. PICCOplus technology is safe, non-invasive and available method of monitoring in
neuroanesthesiology
2. PICCO monitoring during neurosurgical operations on posterior fossa tumors is useful in
diagnosis of hemodynamic disorders thus enable anesthesiologist to correct them timely.
3. PICCO monitoring is informative in revealing of occurring centrogenuous reactions and
in determining of the bounds of surgical decency.
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HIGH INCIDENCE OF SUB-CLINICAL UPPER GASTROINTESTINAL PATHOL-
OGY IN CRITICALLY ILL PATIENTS
R. Appelboam1, C. Day1, S. Hubble1, R. Fraser2
1Royal Devon and Exeter Hospital, Exeter, UK, 2University of Adelaide, Adelaide, Australia
INTRODUCTION. Stress related mucosal disease (SRMD) is estimated to occur in between
75 and 100% of patients within 24 h of admission to Intensive Care [1]. This data is based on
endoscopic findings in symptomatic critically ill patients, and reflects incidence before the
targeted implementation of ventilator bundle protocols and stress ulcer prophylaxis.
Delayed gastric emptying occurs in up to 45% of ventilated patients, precluding successful
enteral nutrition via nasogastric tube [2]. This necessitates the use of prokinetics or post-
pyloric feeding. On our mixed medical and surgical unit, post-pyloric feeding tubes are
inserted under direct vision using oesophago-gastro-duodenoscopy (OGD), allowing us to
report the rate of incidental upper gastrointestinal (GI) pathology in a group of critically ill
patients with no overt upper GI symptoms.
OBJECTIVES. To provide an updated prevalence of upper GI pathology in asymptomatic
intensive care patients compliant with best feeding and ulcer prophylaxis guidelines.
METHODS. Endoscopic reports and medical records of all patients undergoing upper GI
endoscopy to place post pyloric feeding tubes between 1997 and 2008 were examined.
Patients who required urgent endoscopy for GI bleeding and those with an admitting diag-
nosis involving upper GI pathology were excluded. Apart from failed gastric feeding, patients
had no other upper GI symptoms.
RESULTS. 120 patients underwent OGD for placement of post pyloric feeding tubes.
Incidental pathology was identified in 32 patients. There was no difference in age
(59.8 ± 16.7 years vs. 61.6 ± 15.4 years p = 0.58), APACHE II scores (19.5 ± 7.2 vs.
18.7 ± 6.2, p = 0.57) or LOS (19.7 ± 16 days vs. 18.8 ± 15.6 days, p = 0.77) between the
groups. Pathology was identified as follows (n): oesophagitis (12), gastritis (10), duodenitis
(1), gastric ulcer (4), duodenal ulcer (1), hiatus hernia (3) and bile reflux (3). 29 out of 32
(91%) patients were receiving standard antacid protection. Of the 28 patients with SRMD, 8
(29%) were receiving corticosteroids or non-steroidal anti-inflammatory drugs; 7 of these
were already receiving either intravenous ranitidine or omeprazole. 18 of the remaining 20
patients with SRMD were already compliant with best stress ulcer prophylaxis.
DISCUSSION. This observational study demonstrates that over a quarter of critically ill
patients have significant but asymptomatic upper GI pathology, which is mainly inflammatory
in aetiology. This is despite good compliance with evidence based feeding and ulcer pro-
phylaxis guidelines.
CONCLUSIONS. Delay or failure to absorb gastric feed is associated with a high incidence
of SRMD, and should prompt OGD at an early stage. Larger studies are needed to examine
the morbidity and mortality of SRMD in asymptomatic, critically ill patients.
REFERENCES. 1. Fennerty MB (2002) Crit Care Med 30:S351–S355.
2. Ritz MA, Fraser R, Edwards N et al (2001) Crit Care Med 29:1744–1749.
3. Doig GS, Simpson F, Finfer S et al (2008) JAMA 300:2731–2741.
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THE APPLICATION OF EARLY ENTERAL NUTRITION VIA NASO-JEJUNAL
CATHETER IN THE TREATMENT OF SEVERE ACUTE PANCREATITIS
B. Wang1, L. Dong1, Y. Kang1
1West China Hospital, Sichuan University, Intensive Care Unit, Chengdu, China
INTRODUCTION. Some researches have proved that early enteral nutrition may have
positive effects in the treatment of severe acute pancreatitis (SAP), so have some experts
recommended.
METHODS. Prospective, randomized, controlled study of patients with SAP for less than
48 h who underwent early enteral nutrition via naso-jejunal catheter placed in distal of Treitz
ligament. A preset treatment goal was set (including somewhat vital signs and several routine
tests), once the goal were reached in 5-day treatment, patients received 14-day enteral
nutritional (EN) support with Elental or total parenteral nutrition (TPN).
RESULTS. From April 2006 to December 2007, 40 patients were enrolled and 27 patients
completed the trial. After 14-day nutritional support, APACHEII and CT severity index
(CTSI) showed a trend to decrease but no statistical difference was made in EN group, while
serum albumin (ALB) in EN group was significantly higher and C-Reactive protein (CRP)
was lower than TPN group. Infectious complications (including pneumonia, sepsis, peritoneal
abscess and peripancreatic abscess) were lower in EN group, while no statistical difference
was found in non-infectious complications (including ARDS/ARF, intestinal fistula, pan-
creatic fistula and pancreatic pseudocyst), surgical intervention or 30th day mortality. There
was no difference in duration of ventilation, ICU stay or hospital stay between two groups, but
cost of ICU stay was significantly lower in EN group.
CONCLUSION. Early EN via naso-jejunal catheter may prevent exacerbation of pancreatic
necrosis and may improve condition of illness in SAP. Early EN do significantly improve
nutritional condition in SAP. Early EN was associated with an decreased incidence of
infectious complications and cost of ICU stay but not non-infectious complications, surgical
intervention, 30th day mortality, duration of ventilation, ICU stay or hospital stay. Further
researches with large sample capacities may be needed.
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‘‘ANTICATABOLIC’’ NUTRITIVE SUPPORT IN THE ABDOMINAL SEPSIS
PATIENTS: EFFICIENCY AND THE EXPEDIENCY
D. Levit1, A. Levit1, I. Leiderman1
1Regional Clinical Hospital N 1, Intensive Care and Anesthesiology, Ekaterinburg, Russian
Federation
INTRODUCTION. Hypermetabolism–hypercatabolism syndrome with the expressed resis-
tance to the standard nutritive therapy develops in the course of the severity sepsis. In this
case, there is a need in the nutrients decreasing the catabolic reaction, i.e. glutamine, arginine,
omega-3-fatty acids.
MATERIALS AND METHODS. During 2005–2007 after the permission of the Ethic
committee the study on the estimation of the efficiency of anti-catabolic nutritive support
procedure was carried out in 66 surgical ICU patients with the abdominal sepsis (diffuse
peritonitis, pancreatic abscess). Patients were divided into three groups: the first, 21 patients,
the second, 25 patients, the third, 20 patients. Patients in the compared groups were identical
in sex, age, and APACHE-II scale. The standard and anticatabolic support (the solution of
alanine-glutamine dipeptide intravenously, L-glutamine into the tube) was used in Group 1,
standard nutritive support from the 1st day was used in Group 2, and standard nutritive
support from the 3rd day was used in Group 3. Albumin levels, nitrogenous balance, duration
of ICU stay, and nosocomial pneumonia frequency were compared. The obtained results were
processed statistically.
RESULTS. The data obtained are presented in Table 1
TABLE 1







5th day 29.35 ± 1.95 27.46 ± 2.39 21.18 ± 1.23 ? ?
7th day 28.23 ± 1.72 27.23 ± 2.5 24.56 ± 1.49 ? ?
Nitrogenous
balance, g/day
1st day 4.3 ± 1.46 -8.35 ± 1.73 -7.44 ± 1.59 ?
3rd day 3.23 ± 1.77 -4.14 ± 1.29 -7.56 ± 1.47 ?




4 (19%) 7 (28%) 9 (45%) ? ? ?
ICU stay (days) 8.12 ± 1.21 10.7 ± 1.76 14.47 ± 2.04 ?
Thus, the reliably higher level of albumin and nitrogenous balance during all stages of the
study was observed in Group 1 patients as compared with other groups. The worst indices of
protein metabolism were noted in Group 3 patients. The frequency of nosocomial pneumonia
while ‘‘anticatabolic’’ nutritive therapy was 9 and 26% lower than that of the early and later
nutritive therapy, respectively. The duration of ICU stay while using ‘‘anticatabolic’’ and the
early nutritive therapy was 42 and 26% less than the later therapy.
CONCLUSION. It is appropriate to carry out the early anticatabolic nutritive therapy in the
course of the abdominal sepsis.
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NUTRITIONAL SCORE RISK (NSR) TO EVALUATE RENAL FAILURE BASED ON
RIFLE CLASSIFICATION
E. Valencia1, A. Marin2
1Holly Heart of Jesus-CES University, Intensive Care, Medellin, Colombia, 2Holly Heart of
Jesus, Nutritional Support, Medellin, Colombia
INTRODUCTION. The hospital malnutrition is a universal problem that currently can be
detected routinely and consequently combat effectively. It is observed both in developed
countries and in the so called third world, unfortunately in ICU there is nothing universally
accepted to do nutritional diagnosis on acute renal failure (RIFLE), therefore, the aim of our
study has been applying a nutritional score risk to mortality in critically ill patients based on
RIFLE classification.
METHODS.
Setting: We did a prospective observational research study from April 2007 to February
2008. Two hundred and eighteen admitted patients were included, the surveys were filled by
the near relative who lived with the patient, at that moment that the relative showed non-
coexistence with the patient and/or ignorance of its pattern of food ingestion during the
newspaper the survey was discarded. Critically ill patients were selected at random with
pathologies (neurocritical, Sepsis, trauma, patients, obstetrics critics, etc.) in 2 units of adult
intensive cares. Patients were evaluated according to Nutritional Risk Score (NSR): has food
intake declined due to loss of appetite, digest problems 2 points, How many full meals does
the patient eat daily, less than two 3 points, At least one serving of dairy products, one serving
of fruits and vegetables 2 points, takes more than 3 prescription drugs per day 1 point, how
much alcohol per week 2 points, mode of feeding unable to eat without assistance 2 points,
weigh loss or increase in the last 6 months 2 points, Economical level for eating 4 points
Statistical analysis: A validation of the data was used to assess the ability to the new
Nutritional Risk Score to predict mortality in ITU based receiver operating characteristic
(ROC) analysis. The statistical analysis was carried out with the SPSS 10 package, and
p \ 0.05 was considered statistically significant.
RESULTS. The final nutritional assessment was completed for 42 (15.6%) patients, and NSR
in 26 patients. 28 (66.6%) were male and 14 (33.3%) were female. Age average was
67.6 years and NSR 7.57 ± 3.75, and APACHE II score 15.8 ± 7. ROC analysis were done
for mortality according to NSR [ 8 shows a sensibility of 72.7% (IC: 39.1–93.7) and spec-
ificity of 72.1% (IC: 44.9–92) with a ?LR: 2.73, -LR: 0.37; ?PV: 66.7, -PV:78.6, AUC:
0.72, IC: 0.51–0.87, p = 0.0321.
CONCLUSION. Nutritional Risk Score should be included in the Nutritional assessment for
critically ill patients on RIFLE classification at admission to the intensive care unit in order to
detect mortality by nutritional risk. In our study, we found that patients on RIFLE classifi-
cation are in risk of mortality related to malnutrition. The patients not only have high average
of NSR but also add a new risk factor to mortality to the risk created for the renal failure.
REFERENCES. 1. Valencia E, Marin A (2008) Nutricion Hospitalaria 23(5):505–512.
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SUPPLEMENTAL PARENTERAL NUTRITION (SPN) IN ICU PATIENTS FOR
EARLY COVERAGE OF ENERGY TARGET: PRELIMINARY REPORT HEIDEG-
GER CP, THIBAULT R, METHOT C, MAISONNEUVE N, JOLLIET P, DARMON P,
ROMAND JA, PICHARD C
C.-P. Heidegger1, R. Thibault1, C. Methot1, N. Maisonneuve1, P. Jolliet1, P. Darmon1,
J.-A. Romand1, C. Pichard1
1Geneva University Hospitals, Geneva, Switzerland
INTRODUCTION AND AIMS. In ICU patients caloric intake deficit, and its associated
complications, are often observed during Enteral Nutrition (EN). Supplemental Parenteral
utrition (SPN) has been proposed to deliver 100% of the energy target in ICU patients from
day 4 by combining EN?PN with the hypothesis that this approach could optimize their
clinical outcome [1]. We report the 1-year preliminary results of a prospective, controlled,
randomized clinical study, aiming at providing early coverage of energy target by SPN.
PATIENTS AND METHODS. Inclusion criteria were: mean caloric intake of the 3 first days
after admission\60% of predicted energy targets (ESPEN guidelines); expected length of stay
[5 days; expected survival [7 days; no contraindication to EN; patients not receiving PN;
age[18 years. Patients were randomized to receive EN alone (‘‘EN group’’) according to the
usual local practice, or EN ? PN (‘‘SPN group’’) consisting in the administration of PN to
reach the energy target of 100% by day 4 if EN alone was insufficient. The energy target was
measured by indirect calorimetry (IC) and if not possible calculated by a 20–30/kcal/kg per
day need.
RESULTS. One hundred patients were included. Thirteen patients (EN group, n = 4; SPN
group, n = 9) were secondly excluded which left 87 patients for the analysis. Patients’
admission diagnoses were: sepsis (31%); brain surgery (20%); cardiogenic shock (20%);
trauma (14%). At inclusion, EN and SPN groups were similar for age (mean ± SD,
61.0 ± 12.1 vs. 61.6 ± 16.5, NS), sex (67% men vs. 82% female, NS), SOFA (5.9 ± 3.1 vs.
6.9 ± 3.5, NS) and BMI (27.9 ± 5.2 vs. 24.5 ± 5.3, P = 0.03). IC was performed in 46
patients (65%). The main reason for which the IC was not performed was FiO2[0.6 (n = 15,
21%).



















EN (n = 45) 56.0 ± 32.3 82.5 ± 45.5 83.5 ± 30.0 90.5 ± 30.0 93.0 ± 31.0 80.0 ± 31.7
SPN (n = 42) 94.0 ± 30.0 97.0 ± 18.0 97.5 ± 22.0 99.0 ± 31.0 99.0 ± 16.0 98.0 ± 19.0
P value \0.0001 0.002 0.13 0.16 0.42 0.001
CONCLUSIONS. These preliminary data confirm that EN alone delays the delivery of the
energy target in ICU patients and that SPN allows successfully covering the energy target by
day 4.
REFERENCE(S). 1. Heidegger CP, Romand JA et al (2007) Is it now time to promote mixed
enteral and parenteral nutrition for the critically ill patient? Intensive Care Med 33(6):963–
969.
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LOW NUTRITIONAL SCORE RISK IS A COST-EFFECTIVE PROCEDURE TO
EVALUATE MORTALITY AT THE ADMISSION TO THE ICU
E. Valencia1, A. Marin2
1Holly Heart of Jesus Clinic-CES University, Intensive care-Epidemiology Master, Medellin,
Colombia, 2Holly Heart of Jesus Clinic, Nutritional Support, Medellin, Colombia
INTRODUCTION. Low nutritional score risk (NSR) is a score of an increasing importance
at the ICU, and specially mortality and days stay cost related. Based on cost procedures at the
ICU, NSR is one of the fast and simple markers to be developed just thinking on it as a
mortality marker at the admission to the ICU. Depending on the score value the patient could
result more expensive during the stay at the ICU. These differences may imply a distinct
utilization of health resources. Colombian registries comparing hospital cost of procedures at
intensive care in critically ill patients have not been performed yet, although mortality score is
prevalent procedure in this population.
AIM. To analyze hospital cost of being with malnutrition on ICU admission.
METHODS. One year data were collected and 81 patients participated in the study. From 81
patients admitted to the ICU, 56 (69.1%) have score \6, and 25 (30.86%) patients were on
score C6. The total cost from the two groups was compared and cost-effective analysis was
calculated. Cost variables analysed were: total management cost at the ICU, total cost per
patient, cost-effective ratio (Alive patients were analysed as a final aim).
RESULTS. Mortality was the outcome variable that was studied to evaluate cost-effective
ratio. Cost management of the group of patients with malnutrition at ICU admission was
higher than the patients with good nutritional score. To reduce one death on the group of
patients without malnutrition we should spend 247.97 USD. In other words, the cost to treat a
patient with NSR C6 is 3.4 times higher than a patient with NSR \6 (Table 1).
TABLE 1 NSR COST (1 USD = $ 2227.68 COLOMBIAN PESOS)
Cost variable NSR\6 to reduce mortality
(USD)
NSR [6 versus mortality
(USD)
Number of patients 56 25







Total cost per patient $ 25,410,741 (11,406) $ 39,451,209
(17,709)
Cost-effective ratio $ 552,407 (247,97) $ 1,878,629 (843,31)
CONCLUSION. Although the number of patients included was small, this study shows an
approach of the importance of hospital cost in patients with nutritional score to define
mortality at admission at the ICU in Colombia. Besides, was clear the cost-effective differ-
ence to manage a patient without malnutrition score. South America countries should start to
spend more effort to reduce cost and focus on being clear on definition nutritional risk at the
ICU, and NSR it is indicated to know mortality risk and cost management. This is a way of
taking the first step for projecting health costs.
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PROGNOSTIC VALUE OF DELTA OF PREALBUMIN IN CRITICALLY ILL
PATIENTS
J. C. Sandoval Almengor1, H. R. Lopez Perez2, J. Franco Granillo2, J. Aguirre Sanchez2, J. A.
Villalobos Silva2, C. G. Sanchez Castrillo2
1ABC Medical Center, Critical Care Unit ‘Dr. Mario Shapiro’, Mexico DF, Mexico, 2ABC
Medical Center, Critical Care Medicine, Mexico DF, Mexico
INTRODUCTION. Critical illness is characterized by a hypermetabolic stress state in which
patients most commonly demonstrate systemic inflammatory response syndrome (SIRS) and
associated complications of increased infectious morbidity, multiorgan dysfunction syndrome
(MODS), prolonged hospitalization, and excessive mortality. In a recent past nutritional
support was regarded as adjunctive care designed to provide exogenous fuel to support the
patient until the metabolic response had resolved and as an attempt to prevent the adverse
outcome associated with protein calorie malnutrition. More recently, the provision of early
nutrition has become to be seen as a proactive therapeutic strategy by which the clinician may
actually attenuate disease severity, reduce metabolic complications, and benefit patient out-
come. Prealbumin (PA) value are considered one of the gold standard for assessing and
monitoring the nutritional status on admission of a critical ill patients. By tracking PA levels,
we can identify nutritional deficiencies early and help our patients recover more quickly and
try to lower risk of complications. The normal value of PA in adult population is 16–45 mg/
dl.
DESIGN. Prospective trial from November 2008 to April 2009.
METHODS. We conducted a prospective trial in the ICU. We describe demographics
variables: age, sex, BMI, diagnosis, infection, nutrition type, APACHE II, SOFA, length of
stay (LOS) and determine at admission and day 8th, PA, PCR, transferrin, protein intake, total
calories, renal function. We analyze the data with SPSS v.15.0
RESULTS. Total patients (p) N = 60. 28 p with PA B 10 mg/dl (high risk for malnutrition)
and 32 p with PA C 10 mg/dl. The mortality was 25% for the total population. A delta of
PA B 8 mg/dl during the first 8 days in the patients at high risk for malnutrition was asso-
ciated with mortality (p = 0.003) with a sensibility of 75% and specificity of 60%
(AUC = 0.75). A higher protein intake at day 8th was associated with survival (p = 0.01).
We did not found any statistical difference in the value of PA at admission between the
survivors and non-survivors.
CONCLUSIONS. A delta of PA B 8 mg/dl during the first 8 days in the patients at high risk
for malnutrition (PA B 10 mg/dl) was a predictor of mortality in critical ill patients.
REFERENCES. 1. Ingenbleek Y, Van Den Schrieck HG, De Nayer P, De Visscher M (1975)
Albumin, transferrin and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-
RBP) complex in assessment of malnutrition. Clin Chem Acta 63(1):61–67.
2. Mears E (1996) Outcomes of continuous process improvement of a nutritional care pro-
gram incorporating serum prealbumin measurements. Nutrition 12:479–484.
3. Sullivan DH, Sun S, Walls RC (1999) Protein-energy under-nutrition among elderly
hospitalized patients: a prospective study JAMA 281:2013–2019.
4. Chan S, McCowen K, Blackburn G (1999) Nutrition management in the ICU. Chest 115.
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NUTRITIONAL THERAPY FOR ACUTE RENAL FAILURE: A NEW APPROACH
BASED ON ‘‘RIFLE’’ CLASIFICATION AT THE ICU
E. Valencia1, A. Marin2
1Holly Heart of Jesus Clinic-CES University, Intensive Care-Epidemiology Master, Medellin,
Colombia, 2Holly Heart of Jesus Clinic-CES University, Nutrition Support-Epidemiology
Master, Medellin, Colombia
INTRODUCTION. Yet there is no consensus on the amount of dysfunction that defines acute
kidney injury. The variety of definitions used in clinical studies may be partly responsible for
the large variations in the reported incidence ranging from 1% up to 31% and the associated
mortality (from 19 to 83%) as a result of acute kidney injury. To establish a uniform defi-
nition for acute kidney injury, the Acute Dialysis Quality Initiative formulated the Risk,
Injury, Failure, and Loss, and End-stage Kidney (RIFLE) classification.
AIM. To analyze nutrition therapy based on new ARF classification.
METHODS. In our ICU, we have evaluated patients with ARF for nutritional support
according to the RIFLE classification. The population was analysed from March 2007 to
February 2008. During the 12-month study period, 670 adult patients were admitted to ICU,
and 269 (40.14%) patients met the eligibility criteria. Of these patients, 49 (18.2%) were
classified according to ‘‘RIFLE’’: 21 patients (7.8%) were RIFLE-R, 10 (3.71%) were RIFLE-
I, and 18 (6.69%) RIFLE-F, from 42 patients 40.4% had septic shock.
RESULTS. The final nutritional assessment was completed for 42 (15.6%) patients, of whom
28 (66.6%) were male and 14 (33.3%) were female. Their mean age was 67.6 years and
APACHE II score 15.8 ± 7. Nutritional assessment parameters were: body weight
70.3 ± 10.3 kg, body mass index 25.6 ± 3.2 and energy requirements calculated according
to Harris Benedict was 1,333.2 ± 140.7. Among the ‘RIFLE’ group of patients, 36 (85.7%)
were given any form of nutritional therapy [Enteral Nutrition (EN), PN or both]. 19 (45.2%)
received EN, 6 (14.2%) received PN, 4 (9.5%) a combination of both, 1 (2.4%) oral feeding,
and 6 (14.3%) no nutritional support. All EN was delivered via the stomach. Parenteral
Dipeptide Glutamine was supplied in 8 (19%) of patients and. Average protein delivery
51.8 ± 30.9 g (Table 1).
TABLE 1 NUTRITIONAL THERAPY ON RIFLE
Variable Yes No p
Death 17/36 1/6 0.33
Nosocomial infection 13/36 1/6 0.64
LOS (days) 24.2 25 0.053
Mechanical ventilation (days) 14.3 4.25 0.12
CONCLUSION. Until now nutrition therapy in the ICU has always been seen as supportive
nutritional supplementation for patients with or without renal failure, rather than therapeutic.
However, it may now be approached from a different point of view, based on a new clas-
sification of critical illness specifically for ARF. Our new focus facilitates a broader and more
flexible therapeutic management of ARF if patients are first categorized according to RIFLE.
Nutrition therapy based on RIFLE gives us the option to treat patients dynamically. One day a
patient can be categorized as RIFLE F with restrictions on protein intake, but the next day he/
she could be on RIFLE R with less nutritional restriction. This novel approach for nutrition
therapy in critically ill patients with ARF is now our preferred approach.
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MODULATION OF THE FATTY ACID PATTERN, AND INFLAMMATORY
RESPONSE BY THE USE OF A FISH OIL ENRICHED LIPID EMULSION (SMOF)
SECONDARY TO MAJOR SURGERY—A COMPARISON TO AN OLIVE OIL
BASED LIPID EMULSION IN PARENTERAL NUTRITION
S. Philip-Ostermann1, K. D. Ro¨hm2, T. A.H. Scho¨llhorn1, I. Schade2, R. B. Beschmann1,
S. N. Piper1
1Stadtklinik Frankenthal, Department of Anesthesiology and Intensive Care Medicine,
Frankenthal, Germany, 2Klinikum Ludwigshafen, Department of Anesthesiology and Inten-
sive Care Medicine, Ludwigshafen, Germany
INTRODUCTION./OBJECTIVES. Lipid emulsions provide energy and essential fatty
acids to patients requiring parenteral nutrition (PN) [1]. The aim of this study was to assess
the effects of a new lipid emulsion based on soybean oil, medium-chain triglycerides (MCT,
source: coconut oil), olive and fish oil (SMOFlipid) compared with a lipid emulsion based
on olive and soybean oil (ClinOleic) on fatty acid pattern and inflammatory response in
postoperative intensive care unit patients.
METHODS. After approval of the ethical committee, 44 postoperative surgical patients with
an indication for PN were included in this prospective randomised study. Non-protein calories
were given as 60% glucose and 40% lipids. The total energy intake per day was 25 kcal/kg
body weight. Patients were thus allocated to one of two nutritional regimens: Group A
(n = 22) received SMOFlipid 20% (SMOF group), group B (n = 22) a lipid emulsion based
on olive and soybean oil (ClinOleic 20%, control group; CG). PN including lipids were
given for five postoperative days. Vascular cell adhesions molecule (VCAM), tocopherol
(TCP), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) were measured before the
start of infusion (d0), at day 2 (d2) and day 5 (d5) after the start of administration and the ratio
of EPA and arachidonic acid (AA; EPA/AA) as well as the ratio of interleukin-6 (IL-6) and
interleukin-10 (IL-10; IL-6/IL-10) were calculated. The significance level was defined at
p \ 0.05.
RESULTS. There were no significant differences in VCAM-levels at d0 (SMOF:
1,408 ± 684 vs. CG: 1410 ± 719 ng/ml) and d2, whereas at d5 significantly lower VCAM-
concentrations were seen in the SMOF group (1,401 ± 544 ng/ml), compared with the CG
(2,046 ± 932 ng/ml). The inflammatory response objectified by calculation of the IL-6/IL-10
ratio differed also significantly at d5 (SMOF: 8.2 ± 8.4; vs. CG: 16.2 ± 14.2). Significant
higher levels of EPA (d2: SMOF 112 ± 93 vs. CG: 22 ± 11 lmol/l; d5: SMOF 140 ± 93 vs.
CG: 26 ± 12 lmol/l), DHA (d2: SMOF 162 ± 126 vs. CG: 97 ± 37 lmol/l; d5: SMOF
163 ± 75 vs. CG: 91 ± 29 lmol/l) and TCP (d2: SMOF 13 ± 4 vs. CG: 10 ± 5 mg/l; d5:
SMOF 16 ± 4 vs. CG: 12 ± 4 mg/l) at d2 and d5 were observed in the SMOF-group
compared with the CG. Significant differences of the EPA/AA-ratio were calculated at d2
(SMOF: 0.26 ± 0.22 vs. CG: 0.06 ± 0.02) and d5 (SMOF: 0.39 ± 0.16 vs. CG:
0.07 ± 0.03).
CONCLUSIONS. The administration of SMOFlipid induced a significantly reduced pro-
inflammatory response at d5 compared with a lipid emulsion based on olive and soybean oil.
At d2 and d5 EPA, DHA, and TCP-concentrations as well as the EPA/AA-ratio were sig-
nificantly higher in patients receiving a fish oil containing lipid emulsion suggesting a
beneficial effects on the immune response.
REFERENCES. 1. Schlotzer E et al (2004) Ann Nutr Metab 48:263–268.
GRANT. The study was supported in part by Fresenius Kabi, Germany.
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ROLL OF PARENTERAL GLUTAMINE SUPPLEMENTATION ON PATIENTS’
OUTCOME IN THE SURGICAL INTENSIVE CARE UNIT (SICU)
W. T. T. Salem1
1National Cancer Institute, Cairo University, Department of Anesthesia and ICU, Cairo,
Egypt
Glutamine (Gln) was considered a nonessential amino acid. During the excessive organ/tissue
demand of Gln in episodes of stress following trauma, major surgery, endogenous Gln pro-
duction will not be sufficient to meet the increased requirements. After major GIT surgery, as
a treatment of cancer, combined enteral and parenteral nutrition is used to supply the nutri-
tional requirement for these patients.
AIM OF THE STUDY. The aim of the study was to evaluate the effect of Parenteral
Glutamine Supplementation on the outcome of surgical cancer patients after GIT surgery.
MATERIAL AND METHOD. The study was done on 40adult patients admitted to the
SICU, requiring TPN for at least 5 days because of inadequate or failure of enteral nutrition.
EXCLUSION CRITERIA. Persistent hemodynamic instability, renal insufficiency or
hepatic failure. The patients were randomly assigned to two groups:
Control (C group) 20 pts: patients receive nutritional support as usual protocol. Glutamine
(Gln group) 20 pts: patients receive nutritional support as usual protocol ? Dipeptiven
300 mg/day for 7 days. Regimens supplied as constant intravenous infusion over 24 h via
central veins. Standard vitamins, trace elements, electrolytes and insulin therapy were sup-
plied according to the usual practice.
The rate of nosocomial infection and/or wound infection (each site of infection was con-
sidered as a separate infectious episode), ICU and total hospital length of stay, severe
hyperglycemia (defined as a blood glucose level 12 mmol/L) and days of mechanical ven-
tilation were recorded.
RESULTS. There were no difference between groups in demographic data and metabolic and
nutritional parameters. Numbers of diabetic patients, included in both groups were not sig-
nificantly different. There was also no difference in the duration of TPN (6.1 ± 1.1 vs.
6.3 ± 1.1 days for Gln and control group, respectively).
Incidence of pneumonia, surgical wound infection, sepsis, urinary or intravenous catheter
infection was significantly lower in Gln group compared to control group. Days of mechanical
ventilation among ventilated patients and ICU LOS were significantly lower in Gln group
compared to control group
Nitrogen balance was more negative in control patients than in Gln supplemented patients, but
the difference was insignificance. Hyperglycemia was reported in 4 Gln-treated patients and
in 9 control patients, but required insulin therapy in 2 versus 8 patients. Total plasma amino
acids concentrations and Glutamine plasma level increased about 40% in patients receiving
Gln supplementation.
The number of adverse events per patient was significantly lower in Gln group (2.0 vs. 2.8;
p \ 0.01).
CONCLUSION. We have shown that Parenteral Gln supplemented TPN reduces the clinical
complications of surgical patients, mainly through a lower incidence of pneumonia and the
better metabolic tolerance. This is a strong rationale for the use of Gln-supplemented regi-
mens for SICU patients.
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HOW TO ASSESS SUCCESSFUL NUTRITIONAL REQUIREMENTS WHEN
ENTERAL NUTRITION FAILS?
A. Ayucar Ruiz de Galarreta1, M. J. Garcia Monje2, M. Mourelo Farin˜a2, V. Aller Ferna´ndez2,
L. Cordero2, R. Galeiras2, P. Jimenez2
1A Corun˜a University Hospital, Nutritional Support Unit, A Corun˜a, Spain, 2A Corun˜a
University Hospital, Intensive Care Medicine, A Corun˜a, Spain
OBJETIVE. To assess the requirements of complementary parenteral nutrition (CPN) for a
goal of 20–25 kcal/kg per day in medical critical care patients.
PATIENTS AND METHODS. Retrospective observational study made in a University
Hospital Critical Care Unit from 2006 to 2008. The patients received enteral nutrition (EN) as
first nutritional support, and only when less than 75% of the dose was absorbed comple-
mentary parenteral nutrition was added. Enteral nutrition was maintained, if possible, even
when only a small amount of it could be tolerated. The additional parenteral nutrition was
stopped when the EN was greater than 75% of the total dose.
RESULTS. 157 patients received complementary parenteral nutrition. All of them had early
enteral nutrition as first nutritional support, but at some point of their ICU stay they needed
CPN. 19.74% were respiratory illnesses, 17.8% trauma, 17.8% neurocritical, 16% septic
shock, 10.2% cardiac surgery, 7.6% pancreatitis, 3.8% liver disease. The reasons for CPN
were high residual gastric volume (75%), abdominal distension (18%), and diarrhoea, vomits
and digestive haemorrhage (7%).CPN was started on day 6.8 ± 5.9 and needed for an average
of 3.8 ± 1.7 days. The time of CPN was longer in patients with respiratory problems
(4.4 ± 1.9) and septic shock (4 ± 1.3), compare with neurocritical care patients (3.3 ± 2.4,
p: 0.018).
CONCLUSIONS.
1. Unsuccessful enteral feeding in the ICU happened between days 7 to 10, when having a
correct nutritional support is a key point.
2. The average time of CPN is significantly higher in respiratory patients and septic shock,
which correlates with higher morbidity and mortality.
3. When nutritional requirements have not been completed with enteral feeding comple-
mentary parenteral nutrition may be an option to avoid secondary problems due to
nutritional impairment.
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EVOLUTION OF NUTRITIONAL SUPPORT FOR 12 YEARS IN A SURGICAL
CRITICAL CARE UNIT AS QUALITY CRITERION
M. J. Garcia Monje1, A. Ayucar Ruiz de Galarreta2, F. Mosteiro Pereira1, T. Rey Rilo3,
S. Eimil Rua3, C. Nieto Mouronte3
1A Corun˜a University Hospital, Intensive Care Unit, A Corun˜a, Spain, 2A Corun˜a University
Hospital, Nutritional Support Unit, A Corun˜a, Spain, 3A Corun˜a University Hospital, Anes-
thesia Department, A Corun˜a, Spain
INTRODUCTION. The Classic Nutritional support in postoperative patients has been total
parenteral nutrition (TPN), but this type of nutrition is changing based on quality criteria
described on international nutritional guidelines.
OBJECTIVE. To compare the nutritional support in postoperative patients in two different
periods as quality criterion.
PATIENTS AND METHODS. Retrospective observational study made in a University
Hospital surgical critical care unit, from 1997 to 2008. Two different periods were evaluated,
phase I from 1997 to 2002 and phase II from 2003 to 2008. For 12 years the type of
nutritional support received by postoperative patients staying in a surgical critical care unit
was recorded. Different type of surgery was included such cardiac surgery, thoracic surgery
(included lung transplantation), neurosurgery, abdominal surgery (liver transplantation
included), and vascular surgery. The patients were analyzed in four different groups, based on
nutritional requirements:
– Group 1: Postoperative patients with normal functional gut.
– Group 2: Postoperative patients with a jejunostomy
– Group 3: Abdominal surgery and patients with long term ventilation.
– Group 4: TPN in nourished patients and TPN for a period inferior to 5 days (vascular
surgery).
RESULTS. 4,534 patients have been recorded for 12 years, 2,364 from 1997 to 2002 and
2,170 from 2003 to 2008. 67% received TPN, 21% enteral nutrition (EN) and 12% mixed
nutrition (TPN plus EN). When we compared the type of nutrition for groups on both periods:
1: EN increased 13.5% (p: 0.001), mixed nutrition decreased 9.5% (p: 0.038) and TPN
decreased 5% (ns)
2: EN increased 32% (p: 0.001), mixed nutrition decreased 17% (ns) and TPN decreased
14.5% (ns)
3: Mixed nutrition increased (p: 0.017) and EN and TPN decreased (ns)
4: TPN decreased 50%, and during the second period an annual reduction of 63% was
observed during the first 3 years and a reduction of 80% in the other three.
TPN prescribed for less than 5 days was found only in 2% of this kind of patients in the last
3 years.
Based on the type of surgery, patients who underwent thoracic surgery received 32% (p:
0.001) more EN from phase I to phase II, mixed nutrition decreased 17.6 and (p: 0.012) and
TPN 14.4% (p: 0.017). EN also increased in patients with liver transplantation, 12% (p:
0.019).
No changes in nutritional support were observed in neurosurgical patients, EN was prescribed
in 80% and 83% of the patients in both phases.
CONCLUSIONS.
1. Enteral nutrition has increased as a nutritional support in patients who underwent thoracic
surgery, and abdominal surgery, including liver transplantation.
2. Conducting jejunostomy has enhanced enteral nutrition in the immediate postoperative
period.
3. Quality criteria has been followed in patients who underwent vascular surgery, with an
important changed in nutritional support, decreasing TPN and TPN for less than 5 days.
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PROSPECTIVE RANDOMISED COMPARISON STUDY OF TWO METHODS OF
JEJUNAL PLACEMENT OF ENTERAL FEEDING TUBES IN CRITICALLY ILL
PATIENTS: ENDOSCOPIC VERSUS ELECTROMAGNETIC VISUALISED
METHOD
U. Holzinger1, M. Wewalka1, R. Kitzberger1, W. Miehsler1, P. G. H. Metnitz2, C. Madl1
1Medical University of Vienna, General Hospital, Medicine III, ICU 13h1, Vienna, Austria,
2Medical University of Vienna, General Hospital, Anesthesiology and General Intensive Care,
ICU 13i1, Vienna, Austria
INTRODUCTION. Intragastric enteral nutrition is frequently associated with complications
like reflux and vomiting. Therefore, in these patients international guidelines recommend
placement of a jejunal feeding tubes to assure adequate enteral caloric supply. Jejunal feeding
tubes can be placed in different ways. The endoscopic method gaining success rates of correct
jejunal placement of over 90% is regarded as the gold standard. However, it is a sophisticated
technique requiring trained staff. Non-endoscopic methods are mostly easier to apply though
leading to success rates around 75%.
OBJECTIVE. To compare the success rate of correct jejunal placement of a new electro-
magnetic visualised jejunal tube with the endoscopic guided technique in a comparative ICU
patient population.
METHODS. 66 mechanically ventilated patients with persisting intolerance of intragastric
enteral nutrition (repeated vomiting, reflux[250 ml) were randomly assigned (2:1) to receive
an electromagnetic visualised jejunal feeding tube (CortrakTM, CORPAK MedSystems) or an
endoscopic guided jejunal tube (Freka Trelumina, Fresenius-Kabi). Primary outcome
measure was the success rate of correct jejunal placement after 24 h. Secondary outcome
parameters were duration of placement, number of attempts, days in correct position (with
maintained patency) and complications of placement (bleeding).
RESULTS. Data are given as mean ± standard deviation. p\ 0.05 was regarded as statis-
tically significant.
CONCLUSION. Success rate and duration of placement were not different between the two
methods. Number of attempts was less with the electromagnetic visualised method. Days in








n (m/f) 22 (18/4) 44 (27/14) 0.25
SAPS II Score 50 ± 16 52 ± 20 0.66
Success rate (%) 95 90 0.65
Time (min) 17 ± 9 15 ± 13 0.60
Number of attempts 1.9 ± 0.8 1.3 ± 0.8 \0.01
Days in correct
position (d)
15 ± 8 14 ± 14 0.82
Complication rate (%) 18 17 1
Electrolytes, endocrinology, intoxications: 0578–0591
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HYPERNATRAEMIA IN CRITICALLY ILL PATIENTS
J. A. Silversides1, L. D. Quinn1, S. J. Austin1
1Mater Infirmorum Hospital, Intensive Care Unit, Belfast, UK
INTRODUCTION. Hypernatraemia is common in ICU patients, is associated with greater
severity of illness and mortality, and has been proposed as a marker of quality of care. We set
out to determine the incidence of hypernatraemia in our ICU and to identify contributory
factors.
METHODS. In our general medical and surgical ICU, we reviewed laboratory results from
50 ICU patients (excluding uncomplicated post-operative patients, and those admitted for
\24 h) to determine the incidence of hypernatraemia. We defined hypernatraemia as serum
[Na?] [ 145 mmol/l and significant hypernatraemia as [Na?] [ 150 mmol/l. For each epi-
sode of significant hypernatraemia, charts were examined for fluid intake; fluid output
(urinary, GI, and estimated insensible losses); sodium intake (fluids, feed, and drugs); and
diuretic use. We compared these variables between days in which sodium rose and days in
which sodium remained constant or fell. We also noted diagnoses and outcomes, and whether
mild hypernatraemia was present prior to episodes of significant hypernatraemia. Chi squared
and t tests were used for analysis.
RESULTS. The incidence of hypernatraemia was 30% (15/50 patients). There were 11
episodes of significant hypernatraemia in 8 patients, 5 of whom subsequently died. Rising
serum sodium was not associated with negative fluid balance (P = 0.44) but was strongly
associated with higher sodium intake (P = 0.0001). Sodium intake ranged from 11.0 to 778.0
(mean 221.8) mmol/day: 45.5% from intravenous fluids (12.3–713.3 mmol/day), 10.1% from
enteral or parenteral nutrition (1.4–89.5 mmol/day), and 44.4% from drugs (including dilu-
ents; 4.2–342.5 mmol/day). Diuretic use did not differ significantly between days on which
sodium rose (8/28) and those on which sodium fell or remained constant (12/28) (P = 0.61).
In 9 of 11 episodes, mild hypernatraemia ([Na?] 146–149 mmol/l) was present 24 h prior to
sodium concentration rising above 150 mmol/l.
CONCLUSIONS. Hypernatraemia was common in our ICU, and associated with high
mortality. Mild hypernatraemia was identified in most patients before serum sodium rose
above 150 mmol/l, implying inadequate intervention for mild hypernatraemia. Of note was
the lack of association between fluid balance and changes in serum sodium: this conflicts with
the generally held view of hypernatraemia as a function of pure water deficit. In contrast,
while a relationship between higher sodium intake and rise in serum sodium is not widely
recognised, this appeared to be a major contributory factor in our patients. Sodium intake was
in excess of nutritional requirements of 60–100 mmol/day with large contributions from both
intravenous fluids and drugs with their diluents: very little was due to nutritional sodium
intake. Our data demonstrate the need to consider total sodium intake in critically ill patients
(particularly the sodium content of drugs including diluents, and intravenous fluids) when
prescribing medication and enteral or parenteral nutrition.
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INCIDENCE AND PROGNOSIS OF DYSNATREMIAS PRESENT ON ICU ADMIS-
SIONA PROSPECTIVE MULTICENTER COHORT STUDY
G. Lindner1, G. C. Funk2, B. Metnitz1, C. Schwarz3, P. Bauer1, P. G. Metnitz1, W. Druml1
1Medical University of Vienna, General Hospital, Vienna, Austria, 2Otto Wagner Spital,
Department of Respiratory and Critical Care Medicine, Vienna, Austria, 3Krankenhaus der
Elisabethinen Linz, Linz, Austria
RATIONALE. Dysnatremias are common in patients admitted to the intensive care unit
(ICU). It is not known whether the presence of disorders of sodium balance at the time of ICU
admission is independently associated with excess mortality. Thus, we wanted to test the
hypothesis that dysnatremias on ICU admission are independent risk factors for increased
mortality in critically ill patients.
METHODS. We conducted a prospective, multicenter cohort study in 77 medical, surgical,
and mixed ICUs in Austria, with a database of 151,486 adults admitted consecutively over a
period of 10 years (1998–2007).
MEASUREMENTS AND MAIN RESULTS. Most patients (114,170, or 75.4%) had normal
sodium levels on ICU admission. The frequencies of borderline, mild and severe hypona-
tremia were 13.8, 2.7, and 1.2%, respectively. The frequencies of borderline, mild and severe
hypernatremia were 5.1, 1.2, and 0.6%, respectively. ICU length of stay was 3 (2–7) days.
Overall ICU mortality was 12.0%, and overall hospital mortality was 17.6%. All types and
grades of dysnatremia were associated with increased raw and risk-adjusted hospital mortality
ratios. Multiple logistic regression analysis showed an independent mortality risk for both
hyponatremia and hypernatremia. The risk of dying in hospital rose with the increasing
severity of both hyponatremia and hypernatremia. Borderline hyponatremia
(130 B Na \ 135 mmol/L) and borderline hypernatremia (145 \ Na B 150 mmol/L) were
also associated with a substantially increased risk.
CONCLUSIONS. Our results provide strong evidence that both hypo- and hypernatremia
present on admission to the ICU are independent risk factors for poor prognosis.
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INTENSIVE CARE ACQUIRED HYPERNATREMIA AFTER MAJOR CARDIAC-
THORACIC SURGERY IS ASSOCIATED WITH INCREASED MORTALITY
G. Lindner1, G. C. Funk2, M. Mouhieddine1, C. Schwarz3, M. Hiesmayr1, W. Druml1
1Medical University of Vienna, General Hospital, Vienna, Austria, 2Otto Wagner Spital,
Department of Respiratory and Critical Care Medicine, Vienna, Austria, 3Krankenhaus der
Elisabethinen Linz, Linz, Austria
INTRODUCTION. Hypernatremia is a common electrolyte disorder in the medical Intensive
Care Unit (ICU) and was described to be an independent risk factor for mortality. Hyper-
natremia has not been studied in a collective of surgical ICU patients so far, therefore we
wanted to determine the incidence of hypernatremia on a surgical ICU and its effects on
outcome of surgical critically ill patients.
METHODS. In this prospective cohort study all patients admitted to the ICU after major
cardiac surgery between May 1999 and October 2007 were included. Serum electrolytes,
underlying disease and reason for surgery, SAPS II score, ICU length of stay, ICU mortality
and hospital mortality were collected for all patients. Hypernatremia was defined as a serum
sodium exceeding 145 mmol/L. To evaluate the potential impact of ICU-acquired hyperna-
tremia on 28 day hospital mortality Cox’s proportional hazards regression models were used.
MAIN RESULTS. 2,699 patients underwent major cardiac thoracic surgery during the study
period, of which 2,314 were included in the study. 221 (10%) patients acquired hypernatremia
during their ICU stay. Median onset of hypernatremia was on day 4 (2–7). Patients with ICU-
acquired hypernatremia had a higher mortality (19%) compared to patients without hyper-
natremia (8%); p \ 0.0001. Length of stay was increased in patients with hypernatremia (17
vs. 3 days). In a multivariate Cox regression ICU-acquired hypernatremia was an independent
risk factor for mortality.
CONCLUSIONS. Hypernatremia is a common event early in the course of critical illness
after major cardiothoracic surgery and has an independent effect on mortality. Future research
should focus on the impact of hypernatremia on physiologic functions and on adequate and
safe treatment of the electrolyte disorder.
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A PILOT STUDY OF THE EFFECTS OF COMBINED THERAPY WITH FRUSE-
MIDE AND SPIRONOLACTONE ON SERUM SODIUM AND NATRIURESIS IN
CRITICALLY ILL PATIENTS
Y. V. Apte1, R. Bellomo1, S. Warrillow1, D. Goldsmith1, M. Gillies2, F. Mcgain3
1Austin Hospital, Intensive Care Medicine, Heidelberg, Australia, 2St Thomas Hospital,
Intensive Care Medicine, London, UK, 3Western Hospital, Intensive Care Medicine, Mel-
bourne, Australia
BACKGROUND. Hypernatraemia is common in the intensive care unit (ICU) and can result
in problems such as delirium, altered conscious state and seizures. Factors contributing to
hypernatraemia include the administration of loop diuretics as treatment for fluid overload.
Spironolactone is an aldosterone antagonist and promotes natriuresis. It is an established
therapy for congestive cardiac failure.
OBJECTIVE. To assess whether the administration of spironolactone to ventilated patients
receiving a frusemide infusion influences urinary sodium and potassium excretion and
attenuates the tendency to hypernatraemia compared to placebo.
DESIGN. Randomised, double blind, placebo-controlled trial.
PATIENTS. 20 patients with serum creatinine \300 mmol/L on mechanical ventilation in
intensive care within 24-h of commencing a frusemide infusion as treatment for fluid
overload.
METHODS. In addition to standard therapy, patients were randomised to receive either
spironolactone 100 mg three times daily or placebo by nasogastric tube for the duration of
therapy with frusemide infusion. Daily levels of urea and creatinine, 24-h urine sodium and
potassium, fluid balance and 24-h blood levels of aldosterone, hANP, PRA were measured
throughout the duration of frusemide infusion therapy.
RESULTS. Change from baseline to maximum-recorded serum sodium was a median of
5 mmol/L for placebo versus 1 mmol/L for spironolactone (p = 0.179). Changes from
baseline in serum potassium were minimal for both groups (maximal deviation less than
2.1 mmol/L) with no difference between the two groups. There were no significant differ-
ences in total urinary sodium or potassium excretion although a trend to higher urinary
potassium excretion was evident in the group receiving placebo (p = 0.230). No differences
in serum creatinine or urea levels, measured hormone levels, urine volume, daily fluid balance
or frusemide dose emerged between the two groups.
CONCLUSIONS. The administration of high dose spironolactone to ventilated critically ill
patients receiving frusemide by infusion has no significant effects on severity and incidence of
hypernatraemia, natriuresis or potassium balance when compared to placebo.
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MANAGEMENT OF SEVER HYPONATREAMIA ASSOCIATED WITH PSYCHI-
ATRIC MEDICATION AND DIFFICULT AIRWAY
N. A. Shayoub1, I. Ali2, J. Billett2, M. Arain2
1Midland Regional Hospital Tullamore, Anaesthetic Department, Tullamore, Ireland, 2Mid-
land Regional Hospital Tullamore, Tullamore, Ireland
INTRODUCTION. Hyponatraemia is a common and important clinical problem that can be
seen in isolation or associated with other medical illness. It may manifest with nausea,
seizures, coma, cerebral oedema and even death [1]. Some of the psychiatric drugs can cause
hyponatremia with characteristics of SIADH [2].
CASE REPORT. 65 years old Ms JK admitted through A&E with collapse and agitation.
With background of psychiatric history with learning disability and blindness (Corneal
opacity).
She was feeling sick and vomiting for 48 h. She was care dependent and over compliance
with her medications.
Her antipsychotic medications were Fluoxetine, Chlorpromazine, Tolterodine SR and Diaz-
epam.GCS was 11/15 on arrival, SpO2 95% on room air. WCC 23.3, Na 99, K 3.1, Cl 60,
HCO3 27, Urea 2.4, Cr 39, CK 2057. CT Brain showed old left parietal infarct. Few hours
later, she desaturated with upper airway obstruction 2 to airway swelling. Decided to intubate
in theatre, inhalational induction airway maintained with LMA and ENT surgeon standby,
attempts made with intubating LMA/I Gel/Glidoscope eventually intubated with Bougie,
cricoid pressure and pillow under shoulder. Hyponatreamia corrected slowly over 72 hrs.
LRTI was treated with antimicrobials. Because of her respiratory failure, difficult airway and
learning disability she was failed to wean and she was offered tracheostomy on day 19th.
With in a week time she was weaned and discharges from ICU. Her tracheostomy downsized
and removed and went home in 13 days.
DISCUSSION. A systemic review of SSRI associated with hyponatremia and SIADH found,
fluoxetine is commonly causative agent and mechanism of action is not known [3]. Correction
of hyponatremia is usually successful and although it must be done slowly to prevent irre-
versible osmotic demylination [4].
CONCLUSION. Among psychiatric patients hyponatremia is often associated with factors
others than psychogenic polydipsia including medications and medical co morbidities.
REFERENCES. 1. Adrogue´ HJ et al (2000) Hyponatremia. N Engl J Med 342:1581–1589.
2. Miller M (1998) Hyponatremia: age related risk factors and therapy decision. Geriatrics
53:32–48.
3. Liu BA, Mittmann N et al (1996) Hyponatremia and SIADH hormone associated with the
use of SSRI. Can Med Assoc J 155:519–527.
4. Walker GV et al (2008) Survival in a patient with severe paraneoplastic hyponatremia: a
case report. Case J 1:248
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COCAINE-INDUCED ACUTE RENAL FAILURE, THROMBOCYTOPENIA, AND
ELEVATED LIVER ENZYMES
A. Hosseinnezhad1, N. Aeddula1, M. J. Farmer1
1Saint Vincent Hospital, Worcester, USA
BACKGROUND. Cocaine is a naturally occurring alkaloidal extraction of Erythroxylum
Coca, a plant indigenous to South America. Cocaine abuse has been associated with multiple
known adverse effects, including myocardial ischemia, cerebrovascular accidents, pulmonary
edema, and mesenteric ischemia. However, the effects of cocaine on renal, gastrointestinal,
and hematologic systems have not been extensively reported.
CASE PRESENTATION. A 51-year-old man without a significant past medical history was
brought to the hospital with abdominal pain and nausea. He had consumed crack cocaine and
ethanol the day prior to his admission. He denied using other recreational drugs. On admission
he was found to be hypertensive (BP 170/100 mmHg) and tachycardic (HR 134/min).
Physical examination revealed mild right upper quadrant tenderness without rebound. Lab-
oratory investigations revealed a serum creatinine of 3.72, creatine phosphokinase (CPK) of
5885, lactate dehydrogenase (LDH) of 2964 and markedly elevated transaminases, ALT 331
and AST 462. Thrombocytopenia (platelet count 74,000) was also observed. A viral hepatitis
panel was negative. Urine toxicology screening revealed cocaine. Urine myoglobin was
highly positive. Serum bilirubin, alkaline phosphatase, amylase, and lipase were within
normal limits. An electrocardiogram showed sinus tachycardia at a rate of 120 beats per
minute. Radiographic imaging studies including CT scan of abdomen showed no evidence of
pathology. A clinical diagnosis of cocaine toxicity was made and conservative management
was initiated. Despite trending down of liver enzymes during the hospital course (ALT of 38
and AST of 60), he continued to have residual renal insufficiency (creatinine of 2.55), with a
low platelet count (47,000), at the time of discharge.
CONCLUSION. This case illustrates some other complications pertaining to cocaine toxicity
which are not well reported in the literature. In a patient with history of cocaine use presenting
with these manifestations, cocaine itself should be considered as a likely cause. Physicians
should be aware of these potentially life threatening effects of cocaine abuse.
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ROCURONIUM INDUCED CORTISOL SUPPRESSION
G. C. Choutas1, V. G. Nolas1, A. Katsika1, G. Tsolakidis1, G. K. Anthopoulos1
1Intensive Care Unit, ‘‘251’’ General Air Force Hospital, Athens, Greece
INTRODUCTION. The use of intravenous anesthetic agents is known to suppress the
hypothalamic, pituitary, adrenal axis. Opioid use decreases cortisol concentration and the
combination of high doses of diazepam with fentanyl decreases the early release of ACTH
and cortisol concentration suggesting the action of these agents on the hypothalamus.
OBJECTIVE. The present study was designed to research if the structural similarities
between rocuronium (aminosteroid) and cortisol and lazaroids (21-aminosteroids) are
accompanied with similar effects.
METHODS. Prospective study of efficiency of one arm. In 21 patients, serum cortisol was
measured one day before the administration of rocuronium at 08:00 (K1) and 20:00 (K2). The
day of administration serum cortisol was measured at 08:00 (K3) and 20:00 (K4). Urine
cortisol was measured the day of the administration at 08:00(Ka) and 24 h later (Kb). Ro-
curonium was administered at a dose of 0.6 mg/kg
RESULTS. The mean between
J1 (22.6 ± 11.6) and J3 (20.1 ± 9.4), p = 0.444
J2 (16.2 ± 9.2) and J4 (18.9 ± 9.3), p = 0.182
JA (18.9 ± 9.3) and JB (38.6 ± 32.6), p = 0.321
CONCLUSION. With the current sample no significant difference was found in serum and
urine cortisol at any time before and after a single dose of Rocuronium.
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RARE COMPLICATION OF INTERNAL JUGULAR VEIN CANNULATION FOR
HAEMODIALYSIS
D. Duggal1
1Grant Medical Foundation, Pune, India
INTRODUCTION. IJV cannulation has become the preferred approach for temporary
haemodialysis catheter placement following reports of an increased incidence of subclavian
stenosis due to subclavian vein catheterization. The most common complication of IJV
cannulation is internal carotid artery puncture. Other known complications are pneumothorax,
vessel erosion, thrombosis, bleeding, airway obstruction due to haematoma and infection.
Rare cases of thyrocervical trunk pseudoaneurysm, right common carotid artery fistula,
brachial plexus compression due to subclavian artery pseudo aneurysm are reported in
literature.
OBJECTIVES. To report a rare case of complication of IJV cannulation for haemodialysis
where inadvertent right carotid artery cannulation occurred and the complex yet meticulous
management offered to this patient.
METHODS. A 70-year-old gentleman whose right carotid artery got cannulated was sub-
jected to uneventful removal of this catheter after percutaneous insertion of an endovascular
covered stent graft in the right carotid artery.
RESULTS. Our patient had a rare but dreaded complication of haemodialysis cannula
insertion and underwent a very meticulous management of this complication
CONCLUSION. Haemodialysis cannula insertion complications are known but carotid artery
cannulation is a rare and dreaded complication. It can be managed by percutaneous endo-
vascular covered stent graft with no untoward effects.
REFERENCES. Transverse cervical artery pseudoaneurysm: a rare complication of internal
jugular vein cannulation. Am J Nephrol. 2000;20(6):476–482.
2. Pseudoaneurysm of the subclavian-vertebral artery junction-case report and review of the
literature. Vasc Endovascular Surg 2002;36(6):461–464.
3. Brachial plexus compression due to subclavian pseudoaneurysm from cannulation of
jugular vein hemodialysis catheter. Am J Kidney Dis 1998;31(4):694–697.
4. Endovascular stented graft repair of a pseudoaneurysm of the subclavian artery caused
by percutaneous internal jugular vein cannulation; case report. Am J Crit Care.
1995;4(6):472–475.
5. Endovascular treatment of false aneurysm of the thyrocervical trunk. Vasc Endovascular
Surg. 2007;41(1):77–79.
6. Haemodialysis catheter-related right transverse cervical artery pseudoaneurysm and
treatment by coil embolization. Nephrology (Carlton). 2005;10(1):37–39.
7. Carotid-jugular arteriovenous fistula: a complication of temporary hemodialysis catheter.
Am J Nephrol 1995;15(4):332–336.
8. Carotid artery repair after erroneous insertion of a hemodialysis catheter: case report. J
Vasc Access 2006;7(3):136–138
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ANTITHROMBOTIC PROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH
RENAL FAILURE
R. Passos1, L. F. Conceic¸a˜o1, L. Valente1, E. Bulhoes1, F. Dutra1, M. F. Alves1, A. Pedroza1,
E. Miranda1, I. Silva1, E. Brito1, M. Dutra1
1Hospital Portugueˆs, Salvador, Brazil
INTRODUCTION. Deep venous thrombosis with subsequent pulmonary embolism or post-
thrombotic syndrome is a feared complication in the intensive care unit. Therefore, routine
prophylactic anticoagulation is widely recommended. Like other critically ill patients, patients
with renal insufficiency face an increased risk of DVT, at the same time, they are also
predisposed to bleeding because of uremic platelet dysfunction, multiple comorbidities, co-
agulopathies, concomitant treatment with antiplatelet or anticoagulant agents.
OBJECTIVE. The objective of this study was to assess the prevalence of renal failure among
critically ill patients and the use and dosage of antithrombotic prophylaxis in these patients.
Also, we estimated the incidence of major and minor bleeding by daily clinical assessments.
METHODS. In a cross sectional study carried out at four different critical care units at a
same hospital, information on all critically ill patients was collected. Data on the proportion of
patients with renal failure, on the type, use and dosage of antithrombotic prophylaxis were
ascertained.
RESULTS. 156 charts were examinated. 70 patients (46%) had renal disfunction. There was
no difference in the rate of prescription of antithrombotic prophylaxis between patients with
and without renal failure (p = 0.81 and p = 0.94, respectively). DVT developed in seven
patients, five of them in the renal failure group. In patients with renal failure, 52 patients
received prophylaxis with unfractionated heparin and 18 patients received enoxaparin
(p \ 0.01). There was no episode of major bleeding. There were 10 episodes of minor
bleeding, all of them in the group of renal failure patients. Independent risk factors for major
bleeding was aspirin use (hazard ratio, 6.30; 95% CI 1.35–29.4) and enoxaparin use (hazard
ratio, 1.68; 95% CI 1.07–2.66).
CONCLUSION. Renal failure is frequently present in critically ill patients using thrombo-
prophylaxis. This therapy can be associated with minor bleeding in this subgroup of patients.
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PATTERNS OF STROKE VOLUME VARIATION DURING CONTINUOUS RENAL
REPLACEMENT THERAPY: A CASE REPORT
I. Bobek1, D. Cruz1, S. Gramaticopolo2, P. Lentini1, S. Soni1, A. Chronopoulos2, P. Piccinni2,
C. Ronco1
1San Bortolo Hospital, Dep. Nephrology Dialysis and Transplantation, Vicenza, Italy, 2San
Bortolo Hospital, Department of Intensive Care, Vicenza, Italy
INTRODUCTION. One of the most common complications of Continuous Renal
Replacement Therapy (CRRT) in critically ill patients is hypotension. The amount and rate of
fluid removal are both important factors related to this complication.
OBJECTIVES. Here we report a case which demonstrates how the amount and rate of fluid
removal during CRRT affect conventional haemodynamic parameters and dynamic indices of
fluid responsiveness (e.g. Stroke Volume Variation, SVV).
METHODS. A sensor which provides pulse contour analysis parameters was connected to
our patient’s arterial line. Stroke volume, SVV and cardiac output were displayed on one
monitor while the conventional haemodynamic parameters appeared on another. After the
stabilization of the intravascular fluid volume of our patient (defined as achieving a SVV 10%
for at least 5 min) we performed 3 h of fluid removal with two different rates on each of two
consecutive days. On Day 1, we increased the removal rate to 5 ml/kg per hour and on Day 2,
to 4 ml/kg per hour. If/when SVV exceeded 15%, fluid removal was suspended until SVV
returned back into the 10–15% range. Continuous data was recorded at 5 min-intervals, while
static parameters in 30 min-intervals.
RESULTS. On Day 1 (fluid removal rate of 5 ml/kg per hour), our patient had 6 episodes in
which SVV increased to [15% (marked as ‘‘S’’ in Figure/left). As a consequence, fluid
removal needed to be stopped 6 times during the 3 h period. SVV and mean arterial pressure
(Pmean) always changed in a parallel manner during the study. These changes were not
reflected in the values of CVP and SVRI. Total fluid removed in 3 hrs was 985 ml. On
Day 2 (fluid removal rate of 4 ml/kg/h), the patient was more stable. Fluid removal was
interrupted only once (Figure/right).
Total fluid removed in 3 h was 1110 ml. These results suggest that for this particular patient
at this particular time 4 ml/kg per hour fluid removal rate was more optimal than 5 ml/kg per
hour.
CONCLUSION. The use of dynamic indices of fluid responsiveness such as SVV may help
customize RRT treatments for individual patients, allowing them to optimise amount and rate
of fluid removal.
REFERENCES. 1. Pinsky MR, Brophy P, Padilla J, Paganini E, Pannu N (2008) Fluid and
volume monitoring. Int J Artif Organs 31(2):111–126.
2. Cavallaro F, Sandroni C, Antonelli M (2008) Functional hemodynamic monitoring and
dynamic indices of fluid responsiveness. Minerva Anestesiol 74:1–13.
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THE KINETICS OF THE PANCREATIC HORMONE IN TRAUMATIZED
PATIENTS
K. Tanjoh1, T. Azuhata1, R. Tomita2, K. Kinoshita1, T. Moriya1, A. Sakurai1, T. Mukoyama1
1Nihon University, School of Medicine, Department of Acute Medicine, Tokyo, Japan,
2Nippon Dental University School of Dentistry, Department of Surgery, Tokyo, Japan
PURPOSE. The kinetics of the pancreatic hormone glucagon in traumatized patients has not
been minutely investigated as well as that of insulin, despite its significant influence on energy
metabolism. In the present study, we examined the kinetics of glucagon and glucagon-related
peptides assessed by radioimmunoassay, and the molecular forms of these peptides using gel
filtration chromatography. In addition, we discuss glucagon processes in the pancreas and
intestine in traumatized patients in the early operative days.
METHODOLOGY. Twelve traumatized patients who had undergone emergency surgery
were enrolled in this study (group S). Ten healthy volunteers were also enrolled as normal
control subjects (group C). The serum level of glucagon and glucagon-related peptides were
assessed in the early morning fasting state in both groups, on the second postoperative day in
group S, using the glucagon nonspecific N-terminal (glucagon-like immunoreactivity [GLI])
and specific C-terminal [immunoreactive glucagon (IRG)] radioimmunoassays. The molec-
ular forms of these peptides were also estimated using the gel filtration chromatography
method.
RESULTS. Serum IRG in group S was significantly high compared with that of group C
(P \ 0.05). Serum GLI was not significantly different between both groups. In all 12 patients
in group S, a peculiar glicentin-like peptide (GLLP: MW approximately 8,000 Da) other than
pancreatic glucagon was seen on gel filtration chromatography, which was not seen in group
C.
CONCLUSIONS. The kinetics and processing of glucagon in traumatized patients was
different from those of healthy subjects. In traumatized patients, the peculiar processing of
glucagon was processed in the intestine, which is different from the ordinary glucagon pro-
cessing either in the pancreas or the intestine, generating the peculiar glicentin-like peptide
(GLLP).
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METFORMIN-ASSOCIATED LACTATACIDOSIS (MALA) A REAL CHALLENGE
IN NEPHROLOGICAL INTENSIVE CARE MEDICINE
T. Schrauzer1, H. Walter1, K.-U. Eckardt1, S. John1
1University Erlangen-Nuernberg, Nephrology and Hypertension, Nuernberg, Germany
Between January 1 and December 31, 2008 in our 14-bed intensive care unit we took care of
983 patients. Within this period we treated nine patients (0.9%, four male, five female, median
age 64 years, range 54–80 years) with severe Metformin-associated lactatacidosis
(MALA).The pH in the first arterial blood gas rayed between 6.72 and 7.06, pCO2 6 and
27 mmHg, HCO3
- between 1.1 and 6.5 mmol/L, and the base excess between -22 and -
32 mmol/L. The anion gap was elevated in all patients (18–40 mmol) as was the blood lactat
level (90 up to 350 mg/dl). Seven patients were dehydrated due to a gastro-enteric infection;
two patients had taken Metformin for suicide. The blood level of Metformin was elevated in
eight patients, in one patient the level was within normal range. On admission all patients
suffered from acute kidney injury grade 3 (eight RIFLE F, one RIFLE I). The APACHE II
score rayed between 18 and 39 points. On admission to our ICU five patients needed vaso-
pressor therapy, three patients needed mandatory ventilation. We started fluid resuscitation
(10–26 L of crystalloids/48 h) and immediate continuous venovenous hemodialysis over a
period from 7.5 up to 37 h. All patients could be stabilized. In a recent Cochra-
ne review pooled data from 274 comparative trials and cohort studies revealed no cases of
fatal and nonfatal MALAs in 51627 patient-years of metformin use. Thus, the causal rela-
tionship between metformin use and MALA has been discussed
Without questioning the benefits of metformin therapy in type 2 diabetes, we wish to
emphasize that there are some contraindications to its use, stressing the importance of renal
clearance and the possibility of an unpredictable acute renal injury as a result of for example a
dehydration episode.
Patients should be sensitized for signs and symptoms of lactatacidosis like dyspnoe, tachy-
cardia, loss of consciousness and Metformin therapy should be cancelled immediately in any
kind of gastro- enteric infection or renal dysfunction.
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SODIUM VALPROATE TOXICITY, A NOVEL APPROACH
A. M. Cooke1, R. Mac Sweeney1, C. Bell1, C. Loughrey2, G. Allen1
1Belfast City Hospital, Intensive Care Unit, Belfast, UK, 2Belfast City Hospital, Department
of Clinical Chemistry, Belfast, UK
INTRODUCTION. Drug overdoses account for 3.8% of admissions to Intensive Care
Units and anti-epileptic drugs are relatively common agents in intentional overdoses [1, 2].
We use a case report of sodium valproate overdose to illustrate the biochemical management
of potentially fatal hyperammonemia.
CASE REPORT. A 43-year-old man presented with a 40 g sodium valproate overdose. On
admission he was unresponsive and hypotensive. His valproate level was 1470 mg/L (death
being associated with levels greater than 1,000 mg/L) and plasma ammonia was 850 lmol/L
[3]. Despite support for multiple organ failure, he deteriorated with increasing haemodynamic
instability and worsening lactic acidosis. Treatment was initiated to specifically reduce the
valproate and ammonia levels using L-carnitine, sodium benzoate and sodium phenylacetate.
His valproate and ammonia levels responded rapidly and neurological function normalised.
CONCLUSIONS. Hyperammonemia occurs in sodium valproate toxicity through inhibition
of one of the urea cycle enzymes. Sodium benzoate and sodium phenylacetate are metabol-
ically active compounds that can serve as an alternative route of excretion of waste nitrogen:
by conjugating amino groups to create non-toxic molecules which are excreted in the urine,
they are the mainstay of standard treatment for inherited disorders of the urea cycle [4]. It was
postulated that these drugs could also reduce acquired hyperammonemia due to an acquired
urea cycle defect secondary to severe drug toxicity. To our knowledge this is the first report of
sodium benzoate and sodium phenylacetate used to treat potentially fatal valproate poisoning.
REFERENCES. 1. Staber M, Plenderleith J, Wilson E, Binning A (2003) Intensive care
expenditure on overdose admissions. Crit Care 7(S2):245.
2. Robertson MM (1997) Suicide, parasuicide and epilepsy. In: Pedley T, Engel J (eds)
Epilepsy: a comprehensive textbook. Lippencott-Raven, Philadelphia.
3. Isbister GK, Balit CR, Whyte IM, Dawson A (2003) Valproate overdose: a comparative
cohort study of self poisonings. Br J Clin Pharmacol 55(4):398–404.
4. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A (2007) Survival after
treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med
356(22):2282–2292
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HUMAN ATRIAL NATRIURETIC PEPTIDE AND RENAL FUNCTION IN
PATIENTS WITH ACUTE KIDNEY INJURY AFTER CARDIOTHORACIC
SURGERY
C. Mitaka1, M. Ishizuka1, K. Kawada1, Y. Nakajima1, H. Arai2
1Tokyo Medical and Dental University Graduate School, Critical Care Medicine, Tokyo,
Japan, 2Tokyo Medical and Dental University Graduate School, Thoracic Cardiovascular
Surgery, Tokyo, Japan
INTRODUCTION. Acute kidney injury (AKI) is a frequent disorder after cardiothoracic
surgery and is associated with a higher risk of complication or death. Early recognition and
treatment for AKI are very important to prevent progression to severe kidney injury. Human
atrial natriuretic peptide (hANP) is a potent natriuretic, diuretic, and vasorelaxant substance.
We have reported that the intraoperative and postoperative infusion of low-dose hANP pre-
served renal function in patients undergoing abdominal aortic aneurysm repair. Therefore, we
hypothesized that hANP might have protective effects on renal function.
METHODS. We retrospectively investigated the effects of hANP on renal function in
patients with AKI after cardiothoracic surgery between April 1, 1997 and March 31, 2008.
Diagnostic criteria for AKI was based on the criteria of the Acute Kidney Injury Network.
Cardiothoracic surgery included coronary artery bypass graft, valvular operations and thoracic
aortic aneurysm repair. We divided into two groups; hANP group (n = 115) and non-hANP
group (n = 200). Mean arterial pressure, cardiac index, urine volume, serum creatinine
concentration, blood urea nitrogen concentration, doses of catecholamine, furosemide, and
mannitol and rate of dialysis were compared between the two groups.
RESULTS. The rate of hANP infusion was 0.01–0.1 lg/kg/min and duration of infusion was
2–28 days. The dose of furosemide was significantly lower in the hANP group than in the
non-hANP group. Urine volume was significantly increased and concentrations of serum
creatinine and blood urea nitrogen were significantly lower in the hANP group than in the
non-hANP group. In addition, the rate of dialysis was lower in the hANP group than in the
non-hANP group. There were no significant differences in mean arterial pressure, cardiac
index, and dose of catecholamine between the two groups.
CONCLUSION. Infusion of low-dose hANP is useful to preserve renal function in patients
with AKI after cardiothoracic surgery.
Microcirculation and fluid responsiveness: 0592–0604
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BRACHIAL ARTERY PEAK VELOCITY VARIATION TO PREDICT FLUID
RESPONSIVENESS IN MECHANICALLY VENTILATED PATIENTS
M. I. Monge Garcı´a1, A. Gil Cano1, J. C. Dı´az Monrove´1
1Hospital SAS de Jerez, Servicio de Cuidados Crı´ticos y Urgencias, Jerez de la Frontera,
Spain
INTRODUCTION. The degree of cyclic changes in left ventricular stroke volume due to
intermittent positive-pressure ventilation have been demonstrated to accurately reflect pre-
load-dependence in mechanically ventilated patients. Recently, Brennan et al. observed that
respiratory variations in brachial artery peak velocity (DVpeakbrach), were tightly correlated
with radial artery pulse pressure variations (DPPrad), so DVpeakbrach could be use as a non-
invasive substitute in predicting fluid-responsiveness. However, the predictive value of this
parameter was not tested performing a volume challenge and checking the effects in cardiac
output.
OBJECTIVE. To confirm the predictive value of DVpeakbrach as an indicator of fluid
responsiveness in mechanically ventilated patients with acute circulatory failure.
PATIENTS AND METHODS. 35 mechanically ventilated patients in whom fluid loading
was considered due to the presence of at least one sign of acute circulatory failure. Patients
were classified as responders if stroke volume index (SVi) increased C15% after volume
expansion (VE). Maximum and minimum values of Vpeakbrach (Vpeakmax and Vpeakmin,
respectively), were determined over a single respiratory cycle. The respiratory variation in
Vpeakbrach was calculated as the difference between Vpeakmax and Vpeakmin divided by the
mean of the two values and expressed as a percentage. DPPrad and stroke volume variation
measured with the FloTrac/Vigileo system (DSVVigileo), were also calculated.
RESULTS. 19 patients were considered as responders according to the SVi increase after VE.
At baseline, DVpeakbrach, DPPrad and DSVVigileo were significantly higher in responder than in
nonresponder patients (16 vs. 7%; 20 vs. 5%; 16 vs. 8%; P \ 0.001, respectively). SVi
changes induced by VE was correlated with baseline values of DVpeakbrach, DPPrad and
DSVVigileo (r = 0.73, 0.86 and 0.67; P \ 0.001, respectively). The VE-induced decreases in
DVpeakbrach and DPPrad were also correlated with changes in SVi after VE (r = -0.71 and -
0.72, P \ 0.0001, respectively), but not DSVVigileo. A DVpeakbrach of 10% predicted fluid
responsiveness with a sensitivity of 72% and a specificity of 94%, whereas a DPPrad of 8%
had a sensitivity of 94% and a specificity of 94%, and a DSVVigileo of 11% had a sensitivity of
78% and a specificity of 94%. The area under the ROC curve (AUC) was not significantly
different between DVpeakbrach, DPPrad and DSVVigileo (AUC ± standard error: 0.89 ± 0.06,
0.96 ± 0.03, 0.89 ± 0.06, respectively).
CONCLUSIONS. Respiratory variation in brachial artery peak velocity could be a feasible
tool for predicting fluid responsiveness in patients with mechanical ventilatory support.
REFERENCES. Brennan JM, Blair JE, Hampole C et al (2007) Radial artery pulse pressure
variation correlates with brachial artery peak velocity variation in ventilated subjects when
measured by internal medicine residents using hand-carried ultrasound devices. Chest
131:1301–1307
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DOSE-DEPENDENT BENEFIT OF NITROGLYCERIN ON MICROCIRCULATORY
PERFUSION IN PATIENTS WITH CARDIOGENIC SHOCK OR END-STAGE
CHRONIC HEART FAILURE
C. den Uil1, K. Caliskan1, W. Lagrand2, M. van der Ent1, L. Jewbali1, P. Spronk3,
M. Simoons1
1Erasmus Medical Center, Rotterdam, Netherlands, 2Academic Medical Center at the Uni-
versity of Amsterdam, Amsterdam, Netherlands, 3Gelre Hospitals, Apeldoorn, Netherlands
OBJECTIVES. We tested the hypothesis that nitroglycerin, a nitric oxide donor and potent
venodilator, dose-dependently improves tissue perfusion in patients with cardiogenic shock or
end-stage chronic heart failure.
METHODS. A dose-response study was performed in fifteen patients with cardiogenic shock
(n = 9) or end-stage chronic heart failure (n = 6) admitted to Erasmus University Medical
Center. We did hemodynamic measurements at baseline (T0), during increasing infusion rates
of nitroglycerin (T1–T5; up to a maximum dose of 133 lg min-1) and when nitroglycerin had
been stopped (T6). As parameters of tissue perfusion, we measured central-peripheral tem-
perature gradient (delta-T) and sublingual perfused capillary density (PCD). Capillaries were
defined as micro-vessels with a diameter of \20 lm.
RESULTS. Nitroglycerin dose-dependently decreased mean arterial pressure (p = 0.01),
cardiac filling pressures [central venous pressure (CVP): p \ 0.001; pulmonary capillary
wedge pressure: p = 0.001], and mixed-venous oxygen saturation (p = 0.02). Nitroglycerin
decreased delta-T (p \ 0.001; Fig. 1) and improved sublingual PCD (p\ 0.001; Fig. 2).
Macro-hemodynamic and microcirculatory responses to nitroglycerin infusion were consis-
tent in patients with either cardiogenic shock or end-stage chronic heart failure. Analysis of
pooled data showed a correlation between changes in CVP and changes in delta-T (p = 0.02)
and between changes in CVP and changes in PCD (p\ 0.01).
CONCLUSIONS. Nitroglycerin dose-dependently increases tissue perfusion. This increase
was significantly correlated to the decrease in central venous pressure. Further studies should
verify whether monitoring tissue perfusion could optimize current treatment strategies in
patients with severe heart failure or cardiogenic shock.
0594
EFFECTS OF POSITIVE END-EXPIRATORY PRESSURE ON TISSUE O2 SATU-
RATION IN AN ANIMAL MODEL WITH AND WITHOUT HYPOXEMIA
A. Lima1, I. Bikker1, J. Van Bommel1, C. Ince1, J. Bakker1
1Erasmus MC University Medical Centre Rotterdam, Intensive Care, Rotterdam, Netherlands
INTRODUCTION. High positive end-expiratory pressure (PEEP) levels during mechanical
ventilation have been used to avoid lung collapse and impairment of arterial oxygen saturation.
Application of PEEP also decreases venous return and cardiac output, causing secondary poor tissue
perfusion. The direct relationship between PEEP and tissue O2 saturation has not yet been studied.
OBJECTIVES. To investigate in an animal model the effects of acute decreases in global
blood flow brought by incremental increases in PEEP on peripheral tissue oxygenation (StO2)
assessed by near infrared spectroscopy before and after induction of hypoxemia.
METHODS. We performed experiments in five female pigs. Animals were anesthetized and
ventilated in a volume control mode. FIO2 was set to 0.8. Measurements were done in the intact
lung condition (model 1) and after induction of hypoxemia (model 2) by injection of oleic acid.
PEEP was applied in increments of 5 cmH2O each 10 min from baseline (0 cmH2O) to 20 cmH2O
(model 1) or 25 (model 2) after which it was decreased in steps of 5 cmH2O following the same
protocol. Mean arterial pressure (MAP), central venous pressure (CVP), central oxygen saturation
(SvO2) and cardiac output (CO) were continued monitored. StO2 was continuously measured on
the leg using InSpectra Model 650 (Hutchinson Technology Inc.). Differences between group-
s were tested by Wilcoxon signed test. P values \ 0.05 were considered statistically significant.
RESULTS. Hemodynamic and oxygenation variables in the different levels of PEEP strati-
fied by lung condition are shown in the following Tables 1, 2.
TABLE 1 INTACT LUNG. A:P\0.05 VS. BASELINE
PEEP 0 10 15 20
HR 89 102 112 125
MAP 92 95 90 89
CVP 5 8 9 11a
CO 4.8 4.8 4.2 3.7
SaO2 100 100 100 100
SvO2 79 77 73 65
a
StO2 52 51 48 44
a
TABLE 1 PULMONARY EDEMA. A:P\0.05 VS. BASELINE
PEEP 0 10 15 25
HR 151 141 139 174
MAP 96 99 99 76
CVP 5 7 8 11a
CO 5.5 5.6 4.7 3.4a
SaO2 70 86 99 99
a
SvO2 43 54 62 58
StO2 31 41
a 39 36
Elevation of PEEP significantly increased CVP in both models. During manipulation of PEEP,
significant changes of StO2 and SvO2 were also observed. After the normalization of SaO2 in the
model 2, further increments in PEEP levels did not produce significant changes in StO2.
CONCLUSION. Application of high PEEP impairs peripheral tissue oxygenation via its
negative effect on macrohemodynamic variables in the intact lung condition. After induction
of hypoxemia, the increment of SaO2 following application of PEEP may outweigh the
decline of CO, thereby resulting in higher StO2.
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HEMODYNAMIC IMPACT OF RECRUITMENT MANEUVERS IN ARDS
PATIENTS AFTER PRELOAD OPTIMIZATION BY PULMONARY ARTERY
CATHETER OR VIGILEO CRITERIA
M. Rovegno1, A. Bruhn1, E. Tobar2, C. de La Hoz1, G. Hernandez1
1Pontificia Universidad Catolica de Chile, Medicina Intensiva, Santiago, Chile, 2Universidad
de Chile, Unidad de Pacientes Criticos, Santiago, Chile
INTRODUCTION. Recruitment maneuvers (RM) are being increasingly used during
mechanical ventilation (MV) in ARDS pts. Although these maneuvers could add in evaluating
potential lung recruitment or to set PEEP levels, they can also be hemodinamically delete-
rious. This effect could be attenuated by improving preload before the RM.
OBJECTIVES. Our aim was to assess the hemodynamic impact of an isolated RM in patients
previously subjected to preload optimization under invasive (pulmonary artery catheter
(PAC)) or minimally invasive (Vigileo, Edwards USA) hemodynamic monitoring.
METHODS. The study was approved by our local IRB and informed consent was waived.
Inclusion criteria included ARDS patients with MV\72 h, stable central hemodynamics and
a PAC or Vigileo monitoring in place. Before the RM, patients with a PAC were given
volume challenges until cardiac index (CI) increased by \10%. In patients with Vigileo
conversely, volume challenges were administered only with a stroke volume variation (VVS)
[10%. After this period, a RM was performed in all patients (ventilation for 3 min in
pressure control mode at plateau pressure of 45 cm of water). We evaluated immediately
before, during, after and 15 min thereafter, several hemodynamic and respiratory parameters,
including CI. Secondarily, we compared hemodynamic performance in patients volume-
loaded under PAC or Vigileo guidance. Results are expressed as mean ± SD. Statistical
analysis included Fischer’s exact test, and the Wilcoxon or the Mann–Whitney U tests.
RESULTS. We enrolled 12 pts, 7 with PAC and 5 with Vigileo. APACHE II, and PaFiO2
were 17 ± 6 and 224 ± 70.2. Mean basal CI was 3.95 ± 1.0 L/min per m2. PAC versus
Vigileo monitored pts. required [ volume to reach hemodynamic goal (321.4 ± 122 vs.
50 ± 11.8 mL; p = 0.008). During the RM, CI decreased 0.4 ± 0.5 L/min per m2
(p = 0.026); without differences between groups. 83% maintained CI [3.0, and none
decrease CI below 2.5 L/min per m2.
CONCLUSIONS. Preload optimized ARDS patients tolerate recruitment maneuvers without
clinically significant hemodynamic consequences, with a mean decrease in cardiac index of
only 0.4 L/min m2. Preload optimization guided by PAC or Vigileo are equivalent, but this
later allows less volume infusion (Table 1)
TABLE 1 MAIN RESULTS
Variable Before MR During MR p*
HR 96.6 ± 15 96.5 ± 15.6 0.953
MAP 79.6 ± 5.6 80.71 ± 1 0.593
CI 4.2 ± 1.1 3.8 ± 1.1 0.026
ScvO2 73.7 ± 6.5 73.4 ± 6.8 0.594
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IS THERE ANY DIFFERENCE BETWEEN GENERAL ANESTHESIA ALONE OR
ASSOCIATED WITH THORACIC EPIDURAL ANAESTHESIA ON THENAR STO2
ALONG HYPERTHERMIA FOR INTRAPERITONEAL CHEMOTHERAPY?
S. Dagois1, C. Damoisel1, A.-C. Lukaszewicz1, I. Vostroknoutova1, H. Gevorgyan1, C. Lu-
engo1, M. Pocard2, D. Payen1
1Hopital Lariboisiere-APHP, Anaesthesia and Critical Care Department, Paris, France,
2Hopital Lariboisiere, Digestive Surgery Department, Paris, France
INTRODUCTION. Hyperthermic intraperitoneal chemotherapy (HIPEC), associated with
cytoreductive surgery is the only therapy prolonging survival for patients with peritoneal
carcinomatosis.
OBJECTIVE. To evaluate the impact of transient acute hyperthermia on systemic hemo-
dynamic and micro-oxygenation of thenar eminence under general anaesthesia (GA) alone or
associated with thoracic epidural anaesthesia (TEA).
MATERIAL AND METHODS. 15 patients, ASA1 or 2, 9F/6 M, 50.3 y.o. (33–66), with
peritoneal carcinomatosis; GA alone (n = 6) or associated to TEA (n = 9, T8–T9, ropi-
vacaı¨ne 2 mg/ml ? sufentanyl 0.5 mcg/ml) settled before induction. Monitoring: invasive
blood pressure (BP, radial artery), BIS (30–40, Astect Medical System), oesophageal
temperature (Tyco Healthcare), continuous central SvO2 measurement (Edwards Lifesci-
ences), cardiac output (CO, Doppler TE, Doptek). Muscle haemoglobin saturation
measurements (StO2, thenar eminence, non-blocking area) by NIRS (Hutchinson
) and
during occlusion test (3 min, 300 mmHg). Blood flow monitored on forearm by laser-Doppler
(LD, Transonic). Timing of measurements: end of viscerolysis, beginning and end of
chemohyperthermia, and finally at the end of the procedure. Statistics: nonparametric tests
RESULTS. Procedure duration: 11.1 h (8–14) with a large fluid loading (20 ml/kg per hour,
range 9–35) with crystalloids (1/3 0.9% saline, 2/3 ringer lactate), comparable in both groups.
The two groups did not differ for systemic hemodynamic. Hyperthermia induced a moderate
tachycardia similar under GA or GA ? TEA. BP decreased at the end of the procedure, with a
stable CO. Oesophageal temperature increased with hyperthermia, more importantly in the
GA group (p = 0.03). Baseline StO2 was in normal range and stable in the two groups. The
StO2-reperfusion slope did not differ between GA and TEA and increase during hyperthermia.
The more rapid was the drop of occlusion slope (rapid ischemia), the steeper was the
reperfusion slope (vascular recruitment). The forearm skin blood flow (laser-Doppler)
increased with hyperthermia so did the LD-reperfusion slope, with no difference in the two
groups.
DISCUSSION. We have found no difference between GA or TEA ? GA for the conse-
quences of hyperthermia on systemic and tissue perfusion during hypothermic intraperitoneal
chemotherapy. The benefit of one of two anaesthetic procedures remains to be demonstrated
in postoperative period especially for inflammatory parameters.
KEYWORDS. HYPERTHERMIA, TISSUE SATURATION, EPIDURAL ANAESTHESIA
Figure 1
Figure 2
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EFFECTS OF LUNG RECRUITMENT MANEUVERS ON SPLANCHNIC MICRO-
CIRCULATION DURING PORCINE ENDOTOXEMIA
F. Daudel1, J. Gorrasi1, H. Bracht2, S. Brandt3, V. Krejci3, S. M. Jakob1, J. Takala1, H. U.
Rothen1
1Inselspital, University Hospital Bern, Department of Intensive Care Medicine, Bern, Swit-
zerland, 2Universita¨tsklinikum Ulm, Universita¨tsklinik fu¨r Ana¨sthesiologie, Ulm, Germany,
3Inselspital, University Hospital Bern, Department of Anesthesiology and Pain Therapy,
Bern, Switzerland
INTRODUCTION. Sepsis may impair gastrointestinal perfusion due to vasodilation and
redistribution of blood flow. Microcirculatory perfusion deficits may be present despite intact
systemic hemodynamics [1]. Lung recruitment maneuvers (RM), used to re-open atelectatic
lung units and to improve oxygenation during mechanical ventilation [2] may result in
hemodynamic impairment. We hypothesized that the adverse hemodynamic effects of RM
may be potentiated during sepsis. This was tested in a model of porcine endotoxemia.
MATERIAL AND METHODS. Twelve anesthetized and paralyzed pigs underwent lapa-
rotomy and prolonged postoperative ventilation. The lungs were ventilated in volume-
controlled mode with a tidal volume of 10 mL/kg and a PEEP of 5 cmH2O. Systemic (pul-
monary artery catheter), regional (Ultrasonic transit time flowmetry) and microcirculatory
(Laser Doppler flowmetry) blood flows were monitored. After 6 h (=baseline), a recruitment
maneuver was performed with sustained inflation of the lungs to an airway pressure of 30 cm
H2O for 10 s. Thereafter the pigs were randomly assigned to group C (control, n = 6) or
group E (endotoxemia, n = 6). Endotoxemia was induced using a continuous infusion of
lipopolysaccarides (LPS) over 12 h. The RM was then repeated in both groups.
RESULTS. Infusion of LPS provoked a hyperdynamic circulation and a significant increase
in pulmonary arterial pressure in the animals of the endotoxin group. When performed during
endotoxemia (group E), RM decreased aortic pulse pressure, a surrogate of cardiac stroke
volume [3], from 37 ± 14 to 27 ± 13 mmHg (P = 0.024). The blood flows of renal artery,
hepatic artery, celiac trunk, superior mesenteric artery, and portal vein dropped to 71 ± 21,
69 ± 20, 76 ± 16, 79 ± 18 and 81 ± 12%, respectively (% of baseline flows before RM;
mean ± SD; P \ 0.05 all, except hepatic artery [P = 0.086]). Microcirculatory blood flows
of kidney cortex, kidney medulla, liver and jejunal mucosa in group E decreased to 65 ± 19,
77 ± 13, 66 ± 26 and 71 ± 12%, respectively (% of baseline flows before RM; mean ± SD;
P \ 0.05 all, except liver [P = 0.081]). The corresponding recovery times to at least 90% of
baseline regional blood flow and microcirculatory blood flow were between 1 and 5 min. The
decreases in regional perfusion and microcirculatory blood flow and the time to recovery of
these flows did not differ from the controls (P [ 0.05 all).
CONCLUSION. In this animal model of sepsis, endotoxemia did not aggravate the negative
hemodynamic effects of a lung recruitment maneuver. The impairment of regional and mi-
crocirculatory abdominal blood flows is significant but transient in character. Thus, our data
suggest that the hemodynamic effects of a RM are not aggravated in sepsis.
REFERENCES. 1. Sakr Y et al (2004) Crit Care Med 32:1825–1831.
2. Rothen HU et al (1999) Br J Anaesth 82:551–556. 3. Chemla D et al (1998) Am J Physiol
274:H500–H505.
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DYNAMIC INDICES BY PULSECOTM IN POST SURGICAL INTENSIVE CARE
PATIENTS
M. Cecconi1, G. Monti1, D. Dawson1, S. Vamadevan1, M. Hamilton1, G. Della Rocca2, R. M.
Grounds1, A. Rhodes1
1St Georges’s Hospital, General Intensive Care, London, UK, 2Universita` degli Studi di
Udine, Department of Anaesthesia and Intensive Care, Udine, Italy
INTRODUCTION. Predicting fluid responsiveness in the perioperative period is important
in order to haemodynamically optimise patients without overloading them [1].
OBJECTIVE. Studying the ability to predict fluid responsiveness of dynamic indices such as
pulse pressure variation (PPV), stroke volume variation (SVV) and systolic pressure variation
(SPV) as measured by PulseCOTM (LiDCOTMplus).
METHODS. Fully sedated and mechanically ventilated patients, with no spontaneous
respiratory effort and no arrhythmias were admitted post-surgery to the General Intensive
Care Unit and monitored with the LiDCOTMplus. Haemodynamic optimisation was started
according to the unit protocol with the aim to maximise the stroke volume (SV) and then to
reach an oxygen delivery index of 600 ml/min m2. Fluid challenges consisted of 250 ml
boluses of colloid (rate 50 ml/min). A SV increase of [15% was considered a positive
response (fluid responder). PPV, SVV and SPV were recorded prior to fluid administration,
together with static haemodynamic measurements such as mean arterial pressure (mAP),
central venous pressure (CVP) and Heart Rate (HR). Receiving Operator Characteristic
(ROC) analysis was performed to detect the sensitivity and specificity of the test.
RESULTS. 19 fully sedated and mechanically ventilated (tidal volume 8 ml/kg, PEEP
5 cmH2O) post surgical patients were admitted to the General Intensive Care Unit during the
study period. No patients had arrhythmias. The demographic characteristics showed: 12
males, 7 females, mean weight 75 kg (±17), mean height 1.7 m (±0.12), mean age 65 kg
(±16). 27 fluid challenges were performed during the study period. 6 of the 19 (32%) patients
were fluid responders on admission to the unit. ROC analysis did not show the areas under the
curve to be statistically significant for CVP and HR. Areas under the ROC curves were 0.83
for PPV (p \ 0.05), 0.84 for SVV (p \ 0.05), 0.78 for SPV (p \ 0.05) and 0.83 for mAP
(p \ 0.05). The best cutoff values (sensitivity and specificity) to predict fluid responsiveness
were PPV 15% (83%, 82%), SVV 12% (83%, 85%), SPV 8% (83%, 78%) and
mAP 78 mmHg (83%, 67%).
CONCLUSIONS. Dynamic indices measured by PulseCOTM (LiDCO) have a high sensi-
tivity and specificity in predicting fluid responsiveness in fully sedated and mechanically
ventilated patients. A cut off value for SVV of 12% is the most sensitive and specific indicator
of fluid responsiveness.
REFERENCE(S). 1. Michard F, Teboul JL (2002) Predicting fluid responsiveness in ICU
patients: a critical analysis of the evidence. Chest 121:2000–2008.
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PREDICTION OF FLUID RESPONSIVENESS IN SEPTIC PATIENTS WITH A LOW
TIDAL VOLUME
X. Monnet1, A. Bleibtreu1, A. Ferre´1, M. Dres1, C. Richard1, J.-L. Teboul1
1Hoˆpital de Biceˆtre, Assistance Publique-Hoˆpitaux de Paris, Faculte´ de Me´decine Paris-Sud,
Universite´ Paris-Sud 11, Service de Re´animation Me´dicale, EA 4046, Le Kremlin-Biceˆtre,
France
INTRODUCTION. Fluid responsiveness can be accurately predicted by the respiratory
variation of arterial pulse pressure (PPV) in mechanically ventilated patients but it has been
suggested that this prediction is poorer in case of low tidal volume (Vt). We attempted to
confirm this hypothesis. We also tested whether two other tests of fluid responsiveness, the
changes in pulse contour-derived cardiac index induced by passive leg raising (PLR) and by a
15-s tele-expiratory occlusion test (TEO) depend upon the Vt.
PATIENTS AND METHODS. We included 39 patients with septic shock (61 ± 12 years,
33 receiving norepinephrine, SAPS2 = 63 ± 23). In 19 (49%) patients with an acute respi-
ratory distress syndrome the Vt was B7 mL/kg of predicted body weight (6.7 ± 0.4 mL/kg).
We measured the response of cardiac index (pulse contour analysis, PiCCO device) to fluid
administration (500 mL saline over 20 min). Before fluid administration, we recorded the
PPV and the changes in cardiac index induced by PLR and TEO.
RESULTS. Considering the whole population, fluid administration increased cardiac index
by more than 15% (50 ± 44%) in 22 ‘‘responders’’. For predicting fluid responsiveness, the
area under the receiver operating characteristics (ROC) curves were 0.81 ± 0.07 (cut-off
value = 8%, sensitivity = 59%, specificity = 94%) for PPV, 0.89 ± 0.05 (cut-off
value = 9%, sensitivity = 91%, specificity = 88%) for PLR and 0.92 ± 0.05 (cut-off
value = 8%, sensitivity = 59%, specificity = 94%) for TEO. When considering only the 20
patients ventilated with a Vt [ 7 mL/kg of predicted body weight, the area under the ROC
curves were 0.85 ± 0.08 (cut-off value = 10%, sensitivity = 92%, specificity = 89%) for
PPV, 0.86 ± 0.08 (cut-off value = 9%, sensitivity = 91%, specificity = 79%) for PLR and
0.95 ± 0.05 (cut-off value = 6%, sensitivity = 73%, specificity = 100%) for TEO. When
considering only the 19 patients ventilated with a Vt B 7 mL/kg of predicted body weight,
the area under the ROC curves were 0.77 ± 0.11 (cut-off value = 6%, sensitivity = 63%,
specificity = 75%) for PPV, 0.91 ± 0.07 (cut-off value = 9%, sensitivity = 91%, specific-
ity = 100%) for PLR and 0.91 ± 0.07 (cut-off value = 5%, sensitivity = 91%,
specificity = 100%) for TEO. In these patients, when considering an 8% cut-off for PPV,
seven were falsely classified as nonresponders by PPV but all were well classified by PLR and
TEO.
CONCLUSION. When tidal volume is B7 mL/kg of predicted body weight, PPV looses part
of its accuracy for predicting fluid responsiveness. However, the PLR and TEO tests are fully
accurate alternatives in such cases.
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INFLUENCE OF TIDAL VOLUME ON RESPIRATION-INDUCED CHANGES IN
PULSE PRESSURE IN VENTILATED PIGS WITH ARDS SUBJECTED TO
HYPOVOLEMIA
C. U. Wiklund1, D. R. Morel2, H. R. Wiklund3, J.-A. Romand2, K. Bendjelid2
1Karolinska University Hospital, Department of Anesthesiology and Intensive Care Medicine,
Stockholm, Sweden, 2Geneva University Hospitals, Department of Anesthesiology, Phar-
macology, and Intensive Care, Geneva, Switzerland, 3Karolinska University Hospital,
Department of Pediatric Anesthesia and Intensive Care, Stockholm, Sweden
INTRODUCTION. Sensitivity and specificity of respiratory change in pulse pressure (DPP)
to predict preload dependency has been questioned at small tidal volumes (VT) in critically ill
patients suffering from ARDS.
OBJECTIVE. We studied DPP, in pigs with ARDS during reversible hemorrhagic shock.
METHODS. Prospective, observational study in an animal laboratory Investigation Unit.
Sixteen deeply sedated mechanically ventilated pigs were ventilated successively with VT of
10 ml kg-1/respiratory rate (RR) of 15 min-1 and VT of 6 ml kg
-1/RR of 15 or 25 min-1.
ARDS was produced by lung lavage in 8 pigs (ARDS group). Severe hemorrhagic shock was
induced by 40% of total blood volume removed followed by restoration. A two-way analysis
of variance (ANOVA) for repeated measures was used to analyze the combined effects of the
successive interventions (hemodynamic conditions, ventilation modes) as well as to compare
the two treatment groups (ARDS vs. Controls) using Statistica software package. Group data
are presented as mean ± SE values.
RESULTS. Following bleeding, in the Control group ventilated with a VT of 10 ml/kg, DPP
increased from 8.3 ± 0.9 to 19.5 ± 2.9%; p \ 0.001. In ARDS group, this index was also
significantly increased, though to a lesser extent than in the Control group (from 4.8 ± 0.6 to
12.7 ± 3.1%; p \ 0.05). In Control lungs, reduction in VT from 10 to 6 ml/kg decreased
DPP changes by [50% although it remained statistically valid indicator of hypovolemia
whatever RR value (p \ 0.05). In contrast, in ARDS group, DPP was unreliable marker of
hypovolemia at low VT ventilation (p [ 0.05).
CONCLUSIONS. The present study suggests that in pigs with ARDS ventilated with small
VT, DPP is not a sensitive indicator of severe hypovolemia.
Figure legends: O: VT 10 ml kg
-1 RR of 15 bpm; D: VT 6 ml kg
-1 RR of 15 bpm; *: VT of
6 ml kg-1 RR bpm of 25.
Figure 1
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THE EFFECT OF AORTIC CROSS CLAMP ON INTESTINAL AND SUBLINGUAL
MICROCIRCULATION: THE FIRST IN VIVO IMAGING STUDY OF GUT
S. Paravastu1, D. DeBacker2, F. Serracino-Inglott1, A. Pichel3, J. Eddleston3, M. Walker1,
M. Nirmalan3
1Manchester Royal Infirmary, Department of Vascular and Endovascular Surgery, Man-
chester, UK, 2Erasme University Hospital, Brussels, Belgium, 3Manchester Royal Infirmary,
Anaesthesia and Intensive Care, Manchester, UK
INTRODUCTION. Gut ischemia is a recognised complication of aortic cross clamping in
patients undergoing open abdominal aortic aneurysm (AAA) repair, with an incidence
approximately 2% after elective surgery [1]. In addition to direct ischaemia, ischaemia-
reperfusion of the distal vascular beds also contributes to alterations in the microcirculation.
The extent to which ischemia-reperfusion secondary to infra-renal aortic cross clamping alters
the microcirculation in the somatic and visceral beds intra-operatively is currently unknown.
OBJECTIVES. To characterise the microcirculatory changes in somatic (sublingual) and
visceral (intestinal) vascular beds in patients undergoing AAA repair.
METHODS. PatientsundergoingelectiveAAArepairwererecruitedandSidestreamDarkField
imaging (SDF, MicroscanTM, Netherlands) was used to estimate microcirculation. To determine
the effect of reperfusion, sublingual and intestinal (sigmoid colon serosa) microcirculation was
estimated before aortic cross clamping and after the release of the clamp. All measurements were
taken and analyzed in accordance with the consensus document [2]. Simultaneously hemody-
namic variables were recorded using FinapresTM, a well validated finger plethysmograph
technique. Paired t-test was used for statistical analysis using SPSS statistical software.
RESULTS. To date, four male and one female have been recruited. Percentage of perfused
vessels (PPV), total vessel density (TVD), capillary vessel density (CVD), perfused vessel
density (PVD) and microvascular flow index (MFI) of small and large vessels of all images are
presented in Table 1. All values are presented as mean with standard deviation in parenthesis.
TABLE 1 INTESTINAL AND SUBLINGUAL MICROCIRCULATORY
VARIABL










PPV (vessels/mm2) 94% (6.2%) 85% (6.9%) 0.9 99% (1.7%) 93% (5.4%) 0.09
TVD (vessels/mm2) 9.66 (3.5) 8.61 (1.6) 0.5 12.38 (2.0) 10.75 (1.3) 0.3
CVD (vessels/mm2) 7.54 (3.1) 7.37 (1.8) 0.9 10.10 (1.6) 8.64 (1.4) 0.3
PVD (vessels/mm2) 9.11 (3.9) 7.39 (1.4) 0.4 12.20 (2.1 10.07 (1.6) 0.2
MFI (Small Vessels) 2.83 (0.3) 2.71 (0.3) 0.6 3.0 (0) 3.0 (0) 0.1
MFI (Large vessels) 2.65 (0.4) 2.15 (1.3) 0.5 3.0 90) 2.87 (0.2) 0.2
Mean Arterial
Pressure
82 (11) 79 (15) 0.7
Cardiac output 3.9 (1.4) 4.7 (0.9) 0.5
CONCLUSION. This first human in vivo study demonstrates that it is feasible to use the
SDF technology to quantify intestinal serosal microcirculation. Ischaemia-reperfusion related
to aortic cross clamping is not associated with significant microcirculatory abnormalities in
both sublingual and intestinal vascular beds. There was a statistically nonsignificant reduction
in most of the measurable microcirculatory indices at reperfusion stage compared to the
baseline. This may be due to a relatively small sample size or it is possible that the major
determinants of microcirculation are mean arterial pressure and cardiac output, both of which
remained unaltered between the two phases of the study.
REFERENCES. 1. Perry RJ, Martin MJ, Eckert MJ, Sohn VY, Steele SR (2008) Colonic ischemia
complicating open vs endovascular abdominal aortic aneurysm repair. J Vasc Surg 48(2):272–277.
2. De Backer D, Hollenberg S, Boerma C, Goedhart P, Bu¨chele G, Ospina-Tascon G, Dobbe I, Ince C
(2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 11(5):R101.
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ANAESTHESIA INDUCED CHANGES IN TISSUE SATURATION IN RESPONSE TO
VASCULAR OCCLUSION TEST
S. Ranjan1, S. Thomson1, M. L. Tuccillo2, A. Addei3, R. Hagger4, T. Rahman1,
N. Al-Subaie1, M. Hamilton1
1St. George’s Hospital, General Intensive Care, London, UK, 2Ospedale S. Maria della Mi-
sericordia, Clinica di Anestesia e Rianimazione, Udine, Italy, 3St. George’s Hospital, Dept. of
Anaesthesia, London, UK, 4St. George’s Hospital, London, UK
INTRODUCTION. General anaesthesia is associated with changes in the microcirculation
and tissue oxygen uptake
OBJECTIVES. This study looks into muscle tissue saturation using near infrared spectroscopy
(NIRS), both in healthy volunteers and in patients under inhalational general anaesthesia.
METHODS. This was a prospective observational study performed on awake subjects and
anaesthetised patients. A standardised 3 min vascular occlusion test (VOT) was performed by
rapid inflation of a forearm cuff to 50 mmHg above systolic pressure. Muscle tissue oxygen
saturation was measured using a Hutchinson TechnologyTM InSpectraTM StO2 tissue oxy-
genation monitor, with a 15 mm probe applied to the right hand thenar eminence.
This test was carried out on awake healthy volunteers with no concurrent illnesses under
reproducible conditions. In the anaesthetised group a VOT was performed 10 minutes after a
standardised intravenous anaesthetic induction, whilst general anaesthesia was maintained
with oxygen, air and isoflurane. Data were described as median (Interquartile range) and
Mann–Whitney test was performed to assess statistical significance.
RESULTS. A total of 25 healthy volunteers and 22 anaesthetised patients were enrolled.
There were statistically significant differences between the two groups as illustrated in
Table 1. Baseline StO2 was significantly higher in the anaesthetised group [84.00 (7.50) vs.
79.00 (7.00)] %, p = 0.004. After cuff inflation the down slope StO2 was lower in the
anaesthetised group [-8.15 (3.22) vs. -10.92 (3.13)] %/minute, p = 0.001. The subsequent
upslope, on release of the cuff pressure, was also lower in the anaesthetised group [147.75
(86.87) vs. 218.57 (71.04)] %/minute, p = 0.009. The minimum StO2, at 3 min ischemia, was
significantly higher in the anaesthetised group [59.50 (13.25) vs. 45.00 (12.5)] %, p = 0.001
in addition to the area within the occlusion curve [35.45 (15.77) vs. 52.2 (11.85)] %.min,
p \ 0.001. Maximum StO2 was also higher in the anaesthetised group [96.50 (3.25) vs. 94.00
(3.5)] %, p = 0.004. The difference between baseline StO2 and minimum StO2 was found to
be lower in the anaesthetised group [24 (9) vs. 33 (9)] %, p \ 0.001.
TABLE 1 VASCULAR OCCLUSION TEST FINDINGS
Awake healthy vol-
unteers (n = 25)
Anaesthetised
patients (n = 23)
p
Baseline StO2 [median (IQR)] (%) 79 (7) 84 (7.5) 0.004
Down slope StO2 [median (IQR)], %/min -10.92 (3.13) -8.15 (3.22) 0.001
Up slope StO2 (median (IQR)), %/min 218.57 (86.86) 147.75 (71.04) 0.009
Minimum StO2 [median (IQR)] (%) 45 (12.5) 59.5 (13.25) 0.001
Maximum StO2 [median (IQR)] (%) 94 (3.5) 96.5 (3.255) 0.004
Area within occlusion curve [median (IQR)], % min -52.2 (11.85) -35.45 (15.77) \0.001
Area under the reperfusion curve [median (IQR)], %.min 18.5 (6.6) 24.75 (16.05) NS
Baseline StO2-minimum StO2 [median (IQR)], % 33 (9) 24 (9) \0.001
Maximum StO2-baseline StO2 [median (IQR)], % 15 (4.5) 11.5 (7.5) NS
CONCLUSION. This study shows differences in tissue oxygen saturation during a VOT
between awake and anaesthetised patients. This maybe due to anaesthetic related micro
circulatory effects or changes in cellular uptake of oxygen or both.
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PREDICTING VOLUME RESPONSIVENESS BY FUNCTIONAL HEMODYNAMIC
PARAMETERS IN THE STATE OF EXPERIMENTAL CARDIAC INSUFFICIENCY
C. Trepte1, V. Eichhorn1, A. E. Goetz1, D. A. Reuter1
1University Medical Center Hamburg-Eppendorf, Department of Anaesthesiology, Hamburg,
Germany
BACKGROUND. Predicting the response of left ventricular stroke volume-to-volume
administration remains a controversially discussed clinical problem, especially in patients
with acutely compromised cardiac function. Therefore, we investigated the predictive value of
recently implemented functional hemodynamic parameters suggested for the use in critically
ill patients to predict volume responsiveness. These include pulse contour-derived stroke
volume- and pulse pressure variation (SVV, PPV), global end-diastolic—and right-ventricular
end-diastolic volume (GEDV, RVEDV) derived by thermodilution as well as the parameter
RSVT-Angle, derived by the recently reported respiratory systolic variation test (RSVT) in an
experimental model of cardiac insufficiency.
METHODS. 13 anesthestized pigs BW 30.8 kg (±3.7) were investigated. After baseline
measurements cardiac insufficiency was induced by infusion of verapamil until maximum left
ventricular peak pressure (dPmx) reached 50% of baseline values. Then, 20 ml/kg BW of
blood were withdrawn to establish hypovolemia. Consecutively, fluid loading was performed
in each animal in four steps of 7 ml/kg BW each using the shed blood and hetastarch 6% 130
KD. The response to a fluid loading step was considered as positive, if cardiac output
increased more than 10%. Receiver operating characteristic curves were plotted for PPV,
SVV, RSVT-Angle, GEDV and RVEDV. In addition we included measurement of RAP. The
RSVT performs an automated and standardized ventilation maneuver (three consecutive
mechanical breaths with increasing airway pressures) to detect volume responsiveness in
mechanical ventilated subjects.
RESULTS. With volume loading MAP increased from 38 mmHg (±8) to 69 mmHg (±10),
HR from 78 (±9) to 80 (±9), CO from 2.4 l/min (±0.5) to 3.1 l/min (±0.6), GEDV from
375 ml (±63) to 452 ml (±77), RVEDV from 114 ml (±23) to 141 ml (±25) and RAP from
7.5 mmHg (±4.9) to 14.8 mmHg (±7.9). SVV decreased from 12.0% (±3.8) to 6.1% (±1.7),
PPV from 14.1% (±4.3) to 6.2% (±2.2) and RSVT Angle decreased from 20.8 (±3.3) to 6.5
(±3.5). ROC analysis of the investigated parameters is shown below.
CONCLUSION. The recently introduced parameter RSVT-Angle and previously clinically
implemented functional hemodynamic parameters are superior to static indicators of cardiac
preload. These data of fluid responsiveness support the current concept of guiding volume
therapy in patients with compromised cardiac function (Table 1)
TABLE 1
Test Variables PPV (%) SVV (%) RSVT-Angle GEDV RVEDV RAP
ROC curve area 0.84 0.82 0.88 0.77 0.66 0.78
Standard error 0.07 0.06 0.05 0.08 0.08 0.08
95% Confidence interval 0.71–0.97 0.70–0.94 0.77–0.98 0.62–0.92 0.50–0.82 0.63–0.93
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TISSUE OXYGEN SATURATION (STO2) IN PATIENTS UNDERGOING MAJOR
BOWEL SURGERY PREDICTS POST OPERATIVE COMPLICATIONS
N. Al-Subaie1, S. Ranjan2, S. Thomson2, M. L. Tuccillo3, A. Addei4, R. Hagger2,
M. Hamilton4, A. Rhodes1
1St. George’s Hospital, General Intensive Care, London, UK, 2St. George’s Hospital, London,
UK, 3Ospedale S. Maria della Misericordia, Clinica di Anestesia e Rianimazione, Udine,
Italy, 4St. George’s Hospital, Dept. of anaesthesia, London, UK
INTRODUCTION. Dynamic changes in tissue oxygen saturation (StO2) in response to a
vascular occlusion test (VOT) were shown to predict prognosis in patients with sever sepsis. It
is unknown how these changes relate to surgical outcome.
OBJECTIVE. Assess the value of dynamic StO2 changes in response to a VOT in identifying
patients at risk of developing postoperative complications following major bowel surgery.
METHODS. A VOT was performed 10 min after a standardised intravenous anaesthetic
induction, whilst general anaesthesia was maintained with oxygen, air and isoflurane. The test
was performed by the rapid inflation of a pneumatic cuff placed above the elbow for 3 min.
The pressure used to achieve vascular occlusion was 50 mmHg above patient’s systolic.
Muscle tissue oxygen saturation was measured using a Hutchinson TechnologyTM InSpec-
traTM 650 StO2 tissue oxygenation monitor, with a 15 mm probe applied to the right hand
thenar eminence. Patients were divided to two groups based on whether they developed
postoperative complication or not. Complications included were: cardiovascular, respiratory,
infective and major gastrointestinal complications. Data were described and analysed as non-
parametric.
RESULTS. A total of 20 patients were enrolled. Table 1 illustrates the differences in the
VOT derived StO2 variables expressed in medians (interquartile range) along with statistical
significance. Analysis of the receiver operating characteristics, for having an uncomplicated
post operative course, showed that the maximum and minimum StO2 values attained during
VOT had an area under the curve of 0.85 (p = 0.008). Proposed cut-off values to determine
patients with no postoperative complications are: minimum StO2 of 59% (sensitivity and
specificity of 80 and 70%, respectively) and a maximum StO2 value of 97% (sensitivity and
specificity of 80 and 70%, respectively).
TABLE 1 STO2 CHARECTERSTICS OF STUDY PTS
No complications Complications p
Variables
Down slope StO2%/min -7.96 (1.93) -8.93 (4.07) 0.257
Baseline StO2% 87 (5) 82.5 (15) 0.016
Upslope StO2%/min 144 (77.2) 197.14 (76.71) 0.226
Minimum StO2% 62.5 (6) 55 (26) 0.0008
StO2 area within occlusion curve %.min 35.45 (11.8) 46.25 (14) 0.257
StO2 area under the reperfusion curve %.min 18.45 (18.9) 28.25 (14) 0.212
Maximum StO2% 98 (2) 95 (5) 0.007
CONCLUSION. Dynamic StO2 changes in response to a standardised vascular occlusion test
show promise in predicting patients post operative course following major bowel surgery.
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HEMODYNAMIC VARIABLES AND MORTALITY IN CARDIOGENIC SHOCK
C. Torgersen1, M. Du¨nser2, C. Schmittinger1, S. Wagner2, J. Takala2, S. Jakob2
1Innsbruck Medical University, Innsbruck, Austria, 2Bern University Hospital and University
of Bern, Bern, Switzerland
INTRODUCTION. Catecholamines are commonly used inotropes in cardiogenic shock [1].
There are hardly any beneficial effects of catecholamines on the heart itself [2]. Identification
of hemodynamic variables and levels critical for survival could reduce catecholamine
exposition and adverse effects in cardiogenic shock.
OBJECTIVES. To evaluate the association between hemodynamic variables and mortality,
and to identify critical levels of hemodynamic variables to predict death in cardiogenic shock.
METHODS. In this retrospective study, medical records from 03/2005 to 06/2008 were
reviewed for patients admitted to the intensive care unit (ICU) because of cardiogenic shock.
All variables were extracted from the institutional patient data management system database
which stores hemodynamic variables as median values over 2 min. For each hemodynamic
variable, the hourly variable time integral during the first 24 h after ICU admission was
calculated. If hemodynamic variables revealed a significant association with outcome, the
hourly variable time integral of drops below clinically relevant threshold levels was com-
puted. Demographic and clinical data and 28-day mortality were collected in all patients.
Binary logistic regression models adjusted for age, admission year, catecholamine doses and
SAPS II (excl. systolic arterial blood pressure and heart rate) as well as ROC analyses were
calculated to test associations between single hemodynamic variables, threshold levels and
28-day mortality.
RESULTS. Hundred-nineteen patients were included into the analysis. 28-day mortality was
29.4%. The hourly cardiac index (CI) (p = 0.01) and cardiac power index (CPI) (p = 0.03)
time integrals were the only hemodynamic variables that were significantly associated with
mortality. The hourly time integral of CI drops below 3, 2.75 (both p = 0.02) and 2.5
(p = 0.03) L/min per m2 was significantly associated with death but not that of CI drops
below 2 L/min per m2 or lower values (all p [ 0.05). The hourly time integral of CPI drops
below 0.5–0.8 W/m2 (all p = 0.04) was significantly associated with mortality but not that of
CPI drops below 0.4 W/m2 or lower values (all p [ 0.05).
CONCLUSIONS. During the first 24 h after ICU admission, CI and CPI seem to be inde-
pendently associated with 28-day mortality in cardiogenic shock. A CI C 2.5 L/min per
m2and a CPI C 0.5 W/m2 appear to represent critical levels for survival. Randomized con-
trolled trials are required to evaluate whether targeting these levels as early resuscitation
endpoints can improve survival in cardiogenic shock.
REFERENCES. 1. Petersen JW, Felker GM (2008) Inotropes in the management of acute
heart failure. Crit Care Med 36(1 Suppl):S106–S111.
2. Du¨nser MW, Hasibeder WR (2009) Sympathetic overstimulation during critical illness:
adverse effects of adrenergic stress. J Intensive Care (in press)
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ACTIVATED PROTEIN C LEVELS IN PATIENTS WITH CARDIOGENIC SHOCK
B. Fellner1, R. Jarai1, P. Smetana1, M. Freynhofer1, G. Zorn1, O. Wagner2, K. Huber1, A.
Geppert1
1Wilhelminenhospital, 3rd Department of Medicine with Cardiology, Vienna, Austria,
2Medical University of Vienna, General Hospital, Department of Medical and Chemical
Laboratory Diagnostics, Vienna, Austria
PURPOSE. In patients (pts) with severe sepsis low levels of activated protein C (APC) are
associated with high morbidity and mortality. Because inflammation plays an important role
in the development and outcome of cardiogenic shock (CS), we investigated whether pts with
CS have also decreased circulating levels of APC and if these were associated with increased
mortality.
METHODS. We measured serum APC levels in pts with CS following acute myocardial
infarction (MI) and in a control group consisting of pts with uncomplicated MI at day 0, 1, 2,
3, 5, and 7 after onset of shock/MI. Data were correlated to vasopressor-(VP) need, organ
failure and 28 day mortality.
RESULTS. In our study 30 pts with CS fullfilled the inclusion criteria, 6 pts were in the
control group. In 83% of the CS pts (n = 25) an IABP was installed, 73% (n = 22) had to be
mechanically ventilated. On day 0 after onset of shock the mean dose of dobutamin was
5.4 ± 4.6 lg/kg per minute and the mean vasopressor dose 0.49 ± 0.48 lg/kg per minute.
Renal failure was observed in 37% (n = 11), and 50% (n = 15) had renal dysfunction; the
total SOFA score on admission was 8.8 ± 3.0. The ICU and the 28 day-survival were 50%
and the 7 day-survival 73%.
In pts with CS APC levels at baseline were significantly lower than in the control group
(85 ± 27% vs. 103 ± 12%). We noted a decline in APC levels from admission to day 3
(72 ± 38% vs. 124 ± 10%, p \ 0.001). 7 pts with CS died within 72 h. On day 3 non-
survivors of CS did exhibit significantly lower APC levels than survivors (48 ± 28% vs.
85 ± 37%, p = 0.03). PC levels correlated significantly with the SOFA score from day 0 to
day 3. There was no significant correlation with VP-need.
CONCLUSION. Pts with CS show a decline in APC levels. During the course of disease this
decrease is more severe in non-survivors than in survivors and correlates with organ failure.
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REVERSIBLE MYOCARDIAL DYSFUNCTION: A COMMON UNRECOGNIZED
PHENOMENON IN PATIENTS WITH SHOCK?
R. Garcı´a del Moral Martı´n1, M. A. Diaz Castellanos1, J. Martin Lopez1, P. Arnedo Rodri-
guez1, R. Mendez Martin1, M. J. Tortosa Espinola1, E. Rodriguez Delgado1, A. Estivill
Torrus1
1Hospital Santa Ana, Intensive Care Unit, Motril, Spain
INTRODUCTION. Reversible myocardial dysfunction (RMD) is a common phenomenon in
acute and subacute coronary syndromes as stunning or hibernating myocardium. However,
RMD can occur in critical photology of noncoronary origin related to stress, neurologic
disease, postresucitation or sepsis. This phenomenon is called apical ballooning syndrome,
tako-tsubo syndrome or reversible myocardial disfunction.
METHODOLOGY AND RESULTS. Over a six moths period (between June 2008 and
December 2008) we admitted 293 patients in the intensive care unit. We made ecocardiog-
raphy to 44 patients with shock and vasopressor therapy in the first 48 h of admission. 6
patients (13%) had echocardiography findings suggestive of RMD. Any patient has no history
of heart disease, although 80% presents coronary risk factors, mainly smoking. Reasons for
admission in ICU were: septic shock (3), sepsis (1), acute respiratory failure (1) and heart
attack (1). The median age was 45 years (range 25–66) and 2 were women (33%). All the
cases present a markedly reduced left ventricular ejection fraction (median 34.1 ± 6.9%) by
Simpson’s method without ventricular dilatation. Segmental contractility disturbances were
observed in all patients, with the typical ‘‘apical ballooning’’ imaging in 65%. Troponin I
level increase in all patients (median 14, range 3.46–25.42). ECG changes included: ST
elevation (3); ST depression (1) and T changes (2). Acute hypoxemia was the most prevalent
factor in the first 48 h. Left ventricular ejection fraction showed a progressive improvement in
the first days (median 102 h, range 48–192).
CONCLUSION. Reversible myocardial disfunction is frequent in critically ill patients with
hemodynamic impairment. Is a reversible phenomenon with typical echocardiography and
electrocardiography findings with troponin I rising. The optimal management is a conser-
vative therapy.
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HEMODYNAMIC PARAMETERS AND SHOCK TREATMENT AS DETERMINANT
OF THE CORONARY PERFUSION PRESSURE (CPP) IN THE CRITICALLY ILL
PATIENT
L. Hector R.1, S. A. Julio1, M. Poblano1, S. Christian1, A. Janet1, F. Juvenal1
1The American British Cowdray Medical Center I. A.P, Department of Critical Care Medicine
‘‘Dr. Mario Shapiro’’, Mexico DF, Mexico
INTRODUCTION. The perfusion of the coronary artery to the left ventricle occurs primarily
during diastole. So there must be adequate diastolic pressure in the aortic root of both
coronary arteries to be perfused. The CPP should be maintained above 50 mmHg. Below this
critical value. Maintaining an adequate coronary perfusion should be a primary goal in
resuscitation of any patient in shock. The coronary perfusion pressure (CPP) is calculated as
the change in pressure through the coronary artery for the maximum myocardial flow
(diastole). CPP = PAD - PAOP.
AIM. To Determinate the correlation between hemodynamic parameters such as CVP, CI,
PAOP and SvO2 and the treatment of shock on the CPP in the critically ill patients.
METHODS. A retrospective correlation study. We included all patients in a 6 month period
with Swan Ganz (SG) catheter. Were exclude those who have not been given any of the
variables for the calculating of CPP, with the data from the SG the CPP was calculated. The
statistical correlation of variables with CPP was assessed with a bivariate correlation (Pearson
Test), and ROC curve for discrimination of the test. A p value of less than 0.05 was con-
sidered to be statistically significant.
RESULTS. We studied 28 patients, 10 (64%) male patients and 18 (36%) women, the mean
APACHE II score was 19.6 ± 7.5; in the admission the mean CPP was 42.2 ± 10.8 mmHg,
and had a negative correlation con PAOP (p \ 0.001) and CVP (p = 0.001), regarding
mortality it had a negative correlation with the CPP at admission (P = 0.022) in a ROC curve
analysis the cutoff value for CPP for mortality was 42 mmHg with a sensibility of 100% and
specifity of 58% (p = 0.026 AUC 0.854). Also to the 24 h, the CVP and PAOP had a positive
correlation with mortality. (p = 0.016 and 0.026). To the 24 h, the CPP had a positive
correlation with PAOP (p = 0.015) but no with the mortality. There was negative correlation
between CPP and the use of inotropics and vasoactives but without significance.
CONCLUSION. It’s possible to estimate the CPP as a determinant of Reanimation as the
PAOP, SVO2, and CVP. In the same way, we can assess the impact of therapy in this setting,
We expect that a low value of CPP could guide the use of inotropic or vasoactives to
necessary values to try to keep an adequate perfusion, this may also determine an index of the
efficacy and/or impact of treatment on the management of critical care patient, However,
although these data are not conclusive and it could be the opportunity to study it in a deep
way.
REFERENCES. 1. Cheatham M. Calcu´los Hemodina´mic calculations.
http://www.surgicalcriticalcare.net/
2. Feigl EO (1989) Coronary autoregulation. J Hypertens 7(Suppl).
3. Nelson LD, Rutherford EJ. Principles of hemodynamic monitoring. In: Pinsky MR,
Dhainaut JF (eds).
4. CF Barrera-Ramı´rez y col (2005) Fisiologı´a coronaria y su utilidad para el cardio´logo
intervencionista: Medicio´n invasiva de la presio´n y flujo coronarios. Arch Cardiol Mex
75:335–343
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LEVOSIMENDAN AS SPARING EFFECT USING INOTROPE THERAPY
N. Agracheva1, A. Antipin1, L. F. Lorini1
1Ospedali Riuniti di Bergamo, Anestesia e Terapia Intensiva 2, Bergamo, Italy
INTRODUCTION. Acute Heart Failure is the main leading cause of complications in car-
diac surgery. The patients with Low Cardiac Output usually have to be treated with high doses
of catecholamines. However, the catecholamines have side-effects, which could affect on
postoperative survival rate. The process of apoptosis, initialized by catecholamines could
seriously compromise the myocardial function, therefore the medicine dose should be opti-
mized. The therapy with Levosimendan has myocardium sparing effect co signify high-dose
application of catecholamines. We studied the impact of Levosimendan on hemodynamic
characteristics, and the necessity of catecholamine support and the survival rate of patients in
this group.
METHODS. In this study participated 16 centers of cardiac surgery and were included 180
patients in the age of 40–85 years which underwent heart surgery. The medium Euroscore
was 22.3, the medium CI 1.92, medium rate of LVEF was 26.97%. The Levosimendan
infusion lasted 24 h with the estimation of cardiac activity data at the beginning of therapy, in
12 and in 24 h.
RESULTS. The medium dose of inotropes in the group of patients treated with Levosim-
endan was 0.042 mcg/kg/min. (DS 0.035, mediana 0.045 mcg/kg per minute) in the group
without treatment with Levosimendan the medium dose of inotrops was 0.063 mcg/kg per
minute (DS0.02, mediana 0.052 mcg/kg per minute). In the group of patients with Euroscore
rate more than 20, the mortality was significantly lower than predicted (19.5 vs. 40.14%, test
ANOVA p 0.44).
CONCLUSIONS. Levosimendan is a new cardiotonic drug which helps to decrease the risk
of many undesirable effects of catecholamines and allows to get advantages in the treatment
of patients with Low Cardiac Output syndrome.
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EFFECT OF PROPOFOL, MIDAZOLAM AND PENTOBARBITAL ON LEFT
VENTRICULAR FUNCTION IN MALE WISTAR RATS DURING NON-INVASIVE
HEART STUDIES
A. Meert1, R. Lauwers1, I. Hubloue1
1UZ Brussel, Emergency Department, Brussels, Belgium
INTRODUCTION. Transthoracic echocardiography (TTE) and pinhole gated SPECT are
essential tools for serial non-invasive evaluation of cardiac structure and function, in par-
ticular of left ventricular volume. The choice of anaesthetic used for immobilization of the
animal is of great importance since anaesthetic agents have different effects on haemody-
namic and functional cardiac parameters. The dose and the type of anaesthetic may influence
heart rate (beats per minute) and left ventricular (LV) function.
METHODS. Two different studies were performed using pinhole gated SPECT and TTE in
male Wistar rats.
For the TTE study 24 rats were anaesthetized. A linear probe was used for assessing M-mode
images and LV volumes (ml) were calculated using an ellipsoid model 10 min after
administration of anaesthesia. Pentobarbital (n = 8; 50 mg/kg) IP, Propofol (n = 8; 200 mg/
kg) IP and Midazolam (n = 8; 70 mg/kg) IP.
For the pinhole gated SPECT study 12 rats were scanned 2 times with 1 week interval. Once
under Pentobarbital (60 mg/kg IP) anesthesia for the control study and a second time using
the same anesthetics than the TTE study. Pinhole gated SPECT was performed 1 h after
intravenous injection of 330 MBq 99mTc-MIBI. Parameters of cardiac function were derived
using Quantitative gated SPECT.
STATISTICS. Data are expressed as mean ± SD. Differences in continuous variables were
calculated using a Student’s unpaired t test. P values were calculated two-tailed and differ-
ences were considered as significant if P \ 0.05.
RESULTS. Significant lower heart rates were observed in the Propofol (287 ± 23 bpm) and
the Midazolam (305 ± 17 bpm) group compared Pentobarbital in the TTE study but not in
the SPECT study. Although significant changes in EDV and ESV for Midazolam and propofol
resulted in better EF, CO decreased compared to Pentobarbital in both studies. Both studies
demonstrate that Midazolam seems to have a positive inotropic effect on the left ventricular
function (EF 85% in the SPECT study and 91% in the TTE study).
CONCLUSION. It was shown that cardiac function altered dramatically depending on the
anesthetic used. The effect of the anesthetics must be taken into account when investigating
cardiac function and volumes in small animals. Both studies demonstrate that Midazolam
seems to have a positive inotropic effect on the left ventricular function
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LOCAL THROMBOLYSIS IMPROVES RIGHT VENTRICULAR DYSFUNCTION
IN PULMONARY EMBOLISM
S. Alca´ntara Carmona1, L. Nombela Franco2, M. Pe´rez Redondo1, L. Martı´nez A´lvarez1, B.
Balandı´n Moreno1, A. Ortega Lo´pez1, M. Valdivia de la Fuente1, G. Va´zquez Grande1
1Hospital Puerta de Hierro, Intensive Care Unit, Madrid, Spain, 2Hospital Puerta de Hierro,
Cardiology, Madrid, Spain
OBJECTIVE. The role of thrombolysis in the management of pulmonary embolism (PE)
with right ventricular (RV) dysfunction and hemodynamic stability is controversial. Our aim
was to assess the value of local thrombolysis in the pulmonary artery associated with con-
ventional treatment, in a group of these patients, in order to reduce the chance of developing
future pulmonary hypertension.
METHODS. From January 2008 till March 2009, all patients with the following criteria were
included: (1) PE confirmed with helicoidal CT scan; (2) RV dysfunction assessed by at least
one of the following echocardiographic (ECO) findings: (a) subjective alteration of RV
contractility; (b) RV diameter in the apical four chamber view[40 mm; (c) tricuspid annular
plane systolic excursion (TAPSE) \15 mm; (d) tricuspid regurgitation (TR) with systolic
pulmonary artery pressure (SPAP) [30 mmHg; (3) hemodynamic stability (systolic arterial
pressure[90 mmHg). All underwent angiography and pulmonary artery catheterization with
measurement of pulmonary artery pressures (PAP) after diagnosis. Local thrombolysis with
urokinase (UK) (100.000–200.000 UI bolus and infusion of 100.000 UI/h) or alteplase (rtPA)
(10 mg bolus and infusion of 40 mg) was performed, combined with infusion of unfractioned
heparin to achieve APTT levels of 1.5–2 times control values. Control angiography was
performed after 48 h of infusion.
RESULTS. Ten patients fulfilled these criteria. Seven were males. Mean age was
55.7 ± 20 years. 70% had risk factors for PE (40% had undergone a prolonged immobili-
zation). Presenting symptoms were dyspnoea (80%) or syncope (30%). The initial systolic
arterial pressure was 124.1 ± 20.7 mmHg. All patients had thrombus occupying the main and
segmentary pulmonary arteries in the CT. In the ECO: 25% had severe RV dysfunction, 50%
moderate and 25% normal function. Mean RV diameter was 46.5 ± 3.6 mm; TAPSE (n = 7)
was 14.8 ± 4.2 mm; 25% had moderate TR, 25% mild and 50% had a normal function of the
tricuspid valve. Mean PAP was 35.4 ± 12.2 mmHg. Nine patients were treated with UK, with
a mean duration of thrombolytic infusion of 45.5 h (range 12 - 60 h). One received rtPA in a
4 h infusion. Improvement in the control angiography was found in 8/10 patients and in two
of them there was complete resolution of PE. The mean PAP was lowered to
30.7 ± 11.7 mmHg. Follow up ECO (first week) showed normal RV contraction in 80% of
the patients, and the other 20% had only a mild dysfunction. The RV diameter was reduced to
35.5 ± 8 mm; and the TAPSE (n = 9) increased to 22.6 ± 3.3 mm.
Complications: No severe complications were found. However, 40% had hematomas at
puncture site, and although platelets count and fibrinogen remained above 85.000 cel/mm3
and 100 mg/dL, respectively, in two patients treatment could not be completed due to
hematuria and sever acute hepatic dysfunction.
CONCLUSIONS. Local pulmonary artery thrombolysis in our patients was effective in
relieving RV strain.
0612
SHORT AND LONG TERM EFFECTS OF THROMBOLYSIS ON THE RIGHT
VENTRICLE (RV) DYSFUNCTION DURING ACUTE PULMONARY EMBOLISM
IN HEMODYNAMIC STABLE PATIENTS
O. Hamzaoui1, K. Ben Romdhane1, S. Sanouda1, H. Ghezala1, K. Belkhouja1, J. Ben Khelil1,
M. Besbes1
1Abderrahmen Mami Hospital, Intensive Care Unit, Ariana, Tunisia
INTRODUCTION. The RV dysfunction during acute pulmonary embolism (APE) seems to
be associated to increased mortality. Nevertheless, thrombolytic therapy in this group of
patients with cor pulmonale remains controversial and not well investigated. Therefore, we
aimed in this study to examine the effects of thrombolytic therapy in hemodynamically stable
patients, with APE and a core pulmonale.
PATIENTS AND METHODS. Patients admitted to our intensive care unit with a proven
APE (by angio CT scan) and presenting a core pulmonale were enrolled prospectively within
a period of 11 months (November 2007 to October 2008).We administered thrombolytic
therapy to all the patients and we recorded the following echocardiographic parameters : right
to left ventricle surface ratio (RVs/LVs), the left ventricular ejection fraction (LVEF), the
velocity–time integral (VTI) of the aortic flow, the systolic pulmonary artery pressure (sPAP),
tricuspid annular plane systolic excursion (TAPSE) and Peak systolic motion velocity (Sa)
determined by the tissue Doppler of the tricuspid annulus and the presence or not of para-
doxical motion of the interventicular septum. The echocardiographic examination was
performed before and 24 h after thrombolytic therapy. In addition, in a subgroup of patients
echocardiography was realised between one and 6 months of follow up.
RESULTS. We have enrolled 14 patients, among them 7 patients with known chronic
respiratory diseases, with a mean age of 54 ± 18 years and a mean IGSII of 28 ± 14. At
inclusion, the mean value of the mean arterial pressure was 73 ± 10 mmHg and the mean
value of blood lactates was 2.7 ± 0.7 mmol/L. Only one patient presented a non-fatal
bleeding complication (Psoas hematoma).The following Table 1 summarises the echocar-
diographic parameters before and 24 h after thrombolysis.






Right to left ventricle ratio RVs/
LVS
1.1 ± 0.4 0.8 ± 0.4 0.006
sPAP (mmHg) 53 ± 15 42 ± 12 0.0001
TAPSE (mm) 17 ± 5 20 ± 4 0.007
Sa (cm/s) 12 ± 2 13 ± 2 0.2
VTI (cm) 15.7 ± 3 16 ± 3 0.8
LVEF (%) 56 ± 7 59 ± 8 0.1
Septal paradoxical motion 14 3
During the follow up period (between 1 and 6 months), 5 patients had an echocardiographic
examination which confirmed the improvement of the RV function: RVs/LVs decreased from
0.6 ± 0.1 to 0.5 ± 0.006 the sPAP decreased from 35 ± 8 to 26 ± 7, the TAPSE and the Sa
remained stable.
CONCLUSION. Our results suggest that thrombolysis improves RV dysfunction after 24 h.
This effect seems to be not transient up to a 6-month period of follow up and this with no
fatal bleeding complications.
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ISSUE DOPPLER IMAGING VERSUS RADIONUCLIDE SCINTIGRAPHY IN
EVALUATION OF RIGHT VENTRICULAR MYOCARDIAL INFARCTION
R. Aly1, E. Sameh1, A. Andraos2, E. Ahmed3, B. Mohamed3, K. N. Hassan3
1Kasr Al Ainy Hospitals, Guiza, Egypt, 2Kasr Al Ainy University Hospital, Critical Care
Department, Guiza, Egypt, 3Kasr El Ainy, Guiza, Egypt
BACKGROUND. Right ventricular (RV) infarction is detected in 30–50% of inferior wall
myocardial infarction (MI). Early diagnosis of RV infarction complicating inferior wall MI
can reduce morbidity and mortality.
AIM OF THE WORK. The objective of our study is to assess the usefulness of tissue
Doppler imaging in evaluation of RVMI in patients (pts) with a first acute inferior MI in
comparison to First Pass Radionuclide Angiography (FPRNA) which is the gold standard
method. This is followed by a confirmative study by coronary angiography.
PATIENTS AND METHODS. Twenty-five pts with inferior wall MI as defined by elevated
cardiac markers, chest pain, and ECG evidence of inferior MI (elevated ST segment of
C1 mm in leads II, III, aVF) were subjected to full history, clinical examination, left 12-leads
ECG, right chest leads ECG, cardiac markers, TDI to measure myocardial performance index
(MPI) and maximum systolic velocity of the RV lateral annulus (Sm), first pass radionuclide
angiography (to measure RVEF) and coronary angiography to define the occluded vessel and
to localize the occlusion of RCA either before or after the RV branch.
RESULTS. Based on the nuclear study (FPRNA) our 25 pts were divided to Group I (GpI) 13
pts with RVEF C45% (57.38 ± 5.9) and Group II (GpII) 12 pts with RVEF \45%
(37.08 ± 3.2). In GpI, 12 pts TDI showed MPI \0.7 (0.48 ± 0.07) and Sm C12 cm/s
(13.89 ± 1.02 cm/s) and one pt. showed MPI C0.07 and Sm \ 12 cm/s. In Gp II, 10 pts TDI
exhibited MPI C0.7 and Sm\12 cm/s (0.81 ± 0.4 and 9.27 ± 1.7 cm/s, respectively) and 2
exhibited normal MPI and Sm (\0.7 and C12 cm/s, respectively). Based on the coronary
angiography our 25 pts were divided to Gp A (11 pts) in whom the acute occlusion was in the
RCA before the RV branch and Gp B (14 pts) in whom the acute occlusion was in coronary
vessel other than the RCA or in RCA after the RV branch. From Gp A, 10 pts (91%) showed
MPI C0.7 and Sm \12 cm/s and 1 showed normal MPI and Sm. From Gp B 13 pts (93%)
showed normal MPI and Sm while 1 showed MPI C0.7 and Sm \12 cm/s.
CONCLUSIONS. (1) There is a significant correlation between TDI and FPRNA in the
ability to detect RVMI by a sensitivity of 90.9% and specificity of 85.7% (P value 0.0001). (2)
There is a good correlation between the TDI and coronary angiography in the ability to detect
RVMI by sensitivity of 90.9% and specificity of 92.9% (P value 0.0001). (3) Compared to
FPRNA, TDI is considered a new, easy, bed side and less expensive technique in assessment
of RVEF.
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THE INCIDENCE AND THE PROGNOSTIC VALUE OF THE RIGHT VENTRICULAR
(RV) DYSFUNCTION IN PATIENTS SUFFERING FROM ACUTE EXACERBATION OF
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
K. Ben Romdhane1, O. Hamzaoui2, M. Ktari3, N. Khelil3, K. Belkhouja3, J. Ben Khelil3, M.
Besbes3
1Abderrahmen Mami Hospital, Intensive Care Unit, Ariana, Tunisia, 2Aberrahmen Mami
Hospital, Ariana, Tunisia, 3Abderrahmen Mami Hospital, Ariana, Tunisia
INTRODUCTION. The exacerbation of COPD still represent a major cause of mortality in
the intensive care units. Few studies focused on the incidence and the prognostic value of the
right ventricular dysfunction in this group of patients. Tricuspid annular plane systolic
excursion (TAPSE) and Peak systolic motion velocity (Sa) determined by the tissue Doppler
of the tricuspid annulus are simple echocardiographic measures which have already been
shown to be correlated to the systolic right ventricular function in COPD patients at their
baseline state. The diagnostic and the prognostic values of such parameters are still debated
during the acute exacerbation of COPD.
THE AIM OF THE STUDY. Determine the incidence and the prognostic value of the right
ventricular dysfunction in patients suffering from acute exacerbation of COPD.
PATIENTS AND METHODS. This is an observational study in which we included pro-
spectively within an 8 month period all the patients admitted in our ICU for exacerbation of
COPD. For all the patients, routine echocardiographic examination with standard projection
was done and we collected mainly the following parameters: the RV surface, the systolic
pulmonary artery pressure (sPAP), the inferior vena cava diameter, the TAPSE and the Sa.
We also collected the demographic data of the patients, their anterior diseases, the severity
scores (IGSII, APACHEII) and clinical data including the hemodynamic and the ventilatory
parameters. The association of variables with the main outcome was evaluated by a univariate
then a multivariate logistic regression survival analysis.
RESULTS. 83 patients were eligible for the study; mean age 67 ± 11 years, mean IGS II and
APACHE II were, respectively 39 ± 18 and 17 ± 9. Seventy-one patients (85.5%) had
echcardiographic signs of chronic pulmonary heart failure..All the patients needed a venti-
latory support, 49 of them (59%) were intubated. 9 patients (10.8%) were shocked. The right
to left ventricle surfaces ratio was 0.76 ± 0.26 and the mean sPAP was 50 ± 11 mmHg. The
incidence of the RV dysfunction was 34.9% (mean TAPSE value of 1.77 ± 0.57 mm, mean
Sa value of 13.4 ± 4.1 cm/s). There was no correlation between the sPAP and the TAPSE or
the Sa. Mortality rate was 34.9%. Endotracheal intubation (p = 0.000); Shock (p = 0.001);
RV dysfunction (p = 0.000); IGS II C39 (Se = 75%; Sp = 75%), APACHE II C 16.5
(Se = 75%; Sp = 58%), VTI \ 17 cm (Se = 82%; Sp = 75%), TAPSE \ 1.44 cm
(Se = 79%; Sp = 89%), and Sa \ 12.3 cm/s (Se = 75%; Sp = 71%) were associated, at the
univariate analysis, with an adverse outcome. At the multivariate analysis, only TAPSE
(OR = 13.7; [2.38–79.2]), IGSII (OR = 6.26; [1.32–29.6]) and VTI (OR = 5.29; [1.15–
24.18]) were associated to an adverse outcome.
CONCLUSION. The results of our study suggest that the RV dysfunction is frequent during
the exacerbation of COPD. The TAPSE as a parameter of RV systolic function is an inde-
pendent factor of mortality in addition to the VTI and the IGSII score.
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OUTCOMES, QUALITY-OF-LIFE AND INCIDENCE OF SYMPTOMS OF POST-
TRAUMATIC STRESS DISORDER, ANXIETY AND DEPRESSION IN PATIENTS
WITH FULMINANT MYOCARDITIS RESCUED BY EMERGENCY CIRCULA-
TORY SUPPORT
A. Combes1, M. Mirabel1, C. E. Luyt1, P. Leprince1, A. Nieszkowska1, J. L. Trouillet1, A.
Pavie1, J. Chastre1
1APHP Paris, Paris, France
INTRODUCTION. Fulminant myocarditis is a rare disease that can be fatal without
emergency circulatory support if refractory cardiogenic shock develops. Outcomes of these
acutely ill patients remain poorly studied.
PATIENTS AND METHODS. We analyzed short- and long-term outcomes of 35 patients
with fulminant myocarditis who received a mechanical circulatory assist device, e.g. ECMO
or a biVAD (Thoratec, Abiomed) in our unit. Quality of life was evaluated with the Short-
Form 36 questionnaire and symptoms of posttraumatic stress disorder (PTSD) and of anxiety
and depression screened with the Impact of Event Scale and the Hospital Anxiety and
Depression Scale, respectively.
RESULTS. ICU mortality was 34.3%. Independent predictors of ICU mortality were SAPS II
[56 and troponin [12 lg/ml at ICU admission. Three patients received a heart transplant.
Long term outcomes were evaluated in 19 patients (median follow-up, 888 days). Mean
LVEF was 50 ± 10%. SF-36 scores were significantly lower for myocarditis patients com-
pared to that of matched healthy controls for physical role, general health, vitality and social
functioning, but higher than those reported for patients suffering from chronic diseases.
Symptoms of PTSD and of anxiety and depression were reported by 10 and 30% of the long-
term survivors, respectively.
CONCLUSION. Mechanical circulatory assistance can rescue [65% of otherwise fatal
refractory cardiogenic shock due to fulminant myocarditis. Long term prognosis is favorable,
despite persistent physical and social problems and a low incidence of symptoms of PTSD,




THROMBELASTOGRAPHY AND PLATELET FUNCTION ASSAY IN CIRRHOSIS
AND SEPSIS
A. Umgelter1, G. Mo¨ßmer2, R. M. Schmid1, B. Kreymann1
1Technical University Munich, 2nd Medical Department, Munich, Germany, 2Technical
University Munich, Institute of Clinical Chemistry and Pathobiochemistry, Munich, Germany
INTRODUCTION. Commonly measured global plasmatic parameters of coagulation fail to
adequately reflect the hemorrhagic diathesis of cirrhotic patients. In addition, liver function,
infection and coagulation are closely connected and sepsis may cause a further deterioration
of hemostasis. Whereas thrombelastography has been used in the perioperative setting of liver
transplantation, data on cirrhotic ICU patients are scarce.
OBJECTIVES. To evaluate rotational thrombelastometry (ROTEM) and Platelet Function
Analyzer (PFA 100) in cirrhotic ICU patients.
METHODS. 64 patients [20 non-septic and non-cirrhotic patients as controls; 44 ICU
patients with cirrhosis and no sepsis (n = 23), sepsis but no cirrhosis (n = 7) and cirrhotics
with severe sepsis/septic shock (n = 14)] were evaluated using standard laboratory param-
eters, rotational thrombelastometry (ROTEM) and the Platelet Function Analyzer (PFA 100).
RESULTS. Comparing non-septic cirrhotic patients to non-septic non-cirrhotic patients,
MELD-score [15 (11–20) vs. 6 (6–7); p \ 0.001], INR [1.3 (1.2–1.6) vs. 0.9 (0.9–1.0);
p \ 0.001] and thrombin-time (TT) [17 s (16–19) vs. 15 s (14–16); p \ 0.001] were larger in
cirrhotics. D-dimers were increased [622 lg/L (301–851) vs. 219 lg/L (107–350);
p = 0.003]; FVII [36% (23–53) vs. 104% (90–118); p\ 0.001] and AT [49% (32–64) vs.
100% (90–118); p \ 0.001] were decreased. Thrombocyte counts (TC) were also lower in
cirrhotic [96G/L (57–166) vs. 350G/L (267–392); p\0.001]. PFA (epinephrine) [177 s (110–
258) vs. 104 s (91–112); p = 0.001] but not PFA (ADP) was impaired. INTEM clot for-
mation time (CFT) [96 s (53–154) vs. 52 s (41–76); p = 0.003] and mean clot firmness
(MCF) [51 mm (44 vs. 64) vs. 67 mm (60–70); p \ 0.001] were impaired, but not clotting
time (CT).
Among cirrhotic patients, sepsis was associated with higher readings of the endotoxin activity
assay (EAA) [0.556 (0.402–0.683) vs. 0.416 (0.346–0.463); p = 0.021] and higher values for
procalcitonin (PCT) [4.1 ng/ml (1.4–8.2) vs. 0.2 ng/ml (0.2–1.7); p \ 0.001] and IL-6 [90 pg/
ml (40.3–123.2) vs. 29.3 pg/ml (4.2–157.8); p = 0.074].
TT [19 s (18–60) vs. 17 s (16–19); p = 0.021] was prolonged in septic cirrhotic, whereas
there were no differences in d-dimers, antithrombin or TC. There were no differences in PFA
(epinephrine), PFA (ADP) or INTEM-CT, -CFT or -MCF between septic and non-septic
cirrhotics.
Among cirrhotic patients we found correlations between PFA (ADP)—but not PFA (epi)—
and TC (r = -0.373; p = 0.043), INTEM-CFT (r = -0.745; p \ 0.001) and MCF
(r = 0.727; p \ 0.001). INTEM-CT was correlated with EAA (r = 0.379; p = 0.030) and
PCT (r = 0.452; p = 0.009), INTEM-CFT was correlated with TC (r = 0.745; p \ 0.001),
INR (r = -0.352; p = 0.045) and PFA (ADP) (r = 0.373; p = 0.043).
CONCLUSIONS. ROTEM and the PFA 100 assay may be useful for the assessment of
cirrhotic coagulopathy. Whereas results of PFA and ROTEM differed between cirrhotic and
non-cirrhotic patients, neither method discriminated between septic and non-septic cirrhotic
patients.
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EVOLUTION IN COAGULATION PARAMETERS OVER THE FIRST 3 DAYS OF
ICU ADMISSION IN SEPTIC SHOCK PATIENTS: IMPACT ON 30 DAY
MORTALITY
M. Bekaert1, J. Nollet2, P. Depuydt2, J. Decruyenaere2, J. Dewaele2, C. Danneels2, S. Van-
steelandt1, D. Benoit2
1Ghent University, Applied Mathematics and Computer Sciences, Ghent, Belgium, 2Ghent
University Hospital, Department of Intensive Care Medicine, Ghent, Belgium
INTRODUCTION. Readily available coagulation parameters, and more particularly the
evolution of these parameters within the 24 h of ICU admission, have been found to be of
prognostic importance in severe sepsis and septic shock patients. The aim of this study was to
assess whether the evolution of these parameters within the first 3 days of admission remains
of prognostic importance in septic shock patients.
MATERIAL AND METHODS. Variables were retrieved from a large computerized data-
base including all consecutive patients admitted to the Ghent University hospital surgical
(2004–2008) and medical (2006–2008) ICU. All patients requiring [100 ng/kg per minute
norepinephrine in combination with antibiotic therapy for [48 h were included. The impact
of routine laboratory variables reflecting organ (dys)function on 30 day mortality was
assessed by multiple logistic regression analysis in SAS. Three models were built : one
including coagulation parameters [prothrombine time (PT), activated partial thromboplastin
time (aPTT), fibrinogen, and platelets] only, a second additionally including indicators of
renal function and inflammation (ureum, creatinine, C-reactive protein, leucocyte count and
Hgb) and a third additionally including important interventions (mechanical ventilation, fluid
balance and hemodialysis) and age. Evolutions in parameters were modeled trough differ-
ences between consecutive days. All continuous variables had a linear relationship with the
outcome. Area under the receiver characteristic curve (AUC) and the Hosmer–Lemeshow test
(HL-test, p value) were calculated for each model.
RESULTS. 30 day-mortality rates in the total cohort (n = 406), in patients requiring ven-
tilation (n = 372), dialysis (n = 107) or both (n = 98) were 33.7, 36.8, 46.7 and 51%,
respectively. Low PT (%) levels on admission, absence in recovery of PT and fibrinogen
within the first 3 days and a low platelet count on day 3 were independently associated with
mortality in all 3 models (p \ 0.05). The protective effect of the fibrinogen increase within
the first 3 days was attenuated in patients with a concomitant increase in creatinine levels
(interaction term p = 0.04). Creatinine by itself and other indicators of renal failure (urea,
dialysis) were not informative as long as the coagulation parameters remained in the model.
The AUC and the HL-test for the model containing coagulation parameters only and for the
final model additionally adjusted for age (p = 0.005), mechanical ventilation (p = 0.003) and
leucocyte count (p = 0.02) were 0.71 and p = 0.37, and 0.80 and p = 0.90, respectively.
CONCLUSION. Low PT and platelet levels upon admission and on day 3, respectively, and
more particularly the absence in recovery of PT and fibrinogen within the first 3 days of
admission are important independent predictors of 30 day mortality in septic shock patients
and are more informative than variables reflecting renal function within this period.
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RELATIONSHIP BETWEEN ACUTE-PHASE DIC DIAGNOSIS OF JAAM (JAPA-
NESE ASSOCIATION FOR ACUTE MEDICINE) AND SEPSIS RELATED
FACTORS
Y. Sakamoto1, K. Mashiko1, T. Obata2, H. Matsumoto1, Y. Hara1, N. Kutsukata1, N. Saito1,
H. Yokota3
1Chiba Hokusoh Hospital, Nippon Medical School, Department of Emergency and Critical
Care Medicine, Chiba, Japan, 2Microbial Chemistry Research Foundation, Tokyo, Japan,
3Nippon Medical School, Emergency Medicine, Tokyo, Japan
INTRODUCTION. The Japanese Association for Acute Medicine (JAAM) published their
diagnostic criteria for acute-phase disseminated intravascular coagulation (DIC) in 2005 [1].
Recently, new sepsis-related factors, such as high-mobility group box protein 1 (HMGB1) [2]
and endocannabinoids (N-arachidonoylethanolamine [AEA] and 2-arachidonoyl glycerol [2-
AG]), have been reported [3]. Interleukin-6 (IL-6) is a common inflammatory cytokine.
Meanwhile, plasminogen activator inhibitor (PAI-1) and protein C are important coagulation
factors reportedly involved in the coagulation cascade in sepsis. The relations between the
JAAM diagnostic criteria of acute-phase DIC and these sepsis-related markers has not been
previously reported.
OBJECTIVE AND METHODS. A retrospective analysis was performed in 44 patients with
septic shock who were admitted to our intensive care unit between 2005 and 2008. The
patients were separated into two groups: a DIC group (34 cases), in which the patients were
diagnosed according to the JAMM criteria for DIC, and a non-DIC group (10 cases). In
addition, the levels of several sepsis-related factors (HMGB1, AEA, 2-AG, IL-6, PAI-1 and
protein C) were measured. The severity scores and the levels of the sepsis-related factors were
then compared between the two groups.
RESULTS. The average Acute Physiology and Chronic Health Evaluation (APACHE) II
score (DIC group, 28.8 ± 7.8; non DIC group, 21.8 ± 9.0; p = 0.0202) and the average
sepsis-related organ failure assessment (SOFA) score (DIC group, 12.6 ± 4.9;. non-DIC
group, 8.7 ± 2.1; p = 0.0176) differed significantly between the two groups. Furthermore,
the protein C level of the DIC group (30.9 ± 13.0%) was significantly lower than that of the
non-DIC group (56.3 ± 45.6%) (p = 0.0097). However, the levels of the other sepsis-specific
factors (PAI-1: 155.6 ± 57.7 ng/mL in DIC group and 141.3 ± 69.5 ng/mL in non-DIC
group; IL-6: 13912.6 ± 24018.2 pg/mL and 8453.6 ± 12090.7 pg/mL; HMGB-1:
14.7 ± 18.7 ng/mL and 5.3 ± 6.4 ng/mL; AEA: 544.4 ± 698.6 pg/mL and
557.9 ± 444.3 pg/mL; and 2-AG: 15.1 ± 28.4 ng/mL and 10.6 ± 8.4 ng/mL) were not
significantly different between the two groups.
CONCLUSION. Activated protein C treatment might be useful for the treatment of septic
shock, as a significant correlation was observed between the protein C level (indicating the
extent of coagulation disorder) and a diagnosis of DIC according to the JAAM criteria. A
diagnosis of DIC according to the JAAM criteria seems to be a useful indicator of severe
septic shock and coagulation disorder.
REFERENCE. 1. Gando S et al (2006) A multicenter validation of disseminated intravas-
cular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit
Care 34:625–631.
2. Klune JR et al (2008) HMGB-1: endogenous danger signaling. Mol Med 14:476–484. 3.
Maccarrone M et al (2002) Endocannabinoid degradation, endotoxic shock and inflammation.
Curr Drug Targets Inflamm Allergy 1:53–63
0619
RETROSPECTIVE ANALYSIS OF ANTITHROMBIN III SUPPLEMENTATION
THERAPY EFFECTIVENESS IN SEPSIS CASES
Y. Sakamoto1, K. Mashiko1, H. Matsumoto1, H. Yokota2
1Chiba Hokusoh Hospital, Nippon Medical School, Dept. of Emergency and Critical Care
Medicine, Chiba, Japan, 2Nippon Medical School, Emergency Medicine, Tokyo, Japan
INTRODUCTION. Although controversial, early antithrombin III (AT-III) treatment after a
diagnosis of septic disseminated intravascular coagulation (DIC) according to the Japanese
Association for Acute Medicine (JAAM) criteria [1] seems to be an effective strategy for
managing septic DIC. We analyzed the outcomes of a large number of patients with sepsis
who were or were not treated with AT-III.
OBJECTIVE AND METHODS. A retrospective analysis was performed in 88 sepsis
patients who had been admitted to our intensive care unit between January 2000 and
December 2008. The patients were separated into two groups for analysis: an AT-III group
(34 cases), in which the patients were treated with AT-III, and a non-AT-III group (54 cases),
in which AT-III treatment was not administered. In addition, a sub-group analysis was per-
formed in 52 septic patients diagnosed as having DIC according to the JAMM criteria.
RESULTS. The average Acute Physiology and Chronic Health Evaluation (APACHE) II
score (AT-III group, 25.5 ± 8.6; non-AT-III group, 23.1 ± 9.5) and the average sepsis-
related organ failure assessment (SOFA) score (AT-III group, 11.0 ± 4.0;. non-AT-III group,
11.1 ± 4 0.8) were not significantly different between the two groups. The overall survival
rate was 54.5% (a good outcome, judging by the APACHE II score), and the outcome was
significantly related to the APACHE II score, the SOFA score, and a diagnosis of septic DIC
according to the JAAM criteria (p = 0.0137). The outcome of the AT-III group was sig-
nificantly better than that of the non AT-III group (p = 0.0066) (Fig. 1-1). Among the DIC
cases, the survival rate of the AT-III group (25 cases) was significantly better than that of the
non-AT-III group (27 cases) (p = 0.0031) (Fig. 1-2).
Figure 1-1,2
Figure 1-1,2
CONCLUSION. Antithrombin-III supplementation therapy is effective for the treatment of
sepsis and the JAAM criteria for DIC seem to be useful for evaluating the severity of sepsis.
REFERENCE. 1. Gando S, Iba T, Eguchi Y et al (2006) A multicenter validation of dis-
seminated intravascular coagulation diagnostic criteria for critically ill patients: comparing
current criteria. Crit Care 34:625–631
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PREVENTION OF VENOUS THROMBOEMBOLISM IN CRITICAL CARE
PATIENTS WITH MULTIORGANIC FAILURE: ARE WE USING APPROPRIATE
DOSAGE?
R. Ortiz Diaz-Miguel1, M. Sanchez Casado1, A. Pedrosa Guerrero1, V. Hortigu¨ela Martin1,
D. Palacios Castan˜eda1, A. De la Torre Mun˜oz1, M. Quintana2
1Hospital Virgen de la Salud, Toledo, Spain, 2Hospital La Paz, Madrid, Spain
INTRODUCTION AND OBJECTIVES. Critically ill patients present a marked tendency to
thromboembolic disease, which condition an accurate antithrombotic profilaxis. Low-
molecular-weight heparins (LMWHs) are first choice in this profilaxis. Our aim is to evaluate
the LMWH profilactic efficiency, by determining of antifactor Xa activity, in the thrombo-
embolic disease in patients with malfunction of 2 or more organs.
Methods. All adult patients with 2 or more organ failure admitted in ICU with no exclusion
criteria: anuric renal failure, dialysis indications, administering of oral anticoagulants 7 days
prior to admission, unfractionated heparin or LMWH, pregnancy or thrombocytopenia on
admission. Daily monitoring during the first 7 days of the peak and though levels of the
activity level of antifactor Xa. Enoxaparine at dose of 40 mg/day subcutaneously was used (if
clearance \ 30 ml/min, 20mgr). Daily measurement of creatinine clearance, SOFA score,
seric creatinine, coagulation, hemoglobin, platelets, antithrombin III, arterial blood lactate,
hidric balance and complications were recorded.
RESULTS. 11 patients were included in the study. To evaluate antifactorXa activity, peak
and though levels were determined on days 2, 3, 5, and 7 of treatment. Nearly all though
levels (97.7%) have a value of 0 U/ml. The average peak levels were 0.01 ± 0.96 UI/ml,
0.19 ± 0.15 U/ml, 0.19 ± 0.25 and 0.30 ± 0.20 UI/ml without statistical significance. Only
the progression of antithrombim showed statistical change (p \ 0.05). No significant differ-
ences were found between levels of antifactor Xa along progression (dead/alive), neither in
the presence of hidric balance positive or negative nor in the use of vasoactive drugs.
CONCLUSIONS. During the first 7 days of treatment it has been observed an insufficient
level of antifactor Xa activity which, although progressibly increasing by day, 7 day remained
insufficient in 38% of cases. This group of critically ill patients should be studied as a
different in a different perspective and evaluate practical implications of these results.
REFERENCES. 1. Hilbert P, Teumer P, Stuttmann R (2008) Prevention of thromboembo-
lism in German intensive care units: results of a nationwide survey. Anaesthesist. 57(3):242–
50. 2. Muscedere JG, Heyland DK, Cook D (2007) Venous thromboembolism in critical
illness in a community intensive care unit. J Crit Care 22(4):285–289. 3. Geerts WH, Berquist
D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous throm-
boembolism. Chest 133:381S–453S
22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009 S161
0621
ARTERIAL AND VENOUS THROMBOEMBOLIC COMPLICATIONS IN HEPA-
RIN-INDUCED THROMBOCYTOPENIA (HIT) PATIENTS: COLOR DOPPLER
SCANNING EVALUATION
M. Theodorakopoulou1, A. Balanika2, F. Frantzeskaki1, M. Lignos1, P. Kopterides1,
C. Baltas2, E. Melissari3, A. Gouliamos2, I. Dimopoulou1, A. Armaganidis1
12nd Intensive Care Unit Department, ‘‘Attikon’’ University Hospital, Athens, Greece, 22nd
Radiology Department, ‘‘Attikon’’ University Hospital, Athens, Greece, 3Hematology
Department ‘‘Onassio’’ Cardiothoracic Center, Athens, Greece
INTRODUCTION. Heparin-induced Thrombocytopenia (HIT) is estimated to occur in 1–5%
of all patients receiving heparin. The purpose of this study was to investigate by color Doppler
ultrasonography (CDUS) the incidence of thromboembolic complications in medical critically
ill patients with HIT.
METHODS. Over a period of 2 years 78 Intensive Care Unit patients (aged 39–89) that
presented thrombocytopenia were investigated for HIT and underwent arterial and venous
CDUS examination of lower limbs (156 legs). HIT was proven by a positive platelet
aggregation test in 29 patients. Orthopedic, surgical and cardio surgical patients were not
included in the study. We evaluated artery lumen and vein diameter using B-mode and
compression ultrasonography. Flow spectra were evaluated with Doppler scan mode and flow
parameters were calculated for the femoral, popliteal and calf arteries and veins.
RESULTS. The HIT group consisted of 17 females and 12 male patients. Twenty-nine
patients (37%) suffered lower extremities thromboembolic complications. Nineteen patients
(65%) had arterial thrombosis, most prominent of the common femoral, superficial femoral
and posterior/anterior tibial artery. Eight subjects (27%) had deep venous thrombosis, most
prominent of the common femoral and superficial femoral vein.
CONCLUSION. Our study confirmed the remarkably high incidence of thromboembolic
complications, mostly arterial, in critically ill patients with HIT. The routine CDUS of the
lower limb arteries and veins is the faster, very safe, non-invasive radiological procedure
which gives optimal information for the urgent treatment of these patients.
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FIBRINOLYSIS SYSTEM, MONITORED BY THROMBOELASTOGRAPHY (TEG)
AND PAI-1 ACTIVITY, IN SEPTIC PATIENTS UNDERGOING TIGHT GLYCEMIC
CONTROL
S. M. Raineri1, L. Cangemi1, A. Cortegiani1, N. D. Cascio1, G. Mineo1, G. Evangelico1,
A. Giarratano1
1University of Palermo, Anesthesiology and Intensive Care, Palermo, Italy
INTRODUCTION. Hyperglicemia is associated with profound suppression of fibrinolysis,
due to elevated levels of the fibrinolytic inhibitor, PAI-1. It has become evident that the fat-
laden insulin-resistant adipocyte generates PAI-1, strengthening the link between diabetes and
suppression of fibrinolysis. Same studies, involving critically ill patients, intensive insulin
therapy to maintain euglycemia (glucose level, 80–110 mg/dl) lowered in-hospital mortality
mostly by reducing deaths from multiple organ failure. But the risks and benefits of tightly
regulated glucose in different ICU populations was an area of intense investigation yielding
conflicting results. Our aim was to evaluate the fibrinolytic system in septic patients under-
going conventional (\180 mg/dl) or Tight Glycemic Control (TGC) (\120 mg/dl)
METHODS. Actually we enrolled 16 severe sepsis and septic shock patients, without history
of tipe-1 diabetes, admitted in our ICU more than 48 h, randomized to either conventional or
TGC groups. Plasma levels biochemical markers for fibrinolysis and coagulation and TEG
were determined every day for 2 weeks and then on study days 17, 20, 23, and 28. Clinical
data and sepsis-related organ failure assessment (SOFA) scores were also recorded.
RESULTS. The two groups had similar characteristics at baseline. A total of three patients
(37.5%) in the TGC group and four (50%) in the conventional group died. Severe hypo-
glycemia (blood glucose level, \ or = 40 mg/dl) was reported in 1 of 8 patients (12.5%) in
the TGC group and none in the conventional group patients. Table 1 shows the fibrinolytic
and the coagulation assay monitored by TEG.
DISCUSSION. A small enhancement of fibrinolysis could be observed in the TGC group, as
indicated by the Ly30 and Ly60 and PAI-1. Morbidity, rated with the Sepsis-related Organ
Failure Assessment score, was lower in the TGC group.
CONCLUSION. Intravascular and extravascular fibrin formation are characteristic findings
in patients with sepsis, suggesting that the activation of coagulation and the inhibition of
fibrinolysis are important in the pathogenesis of sepsis. In this context, tight glycemic control
seems to reduce the fibrinolytic impairment and morbidity (Table 1)
TABLE 1 COAGULATION STATUS. MEAN (SD)
Baseline Conventional Baseline TGC
Day 7 Day 14 Day 7 Day 14
r (min) 4.3 (1.4) 5.1 (1.6) 5.9 (0.8) 4.8 (1.8) 5.5 (1.3) 6.1 (1.3)
MA (mm) 59 (12) 64 (9) 47 (13) 53 (8) 59 (10) 44 (14)
Ly 30 (%) 3.6 (1.2) 2.9 (1.6) 1.6 (0.8) 3.2 (1.9) 3.6 (1.6) 3.9 (1.2)
PAI-1 (U/ml) 2.5 (0.4) 3.5 (1.1) 5.2 (1.3) 3.1 (0.6) 3.4 (0.9) 2.9 (1.1)
AT III (%) 65 (9) 78 (10) 75 (9) 48 (10) 77 (13) 81 (11)
PC (%) 54 (7) 81 (8) 88 (7) 52 (6) 79 (9) 75 (15)
SOFA 6.2 (0.9) 5.3 (1.4) 5.4 (1.7) 5.2 (1.9) 4.6 (1.5) 4.3 (1.4)
REFERENCE. Finfer S et al (2009) Intensive vs. conventional glucose control in critically ill
patients. N Eng J Med 360:1283–1297.
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ROTATIONAL THROMBELASTOMETRY TO ASSESS THE COAGULATION
SYSTEM IN SEVERE SEPSIS AND THE SYSTEMIC INFLAMMATORY
RESPONSE SYNDROME: A PROSPECTIVE, CONTROLLED TRIAL
C. A. Schmittinger1, M. W. Du¨nser2, C. Torgersen1, W. R. Hasibeder3, G. Luckner1,
V. Mayr1, S. Jochberger1
1Medical University Innsbruck, Anesthesiology and Critical Care Medicine, Innsbruck,
Austria, 2Inselspital Bern, Intensive Care Medicine, Bern, Switzerland, 3Krankenhaus Ried,
Anesthesiology and Critical Care Medicine, Ried im Innkreis, Austria
INTRODUCTION. Few data on the course of rotational thrombelastometry (RoTEM) results
in patients with severe sepsis and postoperative SIRS have been reported.
OBJECTIVE. To describe RoTEM results in patients with infection, severe sepsis, with or
without postoperative SIRS and to define the incidence of hyper- and hypocoagulation and its
association with mortality.
METHODS. Patients presenting with either severe sepsis (n = 49) or postoperative SIRS
(n = 27) were included. Patients with infection but no systemic inflammation (n = 10) and patients
after non-cardiac surgery without SIRS (n = 10) served as controls. Age\19 years, cardiac sur-
gery, massive transfusion, discharge from the intensive care unit (ICU) or hospital before day 7,
central nervous pathology or pregnancy were exclusion criteria. RoTEM and standard coagulation
tests were performed within 36 h after ICU admission, on day 4 and 7. Hyper- and hypocoagulation
were defined as deviations above and below reference ranges for RoTEM analyses (3). Descriptive
methods, student’s t tests and mixed effects models were used for statistical analysis.
RESULTS. Mean values of RoTEM analyses were within reference ranges in all study and
control groups. However, results were extremely heterogeneous showing signs of hypercoag-
ulation in*50% (severe sepsis), 70–75% (infection), 20–50% (SIRS) and 20–60% (no SIRS) of
patients. Hypercoagulation resulted from an increase in the maximum clot firmness (MCF) in
69.3%, a combined MCF increase and shortening of the coagulation (CT) or the clot formation
time (CFT) in 26.8%, and an isolated shortening of the CT/CFT in 3.9% of patients. Hypoco-
agulation was detected in one-third (severe sepsis, SIRS, no SIRS) and 10–50% (infection) of
patients. Mixed coagulation disorders and RoTEM results within reference ranges were found in
10–20% and in one-third of patients in all groups. During the study period, patients with
infection showed a shorter CFT (p = 0.02) and higher MCF (p = 0.01) than patients with severe
sepsis. Patients without SIRS had a shorter CT (p \ 0.001) than patients with SIRS. RoTEM
variables significantly correlated with organ dysfunction (direct correlation for CT and CFT,
indirect correlation for MCF; all p \ 0.001). Changes in RoTEM results over time were asso-
ciated with different 28 day mortality (p \ 0.001). Mortality was lowest in patients in whom
RoTEM results normalized (0%) or signs of hypercoagulation developed (9.1%) and highest in
those presenting with hypocoagulation throughout the study period (58.3%).
CONCLUSIONS. Coagulation disturbances in severe sepsis and SIRS are extremely heter-
ogeneous. Hypercoagulation is most frequent in patients without systemic inflammation and
associated with low mortality. Patients with hypocoagulation appear to have the highest
mortality.
REFERENCES. 1. Lang T, Bauters A, Braun SL et al (2005) Multi-centre investigation on
reference ranges for ROTEM thrombelastometry. Blood Coagul Fibrinolysis 16:301–310
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DOES ACTIVATED PROTEIN C INFLUENCE THE COAGULATION SYSTEM
ASSESSED BY THE ROTATIVE THROMBOELASTOMETRY ANALYSIS
F. Chiairi1, B. Ickx2, L. Barvais2, J.-L. Vincent2, M. Piagnerelli1
1Erasme University Hospital, Department of Intensive Care, Brussels, Belgium, 2Erasme
University Hospital, Department of Anesthesiology, Brussels, Belgium
INTRODUCTION. Activated Protein C (aPC)-treated patients demonstrated antithrombotic
(reduced markers of thrombin generation and accelerated normalization of anticoagulant
factor, protein C and fibrinolytic factors) and anticoagulant effects (prolonged PT and APTT)
[1]. Thromboelastometry (RoTEM) is a whole blood assay allowing to evaluate the visco-
elastic properties during blood clot formation and lysis. The aim of this study was to use the
RoTEM measurements to assess the effects of aPC treatment.
METHODS. In 15 patients with severe sepsis, we performed RoTEM measurements (Intem
and Extem) and measured PT, APTT, fibrinogen, D-dimers and platelet count before and on
the first day of treatment with aPC. RoTEM parameters included coagulation time (CT),
kinetics of clot formation (CFT) and clot firmness (angle a), maximum clot firmness (MCF)
and maximum clot lysis (ML). All variables were analyzed with SSPS statistical program and
compared by a Student’s T-test. A p value \0.05 was considered as significant.
RESULTS. Only the CT Intem increased significantly, reflecting the significant prolongation
of APTT increase with aPC treatment (44[32–48] to 56 [41–76] s, p \ 0.001).
CONCLUSIONS. RoTEM gives no additional information on the coagulation during aPC
treatment for severe sepsis (Table 1)
TABLE 1
INTEM EXTEM
Before aPC After aPC Before aPC After aPC
CT (s) 174 [150–187] 216 [204–230]* 78 [68–153] 98 [69–245]
CFT (s) 65 [50–127] 57 [48–161] 68 [51–118] 69 [62–167]
Angle a () 78 [71–81] 78 [66–81] 77 [68–80] 78 [66–81]
MCF (mm) 66 [63–74] 68 [50–75] 67 [64–75] 69 [47–77]
ML (%) 11[8–12] 11 [6–13] 13 [9–18] 11 [6–13]
* p = 0.004
REFERENCES. 1. Dhainaut et al (2003) Thromb Haemost 90:642–653
S162 22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009
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RECOVERY FROM THROMBOCYTOPENIA AFTER REMOVAL OF PULMON-
ARY ARTERY CATHETER
C. R. Barends1, M. W. Nijsten2, I. C. van der Horst3, F. Ismael2
1University Medical Center Groningen, Anesthesiology, Groningen, Netherlands, 2University
Medical Center Groningen, Critical Care, Groningen, Netherlands, 3University Medical
Center Groningen, Cardiology, Groningen, Netherlands
INTRODUCTION. Thrombocytopenia is a common complication in critically ill patients.
We frequently noted that platelet counts in thrombocytopenic patients with pulmonary artery
catheters (PAC) recover faster after removal of the PAC. Literature on this subject is scarce
[1, 2] and analysis of this phenomenon is compounded by the wide spectrum of causes of
thrombocytopenia.
OBJECTIVES. To analyse the quantitative impact of removal of a PAC on platelet counts.
METHODS. From January 2007 up to June 2008 all patients from the Thoracic Intensive
Care Unit who were monitored with a PAC for more than 3 days were included. The platelet
counts (reference range 150–300 109/L) for these patients were recorded. We studied the
period that the PAC was in situ and a period of at least 3 days after removal of the PAC. The
day-to-day difference in platelet counts (DPC; expressed in 109/L per day) was determined.
RESULTS. In total 52 patients were identified. 43 had thrombocytopenia on the day of
removal of the PAC In 13 patients the nadir of the platelet count occurred 3 or more days
before the removal of the PAC. Three patients did not display thrombocytopenia during their
entire stay.
As expected, mean DPC before PAC removal was significantly lower than mean (±SD) DPC
after removal -3.9 ± 18.2 versus 24.5 ± 24.3 109/L per day, respectively (p \ 0.0001).
It was also observed that for the 13 patients whose platelet count nadir occurred 3 or more
days before removal of PAC the mean DPC before removal was positive but significantly
lower than mean DPC after removal (15.0 ± 10.4 vs. 41.1 ± 24.8 109/L per day, respec-
tively; p = 0.003). This indicates a faster rise in platelet counts after removal of the PAC.
After PAC removal there was no significant difference in DPC between this subgroup and the
main group.
CONCLUSIONS. In the majority of patients with a PAC, platelet counts tended to decrease
until removal of PAC. In those patients who did display a rise in platelet counts before
removal of PAC, recovery of the platelet count was lower with a PAC in situ than post
removal. These data suggest that in thrombocytopenic patients timely removal of a PAC
should be considered as a measure to improve recovery of platelet counts. More research on
this subject is warranted.
REFERENCE(S). 1. Laster J, Silver D (1988) Heparin-coated catheters and heparin-induced
thrombocytopenia. J Vasc Surg 7:667–672.
2. Vicente Rull JR, Loza Aguirre J (1984) Thrombocytopenia induced by pulmonary artery
flotation catheters. A prospective study. Intensive Care Med 10:29–31
GRANT ACKNOWLEDGEMENT. None.
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PULMONARY COAGULOPATHY IN PEDIATRIC ALI/ARDS
R. Samransamruajkit1, C. Thongnuan1, S. Sritippayawan1, J. Deerodejanawong2, N.
Prapphal2
1Chulalongkorn University, Pediatrics, Bangkok, Thailand, 2Chulalongkorn University,
Bangkok, Thailand
BACKGROUND AND OBJECTIVES. ALI/ARDS are the major causes of respiratory
failure, morbidity and mortality among children in pediatric intensive care units (PICUs)
worldwide. Prior works have shown disordered of inflammation and coagulation in ALI/
ARDS. Activated protein C (PC) is a critical endogenous regulator of coagulation and
inflammation in patients with ALI/ARDS. However, the role of PC in pediatric ALI/ARDS is
still obscure. The aim of this study was to investigate the association between PC activity,
coagulogram and clinical outcomes.
DESIGN. Prospective, Descriptive study.
METHODS. Infants and children (age 1 month–16 years, July 2007–December 2008) who
were admitted to PICU with clinical and laboratory diagnosis of ALI/ARDS. Clinical data
were recorded and blood samples kept for further analysis. We then measured the initial basic
coagulogram, the levels of PC activity and protein S antigen (PS).
RESULT. 27 patients were included, mean age was at 6.4 ± 5.17 years, 17 were male (63%)
and 10 were female. 15(55%) were survivors and 12(45%) were non-survivors. Basic coag-
ulogram, e.g. Platelets, PT and PTT were significantly different between survivors and
nonsurvivors (P = 0.01, 0.025, 0.01).The mean plasma PC activity (%) was 72.0 ± 27.6. The
mean plasma PS antigen was 58.52 ± 29.85. There was significantly higher plasma PC
activity in patients who age [8 year than lower age group (P = 0.03). Both plasma PC
activities, PS antigen children with ALI/ARDS were lower than normal children. Plasma PC
activity and protein S antigen (PS) levels were not significant different between the survivors
and nonsurvivors (P = 0.56, 0.85) There was significant correlation between plasma PC with
initial systolic blood pressure (r = 0.5, P = 0.008) and PS antigen (r = 0.41, P = 0.026).
Also, there was a trend of negative correlation between plasma PC with days of ventilator
used (r = 0.03, P = 0.1) and Length of stay in PICU (r = 0.03, P = 0.09).
CONCLUSION. This study suggested that most of pediatric ALI/ARDS had abnormal co-
agulograms including protein C activity and protein S Ag. Children with ALI/ARDS had
lower PC activity/Protein S AG compared to normal control. Plasma PC activity and PS
antigen levels were tended to have negative correlation with days of ventilator used and
length of stay in PICU.
ACKNOWLEDGEMENT. Funded by Rachada Pisek Sompotch fund.
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A NOVEL DDAH1 INHIBITOR IMPROVES SURVIVAL IN A LONG TERM
CONSCIOUS MODEL OF SEPTIC SHOCK
Z. Wang1, V. Taylor1, R. Stidwill1, J. M. Leiper1, M. Singer1
1University College of London, Bloomsbury Institute of Intensive Care Medicine and
Department of Clinical Pharmacology, London, UK
INTRODUCTION. DDAH (dimethylarginine dimethylaminohydrolase) metabolizes
ADMA, an endogenous inhibitor of nitric oxide (NO) synthase [1]. DDAH inhibition thus
offers a novel means of modulating excess NO production in septic shock. As the DDAH-2
isoform is present in immune cells, selective inhibition of the DDAH-1 isoform may improve
haemodynamics without compromising immune function. We thus studied the impact on
survival of the novel DDAH1 inhibitor, L-257, in a conscious rat model of septic shock
METHODS. Conscious instrumented male Wistar rats (approx 300 g body weight) received
1.8 ml faecal slurry intraperitoneally. When blood pressure (BP) dropped 20% below baseline
level (at approx 5–6 h), 1–3 9 10 ml/kg Voluven fluid challenges were given i.v. to restore
pressure, followed by continuous infusion of a 1:1 mix of n-saline ? 5% glucose at a rate of
10 ml/kg per hour. Treated animals also received 3 mg/kg bolus of L-257 followed by a
continuous infusion of 125 mcg/h. Animals were observed until 48 h or death. A Kaplan–
Meier survival analysis was performed.
RESULTS. L-257-treated septic animals (n = 15) showed a significant improvement in
survival compared to untreated animals (n = 15) (Fig. 1). Median survival was 18 vs. 10.5 h
(p = 0.0412). Blood pressure was better maintained in the L-257 treated animals.
L-257 survival
CONCLUSIONS. Selective DDAH-1 inhibition improved haemodynamics and survival in
this severe, long-term, fluid-resuscitated, conscious model of septic shock. This offers a new,
potentially safer, paradigm for NO modulation and a putative therapy.
FUNDING. The Wellcome Trust.
REFERENCE. Leiper J et al (2007) Nature Med 13:198–203.
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COMPARISON OF DDAH-1 INHIBITION AND NOS INHIBITIOR L-NMMA IN AN
ENDOTOXAEMIC RAT MODEL
Z. Wang1, V. Taylor1, R. Stidwill2, J. M. Leiper1, M. Singer1
1University College of London, Bloomsbury Institute of Intensive Care Medicine and
Department of Clinical Pharmacology, London, UK, 2University College of London, Wolfson
Institute of Biomedical Research, London, UK
INTRODUCTION. DDAH (dimethylarginine dimethylaminohydrolase) metabolizes
ADMA, an endogenous inhibitor of nitric oxide (NO) synthase. Selective inhibition of the
DDAH-1 isoform may improve haemodynamics in septic shock without compromising
immune function [1]. We thus compared the impact the effects of the novel DDAH1 inhibitor,
L-257, versus the non-specific NOS inhibitor, L-NMMA at a large dose in a rat model of
endotoxaemic shock.
METHODS. Anaesthetized, spontaneously breathing, cannulated, male Sprague–Dawley rats
(approx 300 g body weight) received 40 mg/kg Klebsiella pneumoniae LPS was given i.v.
over 30 min. Thereafter, all animals received 10 ml/kg/h fluid resuscitation (9:1 mix of 5%
glucose ? Gelofusin). When blood pressure fell[20% below baseline (approx 120–150’ post-
LPS), groups (n = 5) received placebo, L-NMMA (20 mg/kg per hour) or L-257 (3 mg/kg
bolus then 125 lg/h infusion) for 2 h. Animals were observed for a further 1.5 h after ter-
minating the drug infusion. Blood gas analysis and echocardiography were performed at
baseline and study end.
RESULTS. Two animals died in the placebo and L-NMMA groups, and 1 in the L257 group.
Haemodynamics and blood gas analyses were better maintained in the L-257 treated animals
(Table 1, *p \ 0.05 vs. placebo at the end of study).
TABLE 1 * P\0.05 VERSUS PLACEBO AT THE END OF STUDY
Blood pressure (mmHg) Stroke volume (L) Base excess (mmol/l)
Placebo 68.5 ± 26.9 0.12 ± 0.05 -13.5 ± 4.2
L-NMMA 61.3 ± 25.8 0.13 ± 0.1 -13 ± 3.6
L-257 88.7 ± 21.5* 0.19 ± 0.03* -7.9 ± 4.9*
CONCLUSION. Selective DDAH-1 inhibition improved haemodynamics in this severe,
short-term, fluid-resuscitated, endotoxic shock model. This offers a new, potentially safer,
paradigm for NO modulation.
FUNDING. The Wellcome Trust.
REFERENCE. Leiper J et al (2007) Nature Med 13:198–203.
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UNCOUPLING PROTEIN-3 MEDIATES THE LOSS OF MITOCHONDRIAL MEM-
BRANE POTENTIAL IN SEVERE SEPSIS
P. Zolfaghari1, M. Singer1, M. R. Duchen2
1University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK,
2University College London, Department of Cell and Developmental Biology, London, UK
INTRODUCTION. The mitochondrial respiratory chain pumps protons out of the mito-
chondrial matrix, generating a proton gradient [expressed as a mitochondrial membrane
potential (Dwm)] that drives ATP production. Uncoupling protein-3 (UCP3), a member of a
family of transporter molecules found in the inner mitochondrial membrane, may translocate
protons back into the mitochondrial matrix, uncoupling respiratory chain activity from ATP
generation. However, this would also lower Dwm, reducing the mitochondrial production of
reactive oxygen species (ROS) and thus potentially offering protection (Brand 2005).
OBJECTIVES. Though UCP3 mRNA and protein levels are increased in sepsis, the sig-
nificance is unknown. We have shown that Dwm is reduced in skeletal muscle of mice with
severe sepsis. In the present study, we investigated the effect of severe sepsis on Dwm,
comparing both UCP3 wildtype (WT) and knockout (KO) mice.
METHODS. After 24 h of faecal peritonitis (or sham-operated controls), WT and UCP3 KO
mice (n = 6 per group) were sacrificed. Dwm was measured in freshly isolated, perfused dia-
phragm muscle using a voltage-dependent fluorescent probe, tetramethylrhodamine methyl ester
(TMRM) 100 nM. TMRM excitation was imaged using a Zeiss 510 multiphoton confocal
microscope. UCP3 protein in tibialis anterior muscle was quantified by immunoblotting. In a
separate study, the impact of UCP3 on survival from intraperitoneal sepsis was investigated by
comparing mortality of WT and UCP3 KO animals over a 48 hr period (n = 10–11 per group).
RESULTS. UCP3 protein abundance was 1.8 fold higher in septic WT mice at 24 h compared to
paired sham animals (p \ 0.05) while Dwm was significantly reduced (by 26%; *t test p \ 0.05).
Crucially, no significant change in Dwm was found in the UCP3 KO mice (Fig. 1). Despite the
maintained Dwm in septic UCP3 knockout mice, no survival benefit was observed (Fig. 2).
TMRM fluorescence and survival graph
CONCLUSION. UCP3 appears to mediate the reduction in Dwm of skeletal muscle of mice
during severe sepsis. However, this does not confer a survival benefit in a severe model of
sepsis. Further work will explore how this affects the rate of ATP generation, ROS production
and the overall function of skeletal muscle in sepsis.
REFERENCE. Brand MD, Esteves TC (2005) Cell Metab 2(2):85–93.
GRANT ACKNOWLEDGEMENT. This work was funded by the Medical Research Council.
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MITOCHONDRIAL RESPIRATORY CAPACITY GRADUALLY INCREASES DUR-
ING THE FIRST WEEK IN PATIENTS WITH SEVERE SEPSIS OR SEPTIC
SHOCK—A TEMPORAL ANALYSIS OF MITOCHONDRIAL FUNCTION IN
PLATELETS USING HIGH-RESOLUTION RESPIROMETRY
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INTRODUCTION. Severe sepsis and septic shock often results in multiple organ failure
(MOF) which is the leading cause of death in these patients. The cause of MOF is still
unknown but bioenergetic failure due to mitochondrial dysfunction has been proposed as a
plausible mechanism. Human studies are scarce and have mainly investigated mitochondrial
function of muscle biopsies taken during early stages of sepsis. Platelet mitochondria are
readily obtained via blood sampling and their respiratory function could potentially be used as
a non-invasive biomarker of mitochondrial function in remote organs.
OBJECTIVES. The aim of the present study was to establish high-resolution respirometry of
platelet mitochondria in patients with severe sepsis or septic shock and investigate temporal
changes of respiration during the first week after admission to the ICU.
METHODS. Platelets were rapidly isolated from blood samples taken from 18 patients with
severe sepsis or septic shock within 48 h of their admission to the intensive care unit.
Subsequent samples were taken on day 3–4 and day 6–7. Ten healthy blood donors served as
controls. Platelet mitochondrial function was determined in an Oroboros O2 k high-resolution
oxygraph. Endogenous respiration was determined in intact platelets and to investigate the
activity of the individual complexes of the respiratory chain, platelets were permeabilised
with digitonin and stimulated with complex specific substrates and inhibitors.
RESULTS. During thefirst week, following admission to the ICU, mitochondrial respiratory capacity
increased significantly in septic patients. Endogenous respiration of intact platelets increased gradually
following admission and was increased by 29% on day 6–7 compared to the initial value (within 48 h
of admission). In permeabilised platelets complex I-stimulated respiration increased 27% and 47%,
complex II-stimulated respiration 23% and 38% and convergent stimulation (complex I?II) 23% and
40% onday 3–4 and day 6–7, respectively. Compared to healthy controls respiration parameterson day
6–7 were increased significantly. Somewhat surprisingly, no significant differences compared to
control values could be detected at admission (within 48 h) or day 3–4.
CONCLUSIONS. We demonstrate that mitochondrial respiration in platelets is a sensitive
and reproducible parameter that is well suited for detailed and temporal analysis of mito-
chondrial bioenergetics. We conclude that platelet mitochondria in septic patients gradually
increase their respiratory capacity during the first week following admission to the ICU.
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PHOSPHOINOSITIDE-3 KINASE GAMMA ACTIVITY CONTRIBUTES
TO BACTERIAL DISSEMINATION DURING ABDOMINAL SEPSIS
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E. Hirsch2, V. M. Ranieri1
1University of Turin, Department of Anaesthesiology and Critical Care Medicine, Turin, Italy,
2University of Turin, Department of Genetics, Biology and Biochemistry, Turin, Italy
INTRODUCTION. Sepsis is characterized by bacterial infection and the presence of sys-
temic inflammation, which often leads to multiple organ failure (MOF) and death. During
severe septic shock, impaired neutrophil recruitment to the site of infection leads to lack of
adequate bacterial control, thereby allowing bacterial expansion and dissemination. Phos-
phoinositide-3 kinase gamma (PI3 Kgamma), an isoform of the PI3K cell signalling family, is
known to alter neutrophil migrations and contribute to sepsis-induced organ damage; how-
ever, its role in the development of bacteremia and bacterial colonization during sepsis
remains unknown. We hypothesized that mice lacking PI3Kgamma would have improved
bacterial control at the site of infection, resulting in reduced bacteremia and bacterial colo-
nization of distal organs.
METHODS. PI3Kgamma wild-type (WT) and knockout (KO) mice were randomized to
undergo either cecal-ligation and perforation (CLP)-induced sepsis or a sham laparotomy.
After 18 h, plasma, peritoneal and bronchioalveolar lavage (BAL), and tissue of lung, liver,
and spleen were collected under sterile conditions. Lung and liver tissues were flushed prior to
isolation and tissues were homogenized in sterile saline containing 1 mM EDTA. All samples
were serially diluted and plated on soy agar with 5% sheep blood and incubated for 24 h at
37C, following which CFUs were analyzed.
RESULTS. Sham animals had no bacteria present in any of the collected samples. Following
CLP-induced sepsis, wild-type mice had increased bacterial counts in the peritoneal cavity,
significant bacteremia and augmented bacterial colonization of the lung tissue, pulmonary
alveolar space (BAL), liver and spleen. Although, PI3Kgamma KO mice exposed to CLP
showed low amounts of bacteria in the peritoneum and blood, these bacterial levels were
significantly lower than WT. Additionally, KO mice show no significant increase in bacterial
colonization of the lung, BAL, liver, or spleen.
CONCLUSION. Following CLP, PI3Kgamma KO mice show increased control of peritoneal
bacteria, reduced bacteremia and protection against bacterial colonization of distal organs.
This suggests that blockade of PI3Kgamma may confer protection against sepsis through
improving control of bacterial dissemination.
Bacterial Counts
GRANT ACKNOWLEDGEMENT. University of Turin, CIHR.
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DOES AUTOPHAGY CONTRIBUTE TO IMMUNE CELL DEATH AND INFLAM-
MATION IN SEPSIS?
H.-W. Hsueh1, S.-S. Yuan1, Y.-C. Hsieh1
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Republic of China
Apoptosis acts as an important mechanism of immunosuppression during sepsis by causing
depletion of immune cells and inducing an anti-inflammatory cytokine response. Autophagy, an
important host mechanism for removal of intracellular bacteria, has recently emerged as an
important mediator of programmed cell death pathways. Autophagy can also regulate antigen
presentation and improve T cell immunity. In this study, we examined whether autophagy is
involved in immune cell apoptosis and the effects of autophagy activator on apoptotic pathway
and inflammatory mediators in sepsis. To assess this, male mice were subjected to cecal ligation
and puncture (CLP) or sham operation. Mice received either vehicle, autophagy activator
(rapamycin), apoptosis inhibitor (Z-VAD-fmk), or rapamycin in combination with Z-VAD-fmk
after onset of CLP. Our results showed autophagy proteins LC3-II and ATG5-ATG12 complex
markedly decreased in the spleen at 24 h after CLP. Administration of rapamycin increased in
autophagic vacuoles compare to vehicle treated CLP group (Fig. 1). Moreover, administration
of rapamycin, Z-VAD-fmk, or rapamycin in combination with z-VAD-fmk significantly
upregulated LC3-II and ATG5-ATG12 complex. This upregulation was accompanied by
downreulation of active caspase-3 and systemic levels of pro-inflammatory cytokines IL-10 and
MCP-1. In stimulated splenocytes, administration of rapamycin or rapamycin in combination
with z-VAD-fmk substantially inhibited IL-10 and MCP-1 releases, whilst Z-VAD-fmk alone
did not affect IL-10 and MCP-1 releases. These results suggest that upregulation of autophagy
reduces splenocyte apoptosis via caspase-3 in sepsis and that decreased apoptotic cells may have
an effect on suppressing cytokines IL-10 and MCP-1. Thus, activation of autophagy can be a
potential therapeutic strategy in septic patients.
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INTRODUCTION. Despite ample research on pathophysiological mechanisms and thera-
pies, sepsis remains the leading cause of death in non-coronary intensive care units. Excessive
inflammation, oxidative stress and vascular injury are main contributors to organ dysfunction
and are ultimately responsible for the poor outcome. The heme oxygenase (HO) system is
considered one of the most potent cytoprotective systems of the human body. The subform
HO-1 can be induced by numerous factors including reactive oxygen and nitrogen species,
cytokines and lipopolysacchardide whereas HO-2 is constitutively expressed. HO and its end
products CO and bilirubin exert anti-inflammatory and anti-oxidative effects in various in
vitro and animal models for sepsis and inflammation. However, data concerning the induction
and activity during human inflammation are scarse.
OBJECTIVES. The aim of the present study was to determine the induction and kinetics of
heme oxygenase and its end products during experimental human endotoxemia.
METHODS. 10 Healthy volunteers received 2 ng/kg of E.coli LPS intravenously. Thereaf-
ter, blood was obtained at several time points to determine cytokine production, whole blood
HO-1-2 mRNA expression and HO-1 protein content in PBMCs. Also, systemic bilirubin,
HbCO saturation in arterial blood and exhaled CO corrected for breath frequency were
assessed.
RESULTS. After LPS administration, TNF-a, IL-6 and IL-10 increased from below the
detection limit to 1,213 ± 187, 1,521 ± 209 and 73 ± 11 pg/ml, respectively (all: p \ 0.01).
Unexpectedly, expression of HO-1 mRNA decreased 9-fold and HO-1 protein content in
PBMCs declined to minimally 17% compared to baseline at 2 and 4 h after LPS (p \ 0.01).
HO-2 mRNA was decreased maximally fivefold at 4 h after LPS (p \ 0.01). Interestingly, 4 h
after LPS infusion, levels of bilirubin increased from 12 ± 2 to 24 ± 3 lmol/l (p \ 0.05)
and, while HbCO concentration in arterial blood did not increase (remained below 1%), CO
concentration in exhaled breath times breath frequency increased from 36 ± 4 to 68 ± 11 at
5 h after LPS (p \ 0.05).
CONCLUSIONS. While HO mRNA and protein levels decline in whole blood and PBMCs
during human endotoxemia, its end products bilirubin and CO are increased. This indicates
that systemic inflammation during human endotoxemia most likely increases tissue, but not
blood, HO levels.
Heme oxygenase during human endotoxemia
0634
SEPSIS INDUCED BY BOTH GRAM NEGATIVE AND GRAM POSITIVE STRAIN’S
DETERMINES A RAPID OVERGROWTH OF THE ENTERIC COMMENSAL
G- MICROBIOTA AND SUBSEQUENT TRANSLOCATION IN RATS
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Enteric microbiota plays an important role on the gut environment equilibrium and its dis-
ruption has been correlated with the local or systemic disease.
OBJECTIVE. Herein we examined the influence of both Gram positive and Gram negative
sepsis on aerobic and anaerobic facultative Gram negative (G-) microbiota of the small and
large bowel (SB, LB) and their translocation (BT) potentials.
METHODS. Wistar rats (±200 g) were submitted to crescent monobacterial sepsis (S-8 and
S-9 groups, with 108 and 109 CFU/mL/100 g of body weight, respectively, using S. aureus
(ATCC-29213) or E. coli R-6, i.v. inoculation). Samples of duodenum, jejunum, ileum,
cecum, feces, mesenteric lymph nodes (MLN), liver and spleen were harvested at 6, 12 and
24 h post-sepsis and cultured in MacConkey agar medium (n = 6/period/group). Sham
control groups were injected with saline and Naive group, without any procedure, was used to
determine the basal gut G- microbiota distribution along the intestine (n = 6/period/group).
RESULTS. Expressive gut commensal Gram- overgrowth was seen post-sepsis challenge
with both Gram? and Gram- strains. The G- strain sepsis induced a rapid enteric commensal
G- overgrowth and it occurred in a proximal to distal manner, suggesting that the later period
LB overgrowth (12 h) were likely due to the earlier SB overgrowth onset (6 h). Besides, the
higher sepsis degree (S-9) was followed by higher commensal G- bacterial overgrowth in the
SB. The maximum commensal Gram- bacterial overgrowth levels in Naı¨ve and G- strain
sepsis S-8 and S-9 were, respectively: duodenum (0.0 vs. 2.8 vs. 4.7 log10); jejunum (2.5 vs.
4.2 vs. 6.0 log10); ileum (4.0 vs. 7.4 vs. 7.5 log10); and cecum (5.1 vs. 8.0 vs. 7.8 log10). With
G? strain sepsis challenge, the commensal G- overgrowth initiated at 6 h and reached the
maximum in a later period between 12 and 24 h period post sepsis, in both small and large
bowel concurrently. The G? sepsis overgrowth showed a trend to last for a longer period (up
to 24 h period) as compared to G- sepsis (up to 12 h). The maximum levels of the com-
mensal G- overgrowth were in S-8 and S-9, respectively: duodenum (4.2 vs. 3.6); jejunum
(5.4 vs. 5.3); ileum (6.4 vs. 6.8); and cecum (9.6 vs. 7.6). The spontaneous BT to MLN
occurred following both sepsis: 50% at S-8, 5.6% at S-9 with Gram- strain’s sepsis and 30%
at S-8 and 0% at S-9 for Gram? strain’s sepsis. All BT events were observed concomitant to
the highest overgrowth periods and the recovered strain was only E. coli strain.
CONCLUSION. Acute sepsis states provoked by both Gram- and Gram? strains induced a
significant and transient SB and LB commensal G- microbiota overgrowth with potentials to
promote BT within first 24 h post sepsis. Nevertheless, Gram- strain’s sepsis-dependent
overgrowth showed a trend to occur in an earlier period as compared to Gram? sepsis and
suggested to have higher BT potentials.
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INTRODUCTION/OBJECTIVES. Platelet activating factor (PAF), an endogeneous
mediator of inflammation, provokes epithelial barrier dysfunction, septic shock and multiple
organ failure. Over the past years, the pharmacodynamics and inflammatory pathways of PAF
were decrypted, e.g. in the lungs by use of isolated perfused organs improving our under-
standing of pulmonary oedema formation. Surprisingly, the research has not focused to the
same extent on another important barrier organ, the intestine. We used a recently developed
isolated organ model of the rat small bowel [1] to identify the dose response relationships of
PAF in the intestine.
METHODS. Small intestines were dissected from 12 anaesthetized adult female Wistar rats
and perfused vascularly (7.5 ml min-1) and luminally (0.15 ml min-1) in a warm humidified
chamber. After equilibration different amounts of PAF (0.5, 5, 50, 150, 500 and 1,500 pmol)
were applied by bolus administration via the mesenteric artery. In one of the experiments, a
specific PAF receptor antagonist ABT-491 was continuously applied to the vascular buffer.
Arterial, venous and luminal pressures as well as venous, luminal and lymphatic effluent
flows were recorded continuously. The transfer of the macromolecule FITC dextrane from the
vasculature to the lumen and lymphatics was measured every 15 min. All reference param-
eters of the intestine stability and viability were recorded as described before [1].
RESULTS. PAF administration in increasing concentrations from 0.5 to 1,500 pmol resulted
in its typical transitory effects like vasoconstriction (D Pmax from 1.9 to 32 mmHg), loss of
vascular fluid [from 0.8 to 27.6 ml (10 min)-1] and transfer of FITC dextrane from the
mesenteric vascular bed to the luminal fluid [from 1.7 to 373 lg (15 min)-1] and the lymph
[from 6.4 to 191 lg(15 min)-1]. The dose response curves of the normalized data displayed
the typical sigmoid characteristics indicating a specific ligand receptor interaction. The half
maximal effective dose (ED 50) of PAF for the increase of vascular resistance (55.4 pmol)
and the parameters of permeability (157.4 pmol) differed significantly, while the slope factor
of the curves was equal. The administration of ABT-491 abolished the effects of PAF.
CONCLUSIONS. The responses of the mesenteric vascular bed and the intestinal barrier to
PAF were mediated by a specific PAF receptor and were dose dependent. The ED 50 of PAF
leading to intestinal hyperpermeability was threefold higher than the ED 50 needed to evoke
mesenteric vasoconstriction, indicating varying sensitivities to PAF. Mediation via different
and possibly not yet defined second messengers could explain these differences. Further
studies using specific antagonists of the well known mediators linked to PAF like leukotri-
enes, thromboxane, ceramide and PGE2 may clarify their role in the mediation of the
detrimental intestinal effects of PAF.
REFERENCE(S). 1. Lautenschla¨ger et al (2007) Infection 35(Suppl II):31.
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BACKGROUND. Mitochondrial dysfunction in muscle and compromised cellular energetic
status are associated with mortality in septic patients [1]. Mitochondrial function depends on
the balance between expression and assembly of proteins (biogenesis) and their inactivation/
degradation (e.g. due to oxidative/nitrosative stress). Since mitochondrial biogenesis is
associated with recovery of organ function in an animal model of sepsis [3], we have
investigated mitochondrial biogenesis and markers of oxidative stress in critically ill patients.
METHODS. With ethics approval and appropriate consents, critically ill patients were
recruited within 24 h of ICU admission. Age-matched control patients were undergoing
elective hip surgery. Muscle biopsies were taken from vastus lateralis. Mitochondrial enzyme
activities were determined [1] and proteins extracted for immunoblotting. RNA was purified,
reverse transcribed and (a) microarray analysis was performed by hybridisation to Human-6
v2 Expression BeadChip (http://www.illumina.com/pages.ilmn?ID=197) or (b) quantitative
PCR performed. Data were analysed for significance using one-way ANOVA (vs. control).
RESULTS. A total of 10 controls (Ctrl), 10 eventual survivors (Svr) and 6 eventual non-
survivors (NSvr) were analysed:
(a) transcript levels for markers of biogenesis PGC1-alpha and NRF-1 were elevated in Svr
(p = 0.003) but not NSvr;
(b) respiratory complex subunit transcripts showed an overall decrease in NSvr, but were
maintained in Svr group;
(c) decreased respiratory protein subunits for complex IV (p \ 0.05 Svr and Nsvr) and trend
for complex I;
(d) markers of oxidative damage: elevated (3-fold) mitochondrial MnSOD in Svr
(p = 0.01), not in NSvr (p = 0.87); cytosolic GPX marginally decreased in both
patient groups (p = 0.05);
(e) serum IL-6 levels: 100-fold rise in Svr, 4,000-fold rise in NSvr (p = 0.05).
CONCLUSION. An early biogenesis response contributes to maintenance of mitochondrial
functional capacity and a mitochondrial oxidative stress response in patients who went on to
survive. Failure to mount these responses may contribute to cellular energetic dysfunction and
mortality. Lack of clear correlation between IL-6 and PGC1a suggests that factors other than
severity of inflammation may play a significant role in determining the extent of mitochon-
drial biogenesis in critical illness.
REFERENCE(S). 1. Brealey D et al (2002) Lancet 360:219–223.
2. Suliman HB et al (2004) Cardiovasc Res 64:279–288.
FUNDING. Medical Research Council, UK.
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PATIENTS WITH TYPE 2 DIABETES EXHIBIT AN ATTENUATED ADHESION
MOLECULE RESPONSE DURING EXPERIMENTAL ENDOTOXEMIA
A. S. Andreasen1, R. M. Berg2, B. Feldt-Rasmussen3, K. Moller1
1University Hospital Rigshospitalet, Centre of Inflammation and Metabolism, -7641,
Copenhagen, Denmark, 2University Hospital Rigshospitalet, Centre of Inflammation and
Metabolism, Department of Infectious Diseases and CMRC, Copenhagen, Denmark, 3Uni-
versity Hospital Rigshospitalet, Department of Nephrology, Copenhagen, Denmark
Type 2 diabetes (T2D) is associated with an increased risk of infection1. The mechanisms
underlying this remain unclear, although in vitro studies indicate that it may involve aber-
rations in neutrophil function [1]. Upregulation of ICAM, VCAM and E-selectin during
infections are crucial to neutrophil migration during the inflammatory response. We therefore
hypothesized that patients with T2D exhibit an impaired response of these adhesion molecules
during a standardised inflammatory stimulus.
After ethical approval, a thorough physical examination and informed consent, 16 healthy
men and 16 men with type 2 diabetes were given an endotoxin injection (0.3 ng/kg). Mea-
surements of temperature, neutrophils, ICAM and VCAM, and soluble E-selectin in plasma
were done hourly from baseline until 8 h after endotoxin. Data was analysed by two-way
ANOVA for longitudinal measurements with Dunnet-adjusted post hoc t tests.
A marked inflammatory response with increases in temperature and neutrocyte counts was
triggered by LPS, but with no difference between groups. Plasma ICAM and VCAM
increased after LPS (P \ 0.0001 for both), but the response was attenuated in subjects with
T2D (P \ 0.05 for both). E-selectin increased after LPS (P \ 0.0001), with no difference
between groups (P = 0.07).
In conclusion, we found an attenuated ICAM and VCAM response after endotoxin injection
in T2D. We speculate that this may contribute to the increased risk of infection in T2D.
REFERENCES. 1. Peleg et al (2007) Common infections in diabetes: pathogenesis, man-
agement and relationship to glycaemic control. Diabetes Metab Res Rev 23:3–13.
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SINGLE ACUTE BACTERIAL TRANSLOCATION (BT) CHALLENGE INDUCES A
LASTING GUT ASSOCIATED LYMPHOID TISSUE CROSSTALK WITH SYS-
TEMIC IMMUNITY PROVOKING SPLANCHNIC TISSUE HYPOPERFUSION IN
RATS
L. Vilela-Oliveira1, J. L. Menchaca-Diaz1, A. M.A. Liberatore1, R. Salomao2, M. K. Bruni-
alti2, I. H. J. Koh1
1Universidade Federal de Sa˜o Paulo, Surgery, Sa˜o Paulo, Brazil, 2Universidade Federal de
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Growing evidences have pointed out the role of the gut immunity in the worsening of the
critical illness, such as in sepsis, by provoking systemic inflammatory response aggravation.
Herein we evaluated BT-related microcirculation and gut immune changes up to 14 days
following single acute BT-challenge.
METHODS. Wistar rats (n = 162) were submitted to 2 h BT by oroduodenal bacterial
inoculation and confinement in small bowel (10 mL of E. coli 1010CFU/mL) and were
compared to Sham (saline injection) group. At 2, 6, 24, 72 h, 7 and 14 days, animals were
monitored for BT-index (mesenteric lymph nodes, spleen and liver by culture), intravital
mesenteric bed microscopy, Doppler tissue perfusion (jejunum, ileum, liver and kidneys) and
cellular and humoral components of the mesenteric lymph by lymphgram, flow cytometry and
IL-6, IL-10 and INF-g by CBA-Flex assay.
RESULTS. Bacterial recovery was only positive in BT-group with peak at 6 h which became
100% negative at day 7. Significant BT-related tissue hypoperfusion was seen in all organs
(p = 0.0039*) at 2 and 24 h associated with progressive microcirculation injuries. Trafficking
mesenteric efferent lymph cell count was significantly increased at 2, 6, 24 h and 14 days,
although cell composition remained similar to Sham (95% lymphocytes, 5% others) at all
periods. Besides, the lymph Tcd3? predominated over the B cells (cd45RA?, 83% to 12%);
and within T-cells, Tcd4? was higher than Tcd8? (75 vs. 15%) in all periods, but was similar
between groups. Naive cells (cd45RC?) predominated in Tcd4?(55%) and Tcd8?(75%)
population. Memory cells (cd45RC-) was 45% in Tcd4? and 25% in Tcd8?, and the acti-
vated cells (cd25?) were 15% in Tcd4? and 5% in the Tcd8? in all periods, and also did not
differ between groups. However, when the above findings were converted in proportion to the
number of trafficking lymph cells, BT group’s lymph showed a significantly different state of
immune activation as compared to respective sham-groups. Blood leucocytes remained
unchanged at all groups. Besides, the BT-process provoked significant IL-6 increase at 2 and
24 h, which correlated to the periods of high bacterial recovery and tissue hypoperfusion.
IFN-g and IL-10 remained similar between groups on 2, 6, 24 and 72 h periods. After 72 h all
cytokines returned to normal level.
CONCLUSION. Acute and single episode of BT-event determined prolonged BT with
systemic hypoperfusion and microcirculation injuries which lasted for first 3 days. The BT-
related gut-associated-lymphoid-tissue activation with cellular and cytokine profile changes in
the lymph demonstrated the role of the lymphatic BT-route in the generation of the immune
crosstalk between gut and systemic compartments.
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SIMULTANEOUS ASSESSMENT OF RENAL MICROVASCULAR AND INTERSTI-
TIAL OXYGEN TENSION DURING ENDOTOXAEMIA
A. Dyson1,2, M. Legrand1, R. Bezemer1, G. Balestra1, M. Singer2, C. Ince1
1Academic Medical Centre, Department of Translational Physiology, Amsterdam, Nether-
lands, 2University College London, Bloomsbury Institute of Intensive Care Medicine,
London, UK
INTRODUCTION. Dual-wavelength phosphorimetry and tissue oxygen tension monitoring
are two methods capable of determining the partial pressure of oxygen in the microvascu-
lature and interstitium, respectively. These techniques also allow oxygen pressure
measurements to be determined in different anatomical compartments of the same organ, such
as the renal cortex and medulla [1, 2].
OBJECTIVES. To simultaneously assess of microvascular (lPO2) and tissue (tPO2) oxy-
genation in the renal cortex and medulla during endotoxaemia.
METHODS. Anaesthetised and mechanically ventilated male Wistar rats (300 g) breathing
40% O2 underwent arterial (left common carotid) and venous (right jugular) cannulation to
allow BP monitoring and blood sampling, and fluid and LPS administration, respectively.
Macrovascular blood flow in the left renal artery (RBF) was monitored by ultrasonic flow
probes (Transonic Systems, USA). Tissue PO2 was determined using Oxylite probes (Oxford
Optronix, UK) placed in the left renal cortex and medulla to a depth of 0.5 and 2 mm,
respectively. Oxyphor G2 (6 mg/kg) was infused IV and cortical and medullary lPO2
assessed using dual-wavelength phosphorimetry. After a 30-min stabilisation period, rats
(n = 5/group) were subjected to IV LPS (2.5 mg/kg over 15 min) or vehicle (Hartmann’s
solution) and fluid resuscitated throughout (20 ml/kg per hour). Arterial blood was taken at
the end of each experiment to determine base excess (ABE). Statistics were performed using
two-way RM-ANOVA and post hoc Tukey’s test.
RESULTS. Data shown as mean (±SE), *p\ 0.05 between sham and LPS. Timepoints
chosen to reflect the biphasic response to LPS: 0 = baseline, 15 = initial hypotensive phase,
60 = maximal recovery, 240 = end of experiment.
CONCLUSION. In this short-term, fluid resuscitated, severe model of endotoxic sepsis,
temporal changes in BP and renal macrovascular blood flow were observed. Renal cortical
microvascular and tissue oxygenation was initially maintained but gradually decreased over
the course of the experiment. By contrast, medullary microvascular and tissue oxygenation
decreased in both phases of endotoxaemia; this was particularly pronounced in the inter-
stitium. These data support the concept that intrarenal blood flow redistribution occurs during
early sepsis, resulting in medullary hypoxia. In late sepsis, however, both cortical and




















0 102 (6) 4.8 (0.7) 7.2 (0.4) 9.6 (0.5) 2.2 (0.3) 5.3 (0.5)
15 102 (7) 4.7 (0.7) 7.1 (0.4) 9.5 (0.4) 2.7 (0.3) 5.5 (0.5)
60 98 (7) 5.2 (0.6) 6.9 (0.4) 9.6 (0.7) 3.4 (0.2) 5.1 (0.6)
240 92 (9) 5.9 (1.4) 6.8 (0.6) 8.2 (0.4) 3.1 (0.2) 5.7 (1.0) -3.5 (0.7)
LPS
0 99 (6) 4.5 (0.6) 6.9 (0.2) 9.2 (0.5) 2.4 (0.1) 4.9 (0.2)
15 42 (7)* 1.8 (0.2)* 4.9 (0.4)* 9.0 (0.9) 0.8 (0.2)* 4.5 (0.8)
60 72 (6) 3.5 (0.9) 6.7 (0.4) 8.2 (0.5) 1.2 (0.2)* 3.9 (0.8)
240 38 (3)* 1.9 (0.6)* 3.6 (0.6)* 4.3 (0.4)* 0.6 (0.2)* 2.5 (0.7)* -11.3
(0.8)*
GRANT ACKNOWLEDGEMENT. AD is supported by the UK Medical Research Council
and Integrative Pharmacological Fund.
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PLATELET MITOCHONDRIAL MEMBRANE POTENTIAL MAY BE ALTERED
DURING HUMAN SEPSIS
A. Protti1, A. Artoni2, A. Lecchi2, F. Rosini1, N. Bottino3, S. Crotti3, M. L. Caspani3,
L. Gattinoni1
1Universita` degli Studi di Milano, Dipartimento di Anestesiologia, Terapia Intensiva e Sci-
enze Dermatologiche, Milan, Italy, 2Fondazione IRCCS Ospedale Maggiore Policlinico,
Mangiagalli e Regina Elena, Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Milan,
Italy, 3Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Di-
partimento di Anestesia, Rianimazione (Intensiva e Subintensiva) e Terapia del Dolore,
Milan, Italy
INTRODUCTION. Mitochondrial dysfunction may play a pivotal role in the pathogenesis of
sepsis [1]. When damaged, mitochondria lose their physiological polarization, that is, their
negative membrane potential (Dwm).
OBJECTIVES. To study human platelet Dwm during sepsis.
METHODS. Platelets were taken from 16 severely septic or septic shock patients within 24 h
from admission to the Intensive Care Unit and 6 healthy volunteers. After staining with JC-1,
platelet Dwm was measured by flow citometry and expressed as the ratio between normally
polarized (FL2) and abnormally depolarized (FL1) organelles [2]. In septic patients, the
severity of illness at the time of the study was evaluated according to the Sepsis-related Organ
Failure Assessment (SOFA) score, with higher values indicating a higher degree of morbidity
[3]. Data are presented as mean ± standard deviation.
RESULTS. Overall, platelet Dwm (expressed as FL2/FL1) did not differ between septic
patients and healthy volunteers (2.5 ± 1.3 vs. 3.4 ± 0.3; p = 0.11—Student’s t-test). In
septic patients, platelet Dwm was inversely associated with the SOFA score (R
2 0.27;
p = 0.04—linear regression), with the lowest values recorded in the most severely ill sub-
jects. Platelets taken from patients with a SOFA score above the group median value ([9,
n = 7) had a Dwm significantly lower than those taken from less severely ill patients (SOFA
score B9, n = 9) and healthy volunteers (1.6 ± 0.6 vs. 3.2 ± 1.4 vs. 3.4 ± 0.3; p = 0.01—
one way analysis of variance).
CONCLUSIONS. These preliminary data suggest that platelet mitochondrial membrane
potential may be altered in the most severely ill septic patients.
REFERENCES. 1. Brealey et al (2002) Lancet. 2. Cossarizza et al. (1993) Biochem Biophys
Res Commun. 3. Vincent et al (1996) Intensive Care Med.
GRANT ACKNOWLEDGEMENT. Supported by a Grant from the European Society of
Intensive Care Medicine (ECCRN Clinical Research Award 2007) and a Grant from the
Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena di Milano
(Progetto a Concorso 2008–09).
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GENOTYPING OF HLA-DR SHOWS THAT HLA-DRB3 HOMOZYGOSY IS ASSO-
CIATED TO SEVERITY IN SEVERE SEPSIS AND SEPTIC SHOCK
A.-C. Lukaszewicz1, D. Payen1, M. Busson2, P. Loiseau2, B. Megarbane3, E. Azoulay4,
F. Fieux5, V. Faivre1, D. Charron2
1Hoˆpital Lariboisie`re APHP, Universite´ Paris 7 Diderot, De´partement d’Anesthe´sie Re´ani-
mation SMUR, Paris, France, 2Hoˆpital Saint Louis Hospital APHP, Universite´ Paris 7
Diderot, Laboratoire d’Immunologie et Histocompatibilite´, Paris, France, 3Hoˆpital Lariboi-
siere APHP, Universite´ Paris 7 Diderot, Re´animation Me´dicale, Paris, France, 4Hoˆpital Saint-
Louis APHP, Universite´ Paris 7 Diderot, Re´animation Me´dicale, Paris, France, 5Hoˆpital
Saint-Louis APHP, Universite´ Paris 7 Diderot, De´partement d’Anesthe´sie Re´animation, Paris,
France
INTRODUCTION. Major histocompatibility complex class II includes highly polymorphic
genes which have been associated with various inflammatory diseases and infection sucep-
tibility. Among these genes, HLA-DRB genes encode for co-expressed proteins of HLA-DR
molecule to present antigen to T lymphocyte. HLA-DRB1 gene is constitutive, but additional
gene (HLA-DRB3, DRB4 or DRB5) defines variant haplogroups and results in higher amount
of HLA-DR molecule at cell surface. The decrease in monocyte HLA-DR expression was
proposed as a prognosis marker in sepsis.
OBJECTIVES. To study the association: between HLA-DRB polymorphism and
1. prognosis,
2. monocyte HLA-DR expression, and
3. organ failure severity in sepsis.
METHODS. HLA-DRB genes have been studied in 187 septic patients with at least 2 organ
failures (78% septic shock). Genomic DNA extraction: salting-out technique from fresh
peripheral blood leucocytes. Genotyping of 13 alleles of HLA-DRB1 (generic typing): high
resolution DNA based typing (allelic level) using the PCR-Sequence Specific Primers (PCR-
SSP) amplifications. Presence of second gene was deduced from their known association with
HLA-DRB1 alleles: HLA-B3 with HLA-DRB1 (*03,*11,*12,*13,*14); HLA-DRB4 with
HLA-DRB1 (*04,*07,*09); HLA-DRB5 with HLA-DRB1 (*15, *16). Monocyte HLA-DR
expression at D0 by flow cytometry. Statistics: Chi2 of Pearson. Results as median (25–75
percentiles).
RESULTS. 64% males, age: 63 y.o. (18–94), SAPSII 46 (37–57), SOFA 8 (6–11). Mortality
rate 26% at D7, 38% at D28. 87% Caucasian, 8% African, 2% Asian. Frequencies: 70% HLA-
DRB3, 49% HLA-DRB4, 24% HLA-DRB5. No association between HLA-DRB1 alleles and
prognosis or HLA-DR expression level. Presence of a second gene, homozygote or hetero-
zygote, was not associated with outcome but with negative blood culture (p \ 0.05).
Homozygosy for the second gene, especially HLA-DRB3 (23%) presented less organ dys-
function: 21% with SOFA \ 8 compared to 48% heterozygotes (p \ 0.003).
CONCLUSION. In severe sepsis, HLA-DRB polymorphism was not associated with prog-
nosis. HLA-DRB3 homozygosy was associated with less organ dysfunction. HLA-DRB
genotyping may help to define patients with high risk of death.
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MUSCLE TRANSCRIPTOME IN PATIENTS WITH MULTIPLE ORGAN FAILURE
O. Rooyackers1, K. Fredriksson1, I. Tja¨der1, J. Timmons2, J. Wernerman1
1Karolinska Institutet and University Hospital, Anesthesiology and Intensive Care, Huddinge,
Sweden, 2Panum Institute, Copenhagen, Denmark
Muscle wasting and weakness are characteristic problems in ICU patients suffering from
MOF and are well known to negatively affect morbidity and mortality. The aim of this study
was to for the first time assess changes in gene expression in muscle of patients with MOF to
elucidate new molecular mechanism.
Thirteen patients treated in the ICU for MOF and 8 healthy, age and sex matched, control
subjects undergoing elective surgery were included. Muscle biopsies were obtained using a
Bergstrom needle. RNA was extracted using TRIzol and gene expression assessed using the
Affymetrix U133?2 array platform. Data were quality controlled using the Microarray Suite
software (MAS 5.0). All array data were normalized through implementations of the MAS5
algorithm, to a global scaling intensity of 100. The normalized data were analyzed with the
Significance Analysis of Microarray (SAM, http://www-stat.stanford.edu/*tibs/SAM/). SAM
provides a list of ‘‘significant’’ genes and attempts to estimate of the false discovery rate
(FDR), which represents the percentage of genes that could be identified by chance. SAM
assign a score to each gene/probe set as an index of relative difference between groups. For
the data presented, genes were considered significantly changed in ICU patients, when a delta
value corresponding to the number of false significant genes of 5% (q-value), and an average
fold change of 2, was achieved.
All array analyses passed the quality control and were used in the final analyses. Expression
of 1,457 genes was significantly increased (p \ 0.05), whereas expression of 525 genes was
significantly decreased (p \ 0.05) in muscle of the MOF patients. In two recent publications,
genes typically increased or decreased in their expression in several animal models with
muscle wasting (atrophy) and disuse were identified [1, 2]. These genes were defined as
atrogenes. When data from our patients were compared with these atrogenes, good agreement
was obtained for the atrophy specific genes involved in protein degradation, translation and
extracellular matrix proteins, but less for those involved in energy metabolism. When com-
pared with the genes specific for disuse, very little agreement was seen.
Overall analysis of the transcriptome of skeletal muscle in patients with MOF shows a large
number of genes with increased expression. For the first time we show that the loss of muscle
mass and function is accompanied by an activation of the genome rather than an expected
down-regulation. Compared with animal models of disuse the pattern of gene expression
suggests that disuse is not involved in the wasting of muscle in MOF patients to a large extent.
REFERENCES. 1. Lecker SH et al (2004) Faseb J 18:39–51.
2. Sacheck JM et al (2007) Faseb J 21:140–155.
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GENOMIC VARIATIONS WITHIN MATRIX METALLOPROTEINASE-9 ARE NOT
ASSOCIATED WITH SEVERE SEPSIS IN HAN CHINESES
X. Fang1, Q. Chen1, Y. Jin1, S. Wu1, B. Cheng1
1Department of Anesthesiology, the First Affiliated Hospital, School of Medicine, Zhejiang
University, Hangzhou, China
AIMS. Sepsis is a multiple genes disease resulting from the interaction of enviromental and
genetic components. Genomic variations within candidate genes participating in the patho-
physiology of sepsis may impact the clinical course of sepsis. Matrix Metalloproteinase-9
(MMP-9) has been demonstrated to play an important role in organ dysfunction and outcome
of sepsis. However, genetic predisposition of MMP-9 to sepsis remained unknown.
METHODS. The present study investigated common single nucleotide polymorphisms
(SNPs) within the functional regions of MMP-9 gene (rs17576, rs2274756, rs2250889,
rs9509, rs3918240, rs3918241 and rs3918242) in 192 patients with severe sepsis and 262
healthy controls by means of direct sequencing or polymerase chain reaction-restriction
fragment length polymorphism. Meanwhile, the plasma levels of MMP-9 were measured in
32 patients with severe sepsis and 19 healthy controls via enzyme linked immunosorbent
assay.
RESULTS. The genotype distributions and allelic frequencies of above 7 SNPs were not
significantly different between patients with severe sepsis and controls, as well as surviving
and non-surviving patients with severe sepsis (all p \ 0.05). Haplotype GGCTTTC, AG-
GTCTC, GGCCTTC, GACTTAT and AGCCCTC are the five most common haplotypes. The
distributions of the haplotypes also showed comparable between the defined groups. The
median plasma levels of MMP-9 was 37.66 ng/ml (interquartile range [IQR] 21.89–81.34 ng/
ml) in 32 patients within 24 h after diagnosis of severe sepsis, and 30.15 ng/ml (IQR 18.85–
53.11 ng/ml) in 19 healthy controls. Compared to those in surviving patients with severe
sepsis (median 37.66 ng/ml, IQR 17.78–52.49 ng/ml, n = 16) and healthy controls, the
concentrations of MMP-9 appeared an increasing trend in non-surviving patients with severe
sepsis (median 36.06 ng/ml, IQR 23.49–107.60 ng/ml, n = 16).
CONCLUSIONS. The present findings suggest that common polymorphisms within the
function regions of MMP-9 gene may not play a major role in the predisposition to severe
sepsis in Chinese Han cohort. The plasma levels of MMP-9 may associate with the outcome
of severe sepsis. Further studies in large samples need be guaranteed.
REFERENCES. 1. Renckens R et al (2006) J Immunol 176:3735–3741.
2. Steinberg J et al (2003) J Surg Res 111:185–195.
3. Lalu MM et al (2003) Mol Cell Biochem 251:61–66.
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AA GENOTYPE OF B2-ADRENERGIC RECEPTOR GENE POLYMORPHISM
RS1042717 IS ASSOCIATED WITH INCREASED MORTALITY IN SEPTIC SHOCK
T. Nakada1, J. A. Russell1, J. H. Boyd1, R. Aguirre-Hernandez1, K. R. Thain1, S. A. Thair1,
E. Nakada1, M. McConechy1, K. R. Walley1
1University of British Columbia Critical Care Research Laboratories, Heart ? Lung Institute,
St. Paul’s Hospital, Vancouver, Canada
INTRODUCTION. The b2-adrenergic receptor gene (ADRB2) plays a key role in outcome
and response to adrenergic agonists in cardiovascular diseases and respiratory/inflammatory
diseases, including heart failure and asthma. The CysGlyGln haplotype of three functional
ADRB2 (Cys/Arg-19, Gly/Arg16, Gln/Glu27) single nucleotide polymorphisms (SNPs) is
functionally important and associated with outcome in response to adrenergic agonists in
asthmatic patients. Adrenergic agonists form a cornerstone of cardiovascular management of
septic shock and are associated with anti-inflammatory effect. Polymorphisms of a variety of
genes, including cytokines and crucial molecules in innate immune and coagulation system
are related to altered outcome in septic shock. Despite the known functional polymorphisms
within ADRB2, whether this functional haplotype alters outcome in patients receiving
adrenergic agonists in septic shock is unknown.
OBJECTIVES. To determine whether genetic variation of ADRB2 influences outcome of
septic shock.
METHODS. Two cohorts of septic shock patients on admission were studied: a single center
(St. Paul’s Hospital, SPH) cohort (n = 589) and the Vasopressin and Septic Shock Trial
(VASST) cohort (n = 616). The A allele of the rs1042717 G/A polymorphism is in complete
linkage disequilibrium with the CysGlyGln haplotype of ADRB2. Therefore rs1042717 was
genotyped. Differences in hazard of death over 28 days by rs1042717 genotype were ana-
lyzed as a primary outcome with the use of Cox regression. To evaluate differences in
response to adrenergic agonists by rs1042717 genotype, norepinephrine- and salbutamol-
induced inhibition of IL-6 production under mixed inflammatory simulation in lymphoblas-
toid cell lines of known ADRB2 rs1042717 genotype were assessed.
RESULTS. Patients who had the AA genotype of rs1042717 had increased 28-day mortality
in SPH (adjusted hazard ratio 2.23, 95% CI 1.33–3.72, P = 0.0022) and this result replicated
in VASST (adjusted hazard ratio 2.82, 95% CI 1.56–5.09, P = 0.0006). This genotypic effect
was eliminated in those patients treated with corticosteroids. In all patients the AA genotype
was also associated with more organ dysfunction. Patients who had the AA genotype had a
higher heart rate (SPH, P \ 0.05; VASST, P \ 0.05) and a higher day 1–3 norepinephrine
dose (VASST, P \ 0.05). AA genotype was associated with decreased norepinephrine and
salbutamol inhibition of IL-6 production by stimulated lymphoblastoid cells in vitro
(P \ 0.05).
CONCLUSION. AA genotype of the ADRB2 rs1042717 polymorphism, marking homozy-
gotes for the known functional CysGlyGln haplotype, was associated with increased 28-day
mortality, more organ failure, higher heart rate during initial 5 days, and higher norepi-
nephrine infusion rates in patients who had septic shock. The same genotype had reduced
anti-inflammatory effects when norepinephrine and salbutamol inhibited IL-6 production by
stimulated lymphoblastoid cells in vitro.
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APOPTOSIS MARKERS BIM AND BCL2 MRNA TRANSCRIPTION IN PERIPHE-
RAL BLOOD MONONUCLEAR CELLS CAN DISTINGUISH BETWEEN THE
HUMAN HOST RESPONSE IN INFECTION AND SEPSIS
M. White1,2, R. Grealy1,2, M. W. Lawless3, M. J. O’Dwyer1, B. O’Connell4, D. Kelleher5, D.
G. Doherty5, R. Mcmanus5, T. Ryan1
1St James Hospital, Anaesthesia and Intensive Care Medicine, Dublin, Ireland, 2Institute of
Molecular Medicine, Trinity College Dublin, Genomic Research, Dublin, Ireland, 3Center for
Liver Disease, Mater Miscericordiae University Hospital, Dublin, Ireland, 4St James Hospital,
Clinical Microbiology, Dublin, Ireland, 5Trinity College Dublin, Clinical Medicine, Dublin,
Ireland
INTRODUCTION. Apoptotic death of immune effector cells including lymphocytes may
play an important role in the pathological process of sepsis [1]. Autopsy studies of adults who
died of sepsis showed profound apoptosis-induced depletion of CD4?Tcells [2]. Apoptosis
markers such as BIM, BCL-2 and BAX have been shown to be significant in animal models of
infection [3, 4].
OBJECTIVES. We investigated the mRNA transcription of these markers in the human
model of infection and sepsis
METHODS. A prospective observational study. Mononuclear cells were isolated from three
groups. 52 patients with severe sepsis, 15 patients with Gram-negative bacteraemia, but no
organ failure and 10 healthy controls.Total RNA was extracted. BIM, BAX and BCL-2
mRNA was quantified using the technique of quantitative real-time polymerase chain reaction
(qRT-PCR). All values are stated as median and inter-quartile range. Between group com-
parisons was performed by Wilcoxon rank sum test.
RESULTS. BAX mRNA copy numbers were not significantly different between the three
study groups, Control (6.899 9 106; 6.91 9 106–6.55 9 106); bacteraemic (6.69 9 106;
6.78 9 106–6.63 9 106) and sepsis (6.71 9 106; 6.91 9 106–6.55 9 106) ns. BCL-2 mRNA
copy numbers was significantly reduced in the sepsis group (3.96 9 106; 4.17 9 106–
3.55 9 106) compared to the bacteraemic group (4.42 9 106; 4.57 9 106–4.29 9 106) and
the controls (4.42 9 106; 4.83 9 106–3.82 9 106) p \ 0.0001. BIM mRNA copy numbers
were significantly increased in sepsis group (3.24 9 106; 3.36 9 106–3.06 9 106) compared
with bacteraemic (2.93 9 106; 3.05 9 106–2.77 9 106) and control group (2.75 9 106;
3.07 9 106–2.67 9 106) p = 0.0003.
CONCLUSION. Apoptosis may play a role in the human response to infection. Whilst it has
been well characterised in animal models, Bim, a pro-apoptotic member of the BCL-2 family,
neutralises anti-apoptotic members of the BCL-2 family. It is not therefore surprising to find
an increase in Bim mRNA transcription is associated with a decrease in the mRNA tran-
scription of BCL-2, an anti-apoptotic factor. This is further evidence apoptotic death of
mononuclear cells may play a role in the human response to infection.
REFERENCES. 1. Le Tulzo et al (2002) Early circulating lymphocyte apoptosis in human
septic shock is associated with poor outcome, Shock 18, 487–494.
2. Hotchkiss et al (1999) Apoptotic cell death in patients with sepsis, shock, and multiple
organ dysfunction CCM 27:1230–1251.
3. Schwulst et al (2008) Bim siRNA decreases lymphocyte apoptosis and improves survival in
sepsis. Shock 30(2):127–134.
4. Hotchkiss et al (1999) Overexpression of BCL-2 in transgenic mice decreases apoptosis
and improves survival in sepsis. J Immunol 162:4148–4156.
GRANT ACKNOWLEDGEMENT. This study is funded by the Association of Anaesthe-
tists of Great Britain and Ireland and the Intensive Care Society Ireland
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GENE ASSOCIATION NETWORK AS SIGNATURE FOR PROGNOSIS IN SEPTIC
SHOCK
A.-C. Lukaszewicz1, A. Tenenhaus2, V. Faivre1, V. Guillemot3, S. Baulande3, B. Megarbane4,
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APHP, Universite´ Paris 7 Diderot, Re´animation Me´dicale, Paris, France, 5Hoˆpital Saint-Louis
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6Hoˆpital Saint-Louis APHP, Universite´ Paris 7 Diderot, Re´animation Me´dicale, Paris, France
INTRODUCTION. No suitable early biological markers have been shown to predict out-
come in human septic shock. A rapid blood test would help to characterize patients with high
risk of death and might help for therapeutic strategy, particularly for use of high-tech drugs.
Circulating immune cells may contain inflammatory messages to remote organs.
OBJECTIVES. To study if the association and interactions of genes expressed by these cells
may have a signature for outcome in septic shock.
METHODS. Multicentric study (4 ICUs), 48 patients included at D0 of septic shock with at
least 2 organ failure, SAPSII 59 (15) [median (IQR)], SOFA 10 (14). Gene expression
analysis in blood immune cells (PMN removed by centrifugation gradient) by microarray
(HG-U133 Plus 2.0, Affymetrix). Gene of interest selection from differential analysis for
D28 mortality (t test), with fold change [1.5 and p value \0.1. Partial Least Squares
Regression-based partial correlation (PLSPC) applied to survivors and non-survivors sepa-
rately and analysis of the obtained networks in a global point of view. PLSPC uses
exclusively our microarray data and does not use any apriori knowledge to construct the gene
regulation networks.
RESULTS. 229 genes were differentially expressed for prognosis. Globally, gene-to-gene
connexions were fewer in non-survivors: 204 connexions (0.7% of possibilities) compared to
512 (1.2% of possibilities) in survivors. HLA-DRB4 gene has a central position was the most
connected gene in both networks with 12% of connexions in non-survivors (24 genes) and
survivors (63 genes). Only 4 connexions of HLA-DRB4 were similar in survivors and non-
survivors.
CONCLUSION. The number and type of interactions between genes may constitute a sig-
nature for prognosis. HLA-DRB4 expression seemed to have a key position among the genes
differentially expressed at D0 according to D28 outcome.
GRANT ACKNOWLEDGEMENT. PHRC 2002 APHP(AOR02006).
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ACTIVATED PROTEIN C AND GENE POLYMORPHISM IN SEVERE SEPSIS
M.-V. de la Torre-Prados1, A. Garcia-de la Torre2, A. Garcı´a-Alca´ntara1, C. Salazar-Ra-
mirez1, C. Ortiz-Garcı´a3, A. Enguix-Armada3
1Hospital Univertario Virgen de la Victoria, Intensive Care Medicine, Ma´laga, Spain,
2Hospital Universitario Virgen de la Victoria, Laboratorio de Bioquı´mica, Ma´laga, Spain,
3Hospital Universitario Virgen de la Victoria, Departamento de Bioquı´mica, Ma´laga, Spain
INTRODUCTION. The clotting factor recombinant human activated Proteinc C (APC) has
been shown to reduce mortality in septic patients, even though the mechanism is still under
discussion. The aim of the study is to relate the anticoagulation activity with clinical
parameters in these patients.
OBJECTIVES. Patients with severe sepsis or septic shock to assess clinical response, cel-
lular-damage parameters, resistance to APC, the relation with Factor V Gene and hospital
mortality adjusted to time variables and therapeutic treatment based on SSC guidelines.
METHOD. Cohort study of 38 critically ill ICU patients [18 years with a first-time
admission in a university hospital with severe sepsis or septic shock. Inclusion criteria: severe
sepsis or septic shock \24 h defined according to the SSC criteria. Age, sex, previous
pathology, sources of infection, coagulation and inflammatory markers during the first 24 h
were studied. For screening of resistance of APC, we use Dade Behring’s coagulation Proc Ac
R test with BCR’s analyzer, based on activation of the protein C endogenous for incubation of
plasma with the poison of Russell’s snake and posterior determination of the relationship of
the time of activation with and without the activator of the poison of the snake. The activation
and amplification of factor V DNA to the tarjeted patients will be done with the equipment
Light cycle of Roche laboratories by means of the PCR in time real by probes FRET
(Fluorescent Resonance Energy Transfer) and later we will identify possible mutations or
gene poliformism of this tarjet DNA by means of an analysis of curves of merger.
RESULTS. We analyzed 38 consecutive episodes of severe sepsis (16%) or septic shock
(84%) admitted in the UCI. Age: 57 ± 17.1 years; female: 56.8%. The beginning of the
sepsis took place in emergency area in 42% of the cases. The main sources of infection were:
lung 39.5% and abdomen 26%. 63% had medical pathology and 37% received treatment with
rhAPC. ICU mortality was 21%. The profile of death patients were women in a major
percentage (66%, n = 9), average is higher (63 vs. 56 years), as well as the score of clinical
severity, the APACHE II (26 vs. 21, p = 0.02) and SOFA (12.8 vs. 9, p = 0.001), with major
dysfunction organs (4.8 vs. 4.2).
We observed major consumption of protein C (46 vs. 85, p = 0.003) and antitrombin III (48
vs. 80, p = 0.001) in these patients. A whole of 38% (n = 14) received treatment with rhAPC
(28%, n = 4 in the deceased vs. 71%, n = 10 in the survivors). 12% (n = 4) of these treated
patients presented resistance to the Protein C activated and only one of them had hetero-
zygotic Factor V Leiden.
CONCLUSIONS. Preliminary results from this cohort study showed an improvement in the
survival in septic patients under a less consume of protein C. Our data found a scarce
percetange of patients with resistance to APC, due to genetic polymorphism of factor V
Leiden (25% of the cases). Futher research in prospective studies is needed.
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MATRIX-METALLOPROTEINASES 2, 8 AND 9 IN SEVERE SEPSIS—A PRO-
SPECTIVE LONGITUDINAL STUDY OF 44 PATIENTS
F. Gaddnas1, M. Sutinen2, M. Koskela1, T. Salo2, J. Laurila1, V. Koivukangas3, T. Ala-
Kokko1, A. Oikarinen4
1Oulu University Hospital, Department of Anesthesiology, Division of Intensive Care, Oulu,
Finland, 2Oulu University Hospital, Department of Dentistry, Oulu, Finland, 3Oulu University
Hospital, Department of Surgery, Oulu, Finland, 4Oulu University Hospital, Department of
Dermatology, Oulu, Finland
BACKGROUND. In addition to their role in remodeling the extracellular matrix the matrix
metalloproteinases (MMP) have various functions in inflammation and immune response.
PURPOSE. We measured the levels of MMP-2, MMP-8 and MMP-9 in serum and skin
suction blister fluid in order to examine the levels during and after severe sepsis.
MATERIALS AND METHODS. Forty-four patients with severe sepsis and fifteen healthy
controls were enrolled in this prospective longitudinal study. MMP-2, MMP-8 and MMP-9
were analyzed from serum on study days 1, 4, 6, 8 and 10 and from skin suction blister fluid
on days 1 and 5. Additively samples were obtained after three and 6 months from the
survivors.
RESULTS. In blister fluid MMP-8 was elevated in sepsis on days 1 and 5. Pro MMP-2 was
slightly elevated, and the active form was found only in patients with severe sepsis, but not in
controls. Pro MMP-9 was not increased, but again the active form was found only in severe
sepsis. In serum samples, MMP-8 was elevated in severe sepsis compared to controls and the
values had normalized at 3 and 6 months. MMP-2 was elevated until day 6 in sepsis compared
to controls. MMP-9 levels did not change in sepsis. In non-survivors the serum levels of
MMP-8, MMP-2 and MMP-9 were higher in survivors
CONCLUSIONS. Matrix metalloproteinases are elevated in serum and blister fluid in severe
sepsis. Furthermore the levels are higher in non-survivors. These results imply that matrix
metalloproteinases play a significant role in the pathogenesis of severe sepsis.
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KINETICS OF THE IMMUNOMODULATORY PROPERTIES OF ANTIBIOTICS
ON THE INNATE IMMUNITY DURING SEPSIS
C. Bode1, B. Ueberdiek1, O. Boehm1, H. Ehrentraut1, S. David2, P. Knuefermann1, G.
Baumgarten1
1Medical Center Bonn, Departmend of Anesthesiology and Intensive Care Medicine, Bonn,
Germany, 2Medical School Hanover, Department of Medicine, Division of Nephrology,
Hannover, Germany
AIMS. The innate immune system is a crucial factor in the pathogenesis of sepsis. Beside
their anti-infective efficacy, several antibiotics are able to alter the innate immunity towards
pro- or anti-inflammatory response. Some antibiotics have been identified to regulate the
expression of Toll-like receptors (TLRs) and cytokines. However, nothing is known about the
chronological order. The aim of this study was to investigate the kinetics of the immuno-
modulatory antibiotic moxifloxacine (MXF) on the expression of TLRs and proinflammatory
cytokines in an in vitro sepsis model.
METHODS. The monocytic cell line THP-1 was cultivated for 48 h in antibiotic free
medium. Thereafter, the cells were stimulated in three groups by either lipopolysaccharide
(LPS), MXF, the combination of LPS and MXF or phosphate buffered saline (PBS) as control.
The cells were harvested after 2, 6 and 24 h. The quantitative expression of TLR1, TLR2,
TLR4 and TLR6 was measured with real-time PCR after 2 and 6 h. The cytokines TNF-a and
IL-1b were quantified from the supernatant by ELISA after 2, 6 and 24 h. Statistical analyses
were evaluated using Kruskal–Wallis Test followed by Dunnett’s test. P values \0.05 were
considered to be significant.
RESULTS. MXF regulated differentially the expression of TLR 1: After 2 h, TLR1 was
significantly upregulated by MXF alone (1.38 ± 0.09 AU) and in combination with LPS
(1.46 ± 0.2 AU) compared to LPS group (0.71 ± 0.09 AU). Over the course of 6 h, MXF
abrogated the higher mRNA levels of TLR1 by LPS stimulation (2.55 ± 0.39 AU vs.
0.96 ± 0.28 AU). Corresponding to TLR1, the expression of TLR6 was also significant
upregulated in the MXF ? LPS group after 2 h [1.71 ± 0.33 AU vs. 1.15 ± 0.11 AU (PBS)
and 1.043 ± 0.18 AU (LPS)]. However, the expression of TLR2 and TLR4 was neither
influenced by MXF nor modified MXF the upregulation of TLR2 by LPS [1.51 ± 0.37
Arbitrary Units (AU) vs. 1.42 ± 0.10 AU]. The production of TNF-a after LPS treatment was
strongly suppressed by the costimmulation with MXF in the first 2 h (1,049 ± 148.2 pg/ml
vs. 316.1 ± 110.7 pg/ml) and remained significantly reduced after 24 h (891.3 ± 76.41 pg/
ml vs. 638.4 ± 87.66 pg/ml). In addition, IL-1b concentration was down-regulated in com-
bination of LPS with MXF than LPS alone at 24 h protein measurements (2,777 ± 93.34 pg/
ml vs. 1,545 ± 171.9 pg/ml).
CONCLUSIONS. MXF leads to a differential modulation of TLRs in a time-dependent
manner. The production of proinflammatory cytokines after LPS stimulation could be sup-
pressed by MXF at different time points. Thus, this study describes the time course for the
immunomodulatory effects of the antibiotic MXF in an in vitro sepsis model.
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HYPOXIA INDUCIBLE FACTOR-1a (HIF-1a) GENE EXPRESSION IS INCREASED
IN EXPERIMENTAL ENDOTOXAEMIA
A. Hall1, I. Welters1, M. Leuwer1
1University of Liverpool, Clinical Sciences, Liverpool, UK
INTRODUCTION. HIF-1a is a subunit of HIF-1, a transcription factor, whose levels are
increased under hypoxic conditions. Hypoxia reduces the activity of enzymes responsible for
the degradation of HIF. Previous studies have shown that in macrophages exposed to LPS,
HIF-1a promotes the production of inflammatory cytokines, such as TNFa, IL-1, IL-6, and IL-
12. This study also showed that in macrophages, HIF-1a mRNA levels are increased fol-
lowing stimulation by LPS [1]. HIF-1a signals via TLR4, interacts with NF-jB thus
contributing to the cytokine production of LPS-induced sepsis in vivo [1]. HIF-1a mRNA and
protein levels are also increased in adipose tissues during experimental endotoxaemia in mice
[2]. In this study, we have examined whether HIF-1a levels increase in muscle, spleen, liver
and small bowel following an LPS challenge.
METHODS. Lipopolysaccharide (LPS) (25 mg/kg) (Escherichia coli O 111:B4, Sigma-
Aldrich) was injected intra-peritoneally (ip) under general anaesthesia (2% isoflurane in N2O/
O2) into 8–10 week old male C57BL/6 J mice (Charles River, UK). Control animals were
administered equivalent volumes of normal saline, ip. All animals received 1 ml of normal
saline subcutaneously to compensate for fluid losses. Mice were killed at 4 or 24 h after
injection by cervical dislocation. Tissues were removed and immediately frozen in liquid
nitrogen. mRNA levels were determined by quantitative RT PCR in a 12.5 ll reaction volume
consisting of 12.5 ng of reverse transcribed cDNA mixed with optimal concentrations of
primers and probe and qPCRTMCore kit (Eurogentec, UK) in 96-well plates on a Mx3005P
detector.
RESULTS. HIF-1a mRNA levels were elevated in liver (6.5 fold; p = 0.02) and spleen (2.8
fold; p 0.008) 4 h post LPS injection. The changes persisted 24 h after LPS treatment with
increased expression in liver (3-fold; p = 0.01), small bowel (3.1-fold; p = 0.02) and spleen
(3.2-fold; p = 3.23 9 10-5).
DISCUSSION. Our results build on the increasing evidence that HIF-1a levels are increased
during experimental endotoxaemia. We observed a rapid increase 4 h after i.p. injection of
LPS in liver and spleen, which suggests early involvement of these organs in the inflammatory
changes during endotoxaemia. The HIF-1a mRNA levels begin to normalise in the 24 h group
which may indicate some form of cellular adaptation. It is not possible to determine whether
this increase in mRNA is secondary to tissue hypoxia or direct LPS stabilisation of the
molecule. Our results show that this effect is not limited to myeloid cells but also occurs in
tissue depots. Since increases in HIF-1a mRNA expression are not always reflected in HIF-1a
protein levels [3], further studies are warranted to ascertain consistency between HIF-1a
mRNA and protein expression and to explore the role of HIF-1a in sepsis.
REFERENCES. 1. Peyssonnaux C et al (2007) J Immunol 178:7516–7519.
2. Leuwer M et al (2009) Pflugers Arch-Eur J Physiol 457:731–741.
3. Trayhurn P et al (2008) Am J Physiol 295:R1097
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SERUM PROTEINS MODULATE LIPOPOLYSACCHARIDE (LPS) AND LIPOTEI-
CHOIC ACID (LTA)—INDUCED CELL ACTIVATION
J. Kilic1, F. Baldwin1, M.-A. Mouratis2, P. Lepper3, R. Haston2, S. Lowes1, C. Schumann4, T.
Hartung5, O. Boyd1, M. Triantafilou2, K. Triantafilou2
1Brighton and Sussex University Hospitals NHS Trust, Brighton, UK, 2University of Sussex,
Brighton, UK, 3University of Bern, Bern, Switzerland, 4University of Ulm, Ulm, Germany,
5University of Konstanz, Konstanz, Germany
INTRODUCTION. Bacterial structural outer cell wall components, such as LPS and LTA,
are potent initiators of an inflammatory response, but the initial interactions of these bacterial
components with serum proteins remains to be fully elucidated.
OBJECTIVES. In this study we identified serum proteins involved in the innate recognition
of bacterial products and compared proteomic profiles of sepsis survivors, non-survivors and
healthy volunteers. We also compared LPS/LTA-induced cytokine secretion in the presence
and absence of different serum proteins to explore potential immunomodulatory effects.
METHODS. Using affinity chromatography and mass spectrometry we performed a pro-
teomic analysis of LPS- and LTA-binding serum proteins. We isolated several proteins from
normal serum that can interact with LPS and LTA: albumin, LDL, apolipoproteins A-I, A-IV,
D, E, transferrin as well as haemoglobin. To investigate immunomodulatory effects, human
monocytes were incubated with different serum proteins prior to incubation with LPS or LTA
and then analysed for TNF-a concentration. Serum from 25 patients with severe sepsis or
septic shock [1] was analysed to quantify the concentration of the previously isolated LPS-
and LTA-binding proteins. Highly statistical significance was defined as **p \ 0.001 and
*p \ 0.05 statistically significant using the t test.
RESULTS. Cytokine assays revealed that serum proteins apolipoprotein, LDL, transferrin
and holotransferrin could reduce the production of TNF-a (p \ 0.05), suggesting that these
serum proteins are capable of modulating LPS/LTA-induced responses. When compared with
the proteomic profile of serum from septic patients, it was shown that these proteins were in
lower abundance than in healthy volunteers. (Fig 1)
CONCLUSIONS. This suggests that the right balance of these serum proteins in vivo might
be important in determining the pathogenesis of Gram-positive and Gram-negative sepsis. It is
also novel work that demonstrates that the proteins isolated and previously individually
linked with LPS are also associated with LTA.
REFERENCE. 1. Bone RC et al (1992) Definitions for sepsis and organ failure and
guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Con-
ference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
Chest 101(6):1644–1655.
GRANT ACKNOWLEDGEMENT. With thanks to the Biotechnology and Biological
Sciences Research Council, UK.
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DIFFERENCES IN ORGAN AND INFLAMMATORY RESPONSES IN ENDOTOXIN
TOLERANT PIGS EXPOSED TO A SECOND HIT OF ENDOTOXIN
M. Carlsson1,2, M. Lipcsey3, E. So¨derberg3, P. Skorup2, M. Eriksson3, A. Larsson4, J. Sjo¨lin2
1Ma¨larsjukhuset/Eskilstuna County Hospital, Anesthesia and Intensive Care, Eskilstuna, Sweden,
2Uppsala University, Infectious Diseases, Uppsala, Sweden, 3Uppsala University, Anesthesia and
Intensive Care, Uppsala, Sweden, 4Uppsala University, Clinical Chemistry, Uppsala, Sweden
INTRODUCTION. Pretreatment with a low dose of endotoxin has been shown to cause an
attenuation of the inflammatory cytokine release.
OBJECTIVES. To study whether endotoxin tolerance-induced reduction of the inflammatory
response is associated with attenuation in organ dysfunction development.
METHODS. 24 healthy pigs were randomized to 8 groups, Table 1, and given i.v. endotoxin infusion
for 30 or 6 h. The last 6 h, i.e. 24–30 h for the 30 h endotoxin infusion groups was compared to 0–6 h
for the 6 h endotoxin infusion groups. The start of the comparison was defined as baseline (Table 2)
TABLE 1






I 3 30 0.063 1
II 3 30 0.063 4
III 3 30 0.063 0.063
IV 3 30 0.25 1
V 3 30 0.25 4
VI 3 30 0.25 0.25
VII 3 6 1 N/A
VIII 3 6 4 N/A
TABLE 2
Group I IV VII II V VIII
TNF (log ng/L) Baseline (B) 2.13 ± 0.37 2.54 ± 0.06 2.78 ± 0.36 2.40 ± 0.21 2.52 ± 0.29 2.40 ± 0.06
B?6 h 2.30 ± 0.18* 2.57 ± 0.16* 3.79 ± 0.71 2.75 ± 0.34 2.84 ± 0.33 3.40 ± 0.30
Rel.change B?1 h 0.29 ± 0.28* -0.03 ± 0.22* 1.92 ± 0.71 1.35 ± 0.68 0.32 ± 0.27 2.41 ± 0.32
Rel.change B?6 h 0.17 ± 0.21* 0.03 ± 0.12* 1.01 ± 0.68 0.35 ± 0.15 0.33 ± 0.12 1.00 ± 0.24
PaO2/FiO2(kPa) Baseline (B) 39.8 ± 12.8* 27.4 ± 9.3* 62.6 ± 4.0 38.1 ± 17.8 41.7 ± 12.2 49.2 ± 11.5
B?6 h 41.5 ± 4.5 28.4 ± 14.1 42.3 ± 14.6 13.4 ± 3.2 18.9 ± 6.2 34.1 ± 7.2
Index B?3 h 1.2 ± 0.2* 1.0 ± 0.1* 0.4 ± 0.1 1.1 ± 0.8 0.8 ± 0.1 0.6 ± 0.2
Index B?6 h 1.1 ± 0.3 1.0 ± 0.4 0.7 ± 0.2 0.4 ± 0.1 0.5 ± 0.2 0.7 ± 0.1
RESULTS. VII and VIII had higher TNF-a than I and IV, and II and V, respectively. PaO2/
FiO2 ratio, pulmonary compliance, and base excess were not attenuated in I and IV and II and
V as compared to VII and VIII, respectively. II and V had lower values in PaO2/FiO2 and
compliance than VIII at the end of the experiment.
Absolute values at baseline and 6 h after baseline. Values relative to baseline at the time point
of the largest change and at the end of the experiment. Mean ± SD. *significant difference
(P \ 0.05) compared to VII significant difference compared to VIII
CONCLUSIONS. Endotoxemia during 24 h followed by a 4 to 64-fold increase in endotoxin
challenge for 6 h resulted in markedly attenuated inflammatory responses compared to animals not
primed with endotoxin. However, the responses in respiratory function and hypoperfusion were not
similarly attenuated and in animals given the highest second endotoxin hit, respiratory dysfunction
was even more evident than in the endotoxin tolerant animals.
TNF
Proteomic Profiles
22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009 S169
0653
PERSISTENT WHOLE BLOOD DECREASED TNF-A PRODUCTION AFTER LPS
STIMULATION IN SEPTIC ICU PATIENTS
P. Evangelopoulou1, P. Myrianthefs1, K. Venetsanou1, C. Kittas2, E. Manolis2,
G. Baltopoulos1
1KAT Hospital, Athens, Greece, 2University of Athens, Athens, Greece
INTRODUCTION. Sepsis is characterized by inflammation which may evolve to a state of
immunosuppresssion expressed as whole blood decreased cytokine production capacity. The
aim of the study was to examine the time frame of the resolution of immunosuppression
presented in septic critically ill ICU patients.
MATERIAL AND METHODS. We included critically ill ICU patients suffered a septic
episode that were followed-up for a period of 12 months. Whole blood was obtained on days
1, 4, 14, 21, 28 and on 2nd, 3rd, 6th, 12th month thereafter. Whole blood TNF-a production
capacity was evaluated ex-vivo after stimulation with LPS (500 pg) and incubation for 4 h.
Samples were then centrifuged and the supernatants were stored at -70C until TNF-a
measurements using the ELISA method.
RESULTS. We included 8 male patients (6 trauma patients, 2 ischemic stroke) with mean age
of 54.3 ± 7.9 years old and mean ICU stay of 54.6 ± 15.9 days, which presented septic
shock during their ICU stay. TNF-a after ex-vivo LPS stimulation is shown in Fig. 1.
Post LPS stimulation whole blood TNF-a p]
There was a progressive increase of TNF-a production capacity which however was still
under 500 pg/ml after 12 months. Analyzing individual patients we found that one patient
was immunocompetent on day 28th, two patients on 2nd month while the other five were still
immunosuppressed on 12 month evaluation.
CONCLUSIONS. Critically ill patients with sepsis suffer from immunosuppression
expressed as decreased TNF-a production after LPS stimulation which may persist for a
variable period of time after ICU and Hospital discharge.
ACKNOWLEDGEMENT. This study was partially funded by the Special Account for
Research Grant (ELKE/UOA; 4133/21-11-2006)
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EFFECTS OF INFLIXIMAB (REMICADE) AND GLUCOCORTICOIDS ON IN
VITRO LEUCOCYTE CYTOKINE RESPONSES AFTER STIMULATION WITH
LIPOPOLYSACCARIDE (LPS)
T. E. Ruud1, G. Yngvar1, C. D. Krohn1, O. Sveen1, A. O. Aasen1
1Oslo University Hospital, Institute for Surgical Research, Oslo, Norway
During severe inflammatory bowel disease, combination therapy with TNF-a antibodies (e.g.
infliximab), and other immune modulators is often used. Due to addictive immunosuppressive
effects such treatment may increase the risk of opportunistic infections. In a human whole
blood model we have studied the effects of different concentrations of infliximab and/or
glucocorticoids (hydrocortisone or methylprednisolone) on the concentrations of selected
cytokines after LPS stimulation. A multiplex antibody bead kit measuring 25 different
cytokines was used. Infliximab in plasma concentrations seen in patients shortly after an
injection (50–200 lg/ml), inhibited the concentrations of TNF-a, IL-1ra, MCP-1, IL-8 and IL-
12.When combined with methylprednisolone, the TNF-a and IL-1ra levels were further
reduced. A strongly suppressive effect was also seen with very low doses of infliximab (0.08
lg/ml) on the TNF-a concentration. Together with hydrocortisone, infliximab in low doses
enhanced the suppressive effects of hydrocortisone on TNF-a, IL-1b, IL-8 and MIP-a levels.
Immune modulating effects of infliximab were demonstrated even in very low concentrations
seen in patients several weeks after an injection due to a long half-life. Infliximab in all doses
tested enhanced the suppressive effects of glucocorticoids on cytokine concentrations.
ICU economics and management: 0655–0668
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IS RATIONING OF INTENSIVE CARE JUSTIFICALE? A COST EFFECTIVENESS
ANALYSIS
A. Artigas1, D. L. Edbrooke2, C. Minelli3, G. H. Mills2, A. Pezzi4, G. Iapichino5, P. Jacobs6,
D. Corbella4, C. Sprung7, Eldicus Study Group
1Sabadell Hospital-CIBERes, Critical Care Center, Sabadell, Spain, 2Sheffield Hallam Uni-
versity, Sheffield, UK, 3National Heart and Lung Institute, Sheffield, UK, 4Milano University,
Milano, Italy, 5Milano University, Milano, UK, 6University of Alberta, Edmonton, Canada,
7Hadassah Hebrew University Medical Center, Jerusalem, Israel
OBJECTIVE. To assess the cost effectiveness of admission to intensive care
DESIGN. A multi-centre observational study in 11 hospitals in 7 EU countries
SETTING. Intensive care units and hospital wards.
PARTICIPANTS. 7,659 consecutive patients referred for intensive care.
METHODS. 28-day mortality and total hospital cost were compared for patients accepted in
ICU versus patients not accepted and treated in the ward. Daily ICU and ward costs were
estimated using a top-down approach (cost-block method). Subgroup analyses were per-
formed by patient severity on admission (SAPSII predicted mortality:\5%, 5–40%,[40%).
Analyses of effectiveness and cost were performed using multilevel regression models
adjusted for age, Karnofsky score and indication for ICU admission.
RESULTS. Admission to ICU produced a relative reduction in mortality risk of 0.70 (0.52–
0.94; p = 0.017) at 28 days. When subdivided by predicted mortality, the risk of death was:
in the \5% predicted mortality group 1.49 (0.79–2.81; p = 0.213), in the 5–40% group 0.7
(0.51–0.97; p = 0.031) and in the [40% group 0.55 (0.37–0.83; p = 0.004). Average costs
per life saved, measured in dollars for all patients was $103,771; for 5–40% mortality risk was
$117,675 and [40% risk $60,046. Costs per life year saved were for all ICU admissions
$7,065, for 5–40% predicted mortality $8,012 and [40% $4,088. Results were very similar
when considering 3-month mortality.
CONCLUSION. Not only does ICU appear to produce an improvement in survival, but the
cost per life saved falls for those with a [40% risk of death. This suggests that ICU is cost
effective and the concept of rationing should be reconsidered.
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HOSPITAL COST ANALYSIS OF NOSOCOMIAL PMNEUMONIA ACCORDING
TO MECHANICAL VENTILATION REQUIREMENTS AT SOUTH AMERICA
E. Valencia1, E. Giron2, C. Vasco2, J. D. Valencia3
1Holly Heart of Jesus Clinic-CES University, Intensive Care-Epidemiology Master, Medellin,
Colombia, 2Holly Heart of Jesus, Intensive Care, Medellin, Colombia, 3Holly Heart of Jesus
Clinic, Medellin, Colombia
INTRODUCTION. Nosocomial Pneumonia is a health condition of an increasing importance
at the ICU, specially mortality and cost related. Based on a mechanical ventilation require-
ment two types of cost risk factor related are recognized: Nosocomial pneumonia associated
or not to mechanical ventilation. These differences may imply a distinct utilization of health
resources. Colombian registries comparing hospital cost of both two types of in-hospital
pneumonias in critically ill patients have not been performed yet, although nosocomial
pneumonia is prevalent in this population.
AIM. To analyze hospital cost of these two types of nosocomial pneumonia on critical ill
patients.
METHODS. One year data were collected and 218 patients participated in the study. From
218 patients admitted to the ICU, 9 (4.12%) developed nosocomial pneumonia, 209 (95.8%)
patients did not show nosocomial infection, and 55 (26.3%) patients from the last group were
on mechanical ventilation. The total cost from the two groups was compared and cost-
effective analysis was calculated. Cost variables analysed were: total pneumonia cost at the
ICU, total cost per patient, cost-effective ratio (patients who responds to the treatment as a
final aim), and total cost recovery from patients ICU management. Also was taken into
account the cost differences between the group of patients with or without mechanical ven-
tilation and nosocomial pneumonia.
RESULTS. Infection control was the outcome variable that was studied to evaluate cost-
effective ratio. Nosocomial pneumonia was no prevalent over the year. However, cost
management of this group of patients was higher than the patients without infection. To get a
patient free of nosocomial pneumonia with the treatment we should spend 5947 USD. In other
words, the cost to treat a patient with nosocomial pneumonia is 156.5 times more than a
patient without infection (Table 1).













































$ 1,852.958 (831) $ 213.777 (95)
CONCLUSION. Although the number of patients included was small, this study shows an
approach of the importance of hospital cost in both types of patients with nosocomial
pneumonia (with or without mechanical ventilation) in Colombia. Besides, what was clear the
cost-effective difference when a patient developed nosocomial pneumonia. South America
countries should start to spend more effort to reduce cost and focus on prevention of infection
at the ICU. This is a way of taking the first step for projecting health costs.
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MARKET SHARE OF HUNGARIAN INTENSIVE CARE UNITS FROM THE TOTAL
HOSPITAL CARE MEASURED BY THE DIAGNOSIS RELATED GROUPS (DRG)
SYSTEM
S. Varga1,2, L. Boga´r1, I. Boncz2, I. A´goston2, G. Vas2, A. Sebestye´n3, I. Kriszbacher4,
J. Betlehem4
1University of Pe´cs, Department of Anesthesiology and Intensive Care, Pe´cs, Hungary,
2University of Pe´cs, Department of Health-Economics, Policy and Management, Pe´cs,
Hungary, 3County Baranya Health Insurance Fund Administration, Pe´cs, Hungary, 4Univer-
sity of Pe´cs, Institute of Nursing and Clinical Sciences, Pe´cs, Hungary
AIMS. In the early 1990, a Diagnosis Related Groups-like financing system was introduced in
Hungary including all the Hungarian acute care hospitals. The aim of the study is to analyse
the market share of intensive care units (ICUs) according to DRG system.
METHODS. Data were derived from the financial database of the National Health Insurance
Fund Administration, the only health care financing agency in Hungary (1995–2008). All the
intensive care units were involved into the study. The following indicators were used for the
analysis: number of cases, the amount of DRG weight-number and total in-patients care
hospital days. Regression lines and Pearson coefficients (R2) were calculated.
RESULTS. Measuring by the number of cases (patients), the market share of intensive
therapy was between 0.84 and 0.98% in the first 4 years (1995–1998). In the next year a rise
in the market share happened to 1.45% and after that a continuously elevation was found to
1.8% until 2005. During the last 3 years the market share increased to 1.21. Comparing 1995
to 2008 the market share -measured by the number of cases- increased to 144%. Measuring by
the amount of DRG weight-number, the market share of intensive care within in-patients care
increased from 1.17% (1995) to 7.68% (2008) in Hungary. Comparing the start to the end of
the analysed 14 years (1995–2008) the reimbursement share in DRG weight-number
increased 6 times higher. The market share of ICUs from the total in-patients care hospital
days has been increased from 0.99% (1995) to 2.33% (2008). The Pearson coefficients (R2)
for number of cases, DRG weight-number and total in-patients care hospital days are 0.16;
0.90 and 0.97, respectively.
CONCLUSIONS. The market share and health insurance financial conditions of intensive
care units varied significantly between 1996 and 2008. The Hungarian health care reforms
between 2006 and 2008 had a significant effect on the market share and financial conditions of
intensive care units. The overall financial change of DRG system on the Hungarian intensive
care seems to be advantageous.
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DROTRECOGIN ALPHA—CUTTING COST, NOT CORNERS!
S. Jog1, T. Dravid1, P. Phadke2, R. Kulkarni2, N. Bapat2, P. Akole1, B. Pawar1
1Deenanath Mangeshkar Hospital and Research Centre, Intensive Care Medicine, Pune, India,
2Deenanath Mangeshkar Hospital and Research Centre, Internal Medicine, Pune, India
INTRODUCTION. Drotrecogin Alpha (DA) is an effective treatment in sepsis induced Multi
Organ Dysfunction Syndrome (MODS) especially in the presence of Septic Shock (SS)
Optimum duration of treatment of DA is 96 h infusion. Cost of DA infusion for 96 h is
average INR 480,000 (Euro7680) in India, whereas the average cost of 8 days of ICU
treatment of a patient with sepsis with MODS, including bed charges, organ support therapies,
drugs, laboratory investigations and consultation fees is approximately INR 120,000 (Euro
1920). Thus the cost of 24 h infusion of DA is approximately equal to the 8 day cost of
standard ICU care. It is unclear whether stopping DA before 96 h, in patients in whom SS
resolves before 96 h, ultimately affects outcome. This is more relevant in developing coun-
tries like India where cost of 96 h of infusion of DA is beyond the reach of majority of
patients eligible for DA. We performed a prospective study to evaluate this concept.
METHODS. During the period of June 2006 to December 2008, patients with severe sepsis
having C2 Organ Dysfunction (O.D.) were offered the option of DA as an adjunct therapy.
For those who opted for it, DA infusion was initiated within 24 h of onset of SS. DA infusion
was stopped before completion of 96 h only if septic shock was completely resolved,
otherwise was continued for 96 h. Other ICU care was provided as per contemporary standard
of care. All these patients were hemodynamically monitored in the ICU after stopping the
infusion.
RESULTS. 172 patients with severe sepsis having C2 Organ Dysfunction, were offered the
option of DA.18 patients opted for it. In 13 out of these 18 patients DA infusion could be
stopped before 96 h assuring complete reversal of septic shock. Their data were analysed
in this study. Average APACHE II and SAPS II scores were 22.23 ± 3.87and 53.92 ± 14.45,
respectively. 11 out of 13 patients were discharged home after complete recovery. Shock did
not reappear in the subsequent 72 h in any of the 13 patients. Two patients developed new
episode of Ventilatory Associated Pneumonia on day 4 and 10, respectively after stopping the
infusion of DA and could not be salvaged.
CONCLUSION. DA infusion can be safely stopped before completion of 96 h in patients
who show rapid reversal of SS. This is associated with significant cost saving without
compromising the outcome or quality of care (Table 1)
TABLE 1 PATIENT DATA
Variable Value
Duration of Shock before DA 15.92 ± 7.29 h
Complete Reversal of Shock after DA infusion. 50.84 ± 26.07 h
Duration of DA infusion 70.33 ± 20.76 h
Duration of ICU stay 11.61 ± 5.18 days
Total Hospital Bill till discharge or death Per patient (Excluding cost
of DA)
INR 230921 ± 147273 Euro
3694 ± 2356
Cost of DA infusion per patient INR 347,692 ± 38330 Euro
5563 ± 613
Cost saving due to early stoppage of DA (per patient) INR 132,308 ± 38,330 Euro
2117 ± 613
Ref -1Euro & INR 62.5(Average conversion rate in 2008)
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WHAT AFFECT MORE THE COST TO MANAGE PATIENTS AT THE ICU IN
SOUTH AMERICA: AN APPROACH BASED ON MULTIPLE REGRESION MODEL
E. Valencia1, S. Roldan2, F. Velasquez3, J. Calle4
1Holly Heart of Jesus Clinic-CES University, Intensive Care, Medellin, Colombia, 2Holly
Heart of Jesus Clinic-Remington University, Intensive Care, Medellin, Colombia, 3Holly
Heart of Jesus, Intensive Care, Medellin, Colombia, 4Holly Heart of Jesus, Medellin,
Colombia
INTRODUCTION. Cost management of patients at the ICU is important mainly when we
want to know the difference between bed cost, drugs, laboratory cost, radiology, procedures
and ICU piece of equipments. Based on ICU data base we may demonstrate which area
should be monitor to get a future cost reduction at the ICU.
AIM. To develop a multiple regression model to analyze the cost of the ICU.
METHODS. One year data were collected and 143 patients participated in the study. Patients
were admitted at the general mix ICU with patients with different type of pathologies: Septic
shock, neurologic patients, COPD, medical cardiovascular diseases, and postoperative
patients, etc. The average of the age was 63 years, and APACHE II score around 16. The cost
of its pathology was taken into account and also the cost of each analyzed group of data.
STATISTICS. Dependent variable was total cost at the ICU management, and independent
used variables were bed cost, drugs cost, lab cost, radiology cost, cost of procedures, healing
material cost, and piece of ICU equipments cost. SPSS 15 software was used to calculate the
model and 0.05 was considered statistic significant.
RESULTS. The complete and reduced model was get for each of seven groups of analysed
data by the method of variables selection. Correlation matrix was studied in order to get any
co-linearity problem. The t test for the complete model was significant for the majority of the
variables, F = 1164.04 (p = 0.000005), besides r2 up to 0.98, and Durbin-Watson was 1.98.
The multiple regression analysis showed association between total cost at the ICU and
variables such us bed, drug, lab, and equipments. For each increased million in lab cost, the
average of the cost management at the ICU is augmented up to 2.33 millions. Also, drugs cost
was the variable with more power in management total cost. Results of the complete model
are showed: *Total cost management = -1,229.631 ? (1.08 9 bed) ? (2.33 9
lab) ? (0.85 9 drug) ? (1.13 9 procedure) ? (1.14 9 radiology) ? (0.10 9 material) ?
(1.22 9 equipment).
CONCLUSION. This study shows an approach of the importance of hospital cost at the ICU.
We have detected high power by drugs in total cost management of patients and also the
influence of laboratory in final results. In order to reduce cost at the ICU the management
should be not only focus on stay but also in what kind of drugs are formulated to the patients,
and the right indications of laboratory test. South America countries should start to spend
more effort to reduce cost and focus on ‘‘mal-cost-practice’’ at the ICU (Table 1)
TABLE 1 MULTIPLE REGRESSION MODEL RESULTS (COLOMBIAN
PESOS)









Healing material 0.10 0.25
ICU piece of equipments 1.22 0.87
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HOW DEFINE WHEN THE MANAGEMENT WILL COST MORE THAN 978 USD
PER DAY AT THE ICU IN SOUTH AMERICA? AN APPROACH BASED ON
LOGISTIC REGRESION MODEL
E. Valencia1, Y. Gil2, L. A. Loaiza2, A. Zapata3
1Holly Heart of Jesus Clinic-CES University, Intensive Care-Epidemiology Master, Medellin,
Colombia, 2Holly Heart of Jesus Clinic, Nurse Intensive Care, Medellin, Colombia, 3Holly
Heart of Jesus Clinic, Respiratory Therapist, Medellin, Colombia
INTRODUCTION. Based on ICU data we may demonstrate a formula to calculate the
probability to have a cost higher than 978 USD per day at ten ICU. Colombian registries
comparing hospital cost in critically ill patients have not been performed yet, although
intensive care is one of the most expensive services at the hospital.
AIM. To develop a logistic regression model to analyze the cost of the ICU.
METHODS. One year data were collected and 143 patients participated in the study. Patients
were admitted at the general mix ICU with patients with different type of pathologies: Septic
shock, neurologic patients, COPD, medical cardiovascular diseases, and postoperative patients,
etc. The average of the age was 63 years, and APACHE II score around 16. The cost management
at the ICU was split: 1 = More than 978 USD and 0 = less than 978 USD and it was defined as a
dependent variable. Included as an independent variables were all risk to increase the cost at the
ICU: Age, hour of admition, sex, re-intubation, and severe sepsis classification, mechanical
ventilation requirements at the ICU, tracheotomy, nutrition score risk, and ARDS.
STATISTICS. SPSS 15 software was used to calculate the model and 0.05 was considered
statistic significant.
RESULTS. The complete model was get for each of nine groups of analysed data by the
method of variables selection. The model showed a Nagelkerke r2 up to 0.79, and Hosmer and
Lemeshow test Chi2: 2.34 (p = 0.938). The logistic regression analysis showed that the cost
higher than 978 UDS could be explained by the model. When all variables remain constant, a
patient with a reduction in one point in NSR will have a cost OR reduction up to 0.26, and is
statistic significant. Complete model are showed in Table 1. *Probability to get a cost higher
than 978 USD per day management (%) = 1/1 ? 2.7188282-Z. z = 7.21924 - 0,046 (h) ?
0,225(age) - 5,201(sex) - 34,193(Re-intubation) - 13,115(Sepsis severe) ? 45,557
(Mechanical ventilation) - 20,175 (Tracheo) ? 1,326 (NSR) ? 30,475 (SDRA)
TABLE 1 LOGISTIC REGRESSION MODEL RESULTS (COL PESOS)
Variables in the equation b Coefficient Constant = 7,219 Wald Exp (b) = OR
Hour 0.046 0.018 1.04
Age -0.225 2.432 0.79
Gender 5.201 0.621 181.55
Re-intubation 38,285 2,974–6 4,2316
Severe sepsis 13,115 2,131 4,965
Mechanical ventilation -45.557 4.212–6 1.63–20
Tracheotomy 20.175 1.574 5.788
Nutri-score (NSR) -1.326 1.454 0.26
ARDS -30.47 5.480 5.81–14
CONCLUSION. We have detected some sensible variables to explain if the management of
patients at the ICU will require a cost higher than 978 USD per day. In order to reduce cost at the
ICU the management should be not only focus on stay but also in what kind of procedures and
complications appear inherence to the patients or to the management of theirs pathologies. South
America countries should start to spend more effort to reduce ’’mal-cost-practice’’ at the ICU.
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AUDIT OF COST OF INTENSIVE CARE IN AN INDIAN CANCER HOSPITAL
A. P. Kulkarni1, J. Divatia1
1Tata Memorial Hospital, Anaesthesiology, Critical Care and Pain, Mumbai, India
INTRODUCTION. ICU costs, a major component of health care costs, are rising all over the
world. Limited data is available for ICU costs in India.
OBJECTIVES. To find out the costs of intensive care and compare the costs of care for post-
surgical cancer patients with those admitted from oncology ward.
METHODS. The fixed costs were obtained from respective departments. A specially
designed form was filled for calculating variable costs.
RESULTS. Data for variable cost was collected for 101 patients, admitted between 8
November and 29 December 2005. There were 55 postoperative admissions. The ICU LOS
was less for postoperative admissions [64.84 (58.47) vs. 106.84 (64.05) h]. The ICU mortality
was higher in patients admitted from the ward (43.47 vs. 3.6%, p \ 0.05). The mean daily
variable cost of care was 176.37 US$ for all patients, being much higher for patients admitted
from the ward (223.93 vs. 122.06 US$, p = 0.002), excluding professional fees and room
charges. In decreasing order, blood and blood products, drugs (mainly antibiotics), investi-
gations and cardiovascular monitoring were the main components for the variable costs in
ward patients, as these were mainly hematooncology patients. Investigations and imaging was
the highest component of variable costs in postoperative patients. The fixed cost per patient
(assuming 100% occupancy and 650 admissions per year) was 467.56 US$. Salaries of
medical and support staff (67.65%), electricity (10.1%), and equipment (6.99%) were the
main contributors to the fixed costs. Continued use of old equipment (with low or zero
depreciated value) may have led to low costs for equipment. In 2006, the average daily
income for an Indian national was 1.99 US$.
CONCLUSION. Cost of intensive care in India appear to be lower than those in the
developed countries. Intensive care is costlier for patients admitted from oncology ward as
compared to postoperative cancer patients. However from the perspective of much lower
average daily income and absence of national health schemes and insurance cover, these costs
are staggeringly high.
REFERENCES. 1. Jacobs P, Edbrooke D, Hibbert C. Measuring and predicting ICU cost per
patient day: a literature review. Institute of Pharmaco-Economics Working Paper 98–11.
2. ESICM Working group on Cost effectiveness in intensive care medicine available at
http://www.esicm.org, on request.
3. Edbrooke DL, Stevens VG, Hibbert CL et al (1997) A new method of accurately identi-




EXPERIENCES TO BE AVOIDED: DETERMINANTS OF NON-OPTIMAL SATIS-
FACTION IN ICU-PATIENTS
A. W. Schindler1,2, N. Schindler2,3, A. Lueck2, F. Enz2, D. A. Vagts2,4
1KMG Hospital Guestrow, Anaesthesiology and Intensive Care Medicine, Guestrow, Ger-
many, 2University of Rostock, Anaesthesiology and Intensive Care Medicine, Rostock,
Germany, 3University of Rostock, Psychosomatic and Psychotherapeutic Medicine, Rostock,
Germany, 4Hetzelstift Hospital, Anaesthesiology and Intensive Care Medicine, Neustadt/
Weinstraße, Germany
INTRODUCTION. Due to considerable ceiling effects [1] it is futile to ask ICU patients for
their general satisfaction with their treatment. Instead, analysing the experiences of not
optimally satisfied patients as the ‘‘tip of the iceberg’’ can help to discover important causes of
adverse perceived service quality as a measure of outcome quality [2]. Using a questionnaire
we studied which experiences contribute to optimal (oSat) versus non-optimal satisfaction
(noSat) with care in perioperative ICU patients.
MATERIAL AND METHODS. 82 consecutive patients were interviewed anonymously 2–
7 days after discharge from ICU (written informed consent, ethical committee approval) using
a questionnaire to evaluate subjective experiences. One item on ,,general satisfaction’’ and 31
items on intrapersonal (I1–14), communicative (C1–10) and somatic aspects (S1–7) had to be
answered on a 4-point-Likert-scale (1 = full agreement, 4 = full disagreement) [1]. These
medical descriptors were registered: prevalent and acute diseases, SAPS II, SOFA, TISS-28,
interventions, medication, length of stay and of ventilator therapy. Statistics: optimally sat-
isfied patients (‘‘general satisfaction’’: full agreement) were compared to non-optimally
satisfied patients (‘‘general satisfaction’’: no full agreement). Receiver-operating-character-
istic (ROC) curves compared oSat and noSat patients for each separat item. Stepwise forward
regression was used to find independent determinants of dissatisfaction regarding partial
correlations and usefulness (experiences and medical descriptors) [3]. p\ 0,05.
RESULTS. 66 of 82 patients were oSat. ROC-analysis suggested group differences in 17 of
31 aspects; as expected, noSat patients consistently described less desirable experiences.
Stepwise logistic regression revealed that 1 intrapersonal and 2 communicatory aspects
independently determined the group difference (I4: I could trust the staff members; C1: I could
communicate and I was understood; C7: I was treated kindly). Somatic experiences and
medical descriptors did not distinguish between the groups.
CONCLUSIONS. Experiences of patients who are not optimally satisfied with the received
ICU care can be analyzed detailledly to detect causes of adverse perceived service quality.
Our results underline that communicatory and intrapersonal aspects strongly influence this
measure of outcome quality.
REFERENCES. 1. Schindler AW et al (2007) Poster 806; ESCIM Annual congress.
2. Parasuraman A et al. J Marketing 49:41–50,
3. Bortz Statistik 6. Auflage, Springer Heidelberg
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THE RISK OF UNDERESTIMATION OF PATIENT-SUBJECTIVE BURDENS BY
ICU STAFF INCREASES WITH TREATMENT INTENSITY
A. W. Schindler1,2, N. Schindler2,3, F. Enz2, A. Lueck2, D. A. Vagts2,4
1KMG Hospital Guestrow, Anaesthesiology, Guestrow, Germany, 2University of Rostock,
Anaesthesiology and Intensive Care Medicine, Rostock, Germany, 3University of Rostock,
Psychosomatic and Psychotherapeutic Medicine, Rostock, Germany, 4Hetzelstift Hospital,
Anaesthesiology and Intensive Care Medicine, Neustadt/Weinstraße, Germany
INTRODUCTION. Service providers’ wrong guesses about clients’ experiences during a
service encounter are one form of client-professional-gaps (cp-gaps), and cp-gaps are likely to
cause suboptimal service quality [1]. We have shown that cp-gaps can exist between ICU
patients and ICU staff [2]. We hypothesized that cp-gaps are modified by treatment intensity.
MATERIAL AND METHODS. 82 consecutive patients were interviewed anonymously 2–
7 days after discharge from ICU (written informed consent, ethical committee approval) using
a questionnaire to evaluate subjective experiences. General satisfaction and 31 items on
intrapersonal (I1-14), communicatory (C1-10) and somatic aspects (S1-7) had to be answered
on a 4-point-Likert-scale (1 = full agreement, 4 = full disagreement)1. Staff was interviewed
analogously with a questionnaires focussing on staff’s assumptions about patients’ experi-
ences. Length of stay (LOS), duration of mechanical ventilation (DOMV) and the sum of all
TISS 28- and SAPS II-score values cumulated during the whole ICU stay (Rscores) were used
as indicators of treatment intensity. Statistics: Patients answers were weighed for each
measure of treatment intensity (LOS, DOMV, RScores). After weighing, Receiver-operating-
characteristic (ROC) curves analyzed cp-gaps for each separat item. Stepwise forward binary
logistic regression was used to find independent determinants of cp-gaps [3]. p\ 0,05.
RESULTS. In general, cp-gaps were found rather in the intrapersonal and communicative
than in the somatic sphere. Multivariate analysis showed that patients’ burdens were over-
estimated by the staff, when treatment intensity was not taken into account. Alarmingly,
increasing treatment intensity led to underestimation of some of the patients’s burdens by the
staff (blind spots). Blind spots were particularly found in the intrapersonal sphere and in
mechanically ventilated patients.
CONCLUSIONS. Treatment intensity increases the risk that ICU staff underestimates
patients subjective burdens during an ICU stay. Mechanically ventilated patients are at par-
ticular risk that their burdens remain unrecognized.
REFERENCES. 1. Parasuraman A et al. J Marketing 49:41–50,
2. Schindler AW et al (2007) Poster 809; ESCIM Annual congress.
3. Bortz Statistik 6. Auflage, Springer Heidelberg.
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PREDICT: INCREASING THE PARTICIPATION OF THE ELDERLY IN CLINICAL
TRIALS. PRELIMINARY DATA
G. H. Mills1,2, A. Beswick3, A. Cherubini4, J. Oristrell5, C. Hertogh6, K. Szczerbinska7, V.
Lesauskaite8, G. I. Prada9, A. M. Clarfield10, E. Topinkova´11, P. Crome12, PREDICT Study
Group
1Sheffield Teaching Hospitals NHS Trust, Critical Care Department, Sheffield, UK, 2MERCS,
Sheffield, UK, 3Department of Social Medicine, University of Bristol, Bristol, UK, 4Perugia
University, Perugia, Italy, 5Sabadell Hospital, Sabadell, Spain, 6Vrije Universiteit Medisch
Centrum, Amsterdam, Netherlands, 7Jagellonian University Medical College, Krakow,
Poland, 8Kaunas University of Medicine, Kaunas, Lithuania, 9Ana Aslan National Institut of
Gerontolgy and Geriatrics, Bucharest, Romania, 10Ben Gurion University of the Negev, Beer
Sheva, Israel, 11Charles University, Prague, Czech Republic, 12University of Keele, Keele
University Medical School, Keele, UK
INTRODUCTION. Effective treatments may be available for many conditions that affect
older people. However, the evidence that supports these treatments may have been drawn
from patients who were of a younger age range for reasons such as avoidance of comorbidities
and polypharmacy, potential difficulties of understanding or simply established research
habits.
OBJECTIVES. Therefore a nine nation Framework 7 project (Czech Republic, Italy, Israel,
Lithuania, Netherlands, Poland, Romania, Spain, UK) was established to assess clinical trials
in a range of conditions that affect older people (heart failure, hypertension, coronary heart
disease, Alzheimer’s disease, depression and colorectal cancer). These areas commonly
impact on the recovery of older people from critical illness.
METHOD. 5 work packages were established: (1) Systematic Reviews within the literature
covering these areas were examined, plus an assessment of the WHO International Clinical
TrialsRegistry of ongoing trials conducted into the treatment of heart failure. (2) An inves-
tigation into the opinions and experiences of medically related professionals and ethicists to
inclusion of the elderly. (3) An investigation into the opinions and concerns of patients and
their relatives/carers regarding inclusion of the elderly and how participation might be
increased. (4) The conclusions of the first two workpackages will be used to develop a
Patients’ Charter for use across Europe and beyond that will guide future studies to increase
the participation of the elderly in clinical trials wherever this is feasible. (5) The data gathered
and conclusions drawn, including the Charter will be disseminated widely and used for a basis
for further study, development and progress.
RESULTS. 358 relevant articles published up to 2008 were identified. Under-representation
of older people was demonstrated in trials of treatments in a range of conditions. This is often
because of exclusion criteria that relate to comorbidites and concurrent treatments. Little has
been published on ways to increase participation. Seventy currently ongoing trials in heart
failure were identified. These demonstrated a similar picture with fewer than 10% of trials
including patients over 80.
CONCLUSION. The initial workpackage has confirmed that under representation of the
elderly has and is occurring in clinical trials. Why this is occurring and how this can be
reasonably changed will be investigated in workpackages 2 and 3. Initial data suggest a
Charter for the Elderly is necessary (which will impact on all areas of clinical trials) and this
may suggest that a specific assessment of critical care studies may be worthwhile.
GRANT REFERENCE.
Supported by the European Union, FP7 health research, grant number HEALTH-F4-2008-
201917
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INTENSIVE CARE UNIT PHYSICIANS: SOCIODEMOGRAPHIC PROFILE,
WORKING CONDITIONS AND FACTORS ASSOCIATED TO THE BURNOUT
SYNDROME
D. S. Barros1, M. O. S. Tironi2, C. L. N. Sobrinho3, E. J. F. B. Reis4, E. S. M. Filho5, J. M. M.
Telles6, A. G. V. Bitencourt7, F. S. Neves8
1Hospital Santa Izabel, UTI Clı´nica, Salvador, Brazil, 2Universidade de Salvador, UNIFACS,
Salvador, Brazil, 3Universidade Estadual de Feira de Santana, Departamento de Sau´de, Sal-
vador, Brazil, 4Universidade Federal da Bahia, Departamento de Medicina Preventiva,
Salvador, Brazil, 5Hospital Santa Izabel, Salvador, Brazil, 6Hopital Portugueˆs, UTI Geral,
Salvador, Brazil, 7Universidade Federal da Bahia, Salvador, Brazil, 8Escola Baiana de
Medicina e Sau´de Pu´blica, Salvador, Brazil
AIMS. Burnout syndrome is a response to prolonged occupational stress involving three main
dimensions: emotional exhaustion, depersonalization and reduced personal accomplishment.
This study aimed to describe socio-demographic characteristics of intensive care unit phy-
sicians and evaluate factors associated to the presence of Burnout syndrome in this
population.
METHODS. A cross-sectional study was performed to evaluate physicians who have worked
in critical care in the city of Salvador, Bahia, Brazil, with a minimum weekly workload of
12 h. An anonymous self-reported questionnaire, divided in two parts: socio-demographic
characteristics and evaluation of the Burnout syndrome was used according to the Maslach
Burnout Inventory.
RESULTS. From a total population of 333 intensivists, 297 (89%) were studied, most of
them male (70%). The mean age and time after graduation were, respectively, 34.2 and
9 years. The mean medical weekly workload was 72 h. High levels of emotional exhaustion,
depersonalization, and reduced personal accomplishment were found in, respectively, 47.5,
24.6 and 28.3%. Prevalence of the Burnout syndrome, considered as high level in at least one
dimension, was of 63.3%. This prevalence was statistically lower in physicians specialized in
intensive care, as weel in intensivists who reported a hobby or had regular physical activity.
Prevalence was higher in physicians who worked in the intensive care units for more than 24
uninterrupted hours per week. Intensivists with burnout syndrome had lower mean scores of
quality of life evaluated by Whoqol–Bref questionnaire.
CONCLUSIONS. Burnout syndrome had a very high prevalence among critical care phy-
sicians and it was more frequent in the physicians with a higher workload. Therefore,
consideration must be given to measures which might be adopted to modify working con-
ditions, the physician-patient relationship and the motivation of these professionals.
KEYWORDS. Burnout, professional/psychology; Stress; Working conditions; intensive care
units.
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DEMAND-CONTROL MODEL AND BURNOUT SYNDROME IN INTENSIVISTS
FROM SALVADOR, BAHIA, BRASIL
M. O. S. Tironi1, C. L. N. Sobrinho2, D. S. Barros3, E. S. M. Filho4, J. M. M. Telles5, E. J. F.
B. Reis6, A. Almeida7, Y. G. Souza7
1Universidade de Salvador, UNIFACS, Salvador, Brazil, 2Universidade Estadual de Feira de
Santana, Feira de Santana, Brazil, 3Hospital Santa Izabel, UTI Clı´nica, Salvador, Brazil,
4Hospital Santa Izabel, UTI Ciru´rgica, Salvador, Brazil, 5Hospital Portugueˆs, UTI Geral,
Salvador, Brazil, 6Universidade Federal da Bahia, Departamento de Medicina Preventiva,
Salvador, Brazil, 7Universidade Federal da Bahia, Salvador, Brazil
INTRODUCTION. The Demand–Control Model is a worldwide used model that evaluate
the psychological impact of stroke. According to the D–C model, job strain results from the
interaction of two main dimensions of the work environment: psychological demands and
control. The Job Content Questionnaire (JCQ) has been proposed as an instrument for
measuring these work dimensions. Burnout Syndrome is a response to prolonged occupational
stress that involves three main dimensions: emotional exhaustion, depersonalization, and
reduced personal accomplishment.
AIMS. This cross sectional study investigated the association between control-demand model
and Burnout Syndrome in a population of 333 intensivists physicians from Salvador City,
State of Bahia, Brazil.
METHODS. 297(89%) intensivists were reported. An individual, self-report questionnaire
has evaluated the doctors’ psychological aspects of work, using the demand-control model
(Job Content Questionnaire) and their mental health, by using the Maslach Burnout Inventory
(MBI).
RESULTS. The study found excessive work overload, high proportion of doctors on duty,
low income according to hours worked. The prevalence of Burnout Syndrome was 7.4%
considered as high level in three dimensions and it was much strongly associated with the
aspects of work psychological demand than with work control. Doctors in high strain (high
demand and low control) presented prevalence of Burnout Syndrome 10.2 times higher than
those in low strain (low demand and high control) jobs.
KEYWORDS. Work conditions, mental health, demand–control model, Burnout Syndrome,
Intensivists
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ICU MANAGEMENT: THE EFFECT OF HIRING A NURSING DIRECTOR ON
STAFF TURNOVER RATE
F. V. De Marco1, N. C. Leite2, R. Nunes1
1Hospital Vivalle, ICU, Sao Jose dos Campos, Brazil, 2Hospital Vivalle, Human Resources
Department, Sao Jose dos Campos, Brazil
INTRODUCTION. ICU is a complex and stressful environment. High staff turnover is a
major problem that can impact clinical and financial performance. Hospitals leaders have to
set best managerial practices when running this high cost unit in order to assure good talent
management. Leadership is an important issue that can affect job fulfillment and retention of
skilled health professionals. There are controversial data on literature about the best model of
leadership delivery in ICU.
OBJECTIVES. The aim of this study was to evaluate the effect of hiring a nursing director
on staff turnover rate (TR).
METHODS. We retrospectively collected data on TR between November 2006 and Sep-
tember 2008 in our 8-bed ICU (300 admissions per year). We considered two different periods
of observation, the first one (October 2006–September 2007) as pre-intervention (PI) with the
ICU coordinated only by a certified ICU physician and the second one as intervention (I)
period (October 2007–September 2008) with the coordination being shared between a phy-
sician and an intensive care trained nurse. In the I period there was a co-management
responsibility over the multiprofessional team and human resources policy.
RESULTS. TR data are shown in graph 1. The mean TR decreased in the I period (53 vs.
34%; p = 0.09) but it did not reach statistical significance. There were no differences in ICU
occupancy rate (42 vs. 40%; p = 0.82), APACHE II score (11 vs. 12; p = 0.47) and ICU
mortality (8.4 vs. 9.2%; p = 0.72). We observed a difference in ICU staff head count (25 vs.
27; p = 0,009) that could have contributed to reduce workload and TR in I period. Even with
observed trend toward decreased rates in the I period our unit was underperforming in
comparison with other Brazilian units with TR ranging from 25 to 30%.
CONCLUSIONS. We were unable to demonstrate any benefit because our study was not powered
to do so. Further investigation is needed to show if a nursing director could positively impact ICU
staff TR and if co-management between physicians and nurses could better align talent allocation
with ICU business strategy setting the stage for improved clinical and financial operations.
Graph 1
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ICU BUSINESS: EFFECTS OF TV ADVERTISING AS A STRATEGY TO INCREASE
ADMISSIONS AND OCCUPANCY RATE
F. V. De Marco1, E. Oliveira2, F. C. Bruno2
1Hospital Vivalle, ICU, Sao Jose dos Campos, Brazil, 2Hospital Vivalle, Marketing Depart-
ment, Sao Jose dos Campos, Brazil
INTRODUCTION. ICU is a high fixed costs business and private hospitals are facing a
highly competitive commercial environment. In this setting, volume of new admissions and
occupancy rate are directly related to revenue generation, investment capacity and attractivity
to strategic clients. In order to achieve financial viability hospitals have to develop a suc-
cessful marketing mix and choose the appropriate channels of communication. Since critical
care typically has been viewed as a service provided by a hospital, and not a product line,
business plans have not historically been developed to expand and promote critical care.
There are scarce data about the effects of marketing actions on ICU productivity.
OBJECTIVES. The aim of this study is to determine the effects of hospital-directed TV
advertising campaign on ICU admissions and occupancy rate.
METHODS. Our 8-bed ICU operates on overcapacity considering Brazilian standards and
the size of our hospital (50-bed). Between January 2005 and December 2008 we collected
data on admissions and occupancy rate considering that in 2006 and 2007 the hospital
engaged on TV advertising. The themes of the campaigns were hospital-directed and not ICU-
focused. For data analysis we considered three periods: period 1 (01/05–03/06) as pre-
intervention period, period 2 (04/06–12/07) as intervention period (insertions on TV) and
period 3 (01/08–12/08) as post-intervention period (with no insertions on TV).
RESULTS. Data on occupancy rate and its temporal relationship with TV insertions are
shown in graph 1. We admitted 1,044 patients during the study period. We observed a
decreased number of admissions per month in the intervention period when we compared
period 1 and period 2 (24 vs. 18, p = 0.04) and period 2 with period 3 (18 vs. 23, p = 0.03).
We have found an increased occupation rate in the intervention period (36 vs. 40 vs. 38%,
NS) and an increased occupancy peak/mean ratio (2.03 vs. 2.16 vs. 1.55, NS) but it did not
reach statistical significance. We also observed a progressive increase in participation of
emergency room as origin of new ICU admissions (6 vs. 22 vs. 26%, NS) Graph 1.
CONCLUSIONS. We were unable to demonstrate any incremental benefit of TV advertising
on ICU admissions and occupancy rate. As our study considered only a campaign with
sporadical TV insertions and a not ICU-focused strategy, further work is necessary to
determine the effects of regular insertions with ICU-focused themes.
Graph 1
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IMPROVING QUALITY, SAFETY AND COSTS BY IMPLEMENTING A PERFOR-
MANCE MEASUREMENT AND MANAGEMENT APPROACH FOR COMMON
INVESTIGATIONS IN THE ICU
M. E. Wilcox1,2, J. M. Singh1,2, K. Chung1, N. M. Lazar1, S. McIntaggart2, T. E. Stewart1,3
1University of Toronto, Interdepartmental Division of Critical Care and Department of
Medicine, Toronto, Canada, 2University Health Network, Toronto, Canada, 3Mount Sinai
Hospital, Toronto, Canada
INTRODUCTION. Quality and safety in health care are receiving widespread attention,
prompting efforts to decrease practice variation, increase adherence to evidence-based
guidelines, monitor processes, and measure outcomes of patient care. We developed an
approach for integrating evidence-based practice into test ordering and evaluated its impact on
3 common investigations in the intensive care unit (ICU) using a before-after approach.
METHODS. A committee was struck involving hospital administration, clinical experts,
local physician champions and other stakeholders. The committee reviewed financial data and
test utilization patterns to identify high-volume or high-cost investigations for which local
expert opinion felt best practices implementation might improve patient care and decrease
inappropriate utilization. Best practice policies were developed based on existing guideline
statements or expert consultation. These policies were then operationalized using techniques
and tools from Six Sigma’s Develop–Measure–Analyze–Design–Verify–Process. Our strat-
egy included adapting the order interface of the local computerized order entry system using
principles of user interface design. We collected monthly utilization data on the targeted
investigations and reported and disseminated results to front-line care providers. Compliance
with the developed evidence-based guidelines was also reported.
RESULTS. We identified the ordering of serum troponin-I, chest radiographs and blood
culture draws as the target investigations. Following the generation of best-practice policy and
model development, appropriate laboratory testing of troponin-I improved by 18% (from 42%
in the 12 months prior to intervention to 60% over the 6-month project period; p \ 0.05),
with trend towards a reduction in the total number of tests ordered per week in each ICU
(from 532 to 437 pre- and post-intervention; p \ 0.05). A total reduction of chest X-rays
ordered weekly was also observed (average of 116 vs. 80 per week pre- and post-intervention;
p \ 0.01). The compliance for ordering of chest radiographs increased from a pre-interven-
tion baseline of 40% to an average of 83% (p \ 0.001). Lastly, the proportion of paired blood
culture draws increased from 18 to 58% over a 6-month period (p \ 0.001).
CONCLUSION. Our structured, process-oriented intervention model improved compliance
with evidence based guidelines and reduced inappropriate utilization over a 6-month period.
Our methodology for performance measurement and management to implement best practice
is applicable to most areas of healthcare.
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AN EXAMPLE OF PLURAL DEVICE OF ANALYSIS OF THE MORTALITY IN AN
ICU
K. D. Tonduangu1, P. Adande1, D. Gizolme1, S. Naisseh1, R. Malaca1, F. Jungfer1
1Centre Hospitalier de Sens, Sens, France
OBJECTIVES. The mortality translates the unfavourable outcome and is a major element of
the dashboard in an intensive care unit. The raw statistics of deaths are not relevant enough.
So the medical team has set up a plural device of analysis to carry a critical glance on the way
the patients are taken care, including French regulatory framework and intensivists guidelines.
The aim of this communication is to share our experience and contribute to the reflexion about
ICU performance measure.
METHODS. 8 items: 1. Percentage of the deaths: it is the administrative required data. 2.
Severity of the current disease: the SAPS II Score is used for all the ICU patients for the valuation
of stays in France and allows a comparative approach; however the scale of the distance between
predicted versus observed mortality puts the focus on the methodological limits of the tool. 3.
Health status: autonomy (KNAUSS) and pre-existent diseases (MAC CABE) are determinant
for the prognosis. 4. Length of stay before death: related to the SAPS II score, it focuses on the
admission policy. 5. Therapeutic limitations: decided, respectively to the legal procedure, they
influence the statistics and the length of stay. 6. Mortality and morbidity review: since 2001 every
death is analysed, and now according to the recognized method of the national accreditation
agency, in order to detect unwanted events and identify their avoidability. 7. Follow-up after
ICU release: consulting administrative data and phone survey beside familial doctors gives a
more global approach of the effective result of the stay and neutralize a special release policy. 8.
Iatrogenic factor for the admission: used data for risk management and public health.
RESULTS.
1. 15.98%
2. See Table 1
TABLE 1 SEVERITY OF THE CURRENT DISEASE




All patients 44 15.98% 34.8%
Dead patients 71.5 100% 82.6%
Surviving patients 38.5 0% 23%
3. See Table 2
TABLE 2 HEALTH STATUS
MAC CABE SCORE 1 2 3 KNAUS SCORE A B C D
All patients 92 199 28 50 168 91 10
Dead patients 5 37 9 4 26 19 1
Surviving patients 87 162 21 46 142 72 9
4. See Table 3
TABLE 3 LENGTH OF STAY BEFORE DEATH
Stay length before death \24 24/48 h J3 a` J7 J8 a` J20 [20 J
No of patients/% 10/6% 11/22% 15/28% 12/24% 3/6%





CONCLUSION. The statistics of deaths examined without enough precision do not inform
about medical performance and care. This experimental device allows our team to have an
interesting analysis of each case and of local policy. A complete benchmark approach through
shared indicators is required to optimise the reflex ion.
REFERENCES. 1. Guidet B (2003) Introduction a` l’analyse de la performance en
re´animation . Re´animation vol 12.
2. Lilian Minne (2008) Evalaution of SOFA-based models for predicting mortality in the ICU:
a systematic review. Crit Care.
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CHARACTERIZING THE PROFILE OF RISK OF HOSPITAL MORTALITY IN
DIFFERENT ICUS
P. Bauer1, H. Hochrieser1, B. Metnitz1, P. Metnitz1, R. P. Moreno2
1Medical University of Vienna, Vienna, Austria, 2Unidade de Cuidados Intensivos Poliva-
lente, Hosp. de St. Anto´nio dos Capuchos, CHLC, E. P. E., Cascais, Portugal
INTRODUCTION. We propose a new method to visualize the profile of risk within a subset
of patients, e.g. of patients admitted to a specific ICU over a given period of time. Risk
adjustment can be based on any score S predicting a dichotomous outcome variable. As an
example we further on consider SAPS 3 predicting hospital mortality at admission to the ICU.
MATERIALS AND METHODS. To develop a method compute the profile of risk within a
subset of patients we calculate the SAPS 3 value at which the hospital mortality p is predicted
inverting the function which predicts the risk of hospital mortality published in Moreno et al.
(2007). We call this value SAPS 3p.
From the subset of patient data in a single ICU (indexed by i) we estimate the risk of hospital
mortality pi(SAPS) in this specific ICU based on a logistic regression model with the SAPS 3
score of the individual patients as the single predictor. This simple model will in general
produce reasonable parameter estimates even if the sample sizes in the individual ICUs are
rather limited. We then plot the relative ICU-specific risk estimate ri = pi(SAPSp)/p as a
function of p together with its point-wise confidence intervals. Thereby we achieve an
appealing graphical presentation of the risk profile within the ICU over the whole span
relative to the hospital mortality p estimated from the large SAPS 3 data set together with its
variability.
RESULTS. We applied the method to the ICUs in the SAP3 data set and compared the
estimated individual risk profiles to those estimated by non-parametric methods. The simple
method achieved a satisfactory fit of the ICU-specific relative risks with a tendency of slightly
overestimating the relative risk for patients with extremely low risk (and consequently
extremely low values of the expected risk in the denominator). We also looked at the results
when patients in the very low risk categories are excluded from estimating the ICU-specific
risk profile. Truncating the samples at 5 and 95%, respectively of predicted mortality achieved
the best results, because it does not truncate too many patients, improves the fit at the low tail
and has practically no impact at the high tail.
The graphical distribution of all histograms for the Hosmer–Lemeshow Goodness-of-fit Test,
presented as the density of the CHIsqare distribution with 8 degrees of freedom, demonstrates
a quite good fit.
CONCLUSIONS. The method presented here for the first time allows the use to have a
graphical presentation of the risk profile within the ICU over the whole span relative to the
hospital mortality, and not just a point estimate as when using the classical Standardised
Mortality Ratio method.
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EFFECTS OF ORGANIZATIONAL CHANGE IN THE CARDIAC SURGICAL ICU:
COMPARISON INTENSIVIST-LEAD MODEL VERSUS SURGEON-LEAD MODEL
A. Kogan1, E. Segal2, Y. Kasiff1, P. Ghosh1, S. Preisman3, E. Raanani1
1Sheba Medical Center, Department of Cardiothoracic Surgery, Ramat Gan, Israel, 2Sheba
Medical Center, Intensive Care Unit ‘A’, Ramat Gan, Israel, 3Sheba Medical Center,
Department of Anesthesiology, Ramat Gan, Israel
INTRODUCTION. The practice of cardiac surgery has become increasingly complex and
high risk. Increasing complexity of cardiac surgical cases requires a new level of critical care
performance. The aim of the study was evaluation of the impact of a newly appointed
intensivist on cardiac surgical intensive care unit patient outcomes and quality of care
variables.
MATERIALS AND METHODS. We performed observational cohort study with historical
controls in eight-bed cardiac surgical intensive care unit (CSICU) in tertiary university
hospital. Mortality, ventilation time, length of stay in the CSICU and hospital (LOS) were
compared between two 24-month periods, before and after the appointment of intensivist.
Data regarding these patients were collected using the department database.
MEASUREMENTS AND MAIN RESULTS. We analyzed 1,646 patients before (first
period) and 1,548 patients after (second period) the intensivist appointment. The unadjusted
in-hospital mortality decreased from 6.68% (110 patients) in the first period to 4.78% (74
patients) in the second period (p \ 0.01). The mortality predicted according to EuroSCORE
was 8.76 ± 11.3% in the first period and 8.9 ± 12.5% in the second (NS). Mean ventilation
time was unchanged—37 ± 119.2 versus 37.7 ± 108.2 h (NS). Mean ICU LOS and mean
hospital stay were unchanged—2.8 ± 6 versus 3.1 ± 6.7 days (NS) and 8.8 ± 11.3 versus
8.9 ± 12.5 days (NS). ICU readmission rate decrease from 4.8 to 3.1%. In the very high risk
groups (EuroSCORE[10) mortality decrease from 37.03 to 15.32% (p [ 0.01). In the group
of patients B70 years old mortality decrease from 11 to 6.81% (p \ 0.05). In the low,
intermediate and high risk groups (EuroSCORE 0–3, 4–6, 7–10) and in the groups of patients
younger than 70 mortality was unchanged.
CONCLUSIONS. The appointment of intensivist-led team model in the cardiac surgical
intensive care unit was associated with decreasing ICU mortality, particularly in the very
high-risk group and elderly patients. These findings can be interpreted as providing support
for the hypothesis that intensivist-driven ICU model may result better outcome.
S174 22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009
0673
DISPARITIES IN MANAGEMENT PRACTICES FOR ACUTE CORONARY SYN-
DROME AT DIFFERENT HEALTH CARE DELIVERY SITES AND IMPACT ON IN-
HOSPITAL OUTCOME
A. Kumar1, M. Somani1, R. C. Ahuja2, S. Gattani3
1Avadh Hospital And Heart Centre, Critical Care Medicine, Lucknow, India, 2King George’s
Medical University, Medicine, Lucknow, India, 3Avadh Hospital And Heart Centre, Cardi-
ology, Lucknow, India
INTRODUCTION. Coronary artery disease (CAD) in contemporary society has
afflicted population in an epidemic proportion. The increasing prevalence of CAD is likely to
make the situation worse in near future. India and other similar countries have a hospital
based disease oriented health care delivery system which is not organized to equity of care
and extremely varied care ranging from rudimentary to the best available in the world for the
management of Acute coronary syndrome (ACS) are available
OBJECTIVES.
1. To document the management practices of ACS and their impact on in- hospital outcome
at different health care delivery sites
2. To document the reasons for disparities in management practices of ACS at different sites
3. To develop package(s) of educational material to address the important disparities in
management practices of ACS so as to achieve a specified standard of care at different sites
MATERIALS AND METHODS.
Study design. An interviewer administered questionnaire based cross sectional survey and
validation of reported practices vis a vis actual practices by reviewing case records
Subjects. Health care providers (HCP) taking care of patients of ACS and attendants of
patients of ACS admitted at sites of study.
Sites. Government, teaching, tertiary hospital, Government, teaching and non teaching,
secondary hospital, Private, nonteaching, secondary hospital.
METHODS. HCP of the study sites were interviewed by the investigator and with their
permission information was abstracted about current practices for managing consecutive 20
patients with ACS under their care.
RESULTS. Oxygen administration was not guided by oxygen saturation by 35% of HCP.
Thrombolysis was done inappropriately by 14%, 95% CL; 6, 26 of HCP. Heparin was used
inappropriately by 41%, 95% CL; 28, 55 of HCP.b blockers were used inappropriately by 32%,
95% CL; 20, 46 of HCP. I/V b blockers were inappropriately not used by 39%, 95% CL; 26, 53 of
HCP. Nitrates were used inappropriately by 78%, 95% CL; 65, 88 of HCP. ACE Inhibitors were
used inappropriately by 35%, 95% CL; 23, 49 of HCP. Pre-discharge risk stratification of patients
by HCP varied from 14 to 93%. 0.96% of HCP were aware of recent guidelines for managing
patients of ACS. Validation of reported practices showed that the actual appropriate practices were
5–50% lower than reported. Lack of resources (96%) lack of regular updates of guidelines for ACS
(91%), lack of trained staff were the main reasons for disparities in management of ACS at
different sites. Maximum mortality 21%, 95% CL; 11, 34 and maximum dissatisfaction with
treatment 37%, 95% CL; 28, 56 was seen at site where inappropriate practices were maximum. The
cost of treatment at various sites varied from Rs3815 ± 1821 to Rs12923 ± 4612
CONCLUSIONS. Management practices for ACS at various sites vary despite similar
patient characteristics and are associated with significant differences in the in-hospital out-
comes. Formulating and applying requisite measures in form of appropriate package(s) can
improve survival and cost effectiveness.
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LIMITED NETWORKING BETWEEN INTENSIVE CARE UNITS IN
SWITZERLAND
A. Klarer1, C. Hoess2, M. Maggiorini1
1University of Zurich, Medical Intensive Care Unit, Zurich, Switzerland, 2Kantonsspital
Mu¨nsterlingen, Intensive Care Unit, Mu¨nsterlingen, Switzerland
INTRODUCTION. The demographic evolution of the population in our country, the
increasing polymorbidity of patients admitted to the hospital and the increasing standard of
life challenge intensive care unit (ICU) capacities to admit critically ill patients. Therefore, to
optimize ICU bed availabilities, there is an increasing need for networking between large and
small ICUs in our country.
OBJECTIVES. To investigate the need and director’s willingness of establishing a network
of ICUs in Switzerland with regard to patient allocation as well as postgraduate training and
continuing medical education (CME) of ICU physicians.
METHODS. A questionnaire containing 19 questions and illustrations of 7 clinical situations
was sent to the medical directors of all ICUs accredited by the Swiss Society of Intensive Care
Medicine (SSICM). The 19 questions were divided in three parts: the first section was spe-
cifically designed to obtain information on the organization and structure of the ICU. The
second identified criteria for patients’ transfer in several clinical conditions. The third
investigated the actual and possible future practice of postgraduate training and CME of
physicians employed on an ICU. The survey was voluntarily anonymous.
RESULTS. A total of 92 questionnaires was sent, 28 questionnaires were returned, providing
a 30% response proportion. 7 (25%) were small ICUs (B6 beds), 14 (50%) medium sized
ICUs (7–9 beds), 5 (18%) large ICUs (C10 beds). In two answers (7%), the number of ICU
beds was missing.
Most ICUs of small and medium size perform 1–5 patients’ transfers per month, large ICUs
perform less (\1 per month). 73% of transfers are performed due to medical reasons, which
are preferentially acute respiratory failure [acute lung injury (ALI) or acute respiratory dis-
tress syndrome (ARDS)] and circulatory shock. In contrast, small ICUs tend to keep post-
surgical patients and patients with ALI/ARDS. Large ICUs are willing to accept any kind of
pathologies, preferentially patients with circulatory failure and ALI/ARDS. Further reasons
for transfer are missing capacity of ICU beds and limited resources with regard to infra-
structure and personnel.
Current postgraduate training and CME programs are network based in 85% of all ICUs. Of
the small/medium sized ICUs, 42% include a large ICU in their CME network, whereas the
remaining are organized within a regional network of small/medium sized ICUs.
CONCLUSIONS. The results of the present survey indicate that networking for patients’
care between ICUs is limited and mostly unidirectional from small/medium sized to large
ICUs. Conversely, there is considerable networking with regard to postgraduate training and
CME of ICU physicians. The fact that patients with ALI/ARDS are preferably kept in small
ICUs could have an impact on patient safety.
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SURVEY OF ATTITUDES AND BEHAVIORS OF HEALTHCARE PROFESSION-
ALS ON DELIRIUM IN THE ADULT AND PEDIATRIC INTENSIVE CARE UNIT IN
CHINA
B. Cheng1, X. Liu2, G. Xie1, Y. Jin1, T. Zhu1, X. Fang1
1The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China,
2The Chindren’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
INTRODUCTION. Delirium is a common yet underdiagnosed neuropsychiatric disorder in the
intensive care unit (ICU), which is defined as an acute change in mental status or a fluctuating
courses, impaired attention and disorganized thinking. Delirium could be caused by a general
medical condition or its treatment and contribute to poor short and long term outcomes, but little is
known about healthcare professionals’ opinions regarding delirium or how they manage it, and
no study on professionals’ attitudes and behaviors of delirium conducted in China has been.
OBJECTIVE. To assess the medical community’s attitudes and practices regarding delirium in
the adult and pediatric intensive care unit (ICU) in China.
METHODS. A questionnaire survey was distributed to healthcare professionals including 31
doctors, 75 nurses and 4 respiratory therapists (RT) in the first affiliated hospital of Zhejiang
university and the affiliated children’s hospital of Zhejiang university between Feb 2009 and May
2009. 110 questionnaires was send to these two ICUs and participants completed 105 of the
surveys (95.5% was finished).
RESULTS. Eleven percentages of the respondents thought[50% of their patients experience
delirium in ICU. Delirium in ICU was considered a significant or very serious problem in the
intensive care unit by 78% of respondents, and underdiagnosis was acknowledged by 56.2%,
while, 35.2% showed unaware of the characteristics of delirium. Brain injury, hypoxemia and old
age were regard as the leading causes of delirium, and 70.5% respondents ignored the influence of
sedative and analgesia therapy on delirium. 80% respondents thought delirium should be treated,
but neither regular screening for delirium, nor using a specific tool for delirium assessment was
conducted in the two ICUs.
CONCLUSIONS. In present survey, delirium is a poorly aware problem to the healthcare pro-
fessionals in the adult and pediatric ICU in China. Practitioners using none of a specific screening
tool to assess critical care patients for delirium. The results of this survey provide data to draw
professionals’ attention on the perceived importance and practices of monitoring and treatment of
delirium in the ICU in China.
REFERENCE(S). 1. Ely EW, Shintani A, Truman B et al (2004) Delirium as a predictor of
mortality in mechanically ventilated patients in the intensive care unit. JAMA 291:1753–1762.
2. Ouimet S, Kavanagh BP, Gottfried SB et al (2007) Incidence, risk factors and consequences of
ICU delirium. Intensive Care Med, 33:66–73.
3. Cheung CZ, Alibhai SM, Robinson M et al (2008) Recognition and labeling of delirium
symptoms by intensivists: does it matter? Intensive Care Med 34(3):437–446. 4. Patel RP,
Gambrell M, Speroff T et al (2009) Delirium and sedation in the intensive care unit: Survey of
behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 37:825–832.
GRANT ACKNOWLEDGEMENT. None.
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LENGTH OF STAY IN NORDIC ICUS
H. Flaatten1, S. Walther2, J. Martner3, T. Nolin4, K. Strand5, P. Mussalo6, M. Reinikainen7,
T. Ala-Kokka8, Nordic ICU Outcome Research Group
1Haukeland University Hospital, ICU, Bergen, Norway, 2Linkøping University Hospital, Dept
of Cardiothoracic Anaesthesia and Intensive Care, Linkøping, Thailand, 3Sahlgrenska Uni-
versity Hospital, Anaesthesia and Intensive Care, Gothenburg, Sweden, 4Kristianstad
Hospital, Anaesthesia and Intensive Care, Kristianstad, Sweden, 5Stavanger University
Hospital, ICU, Stavanger, Norway, 6Intensium Ltd., Kuopio, Finland, 7Kuopio University
Hospital, Kuopio, Finland, 8Oulu University Hospital, Oulu, Finland
The determinants for length of stay in the ICU (LOS-ICU) are several. The severity of illness
in critical ill patients plays a major role, but LOS-ICU may also reflect organisational factors
like admission criteria, staffing and availability of intermediate care units. The main goal of
this study was to analyze the ‘‘normal’’ variation of LOS in ICUs in Finland, Sweden and
Norway.
METHODS. Routinely collected and validated data from three Nordic national ICU registries
(Finland, Sweden and Norway) was merged for admissions in year 2006 (n = 53.305). LOS
was registered as the number of hours spent in the ICU converted to days. Comparison of LOS
was performed with regard to country, age groups and type of hospitals. Analysis was also
performed with regard to the further expected LOS defined as mean LOS-ICU for each group
minus days already spent in the ICU. Mean and 95% are given for LOS values where needed.
RESULTS. Mean LOS (all admissions) was 3.2 days ranging from 4.77 days (4.62–4.92) in
Norway, 3.26 days (3.17–3.35) in Finland and 2.55 days (2.49–2.61) in Sweden. One major
reason for this was the different distribution of LOS-ICU groups (shown in the Fig. 1) where
both Sweden and Finland had large groups of patients staying\24 h in the ICU. Only 1.1% of
all admissions had a LOS above 4 weeks. In the group aged [80 years the mean LOS-ICU
was 2.5 days (2.36–2.58) compared to 3.3 (3.25–3.37) days in patients\80 years. LOS-ICU
in the university hospitals was 3.5 days (3.46–3.62), in regional/central hospitals 3.1 days
(3.01–3.17) and in local hospitals 2.7 days (2.59–2.83).
The expected further LOS at different interval from day 1 to 28 is shown in the Table 1.
TABLE 1 EXPECTED FURTHER LOS-ICU
1 day 2 days 3 days 4 days 5 days 6 days 7 days 14 days 21 days 28 days
3.2 4.0 5.2 6.2 7.0 7.6 8.2 8.8 11.2 14.2
CONCLUSIONS. Most patients have a short LOS-ICU in Nordic ICUs with only 1% defined
as long admissions. There are obvious country differences in admission policy to the ICU.
Younger patients and patients in University hospital have an increased LOS-ICU.
LOS-ICU in different countries
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MORTALITY COMPARISON BETWEEN ICU PATIENTS ADMITTED DURING
DAYTIME AND NIGHT SHIFTS
F. V. De Marco1, M. E. Rodrigues1, M. M. Barbosa1, W. M. Imanishi1, A. L. Guimaraes1
1Hospital Vivalle, ICU, Sao Jose dos Campos, Brazil
INTRODUCTION. There is a growing concern among ICU clinicians and hospital managers
about patient safety. In this context, issues like budget restraints, shortage of skilled pro-
fessionals and excessive workload in ICU may put patients admitted on night shifts at risk of
worse outcomes. These issues could gain special importance in small private hospitals with
low volume of patients and squeezed operating margins. There are controversial data on
literature about this topic.
OBJECTIVES. This study is aimed at determining whether mortality rates among ICU
patients differ according to the time of ICU admission.
METHODS. We have collected prospectively data on consecutive ICU admissions between
April 2003 and July 2007 in our 8-bed unit of a 50-bed private hospital. Patients were grouped
according to their time of admission and compared using univariable and multivariable
analyses. We have considered nigh shift the period between 18:00 pm and 7:00 am.
RESULTS. There were 1,641 consecutive patients. Of these patients, 677 (41.7%) were
admitted at night shifts. The group admitted at nigh shifts were more critically ill according
the APACHE II score (9.6 vs. 8.0, p \ 0.001), stayed at ICU for longer periods (4.3 vs. 3.0,
p \ 0.001), used more supportive procedures like mechanical ventilation (24.2 vs. 15.7%,
p = 0.001), CVC insertion (29.7 vs. 22.3%, p = 0.001), parenteral nutrition (8.9 vs. 5.8%,
p = 0.018), developed more nosocomial infections like surgical site infections (1.9 vs. 0.5%,
p = 0.007) and had a higher in-hospital mortality (10.2 vs. 7.4%, p = 0.043). The unadjusted
odds ratio for night shift admission and in-hospital mortality was 1.43 (95% confidence
interval, 1.01–2.02) but when we have adjusted for initial disease severity the effect of the
time of ICU admission on mortality disappeared.
CONCLUSIONS. In our ICU, night shift admissions were not associated with higher mor-
tality.
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COMPLIANCE WITH FAST HUG EVIDENCE BASED PRACTICES IN A GEN-
ERAL ICU
F. V. De Marco1, M. E. Rodrigues1, M. M. Barbosa1
1Hospital Vivalle, ICU, Sao Jose dos Campos, Brazil
INTRODUCTION. The application of Fast Hug mnemonic (Feeding, Analgesia, Sedation,
Thromboembolic prophylaxis, Head-of-bed elevation, stress Ulcer prevention and Glucose
control) may help improve the quality of care received by ICU patients. It can be used as a
checklist and helps the multiprofessional team to deliver evidence based care at the bedside.
OBJECTIVES. The aim of this study was to determine the proportion of critically ill patients
meeting Fast Hug evidence based practices.
METHODS. The study was conducted in a 8-bed medical and surgical ICU of an private
hospital. Between january 2006 and December 2008 we collected prospectively data from
every patient admitted to our ICU. We considered the following indicators to define com-
pliance to Fast Hug : early administration of enteral nutrition (48 h), proportion of 12 h-shifts
with pain classified as moderate or intense during nursing assessment, proportion of wake-up
call (sedation vacation) practice in mechanically ventilated (MV) patients, pharmacological or
mechanical prophylaxis of deep venous thrombosis for at risk patients, proportion of venti-
lator-days maintaining a C30-degree head-of-bed (HOB) elevation, pharmacologic stress
ulcer prevention for patients on MV and proportion of patient-days receiving enteral or
parenteral nutrition support (nutrition-days) with glucose levels above 170 mg/dl.
RESULTS. We admitted 737 consecutive patients (417 male), the mean age was 53.8 years,
the mean APACHE II score was 10.5, ICU LOS was 4.6 days, SMR was 0.8 and overall ICU
mortality was 10.3%. Compliance data are shown in Table 1.
TABLE 1
Indicator (for eligible patients) Results (%) Standard (%)
Early administration of enteral nutrition 75 100
Proportion of 12 h-shifts with pain 4.5 zero
Proportion of wake-up call practice 43 80
Prophylaxis of deep venous thrombosis 70 90
C30-degree HOB elevation 99 97
Stress ulcer prevention 98 95
Hyperglicemia on nutrition support 32 25
CONCLUSIONS. These preliminary data show there is a variation in translating clinical
evidence into clinical practice and that some practices gain more acceptance than others
among ICU staff. We need to identify the drivers of clinical acceptance in order to deliver
quality care for critically ill patients.
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PROMOTING INFECTION CONTROL IN THE ICU USING A TARGETED ‘PUSH-
AND-PULL’ INTERVENTION
C. Agvald-O¨hman1, J. Struwe2, H. Hanberger3, S. Walther4
1Karolinska University Hospital Huddinge, Department of Anaesthesiology and Intensive
Care, Stockholm, Sweden, 2Karolinska Institutet, Swedish Institute for Infectious Disease
Control, Solna, Sweden, 3Faculty of Health Sciences, Linko¨ping University, Dept of Clinical
and Experimental Medicine, Linko¨ping, Sweden, 4Linko¨ping University Hospital, Dept of
Cardiothoracic Anaesthesia and Intensive Care, Linko¨ping, Sweden
INTRODUCTION. Working with quality improvement in health care is of increasing
importance. Many interventions are of the type ‘‘push’’, an activity which focuses on a goal-
directed project that often leads to changes in behaviour on a short term basis. ‘‘Pull’’
interventions that focus on follow up, feedback of results, review and audit of the unit are
rarer.
OBJECTIVES. To assess if a ‘‘push-and-pull’’ intervention targeted at nosocomial infections
in the ICU could promote changes in practices that were stable over time.
METHODS. The intervention ‘‘push’’ was a 1-day local session offered to 30 Swedish ICUs
of which 12 could participate. The subject was infection control practices, particularly
focusing on diagnosis and prophylaxis of nosocomial infections in the ICU. New methods for
diagnosing ventilator-associated pneumonia (VAP) and intravascular device (IVD)-related
infections were introduced. These were quantitative endotracheal aspirates (QEA) for VAP
and time to hub-positivity for diagnosing intravascular device (IVD)-related infections in situ.
A general overview of how to improve compliance with infection control measures to reduce
nosocomial infections was also discussed interactively. Teaching was planned in concert with
a group of experts but undertaken by only one of us (CAO¨).
The next intervention ‘‘pull’’ started with a letter to the physician-in-charge at all units
5 months after the 1-day session. It was a reminder of what had been discussed during the
visit and a promotion of a questionnaire that would be sent 6 months after the visit. The
questionnaire focused on what changes in diagnostic tools and registration that actually had
been performed since the intervention.
RESULTS. Compliance to infection control hygiene measures was a focus in 10/12 ICUs
already from the start, and the remaining 2 ICUs started a programme after the ‘‘push’’
session, all units said that motivation to work with these issues had increased after the visit.
QEA as a complement to other microbiological samples, was used by 4/12 before and 6/12 six
months after the session. Time to hub-positivity to diagnose IVD related infections was used
by 3/12 ICUs before and 7/12 after the session. The majority of the units that had not started
to use the two methods yet, had started collaboration with their laboratories to implement
these techniques.
CONCLUSION. This pilot study indicates that a targeted ‘‘push-and-pull’’ intervention could
be a method to reach desirable changes in order to improve infection control. Periodically
follow-ups are needed during a period of 2–5 years to assess if changes are sustained, or if
additional interventions of type ‘‘push-and-pull’’ are needed.
GRANT ACKNOWLEDGEMENT. The Swedish Intensive Care Registry (SIR) and the
Swedish strategic programme against antibiotic resistance (Strama).
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HAND HYGIENE FREQUENCIES IN INTENSIVE CARE UNIT, KING FAHAD
HOSPITAL HOFUF, SAUDI ARABIA
M. Chaudhary1, A. Al Hilal2, E. Alsaleh3
1Ministry of Health, King Fahad Hofuf Hospital, KSA, Infection Control, Hofuf, Saudi
Arabia, 2Al Mana Hospital, Hofuf, KSA, ICU, Hofuf, Saudi Arabia, 3King Fahad Hofuf
Hospital, Infection Control, Hofuf, Saudi Arabia
BACKGROUND. Hand hygiene is a basic for the control of nosocomial infection. Our study
revealed the poor compliance with hand hygiene in health care workers. We attempted to
enhance compliance with hand hygiene by implementing education, training, and perfor-
mance feedback.
METHODS. We monitored the overall compliance with hand hygiene during routine patient
care in intensive care unit of King Fahad Hospital Hofuf, Saudi Arabia, for compliance of
hand hygiene before patient examination, after patient examination and after any procedure
on patient. This was done before implementation of a hand hygiene education, training, and
performance feedback program. Observational surveys were done from in the ICU for
6 months in 2007.
RESULTS. We observed 2,286 Opportunities for hand hygiene in ICU Patient care. Com-
pliance to hand washing was 31.1%. Used Hand hygiene 31.1% As indicated before or after
(overall) 4.1% As indicated before doing any procedure 40.8% As indicated after doing any
procedure 54.3% As indicated after removing gloves
CONCLUSION. Overall compliance of hand hygiene in ICU is low and a program consisting
of focused education and frequent performance feedback may produce a sustained
improvement in compliance with hand hygiene.
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AN AUDIT OF IV PARACETAMOL USAGE ON THE INTENSIVE CARE UNIT
(ICU) IN AMNCH
C. Gowing1, V. Bhagwan1, M. Donnelly2
1AMNCH, Pharmacy Department, Dublin, Ireland, 2AMNCH, Intensive Care Unit, Dublin,
Ireland
AIMS/OBJECTIVES.
• To undertake an audit of IV paracetamol usage on ICU with respect to appropriateness and
cost implications of it’s use.
• To carry out a survey of ICU nurses regarding current practice with respect to paracetamol
administration.
METHODOLOGY. The study was conducted prospectively from mid March to April 2008
• Each patient’s prescription chart was reviewed on each visit to ICU and the number of
doses of IV paracetamol received in the preceding 24 h was recorded.
• Medical and nursing notes were also reviewed for fluid, mobility and feeding status
A questionnaire was designed to assess nurse practice with respect to paracetamol
administration.
RESULTS. Audit.
In total, 86 doses of IV paracetamol were administered during the data collection time frames
reviewed. Of these, 25 (29.1%) were deemed appropriate, i.e. the patient was receiving no
other medicines by a non-IV route. 61 doses (70.9%) were deemed inappropriate, i.e. the
patient was receiving their regular medications via a non-IV route (NG/PO). No patient was
written up for all four routes, i.e. IV/NG/PO/PR and no patient received paracetamol via the
PR route.
Questionnaire
23 questionnaires were completed by ICU nurses. If paracetamol was written up for all routes
(IV/NG/PO/PR), 95.7% of respondents agreed that they would change the route of admin-
istration as the patient’s condition changed.
If a patient was nil by mouth, 30.4% of nurses would administer paracetamol via the PR route,
69.6% would not.
IV Paracetamol use has a high opportunity cost (1 g QDS IV for 24 h = €22.08, 1 g QDS PO
for 24 h = €0.08), therefore the inappropriate prescription and use of IV paracetamol must be
addressed.
RECOMMENDATIONS.
• Present results back to relevant stakeholders (nurses and doctors) including a poster
format for ICU.
• Achieve buy-in from all stakeholders and educate them re: cost savings.
• Consider making soluble sachets stock on ICU to facilitate NG administration.
• To implement changes and review usage of IV paracetamol in ICU in the future to see if
usage has decreased and to continue the audit cycle.
• To evaluate appropriateness of IV paracetamol use hospital-wide in AMNCH.
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LONG-STAY CRITICALLY ILL PATIENT: A COMPLEX PROBLEM IN THE
DEVELOPING COUNTRY
K. Baccar1, N. Baffoun1, M. Ben Salah1, C. Kaddour1
1Institute of Neurology, Anesthesiology and Critical Care, Tunis, Tunisia
INTRODUCTION. In our country the number of intensive care (ICU) bed per head of
population is much lower. The pressure on ICU bed is considerable [1]. The goal of this study
was identify characteristics and outcomes of these patients in ICU for a long time stay.
METHODS. Data from all patients admitted to our a 10-bed ICU were collected retro-
spectively from consecutive adult patient requiring at least 30 days of ICU admitted between
January 2004 and December 2008.
We recorded details of the course and compared survivors and non-survivors: age, diagnosis,
total number of ICU days, duration requiring invasive ventilator support (Vm) with or with
out renal replacement therapy, severity illness scores: [APACHE II], MODS and Omega score
[2] and outcomes.
RESULTS. During 5 years study period there were a total of 1,619 patients admitted in our
ICU. 78(4.8%) of them met the inclusion criteria.
The mean age was 40.3 years [16–75]. The median duration of stay was 47 days [range 31–
135]. The reason for admission was medical diseases 40 (51.3%) patients: 35 of them have a
neurological diseases. Post operative admission concerned 38 (48.7%) patients: 8 for them
obstetrical surgery, 25 after neurosurgery, 3 post orthopaedic surgery, 2 post cardiac surgery.
Duration of Vm was 28.2 days [range 6–80], APACHE II was 17.5 [range 9–34], initial
MODS was 5[range 2–16] and Omega score 560.9 [range 277–1645]
The outcomes of patients on ICU was 36 (46.1%) survivors and 42 (53.8%) died the char-
acteristics was represented in Table 1.
Survivors mean [range] versus Patients Non survivors
Age (years)41[17–67] versus 40[16–75]
Apache II 16.3[9–28] versus 18.5[7–34]
Initial MODS 4.7 [2–8] versus 5.5 [4–16]
Medical diseases 20 versus 20
Post operative illness 16 versus 22
Dialysis or Apheresis 4 patients versus 8
Vm per day 19.1 [6–49] versus 36 [6–80]
Omega score 425.8 [277–854] versus 676.6 [296–1545]
ICU stay (days) 43 [34–135] versus 51 [31–135]
CONCLUSION. One predominant factor in long stay ICU and outcomes in the unit was
occurrence of ARDS, acute renal failure, severity neurological disabled and acquired critical
illness polyneuromyopathy significantly contributes to explained difficulty weaning from Vm
and their discharge because in our country we have not hospital or unity intermediate care or
step down units for high intensity patients not requiring Vm or available chronic ventilator
units
Short- and long-term outcomes: 0683–0696
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VALIDATION OF THE SABADELL SCORE
E. Palencia Herrejo´n1, P. Rico-Cepeda2, D. Dı´az-Dı´az2, A. Martı´nez de la Ga´ndara2, M.
Villanova Martı´nez2, B. Bueno Garcı´a2
1Hospital Infanta Leonor, Servicio de Medicina Intensiva, Madrid, Spain, 2Hospital Infanta
Leonor, Madrid, Spain
In the Sabadell score, the intensivist in charge of the patient assigns at ICU discharge one of
the following scores: good long-term prognosis (0 points), poor long-term prognosis
([6 months) with unlimited ICU readmission (1 point), poor short-term prognosis
(\6 months), with debatable ICU readmission (2 points), and death expected during hospi-
talization with ICU readmission not recommended (3 points). Sabadell score has been shown
to be useful to predict hospital post-ICU mortality. Although increasingly used, Sabadell
scoring is subjective; inter-rater agreement has not been tested previously, and has not been
externally validated.
In an 8 bed polyvalent ICU of a 210 bed hospital, Sabadell score was assigned to all patients
discharged from the ICU from 1 December 2008 to 31 March 2009 by his physician in charge
(rater A). After completion of this period, a second rater (rater B), blinded to the scoring from
rater A, assigned independently his own Sabadell score to all patients after reviewing clinical
history and patient charts. All discharged alive patients (162) were included.
Prevalences of the individual scores were different (P \ 0.001), and diminished from 0 to 3
for both raters. This marginal heterogeneity poses limitations to the interpretation of kappa
indices. There was a good agreement as measured by means of kappa index with quadratic
weights (kappa 0.68; 95% CI: 0.59–0.78; P \ 0.001 for kappa [ 0; P = 0.046 for
kappa [ 0.6). For individual scores, agreement varied widely (non-weighted kappa for
individual scores, K0: 0.61; K1: 0.23; K2: 0.13; K3: 0.47). Global percentage of crude
agreement was 59.3%; individual crude agreements were: 80.2% for score 0, 67.3% for score
1, 80.2% for score 2, and 90.7% for score 3. Positive and negative agreements varied widely
between the four possible scores.
Due to the subjective nature of the Sabadell score and the limitations of the kappa indices, we
hypothesized that, as it measures a continuous latent trait (‘‘risk of death estimated at ICU
discharge’’), a polychoric correlation coefficient can be a better agreement estimator. R*
correlation coefficient was 0.83 (P \ 0.001), with good fit, suggesting that discrimination was
good for both raters, and in close agreement for the latent trait. This high correlation with only
moderately good agreement for some categories suggest the necessity of increasing intensivist
training, and/or to improve possible inconsistencies of the score itself.
CONCLUSION. Inter-rater global agreement for Sabadell score is good, but individual
categories are less reliable. The Sabadell score is better viewed as measuring a latent trait, and
ICU physicians with adequate training show excellent reliability in estimating the risk of
death at ICU discharge, despite only moderate agreement in individual scores, probably
reflecting inadequate tresholds in the score. Further data are needed before definitive vali-
dation of the Sabadell score.
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SABADELL SCORE TO PREDICT POST-ICU DISCHARGE HOSPITAL
MORTALITY
E. Palencia Herrejo´n1, P. Rico-Cepeda2, D. Dı´az-Dı´az2, A. Martı´nez de la Ga´ndara2, M.
Villanova Martı´nez2, B. Bueno Garcı´a2, G. Andrade-Vivero2, G. Heras la Calle2, M.
Rodrı´guez Aguirregabiria2
1Hospital Infanta Leonor, Servicio de Medicina Intensiva, Madrid, Spain, 2Hospital Infanta
Leonor, Madrid, Spain
Sabadell score was created to aid predicting vital prognosis and allocating resources after ICU
discharge, but its capacity to predict alone the hospital post-ICU mortality is limited. No study
has addressed the relative importance of other prognostic factors besides Sabadell score, and
no model has been suggested to predict hospital mortality at ICU discharge including Sabadell
score.
The objective of this study was to assess the capacity of Sabadell score to predict the hospital
post-ICU mortality, and create a multivariate predictive model, as parsimonious as possible,
able to improve the predictive capacity of Sabadell score alone. All 162 patients surviving
ICU admission during a 4-month period in an 8 bed ICU community hospital were included.
11.3% of patients died in the hospital after ICU discharge. Sensitivity and specificity of
Sabadell score ‘‘3’’ to predict hospital post-ICU mortality were both 72.2%. In order to
improve this predictive ability, a multivariate model was builded, including three admission-
related variables (SAPS-3, age and a dichotomic variable: ‘‘any explicit therapeutic limitation
stated at ICU admission’’, and one discharge-related (Sabadell score). In univariate analysis,
all four variables were related to hospital mortality, and all three admission-related variables
were related to Sabadell scoring at discharge (as assessed by ordinal logistic regression). A
logistic model was builded to predict hospital mortality, including SAPS-3, age, therapeutic
limitation at admission and Sabadell score. This model was highly significant and predicted
very accurately hospital mortality. Individual associations were: Sabadell: OR 7.07, 95% CI
2.30–21.76, P = 0.001; SAPS-3: OR 1.1, 95% CI 1.04–1.20, P = 0.002; age: OR 1.07, 95%
CI 0.99–1.14, P = 0.081; and therapeutic limitation: OR 1.35, 95% CI 0.19–9.49, P = 0.762.
After deleting therapeutic limitation at admission, the reduced model retained all its predictive
ability. Percentage of correct predictions was 94.8%. This reduced model had excellent
calibration (Hosmer–Lemeshow goodness of fit chi-square: P = 1.000) and discrimination
(AUC ROC 0.965).
This simple model including only SAPS-3, age and Sabadell score is the most accurate model
to date to predict post-ICU mortality at ICU discharge, and could be useful to plan post-ICU
care when combined with the preferences of patients and families and available resources.
This model requires external validation in a greater number of patients and different ICU
before its application.
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WARD MORTALITY AFTER ICU DISCHARGE: A MULTICENTER VALIDATION
OF THE SABADELL SCORE
R. Fernandez1,2, Sabadell Score Study Group
1Hospital Sant Joan de Deu/Fundacio Althaia, Intensive Care, Manresa, Spain, 2CIBERES,
Mallorca, Spain
CONTEXT. Tools for predicting post-ICU patients’ outcome are scarce. A single-center
study showed that the Sabadell Score classified patients into 4 groups with clear-cut differ-
ences in ward mortality.
OBJECTIVE. To validate the Sabadell Score using a prospective multicenter approach.
DESIGN. Prospective multicenter cohort study.
SETTING. Thirty-one ICUs of varied size and affiliation in Spain.
PATIENTS. All patients admitted in the 3-month study period. We recorded
(a) at ICU admission: age, sex, severity of illness, and do-not-resuscitate orders,
(b) during the ICU stay: ICU-specific treatments, ICU-acquired infection, and acute renal
failure, and
(c) at ICU discharge: the Sabadell Score.
MAIN OUTCOME MEASURE. Hospital survival. Statistical analyses included one-way
ANOVA and multiple regression analysis with ward mortality as the dependent variable.
RESULTS. We admitted a total of 4,132 patients (mean age 61.5 ± 16.7 years) with median
predicted mortality of 14 (7.36%); 545 patients (13%) died in the ICU and 3,587 (87%) were
discharged to the ward. At ICU discharge, patients were classified on the Sabadell Score as:
Score 0 ‘‘Good prognosis’’: 2,422 patients (67.5%), Score 1 ‘‘Long-term poor prognosis’’: 724
(20.2%), Score 2 ‘‘Short-term poor prognosis’’: 340 (9.5%), and Score 3 ‘‘Expected hospital
death’’: 99 (2.8%). Overall ward mortality was 6.7%; ward mortality was 1.5% in patients
with Score 0; 9% in those with Score 1; 23% in those with Score 2, and 64% in those with
Score 3.
Variables associated with ward mortality in the multivariate analysis were: Predicted risk of
death (OR 1.016 [1.009, 1.023]), ICU readmission (OR 5.9 [3.8, 9.1]), Sabadell score 1 (OR
4.7 [2.9, 7.5]), Sabadell score 2 (OR 15.7 [9.8, 25.3]), and Sabadell score 3 (OR 107.2 [58.7,
195.9]).
CONCLUSION. We confirm the ability of the Sabadell Score at ICU discharge to define 4
groups of patients with very different likelihood of hospital survival (Fig. 1)
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POST-ICU SURVIVAL PROGNOSTIC SCALE
P. Martinez-Lopez1, M. V. De la Torre-Prados1, A. Vallejo-Baez1
1Hospital Virgen de la Victoria, Intensive Care Medicine, Malaga, Spain
INTRODUCTION. ICU survival is a quality indicator for ICU performance. But what
happens once they are in a general ward? There few studies about that, and some show
mortality rates Post-ICU above 25%. There are prognostic scores for survival, built with data
gathered in the first hours-days of the stay that do not take in account comorbidities produced
in ICU (tracheostomy, polineuropathy, parenteral nutrition, …). It is necessary to develop
new scores based on data available at the end of ICU to identify those patients that could
benefit of a follow-up program after ICU.
OBJECTIVE. To identify a set of variables at ICU discharge that justifies to implement a
follow-up program or discharge to semicritical care units.
METHODS. We study consequitives patients discharged from ICU during April–June 2008.
We register Sabadell Subjective Scale (SSE, group 1: good vital prognosis; group 2: poor
prognosis at medium term or [1 year and readmission in ICU not-limited; group 3: poor
prognosis at short term or\1 year and readmission in ICU debatable; group 4: death likely in
the current admission), origin, predicted inhospital mortality according to APACHE-II, risk
factors associates with bad prognosis (mechanical ventilation, parenteral nutrition, vasoactive
drugs, tracheostomy, renal failure, nosocomial infections), readmission and vital status at
hospital discharge and 60 days.
RESULTS. We evaluated 245 patients. Age (mean ± standard deviation and range)
63.7 ± 14 years (20–89); males 65.9%; origin on admission was Emergency Department in
61%, hospital wards 18.3%, surgery theatre 16.3%. Intra ICU mortality rate was 8.9%
(n = 22), in ward post ICU 17 (9%) and at day 60 7.6% (n = 17). SSE in ICU survivors
showed good prognosis (group 1) in 61.9% (n = 138), poor prognosis in long term (group 2)
27.8% (n = 62), poor prognosis in a short term (group 3) 6.7% (n = 15), and no survival to
hospital admission (group 4) 3.6% (n = 8). In following the table we compare some variables
according to prognosis evaluation and survival after ICU discharge.
CONCLUSIONS. Patient with poor prognosis are characterized by an ICU stay longer than
7 days, predicted mortality according to APACHE-II around 50% and more bad outcome risk
factors (comorbidity, complications or therapeutic support), to keep in ward with tracheos-
tomy significantly increases risk of death.
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EVALUATION OF PATIENT OUTCOMES AT 6 MONTHS IN ICU
E. M. Neutel Silva Machado1, E. Gomes1, T. Cardoso1, C. Dias2, I. Araga˜o1
1Hospital de Santo Anto´nio, Intensive Care Unit, Porto, Portugal, 2Hospital de Santo Anto´nio,
Servic¸o de Bioestatistica e Informatica Me´dica,FMUP, Porto, Portugal
INTRODUCTION. Extended follow-up of survivors of ICU treatment has shown many
patients suffer long-term physical and psychological consequences that affect their health-
related quality of life (HRQoL).The crucial need to measure clinical outcomes patient centred
has been the focus of several studies.
OBJECTIVES. The present study has two objectives: measure clinical patient outcomes of
survivors of critical illness in our ICU concerning to HRQoL, Impairment, Disability, and
Handicap; evaluate and report the patient’s needs.
METHODS. Data was collected from the prospective Follow-Up Registry 6 months after the
discharge. We assessed these variables: HRQoL was measured by the EuroQoL (EQ-5D);
anxiety and depression was measured by the Beck and Zung tests; and post traumatic stress
disorder (PTSD) symptoms was measured by the PTSS-14; handicap was measured by
Extended Glasgow Outcome Scale (GOSE).
RESULTS. We found depression in 38%, anxiety in 50% and PTSD risk in 13% of the
survivors. When we measured handicap with GOSE, 33% patients were dependent from
others and 40% recovered completely. In regards to HRQoL there were no problems in
mobility, self-care, usual activities, pain or discomfort, anxiety/depression in 52, 64, 37, 51
and 48%, respectively. 50% of the patients perceived current health state worse than before
ICU stay.Median EQ-VAS was 60 (IQR 50–80) and median EQ-VAS index was 67 (IQR 48–
91). We orientated patients to others specialities in 42% (21% to psychiatry) 0.60% of the
survivors did not return to previous job or usual activities.
CONCLUSIONS. Knowledge of the prevalence of physical and psychological morbidity in
our ICU survivors was important because this data generated models of causality, prognosis
and possible interventions dependent on this accurate determination of prevalence.
REFERENCES. 1. Hayes JA, Black NA, Jenkinson C, Young JD, Rowan KM, Daly K,
Ridley S (2000) Outcome measures for adult critical care: a systematic review. Health
Technol Assess 4(24):1–111. 2. Angus DC, Carlet J (2003) Surviving intensive care: a report
from the 2002 Brussels Roundtable. Intensive Care Med 29(3):368–377.
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DETERMINANTS AND OUTCOME OF INTENSIVE CARE UNIT ADMISSION OF
VERY ELDERLY PATIENTS IN FRANCE: A MULTICENTER COHORT STUDY
A. Boumendil1, A. C. Derek2, A.-L. Guitonneau3, A.-M. Menn4, C. Ginsburg5, D. Pateron6,
M. Garrouste-Orgeas7, D. Somme8, T. Simon9, P. Aegerter10, B. Guidet1,11
1INSERM, UMR-S707, Paris, France, 2University of Pittsburgh School of Medicine,
Department of critical care, Pittsburgh, USA, 3Assistance Publique, Hoˆpitaux de Paris,
Hoˆpital Bichat, Emergency Department, Paris, France, 4Victor Dupouy Hospital, Emergency
Department, Argenteuil, France, 5Assistance Publique, Hoˆpitaux de Paris, Hoˆpital Cochin,
Emergency Department, Paris, France, 6Assistance Publique, Hoˆpitaux de Paris, Hoˆpital
Saint-Antoine, Emergency Department, Paris, France, 7Saint Joseph Hospital Network, Sur-
gical ICU, Paris, France, 8Assistance Publique, Hoˆpitaux de Paris, Hoˆpital Europe´en Georges
Pompidou, Geriatric Unit, Paris, France, 9Assistance Publique, Hoˆpitaux de Paris, Hoˆpital
Saint-Antoine, URC-EST, Paris, France, 10Assistance Publique, Hoˆpitaux de Paris, Hoˆpital
Ambroise Pare´, Department of Public Health, Boulogne-Billancourt, France, 11Assistance
Publique, Hoˆpitaux de Paris, Hoˆpital Saint-Antoine, Medical ICU, Paris, France
BACKGROUND. Increasing numbers of very elderly patients are requiring intensive care.
Few studies have examined the determinants and benefits of intensive care unit (ICU)
admission of patients over 80.
STUDY DESIGN AND PARTICIPANTS. Prospective observational study of all patients
over 80 possibly qualifying for ICU admission who presented to the emergency department of
15 hospitals in the Paris (France) area during a 1-year period.
METHODS. The outcome measures were ICU eligibility, as assessed by the ED and ICU
physicians; in-hospital mortality; and vital and functional status 6 months after the ED visit.
We examined the criteria that determine ICU eligibility of patients over 80; inter-hospital
variability of ICU eligibility; and the impact of ICU eligibility on short-term and mid-term
vital and functional outcome.
RESULTS. 2,646 patients (median age 86 years; interquartile range 83–91) were included in
the study, of whom 12.4% were deemed eligible for ICU admission. Nine eligible patients
were not admitted to an ICU, and 7 patients who were not considered eligible were finally
admitted to an ICU. The real ICU admission rate was 12.4%. The overall in-hospital and 6-
month mortality rates were, respectively, 27.2 and 50.7%.
At 6 months, 57.5% of the patients had died or had a functional deterioration. The ICU
eligibility rates ranged from 5.6 to 38.8% across the participating centers, and this variability
persisted after adjustment for patient characteristics.
ICU eligibility was not significantly associated with either hospital or 6-month outcome in a
model that predicted outcome.
CONCLUSIONS. In France, the likelihood that a very elderly person will be admitted to an
ICU varies widely from one hospital to another. It is not obvious that outcome were affected
by ICU admission.
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THE EFFECT OF AUTOMATIC WEANING FROM MECHANICAL VENTILATION
ON QUALITY OF LIFE—PRELIMINARY RESULTS OF A ONE-YEAR-FOLLOW-
UP STUDY
D. Scha¨dler1, L. Kaiser1, G. Elke1, S. Pulletz1, I. Frerichs1, J. Scholz1, T. Ku¨chler2, N. Weiler1
1University Medical Centre Schleswig-Holstein, Campus Kiel, Department of Anaesthesiol-
ogy and Intensive Care Medicine, Kiel, Germany, 2University Medical Centre Schleswig-
Holstein, Campus Kiel, Clinic for General and Thoracic Surgery, Kiel, Germany
INTRODUCTION. Automatic weaning from mechanical ventilation is gaining increasing
interest. Several clinical trials have shown that the use of automatic weaning is safe and may
have beneficial effects on the duration of mechanical ventilation [1, 2]. The quality of life of
patients subjected to automatic weaning has not been studied so far.
OBJECTIVE. To determine whether automatic weaning with SmartCare/PS (SC, Dra¨ger
Medical AG & Co. KG, Lu¨beck, Germany) compared to protocollized weaning influences
quality of life.
METHODS. Patients were systematically followed-up 1 year after being included into a
randomized controlled trial investigating the effect of automatic weaning with SC on total
ventilation time compared to a weaning protocol [1] (clinicaltrials.gov ID00445289). Quality
of life was measured using the European Organization for Research and Treatment of Cancer
(EORTC) QLQ-C30 3.0 questionnaire including the lung module LC13 [3]. Statistical
analysis was performed using the Mann–Whitney test. A p value \0.05 was considered
statistically significant.
RESULTS. 232 of the 300 initially included patients were already followed-up. Overall
mortality rate was 29.7% (n = 89). 127 of the 143 available patients gave consent to fill out
the questionaire. 81 (63.8%) questionnaires were sent back to the study site. QLQ-C30 3.0
score was 64 ± 15 (n = 43) in the protocol and 61 ± 13 (n = 37) in the SC group
(p = 0.42) (Fig. 1). LC 13 score amounted 34 ± 8 in the protocol compared to 35 ± 6 in the
SC group (p = 0.59). (Figure 1)
CONCLUSION. Our preliminary data indicate that automatic weaning does not influence
quality of life after 1 year when compared with protocol-driven weaning. The study design
did not allow us to measure quality of life before randomization.
REFERENCES. 1. Scha¨dler D et al (2008) Intensive Care Med 34(Suppl 1):S10.
2. Lellouche F et al (2006) Am J Respir Crit Care Med 174:894–900.
3. Aaronson NK et al (1993) J Natl Cancer Inst 85:365–376
GRANT ACKNOWLEDGEMENT. The study was supported by a grant from Dra¨ger
Medical Ag & Co. KG, Lu¨beck, Germany.
0690
THE IMPACT OF EVENT SCALE IS NOT EFFECTIVE IN DIAGNOSING POST
TRAUMATIC STRESS DISORDER IN SURVIVORS OF CRITICAL ILLNESS
M. Sleeswijk1, J. Liesveld1, C. Be2, A. Rijkeboer1
1Flevo Hospital, ICU, Almere, Netherlands, 2Psychiatric Centrum Symfora Group, Almere,
Netherlands
INTRODUCTION. Patients who survive critical illness may develop post traumatic stress
disorder (PTSD). The prevalence of PTSD in critically ill patients is approximately 22% [1].
There are many diagnostic tools to diagnose PTSD such as the impact of event scale (IES)
which is frequently used in critically ill patients [1]. In a prospective follow-up study we
evaluated whether IES was indeed effective in diagnosing PTSD in survivors of critical illness
visiting an intensive care follow-up clinic.
OBJECTIVES. Patients admitted to our general ICU in 2008 and who stayed for more than
24 h were invited to visit our follow-up clinic.
Methods. 6 months after hospital discharge patients received an invitation including a
questionnaire containing hospital anxiety and depression scale (HADS) and IES. Those with
psychiatric symptoms were given the possibility to visit our psychiatric consultation clinic.
RESULTS. We invited 117 patients. 43 patients had no complains and had no need to visit
the clinic, 16 patients did not show at their appointment. 58 patients returned their ques-
tionnaire and visited the follow-up clinic. Results of the HADS and IES are shown in the
Table 3. Patients were referred to a social worker and 9 patients to a psychiatrist. After
psychiatric consultation patients were diagnosed with an adaptive disorder (4), depression (1),
grief disorder (1) and cognitive dysfunction (1). Two patients did not show at their
appointment. No PTSD was diagnosed (Table 1).
TABLE 1 PSYCHIATRIC SYMPTOMS
Number of patients (%) N = 58
IES[26 16 (28%)
IES[19 24 (41%)
HADS depression [8 13 (22%)
HADS anxiety [8 16 (28%)
Patients referred to a
psychiatrist N = 9
(mean ± SD)
IES 54 ± 22
HADS depression 10 ± 5.5
HADS anxiety 12 ± 4.7
CONCLUSION. In our evaluation a positive IES (score[26) did not indicate a diagnosis of
PTSD. Referral to a psychiatrist is needed to confirm the diagnosis. Using the IES in survivors
of critical illness as a diagnostic tool overestimates the incidence of PTSD.
REFERENCE. 1. Dimitry S, Davydow MD, Jeneen M et al (2008) Posttraumatic stress
disorder in general intensive care unit survivors: a systematic review. General Hospital
Psychiatry 30:421–434
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METHODOLOGICAL COMPARISON OF TWO GENERIC HEALTH-RELATED
QUALITY OF LIFE INSTRUMENTS (EQ-5D AND 15D) IN INTENSIVE CARE AND
HIGH-DEPENDENCY UNIT PATIENTS
T. Vainiola1
1Helsinki University Hospital, Helsinki, Finland
PURPOSE. Within intensive care medicine, the EQ-5D has been recommended as the pre-
ferred generic preference-based HRQoL instrument although comparisons between different
preference-based HRQoL instruments are lacking. Our aim was to compare whether two
generic HRQoL instruments (EQ-5D and 15D) produce comparable results in intensive care
(ICU) and high-dependency unit (HDU) patients.
METHODS. Information on HRQoL was obtained with both instruments from 929 patients
at 6 and 12 months after treatment at an ICU or HDU.
RESULTS. The HRQoL scores varied according to the instrument used and their distribu-
tions were quite different. Compared to the 15D the EQ-5D had some problems, namely an
ill-behaved distribution of scores with a remarkable ceiling effect and relatively poor sensi-
tivity to detect change. On the other hand 15D may overestimate the HRQoL of patients with
severe disability.
CONCLUSION. Our findings challenge the recommendation to use the EQ-5D as the pre-
ferred HRQoL instrument in studies dealing with critically ill patients and warrant further
comparative studies. Of note, the choice of the HRQoL instrument may have a substantial
effect on cost-utility results obtained with different instruments.
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QUALITY OF LIFE AFTER CONTINUOUS RENAL REPLACEMENT THERAPY:
PRELIMINARY RESULTS OF A RETROSPECTIVE SURVEY IN CRITICALLY ILL
PATIENTS
J. D’Cunja1, M. Zimmermann1, P. Fodor1, A. Zollinger1, C. K. Hofer1
1Triemli City Hospital, Institute of Anesthesiology and Intensive Care Medicine, Zurich,
Switzerland
INTRODUCTION. Acute renal failure (ARF) is a serious complication of critically ill
patients associated with an elevated mortality and relevant financial expenses of intensive care
unit (ICU) services. Only limited data are available on outcome in ICU patients requiring
continuous veno-venous hemodiafiltration (CVHDF). Although the estimated mortality rates
at 1 year following hospital discharge range from 57 to 78% [1] it may be important to
evaluate quality of life in these patients. Aim of this survey was to assess mortality and quality
of life in ICU patients requiring CVHDF for ARF.
METHODS. Patients with CVHDF during a ICU stay (January 2006–December 2007) were
contacted by telephone 1 year after their discharge. A structured interview was performed in
order to assess quality of life using the validated psychometric SF-36 health survey. Norm-
based scoring of the SF-36 profile (transformed to a mean = 50 ± 10) was analysed con-
sidering patient related data at admission (i.e. age, diagnosis, SAPS, APACHE II), indication
of CVHDF (i.e. aetiology of ARF), duration of CVHDF and mortality (ICU and 1-year). Data
were obtained from the hospital main data base. T-test and v2-test were performed for sub-
group analysis. Multiple regression analysis was done in order to identify risk factors related
to ICU/1-year mortality and reduced quality of life. P \ 0.05 was considered significant. Data
are presented as mean ± SD.
RESULTS. A total of 3,929 patients received ICU treatment during a 2-year period (mortality
rate = 3.7%). 147 patients (3.7%) undergoing CVHDF were identified (general surgery: 43
[29.3%], cardiac surgery: 52 [35.4%], internal medicine: 52 [35.4%]). Mean age was
68.4 ± 14.1 years, SAPS and APACHE II were 44.9 ± 16.3 and 21.1 ± 6.3, respectively.
ICU length of stay was 13.1 ± 12.7 days, duration of CVHDF was 6.5 ± 7.4 days. Main
indications for CVHDF were ARF during septic shock (55/147; 37.4%) followed by ARF due
to low cardiac output (45/147; 30.6%). Total ICU and 1-year mortality rate were 40.11% (59/
147) and 57.1% (84/147), respectively. There was no significant difference of ICU and 1-year
mortality between sepsis and low output patients or other subgroups. ‘‘Sepsis’’, SAPS \ 45
and APACHE II \ 21 were significant predictors of mortality. 49 patients (77.7%) responded
to the questionnaire: Norm-based SF-36 physical and mental health components ranged
from 38.0 ± 13.9 to 49.4 ± 10.6, physical and mental component summary (PCS and MCS)
for the total patient population was 41.0 ± 9.4 and 49.9 ± 9.9, respectively. PCS and MCS
did not significantly differ for different subgroups, no significant risk factors for reduced
quality of life could be evaluated.
CONCLUSION. These preliminary results reveal a high ICU and 1-year mortality rate in
patients after CVHDF treatment for ARF. However, only moderate limitations with respect to
quality of physical and mental health in survivors could be observed.
REFERENCE. 1. Acta Clin Belg Suppl 2007;(2):337–340.
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THE GUILLAN-BARRE´ SYNDROME EFFECTS IN THE QUALITY OF LIFE
AFTER DISCHARGING ICU
S. E. Mataloun1
1University of Santo Amaro, Brazil, Intensive Care, Sa˜o Paulo, Brazil
INTRODUCTION. There are some patients with Guillan–Barre´ Syndrome (GBS) that
require intensive care, either owing to the accentuated progression of their clinic history or
because of the evolution towards acute respiratory failure. Most of the times, there are deep
sequelae that cause impact on the quality of life (QOL) of those patients. There is no specific
score for the assessment of physical and/or motor inability in GBS patients.
OBJECTIVE. Assess the QOL of GBS patients admitted at ICU, after hospital discharge,
utilizing the SF-36 and the Barthel Index.
METHODS. Through a review of patient records, GBS incidence in the population of ad-
mited patients at the ICU of Hospital Estadual do Grajau´ in the period from April 2005 to
October 2008 was perceived and a study file was elaborated with demographic data referring
to the ICU period. For the patients’ follow, telephone contact was established and after
consent was granted, those who agreed responded to SF-36 and Barthel Index questionnaires.
Telephone contact was not possible only in one patient. Additionally, the professional activity
of the patient was evaluated before and after the disorder.
RESULTS. In this sample, seven patients presented a GBS diagnostic, reflecting 0.5% of the
total group. Out of the seven patients, six presented previous infections. The mean average
ICU length of stay period was 14.4 days. Three patients required mechanical ventilation
(42.8%). Tracheotomy was performed in two patients. All of them were supplied with
immunoglobulins. The evaluation report results as per the Barthel Index and the SF-36 are on
Tables 1 and 2, respectively.
CONCLUSION. GBS patients undergo impact in QOL, although there was a considerable
physical recovery after a period of 1–2 years. Results may help doctors to be aware that a
careful neurological exam may be complemented with the opinion of their patients regarding
their QOL.
0694
LONG-TERM EVALUATION OF CRITICAL CARE PATIENTS - PRELIMINARY
RESULTS
J. Sangiogo Haas1,2,3, S. R. Rios Vieira1,2, C. Teixeira3,4, R. Pinheiro Oliveira3,4
1Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Cieˆncias Me´dicas,
Porto Alegre, Brazil, 2Hospital de Clı´nicas de Porto Alegre, Critical Care Unit, Porto Alegre,
Brazil, 3Hospital Moinhos de Vento, Critical Care Unit, Porto Alegre, Brazil, 4Grupo Hos-
pitalar Santa Casa de Porto Alegre, Critical Care Unit, Porto Alegre, Brazil
INTRODUCTION. Functional status of individuals is a marker of quality of life. It is
important to evaluate long term follow up from critically ill patients principally from those
that leave the intensive Care Unit (ICU) and come back to society.
OBJECTIVE. To assess the Follow up of survivors from two general ICU at least 18 months
after ICU discharge and to evaluate factors associated with survival or death.
METHOD. We analyzed all patients admitted in two general ICU during 1 year. During
admission all descriptive data related to ICU hospitalization, including SOFA, APACHE II
and TISS scores, were collected. In a second moment (18–46 months after discharge from
ICU) a telephone interview with patients or their responsible was done. This interview
evaluated if patients were still alive and assessed the functional status using the Karnofsky
scale and the Activities for Daily Living (ADL) scale.
RESULTS. From a total number of 1219 patients, 76.1% (n = 928) were discharged from
ICU and 84.4% (n = 783) left the hospital. 26.3% (n = 206) died before the interview that
occurred on average 27 months (±9 months) after discharge from ICU. 34 subjects refused to
participate and 35 were not found. Therefore, 506 subjects answered the interview, 18%
(n = 91) of them being evaluated before 24 months and 82% (n = 415) being still alive after
this period. Comparing your current health condition of the previous hospitalization in the
ICU, the perception of the subjects was that 34% (n = 174) felt almost equal, 34% (n = 173)
it was better and 31% felt is worse (p [ 0.05). From all patients 48% (n = 584) used
mechanical ventilation (MV) having a survival rate in 24 months of 26.4% (n = 154). Renal
replacement therapy (RRT) was used in 150 subjects, which survival rate at the 24th month
was 20% (n = 30). Survivors were younger (61 years ± 18 vs. 6 years ± 7, p \ 0001).
APACHE II score was lower in survivors (12.55 ± 7.44 vs. 18.97 ± 8.88, p \ 0001). Sepsis
was diagnosed in 25.7% (n = 313) having a death rate in 24 months of 80% (n = 252).
CONCLUSION. This preliminary evaluation indicated that factors as MV, RRT APACHE
score and sepses are associated with higher mortality in ICU. A great number of patients are
still alive in 24 months. More analysis is needed for greater consistency of data.
0695
LONG-TERM OUTCOME AFTER CARDIAC ARREST TREATED WITH THERA-
PEUTIC HYPOTHERMIA: RESULTS FROM THE SWEDISH INTENSIVE CARE
REGISTRY
E. Dellcrantz1, J. Martner2, T. Nolin3, C.-J. Wickerts4, M. Fredrikson5, S. Walther1, on behalf
of the Swedish Intensive Care Registry
1Linko¨ping University Hospital, Department of Cardiothoracic Anaesthesia and Intensive
Care, Linko¨ping, Sweden, 2Sahlgrenska Academy, University of Gothenburg, Dept of
Anesthesiology and Intensive Care, Go¨teborg, Sweden, 3Central Hospital, Dept of Anaes-
thesia and Intensive Care, Kristianstad, Sweden, 4Danderyds Sjukhus, Dept of Anesthesiology
and Intensive Care, Danderyd, Sweden, 5Linko¨ping University, Dept of Experimental and
Clinical Sciences, Linko¨ping, Sweden
INTRODUCTION. Clinical application of therapeutic hypothermia after cardiac arrest has
rapidly become accepted although evidence from high quality clinical studies is limited.
OBJECTIVE. To examine long-term survival following treatment of cardiac arrest with
therapeutic hypothermia.
METHODS. Admissions in the Swedish Intensive Care Registry (http://www.icuregswe.org)
during 2004–2008 were examined. Patients with cardiac arrest were identified by the principal
diagnosis at discharge from ICU. Age, gender, illness severity (APACHE II) and length of
ICU-stay were analyzed per treatment group (with or without therapeutic hypothermia) and
using Chi2 and t-tests. Survival was examined with the Kaplan–Meier method. Logistic
regression was used to calculate crude and adjusted odds ratios.
RESULTS. We identified 1,989 first admissions (readmissions excluded) with cardiac arrest
as principal diagnosis. Patients that received therapeutic hypothermia (n = 728) were more
likely to be male (P \ 0.001), they were younger (64 vs. 68 years, P \ 0.001) and had higher
APACHE II scores (24 vs. 22 points, P \ 0.001). Survival in the hypothermia group was
significantly greater (Fig. 1). The odds ratio (95% CI) for 90-days survival with therapeutic




CONCLUSION. Therapeutic hypothermia after cardiac arrest was associated with improved
long-term survival.
0696
USEFULNESS OF INTRA-AORTIC BALLOON PUMP COUNTERPULSATION IN
PATIENTS WITH CARDIOGENIC SHOCK FROM ACUTE MYOCARDIAL
INFARCTION: A LONG-TERM FOLLOW-UP STUDY OF 300 PATIENTS
J. Cheng1, S. Valk1, C. den Uil1, M. van der Ent1, W. Lagrand2, M. van de Sande1, R. van
Domburg1, M. Simoons1
1Erasmus Medical Center, Rotterdam, Netherlands, 2Academic Medical Center at the Uni-
versity of Amsterdam, Amsterdam, Netherlands
INTRODUCTION. Although intra-aortic balloon pump (IABP) counterpulsation is
increasingly being used for treatment of patients with cardiogenic shock from acute myo-
cardial infarction (AMI), data on long-term outcome is lacking.
OBJECTIVES. The aim of this study was to evaluate 30-day and long-term mortality, and
their predictors, in patients with AMI complicated by cardiogenic shock who were treated
with IABP counterpulsation.
METHODS. From January 1990 to June 2004, 300 consecutive patients treated with IABP
were included. Median follow-up duration was 6.1 years (range 0–15 years). A Cox-pro-
portional hazards model was used to identify predictors of long-term outcome.
RESULTS. Mean age of the study population was 61 ± 11 years and 79% of the patients
were men. Survival until IABP removal after successful hemodynamic stabilization was 70%
(n = 211). Overall cumulative 30-day survival was 58%. Thirty-day mortality decreased over
time from 52% in 1990–1994 to 36% in 2000–2004 (p \ 0.05). In patients who survived until
IABP removal, cumulative 1-, 5-, and 10-year survival rates were 69, 58 and 36%, respec-
tively. Adjusted predictors of long-term mortality were arrhythmias during ICU stay (HR 1.8,
95%CI 1.2–2.9) and renal failure during ICU stay (HR 2.5, 95% CI 1.3–5.1). After adjust-
ment, treatment with primary percutaneous coronary intervention (HR 0.5, 95% CI 0.3–0.9)
or coronary artery bypass grafting (HR 0.4, 95% CI 0.2–0.8) were associated with lower long-
term mortality.
CONCLUSIONS. In patients with AMI complicated by cardiogenic shock treated with
IABP, 30-day survival improved over time. An encouraging number of patients survived at
the long-term. Revascularization strategies were associated with a beneficial outcome.
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IS IT NECESSARY FOR NURSES TO KNOW ABOUT THE QUALITY OF LIFE OF
PATIENTS FOLLOWING INTENSIVE CARE?
C. A. Wedgeworth1
1University College Dublin, School of Nursing, Midwifery and Health Systems, Dublin,
Ireland
There is increasing evidence that survivors of critical illness who required intensive care
suffer from impaired quality of life (Rubenfeld 2009). Research carried out in Europe, North
America and Australia report that patients recovering from critical illness experience physical
and psychological impairments that affect their every day quality of life (Dowdy et al. 2006).
Recovery is slow ranging from six months to two years (Angus et al. 2002). The factors that
have been reported to determine long-term survival include age, comorbidity, primary
diagnosis and severity of illness (Williams et al. 2008).
The aim of this presentation is to critique current research that measured the quality of life of
survivors of critical illness who required intensive care. Current literature suggests that the
reductions in quality of life found in survivors from specific diagnostic groups of critical
illness, for example Sepsis, are indistinguishable from other critically ill patients (Granja et al.
2004). Hence literature measuring the quality of life of patients from a variety of diagnostic
groups will be included in this review.
The heterogeneity of critical illness and individuality of coping mechanisms make the design
of research studies challenging. This presentation will examine these challenges in relation to
the subjective and objective nature of quality of life, the appropriate timing and current
validated tools of assessment.
It is essential for nurses to be aware of the short and long-term physical and psychological
consequences associated with the combined effects of illness, the intensive care experience
and the uncertain recovery period for both patients and their families. Such information could
facilitate nurses to advice patients and significant others that even after leaving the intensive
care unit there is still a relative risk of morbidity and mortality to be faced in the following
years. Patients and families need to be prepared for a slow recovery period and the potential
need for rehabilitation, follow-up, and ongoing treatment.
REFERENCES. 1. Angus DC, Carlet J. Brussels Roundtable participants (2002) Surviving
intensive care: a report from the 2002 Brussells Roundtable. Intensive Care Med 29 (3):368–
377.
2. Dowdy DW, Eid MP, Sedrakyan A, Mendex-Tellez PA, Pronovost PJ, Herridge MS,
Needham DM (2006) Quality of life in adult survivors of critical illness: a systematic review
of the literature. Intensive Care Med 31:611–620.
3. Granja C, Dias C, Costa-Pereira A, Sarmento A (2004) Quality of life of survivors from
severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit
Care. 8:R91–R98.
4. Rubenfeld GD (2009) Improving clinical trials of long-term outcomes. Crit Care Med
37:S112–S116.
5. Williams TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E, Lee KY, Webb SAR (2008)
Determinants of long-term survival after intensive care. Crit Care Med 36(5)
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THE PATIENT’S PERSPECTIVE: ONE KEY TO IMPROVING ICU CARE AND
TREATMENT
D. A. Rier1
1Bar-Ilan University, Sociology and Anthropology, Ramat-Gan, Israel
INTRODUCTION. This paper arises from reflecting on my own ICU hospitalization (see
Rier, 2000), in light of published accounts of the ICU patient experience.
OBJECTIVES. (1) Describe key aspects of my experience as an ICU patient; (2) highlight
certain insights from the illness narratives literature; and (3) suggest how attending to the
patient’s perspective can improve care.
METHODS. First-hand case report; literature review; visits to and/or observation of ICUs on
four continents, 2007–2009.
RESULTS. First: even the weakest, most dependent patients can have rich interior lives
(Bauby 1997); this bears special implications for staff. Second, the essence of the patient
experience is dependence (both physical and emotional) on staff (and visitors), along with a
shrinkage of one’s life to the few square meters around the bed. In this environment, how staff
relates to and communicates with patients assumes immense significance (Baier and Scho-
maker ([1986]1995; Rier 2000). Communication with patients is extremely important, both
for proper pain management, and for maintaining patients’ emotional well-being. Even small
gestures can affect a patient’s mood. Staff’s efforts to support patients can prevent loneliness
and depression, and strengthen their will to live. Third, cultivating hope and optimism may
require concealing from patients various aspects of their condition, as Simpson (1982) per-
ceptively noted regarding her own experiences. Fourth, an often-overlooked aspect of the
patient experience involves the spatial ecology of the unit. Visits to ICUs on four continents
revealed a great variety of physical layouts, with a wide disparity in the proximity of nurses to
patients. The effect of these differences on the patient experience has barely been examined in
the academic literature. Anecdotal evidence suggests that culture and stage of illness can
influence these patterns significantly. Finally, we know virtually nothing about how gender
mediates the ICU patient experience.
CONCLUSIONS. ICU patients can have very active interior lives. Staff (as well as visitors)
have enormous influence on patients’ moods, on their will to survive, and on their quality of
life while in the unit. Continued research, ideally on larger populations, and employing
memory aids to prompt adequate recall of ICU experiences, is necessary. Topics such as:
disclosure of information; spatial unit design and its impact on social support; and gender
deserve particular attention.
REFERENCE(S). 1. Baier S, Schomaker MZ 1995. Bed Number Ten. CRC, NY.
2. Bauby J-D (1997) The Diving-Bell and the Butterfly (tr. by J. Leggatt). Vintage, NY.
3. Rier DA (2000) The missing voice of the critically ill: a medical sociologist’s first-person
account. Sociology of Health and Illness 22:68–93.
4. Simpson ES (1982) Notes on an Emergency: A Journal of Recovery. WW Norton, London
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LONG TERM OUTCOME AND QUALITY OF LIFE OF ICU PATIENTS MEA-
SURED WITH THE EQ-5D QUESTIONNAIRE
C. Psomiadis1, F. Michailidou1, C. Dolma1, A. Tzenalis1, B. Tsapas1, A. Ntantana1
1Papageorgiou General Hospital, Thessaloniki, Greece
INTRODUCTION. The main goal of the ICU care is the reduction of morbidity and mor-
tality. However, less attention is paid to quality of life (QOL) after ICU discharge. The aim of
our study was to evaluate the mortality and the QOL of ICU patients at six months and one
year after ICU discharge.
METHODS. Over a period of 1 year, all ICU patients hospitalized for more than 48 h were
included in the study. We evaluated the patient’s ICU and in-hospital mortality and the
mortality and the QOL 6 months and 1 year after ICU discharge. The QOL was evaluated
with a telephone interview using the EQ5D questionnaire. The EQ-5D questionnaire evaluates
the mobility (MO), autonomy (AU), the usual daily activities (DA), the anxiety or depression
(AD) and the presence of discomfort or pain (DP) in three levels of severity (1 = No problem,
2 = moderate disability, 3 = severe disability) and the patients overall health status in a scale
from 0 to 100. Non-parametric variables were analysed using the Wilcoxon signed ranks test
and parametric variables with the paired t test.
RESULTS. The data of 303 patients admitted in the ICU (208 M/95F) aged 58 ± 17 years
were analysed. Among them 67 died in the ICU (22.1%), and 40 (13.2%) died in the hospital
after ICU discharge (overall in-hospital mortality 35.3%). Of the 196 patients discharged alive
from the hospital, 21 (7%) died during the first 6 months and only 4 (1.3%) afterwards.
Overall year mortality 43.5% of all patients. A statistical significance was found between dead
and alive patients in age (63 ± 16 vs. 55 ± 18 years) and in ICU stay (8 ± 10 vs.
11 ± 11 days) but not in the APACHE score on admission (17 ± 3 vs. 16 ± 2). Overall
health status at 6 months was estimated at 65% and significantly improved at 1 year 75%
(p \ 0,01). A statistical significance was also found between 6 months and 1 year in QOL
indices; Precisely, improvement was observed in MO from 2.5 to 2.62 (p \ 0,05), in DA from
2.3 to 2.5 (p \ 0.01), in DP from 2.5 to 2.7 (p \ 0.01) and in AD from 2.3 to 2.5 (p \ 0,01)
but not in AU (2.68 vs. 2.7 p = NS). At 1 year, 67% of the patients who worked prior to the
ICU admission had returned to work.
CONCLUSION. In hospital mortality of ICU patients remains very high. On the contrary
mortality after hospital discharge is low. QOL 6 months seems to be satisfactory and continue
to improve at 1 year.
0700
SATISFACTION WITH NURSING CARE IN RETURNING HOME OF LIVER
TRANSPLANT
A. P. Da Costa Alves1
1Hospital de Curry Cabral, ICU, Lisbon, Portugal
INTRODUCTION. In differentiated healthcare, the promotion of health and health education
activities are indispensable for personal empowerment, preparing the individual to prevent
complications of his own disease, exercising a greater control over his own health, resulting in
global health gains.
This investigation was intended to analyse the satisfaction of liver transplant patients about
the nursing care given, concerning health education, as well as to try and identify aspects that
influenced the patient’s perception and experience when dealing with the preparation of
returning home.
METHODS. The study was descriptive, with a mixed approach of exploratory and mixed
inquiry, with qualitative and quantitative orientation, in a deductive-inductive direction. The
inquiry was based on the scale ‘‘As suas Opinio˜es sobre os Cuidados de Enfermagem’’-
(1999), Portuguese version Center of Studies and Inquiry in Health (in Faria 2006), adapted
and validated to the Portuguese population from the original scale of de Bond, S.; Thomas, L.
et al. (1995) ‘‘The Newcastle Satisfaction With Nursing Scale’’-(1988) Centre for Health
Services Research, University of Newcastle Upon Tyne, UK. The population integrated a
convenience sample of 75 liver transplant patients. The results were based on the methodo-
logical movement structure, level of expectations, experience and perception of the patient’s
satisfaction.
RESULTS. Of the 75 patients, 72% were male and 28% were female, with mean age of
45.6 years, and mean hospital stay of 26.4 days. Regarding chronic illnesses: 39% Cystic
Fibrose and PAF, 20% Viral hepatitis and 20% liver cirrhosis. This study draws attention to
the fact that demographic factors such as age (0.024 p) and hospitalisation time (\0.001 p)
influenced expectations, as well as previous experiences influenced the manner in which these
patients received information during their hospital stay. The patients submitted to liver
transplant, questioned in this study, affirmed, in a global manner, that nursing care given
during admission, concerning health education for returning home were ‘‘Good/Very Good’’
(85%) and ‘‘Reasonable’’ (15%).
CONCLUSION. Expectations, previous experiences, experience with and perceptions about
nursing care as well as hospital discharge preparation were in this context, recognized as
influences on the satisfaction of nursing care given. It is indispensable, therefore, that
activities related to health education autonomously developed by nurses, contribute to
emphasize the professional role of nursing care, highlighting the nurse’s intervention with the
patient and/or family when returning home.
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PROVIDING NURSING CARE TO FAMILY CAREGIVERS
M. F. Oliveira1, P. A. Sousa1, C. Areias2, P. A. Estorninho2, A. C. Moreira2
1Escola Superior de Enfermagem do Porto, Porto, Portugal, 2Unidade Local de Sau´de de
Matosinhos (ULSM), Hospital Pedro Hispano (HPH), Medicina M, Matosinhos, Portugal
INTRODUCTION. Providing nursing care to family caregivers’ constitutes one of the most
demanding and important activities by nurses. In this direction, nurses assume a fundamental
role, once they must to prepare the family caregiver to take care at home of the dependent
person, by giving the right solution on each case.
OBJECTIVES. The aim of this part of study was to know the nature of nursing interventions
when they identified family caregivers’ needs, centered in returning home of the dependent person.
METHODS. Retrospective collection data of all patients admitted to the Medicine ward of
ULSM-HPH from the 1st January 2008 to 31th December 2008. The data collection was
accomplished appealing to the analysis of the records documented in the computer system
using the ICNP.
RESULTS. By the analysis of the nursing data, 918 ill persons were admitted at the unit. We
found 411 cases (44.8%) in which the caregiver it was a target of attention, since there was a
need for continuity of care at home. 4564 records were documented based on nursing
interventions centered on the family caregivers’. The action type with more records are the
‘‘teaching’’ with 2909 (63.7%), followed by ‘‘training’’ with 859 (18.8%), and ‘‘instructing’’ with
242 (5.4%); others nursing interventions have 540 records (12.1%). So we decided to stick with
only these three actions types. The Table 1 below shows the records of the action types in each
Nursing Phenomenons with its dimensions (‘‘skills learning’’ and ‘‘knowledge’’).
TABLE 1 RECORDS ON NURSING PHENOMENON ON ITS DIMENSIONS




Pressure Ulcer 722 (80.7%) 42 (4.7%) 131 (14.6%) 895 19.6
Turning of own
body
314 (61.9%) 46 (9.1%) 147 (29.0%) 507 11.1
Self Care:
Feeding
256 (60.2%) 21 (4.9%) 148 (34.8%) 425 9.3
Self Care:
Toiletting
254 (67.0%) 20 (5.3%) 105 (27.7%) 379 8.3
Self Care:
Hygiene
241 (69.9%) 14 (4.1%) 90 (26.1%) 345 7.6
Self Care:
Dressing
244 (73.3%) 23 (6.9%) 66 (19.8%) 333 7.3
Transfer of own
body
147 (62.8%) 22 (9.4%) 65 (27.8%) 234 5.1
Falling 189 (85.1%) 7 (3.2%) 26 (11.7%) 222 4.9
Others 1224 26.8
With regard to Nursing Phenomenons in its Dimensions we found more interventions related
with the caregiver in ‘‘Pressure Ulcer’’ with 895 (19.6%), followed by ‘‘Turning of own
body’’ with 507 (11.1%), and ‘‘Self Care: Feeding’’ with 425 (9.3%). We also found in these
Phenomenon Nursing Dimensions, the action type ‘‘teaching’’ as the most recorded, over than
60%, since the main dimension identified by nurses is focuses on knowledge not demon-
strated. These kind of interventions have the focus on the potential for enhancement of family
caregivers knowledge and skills learning to prevent pressure ulcers and impaired nutrition.
CONCLUSIONS. In conclusion, we can say that nurses try to provide knowledge to family
caregivers’, which allows them to take care of the dependent person at home. There is also
concern about the caregivers training in the instrumental field.
0702
THE USE AND PRACTICE OF PATIENT DIARIES IN ICU FOLLOW-UP IN
SWEDEN
E. A˚kerman1, A. Granberg-Axell’2, A. Ersson1, B. Fridlund3, I. Bergbom4
1University Hospital Malmo¨, Intensive Care Unit, Malmo¨, Sweden, 2Karolinksa Institutet,
Department of Neurobiology, Care Sciences and Society, Stockholm, Sweden, 3Jo¨nko¨pings
University, School of Health Sciences, Jo¨nko¨ping, Sweden, 4The Sahlgrenska Academy
University of Gothenburg, Institute of Health and Care Sciences, Gothenburg, Sweden
Since 1991, patient diaries have been used in ICU follow-up in Sweden. There is a paucity on
relevant data evaluating the effect of this tool and also on what premises patients are enrolled.
Likewise, data are sparse on the diaries’ design, content structure and the use of photos. The
aim was to describe and to compare the extent and application of patients’ diaries in Sweden
in relation to ICU levels and some form of ICU follow-up like telephone or personal contact.
Data was collected by a semi-structured telephone-interview with dedicated personnel. The
results were analysed with descriptive statistics and differences between the ICU levels were
explored by v2 analysis. Qualitative manifest content analysis was done to explore the reasons
and aims for diary writing. Of all ICUs (99%) responded and 75% used diaries. The source of
inspiration was collegial rather than from scientific data. The main reason for diary keeping
was to help the patient to recapitulate the ICU stay. Discrepancies between the different levels
of ICUs were detected in patient selection, dedicated staff for follow-up and the use of photos.
Comparison between the v2 analysis and the content analysis result displayed incongruence
between the set goals and the activities for achievement but did not explain the procedural
differences detected between the ICU levels.
CONCLUSION. The use of diaries in the post-ICU follow-up is common in Sweden. A
majority use defined goals and content structure. However, there are differences in practice
and patient recruitment among the levels of ICUs. These discrepancies are not based on
evidence based data nor on ongoing research or evaluation but merely on local opinion. As
ICU follow-up is resource intense and time consuming it is paramount that solid criteria for
patient selection and guidelines for the structure and use of diaries in post ICU follow-up are
defined.
0703
THE COPING MECHANIZMS BETWEEN CIRITCAL CARE AND OTHER ACUTE
CARE NURSES IN HUNGARY
J. Betlehem1, I. Boncz2, J. Marton-Simora1, G. Nagy1, K. Deutsch1, A. Sebestyen3, Z.
Gondocs4, A. Olah5
1University of Pecs, Faculty of Health Sciences, Department of Emergency Care, Pecs,
Hungary, 2University of Pecs, Faculty of Health Sciences, Institute of Helath Care Man-
agement and Health Policy, Pecs, Hungary, 3Baranya County Health Insurance Fund, Pecs,
Hungary, 4Hungarian National Ambulance Service, Budapest, Hungary, 5University of Pecs,
Faculty of Health Sciences, Department of Nursing Sciences, Pecs, Hungary
BACKGROUND. The environment of caring for acutely ill patient is always a stressful job
which requires various coping strategies from nurses. Our aim was to detect the differences in
coping strategies between nurses in critical care (intensive, coronary care, emergency room)
setting and in other acute care units (surgery, acute internal medicine).
METHODS. A cross-sectional study design was used to explore the coping strategies in acute
care settings in a Hungarian hospital in 2008. An adopted standardized tool (Folkman–
Lazarus) was applied to measure coping behaviour. Inclusion criteria were working in the
given setting more then 2 years as a bed-side staff nurse and not being involved in managerial
tasks. The data analysis was done with Chi-square, T-test and ANOVA method using SPSS
14.0. (p \ 0.05)
RESULTS. Out of 130 self-fill in questionnaire 114 was evaluated, making a response rate of
80%. The average age was 37.8 years and 87% of the was female. Almost half of the nurses
(54 persons) worked in critical care units and the rest in other acute words (60 persons).
Nurses work in 12 h shifts predominantly (80%). The majority of the critical care nurses use
the planful problem solving (2.86 vs. 2.81, p = 0.048), distancing (2.69 vs. 2.56, p = 0.046),
positive reappraisal (2.68 vs. 2.60, p = 0.46), confrontive coping (1.49 vs. 1.37, p = 0.04).
More non-critical care nurses apply escape-avoidance, than other acute nurses (2.68 vs. 2.50,
p = 0.032). In seeking social support (2.19 vs. 2.20, p = 0.52), self-controlling (1.69 vs. 1.69,
p = 0.32), accepting responsibility (1.71 vs. 1.71, p = 0.56) there were no significant dif-
ference between the two groups.
DISCUSSION. The acute care nurses use both, problem-centred and emotional coping in the
same time. For them informational and tangible social support, efforts to regulate their
emotions and actions are important. Facing problem with a concomitant theme of trying to put
things right play the same role in their every day coping. Critical care nurses tend to choose
solutions in a problem focused way more. They make cognitive efforts to detach themselves
and to minimize the significance of stressful situation. Although some emotional aggressive
events can be detected as well which requires prevention methods in order to avoid aggression
to patients.
REFERENCES. 1. Lazarus R, Folkman S (1984) Stress, appraisal, and coping. Springer
Publishing, New York.
2. Palfi I, Nemeth K, Kerekes Z, Kallai J, Betlehem J (2008) The role of burnout among
Hungarian nurses. Int J Nursing Practice. 14(1):19–25.
3. Rozsa S, Purebl Gy, Susa´nszky E, Ko N, Szadoczky E, Rethelyi J, Danis I, Skrabski A,
Kopp M (2008) (2008) A megkuzde´s dimenzioi: a kofliktusmegoldo kerdoiv hazai adapta-
cio´ja. Mentalhigiene es Pszichoszomatika 9. 3:217–241.
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WELCOME TO TEAM LEADER SCHOOL!
C. Carbery1, S. Fankhauser1
1St Vincent’s Hospital, Intensive Care Unit, Melbourne, Australia
INTRODUCTION. With the changing nature of Intensive Care we are now facing chal-
lenges which require an innovative and targeted approach to achieve better outcomes for our
patient and provide greater job satisfaction and support for nursing clinicians in intensive
care.
Some of the challenges that have prevailed in this ICU over the last 5 years include: delayed
discharge, skill mix, Elective Surgery and increase in ICU bed numbers.
Addressing the issues that currently face our day to day work looking at future work influ-
ences (opening even further beds), succession planning, maintaining and promoting a safe and
supportative work environment, creating awareness of outside factors that directly impact the
daily management of ICU have lead to the development of the Team Leader Programme.
Through the linking of management and leadership skills with clinical practice, The Team
Leader Programme, aimed to provide the Clinical Nurse Specialist with the actions, knowl-
edge, tools and support to enhance the units current and future practice.
METHODS. The competency-based programme was based on structured support and
guidance from Nurse Unit Managers, development of individual and generic objectives,
continuous progress and development review and enhancement of clinical skills. Objectives
focussed on three main themes: facilitating improvement in patient flow, multidisciplinary
communication and quality and standards of patient care. In addition, a monthly evaluation of
key performance indicators, which would reflect the effectiveness of the programme, was
conducted. These included RISKMAN incidents and elective case cancellations. Staff forums
were conducted prior to introduction and at completion of programme.
RESULTS. All participants completed competencies, objectives and performance reviews
facilitated by the ICU Management team. An audit was conducted reviewing RISKMAN
incidents pertaining to patient care prior to the introduction of the programme and through the
6-month study period. Number of incidents relating to sub-optimal care significantly reduced.
Staff forum demonstrated improvement in review and assessment process including com-
munication and documentation. Reduction in cancellation by ICU of elective cases was
shown. Elective HDU cases benefited as a result.
CONCLUSION. The Team Leader Programme equipped nurses with the management and
leadership skills to proactively address and improve patient care and flow. The progress
demonstrated has encouraged further development in patient care initiatives to ensure patient
throughput while still maintaining elective and emergency needs.
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PATIENT’S CARE IN AN ADULT ICU: SHALL WE RESTORE FAMILY’S
PARTICIPATION?
M. Thirion1, J. Salor1, J. Allyn1, G. Mourissoux1, O. Pajot1, G. Plantefeve1, H. Mentec1
1CH Victor Dupouy, Medico-surgical ICU, Argenteuil, France
OBJECTIVES. We evaluated patients’, families’ and staff’s opinion on feasibility, satis-
faction and stress concerning participation of relatives to patient’s care in an adult ICU.
METHODS. In an adult ICU of a general hospital, we conducted a two-phase study. First,
anonymous questionnaires were given to caregivers to identify eligible cares among a list of
26 (aiming comfort but also washing the deceased, attending medical examination or tech-
niques or resuscitation); and to evaluate predicted satisfaction of patients, relatives and stress
on the staff. Eligible cares were defined as having mean scoring more than 8 on a 10 points
scale ranging from 0 = too risky/not feasible to 10 = not risky/fully feasible, not eligible
cares as scoring less than 5. Second, families’ and patients’ opinions were anonymously
collected (study still in process) on eligible cares on a 10 points scale.
RESULTS. ICU staff (n = 49): 100% of staff members answered the questionnaire (nursing
assistants 17, nurses 24, medical staff 8). 11 cares were considered eligible, 6 cares were
judged not eligible and 9 cares scored between 5 and 8 meaning intermediate opinion. Not
eligible cares were mostly those involving caring of intubated patients with risk due to the
proximity of the oro-tracheal (OT) tube (e.g. shaving or cleaning oral cavity). Eligible cares
consisted of those involving care to non-ventilated patients or far from the OT tube (e.g.
helping a patient to eat or massaging hands and feet). The project of relatives’ participation to
care was judged interesting (mean 7.6 ± 3.3), having moderate impact on caregivers’ stress
(mean 5.4 ± 3.1) and improving families’ satisfaction (mean 7.6 ± 2.6).
Patients (n = 26, 14 males, 12 females): median [extremes] age was 67 [19–86], SAPSII :
46.5 [10–95], SOFA: 4.5 [0–14], duration of ICU stay: 5.5 [2–63] days. The project aroused
high interest (7.6 ± 3), evaluated patients’ and families’ satisfaction were high (7.9 ± 2.3
and 7.4 ± 3.2, respectively), impact on stress moderate (4.7 ± 4.4). Most of proposed cares
resulted in high satisfaction except those involving patients’ intimacy (e.g. toilet, attending
medical examination). Acceptance of care by a spouse was almost unanimous, but by other
relatives more variable.
Families (n = 20): The same results (interest: 8.3 ± 3.3, evaluated patients’ and families0
satisfaction: 8 ± 3.3 and 8.7 ± 2.7, respectively, impact on stress: 4.7 ± 4.4) and reserva-
tions about intimate cares as patients were expressed by family members, and mixed opinion
concerning attending resuscitation.
CONCLUSION. Relatives’ participation to critically ill patients’ care aroused high pre-
dictable satisfaction in caregivers, family members and patients. Reservations were expressed
concerning intimacy and by caregivers concerning risk due to oro-tracheal intubation. Giving
care to an adult critically ill patient was anticipated as moderately stressful and might be
proposed to family members.
GRANT ACKNOWLEDGEMENT. No grant.
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FINDING HUMANITY AMONG ALL THE TUBES, MACHINES, AND INSTRU-
MENTS. DEALING WITH FRIENDS AND FAMILY OF PATIENTS IN THE
INTENSIVE CARE UNIT
K. Leppa¨nen1, M. Lahtinen1, A. Ahlqvist1
1South Karelia Central Hospital, ICU, Lappeenranta, Finland
The purpose of this project was to develop how to deal with and support friends and family of
ICU patients. Additionally, the goal was to write an evidence based functional model on this
subject and to formulate a functional guide for use in the orientation programme for new
employees. In studying the kinds of support needed by the friends and family of ICU patients
from their point of view, emotional, informational, and concrete support were investigated.
A questionnaire targeted at the family and friends of ICU patients was developed to determine
what kinds of experiences of support they had while their loved one was in the ICU. The data
was collected from January through May of 2006. The target group consisted almost
exclusively of family members of the ICU patient, and was given to the families of 50 patients
during the research period. The questionnaire was given to the family during the second visit
to the ICU and the results were analysed using the EXCEL statistics programme.
The majority of the family members and friends that participated in this study felt that during
the ICU stay they were in need of support, especially from the nurses, doctors, and social
workers. The staff had provided sufficient support to 88% of the respondents. These
respondents felt that their need for information had been satisfied by the staff of the ICU. In
their opinion, information received from the doctors as well as the nursing staff had been
based in fact, had been understandable, cohesive, and pertinent. The possibility to discuss
matters with the doctors was adequate for 63% of the respondents. The informational support
was well provided. In conjunction with this project, a guidebook was developed for the family
and friends of ICU patients that explained practical aspects of intensive care that are very
important. Responses to a questionnaire done during this project indicated that 85% had
indeed read the information, and that the majority of these had benefitted from the contents of
the guidebook. The results of this project reveal that friends and family of patients in the ICU
received adequate information from the staff of the ICU.
Respondents reported that during visits to the ICU, they had received the emotional support
that was needed. All of the respondents felt that their loved one had received good care while
in the ICU, and they had complete trust in the professional expertise of the ICU staff. They
also felt that the staff took their wishes into consideration concerning the care of the patient
(80%). According to the results, the respondents felt that the need for concrete support was
less important when compared to the need for emotional and informational support.
This development project revealed valuable information about the experiences of the family
and friends of ICU patients about support received from the staff. These results will be used in
the future as part of the orientation programme for nurses new to the ICU.
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CAREGIVERS0 NEEDS IDENTIFIED BY NURSES
M. F. Oliveira1, P. A. Sousa1, C. Areias2, P. A. Estorninho2, A. C. Moreira2
1Escola Superior de Enfermagem do Porto, Porto, Portugal, 2Unidade Local de Sau´de de
Matosinhos (ULSM), Hospital Pedro Hispano (HPH) - Medicina M, Matosinhos, Portugal
INTRODUCTION. Today, an increasing number of family members assume great respon-
sibility by taking on tasks that would normally be performed by nursing staff. They represent
a large and extremely important group for the care recipient and the health services. In this
direction, nurses assume a fundamental role, once they must to prepare the family caregiver to
take care at home of the dependent person.
OBJECTIVES. The aim of this part of study was to recognize the family caregivers0 needs
identified by nurses, when they have a dependant to take care at home, in order to adjust the
nursing interventions to obtain the best results on the caregivers0 preparation.
METHODS. Retrospective collection data of all patients admitted to the Medicine ward of
ULSM-HPH from the 1st January 2008 to 31th December 2008. The data collection was
accomplished appealing to the analysis of the records documented in the computer system
using the ICNP.
RESULTS. By the analysis of the nursing data, 918 ill persons were admitted at the unit. We
found 411 cases (44.8%) in which the caregiver it was a target of attention, since there was a
need for continuity of care at home. 3,356 records were documented based on nursing
diagnoses centered on the family caregivers0. The dimensions with more records are the
‘‘knowledge’’ with 2,202 (65.6%), followed by ‘‘skills learning’’ with 752 (22.4%), and
‘‘Involving’’ with 268 (8.0%); others dimensions have 134 records (4%). We decided to stick
only the two dimensions with the most number of records: ‘‘skills learning’’ and ‘‘knowledge’’
(2,954 records), making the analysis of the status ‘‘demonstrated and not demonstrated’’ in
each Nursing Phenomenon. The data are shown in the Table 1 below.




















Pressure Ulcer 30 (6.7%) 59 (13.2%) 104 (23.3%) 253 (56.7%) 446 15.1
Self Care:
Feeding
55 (15.4%) 71 (19.9%) 88 (24.7%) 142 (39.9%) 356 12.1
Turning of
own body
31 (9.7%) 65 (20.4%) 72 (22.6%) 150 (47.2%) 318 10.8
Self Care:
Toiletting
31 (11.0%) 51 (18.1%) 66 (23.5%) 133 (47.3%) 281 9.5
Self Care:
Hygiene
19 (7.6%) 49 (19.7%) 57 (22.9%) 124 (49.8%) 249 8.4
Self Care:
Dressing
30 (12.0%) 49 (19.7%) 54 (21.7%) 116 (46.6%) 249 8.4
Self Control:
Infection
23 (10.3%) 31 (13.9%) 52 (23.3%) 117 (52.5%) 223 7.5
Transfer of
own body
13 (6.1%) 43 (20.2%) 42 (19.7%) 115 (54.0%) 213 7.2
Others 36 (5.8%) 66 (10.7%) 155 (25.0%) 362 (58.5%) 619 21.0
With regard to Nursing Phenomenon with more diagnoses related with the caregiver, the
Nursing Phenomenon with more records is the ‘‘Pressure Ulcer’’ with 446 (15.1%), followed
by ‘‘Self Care: Feeding’’ with 356 (12.1%) and the ‘‘Turning of own body’’ with 318 (10.8%),
focus on the potential for enhancement of family caregivers knowledge and skills learning to
prevent pressure ulcers and impaired nutrition.
CONCLUSIONS. We can say that in all Nursing Phenomenon identified, the dimension
‘‘knowledge not demonstrated’’ is the one with more records, showing the concern of nurses
for this area. It appears, with the exception of the ‘‘Transfer of own body’’, the rate of
resolution of the situation is over than 40%, which shows concern of nurses for the returning
home of the dependent person.
0708
EVALUATION OF CRITICAL CARE NURSES0 WORK ENVIRONMENT AND JOB
SATISFACTION IN GREECE
G. Topalidou1, K. Karagiannaki1, N. Liamou1, P. Kontou1, A. Gogou2, K. Flamouropoulou1
1Papanikolaou Hospital, ICU, Thessaloniki, Greece, 2Agios Dimitrios Hospital, Thessaloniki,
Greece
AIMS. There is a significant body of evidence that adequate nursing care has a great impact in
the quality of inpatient care. However, an increasing intention to leave ICU is recorded among
critical care nurses. The purpose of the study was to evaluate the status of critical care work
environment, as well as the job satisfaction, as perceived by critical care nurses in Greek ICUs
and to identify the sources of dissatisfaction.
METHODS. Cross-sectional survey conducted in the ICUs of nine national and two private
hospitals in Greece. A 40-item Questionnaire, primarily based on NWI-R, was distributed
over a period of 1.5 year to critical care nurses. Demographics, organizational environment,
satisfaction and intention to leave were collected on a Self-report basis. Perception of each
item was indicated by answering strongly disagree (1) to strongly agree (4) on a Likert scale.
All surveys were anonymous
RESULTS. A sample of 245 nurses (79.2% women and 20.8% men) was obtained. Response
rate was 62%. Their mean age was 35 ± 6.8 years, experience in health care
10.4 ± 6.8 years, time in ICU 7.2 ± 5.4 years while time in current position 6.1 ± 5 years.
The majority of responders perceive communication, collaboration and team working with
physicians as good or quite good (81.4, 80.2 and 84.1%, respectively) while they recognize
value physicians bring to the work of the organization. Furthermore, they agree that nurse
manager is a good leader and supportive of them, while they rate communication with
administration as poor or fair. Nearly half of them believe that their work schedule is not
flexible.
A substantial number of nurses have a negative or quite negative perception regarding
staffing, auxiliary staff, nurse/patient ratio and available time per patient (84, 65.8, 87.3, and
68.3%). The majority of them view negatively their salary, career development opportunities,
acknowledgement of their contribution and use of their diagnoses.
Intention to leave ICU was expressed by 31.8% of participants. Their plan to leave was
independently associated with organizational climate factors, while the role of nurse manager
seemed to have a positive impact on their desire to remain in ICU.
CONCLUSIONS. Our findings are consistent with other studies, indicating that nurses’
problems are common worldwide. It is important to know the factors that are associated with
nurses’ dissatisfaction about work environment in ICU, since high quality nursing care can
affect significantly patient outcome.
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NURSING ACTION IN THE CONFUSED PATIENT
P. A.O. Marques1
1Escola Superior de Enfermagem do Porto, Porto, Portugal
INTRODUCTION. The exponential growth of elderly population present new challenges to
the health care providers’ systems: the modification of the paradigm of care and the devel-
opment of content for Nursing Information Systems, that support the nurses’ clinical decision.
OBJECTIVE. The ‘confusion’, a phenomenon associated with age, has ethical and safety
implications to the patient, and high social, political and economical costs. After improve-
ments in diagnosis and treatment, there is no evidence that support changes in practice, as it is
being managed with individual criteria. As so, we want to understand its clinical utility.
MATERIAL AND METHODS.
(a) Study of action research in an acute medical unit, where we applied the NEECHAM
scale;
(b) Interviews to nurses and participant observation. We used the method of Strauss and
Corbin to generate a Grounded Theory, using the informatics program NVivo7.
OUTCOMES. The model created, suggests the importance of simultaneously considering
two areas: the Functional Status (FS) and Behavioral Responses (BR). From this conceptual
model emerged different types of confused patients.
DISCUSSION. The importance of the outcomes to the clinical practice is significant. The
next step will be the application of the algorithm in the computer application SAPE (Support
System of Nursing Practice), using the ICNP. When used together, FS ? BR, emerged
patients with common characteristics. It is possible to allocate ab initio a series of inter-
ventions, helping nurses to decide, and promoting nursing sensitive outcomes.
0710
ESTIMATION OF AN ICU PATIENT’S HEIGHT AND WEIGHT BY HEALTHCARE
PROFESSIONALS
S. Wolf1,2, A. Riess3, L. Schuerer1, P. Friederich3, C. B. Lumenta1, J. F. Landscheidt1
1Klinikum Bogenhausen, Neurosurgery, Muenchen, Germany, 2Charite Universitaetsmedizin
Berlin, Campus Virchow, Neurosurgery, Berlin, Germany, 3Klinikum Bogenhausen, Anes-
thesiology, Muenchen, Germany
OBJECTIVES. In a patient newly admitted to the intensive care unit, usually the height and
weight are not precisely known. However, to facilitate comparison between patients, these
values are required for indexing physiologic values like Cardiac Output (CO), Global End-
diastolic Volume (GEDV) or Extravascular Lung Water (EVLW) derived from
transpulmonary thermodilution. To investigate the error of estimating height and weight, we
analysed prospective data from a previous trial on the age dependence of GEDV [1].
METHODS. Patients scheduled for elective brain tumor surgery were measured and
weighted at study inclusion. On the following day, postoperatively the patients were routinely
admitted to the Neurosurgical Intensive Care Unit. A member of the ICU team was asked to
estimate the patient’s height and weight. For analysis, both values were compared to the
preoperatively measured ones using the approach according to Bland and Altman [2].
RESULTS. Data was available from 109 pairs of estimated and measured values. Patient’s
measured height ranged from 149 to 194 cm, measured weight ranged from 47 to 125 kg. On
average, bias in height estimation was 0.9 cm, with a 95% precision range of -13.4–15.2 cm.
Mean weight estimation bias was -2.9 kg, with a 95% precision range of -21.8 kg to
15.9 kg. This resulted in a mean bias for body surface area of -0.7%, the 95% precision
ranging from -12.1 to 13.5%. The sex of the patient or the profession of the estimating ICU
team member (nurse/physician) did not influence these results.
CONCLUSIONS. Estimation of height and especially weight of a patient is weakly performed by
healthcare professionals. This has impact on the accuracy of indexed values of transpulmonary
thermodilution (and other size- or weight-related measurement and treatment in the ICU).
REFERENCES. 1. Rieß A et al (2009) Global end-diastolic volume and global end-diastolic
volume index are age dependent in awake, spontaneous-breathing patients after elective
craniotomy. Crit Care 13(Suppl 1): P216. 2. Bland JM, Altman DG (1986) Statistical methods
for assessing agreement between two methods of clinical measurement. Lancet 307–310.
GRANT ACKNOWLEDGEMENT. The core study on the age relationship of transpulmonary
thermodilution preload [1] was supported by Pulsion Medical Systems, Munich, Germany.
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AGE AND MECHANICAL VENTILATION: AN ICU SURVEY
R. Garcı´a del Moral Martı´n1, M. A. Diaz Castellanos1, E. Garcia Molina1, M. Arias Diaz1,
E. Morales Laborias1, M. Rodriguez Aranda1, Y. Jimenez Cabrera1, I. Fernandez Lopez1
1Hospital Santa Ana, Intensive Care Unit, Motril, Spain
INTRODUCTION. The ederly population is growing in Spain, Europe and USA. Many
investigators have reported rising number of elderly patients in the intensive care units.
OBJECTIVE. To analyze outcome and factors that may influence mortality in critically ill
elderly patients with mechanical ventilation.
METHODOLOGY. We made a retrospective review of the ICU database betweeen June
2006 to July 2008. We used 75 years as aged cutt-off point and Charlson index for comor-
bidity assessment. The Mann–Whitney test and T-student test were used to analyse continuous
variables with a non-normal and normal distribution in two groups of patients. Categorical
variables were compared using chi-square analysis. Multivariate logistic regression analysis
was applied to determine the independent contribution of clinical variables to the prediction of
mortality as a dependent variable. Statistical analyses were performed using SPSS 12.0.
RESULTS. We registered 955 patients in the study period. 168 (18%) were ventilated
patients. We excluded 23 with ICU stay less than 24 h.
In the multivariate analyses hospital mortality increased with age [75; APACHE III,
APACHE III without age influence (Tables 1, 2, 3)
TABLE 1 UNIVARIATE ANALYSIS
\75 years [75 years P
N 97 46
Age (median) 57 80
APACHE III (median) 69.9 84 0.006
APACHE III without age inlfluence (median) 61.5 65.9 0.38
ICU stay 7.35 6 0.46
Charlson index 1.29 1.55 0.33
ICU mortality 27 (28%) 28 (60%) \0.001
Hospital mortality 33 (34%) 31 (67%) \0.001
Mortality by APACHE III 0.31 0.50
TABLE 1 MULTIVARIATE ANALYSIS
p OR 95% CI
Age[75 years 0.04 4.83 1.54–10.76
APACHE III \0.001 1.039 1.016–1.061
APACHE III (without age) \0.001 1.036 1.015–1.058
Charlson index 0.49 1.128 0.79–1.6
Diagnosis 0.94 0.99 0.78–1.24
TABLE 1 DIAGNOSIS
\75 years [75 years
Surgical 24 (25%) 12 (26%)
Coronary ans cardiac insufficiency 9 (9.3%) 6 (3%)
Neurologic 11 (11%) 2 (4.3%)
Sepsis (non surgical) 7 (7.2%) 3 (6.2%)
Respiratory failure 20 (20.8%) 8 (17.3%)
Cardiac arrest 14 (14.5%) 11 (23%)
Others 4 (4.1%) 2 (4.3%)
CONCLUSION.
1. ICU and hospital mortality in ventilated patients[75 years is higher than young patients.
2. ICU mortality in ventilated patients[75 years is higher than predict mortality by APACHE III.
3. ICU stay is shorter in elderly patients.
4. In our population of ventilated elderly patients ICU mortality is not higher than bibliography.
5. Elderly patients have not higher comorbidity weigh with Charlson index.
6. ICU and hospital mortality were increased with age [75 years and APACHE III in the
multivariate analyses.
0712
EVOLUTION OF ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS
SYNDROME MORTALITY IN AN INTENSIVE CARE UNIT IN SOUTHERN
BRAZIL
L. Fialkow1, M. Farenzena1, S. R.R. Vieira1, M. C. Bozzetti1
1Hospital de Clı´nicas de Porto Alegre, Critical Care Division, Porto Alegre, Brazil
INTRODUCTION. ALI(includingitsmostsevereform,ARDS)mortalityratesarehighdespiteadvances
inthemanagementofpatientswiththiscondition.TheknowledgeabouttheevolutionofALI/ARDSmortality
could contribute to characterize the dynamic profile of these patients and to improve therapeutic strategies.
OBJECTIVES. Our objectives were to compare the ALI/ARDS mortality rates and the ALI
mortality risk factors between two cohort studies of the same ICU in different periods of time:
1999/2000 (2000 cohort) and 2004/2007(2007 cohort).
METHODS. Prospective cohort that included 1115 patients admitted to the ICU of a tertiary
teaching hospital (Hospital de Clı´nicas de Porto Alegre) between April/2004 and April/2007
who needed Mechanical Ventilation (MV) for at least 24 h. These results were compared with
a previous cohort of 1,301 patients admitted in the same ICU between April/1999 and April/
2000. In both studies all patients were evaluated regarding the presence/development of ALI/
ARDS according to the 1994 American-European Consensus Conference. Data were com-
pared between the two cohorts using Student0s-t or Chi square tests. Multivariate analysis by
conditional logistic regression was used to identify ALI mortality risk factors.
RESULTS. In ALI patients (n = 50/2000 cohort; n = 347/2007 cohort) we observed: (a) an
increase in both hospital (from 48 to 67%, p = 0.02) and ICU mortality (from 44 to 63%, p = 0.01);
(b) a higher mean (±SD) APACHE II score (from 17.7 ± 6.5 to 23.7 ± 8.2, p\ 0.001), and (c) an
increased percentage of patients with three or more organ failures (from 30 to 42%, p \0.001).
Regarding ARDS patients (n = 30/2000 cohort; n = 307/2007 cohort), there were an increase in
hospital mortality (from 47 to 68%, p = 0.03), in the mean (±SD) APACHE II score (from
17.6 ± 6.9 to 23.6 ± 8.3, p\ 0.001) and in medical patients (from 46 to 73%, p = 0.01). The
factors independently associated with increased hospital mortality in ALI patients were renal
(p = 0.002) and hematological (p = 0.02) failures in the 2000 cohort. In the 2007 cohort, renal
(p = 0.01) and hematological (p = 0.02) failures, use of vasoactive drugs (p \0.001) and ICU
length of stay (p\ 0.001) were independently associated with mortality.
CONCLUSIONS. We observed an increase in the mortality rates of patients with ALI/
ARDS, which according to the APACHE II score and the percentage of three or more or organ
failures, are more severely ill. Renal and hematological failures remained independently
associated with mortality in these patients. The results suggest that ALI/ARDS patients in our
ICU have more severe illness, what could explain the increase in the mortality rates high-
lighting the relevance of a better understanding of such findings.
REFERENCES. Fialkow et al (2002) Intensive Care Medicine 28:1644–1648.
GRANT ACKNOWLEDGEMENT. FIPE/HCPA and PIBIC/CNPq/UFRGS.
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INFLUENCE OF THE DURATION OF INVASIVE MECHANICAL VENTILATION
ON OUTCOME
S. Demoitie1, M. Claus2, P. Dechamps2, C. Melot1, J.-L. Vincent1
1Erasme University Hospital, Brussels, Belgium, 2CHU Saint-Pierre, Brussels, Belgium
INTRODUCTION. The outcome of critically ill patients receiving mechanical ventilation
has often been studied in specific groups of patients. The objective of our study was to assess
the influence of the duration of mechanical ventilation on hospital mortality in a mixed
population of critically ill patients.
METHOD. Review of all consecutive adult patients who received mechanical ventilation in a
mixed medical-surgical intensive care unit during a 22-month period.
RESULTS. Of the 1148 patients admitted, 351 were mechanically ventilated patients
(30.6%). They had a median age of 60 years and a hospital mortality of 45%. The duration of
mechanical ventilation was longer in patients who died than in patients who survived (6 days
[2–10] vs. 3 days [0.75–8]), but this was not an independent predictor of hospital mortality.
Factors independently associated with hospital mortality were age (OR 1.05, 95% CI 1.03–
1.07), cancer (OR 6.56, 95% CI 2.21–19.51), chronic respiratory disease other than asthma
and chronic obstructive lung disease (OR 5.75, 95% CI 2.02–16.27), cardiac arrest during
hospital stay (OR 3.89, 95% CI 1.38–10.94), coma due to other causes than intoxication (OR
10.16, 95% CI 4.1–25.19), thrombocytopenia (OR 3.5, 95% CI 1.3–9.39), need for adrenergic
support (OR 4.3, 95% CI 2.23–8.29) and lowest PaO2/FiO2 ratio (OR 2.36, 95% CI 1.46–
3.79).
CONCLUSION. Survival in mechanically ventilated patients is determined by the under-
lying medical condition leading to mechanical ventilation, some co-morbidities and the
complications that may occur during mechanical ventilation. The duration of mechanical
ventilation per se does not independently predict hospital mortality.
0714
LOW LEVELS OF CIRCULATING LEUKOCYTE AND PLATELET MICROPAR-
TICLES ARE ASSOCIATED WITH POOR OUTCOME IN ACUTE RESPIRATORY
DISTRESS SYNDROME
C. Guervilly1, R. Lacroix2, J.-M. Forel1, A. Roch1, L. Camoin-Jau2, F. Dignat-George2, L.
Papazian1
1Re´animation Me´dicale, APHM, Universite´ de la Me´diterrane´e, URMITE CNRS-UMR 6236,
Marseille, France, 2UMR-S 608, INSERM, Universite´ de la Me´diterrane´e, Marseille, France
INTRODUCTION. Microparticles (MPs), are effectors in vascular pathology. Lesions of
lung vessels are involved in ARDS.
OBJECTIVES. We tested the hypothesis that MPs are increased in patients with ARDS and
that specific subpopulations of MPs are associated with outcome.
METHODS. Fifty-two patients were enrolled in the study within the first 24 h of ARDS.
Bronchoalveolar lavage (BAL) and blood samples were performed on day 1 and day 3. A
control group (spontaneously breathing subjects) included 13 patients for BAL analysis.
Leukocyte-derived [CD45?], polymorphonuclear neutrophil [CD11b?/CD66b?], endothelial
[CD31?/CD41-] and platelet [CD41?] MPs were measured in arterial blood and in BAL
samples using flow cytometry. Survival was registered at day 28.
RESULTS. At day 1, levels of leukocyte-derived [CD45?] and neutrophil-derived [CD11b?/
CD66b?] MPs were increased in the BAL fluid from ARDS patients as compared with
controls (p \ 0.02 each). At day 1, survivors (n = 31) had higher MPs counts in plasma from
platelet origin [CD41?] (p = 0.02) and leukocyte origin [CD45?] (p = 0.05) than nonsur-
vivors (n = 21). In logistic regression analysis, a low level of circulating CD45? (\60
elements/microliter) was associated with a higher mortality rate (odds ratio, 4.6; 95% con-
fidence interval, 1.08–19.49; p = 0.03).
CONCLUSIONS. Release of MPs is a common process in the acute phase of ARDS. Low
levels of systemic leukocyte-derived [CD45?] MPs are associated with worse prognosis.
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PROGNOSTIC IMPACT OF CT-PRO-ENDOTHELIN-1 IN CRITICALLY ILL
PATIENTS WITH AND WITHOUT ACUTE RESPIRATORY FAILURE
B. Meyer1, J. Struck2, N. Morgenthaler2, A. Bergmann2, G. Heinz1, P. Wexberg1, R. Pacher1,
M. Hu¨lsmann1
1Medical University of Vienna, General Hospital, Vienna, Austria, 2B.R.A.H.M.S.AG,
Hennigsdorf, Germany
INTRODUCTION. Endothelin is a neurohormone that is elevated in various pulmonary
diseases as well as in certain non-pulmonary causes, e.g. in endotoxemia and heart failure.
The prognostic impact of endothelin in critically ill patients is essentially unknown. CT-pro-
endothelin-1 (CT-pro-ET-1) is a stable precursor molecule of endothelin.
OBJECTIVES. We aimed to assess the prognostic impact of CT-pro-ET-1 in patients pre-
senting with acute respiratory failure. Moreover, we aimed to compare the prognostic impact
of CT-pro-ET-1 in patients with and without acute respiratory failure.
METHODS. In a 17 months study period, we included 344 critically ill patients in this
prospective observational study. A total of 78 patients presented with acute respiratory failure
on ICU admission, 266 patients had various other diagnoses excluding acute respiratory
failure on ICU admission. Blood samples for determination of CT-pro-ET-1 were obtained in
all patients on ICU admission. CT-pro-ET-1 was determined by use of a recently developed
sandwich immunoassay.
RESULTS. A total of 66 patients had acute respiratory failure attributed to a primary pul-
monary cause (COPD n = 15, pulmonary hypertension n = 7, pneumonia n = 17, ARDS
n = 3, pulmonary embolism n = 6, postoperative respiratory failure n = 12 and various/
mixed other causes n = 6), 12 patients presented with acute cardiogenic edema. On ICU
admission, patients with acute pulmonary respiratory failure had significantly higher CT-pro-
ET-1 levels compared to patients with cardiogenic edema and patients without acute respi-
ratory failure (193 ± 117 vs. 160 ± 67 vs. 148 ± 94 pmol/l, p = 0.007, respectively). In
patients with pulmonary respiratory failure and cardiogenic edema, however, there was no
statistically significant difference in CT-pro-ET-1 levels between ICU survivors and ICU non-
survivors (195 ± 155 vs. 191 ± 127 pmol/l, p = 0.908 and 160 ± 75 vs. 164 ± 5 pmol/l,
p = 0.940, respectively). In contrast, in the mixed cohort of critically ill patients without
acute respiratory failure on ICU admission, CT-pro-ET-1 levels were significantly higher in
patients who died in the ICU compared to ICU survivors (179 ± 95 vs. 140 ± 93 pmol/l,
p = 0.007).
CONCLUSIONS. CT-pro-ET-1 plasma levels are elevated in patients with acute respiratory
failure. However, in the subgroups of patients with pulmonary failure and in patients with
cardiogenic edema, elevation of CT-pro-ET-1 did not provide statistically significant prog-
nostic information with regard to ICU survival. In contrast, in the mixed cohort of critically ill
patients without respiratory failure on ICU admission, elevation of CT-pro-ET-1 was a potent
predictor of ICU death.
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THE EFFECT OF PLASMA HOMOCYSTEINE LEVELS ON CLINICAL OUT-
COMES OF PATIENTS WITH ALI/ARDS
I. Tsangaris1, A. Tsantes2, G. Tsaknis1, C. Kroupis3, P. Kopterides1, C. Papageorgiou1,
M. Lignos1, E. Mavrou1, M. Theodorakopoulou1, I. Dimopoulou1, A. Armaganidis1
1Attikon University General Hospital, Medical School, University of Athens, 2nd Critical
Care Department, Athens, Greece, 2Attikon University General Hospital, Medical School,
University of Athens, Laboratory of Haematology and Blood Bank Unit, Athens, Greece,
3Attikon University General Hospital, Medical School, University of Athens, Department of
Clinical Biochemistry, Athens, Greece
INTRODUCTION. Several reports have shown that homocysteine promotes thrombosis by
disturbing the procoagulant-anticoagulant balance, while alterations in coagulation and
fibrinolysis have been suggested as important pathogenetic and prognostic determinants of
mortality in ALI/ARDS. The aim of the study was to evaluate the effect of plasma homo-
cysteine levels on the outcomes of critically ill patients with ALI/ARDS.
METHODS. Sixty-nine consecutive ventilated patients with ALI/ARDS were studied. Blood
samples were drawn within 3 days of clinical recognition of ARDS. Measurement of plasma
homocysteine, vitamin B12, folate, creatinine, protein C and plasminogen-activator inhibitor-
1 (PAI-1) antigen levels, and genotyping of the methylenetetrahydrofolate reductase
(MTHFR) gene C677T and A1298C polymorphisms were carried out. The primary outcomes
were 28- and 90-day mortality, while secondary outcomes included non-pulmonary organ-
failure-free days, liberation from mechanical ventilation up to day 28 and ventilator-free days
over the 28 days after enrollment.
RESULTS. In the multivariable analysis, plasma homocysteine concentration adjusted for
age, APACHE II score, MTHFR C677T and A1298C polymorphisms, and levels of PAI-1
antigen, protein C, creatinine, vitamin B12 and folate was found to affect significantly
mortality at 28 and 90 days (p = 0.39 and p = 0.83, respectively), the number of days
without organ failure besides lungs (p = 0.38), the probability of being free from mechanical
ventilation at day 28 (p = 0.63) and the number of days without ventilation assistance
(p = 0.73).
CONCLUSION. Our data suggest that increased plasma homocysteine levels, either alone or
in synergy with other thrombophilia risk factors like protein C and PAI-1 levels, do not seem
to adversely affect the prognosis in ALI/ARDS patients.
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MULTIVARIATE ANALYSIS OF MORTALITY IN A STUDY WITH PATIENTS
WITH ACUTE RESPIRATORY DISTRESS SYNDROME
M. C. Pintado Delgado1, R. de Pablo Sa´nchez1, E. Lo´pez Ramos1, M. Trascasa Mun˜oz de la
Pen˜a1, M. Rasco´n Risco1, J. A. Cambronero Galache1, I. Arribas2
1Hospital Universitario Principe de Asturias, Critical Care Unit, Alcala de Henares, Spain,
2Hospital Universitario Principe de Asturias, Research Foundation, Alcala de Henares, Spain
INTRODUCTION. Although the Acute Respiratory Distress Syndrome Network (ARDS
Network) study [1] demonstrated that ventilation with low tidal volume improves mortality, it
is still very high. There have been described several risk factors associated with an increased
mortality in this patients [2-4]. We decided to re-evaluate these risk factors when the patients
are under protective ventilation.
OBJECTIVES. To analyse the risk factors of mortality at 28 days in a study in patients with
ARDS using a Cox regression model.
METHODS. We analysed the risk factors or mortality at 28 days in a cohort of patients who
met the ARDS criteria of the Consensus Conference [5] after 24 h in mechanical ventilation
with low tidal volume (6–8 ml/kg weight), and who were part of study comparing two
methods of setting the level of positive end-expiratory pressure (PEEP): according the
ARDSNetwork standard-of-care recommendations [1] or above the lower inflection point of
the pressure-volume curve of the respiratory system according the method proposed by Suter
[6]. Variables with normal distribution were described as mean ? SD, with non-normal
distribution as medians and interquartile ranges.
RESULTS. We included 70 patients in our study. Baseline characteristics of patients were
mean 54.86 ? 2.11 years of age, 70% male, APACHE II 19.64 ? 0.85, Multiple Organ
Dysfunction Score (MODS) 8.43 ? 0.38, Sepsis-Related Organ Failure Assessment (SOFA)
9.11?0.45, Acute Lung Injury Score (LIS) 3 (2.5–3.25) and PaO2/FiO2 139.55?4.31 mmHg.
The global mortality at 28 day was 30% and hospital mortality was 42.82%. The selection of
variables initially included in the model were age [75 years, female sex, SOFA [9, MODS
[8, worse LIS[3.25, plateau pressure[30 cmH2O, pH at inclusion\7.34, PEEP level[10
cmH2O, multiorgan failure free-days at day 28 [17.5 days, respiratory failure free-days at
day 28 [13 days, cardiovascular failure free-days at day 28 [19 days, baseline PaO2/
FiO2 \ 100 mmHg, APACHE II [19, PEEP set according ARDS Network study. The
multivariate analysis of mortality at day 28 showed that the variables associated indepen-
dently with an increase in mortality were the following: female sex, setting PEEP as in the
ARDSNetwork study, SOFA [ 9, APACHE II [ 19 and pH \ 7.34 at baseline.
CONCLUSIONS. The mortality of the ARDS still continues very high, and it is related to the
female sex, presence of acidosis and severity of the underlying cause of ARDS. As in
previous studies the degree of hypoxemia is not correlated with the mortality.
REFERENCES. 1. N Engl J Med (2000) 342:1301–8. 2. Brun-Buisson (2004) Intensive Care
Med 30:51–61. 3. Roca. Med Intensiva (2006) 30:6–12. 4. Agarwald (2006) Chest 130: 724–




SYSTEMATIC EVALUATION OF OUTCOMES FOR PATIENTS REQUIRING
PROLONGED MECHANICAL VENTILATION
L. Rose1,2,3,4, I. Fraser2,5, L. Mckenzie5, J. Tessolini5
1University of Toronto, Lawrence S. Bloomberg Faculty of Nursing, Toronto, Canada,
2Toronto East General Hospital, Provincial Centre of Weaning Excellence, Toronto, Canada,
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INTRODUCTION. Recent trends indicate the number of patients requiring prolonged
mechanical ventilation (PMV) (C21 days) and protracted weaning (C7 days) is rising.
Comprehensive data on anticipated outcomes are important to guide clinician, patient, and
family decision-making.
OBJECTIVE. To synthesize studies reporting characteristics and outcomes (weaning suc-
cess, ventilator dependence, hospital mortality, discharge dispositions, and 1-year survival)
for patients requiring PMV.
METHODS. We included studies reporting a cohort mean (or median) of C21 days venti-
lation in intensive care units (ICU), or studies describing patients admitted to a respiratory
unit, weaning facility or long-term acute care hospital (LTAC) for PMV. Medline, EMBASE
and CINAHL databases (1990–2008) were searched using the terms: PMV; long term
mechanical ventilation; ventilation; weaning; prolonged; length of stay; and ICU, individually
and in combination. Reference lists of identified papers also were examined. Two reviewers
independently determined paper eligibility based on predefined criteria. Database searching
yielded 324 citations of which 40 reports describing 12,866 patients were selected for
independent data abstraction.
RESULTS. Eighteen (45%) prospective cohorts, 20 (50%) retrospective cohorts and 2 (5%)
retrospective case control studies were identified. Of the 40 studies, 26 (65%) described
cohorts admitted to specialized weaning units, 10 (25%) described patients receiving PMV in
ICU, 1 (2.5%) described patients admitted to a LTAC without a weaning unit, and 1 (2.5%)
described a weaning program, as opposed to physical location. Two (5%) case control studies
reported patients transferred to a LTAC or weaning unit compared to historical controls in
ICU or hospital wards, respectively. Patients ranged in age from 44 to 74 years; the pro-
portion of females from 27 to 58%. Mean duration of ventilation prior to non-ICU admission
ranged from 14 to 58 days; mean duration of ventilation following admission ranged from 6
to 50 days. Total mean ventilation duration for ICU cohorts was 26–60 days. Weaning
success for patients discharged alive ranged from 26 to 81% (non-ICUs mean 53%, 95%
confidence interval [CI] 35–71%; ICUs 57%, 95% CI 26–88%). The proportion of patients
remaining ventilator dependent ranged from 3 to 68% in non-ICUs (mean 23%, 95% CI 8–
38%) and 0–29% in ICUs (mean 7%, 95% CI 0–23%). Mortality ranged from 5 to 50% (mean
25%, 95% CI 10–41%) in non-ICUs and 14–49% in ICUs (mean 37%, 95% CI 7–67%). 1-
year survival (reported 16/40 [40%] studies) was 23–69%; ICU-studies (4/16, 25%) was 39–
46%. The proportion of patients discharged home ranged from 1 to 80% (mean 31%, 95% CI
14–49%).
CONCLUSIONS. Due to considerable variability in published reports the contribution to
outcomes of patient characteristics, weaning interventions, health system organization and
practice change over time remains unclear.
GRANT ACKNOWLEDGEMENT. Nil.
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OUTCOME PREDICTORS OF HIGH FREQUENCY OSCILLATORY VENTILA-
TION IN ADULT ARDS
S. A. Jog1, T. Dravid1, P. Rajhans1, P. Akole1, B. Pawar1, B. Bhurke1, A. Phadake2, R.
Kulkarni2
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INTRODUCTION. High Frequency Oscillatory Ventilation (HFOV) is a promising rescue
ventilatory modality in severe ARDS. Other modalities available for these patients are NO
Inhalation, ECMO or Prone Ventilation. Various outcome predictors of HFOV in severe
ARDS studied so far are APACHE II score, duration of conventional ventilation before
HFOV, pulmonary or extra pulmonary ARDS and improvement in oxygenation after HFOV.
The purpose of this study was to predict response to HFOV either before or after its initiation,
so that likely non responders could be switched to alternative rescue therapies early, to get
their benefit. Hence we retrospectively analysed the outcome predictors of HFOV in adult
ARDS patients.
METHODS. Setting 40 bedded multidisciplinary ICU of a Tertiary Care Hospital in Pune
India. HFOV ventilation ARDS patients receiving Volume Controlled Ventilation (VCV) as
per the ARDSnet protocol with PO2/FiO2 B 150 in spite of PEEP C 12 cm and FiO2 C 0.7,
were considered for HFOV as rescue therapy. All patients were followed up till discharge
from the hospital (Survivors) or death (Nonsurvivors).
RESULTS. Data of 39 patients were analysed. There were 12 survivors and 27 nonsurvivors.
Mortality rate of 69.24% was attributable to ‘‘Rescue use’’ of HFOV and 32 patients having
multiorgan failure before HFOV. Tables 1 and 2 show parameters evaluated as outcome
predictors. Binary Logistic Regression model was used to predict survival as successful
response to HFOV.
Statistical Analysis 95% Confidence Interval for Odds ratio. P value [0.05- No significant
relationship of outcome predictors with the log of odds. *P value for the coefficient of
‘‘25%reduction in OI at 24 h’’ is 0.026\ 0.05, shows that there is significant relationship of
25%reduction in OI with survival. Odds ratio is a ratio of probability of survival to probability
of death.
TABLE 1 PRE HFOV VARIABLES




APACHE II score 0.93 0.27
Presence of Multiorgan Failure 1.00 1.00
Pulmonary OR Extrpulmonary ARDS 1.21 0.78
VCV hours 1.01 0.31
PEEP 0.87 0.25
Plateau Pressure VCV 0.97 0.68
pH VCV 0.70 0.64
PCO2 VCV 0.99 0.46
OI. VCV 1.01 0.62
TABLE 2 POST HFOV VARIABLES




pH 24 h HFOV 0.82 0.25
PCO2 24 h HFOV 1.01 0.77
25% reduction in OI. at 24 h* 11.85* 0.02*
Hemodynamic instability after HFOV 1.70 0.43
HFOV Duration hours 0.99 0.44
CONCLUSION. Reduction of Oxygenation Index by at least 25% within 24 h after initiation
of HFOV emerged as a single, statistically significant outcome predictor which could predict
successful response to HFOV in Adult ARDS. Patients in whom this is not achieved may be
switched to alternative rescue therapies.
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NONINVASIVE MECHANICAL VENTILATION (NIV) IN CLINICAL PRACTICE: A
ONE YEAR EXPERIENCE IN A TERTIARY HOSPITAL
M. Camara1, C. Dias1, S. Silva1, G. Silva1, J. No´brega1, E. Maul1
1Hospital Central do Funchal, Funchal, Portugal
INTRODUCTION. NIV has emerged as an important tool in the treatment of acute respi-
ratory failure (ARF).It can reduce substantially the need for endotraqueal intubation and
mechanical ventilation (MV) in a number of clinical conditions. It can also reduce the
incidence of complications associated with MV, the hospital length of stay and mortality.
AIMS. To report our experience with NIV via face mask in a tertiary hospital after an
educational programme for physicians and nurses and a supervised implementation of a
protocol. To evaluate the feasibility and outcome results of NIV in daily clinical practice.
METHODS. A prospective cohort study, over 24 months. 81 patients with heterogeneous
forms of acute respiratory failure (ARF) were included. The patient population was divided
into 2 groups: hypoxemic respiratory failure and hypercapnic respiratory failure. All patients
received pressure support ventilation (PSV). Medical records were analysed for physiological
and outcome variables for all patients who received NIV for respiratory failure.
RESULTS. 81 patients were included (61.7% male), with a mean age of 68.7 years. Chronic
obstructive pulmonary disease (38.3%) was the most frequent condition that motivated NIV
followed by pneumonia (29.7%) and acute pulmonary edema (29.6%). NIV failure in the total
population was 20.86% (pneumonia 64.91% and post-extubation/weaning 30%). Complica-
tions were registered in 32.1% of the patients, discomfort being the most frequent (53.6%).
The hospital length of stay was 15.6 days. We did not find any independent predictive factor
with statistical significance between the responders and the non-responders. The overall
mortality was 21% and with no statistical significance between groups. Survival estimated by
Kaplan-Meier curves showed a lower survival in the hypoxemic group (log-rank test:
p = 0.03).
CONCLUSIONS. This study demonstrates our experience in the implementation of a NIV
clinical protocol. The results suggest that NIV could be considered as a first line ventilatory
treatment of acute respiratory failure of different etiologies, as a promising weaning technique
and for post-extubation ventilatory support. However, NIV should be performed by a moti-
vated and sufficiently trained care team in order to obtain the best results.
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OUTCOMES OF ALI/ARDS IN VITORIA, BRAZIL
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INTRODUCTION. Recent studies indicated a mortality of ALI/ARDS around 30–40%.
OBJECTIVES. to evaluate the outcomes of ALI/ARDS requiring invasive mechanical
ventilation in Vitoria, city in the southeast of Brazil.
METHODS. A 15-month prospective observational study (October 2006 to December 2007)
was carried out in 14 adults ICU, total of 175 ICU beds. Data was collected daily for 7
consecutive days and on the 14th and the 28th day after diagnosis of ALI/ARDS according to
the AECC criteria, in patients aged 18–75 years, who required invasive ventilation for more
than 24 h. Period of follow-up was 28 days.
RESULTS. From the 7.133 admissions, 130 patients fullfilled ALI/ARDS criteria (1.82%).
ALI represented 37.6% and ARDS 62.4% of the patients. Males (62.3%), mean age of
44.24 ± 15.95 years. Mean length of ICU stay was 26.48 ± 18.74 days; duration of
mechanical ventilation was 21.41 ± 15.41 days. APACHE II for ARDS/ALI (21.31/19.69)
and LIS (2.39/1.86). The mean FIO2 was 0.68 ± 0.20. Mean tidal volume was
9.36 ± 2.49 mL/kg PBW and mean PEEP levels 9.4 ± 3.6 cmH2O. Mean plateau pressure
was 26.14 ± 7.84 cmH2O (92% in pressure control ventilation). Overall mortality at 28 days
was 31.9% for ALI and 43.2% for ARDS.
CONCLUSIONS. In Vito´ria, Brazil, the 28-day mortality for ARDS was 43.2% and for ALI
31.9%.
0722
MORTALITY AT 28 DAY IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS
SYNDROME IN TWO STRATEGIES OF SETTING POSITIVE END-EXPIRATORY
PRESSURE
M. D.C. Pintado Delgado1, R. de Pablo Sa´nchez2, I. Arribas3, M. Trascasa de la Pen˜a2, L. R.
Esther2, M. Manso Alvarez2, J. A. Cambronero2
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Universitario Principe de Asturias, Critical Care Unit, Alcala de Henares, Spain, 3Hospital
Universitario Principe de Asturias, Alcala de Henares, Spain
INTRODUCTION. In patients with Acute Respiratory Distress Syndrome (ARDS) in
mechanical ventilation the application of positive end-expiratory pressure (PEEP) improves
oxygenation, but also has deleterious effects [1, 2]. There are several methods to determine
the level of PEEP to employ, although none of them have demonstrated to be the best. Exist
few randomized controlled trial studies [3–8] that compare these methods; more of them
compares a fixed level of PEEP according de fraction of inspired oxygen (FiO2) applied to the
patient, and a PEEP level set according the lower inflection point of the pressure-volume
curve (P–V curve) of the respiratory system. Objectives: To compare the effect on mortality
at 28 days of two strategies of set PEEP in patients with ARDS ventilated with low tidal
volumes.
METHODS. We included consecutive patients who met the ARDS criteria of the Consensus
Conference [9], after 24 h under mechanical ventilation with low tidal volume (6–8 ml/kg
weight) and limitation of pressures on airway at 35 cmH2O. They were randomized into two
groups: a group control, where PEEP was set according the FiO2 applied as in the ARDS
Network study [10], or a interventional group, where PEEP was set according the method
proposed for Suter [1], which consist in setting PEEP level above the lower inflection point of
the P–V curve. In both groups PEEP level was set daily [11].
RESULTS. We included 70 patients, 36 in control group and 34 in interventional group. The
global mortality at day 28 was 30% and hospital mortality was 42.85%. The main cause of
mortality was the multiorgan failure (70%), followed by refractary hypoxemia (10%). In the
control group, mortality at day 28 was 38.9 versus 20.6% on interventional group (p = 0.12);
this trend was kept when we analyzed the mortality depending on the origin of the SDRA
(Pulmonary ARDS: mortality at day 28 were 37.5% in the control group vs. 13.33% in the
interventional group, p = 0.15. Extrapulmonary ARDS: 41.66% in control group vs. 26.31%,
p = 0.44). When we analyzed the survival by means of the curve of Kaplan–Meier, we found
that the interventional group had a better survival at 28 days, although it did not reached
statistical significance.
CONCLUSIONS. In this pilot study, a mechanical ventilation on patients with ARDS based
on low tidal volume and a level of PEEP set above the lower inflection point of the P–V curve
of the respiratory system is associated with a strong tendency to a lower mortality at day 28.
REFERENCES. 1. Acosta (2007) Crit Care Clin 23:251–262.
2. Villar (2005) Minerva Anestesiol (2005) 71:265–272.
3. Amato (1998) N Engl J Med 338:347–354.
4. Ranieri (1999) JAMA 282:54–61.
5. Villar (2006) Crit Care Med 34:1311–1318.
6. Brower (2004) N Engl J Med 351:327–336.
7. Mercat (2008) JAMA 299:646–655.
8. Meade (2008) JAMA 299:637–645.
9. Bernard (1994) Am J Respir Crit Care Med 149:818–824.
10. N Engl J Med (2000) 342:1301–1308.
11. Suter (1978) Chest 73:158–162
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INTRODUCTION. COPD is a major cause of chronic morbidity and mortality throughout
the world. However the real contribution of COPD comorbidity in intubated patients mortality
is unknown.
OBJECTIVE. The aim of the study was evaluate the impact of non-exacerbated COPD in
mortality of patients under mechanical ventilation, admitted to ICU for any disease.
METHODS. An observational cohort study was performed in a multidisciplinary ICU. All
the patients under mechanical ventilation for more than 48 h, in which the lower tract
infection was ruled out at admission were included. Patients were divided in two groups
depending on the presence of COPD (COPD, NON-COPD). Demographic variables,
comorbidities, illness severity at admission, ICU complications and ICU mortality were
collected. Analysis was performed using statistical SPSS v13.0 (Chicago, III).
RESULTS. 235 patients were enrolled, 60 (25.3%) of whom were COPD. At baseline COPD
patients were older (68.5 vs. 53.4 years, p \ 0.05), and admitted to ICU for a medical disease
more often than NON-COPD (73.3 vs. 40.6%, p \ 0.05). COPD patients were most severe at
admission (APACHE II score; 21.5 vs. 19.5; p \ 0.05).There were no statistical differences in
development of VAP (11.9 vs. 16.0/1,000 MV day) and neither in the length of mechanical
ventilation (14.0 vs. 13.4 days). Overall mortality was 26.4%, being higher in COPD group
compared to NON-COPD (36.7 vs. 22.9%; p \ 0.05), even adjusted for severity of illness at
admission (HR = 2.07 95% CI 1.22–3.54; p \ 0.05). Age (55.9 vs. 61.3; p = 0.03), COPD
(22 vs. 35.5%; p = 0.03), APACHE II at admission (19.2 vs. 22.4; p \ 0.05), SOFA at day 1
(6.5 vs. 8.3; p \ 0.05) and shock at admission (50.9 vs. 77.4%; p \ 0.05) were variables
associated with ICU mortality in univariate analysis. A multivariate analysis (Cox regression)
documented that medical condition (HR = 1.80 95% CI 1.03–3.17); COPD (HR = 1.9 95%
CI 1.13–3.42) and shock at admission (HR = 2.1 95% CI 1.05–4.27) were variables inde-
pendently associated with ICU mortality. Among COPD patients only SOFA score at
admission was independently associated whit mortality (HR = 1.16 95% CI 1.01–1.37).
CONCLUSION. COPD was associated with an increased mortality in intubated patients
admitted to ICU. Neither development VAP nor the presence other comorbidities were
associated with high mortality. The COPD patient outcome was related with development of
multiorgan disfunctions.
GRANT ACKNOWLEDGEMENT. Supported in part by Marato TV3; AGAUR 2005/SGR/
920 and CIBERes 06/06/0036.
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PREDICTORS OF PROLONGED MECHANICAL VENTILATION AFTER CORO-
NARY ARTERY BYPASS GRAFTING SURGERY: A RETROSPECTIVE ANALYSIS
N. Veziroglu Akovali1, P. Zeyneloglu2, A. Pirat2, G. Arslan2
1Baskent University, Ankara, Turkey, 2Baskent University, Anesthesiology, Ankara, Turkey
OBJECTIVE. Prolonged mechanical ventilation after coronary artery bypass grafting
(CABG) surgery is associated with increased intensive care unit and hospital stay and may
contribute to postoperative morbidity and mortality. The objective of this study was to
identify the predictors of prolonged mechanical ventilation for patients who had CABG
surgery, by evaluating some pre- and intraoperative variables.
METHODS. Consecutive patients who had CABG surgery between December 2004 and
December 2007 were retrospectively evaluated. Both reexplorations and patients died after
undergoing surgery were excluded. Prolonged mechanical ventilation was defined as longer
than 12 h of mechanical ventilation after the surgery. Subjects’ preoperative and intraoper-
ative data were recorded.
RESULTS. Of the 455 patients, who were included in the final analysis, 72 (15.8%) required
prolonged mechanical ventilation after CABG surgery. Compared with the patients who did
not require prolonged mechanical ventilation those who did had significantly higher incidence
of intraoperative hypotension, intra-aortic balloon pump and vasopressor requirements
(p = 0.039, p = 0.001 and p = 0.042, respectively). Analysis allowed us to identify:
increased age (OR = 1.038, 95% CI = 1.009–1.068) and intraoperative muscle relaxant
usage (OR = 1.064, 95% CI = 1.008–1.122), as independent predictors of prolonged
mechanical ventilation.
CONCLUSION. We have evaluated increased age and intraoperative muscle relaxant usage
as perioperative variables that might predict prolonged mechanical ventilation after CABG
surgery. Identification of these factors may allow the development of strategies to optimize
patient’s management.
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PULMONARY SURFACTANT ADMINISTRATION FOR ACUTE RESPIRATORY
DISTRESS SYNDROME PATIENTS
S.-W. Huang1, X.-D. Guan1
1The First Affiliated Hospital of Sun-Yat Sen University (SUMS), Surgical Intensive Care
Unit (SICU), Guangzhou, China
OBJECTIVES. The purpose of this study was to perform exogenous surfactant adminis-
tration in post-operative patients with acute respiratory distress syndrome (ARDS) to assess
whether this therapy may be useful in post-operative patients with ARDS.
METHODS. The primary outcome measure was mortality in 28 days. Secondary measures
included oxygenation (PaO2:FiO2 ratio) and APACHE II and chest X-ray result. Twenty
patients conformed to ARDS criteria and received endotracheal administration pulmonary
surfactant (Curosurf, Chiesi, 20 mg/kg per days 9 3 days) by Fiberoptic bronchoscopy.
Oxygenation, APACHE II and chest x-ray result would be checked.
RESULTS. After pulmonary surfactant therapy in 3 days, oxygenation in 13 patients (13/20)
was more significant higher than that before (155 ± 5 vs. 83 ± 3, P \ 0.05), APACHE II was
more significant lower than that before (20 ± 2 vs. 15 ± 2, P \ 0.05). In 7 days, chest X-ray
result in seven patients (7/20) was improved but thirteen patients (13/20) along with interstitial
fibrosis. Eleven patients died and nine patients survived (mortality in 28 days = 55%).
CONCLUSIONS. Exogenous pulmonary surfactant administration may improve oxygena-
tion and APACHE II in post-operative patients with ARDS but has not been shown to
improve mortality. Whether an effective adjunctive therapy in ARDS, it seems that higher
doses administration might yield better efficacy but needs further investigation.
KEYWORDS. Pulmonary Surfactant, Acute Respiratory Distress Syndrome (ARDS).
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BRONCHOALVEOLAR LAVAGE (BAL) AND SUPPLEMENTATION WITH EXOG-
ENOUS SURFACTANT IN ADULTS WITH ACUTE RESPIRATORY DISTRESS
SYNDROME (ARDS)
S. Busani1, I. Cavazzuti1, L. Fabbri2, L. Lumachi2, D. Lo Pardo3, F. Michielan4,
P. A. Vassalli5, D. Pacini6, G. D’Este7, M. Girardis1, A. Pasetto1
1Servizio e Cattedra di Anestesia e Rianimazione 1, Policlinico di Modena, Modena, Italy,
2Servizio di Anestesia e Rianimazione, Ospedale Universitario Careggi, Firenze, Italy,
3Servizio di Anestesia e Rianimazione, S. Giovanni di Dio e Ruggi ‘Aragona, Salerno, Italy,
4Servizio di Anestesia e Rianimazione, Ospedale S. Antonio, Padova, Italy, 5Servizio
Anestesia e Rianimazione, Ospedale Bassano del Grappa, Bassano del Grappa, Vicenza, Italy,
6Servizio Anestesia e Rianimazione, Ospedale San Martino, Genova, Italy, 7Servizio di
Anestesia e Rianimazione, Policlinico Casilino, Roma, Italy
INTRODUCTION. Exogenous surfactant’s impact on mortality and respiratory outcomes in
adults with ARDS is still controversial, furthermore dosages and ways of administration are
not standardized in these patients [1–3]. The aim of our case-control study was to show early
effects on respiratory system in adults with ARDS underwent surfactant protocol shared by 13
Italian intensive care units.
MATERIALS AND METHODS. Patients enrolled were adults with ARDS defined by the AECC
criteria [4]. Curosurf (porcine surfactant, Chiesi Pharmaceutical, Italy) two-stage protocol was
applied within 48 h from the ARDS diagnosis and performed with fiberoptic bronchoscope. First
stage was BAL with 240 mg of Curosurf diluted in 100 mL of saline; this volume was then divided
in 5 aliquots administered to each pulmonary lobe. After 30 min from the BAL a supplementation
with a solution of 240 mg of Curosurf in 10 mL of saline was instilled in each lobe. We matched
treated patients with other adults with ARDS. Recruitment manoeuvres were performed at enrol-
ment and every 12 h in each group. We recorded respiratory parameters at enrolment and every 6 h
for the first 24 h and Lung Injury (LI) Score at enrolment and after 24 h. We recorded also each
possible adverse event. Respiratory variables and LI Score were compared using an ANCOVA
model. P \0.05 was considered significant.
RESULTS. 25 patients were treated with Curosurf and 25 patients were enrolled as control group.
Twelve patients had indirect ARDS in each group. No statistical differences between the groups
were found in age, weight and SAPS II. No adverse events were recorded during the study in the
treated group. Results for respiratory parameters and LI Score of the 2 groups are listed in Table 1.
TABLE 1 RESPIRATORY PARAMETERS AND LI SCORE
Parameters Baseline 6 hours 12 hours 24 hours
PaO2/ 98.8 ± 17.2 99.8 ± 23.8 102.1 ± 21.2 102.2 ± 19.9
FiO2 Control Curosurf 98.5 ± 29.5 142.0 ± 37.6* 150.6 ± 29.7* 168.4 ± 45.4*
Compliance (mL/cmH2O) 27.2 ± 5.0 26.9 ± 3.1 27.4 ± 4.4 27.7 ± 4.0
Control Curosurf 29.0 ± 3.9 34.6 ± 4.1* 37.0 ± 3.1* 35.2 ± 4.2*
Plateau Pressure (cmH20) 28.1 ± 3.1 28.2 ± 3.4 28.0 ± 3.7 28.4 ± 3.3
Control Curosurf 27.4 ± 4.4 25.2 ± 3.3 23.9 ± 2.1* 25.0 ± 4.2
Tidal volume (mL/kg BW) 7.1 ± 1.2 7.1 ± 1.3 7.2 ± 1.2 7.2 ± 1.5
Control Curosurf 7.1 ± 1.5 7.0 ± 1.4 7.0 ± 1.0 7.0 ± 1.5
Lung Injury Score 2.9 ± 0.2 3.0 ± 0.3
Control Curosurf 2.8 ± 0.5 2.3 ± 0.5*
*p\ 0.05
CONCLUSIONS. In our protocol we administered a total amount of 1,440 mg of Curosurf
that means approximately 1,425 mg of phospholipids (PHL), a much lower concentration of
PHL compared with previous studies [1–3]. Our two-stage protocol rises from the belief that
higher dosages instilled in many studies are related to the inactivation of the exogenous PHL
by the inflammatory mediators released in the ARDS lung that could be partly removed with a
BAL, as reported in paediatric patients [5], before the supplementation.
Early benefits on oxygenation and static compliance and LI Score improvement at 24 h in the
treated group could identify our protocol with Curosurf as a supportive ‘‘bridge’’ to the
etiological resolution of the ARDS in adults, however, a randomized controlled trial is
mandatory to confirm these results.
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EXTRA-CORPOREAL LUNG SUPPORT AS AN ALTERNATIVE TO MECHANI-
CAL VENTILATION
M. Belliato1, A. Bottazzi1, M. Pagani1, F. Sciutti1, S. Pifferi1, L. Carnevale1, R. Imberti1,
D. Radolovich1, C. Lo Coco1, G. A. Iotti1
1Fondazione IRCCS Policlinico San Matteo, S.C. Anestesia e Rianimazione II, Pavia, Italy
INTRODUCTION. In respiratory failure extra-corporeal lung support (ECLS) plays a rescue
role complementary to non effective mechanical invasive ventilation. However, in certain
cases we can indicate alternative uses of it: as to maintain a non-invasive ventilation (NIV) no
longer effective, to artificially replace the injured lungs and to avoid risks and complications
due to mechanical ventilation.
AIM OF THE STUDY. To review the use of ECLS in non-intubated patients on NIV, in our
ICU.
PATIENTS AND METHODS. In the last 18 months four adult patients were treated with
ECLS?NIV: pumpless arterial-venous (pav) technique was used in three patients waiting for
lung transplant, whereas a veno-venous (vv) technique was used in an immunosuppressed
patient suffering from P. Carinii pneumonia.
RESULTS. The vvECLS ? NIV association, applied for 5 days, was a successful bridge-to-
recovery for the patient suffering from pneumonia. In one of the three patients waiting for
lung transplant, the pavECLS ? NIV association, applied for 1 day, was a successful bridge-
to-transplant, with patient recovery. In another case, after 3 days it was necessary to switch
from pavECLS ? NIV to invasive ventilation and vvECLS, thus supporting the patient until
the transplant was successfully performed. The third patient waiting for lung transplant was
intubated after 13 days on pavECLS ? NIV, and died after 32 days of ECLS, before the
organ was available.
CONCLUSIONS. In patients with a good level of consciousness and affected by a reversible
pathology or candidates to lung transplant, ECLS can be added to NIV with the purpose to
avoid or postpone invasive ventilation. We applied this approach in patients with low risk of
complications due to ECLS and high risk of complications due to invasive ventilation. By
adding ECLS, invasive ventilation was avoided in two patients, and postponed in two patients.
Three of four patients were successfully discharged from the hospital. Veno-venous ECLS
was found to be more effective than pumpless arterial-venous ECLS to prevent the need of
invasive ventilation.
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A NEW METHOD FOR REDUCING THE RISK OF OXYGEN TOXICITY IN
APNOEIC OXYGENATION WITH EXTRACORPOREAL CO2 REMOVAL
N. D. Nielsen1, A. Granfeldt2, B. Kjaergaard3, S. T. Vistisen1, A. Larsson1
1Anaesthesia and Intensive Care Medicine, North Denmark Region, Aarhus University
Hospital, Anaesthesia Research Unit, Aalborg, Denmark, 2Aarhus University Hospital, Aar-
hus Sygehus, Department of Anaesthesiology and Intensive Care Medicine, Aarhus,
Denmark, 3Aalborg Hospital, Aarhus University Hospital, Department of Thoracic Surgery,
Aalborg, Denmark
INTRODUCTION. We have shown that apnoeic oxygenation (AO) combined with extra-
corporeal CO2-removal (AO-ILA) can maintain adequate oxygenation and gas exchange in an
animal model of acute lung injury (ALI) [1]. However, we have further shown that if an
inspiratory fraction of O2 (FiO2)\1.0 is used during AO, alveolar accumulation of N2 quickly
leads to arterial hypoxemia (unpublished data). Thus, FiO2 1.0 is mandatory when using AO-
ILA. This is a potential disadvantage for AO-ILA, since this high alveolar O2 concentration
might be toxic. We hypothesized that if N2 is trapped in the lungs before AO with FiO2 1.0 is
initiated, a non-toxic alveolar O2 concentration could be obtained while providing adequate
arterial oxygenation. The aim of this animal study was to test whether using FiO2 0.5 before
AO (thus trapping N2 in the lungs) could give and maintain adequate oxygenation.
METHODS. The study was approved by the animal ethics committee. Eight 70 kg pigs were
anaesthetized and intubated. The following series was conducted in a random sequence:
Series 1 and 2; FiO2 before AO: 0.5; FiO2 during AO: 0.5; CPAP (continuous positive airway
pressure): 10 or 1 cmH2O. Series 3 and 4; FiO2 before AO: 0.5; FiO2 during AO: 1.0; CPAP:
10 or 1 cmH2O. AO was performed for 20 minutes or until peripheral O2 saturation (SpO2)
\60%. Blood gasses were drawn at regular intervals.
RESULTS. Results are median (range). In series 1–2 arterial partial pressure of O2 (PaO2)
decreased below 52 mmHg within 6 min in all animals. In series 3 PaO2 decreased from 274
(233–291) mmHg to 80 (69–98) mmHg within 5 min, but maintained at this level during the
20 min study period. Arterial O2 saturation (SaO2) decreased in two phases: A quick decrease
to 94 (89–99)% during the first 3 min, and then linearly to 79 (72–82)% during the rest of
study period. In series 4, PaO2 decreased from 281 (227–307) mmHg to 63 (52–73) mmHg
within 5 min and maintained at that level. However SaO2 fell below 60% in 2 pigs within
15 min.
DISCUSSION/CONCLUSION. Using FiO2 \ 1.0 before AO and continuing with FiO2 1.0
during AO seems to be a feasible method to achieve an acceptable alveolar O2 concentration
during AO. In this exploratory study, without extracorporeal CO2-removal, the initial fast
decline in PaO2 was probably due to trapping of the dead space N2 into the alveoli, while the
following slow decline was due to alveolar CO2-accumulation. The difference between series
3 and 4 was probably caused by the lower relative dead space/gas exchange space ratio with
CPAP 10 causing less initial N2 accumulation in the gas exchange space. If the method should
be used to reduce the alveolar O2 concentration in AO-ILA, measurement of dead space and
FRC would thus be helpful to calculate the FiO2 to be used before AO-ILA in order to obtain a
safe alveolar O2 concentration.
REFERENCE. 1. Nielsen ND et al (2008) ASAIO J. 54:401–405.
GRANT ACKNOWLEDGEMENT. No private funds have supported the study.
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CONVENTIONAL CONVECTIVE VENTILATION IS NECESSARY TO PREVENT
ALVEOLAR ACCUMULATION OF NITROGEN: A STUDY DURING APNEIC
OXYGENATION AND EXTRACORPOREAL CO2 ELIMINATION
N. D. Nielsen1, G. Andersen2, B. Kjaergaard3, M. E. Staerkind1, A. Larsson1
1Anaesthesia and Intensive Care Medicine, North Denmark Region, Aarhus University
Hospital, Anaesthesia Research Unit, Aalborg, Denmark, 2Aarhus University Hospital,
Skejby, Department of Radiology, Aarhus, Denmark, 3Aalborg Hospital, Aarhus University
Hospital, Department of Thoracic Surgery, Aalborg, Denmark
INTRODUCTION. It has been suggested that ventilation with very low tidal volumes (Vt)
would be beneficial in acute lung injury (ALI). We have recently shown that using an
inspiratory fraction of oxygen (FiO2) of 1.0 in apnoeic oxygenation (zero Vt) combined with
pumpless extracorporeal CO2 removal (AO-ILA) could maintain excellent oxygenation and
normocapnia in a lung recruited, animal ALI-model for 8 h [1]. However, during pilot tests
with FiO2 \ 1.0, hypoxemia developed within 30 min. Based on old studies [2], we
hypothesized that this impairment of arterial oxygenation was due to alveolar N2 accumu-
lation. However, fast absorption of N2 in collapse prone lung regions after denitrification
could not be excluded. The aim of this study was therefore to assess the rate of development
of hypoxemia, the alveolar gas content after 20 min, and atelectasis formation using AO-ILA
with a FiO2 of 0.5.
METHODS. The study was approved by the Danish National Animal Ethics Committee.
Four pigs (median weight: 69 kg) was anaesthetized and intubated. Mild lung injury was
induced by repeated alveolar lavage after which the lungs were recruited and then ventilated
with a FiO2 of 1.0 and a positive end-expiratory pressure (PEEP) of 10 cmH2O for 30 min. A
pumpless membrane lung (iLA Membrane Ventilator, Novalung, Germany) was connected in
an arteriovenous shunt for CO2 elimination. A new lung recruitment manoeuvre was per-
formed and the tracheal tube was connected to a constant airway pressure of 20 cmH2O and a
FiO2 of 1.0 or 0.5. In each animal AO-ILA was performed in two series of 20 minutes with
the two oxygen concentrations, while arterial oxygenation was monitored by repeated arterial
blood samples. After each 20 min period the alveolar fractions of oxygen and CO2 (FAO2 and
FACO2) were measured. Subsequently formation of atelectasis during AO-ILA with FiO2 of
1.0, respectively 0.5 was assessed by computed tomography (CT).
RESULTS. All values are median (with range). After 20 min of AO-ILA with a FiO2 of 0.5
arterial partial pressure of oxygen (PaO2) decreased to 48 (36–56) mmHg (10% of baseline),
whereas when a FiO2 of 1.0 was used PaO2 was maintained above 400 mmHg even after
20 min. When a FiO2 of 0.5 was used FAO2 was 0.07 (0.06–0.09) and FACO2 was 0.08 (0.07–
0.08) after 20 min of AO-ILA, indicating an alveolar N2-concentration of about 85%. With
neither FiO2 any new atelectasis was found by CT.
CONCLUSION. When apnoeic oxygenation is used in combination with extracorporeal CO2
removal, a FiO2 of 1.0 is essential to avoid alveolar nitrogen accumulation and arterial
hypoxemia.
REFERENCES. 1. Nielsen ND, Kjærgaard B, Koefoed-Nielsen J, Steensen CO, Larsson A
(2008) ASAIO J 54:401–405.
2. Holmdahl MH (1956) Acta Chir Scand Suppl 212:1–128.
GRANT ACKNOWLEDGEMENT. No private funds have supported the present study.
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IS MOBILE EXTRACORPOREAL MEMBRANE OXYGENATION A SAFE TOOL
TO TRANSFER SEVERELY HYPOXAEMIC PATIENTS BECAUSE OF ACUTE
RESPIRATORY DISTRESS SYNDROME OR CARDIAC FAILURE?
J. F. Cambier1, P. Bulpa1, S. Bouhon1, M. Gonzalez1, I. Michaux1, E. Installe´1, A. Dive1,
P. Evrard1
1Mont-Godinne University Hospital, Intensive Care Unit, Yvoir, Belgium
BACKGROUND AND AIM. Acute respiratory distress syndrome (ARDS) is still a syn-
drome with a high mortality rate. Although the improvement of therapeutic measures, some
patients (pts) remain severely hypoxaemic. In such pts, Extracorporeal Membrane Oxygen-
ation (ECMO) may be an additional therapeutic option. However, inter-hospital transfer of pts
who need an ECMO can be very dangerous because extreme hypoxaemia or haemodynamic
instability may be associated with cerebral hypoxia and death. In this work, we report our
experience on mobile ECMO system initiated in the referal hospital to secure transfer.
METHODS. Our database was retrospectively analyzed and we report on 15 consecutive pts
transferred to our hospital under ECMO assistance. 12 of them required this technique
because of ARDS refractory to conventional treatment and the other 3 because of cardio-
circulatory failure unresponsive to best therapy. Percutaneous veno-venous (VV; n = 11) or
veno-arterial (VA; n = 4) ECMO support consisted of a single membrane oxygenator and a
centrifugal pump. All the pts were ventilated, sometimes with an associated nitric oxide
delivery system and the transfer monitoring equipment included a pulse oxymetry, an ECG
and an invasive pressure. Three persons composed the transfer team (1 experienced ICU
physician, 1 nurse and 1 ECMO specialist) and the transport was always by ambulance.
RESULTS. The transfer of all pts was feasible thanks to a systemic oxygenation and hae-
modynamic status improvement by the ECMO, after a median door-to-door transfer time of
73 min (range 26–105). No significant complication was noted during the transfer except a
transient loss of electric power supply. In ARDS pts, PaO2/FiO2 improved from 52.5 mmHg
(range 26–66.4) to 111 mmHg (range 47–271) and from 62 mmHg (range 45–88) to
327 mmHg (range 250–390) by the cardiac pts, respectively, before and after the initiation of
ECMO. The mean weaning length for the ECMO system was 7 days. Mean ICU and hospital
stay duration was, respectively, 21 days (range 1–55) and 31 days (range 1–110). Four pts
died because of brain death due to neurotrauma, pneumonia, candidemia and hemorrhagic
abscesses associated to a subarachnoidal hemorrhage, with a mean period of 5 days after the
initiation of the ECMO system. One pt died a few days after his transfer from the ICU to
pneumology department, after a 47-day length stay in the ICU. Our mortality rate at 1 month
is 26.6% which seems better than other results reported. All pts suffering from cardiogenic
shock survived, after combined cardiac surgery.
CONCLUSION. In severely hypoxaemic pts, ECMO support seems to be a good tool for a
safe transfer, with an experimented team. It provides the possibility of recovering functional
lung or heart. Cardiocirculatory failure appears as a preferential indication. Further ran-
domized control trials are needed to confirm our results.
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TGI, TRACHEAL GAS INSUFFLATION DURING THE MECHANICAL VENTILA-
TION IN CHILDREN
K. Pizingerova1, J. Kobr1, J. Fremuth1, L. Sasek1, S. Fikrlova1
1Faculty of Medicine in Pilsen, Charles University in Prague, Pediatrics, Plzen, Czech
Republic
OBJECTIVES. Undesirable hypercapnia even with satisfactory oxemia can occur during the
initial hours of mechanical ventilation therapy of serious pulmonary disorders. It is a result of
imperfect gas exchange on the alveolo-capillary membrane. Prolonged hypercapnia induces a
cascade of hemodynamically inconvenient adaptation mechanisms. Peripheral vasodilatation,
systemic hypotension and compensatory tachycardia appear. There is a decrease of the sen-
sitivity of myocardial adrenergic receptors, the contractility and the cardiac output.
Hypercapnia can be effectively decreased by TGI during mechanical ventilation.
METHODS. TGI is indicated in order to eliminate CO2. It is an unconventional supplement
to mechanical ventilation. This method requires the use of a special tracheal cannula of the
Boussignac type. With the flow of 1–2 l/min the cannula enables tracheal insufflation of the
moist and tempered gas independently of the inspiratory cycle of the device. The continuous
insufflation literally ‘‘splashes’’ the alveoli. The result is a very effective and rapid elimination
of CO2. The insufflated gas does not take part in the diffusion on the alveolo-capillary
membrane.
RESULTS. The authors present their experience from 33 cases of serious pulmonary dis-
orders in children when they used TGI in order to solve persistent hypercapnia during
complicated mechanical ventilation.
CONCLUSIONS. The decrease of hypercapnia contributes to the quick adjustment of the
sensitivity of myocardial adrenergic receptors and to the normalisation of the contractility and
the cardiac output. After the elimination of CO2 it is possible to set the ventilator back to the
conventional mode of mechanical ventilation.
KEYWORDS. TGI, hypercapnia, mechanical ventilation, children.
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DEVELOPMENT OF AN AUTOMATED OXYGEN DELIVERY DEVICE FOR
SPONTANEOUSLY BREATHING PATIENTS—THE FREE O2 PROJECT—PRE-
LIMINARY RESULT
E. L’Her1, F. Lellouche2
1Chaire de Recherche en Me´decine d’Urgence, Universite´ Laval/CHAU Hoˆtel Dieu de Le´vis/
CHAU Que´bec, Me´decine Familiale et Me´decine d’Urgence, Que´bec, Canada, 2Institut de
Cardiologie et de Pneumologie de Que´bec/Universite´ Laval, Que´bec, Canada
Oxygen is often given by medical and paramedical staff, and treatment should be targeted to
saturation and adjusted to patients condition.
OBJECTIVES. Automation of oxygen administration has the potential to reduce clinicians
workload and to improve both compliance to protocols and patients safety.
METHODS. Free O2 was designed as a closed-loop administration device based both on a
proportional integral control (PIC) and on knowledge-transfer of clinical rules (CR). It is
dedicated either to be used for adult or pediatric patients, in hospital or in community settings.
These algorithms were embedded in a miniaturized computer connected to a side-stream
capnograph and oxygen saturometer as inlet parameters, and to an electronic solenoid valve as
outlet parameter. Input parameters were measured each second, and O2 flow adjustments
were performed each 3 s. Data are continuously monitored and stored in the computer
internal memory (up to 6 months continuous monitoring). Prototype performance was vali-
dated on healthy volunteers, while inducing progressive decremental hypoxic conditions
(FIO2 21–3%).
RESULTS. As compared to air or continuous O2 breathing, both CR and PIC allowed to limit
oxygen desaturation, whatever the hypoxic condition. In less than half an hour, more than
2,000 measurements and a mean 500 flow adjustements were performed by controlers with
Free O2 (CR and PIC). Transient oxygen desaturation (\85%) occurred in 100% cases at FIO2
5 and 3% without oxygen, in 13% under O2 continuous flow and PIC and in 17% under CR
regulation at FIO2 3%. Mean SpO2 was below 83% under air, 87 ± 1.6% under O2, and
[90% either under PIC or CR at FIO2 3%.
CONCLUSION. Automation of oxygen administration is feasible and effective. FreeO2,
either using PIC or CR algorithms has the potential to improve patients0 safety and to reduce
clinicians0 workload. Allowing frequent and rapid oxygen flow adjustments, it may be spe-
cifically indicated in highly unstable hypoxemic patients, in patients with transient nocturnal
desaturation, or in patients at risks of hypoventilation (Fig. 1)
GRANT ACKNOWLEDGEMENT. The authors acknowledge the help of the Departement
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EXPERIMENTAL BENCH-TEST EVALUATION OF EXPIRATORY LINE PRO-
TECTION DURING AEROSOLIZATION UNDER MECHANICAL VENTILATION—
IMPACT OF THE FILTER TYPE AND HUMIDIFICATION MODALITIES
E. L’Her1, F. Lellouche2, P.-A. Bouchard2, J. Poitras3
1Chaire de Recherche en Me´decine d’Urgence, Universite´ Laval/CHAU Hoˆtel Dieu de Le´vis/
CHAU Que´bec, Me´decine Familiale et Me´decine d’Urgence, Que´bec, Canada, 2Institut de
Cardiologie et de Pneumologie de Que´bec/Universite´ Laval, Que´bec, Canada, 3CHAU Hotel-
Dieu de Le´vis, De´partement de Me´decine d’Urgence, Le´vis, Canada
INTRODUCTION. There are no standards for expiratory line protection while performing
aerosols under mechanical ventilation. Different types of filtering devices are used in routine
(mechanical, hygroscopic, hygrophobic), in order to avoid flow transducers dysfunctions
induced by gas-flow increased resistance.
OBJECTIVES. The objectives of this experimental bench-study were: (1) to validate the
manufacturers0 data about existing filters’ characteristics; (2) to evaluate the performance of
these filters, according to different types of humidification circuits; (3) to validate the use of a
specifically dedicated expiratory line protection filter (ServoGuard, Maquet).
METHODS. A respiratory system analog was build up using a 1L test lung and an Evita 2
dura ventilator (Dra¨ger Me´dical). Colimycine aerosolization was performed using a contin-
uous 6 MU dose, delivered by a piezoelectric aerosolisor (Aeroneb pro). A Fisher-Paykel
MR850 heated-humidifier was connected to different types of circuits (unheated, single
heated RT212, biheated—new [RT340] and old [RT100] generation). The experimental
device comprised a slotted measuring section of both flow and pressures transducers (IMT
PF300); Measurements were carried out using continuous flow (ranging from 10 to 100 L/
min) and constant temperature (21C). Basal characteristics were obtained from each filter
still dry. Same measurements were performed after 12 and 24 h of continuous in vitro use,
under each experimental condition. We considered as a security limit a maximal increase of
resistive pressure not to exceed 6.0 cmH2O whatever flow, even when saturated.
RESULTS. At baseline, all dry filters remained below the security limit. However, three
categories of filters intrinsic performances could be individualized: low resistance (n = 2);
intermediate (n = 8); and high resistance to flow (n = 2). During aerosolisation, the Ser-
voguard allowed an effective protection of the circuit (for up to 48 h) whatever the type of
humidification circuits, at the notable exception of the unheated circuit. Several occlusions
occurred with other types of filters before the first 12 h of use, especially for HME who were
sometimes occluded after a short period of use (from 2 to 7 h). Standard mechanical filters
allowed a satisfactory expiratory line protection, but only in case of biheated circuits.
CONCLUSION. Expiratory circuit protection is likely to involve brutal occlusions under
aerozolisation, mostly related to the humidification mode, as the filter material density
increases after several hours of use. This concept must be taken into account from a patients’
security point of view. New generation biheated circuits and specifically dedicated filters
should be put forward.
This experiment was made possible by a grant from Maquet France SA
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ADVANTAGES OF REMIFENTANIL VERSUS INTERMITTENT BOLUSES OF
MIDAZOLAM/TRAMADOL SEDATION FOR MECHANICALLY VENTILATED
PATIENTS
V. Malenkovic1
1CHC Bezanijska Kosa, Anaesthesiology, Belgrade, Serbia
INTRODUCTION. Hypnotic-based sedation (HBS), where midazolam was used, with
tramadol as needed has been common. The invention of remifentanil has allowed greater use
of analgesia-based sedation (ABS) with relief of discomfort from the tracheal tube or pain.
OBJECTIVE. The aim of this study was compared the safety and efficiency of an analgesia-
based sedation regime using remifentanil with a conventional hypnotic-based sedation regime
in patients requiring prolonged mechanical ventilation for up to 72 h.
METHODS. In this prospective, randomised, single-centered study, a total of 60 patients
(56–75 years old), who had undergone abdominal surgery, were postoperatively assigned to
one of two treatment regiments for sedation in the ICU for 12–72 h. Patients in the ABS
group (n = 30) received remifentanil (6–9 lg kg-1 per hour). Patients in the HBS group
(n = 30) received midazolam (0.02 to 0.2 mg kg-1 h-1) and tramadol (100 mg/6 h). Patients
were sedated to an optimal Riker Sedation-Agitation Scale (RSAS) score of -1 or 1, Remsy
score (RS) of 1–3 and a pain intensity (PI) score of 0 or 2. SAS, PI, heart rate (HR) and mean
arterial pressure (MAP), APACHE ll and SOFA score were continuously monitored
throughout the treatment period and were recorded at the time of each bolus dose and/or
change in infusion rate of any of the study drugs. Adverse events were recorded from the start
of the study drug until the end of the post-treatment period.
RESULTS. 30 patients received ABS, 29 of the patients receiving remifentanil without the
use of supplementary hypnotic agents. In the HBS 20/30 of patients either morphine or
fentanyl was used as the analgesic agent, titrated to obtain adequate pain control. The vari-
ation in the mean RSAS over 24 h was -1 to ?1 for remifentanil group and -2.7 to ?3.0 in
the comparator group. The variation in the mean PI over 24 h was 1.5–1.6 for the remifentanil
group and 1–3.7 for the comparator group. Variation of MAP, HR, pCO2 was less in rem-
ifentanil than in control group.
CONCLUSIONS. Analgesia-based sedation with remifentanil was well tolerated. No sig-
nificant statistical difference in duration of mechanical ventilation of critically ill patients and
total mortality rate is noticed, but it is decided that it definitely improves the healing process
in comparison to standard hypnotic-based sedation regimes in ICU patients requiring venti-
lation for up to 72 h.
REFERENCE. Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H (2004) Remifentanil
versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a
randomised double blind study. Anesthesiology 101:640–664
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IMPACT OF THE ROUTE OF APPLICATION OF ACETAZOLAMIDE ON HYP-
OXIC PULMONARY VASOCONSTRICTION (HPV)
W. Boemke1, P. A. Pickerodt2, R. E. C. Francis1, F. Neubert1, E. R. Swenson2, C. Ho¨hne3
1Charite´, Department of Anaesthesiology and Surgical Intensive Care CCM/CVK, Berlin,
Germany, 2University of Washington, Department of Medicine, Seattle, USA, 3University
Leipzig, Department of Anaesthesiology and Intensive Care Medicine, Leipzig, Germany
INTRODUCTION. The carbonic anhydrase (CA) inhibitor acetazolamide (ACZ) reduces
HPV in isolated lungs, intact animals and in humans.
OBJECTIVE. The aim of the study was to determine the most effective route of adminis-
tration with respect to reduction in pulmonary artery pressure and plasma ACZ
concentrations. The higher the plasma concentration of ACZ the greater the side effects of
ACZ, e.g. acid base disturbances due to sodium bicarbonate excretion. We therefore studied
the impact of inhaled, intravenous and oral ACZ administration routes on the pulmonary
vascular pressure response in conscious, spontaneously breathing dogs during acute hypoxia.
METHODS. Eight female Beagle dogs were kept under standardized environmental condi-
tions. Each dog was studied four times in randomized order. Protocol (1): Controls; (2):
inhaled ACZ (750 mg); (3): ACZ IV (2 mg/kg bolus and 2 mg/kg per hour continuously); (4):
oral ACZ (5 mg/kg twice, 12 and 1 h before the experiment). During all experiments, dogs
breathed spontaneously via a ventilator circuit. First hour: normoxia (FiO2 = 0.21); followed
by 2 h of hypoxia (FiO2 = 0.1–0.09). Arterial oxygen tension (PaO2), mean pulmonary artery
pressure (MPAP), pulmonary vascular resistance (PVR), acid-base changes and ACZ plasma
levels were determined at the end of each experimental hour. Data are given as mean ± SEM;
p \ 0.05 (GLM ANOVA).
RESULTS. During hypoxia PaO2 was 36–38 ± 1 mmHg in all protocols. In Controls, MPAP
increased from 13 ± 1 (normoxia) to 20 ± 1 mmHg and PVR from 269 ± 18 to 473 ± 33
dyn s cm-5 with hypoxia. With ‘‘ACZ inhaled’’ MPAP was 13 ± 1 mmHg and PVR
298 ± 21 dyn.s.cm-5 during normoxia and did not increase during hypoxia (16 ± 1 mmHg
and PVR 388 ± 30 dyn.s.cm-5) but prevention of HPV was more pronounced with ‘‘ACZ
IV’’ (MPAP 14 ± 1 mmHg; PVR 335 ± 29 dyn.s.cm-5 during hypoxia). Oral administration
of ACZ—in the dosage used—could not prevent an increase in MPAP from 13 ± 1 to
18 ± 1 mmHg, and PVR from 310 ± 21 to 485 ± 50 during hypoxia. ACZ plasma levels
during hypoxia where 8.5 lg/ml (IV), 3.4 lg/ml (inhaled) and 3.1 lg/ml (oral).
CONCLUSION. Inhaled ACZ is absorbed via the pulmonary epithelium and reduces HPV in
conscious dogs. However, it appears not to be possible to selectively reduce HPV through
ACZ inhalation. We found typical systemic effects of CA inhibition through ACZ spill over
into the systemic circulation when ACZ was inhaled. Hypoxic pulmonary vasoconstriction
was most effectively reduced by intravenous delivery of ACZ, but plasma concentrations
were also highest during this route of application.
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PULMONARY AND HEMODYNAMIC RESPONSES TO FRUCTOSE-1,6-DIPHOS-
PHATE IN PATIENTS WITH LUNG INJURY
A. K. Markov1, R. Didlake1, S. Raju1, B. Heath1, G. Poole1, T. Skelton1
1University of Mississippi School of Medicine, Jackson, USA
Experimental data indicates that treatment with Fructose-1,6-Diphosphate (FDP) significantly
reduces lung injury caused by a-naphtylthiourea, sepsis and endotoxemia. Based on these
observations, this study investigated the possibility of improving pulmonary function and
hemodynamics by adding FDP to standard therapy to treat patients with acute respiratory
failure (ALI/ARDS). We used a non-randomized design in which each patient served as his
own control. Treatment with IV FDP (EsafosfinaTM) 10% 150 mg/kg Q6H for an average of
18 ± 2.9 infusions was given to 40 consecutive patients with ALI/ARDS resulting from
complications of sepsis, trauma, aspiration, near drowning, smoke inhalation, and following
heart and lung transplantations. FDP treatment was discontinued after substantial improve-
ment of oxygenation and hemodynamics. Pulmonary function parameters before (B) and after
(A) FDP treatment are given below and expressed as means ± SEM; *P \ 0.001.
Pulmonary artery pressure, resistance and PWP declined following FDP treatment from
27.8 ± 1.5 to 22 ± 1.4 mmHg; 390 ± 31 to 248 ± 20 dyn cm s-5 (P\ 0.001) and
14.4 ± 1.03 to 11.8 ± 1.17 mmHg (P \ 0.001) and so did heart rate (P \ 0.001) while
arterial pressure and cardiac output increased (P \ 0.001). At 45 days post treatment, 30 of
the 40 patients were alive (75%). As the study is non-randomized, no conclusion can be drawn
on survival. The observed improvement in pulmonary function by FDP was most likely due to
its known capabilities to curtail oxyradicals generation by neutrophils and suppress inflam-
matory cytokines expression. Hemodynamic improvement is attributed to the
pharmacodynamic properties of FDP to enhance energy production from glycolysis in
hypoxia (Table 1)
TABLE 1 RESULTS
PEEP-cmH2O O2% PaO2 mmHg PaO2/FiO2 Index
B A B A B A B A
9.6 6.1* 62 42* 73 101* 130 260*
±0.7 ±0.93 ±3.3 ±2.03 ±3.4 ±3.4 ±8.4 ±15.3
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OUTCOME OF PATIENTS WITH CERVICAL NECROTIZING FASCIITIS TREA-
TED ACCORDING TO THE KAROLINSKA HOSPITAL GUIDELINES 1998–2008
A. C. Larsson1, B. Ga˚rdlund2, F. Lind1, B. Nordlander3, C. Frostell4
1Karolinska University Hospital, Anaesthesia and Intensive Care, Hyperbaric Medicine,
Stockholm, Sweden, 2Karolinska University Hospital, Infectious Diseases, Stockholm,
Sweden, 3Karolinska University Hospital, ENT, Stockholm, Sweden, 4Karolinska University
Hospital, Anaesthesia and Intensive Care, Stockholm, Sweden
INTRODUCTION. Cervical necrotizing fasciitis (CNF) is a serious, rapidly progressive
infection along fascia planes that sometimes involves skin, subcutaneous and muscle tissue.
The condition, often of dental or pharyngeal origin, is feared due to rapid progress and a
mortality rate of up to 25% or more (Krenk et al.). Karolinska University Hospital has since
1998 used guidelines to ensure rapid recognition of the diagnosis and treatment of these
patients. The guidelines advocates a multidisciplinary approach with
1. imipenem/cilastatin and clindamycin and, if in septic shock, one dose of gentamicin,
2. early extensive, tissue-saving debridement,
3. hyperbaric oxygen (HBO) therapy for intermittent oxygenation of infected hypoxic
tissues,
4. frequent CT scans or MRTs to assess the need for repeated surgical intervention.
OBJECTIVES. To report the outcome of CNF at Karolinska University Hospital during
1998–2008.
METHODS. Medical charts were analysed retrospectively for all patients treated according
to the Karolinska Hospital guidelines for CNF during 1998–2008. Fifty-two cases of CNF
were found, aged 19–89 years (mean 52 ± 16), 31/52 males, 48/52 patients were treated in
the intensive care unit.
RESULTS. Forty-nine of the fifty-two patients recovered, all deaths were in the intensive
care group. Streptococcus of the milleri group were the predominant pathogens found in
initial tissue cultures.
The intensive care patients had an APACHE II score of 3–37 (mean 16 ± 8), a mean time on
ventilator 12 (±11) days, 34/48 (71%) were treated with inotropic drugs and 8/48 (16.7%)
with inotropic drugs and dialysis. Mean length of stay in intensive care in Karolinska Uni-
versity Hospital was 16.6 (±18.6) days.
Expected mortality rate according to APACHE II score for septic patients would have been
26%, our 90 day mortality rate was 6.2%.
CONCLUSION. Our case series has demonstrated that patients with CNF treated according
to the Karolinska Hospital guidelines including HBO have an outcome with a 90 day mor-
tality considerably lower than that indicated by their APACHE II score. The results are
similar to those found by Krenk et al. (2007).
REFERENCES. 1. Krenk L et al (2007) Necrotizing fasciitis in the head and neck region: an




NECROTIZING SOFT TISSUE INFECTIONS—A PROSPECTIVE STUDY OF 145
PATIENTS TREATED AT A SINGLE INSTITUTION
N. Shaikh1, H. Abdual Rahman2, K. I. Maull2
1Hamad Medical Corporation, Anesthesia andIntensive Care, Doha, Qatar, 2Hamad Medical
Corporation, Department of Trauma Surgery, Doha, Qatar
Over a recent 10-year period, 145 patients with necrotizing soft tissue infections (NSTI) were
admitted with illness severe enough to warrant intensive care unit (ICU) confinement.
Comprehensive patient data was entered prospectively into a customized NSTI registry and
forms the basis of this report.
AIMS. The purpose of this study was to identify factors critical to survival, compare clinical
observations with empirical data and experiences of other investigators, and develop clinical
strategies for improved outcome.
METHODS. From 1995 to 2005, all ICU patients with NSTI were entered into a database
which included demographics, causative and predisposing factors, co-morbid conditions,
complications, sequential organ failure assessment scores (SOFA), site if infection, bacteri-
ology, outcome and other data elements. These data were carefully defined, aggregated, and
subjected to statistical review.
RESULTS. Patients ranged in age from 14 to 74 years. Overall survival was 80%. Factors
which threatened survival included age [60 years (p \ 0.01), [2 co-morbid risk factors
(p \ 0.02), hypertension, and obesity. Underlying kidney disease was not a risk factor but the
development of renal failure was highly lethal (p \ 0.001). Patients who died had longer
duration of symptoms prior to treatment, were more likely to have anatomic involvement of
the thigh, buttock or abdomen, and culture positive for streptococci, coliforms or bacteroides.
Shock at presentation (p \ 0.001) and the development of multi-organ failure (p \ 0.001)
were independent threats to survival. Although both diabetes mellitus and NSAID use
occurred in [50% of patients, neither independently affected survival.
CONCLUSIONS. NSTI causes serious illness with a mortality of 20% in this study.
Aggressive initial treatment to restore tissue perfusion of patients presenting hypotensive and
proactive efforts to prevent multi-system organ failure can improve survival. The elderly,
hypertensive or obese patient is at particular risk. Infection site and bacteriology appear to be
important survival determinants, defining a role for both aggressive debridement and tailored
antimicrobial therapy.
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CERVICAL NECROTIZING FASCIITIS AND ITS OUTCOME
N. Shaikh1, Y. Hanssens2, M.-A. Kettern1, A. Louon1
1Hamad Medical Corporation, Department of Anesthesia and Intensive Care, Doha, Qatar,
2Hamad Medical Corporation, Department of Pharmacy - Clinical Pharmacy Services, Doha,
Qatar
BACKGROUND. Necrotizing fasciitis (NF) is a rapidly progressing infection of the fascia
and subcutaneous tissue. NF is a surgical emergency, if not diagnosed early and treated
properly, it can be fatal. NF is common in the groin, abdomen and extremities, but rare in
neck and head area. Cervical NF however is an aggressive infection of neck- and head area
with devastating complications including airway obstruction, pneumonia, pulmonary abscess,
jugular vein thrombophlebitis, mediastinitis and septic shock. The mortality rate is high
(12–30%).
AIM. To assess presentation, risk factors, co-morbid diseases, type of infection, severity of
the disease and intensive care outcome of cervical NF.
METHODS. The medical records of 94 patients treated for necrotizing fasciitis in the sur-
gical intensive care unit (SICU) of Hamad Medical Corporation, from January 1995 to
February 2005 were reviewed retrospectively.
RESULTS. Out of 94 patients, 5 patients had cervical NF, this accounts for 5.3% of all
patients. The mean age was 41.2 ± 14.8 years with 4 patients being male. Sixty percent of
patients had an operative procedure as predisposing factor and 80% of patients received non-
steroidal anti-inflammatory drugs (NSAID) before admission. The only co-morbid disease
was diabetes mellitus (60%). All NF patients were febrile on admission and had leucocytosis
(WBC of 17.1 ± 7.0). The mean sequential organ failure assessment (SOFA) score on
admission to SICU was 8.8 ± 3.6. During the initial 24 h post admission, these patients
received an average of 5.8 ± 3.0 l of IV fluid, 2.0 ± 1.4 units of packed RBC, 4.8 ± 3.6
units FFP and 3.0 ± 4.5 units of platelet concentrate. All patients had surgical debridement
done at least two times, were intubated for 5.2 ± 5.1 days and stayed in SICU for
6.4 ± 5.2 days. Antibiotic treatment consisted of piperacillin/tazobactam in three patients
(60%): one patient grew Escherichia coli, one patient grew Streptococcus pyogenes and one
patient grew Streptococcus pyogenes plus Staphylococcus aureus. Piperacillin/tazobactam
was combined with clindamycin in 1 patient growing Peptostreptococcus spp., and me-
ropenem was used in 1 patient growing Enterobacter cloacae.
Sixty percent of cases had multiorgan dysfunction syndrome (MODS) and one patient died.
CONCLUSION. Cervical NF remains a severe type of infection with devastating compli-
cations. In this small study, we found only DM to be an associated co-morbid condition.
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INTRAOPERATIVE RISK FACTORS ON SURGICAL WOUND INFECTION.
MULTICENTRE STUDY IN 59 CATALONIAN HOSPITALS
L. Contreras1, L. Garcia-Huete1, V. Mayoral1, A. Cabrera1, C. Ribes1, A. Montero1, J. Canet2
1Universitary Hospital of Bellvitge, Anesthesia, L’Hospitalet de Llobregat, Spain, 2Main
Project Researcher Germans Trias i Pujol Hospital, Anesthesia, Badalona, Spain
INTRODUCTION. Surgical wound infection (SWI) is a common and important complica-
tion of surgery. Co-morbidities patient and accurately intraoperative management of them are
relevant factors of its incidence.
OBJECTIVES. To establish incidence of SWI and identify intraoperative risk factors that
can increase it.
METHODS. Prospective, observational, multicentre study from one year (2006–2007) in 59
hospitals of Catalonia.Variables assessed: type of incision, position, type of anesthesia,
respiratory parameter, administration of muscle relaxant, nausea/intraoperative vomiting,
bronchoaspiration suspicion, respiratory complications (bronchospasm, desaturation, hyper-
capnia, high airway pressure), cardiovascular complications, blood transfusion, volume input,
bleeding, surgery length, length of anaesthesia (hours). Chi-square and T-student test were
analysed.
RESULTS. 2,991 patients were studied. 50.7% male and 49.3% female; elective surgery
70.7%; emergency surgery 11.8% and ambulatory major surgery 17.5%; ASA I 30%, ASA II
52.2%, ASA III 16% and ASA IV 1.8%. Intraoperative blood transfusion 3.8%. 13.7%
suffered from postoperative complications, 5% suffered from respiratory complications, 4.2%
cardiovascular ones and 4.7% suffered from SWI. Next variables have shown high signifi-
cance on SWI: incision (p 0.000) high incidence in sternotomy/thoracotomy/medium
laparotomy and subcostal incision (14.8%); position (p 0.000) hyperextended supine position
had more frequent SWI (17.4%); type of anesthesia (p 0.010) highest on general anesthesia
(5.8%) and combined one also (7.0%); airway high incidence in nasotraqueal intubation
(7.1%) and having a tracheostomy previous to anesthesia induction (28.6%); needs of ther-
apeutic maneuver of alveolar recruitment (p 0.007); need of PEEP (p 0.003); muscle relaxant
administration during surgery period (p 0.000); extubation deferred (p 0.000); hypercapnia
(p 0.005); desaturation event (p 0.007), arterial hypotension (p 0.042); bleeding (p 0.000),
blood transfusion (p 0.000), length of surgery (p 0.000) and length of anaesthesia (hours)
(p 0.000).
CONCLUSIONS. Despite improvements in prevention SWI is as frequent as others medicals
postoperative complications, we should emphasize on all the measures that can decrease its
occurrence. About intraoperative measures we should take special attention on maintain good
perfusion and good tissular oxygenation, keep special attention on aseptic surgery and being
accurately in management of general anaesthesia and transfusion. We should emphasize do
not forget patient co-morbidities and its optimisation before surgery.
REFERENCE. 1. The Journal of Hospital Infection 2008;70(suppl 2):3–10 Surgical site
infections: epidemiology, microbiology and prevention.
2. Owens CD, Stoessel K (2008) Annals of Surgery. 248(2):259–265. A multivariate analysis
of potential risk factors for intra-and postoperative complications in 1316 elective laparo-
scopic colorectal procedures. Kirchhoff P; Dincler S, Buchmann P.
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RETROSPECTIVE ANALYSIS OF VASCULAR SURGICAL PATIENT ADMITTED
AT THE INTENSIVE CARE UNIT IN THE LAST SIX YEARS
J. Ferreira1, A. Canedo1, P. Fernandes1, N. Garrido1, H. Rebelo1, D. Branda˜o1, M. Maia1,
S. Braga1, J. Vasconcelos1, P. Castelo˜es1, A. Vaz1
1Centro Hospitalar Vila Nova de Gaia Espinho EPE, Porto, Portugal
INTRODUCTION. The number of vascular surgery patients is increasing worldwide. Their
characteristics should be updated after the development of cardiovascular treatments.
OBJECTIVE. Review the morbidity and mortality of patients admitted at intensive care unit
(ICU) in the postoperative period of a vascular surgery intervention, in the last 6 years.
METHODS. A retrospective medical record review of all patients admitted at the ICU from
2002 to 2008 was performed.
RESULTS. From 3,054 patients admitted at the ICU, 57 (1.8%) were in the post-operative
period of a vascular surgery intervention. The average age was 63.4 ± 14.8 years. The
majority, 37 (64.9%) were males and 21 (42.8%) had non elective operation. The mean ICU
stay was 8.23 ± 6.9 days. The main diagnoses at admission were respiratory insufficiency.
Twenty-three (40.4%) were submitted to aortoiliac interventions. Hypertension was the most
prevalent (36 patients) risk factor and thirteen patients had more than three risk factors. Co
morbidity: 26 (45.6%) had coronary artery disease (defined as history of angina or acute
myocardial infarction), 23 (40.3%) peripheral vascular disease and 20 (35.1%) aneurismatic
disease. The overall mortality was 18.2% and the main cause was acute respiratory distress
syndrome (ARDS).
Conclusions. Comparing the results of this small study with the published literature, it was
evident that mean age was inferior, but mortality and mean ICU stay was superior in this
sample. We realized that this two data were related: patients who died had a superior mean
ICU stay (13.1 days). This could be explained by the huge number of aortoiliac intervention
and the high prevalence of clinical coronary heart disease. Nevertheless, we suspect that the
real prevalence of this disease is superior. It was just analysed the presence of symptomatic
pathology. The most frequent risk factor was hypertension; probably due to its huge preva-
lence in Portuguese population. However, we suppose that risk factors were understated,
consequently to incomplete records registration. It is emphasized ARDS is the leading cause
of death. This fact is according to recent literature. Respiratory complication is the major
source of mortality, contradicting the traditional data that cardiac disease was the main cause
of death, and reflecting the improvements in cardiac field.
The high mortality rate, caused by ARDS in a young sample with cardiovascular risk factors
stresses the attention that should be given to pulmonary lung diseases.
REFERENCES. 1. Keegan MT, Whalen FX, Brown DR, Roy TK, Afessa B (2008) Acute
physiology and chronic health evaluation (APACHE) III outcome prediction after major
vascular surgery. J Cardiothorac Vasc Anesth 5:713–718.
2. Callaghan CJ et al (2005) Overnight intensive recovery: elective open aortic surgery
without a routine ICU bed. Eur J Vasc Surg 30:252–258.
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MICROBIOLOGICAL EVOLUTION AND PROGNOSIS IN INTENSIVE CARE
UNIT OF PERITONITIS WITH MULTIPLE RELAPAROTOMY
G. Dufour1, N. Kermarrec1, C. Muller2, J.-P. Marmuse3, P. Montravers1
1University Hospital Bichat-Claude Bernard, Departement of Anesthesiology and Surgical
ICU, Paris, France, 2University Hospital Bichat-Claude Bernard, Departement of Microbi-
ology, Paris, France, 3University Hospital Bichat-Claude Bernard, Departement of General
Surgery, Paris, France
INTRODUCTION. The persistence or recurrence of intra-abdominal sepsis during care of
community or postoperative peritonitis is usually defined as tertiary peritonitis (TP). Clinical
features of TP are characterized by sepsis, multiple organ failure, multiple relaparotomies (R),
complex medico-surgical care and high mortality rates. Publications on this issue are limited
[1, 2].
OBJECTIVES. Our purpose was to analyse clinical and microbiological data of our patients
(pts) who underwent multiple R for TP.
METHODS. Between 1999 and 2007, TP observed in a single surgical intensive care unit
(ICU) were retrospectively analyzed. The clinical and microbiological evolution according to
the number of R and prognosis was assessed. Results are shown by median and interquartile
or proportions. Comparison of proportions was made using Chi-2 test (p \ 0.05 significant).
RESULTS. 109 pts [65 male (60%), age 51 (52–73), IGSII 50 (36–59)] admitted in ICU for
community peritonitis (30%) or postoperative peritonitis (70%) developed TP. In 65% of
them, at least one severe comorbidity was found. All the pts underwent Cone R (R1), 55
pts C two R (R2) and 33 pts C three R (R3) for a total of 197 R. At the time of R, the SOFA
score was similar from R1 to R3: 7 (5; 12). Persistent signs of infection were the main cause
of R from R1 to R3: 76–85% of the pts. An uncontributive R (no clinical evidence of
peritoneal infection) was reported 39 times (20%). The microbiological evolution of perito-
neal samples from initial surgery to R3 showed increased proportions of non-fermenting
Gram-negative bacilli (NF-GNB) (5–24%, p \ 0.01), unchanged proportions of enterobac-
teriaceae, staphylococci and candida, and decreased proportions of anaerobes (13–2%,
p \ 0.01). From initial surgery to R3, the proportion of multi-drug resistant bacteria (MRB)
increased from 17 to 75% of the isolates (p \ 0.01). The proportion of inadequate empirical
antimicrobial therapy (EA) was stable whatever the number of R (25% in all cases). However,
the proportion of adequacy for EA was higher with triple therapy than bitherapy (97 vs. 78%,
p\ 0.05). The clinical improvement of the pts after R (expressed in terms of catecholamine
requirements or number of organ failure) was not correlated to the number of R. Mortality in
ICU was 45% linked to TP in 95% of the cases without correlation with number of R.
CONCLUSIONS. TP are characterized by severe sepsis with multiple organ failures, a high
rate of MRB and a low correlation between evolution and the number of R. The increasing
proportion of MRB suggests the prescription of broad spectrum EA with enlarged spectrum
with the number of R.
REFERENCES. 1. Buijk et al (2002) Intensive Care Med 28:1024–1029.
2. Nathens et al (1998) World J Surg 22:158–163.
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PROGNOSTIC FACTORS IN PATIENTS WITH INTRA-ABDOMINAL INFECTION
AND SEVERE SEPSIS
L. Zoric1, S. Pallancher1, J. Y. Lefrant1
1Faculte´ de Me´decine Montpellier-Nimes Universite´ Montpellier I, Division Anesthe´sie
Re´animation Douleur Urgence GHU Care´meau, CHU Nimes, Nimes, France
INTRODUCTION. Intra-abdominal infections (IAI) may be complicated by organ failure in
20–40% of patients. They are the second cause of severe sepsis and/or septic shock.
OBJECTIVES. To describe clinical and bacteriological features of IAI with severe sepsis
and/or septic shock and examine prognostic factors of death.
METHODS. From a data base including 445 patients in severe sepsis and/or septic shock
during 2006, patients with IAI (bilary track infection or peritonitis) were studied. Clinical,
microbiological and therapeutic characteristics are collected. To isolate predictive factors of
death, an univariate analysis was performed followed by a multivariate analysis (p \ 0.05 is
significant).
Results :103 patients were included. Community-acquired infection rate was 63.1% (n = 65/
103). SAPS II score was 50 (41–58) and number of organ failure was 5 (4–5). The overall
mortality rate was 41.8% (n = 43).
Bacteriological samples were positive in 82.5% of patients (n = 85/103). Isolated microor-
ganisms are shown in Table 1 .








Positive bacteriological samples 55 30
E.coli 31 (56.4%) 11 (36.7%) 0.06
Enterobacteriaceae 15 (27.3%) 15 (50%) 0.08
Pseudomonas aeruginosa 4 (7.3%) 7 (23.3%) 0.09
Anaerobes 25 (45.5%) 12 (40%) 0.48
Cocci gram positive 26 16
M. R.S. A.(Methicillin Resistant
Staphylococcus Aureus)
2 0
Enterococci 16 (29.1%) 6 (20%) 0.42
Yeasts 4 (7.3%) 3 (10%) 0.7
The distribution of microorganisms was different in community-acquired and nosocomial
infections. Empirical antibiotic therapy targeted the pathogens in 62.4% IAI (n = 53/85).
In multivariate analysis, SAPS II at admission was the only predictive mortality factor at day
28.
CONCLUSIONS. In patients with severe sepsis and/or septic shock secondary to IAI, SAPS
II at admission is the main predictive factor of mortality at day 28.
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UTILITY OF STREM-1 IN DIAGNOSING ETIOLOGY OF ARDS IN PATIENTS
WITH ABDOMINAL PATHOLOGY
P. Ramı´rez1, P. Kot1, V. Marti1, D. Gomez1, V. Saiz1, R. Martinez1, D. Pico1
1Hospital Universitario La Fe, Valencia, Spain
Critical patients with abdominal pathologies often develop an acute respiratory distress
syndrome (ARDS). On many occasions, we could question if the ARDS is due to the
abdominal pathology or caused by a nosocomial pulmonary infection.The soluble triggering
receptor expressed on myeloid cells 1 (sTREM-1) has already been proved to be useful in
diagnosing pulmonary infections.
OBJECTIVE. Our objective is to asses the usefulness of sTREM-1 in the aetiological
diagnosis of ARDS in critical patients with abdominal pathology.
METHODS. In patients with abdominal pathology and ARDS, we analysed samples of
alveolar lavage and peritoneal fluid. Microbiological and cytological analyses were done, as
well as sTREM-1 levels with ELISA method. Clinical and laboratory tests were performed to
complete diagnosis. Mann–Whitney U test was used to perform statistical analysis.
RESULTS. We included 21 patients in the research. Average age was 48 years (SD 17) and
68% were men. Mean APACHE II score on ICU admission day was 19 points (SD 6) and
mean SOFA value on the day of evaluation was 13 points (SD 3).
The most frequent abdominal pathologies were: spontaneous bacterial peritonitis (27%),
enteritis (23%) and acute pancreatitis (14%). In 41% of the patients a pulmonary infection
was diagnosed, in 27% an abdominal infection was diagnosed, in 27% both infections
coexisted.
Mean alveolar sTREM-1 level was 1713 pg/ml (1512 pg/ml if an abdominal infection existed
and 2,027 pg/ml if there was a pulmonary infection). Mean peritoneal sTREM-1 level was
1,424 pg/ml (2,198 pg/ml if an abdominal infection existed and 1,275 pg/ml if there was a
pulmonary infection).
To distinguish between the absence and presence of an abdominal infection, the sTREM-1 in
peritoneal fluid (p \ 0.001) and serum procalcitonin (p 0.18) were of utility. To distinguish
between the absence and presence of a pulmonary infection, alveolar sTREM-1 (p 0.019) was
of utility as well. A ratio alveolar sTREM-1/peritoneal sTREM-1 [1 strongly indicated a
pulmonary infection (sensitivity 63%, specificity 100%) whereas a ratio\2 strongly indicated
an abdominal infection (sensitivity 89%, specificity 83%).
CONCLUSIONS. In critical patients, the inflammatory response is never only a confined
phenomenon, but a systemic one. However, sTREM-1 keeps certain capacity to indicate the
infectious origin. Establishing the aetiology of ARDS could have important treatment
implications, meanly the indication of surgery if an abdominal infection is diagnosed.
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SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT (SDD):
ADVERSE EFFECTS ON THE GASTRO-INTESTINAL TRACT
R. Meacher1, D. Doberenz1, B. Nalla1, M. Templeton1
1Intensive Care Unit, Charing Cross Hospital, Imperial NHS Trust, London, UK
INTRODUCTION. Selective decontamination of the digestive tract (SDD) has been shown
to reduce mortality in intensive care patients with an expected duration of ventilation of
[48 h. SDD was introduced into our ICU in January 2007. Patients who are expected to be
ventilated for [48 h are given liquid colistin, tobramycin, vancomycin and nystatin, to the
oral cavity and by gastric tube, in addition to 48 h of intravenous antibiotics. We have
previously reported a reduction in acquisition of multi-resistant Acinetobacter with SDD.
Also, since the introduction of SDD we have noted a rise in the frequency of loose stools
which has resulted in delayed discharge from our ICU.
OBJECTIVES. To determine the effect of SDD on the gastro-intestinal tract.
METHODS. Retrospective observational study including all patients admitted and ventilated
for more than 48 h during May and June in 2006 (before the introduction of SDD), and in the
same periods in 2007 and 2008 (after the introduction of SDD). Patients were identified by search
of the ICU database (Acubase) and data obtained by review of bedside charts. The presence of
loose stools or three or more stools during a ventilated day was noted. The proportion of days
with loose or frequent stools was compared to the total number of ventilated days during each
period and these percentages compared by z-test and v-squared test. The hospital microbiology
database was examined to ascertain the frequency of stool testing and any positive results.
RESULTS.
CONCLUSION. The data shows that SDD results in an increase in the number of ventilated
days when patients pass loose or frequent stools. The loose stools appear non-infectious in
nature. Initially a large number of stool samples were sent to the laboratory but this was
reduced by 2008. This data has implications for the safe discharge to the wards of patients
who have received SDD. As there are few reported cases of C difficile resistance to vanco-
mycin (as contained in our SDD) we would suggest testing for C difficile toxin is unnecessary
and wasteful unless there is another clinical indicator of infection (Table 1)







Patients admitted and ventilated [48 h 35 32 39
Patients charts analysed 30 23 31
Total ventilated days 451 248 357
Total ‘‘loose stool’’ days 110 100 147
% ventilated days with loose/
frequent stools
24.4 40.3 41.2
p value z test – p \ 0.001 p \ 0.001
p value v squared test – p \ 0.001 p \ 0.001
Stool samples sent 65 57 33
Positive results 1 (C diff toxin) 0 0
REFERENCES. 1. de Smet AMGA et al (2009) Decontamination of the digestive tract and
oropharynx in ICU patients. N Engl J Med 360:20–31.
2. Doberenz DT, Templeton M, Meacher R (2008) Reduction of ICU acquired MRSA,
Acinetobacter and VRE with introduction of SDD. Intensive Care Med 34(S1):S184
FUNDING. NIHR Biomedical Research Centre funding scheme.
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ANALYSIS OF BIOFILM IN EXTERNAL VENTRICULAR DRAINAGE. RELA-
TIONSHIP TO INFECTIOUS COMPLICATIONS. PRELIMINARY RESULTS
P. Ramı´rez1, M. Gordon1, S. Gil-Perotin1, V. Marti1, J. M. Sahuquillo1, I. Calleja1
1Hospital Universitario La Fe, Valencia, Spain
AIMS. Ventriculitis is one of the most feared complications of external ventricular drainage
(EVD). It is considered that the formation of a biofilm on the surface of EVD catheters may be
related to the pathogeny of ventriculitis. We started this project with the aim of demonstrating
the presence of biofilm on EVD of our unit and analysing its relationship to infectious
complications.
METHODS. We locate patients with EVD and do cerebrospinal fluid culture of vigilance
three times a week. Once the EVD is removed, we divide the catheter into two sections: one is
microbiologically cultured and the other one is processed with aldheyde fixation and alcohol
dehydratation and examined through scanning electronic microscope. Data are analysed with
the statistics program SPSS 15.0.
RESULTS. We have so far analysed 10 EVD. All devices were placed for the treatment of
acute hydrocephalus in patients with intracerebral haemorrhage with ventricular involvement
and remained, on an average, 9 ± 4 days. We have clinically and microbiologically diag-
nosed ventriculitis in four patients: three cases from Acinetobacter baumanii and one case
from Klebsiella pneumoniae. We have also found two positive cultures without other diag-
nostic criteria of ventriculitis: one cerebrospinal fluid culture and one culture of catheter
positives for coagulase-negative Staphylococcus. We have observed biofilm in all these seven
cases and also in another patient without evidence of bacterial presence.
CONCLUSIONS. The presence of biofilm seems to be a relatively common phenomenon on
the surface of EVD catheters. It is clearly associated with ventriculitis but the preclinical
presence of bacteria may relate to an incipient biofilm formation.
EVD biofilm. A. baumanii ventriculitis
GRANT ACKNOWLEDGEMENT. Goverment grant PI07-90828.
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PERIOPERATIVE INCIDENCE OF NOSOCOMIAL INFECTIONS IN IMMUNO-
COMPROMISED HEART TRANSPLANTED PATIENTS ON THE ICU
D. Hutschala1, A. Zuckermann2, D. Dunkler3, M. Gro¨mer2, E. Tschernko1
1Medical University of Vienna, General Hospital, Cardiothoracic and Vascular Anaesthesi-
ology and Intensive Care Medicine, Vienna, Austria, 2Medical University of Vienna, General
Hospital, Cardiothoracic Surgery, Vienna, Austria, 3Medical University of Vienna, General
Hospital, Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics,
Vienna, Austria
BACKGROUND. Nosocomial infections in pharmacologically immunosuppressed patients
remain the major cause of morbidity and mortality after heart transplantation (htx). Therefore,
we investigated the incidence of infections and changing practice in antibiotic therapy and
prophylaxis in htx-patients at our institution over time.
METHODS. We retrospectively analyzed data of 340 heart recipients for perioperative
infections and ICU-mortality. Patients underwent htx between January 2000 and December
2008. The Euro-Score and additionally the SAPS II-Score were calculated in each patient.
Perioperative sepsis, severe sepsis and septic shock were defined in accordance to interna-
tional standards. We analyzed the number of patients receiving antimicrobial combination
therapy with or without concomitant antimicrobial and/or antiviral medication. The incidence
for extracorporeal membrane oxygenation (ECMO) due to acute graft failure was evaluated.
ICU-outcome and 30 day mortality were analyzed on an annually basis. Data are given as
median if not otherwise stipulated.
RESULTS. Euro-Score significantly increased over the years: 6 (range) in 2000 versus 11
(range) in 2008 (p = 0.026), indicating that gradually sicker recipients were accepted for htx.
Due to this ECMO support was required in 12.9% of patients in 2000 versus 17.5% in 2008
(p = 0.043). The incidence of sepsis and septic shock showed a tendency to increase over the
years (11% in 2000 vs. 15% in 2008; [p = 0.058]). The administration of a combination (two
or more) of broad spectrum antibiotics rose significantly from 2000 (44% of patients, n = 24/
54) to 2008 (90% of patients, n = 36/40) (p \ 0.001). In 2000, 5 patients (9.3%) required
concomitant antimycotic therapy compared with 28 patients (70%) in 2008 (p \ 0.001).
Despite acceptance of severer compromised recipients and increasing need for perioperatives
circulatory support with ECMO ICU-mortality decreased over the years (actual ICU-mortality
was 12.9% in 2000 vs. 2.5% in 2008). In 2008, none of our heart recipients died within the
first 30 days after htx.
CONCLUSION. Our data show that the incidence of infections after htx could not be
reduced over the last decade. This is probably at least partially due to acceptance of severer
compromised recipients with concomitant complicated surgical course (ECMO and revi-
sions). Antibiotic therapy changed significantly over the years. Early use of a combination of
potent broad spectrum antibiotics together with antimycotic therapy was established over
2005. This change in antibiotic therapy seems to be at least one reason for the reduced
incidence of sepsis induced ICU-mortality in our immunocompromised heart transplanted
patients.
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INFECTIONS BY ENTEROCOCCUS FAECALIS IN A SICU
A. Larentzakis1, H. Markogiannakis1, P. Drimousis1, N. Pachylaki1, E. Samara1, A. Xan-
thaki2, M. Toutouza2, E.-M. Theodoraki1, K. G. Toutouzas1, D. Theodorou1, S. Katsaragakis1
1Hippokrateion Hospital, Athens Medical School, University of Athens, Surgical Intensive
Care Unit, 1st Department of Propaedeutic Surgery, Athens, Greece, 2Hippokrateion Hospital,
Department of Microbiology, Athens, Greece
AIM. To evaluate the clinical and microbiological characteristics of patients developing ICU-
acquired Enterococcus faecalis infections in our Surgical Intensive Care Unit (SICU).
METHODS. Data for all SICU patients are prospectively collected in our database. Data for
cases sustaining ICU-acquired infections by E. faecalis from 2001 to 2006 were analyzed.
RESULTS. Among 1,182 hospitalized patients, 262 (22%) had an ICU-acquired infection. Of
them, 40 sustained an E. faecalis infection (15.3% of the patients with an infection and 3.4%
of the total group). Mean age of the patients with an E. faecalis infection was
68.8 ± 8.1 years and APACHE II score 19.4 ± 5.3 (female: 57.5%). Patients’ diagnoses
were acute peritonitis (n = 12, 30%), gastrointestinal cancer (n = 10, 25%), acute small or
large bowel obstruction (n = 5, 12.5%), gastrointestinal tract hemorrhage (n = 3, 7.5%),
acute superior mesentery embolism (n = 2, 5%), acute pancreatitis (n = 2, 5%), penetrating
abdominal trauma (n = 2, 5%), acute cholangitis (n = 2, 5%), and acute cholecystitis (n = 2,
5%). All patients were operated while 30% (n = 12) had more than one operations. Twenty-
six cases (65%) underwent intestinal surgery, 5 (12.5%) biliary tract operative procedures/
cholecystectomy, 4 (10%) esophageal/gastric surgery, 3 (7.5%) hepatectomy, and 2 cases
(5%) had pancreatic surgical procedures. Bloodstream (n = 17, 42.5%) and surgical site
infections (n = 16, 40%) were the predominant infection sites. The isolated pathogens pre-
sented high resistance to the majority of antibiotics. In particular, high sensitivity was
observed only to linezolid (100%), vancomycin (75%), and teicoplanin (75%). Mean SICU
and hospital length of stay was 31.5 ± 7.4 and 43.4 ± 8.5 days, respectively. Morbidity and
mortality rates were 70 and 45%, respectively. The most common complications were septic
shock (n = 20, 50%), acute respiratory failure (n = 18, 45%), renal (n = 14, 35%), cardiac
(n = 11, 27.5%) and hepatic failure (n = 9, 22.5%), coagulopathy (n = 14, 35%) and
thrombocytopenia (n = 12, 30%).
CONCLUSION. ICU-acquired Enterococcus faecalis infections are a significant problem in
SICUs due to high correlated multiresistance, morbidity, and mortality. Recognition and
analysis of the features of these patients is critical for prevention and treatment of such
infections.
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INFECTIVE PROBLEMS IN PATIENTS ADMITTED TO ICU. COMPARATIVE
ANALYSIS OF INFECTION AS REASON FOR ADMISSION OR AS COMPLICA-
TION DURING ICU STAY
R. Reig-Valero1, R. Abizanda-Campos1, B. Vidal-Tegedor1, R. Gonza´lez-Luis1, S. Altaba-
Tena1, P. Lorente-Garcı´a1, E. Rodrı´guez-Martı´nez1
1General Hospital of Castello´n, Intensive Care Unit, Castello´n de la Plana, Spain
INTRODUCTION AND AIM. Infection could also be a reason for ICU admission and a
complication appeared during ICU stay. It is usually thought that intra ICU infections have a
worse survival outcome when compared to those causing ICU admission. Our aim had been to
assess this possibility in patients admitted to our IC department.
SETTING. Nineteen beds ICU in a University associated hospital.
PERIOD AND SAMPLE. All consecutive admissions to our ICU since January 2007 to
October 2008.
PATIENTS AND METHOD. A total of 1945 patients were considered. In 175 of them an
infective problem was the reason for admission and in 135 infections appeared as a com-
plication during ICU stay. Data collected were origin of admission, readmission rate, length
of stay (LOS), severity and risk of death (SAPS3) and observed hospital mortality. Attendance
variables were the need of ventilatory support (MV), its duration, the need of complex
haemodynamic monitoring (HEMO), the need of continuous renal replacement therapy
(CRRT), the incidence of ventilation associated pneumonia (VAP) and multiorganic failure
(MOF). Statistical significance was studied by SPSS/PC 15.0 and confidence interval analysis
(CIA) programs. Signification level was 0.05.
RESULTS. Confirmed infection was present at admission in 172 (medical patients 80%,
admitted from hospital wards 51%, LOS 14.3 ± 14 days, risk of death 46% and mortality rate
37%) and 135 patients during ICU stay (medical 70%, from ward 35%, LOS
27.5 ± 19.5 days, death risk 46% and mortality rate 36%). MV was needed in 83 versus 91%
of the samples, HEMO 44 versus 36%, CRRT 26 versus 22% and MOF 29 versus 25%.
(p \ 0.05 for all comparisons), except for risk of death and observed mortalities.
CONCLUSIONS. In our experience, and with strict infection diagnostic criteria, infection as
reason for admission and infection appeared during ICU stay does not have different outcome
estimations or mortality outcomes, but the second one is more resources consuming. Any
measure addressed to decrease the incidence of intra—ICU infections could be related to a
more efficient management.
Fungal infections and novel diagnostic approaches:
0750–0763
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EPIDEMIOLOGY AND RISK FACTORS FOR CANDIDEMIA IN NON-NEUTRO-
PENIC CRITICALLY ILL PATIENTS
F. J. Gonzalez de Molina1, C. Leon2, S. Ruiz Santana3, A. Loza2, F. Lucena2, B. Galvan4,
A. Blanco5, A. Utande Vazquez6, M. A. Blasco Navalporto7, M. J. Lopez8, CAVA Study
Group
1Hospital Universitario Mutua de Terrassa, Intensive Care Medicine, Terrassa, Spain, 2Hos-
pital Universitario de Valme, Sevilla, Spain, 3Hospital Universitario Dr. Negrin, Las Palmas
de Gran Canarias, Spain, 4Hospital Universitario La Paz, Madrid, Spain, 5Hospital Central de
Asturias, Oviedo, Spain, 6Hospital Universitario Miguel Servet, Zaragoza, Spain, 7Hospital
Severo Ochoa, Leganes, Spain, 8Hospital General Yagu¨e, Burgos, Spain
OBJECTIVES. To determine the incidence and risk factors for candidemia in the non-
neutropenic critically ill patient, and to assess changes in the epidemiology of candidemia
over the past decade.
METHODS. Prospective cohort observational and multicenter study divided into two peri-
ods: between May 1, 1998 and January 30, 1999, 73 medical-surgical ICUs of 70 Spanish
hospitals participated in the EPCAN project (Prevalence Study of CANdidiasis), and between
April 1, 2006 and June 30, 2007, the ICUs of 36 hospitals from Spain, France and Argentina
participated in the CAVA project (Validation Study of the ‘‘Candida score’’ Evaluation
System). In both periods, all non-neutropenic critically patients admitted in the ICU for more
than 7 days were included. Demographic data, length of stay, severity indexes, comorbidities,
and risk factors were recorded. Continuous variables were compared with the Student’s t test
and categorical variables with the chi-square test. All variables with P B 0.1 in the univariate
analysis were included in a stepwise logistic regression model.
RESULTS. Of a total of 2,775 patients recruited in both study periods, 97 cases of candi-
demia were diagnosed, with an incidence of 33.8 episodes of candidemia per 1,000 patients or
1.5 per 1,000 patients-year. Candida albicans was the causative pathogen in 58.3% of cases
and non-albicans species in 41.7%. In the multivariate analysis, independent risk factors for
candidemia were severe sepsis or septic shock (OR = 3.63, 95% CI 2.18–6.04); multifocal
Candida spp. colonization (OR = 2.70, 95% CI 1.60–4.56); total parenteral nutrition
(OR = 2.35, 95% CI 1.35–4.09), and length of ICU stay (OR = 1.014, 95% CI 1.005–1.023).
The crude mortality rate was 59.8% in patients with candidemia and 35.4% in patients without
candidemia. There were no statistically significant differences in the incidence of candidemia,
distribution of Candida spp., length of ICU stay, rate of empirical antifungal treatment, or
candidemia-associated crude mortality despite the introduction of new azoles and
echinocandins.
CONCLUSIONS. The epidemiology of candidemia in our tertiary hospitals did not change
significantly over the past 10 years. Risk factors for candidemia were severe sepsis of septic
shock, multifocal colonization, total parenteral nutrition, and ICU length of stay.
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RESULTS OF ONE YEAR USE OF CASPOFUNGIN IN INVASIVE CANDIDIASIS
A. Doblas Claros1, A. Tristancho Garzo´n1, M. Garcı´a Sa´nchez1, M. Rodrı´guez Carvajal1,
D. Mora Lo´pez1, H. Gonza´lez Pin˜ero1
1Servicio Andaluz de Salud. Hospital Juan Ramo´n Jime´nez, Unidad de Cuidados Intensivos,
Huelva, Spain
INTRODUCTION. The echinocandins are a relative new great treatment of invasive can-
didiasis. Therefore, we must grow our clinical experience and knowledge on its management.
OBJECTIVES.
1. To analyse the appropriate prescription of caspofungin in invasive candidiasis in our
Intensive Care Unit (ICU).
2. To determine the hospital mortality and risk of mortality associated with the use of
caspofungin in our patients with invasive candidiasis.
METHODS. We collected prospectively the data of all the patients treated with caspofungin
during the year 2008 in our medical-surgical ICU for adult non-coronary critically-ill patients,
and we reviewed retrospectively Candida spp. isolations, ‘‘Candida Score’’, APACHE II, risk
of mortality predicted by the APACHE II, initial SOFA, and maximum SOFA.
RESULTS. There were 387 admissions of patients in our ICU during the year 2008, and we
prescribed 23 treatments of caspofungin in 19 patients, because four patients were treated
twice during their stay in our ICU. We obtain 14 significant isolations (73.7% of all the
patients treated with caspofungin): funguemia: 6, intraabdominal surgical samples: 5, deep
surgical incision samples: 2, superficial surgical incision sample: 1. The Candida species
isolated were: C. glabrata: 6, C. tropicalis: 5, C. albicans: 3, C. krusei: 2 (81.25% of non-
albicans species), there were 2 infections with 2 different species of Candida, 17 patients have
intrabdominal invasive candidiasis, and only 2 patients were neutropenic with pneumonia.
All the patients had at least a ‘‘Candida Score’’ of 3 points, and their mean value was 4 points.
The mean APACHE II score of these patients was 26.21 points, and their mean hospital
mortality risk by APACHE II was 59.12%, the actual hospital mortality was 52.63%.
The mean initial SOFA score was 8.47 points, and the mean maximum SOFA score 12.05
points.
CONCLUSIONS. The prescription of caspofungin was suited in our patients, because all of
them had at least 3 points in the ‘‘Candida Score’’, therefore, with a very high probability of
invasive candidiasis, that is strengthend with a great proportion of significant Candida iso-
lations (73.7%). Moreover, the very high proportion of Candida non-albicans (81.25%)
indicates the empirical use of an antifungal agent other than fluconazol, especially echino-
candins. Finally, the hospital mortality of these patients was 5.49% smaller than predicted by
the APACHE II, that seems an appropriate outcome.
REFERENCES. 1. Leo´n C, Ruiz-Santana S, Saavedra P et al (2006) A bedside scoring
system (‘‘Candida Score’’) for early antifungal treatment in nonneutropenic critically ill
patients with Candida colonization. Crit Care Med 34:730–737.
2. Pappas PG, Kauffman CA, Andes D et al (2009) Clinical practice guidelines for the
management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin
Infect Dis 48.
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CANDIDEMIA DUE TO CANDIDA ALBICANS VS. NON-ALBICANS CANDIDA
SPP. IN NON-NEUTROPENIC CRITICALLY ILL PATIENTS. A PROSPECTIVE
MULTICENTER COHORT STUDY
F. J. Gonzalez de Molina1, C. Leon2, L. Alvarez Rocha3, A. Martinez Pellus4, A. Blanco5, B.
Galvan6, M. Marin7, A. Ubeda7, CAVA Study Group
1Hospital Universitario Mutua de Terrassa, Intensive Care Medicine, Terrassa, Spain, 2Hos-
pital Universitario de Valme, Intensive Care Medicine, Sevilla, Spain, 3Hospital Juan
Canalejo, Intensive Care Medicine, A Corun˜a, Spain, 4Hospital Virgen de la Arrixaca,
Intensive Care Medicine, Murcia, Spain, 5Hospital General de Asturias, Intensive Care
Medicine, Oviedo, Spain, 6Hospital Universitario La Paz, Intensive Care Medicine, Madrid,
Spain, 7Hospital Universitario de Valme, Sevilla, Spain
OBJECTIVES. To compare the epidemiology, risk factors, impact of risk factors on mor-
tality and antifungal treatment in non-neutropenic critically ill patients with candidemia due
to Candida albicans and candidemia due to non-albicans species.
METHODS. Prospective cohort study carried out in 36 medical-surgical ICUs from Spain,
France and Argentina. All non-neutropenic critically ill patients admitted between April 2006
and June 2007 for more than 7 days were included. Demographic data, severity indexes, risk
factors for candidemia, and antifungal treatment were recorded. Patients were followed until
hospital discharge or death. Continuous variables are expressed as mean (standard deviation,
SD) or median (25th–75th percentile) and were compared with the Mann–Whitney U test or
the Kruskal–Wallis test. Categorical variables are expressed as percentages and compared
with the chi-square test or the Fisher’s exact test. Data were also analyzed in a stepwise
logistic regression model.
RESULTS. Thirty-eight cases of candidemia among 1,107 patients recruited were diagnosed
(incidence 3.4% or 1.5 per 1,000 patients-year). Candida species was unknown in 1 case. In
the remaining 37 cases, C. albicans was the causative pathogen in 59.5% (n = 22) and non-
albicans species in 40.5% (n = 15), including C. parapsilosis (24.3%, n = 9), C. tropicalis
(8.1%, n = 3), C. glabrata (5.4%, n = 2), and C. krusei (2.7%, n = 1). History of COPD was
the only risk factor for C. albicans candidemia (OR = 2.15, 95% CI 1.45–3.21). There were
no statistically significant differences between candidemias caused by C. albicans and non-
albicans species regarding demographics, length of ICU stay, severity indexes, Candida
colonization scores (Pittet, Candida score, Seville score), and mortality rate (54.5% for C.
albicans candidemia versus 46.7% for non-albicans species candidemia; in both cases,
mortality rates were significantly higher than those predicted by APACHE II and SOFA
scores at the time of ICU admission and diagnosis of candidemia). Seven patients were not
given antifungals (C. albicans 4, non-albicans species 3) and all of them died. In patients
treated with antifungals, the median days for starting treatment was 1 (range 0–4) without
differences between groups. In all treated cases, the selection of the antifungal agent was
appropriate according to the Candida spp. isolated.
CONCLUSIONS. Candidemias occurring in ICU patients were caused by C.albicans in
59.5% of cases and by non-albicans species in 40.5% (predominantly C. parapsilosis). COPD
as underlying condition was more frequent in patients with C. albicans candidemia. Differ-
ences in crude mortality rates between both groups were not found. In patients receiving
antifungal agents, treatment was started early and was appropriate to the species.
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RISK FACTORS IMPLICATED IN PROVEN FLUCONAZOLE-RESISTANT CAN-
DIDEMIA: PROSPECTIVE ANALYSIS FROM SIX YEARS COLLECTING DATA
A. Diaz-Martin1, J. Garnacho-Montero1, M. Ruiz2, E. Garcia-Cabrera3, J. A. Marquez-
Vacaro1, J. Aznar-Martin2, C. Ortiz-Leyba1
1H. U. Virgen del Rocio, Intensive Care Unit, Seville, Spain, 2H. U. Virgen del Rocio,
Microbiology, Seville, Spain, 3H. U. Virgen del Rocio, Infectious Disease, Seville, Spain
INTRODUCTION. Numerous studies tried to identify risk factors for candidemia caused by
non-albicans species or by potentially fluconazole-resistant species (C. glabrata and C.
krusei) with conflicting results, specially whether previous fluconazole (FLU) therapy con-
stitutes an independent risk factor. We hypothesize if the results of these approaches will
differ from the analysis evaluating risk factors of microbiologically proven FLU resistant
candidemia.
METHOD. Prospective study, including adults patients with candidemia in our hospital,
from 2003 to 2008. We analyzed demographic risk factors, underlying diseases, neutropenia,
renal insufficiency (RI), transplantation, previous surgery, TPN, APACHE II on the day the
positive blood culture was taken, renal replacement therapy and prior treatment with anti-
biotic and/or antifungals. We attempted to identify implicated risk factors performing these
three analyses: (1) C. albicans versus C. non-albicans, (2) Potentially FLU-resistant species
(C. glabrata and C. krusei) versus FLU-sensitive species and (3) Species with microbio-
logically confirmed FLU resistance versus species with microbiologically proven FLU
sensitivity. The FLU susceptibility determination was made by a commercial colorimetric
antifungal test (Sensititre YeastOne) incubated at 35C and reading the change of colour from
blue to red at 24 and 48 h.Statistical analysis: chi-square or Fisher’s exact test, Student’s t or
Mann–Whitney U test as needed, and multivariate analysis including variables with p \ 0.05
in the univariate analysis.
RESULTS. 224 candidemia episodes, of which 94 occurred in the ICU. There were 195
(87.1%) isolates of C. FLU-sensitive species (105 C. albicans, 39 C. parapsilosis, 37 C.
tropicalis, 11 C. glabrata, 3 C. guillermondii) and 29 (12.9%) isolates of C. FLU-resistant
species (14 C. krusei, 15 C. glabrata).The first analysis did not show any independent risk
factors, the second one showed that prior antibiotic treatment [OR 0.189 (95% IC 0.049–
0.733, p = 0.016)] and solid organ transplantation [OR 15.37 (95% IC 1.36–173.39,
p = 0.027)] were independent risk factors for potentially FLU-resistant candidemia. In the
third analysis, neutropenia [OR 7.88 (95% IC 2.20–28.20, p = 0.001)], RI [OR 3.46 (95% IC
1.24–9.67, p = 0.018)] and FLU pre-treatment [OR 4.42 (95% IC 1.47–13.32, p = 0.008)]
were independent risk factors for microbiologically confirmed FLU-resistant candidemia.In
the critically ill patients, the first and second analyses showed not independent risk factors,
whereas the last one showed that FLU pre-treatment [OR 7.59 (95% IC 1.35–42.43,
p = 0.021)] and RI [OR 7.31 (95% IC 1.08–49.41, p = 0.041)] were the variables inde-
pendently associated with microbiologically confirmed FLU resistant candidemia.
CONCLUSION. Prior FLU treatment is an independent risk factor only for candidemia
caused by microbiologically confirmed FLU resistant species. These findings may explain the
contradictory results found by previous studies.
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CANDIDA ALBICANS INFECTIONS IN A SURGICAL INTENSIVE CARE UNIT IN A
UNIVERSITY HOSPITAL IN GREECE
A. Larentzakis1, H. Markogiannakis1, P. Drimousis1, A. Xanthaki2, M. Toutouza2, G. Pro-
kopaki3, A. Burnetas3, D. Theodorou1, K. G. Toutouzas1, S. Katsaragakis1
1Hippokrateion Hospital, Athens Medical School, University of Athens, Surgical Intensive
Care Unit, 1st Department of Propaedeutic Surgery, Athens, Greece, 2Hippokrateion Hospital,
Department of Microbiology, Athens, Greece, 3University of Athens, Department of Math-
ematics, Athens, Greece
OBJECTIVES. The aim of this study was to identify and evaluate the clinical features of
patients sustaining Candida albicans infections in our Surgical Intensive Care Unit (SICU).
METHODS. Data for all patients hospitalized in our SICU are prospectively collected in a
database. Data for cases developing ICU-acquired infections by C. albicans between January
2001 and December 2007 were retrieved and analyzed.
RESULTS. Among 1,255 hospitalized patients, 287 (22.8%) had an infection. Fifty-nine
cases developed an ICU-acquired C. albicans infection during their SICU stay and composed
our study group (20.5% of the cases with an infection and 4.7% of the total group of patients).
Mean age of these patients was 66.2 ± 6.5 years and APACHE II score 21.6 ± 5.2 (men:
n = 32, 54.2%). The most frequent underlying surgical pathology (hospital admission diag-
nosis) was gastrointestinal cancer (n = 23, 39%), mechanical small or large bowel
obstruction (n = 11, 18.7%), acute peritonitis (n = 11, 18.7%) and pancreatitis (n = 6,
10.2%). The majority of the patients was operatively treated (n = 54, 91.5%); 30 (50.8%)
underwent intestinal surgery, 7 (11.8%) biliary tract operations, 6 (10.2%) esophageal/gastric
surgery, 6 (10.2%) hepatectomy, and 5 cases (8.5%) had pancreatic surgical procedures.
Urinary tract, surgical site, bloodstream and respiratory tract infections constituted the most
common infection sites. Complication rate of these patients was 76.2% (n = 45); septic shock
was the most frequent complication (n = 35, 59.3%) followed by acute respiratory failure
(n = 30, 50.8%), renal (n = 28, 47.4%), cardiac (n = 20, 34%) and hepatic failure (n = 18,
30.5%). Mortality was 50.8% (n = 30). Mean SICU and hospital stay was 29.5 ± 7.4 and
41.7 ± 8.3 days, respectively.
CONCLUSIONS. Candida albicans infections are frequent in SICUs. Identification and
analysis of the characteristics of the patients developing these infections is important for their
prevention and treatment.
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EPIDEMIOLOGY, MANAGEMENT AND RISK FACTORS OF CANDIDEMIA IN
CRITICAL CARE
E. Paramythiotou1, F. Frantzeskaki1, A. Antoniadou2, E. Dimitriadou1, A. Armaganidis1
1Atticon University Hospital, 2nd Department of Critical Care, Athens, Greece, 2Atticon
University Hospital, 4th Department of Internal Medicine, Athens, Greece
INTRODUCTION. Candidemia is frequently encountered in the nosocomial setting and
often fatal for critically ill patients. We retrospectively studied the epidemiology, manage-
ment and risk factors of candidemia, in a polyvalent intensive care unit of a tertiary care
hospital.
PATIENTS AND METHODS. Between October 2006 and March 2009 all adult patients
with candidemia, proven during their hospitalization in our 18-bed ICU, were included.
RESULTS. During the study period, 33 patients with isolated candidemia (6.28% of the total
number of hospitalized ICU patients) were included. Eight of them (24%) had received
antifungal prophylaxis. In 48% of the cases, candidemia occurred within the first 10 days after
ICU admission, whereas the mean time (±SD) elapsed between ICU admission and candi-
demia onset was 24 ± 26 days. C. albicans remained the most frequently isolated species,
accounted for 51.5% of the isolates, followed by C.glabrata (18%), C.parapsilosis (15%), C.
krusei (9%) and C.tropicalis (6%). Caspofungin was the most commonly introduced treatment
(66%), followed by liposomal amphotericin B (21%), fluconazole (6%), voriconazole (3%)
and anidulafungin (3%). The mean (±SD) therapy duration was 20 ± 13 days, while treat-
ment regimen was modified in 24% of patients. Isolates were eradicated in 19 patients (57%)
and the mean (±SD) time of sterilization of cultures was 10 ± 5 days after treatment
introduction. However, signs and symptoms of candidemia were eliminated in 13 patients
(39%). The attributable to candidemia mortality rate was 45%, while the all-cause mortality
rate was 70%. Regarding the most frequently reported conditions predisposing to candidemia:
an indwelling vascular catheter was present in all patients, while 94% of them had received
broad spectrum antibiotics, during the last 10 days before candidemia onset. In 8 (24%) of the
cases, a prior surgery had occurred, while in 5 (15%) of them an abdominal surgery was
present. 10 patients (30%) received total parenteral nutrition, 12 (36%) were in continuous
renal replacement therapy, 9 (27%) were under corticosteroid therapy and 4 (12%) received
immunosuppressive drugs. Diabetes mellitus was present in 6 (18%) patients, a malignancy in
5 (15%) and severe sepsis in 21 (63%) patients. All patients were mechanically ventilated.
Ostrosky prediction rule was positive in 18 patients (54%), while Candida colonization was
observed in 5 (15%) of patients.
CONCLUSIONS. Candidemia is a growing concern in the ICU, as it is associated with a
high mortality rate. C.albicans remains the most commonly isolated species.
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IMPACT OF ANTIFUNGAL AGENTS ON OUTCOMES IN NON IMMUNOCOMPR-
OMIZED ICU PATIENTS: A CASE CONTROL STUDY
E. Azoulay1, J. Zahar2, A. Franc¸ais3, M. Darmon1, C. Adrie4, M. Garrouste5, Y. Cohen6,
A. Descorps-Declere7, D. Goldgran-Toledano8, J. Timsit3, The Outcomerea Study Group
1Saint-Louis, Paris, France, 2Necker, Paris, France, 3Grenoble University Hospital, Grenoble,
France, 4Cochin Hospital, Paris, France, 5Saint-Joseph, Paris, France, 6Avicenne, Paris,
France, 7Beclere, Clamart, France, 8Gonesse, Gonesse, France
INTRODUCTION. Patients with ICU-acquired sepsis benefit from early and adequate
antibacterial agents. The adjunction of antifungal agents (AFA) remains controversial.
METHODS. Among the 7,219 patients included the Outcomerea database between 1996 and
2007, AFA were prescribed in 640 (8.8%) patients, including 334 nonimmunocompromized
patients mechanically ventilated for more than 2 days.
RESULTS. Patients receiving AFA (AFA?) were medical in half the cases, admitted for
peritonitis in 17.5% of the cases and had a SOFA score day 1 at 7 (4–9) and a SOFA score at 5
(3–9) on treatment implementation day. AFA were prescribed at day 15 (5–21) and for 7 (3–
10) days. AFA administration was for curative purpose in 26 (10%) patients (23 candidemia
and 3 peritonitis), and fluconazole was the most frequently prescribed drug (57%).
260 patients AFA? were paired with 262 AFA- patients (on year of ICU admission, center,
medical versus surgical patients, presence of central line at day 1, TPN, risk of death ±10%
and time in the ICU before AFA prescription. Overall, AFA? patients had increased hospital
mortality compared to paired controls (43 vs. 31%, OR 1.74 (1.18–2.59), p = 0.005).
AFA? patients required more frequently life sustaining therapy and for a longer duration.
Accordingly, their ICU stay was longer [25 (9–31) vs. 21 (8–28) h, p = 0.01]. After AFA
administration, AFA? patients were at higher risk for carriage of multi-resistant bacteria
(21.2 vs. 5%, p \ 0.0001) and presented more frequently an episode of VAP than AFA-
patients (10 vs. 5.3%, p = 0.05).
Among the 522 exposed and unexposed patients, information regarding Candida colonisation
was available in 384 (73.6%) patients, including 180 (46.9%) patients colonized in at least
one site (68 patients with multiple colonization). Candida albicans accounted for only half the
identified species. AFA? patients had higher colonization index and Candida score than
AFA- patients (CI 0.32 vs. 0.14, p \ 0.0001 and Candida score at 2 (1–3) vs. 3 (2–4),
p \ 0.0001). After adjustments on Candida colonization, mortality in AFA? patients was no
longer different than these from AFA- patients [OR 1.24 (0.67–2.31), p = 0.50]. Adjustments
made on Candida score or colonization index provided similar results. Strikingly, in patients
in whom Candida colonization follow-up was available, AFA? patients were at higher risk of
loosing their colonization than AFA- patients (20.3 vs. 10.2%, p = 0.006).
CONCLUSION. AFA are prescribed in up to 9% of critically ill patient. In 90% of the cases,
treatment’s indications are prophylaxis or pre-emptive therapy. Patients receiving AFA are
sickest, with more frequently unresolved acute diseases requiring heavier and longer organ
support, and with higher hospital mortality. By showing that AFA succeed to decrease
mortality of AFA? patients to the level of this from AFA- patients, this study suggests
benefit from AFA and depicts the framework of an interventional study.
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DETECTION OF BACTERIAL AND FUNGAL PATHOGENS ASSOCIATED WITH
SEPSIS IN PATIENTS PRESENTING TO THE EMERGENCY ROOM
E. L. Tsalik1,2, D. Jones2, B. Nicholson2, L. B. Caram1,2, O. Liesenfeld3, V. G. Fowler1, S. W.
Glickman4, L. P. Park2, S. F. Kingsmore5, C. B. Cairns4, C. W. Woods1,2
1Duke University Medical Center, Internal Medicine, Durham, USA, 2Durham VA Medical
Center, Internal Medicine, Durham, USA, 3Roche Molecular Systems, Pleasanton, USA,
4University of North Carolina at Chapel Hill, Emergency Medicine, Chapel Hill, USA,
5National Center for Genome Resources, Santa Fe, USA
Morbidity and mortality from community-acquired sepsis continues to be a major health care
burden. Blood culture remains the gold standard to identify bloodstream infection despite its
low sensitivity and prolonged incubation time. In this study, we sought to establish the clinical
utility of pathogen DNA detection in blood by multiplex PCR as compared to and in con-
junction with conventional blood culture.in patients presenting to the emergency department.
We enrolled patients with suspected infection and at least two Systemic Inflammatory
Response Syndrome (SIRS) criteria presenting to the emergency department at Duke Uni-
versity Medical Center and the Durham VA Medical Center. We obtained blood cultures from
all patients and performed multiplex PCR using the Light Cycler SeptiFAST test on con-
current whole blood. After review of patient records, an infectious diseases clinician
categorized patients according to likelihood of infection.
Of 290 patients enrolled, we identified 206 (71%) patients with confirmed or likely infection and
84 (29%) with no identified infectious etiology. The most common sites of infection were urinary
tract (45), lung (37) and skin (34) accounting for 69% of all identified sites. Staphylococcus aureus
and Escherichia coli accounted for 58.6% of causative organisms. Patients with definite infection
had higher rates of positive blood cultures (31 vs. 0% in those without infection) and positive PCR
(24 vs. 2% in those without infection). Patients with definite infection also had increased IL-6, PCT
and CRP levels compared to patients without infection. Of 39 subjects with concordant positive
results, blood culture and multiplex PCR identified the same etiologic agent in 37 cases. Including
polymicrobial isolates, blood culture and PCR each identified a total of 63 organisms on the list of
PCR-detectable organisms. Excluding contaminants, blood culture demonstrated a sensitivity,
specificity, PPV, and NPV of 31, 100, 100, and 37%, respectively, whereas the same test char-
acteristics for multiplex PCR were 24, 98, 96 and 34%. Combining the results of PCR with blood
culture improved sensitivity to 36% without a change in specificity. Multiplex PCR detected
polymicrobial infections more often than blood culture.
Detection of pathogen DNA by multiplex PCR is highly correlated with signs and symptoms
of sepsis. The combination of blood culture and multiplex PCR enhances the performance of
microbiological techniques for the detection of bloodstream infection.
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CHARACTERIZATION OF SEVERE PLASMODIUM FALCIPARUM MALARIA
PATIENTS IN AN ANGOLAN GENERAL ICU: A THREE YEARS REVIEW
E. Toma´s1,2, E. Lafuente2, E. Filipe1, E. Viegas1, A. Sa´3, F. Silva1, M. L. Antunes1
1Clı´nica Sagrada Esperanc¸a, General ICU, Luanda, Angola, 2Centro Hospitalar Tamega e
Sousa, General ICU, Penafiel, Portugal, 3Centro Hospitalar Tamega e Sousa, Internal Med-
icine, Penafiel, Portugal
INTRODUCTION. Malaria is the most important human parasitic disease, causing an
estimated 500 million clinical cases and more than 1 million deaths annually. Plasmodium
falciparum is responsible for the most serious form of the disease, with a significant mortality
rate in the absence of prompt recognition and urgent appropriate patient management.
OBJECTIVE. To characterize severe Plasmodium falciparum malaria patterns in patients
admitted to an Angolan general ICU.
METHODS. A retrospective study based on medical records of adult patients with severe
Plasmodium falciparum malaria admitted between January 2006 and December 2008 at the
general ICU of Clı´nica Sagrada Esperanc¸a, an Angolan University-affiliated teaching hospital.
We collected data on demographics, malaria-related immunity status, clinical presentation,
WHO malaria severity criteria, laboratory findings and outcome. Continuous data were
analyzed with Students t-test. A P of less than 0.05 was regarded to be significant.
RESULTS. Out of 114 patients admitted with diagnosis of malaria in the study period, we
enrolled 56 patients. Forty-four (79%) were males. The mean age was 43.0 ± 12.9. Twenty-
eight (50%) were non-immune and only two were adherent to chemoprophylaxis, but reported
taking it incorrectly. Fifty-two percent were admitted during the second trimester. The mean
APACHE II was 15.4 ± 8.7 with a mean predicted dead rate of 25.9%. The mean SOFA on
admission was 7.6 ± 3.6. Fever (82%) followed by headache (41%) and gastrointestinal
symptoms (36%) were the most common symptoms on admission and jaundice (61%) the
most common sign. The mean duration of symptoms prior to presentation at the ED was
6.1 ± 4.3 days. Malaria diagnosis was confirmed within 24 h of admission to our hospital in
all the cases. Twelve patients presented two or more WHO severity major criteria. Forty-one
patients were treated with quinine and twelve with artemether. Nineteen patients (34%)
required ventilatory support, 20 (36%) intermittent hemodialysis and 12 (21%) vasopressor
support. The mean ICU length of stay was 5.5 ± 3.8 days. The 2-day mortality rate and total
ICU mortality rate recorded was 10.7 and 37.5%, respectively.
CONCLUSIONS. In this review, the criteria usually pointed as predictors of a poor outcome
on sepsis cases were found to have statistical significance in malaria-related deaths (Table 1)







Age, Mean ± SD 43.7 ± 12.5 42.0 ± 14.0 0.66
APACHE II, Mean ± SD 12.1 ± 6.2 21.0?9.4 \0.0001
SOFA on admission (total),
Mean ± SD
6.5 ± 3.3 9.6 ± 3.5 0.0013
Non-lmmure, n (%) 18(51.4) 10(47.6) 0.79
Two or more WHO severitv criteria,
n(%)
1 (0.3) 11 (52.41) \ 0.0001
Platelets (X103/mm3), Mean ± SD 85.5 ± 86.3 65.3 ± 57.3 0.35
Bilirubin (mg/dl), Mean ± SD 4.8 ± 4.7 6.9 ± 7.2 0.08
Creatinine (mg/dl), Mean ± SD 3.6 ± 3.15 3.9 ± 2.6 0.67
C-reactive protein (mg/l), Mean ± SD 118.0 ± 87.5 140.0 ± 103.0 0.45
Arterial lactates (mmol/I), Mean ± SD 3.4 ± 2.89 5.4 ± 4.6 0.019
Parasitemia (X103parasites/mm3).
Mean ± SD
30.5 ± 28.8 27.8 ± 36.7 0.73
REFERENCES. 1. WHO (2000) Trans R Soc Trop Med Hyg.
2. Mphahlele BJ et al (2008) Polskie archiwum medycyny wewne˛trznej
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LIGHTCYCLER SEPTIFAST AS A TOOL TO ENHANCE THE DETECTION OF
BACTEREMIA AND FUNGEMIA IN PATIENTS WITH INTRAABDOMINAL
INFECTION DURING ANTIMICROBIOLOGICAL THERAPY
A. Kalenka1, S. Schmid1, J. Timm1, G. Beck1
1University Medical Centre Mannheim, Department of Anesthesiology and Surgical Intensive
Care Medicine, Mannheim, Germany
Inadequate antimicrobiological treatment was reported to be the most important determinant
of outcome in septic patients. The classic gold standard to detect bacteremia in septic patients
is the blood culture (BC). Up to two-third of severe sepsis cases are BC negative, especially
when the patient already received empirical antimicrobiologial therapy.
The aim of our preliminary study was to determine the additional diagnostic value of the
LightCycler SeptiFast MGrade test (Roche Diagnostics) in the blood of patients with com-
plicated intraabdominal infection (cIAI) during empirical antimicrobiological therapy. The
SeptiFast test is a multiplex PCR test that can detect nucleic acids from the most common
pathogens (approximately 90%) responsible for hospital-associated bacteremia and takes 6–
7 h to perform.
The study enrolled 18 patients with severe sepsis and cIAI during empirical antimicrobio-
logical therapy. BC and blood for the SeptiFast were taken at the same time point. The
patients received at least one full dose of empirical antibiotic therapy at this time point.
BC were negative is 13 cases, in 3 cases positive and 2 were classified as contamination.
SeptiFast were positive in 10 cases, in 7 cases negative and 1 was classified as contamina-
tion. Eight BC negative samples revealed relevant pathogens by the SeptiFast test. Five
negative BC were also negative in the SeptiFast test. Two tests pairs were identical in BC and
SeptiFast, including one contamination. One BC found a multiresistent Staph. aureus not
identified by the SeptiFast test. One BC showed Candida glabrata whereas polymicrobio-
logical results were identified by the SeptiFast test.
The BC negative and SeptiFast positive pathogens were: Enterococcus faecium, E. coli,
Pseudomonas aeroginosa and Candida albicans. In five of these cases antimicrobiological
therapy were adjusted.
Multiplex PCR (SeptiFast) detected potentially significant bacteria and fungi that were not
found by BC in patients with severe sepsis during antimicrobiological therapy. The SeptiFast
test may serve as a tool to detect relevant blood stream pathogens under antimicrobiological
therapy.
REFERENCE. 1. Rangel-Frausto et al (1995) JAMA 273:117.
2. Sands et al (1997) JAMA 278:234.
3. Louie et al (2008) Crit Care Med 36:1487.
ACKNOWLEDGEMENTS. The study was supported in part by Roche Diagnostics,
Mannheim, Germany
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LIGHTCYCLER SEPTIFAST AND VCS: RELATIONSHIP BETWEEN TWO INNO-
VATIVE INSTRUMENTS IN SEVERE SEPSIS AND SEPTIC SHOCK
N. D. Cascio1, G. Mineo1, A. Cortegiani1, L. Cangemi1, G. Virga1, S. M. Raineri1
1University of Palermo, Anesthesiology and Intensive Care, Palermo, Italy
INTRODUCTION. Neutrophil count is normally used as diagnostic tool of bacterial
infections, but it is not specific and accurate. Many authors have analyzed the clinical use-
fulness of VCS parameters: channels of cell volume (V), conductivity (C), and light scatter
(S) in reactive neutrophils to find relationship between these data and infections. In a recent
study a significative increase of mean of cell volume and an important decrease in mean of
light scatter in adult septic patients are described; they could have a remarkable role also in
patients non presenting leucocytosis or neutrophilia. The aim of this study is to compare
retrospectively the results of LightCycler Septifast, as sepsis diagnostic instrument, and VCS
values by Coulter LH750, in critical adult patients with severe sepsis and/or septic shock and
presenting neutrophilia ([12.000).
MATERIALS AND METHODS. Actually we enrolled 24 patients with severe sepsis and
septic shock (ACCP/SCCM) and neutrophilia and collected 38 blood sample. Two groups
were created: group S? (20) with positive PCR results and Group S- (18) with negative PCR
results. All the blood samples were analyzed with Coulter LH750 for VCS values.
RESULTS. Results are shown in Table 1.
TABLE 1 VCS IN GROUP S? AND GROUP S-
Group S? Group S-
SD V 13.41 18.49
MV 169.33 170.91
SD C 2.64 1.58
MC 141.33 140.83
SD S 8.25 7
MS 133.16 134.5
In our two group of patients there are not significative difference of V, C, S values between
Group S? and Group S-
DISCUSSION. The diagnosis of sepsis is normally based on microbiological culture. Other
procedures as PCR system (as Septifast), value of RCP, microscopic analysis of peripheral
blood sample could be useful. Slide of peripheral blood requires a lot of time and depends on
human capacity and ability, but the VCS parameter obtained by Coulter LH750 requires only
few minutes. In our study, we investigated if there is an added value of V, C, S, in diagnosis of
sepsis.
CONCLUSION. We obtained similar results in both groups of patients (S? and S-) and we
concluded there is not relationship between sepsis showed by Septifast and VCS parameters,
and the use of VCS does not seem to be useful in diagnosis of sepsis.
REFERENCE. Chaves F, Tierno B, Xu D (2005) Quantitative determination of neutrophil
VCS parameters by the Coulter automated hematology analyzer: new and reliable indicators
for acute bacterial infection. Am J Clin Pathol 124:440–444
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PCR, SCREENING OF NOSE AND PERINEUM VERSUS EXTENDED CULTURE
BASED SCREENING FOR MRSA IN INTENSIVE CARE PATIENTS
N.-O. Hu¨bner1, S.-O. Kuhn2, T. Brenig3, G. Schro¨der4, I. Steinmetz4, A. Kramer1
1Ernst-Moritz-Arndt-University Greifswald, Institute of Hygiene and Environmental Medi-
cine, Greifswald, Germany, 2Ernst-Moritz-Arndt University Greifswald, Department of
Anaesthesia and Intensive Care Medicine, Greifswald, Germany, 3BDH-Hospital Greifswald,
Greifswald, Germany, 4Ernst-Moritz-Arndt-University Greifswald, Friedrich-Loeffler-Insti-
tute of Medical Microbiology, Greifswald, Germany
BACKGROUND. Colonisation and infections with Methicillin-resistant Staphylococcus
aureus (MRSA) are a major problem worldwide. Nares, mouth, arm pits, groins and chronic
wounds are typical sites for MRSA colonisation. Furthermore, colonisation of gut, lung and
vagina are reported, too. Early detection of a MRSA—colonisation by screening has been
shown to significantly improve infection control and prevent further spread of resistant
strains. Especially intensive care patients transferred between hospitals are often screened and
isolated preemtively to minimise cross-colonisation between units. Polymerase-chain-reaction
(PCR) based assays are faster than cultural tests, but are more costly and currently not
validated for all sites. Therefore, complete screening of all possible colonisation sites with
PCR-based methods is impossible. On the other hand, PCR based assays would allow to stop
isolation precautions sooner and make earlier rehabilitation possible.
METHODS. We assessed, whether a PCR—screening of nares and perineum is equal to a
conventional, culture-based screening of all possible colonisation sites. From August 2007 to
February 2008, intensive care patients transferred from the ICU of the University Hospital
Greifswald to the early neurological rehabilitation unit of the BDH-Hospital Greifswald (the
priority centre for treatment of severe cranium and brain damage in Mecklenburg—Pomm-
erania, Germany) were screened for MRSA before and after transfer by PCR (nares,
perineum) and by culture (head, nares, mouth, arm pits, groins, chronic wound and catheter
insertion sites), respectively.
RESULTS. No patient tested negative for MRSA in the PCR became positive in the culture.
PCR results were available within 8 h, while conventional tests took at least 48 h. Using
PCR-based screening saved 2 days of isolation. Higher costs for the test itself are more than
out weighted by earlier stop of isolation precautions. PCR-based screening has now proven to
be secure and cost efficient for this setting in everyday practice.
0762
VALUE OF LIGHTCYCLER SEPTIFAST IN DETECTION OF VENTILATOR-
ASSOCIATED PNEUMONIA
A. Kalenka1, J. Timm1, S. Schmid1, G. Beck1
1University Medical Centre Mannheim, Department of Anesthesiology and Surgical Intensive
Care Medicine, Mannheim, Germany
Ventilator-associated pneumonia (VAP) is an important cause of morbidity and mortality in
ICU patients. Delayed diagnosis and subsequent delay in initiating appropriate therapy may
be associated with worse outcome [1]. Several diagnosis criteria have been proposed for the
diagnosis of VAP, nonetheless an acceptable gold standard does not exist. Blood cultures are
relative insensitive in the diagnosis of VAP.
We want to report results from patients with suspected VAP and the value of the LightCycler
SeptiFast MGrade test (Roche Diagnostics) in comparison with BC and tracheal aspirates.
The SeptiFast test is a multiplex PCR test that can detect nucleic acids from the most common
pathogens (approximately 90%) responsible for hospital-associated bacteremia.
In the study 32 patients with suspected VAP (CPIS Score[5, [2]) were enrolled. Collection of
tracheal aspirates and blood for BC and SeptiFast were taken at the day of clinical diagnosis
of VAP.
SeptiFast tests were positive in 13 cases. S. aureus was the dominant pathogen in 6 cases. BC
were positive only in 4 cases, including 2 cases of S. aureus bacteremia also displayed by the
SeptiFast test. Two positive BC were not displayed in the SeptiFast test, one of them were
assessed as contamination. Tracheal aspirates revealed in 22 cases growth of bacteria and
funghi. Predominantly Candida albicans was found in 10 cases, assessed as colonisation not
treated with an antifungal therapy. In six cases results from tracheal aspirates were assessed as
relevant pathogen not displayed in the SeptiFast results.
The SeptiFast test is more sensitive in the detection of relevant blood pathogens in VAP than
the BC. The multiplex PCR may help in the discrepancy between bacteremia associated with
VAP and colonisation of tracheal aspirates.
REFERENCES. 1. Iregui M et al (2002) Chest 122:262.
2. Pugin et al (1991) Am Rev Respir Dis 143:1121
GRANT ACKNOWLEDGEMENT. The study was supported in part by Roche Diagnostics,
Mannheim, Germany.
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CLINICAL APPLICATION OF DIFFERENTIAL TIME TO POSITIVITY OF
BLOOD CULTURES AS A DIAGNOSTIC METHOD FOR CATHETER-RELATED
BLOODSTREAM INFECTION
C. Sabatier1, G. Gruartmoner1, R. Ferrer1, X. Garcı´a1, M. Duarte1, M. Colomina1,
D. Alcara´z1, D. Fontanals2, J. Valle´s1, CIBER-Enfermedades Respiratorias
1Hospital de Sabadell, Corporacio´ Sanita`ria Parc Taulı´, Centre de Crı´tics, Sabadell, Spain,
2Hospital de Sabadell, Corporacio´ Sanita`ria Parc Taulı´, Servei de Microbiologı´a, Sabadell,
Spain
INTRODUCTION. Clinical suspicion of catheter-related bloodstream infection (CR-BSI)
requires, in many cases, the catheter withdrawal. Definitive diagnosis is confirmed only in 15–25%
of the withdrawn catheter. Differential time to positivity (DTP) of blood cultures has been validated
by or group [1] and others as an accurate diagnostic method of CR-BSI avoiding unnecessary
catheter withdrawal.
OBJECTIVE. To prove the safety and the useful of DTP in comparison with a standard
method that needs catheter removal.
METHOD. We performed a prospective and randomized study in a medical-surgical ICU
during a 20 month period (July 2007–February 2009). Patients admitted in the ICU requiring
a central venous device were included. At the moment of CR-BSI suspicion, excluding those
with hemodynamic instability, patients were randomly assigned to a diagnostic method.
Group 1: standard [2]. Group 2: DTP, 2 peripheral vein blood cultures and a catheter hub
blood culture were simultaneously carried out. Times to positivity of all the blood cultures
were automatically registered (BacT/ALERT; Organon Teknica). The diagnosis of CR-BSI
was considerate when all the cultures were positive for the same micro-organism and DTP C
120 min. We compared clinical and microbiological data, rates of CR-BSI and management
of catheter between two groups using v2 and Student’s t test.
RESULTS. 133 patients were included. 52 patients with suspicion of CR-BSI were ran-
domized (77% males, 59 years ± 19, APACHE II 22 ± 10) with no difference between both
groups. While CR-BSI and colonization rates were not different between groups, DTP




EPISODES OF CR-BSI SUSPICION 37 26
CR-BSI 5 4 0.87
COLONIZATION 5 3 0.78
CATHETERS RELATED TO CR-BSI 17 13 0.88
MAINTAINED CATHETERS 0 30 \0.001
COMPLICATIONS 0 0
There was no difference in the evolution of inflammatory parameters: DCRP (0.4 ± 6 vs.
0.8 ± 3; p = 0.86), Dleukocytoses (1,405 ± 2,105 vs. 1,201 ± 2,090; p = 0.94), Dtemper-
ature (0.33 ± 0.8 vs.0.84 ± 0.7; p = 0.27) during the 24 h following the suspicion of CR-
BSI between the two methods. The micro-organisms who caused CR-BSI were S. epidermidis
(4 cases), S. aureus (1), MRSA (1), Pseudomonas aeruginosa (2), Enterobacter cloacae (1).
CONCLUSION. A diagnostic strategy of CR-BSI by DTP method allows unnecessary catheter
withdrawal. However, we did not found increase in morbidity due to new catheter insertion. Delay
in the catheter removal in cases of CR-BSI does not involved increase in morbidity.
REFERENCES. 1. Garcia X et al (2007) Intensive Care Med 33:S200.
2. Maki DG et al (1977) N Engl J Med 296:1305–1309.
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A LARGE OUTBREAK OF KPC-PRODUCING KLEBSIELLA PNEUMONIAE AND
EFFORTS TO CONTROL IT
E. Papadomichelakis1, K. Pontikis1, F. Matthaiopoulou1, E. Paramythiotou1, V. Exarhou1,
E. Karkali1, A. Antoniadou2, E. Giamarellou2, A. Armaganidis1
1Attikon General University Hospital, 2nd Intensive Care Department, Athens, Greece,
2Attikon General University Hospital, 4th Internal Medicine Department, Athens, Greece
AIMS. Klebsiella pneumoniae Carbapenemase (KPC)-producing Klebsiellae pneumoniae
(Kp) have been reported from around the world, especially the US and Israel. We describe an
outbreak of KPC-Kp that occurred in our ICU and the efforts to control it.
METHODS. The study was performed in a 21-bed ICU in a teaching hospital. The nurse-to-
patient ratio is 1-to-3 during all shifts. ICU patients are routinely screened on admission, then
rectally once and tracheally twice weekly. The outbreak was first noticed in late September 2008.
Screening for KPC-production was introduced by boronic acid disk test and the epidemic was
prospectively followed. Furthermore, all Kp strains isolated during 2007 and 2008 were retro-
spectively submitted to boronic acid disk testing and to PCR for a KPC gene. All patients found to
be colonized or infected with KPC-Kp from January 2007 to March 2009 were included in the
study. On detection of the epidemic, several staff meetings were arranged to communicate the
problem and encourage hand hygiene and contact precautions. On December 2008 cohorting of
colonized or infected patients began. Cohorted patients were limited to two of the four ICU wards.
Weekly efforts were made for dedicating nursing staff to KPC patients only, although this was not
always affordable due to nurse unavailability. New admissions were not quarantined and their final
disposition depended on the results of their admission screening, usually reported 3–4 days later.
EPIDEMIC CURVE
RESULTS. From August 2007 to March 2009, KPC-pK was isolated from 53 patients. Mean
age was 68 years, with 25 cases being male and mean admission APACHE II 19. Forty-six of
them were mechanically ventilated, 12 had renal failure, 7 were immunosuppressed and 12
had recent surgery. Crude ICU mortality was 53%. KPC-pK was imported in 20 cases and
ICU-acquired in 27. Thirteen patients (25%) were infected (9 BSI, 3 VAP, 1 SSI). Infections
were treated with a varying combination of colistin, tigecycline and/or gentamycin. All BSIs
had a favorable outcome. One VAP and the SSI showed no improvement but the patients died
of other causes. Overall, in no case was the KPC-pK infection considered the cause of death.
CONCLUSIONS. The outbreak seems to be getting into an endemic status. Although transmission
in the ICU seems to be more or less controlled, increased admissions of unidentified carriers,
detection delays until cohorting and low nurse-to-patient ratios seem to be major obstacles to
outbreak control.
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RISK FACTORS FOR ISOLATION OF THIRD GENERATION CEPHALOSPORIN
RESISTANT ESCHERICHIA COLI OR KLEBSIELLA PNEUMONIAE IN INTEN-
SIVE CARE
C. Hill1
1King’s College London, London, UK
INTRODUCTION. Antibiotic resistant infections are a major problem in intensive care.
Identifying potential risk factors for this could help with prioritising interventions. Previous
research on this issue has had inconsistent results.
OBJECTIVES. To identify risk factors for the isolation of third generation cephalosporin
(3GC) resistant Escherichia coli or Klebsiella pneumoniae from patients in the Intensive Care
Unit of a large teaching hospital.
METHODS. Isolates were from any clinical specimen, and were not differentiated as
infection/colonisation. Case group 1 had had 3GC sensitive E. coli or K. pneumoniae isolated
from them. Case group 2 had had 3GC resistant E. coli or K. pneumoniae isolated from them.
Controls did not have E. coli or K. pneumoniae isolated from them. Factors analysed were
unit length of stay (LOS), Apache II score, age, total days of 3GCs (cefotaxime, ceftazidime
and ceftriaxone), and total days of ‘other antibiotics’ (ciprofloxacin, gentamicin and tazocin).
A Colonisation Pressure Index (CPI) was developed that aimed to indicate the potential risk of
cross infection on the unit. The data used was available from unit and hospital audit data, and
was analysed using logistic regression. Initially a single control group was randomly selected
from all eligible admissions (case-case-control methodology, Kaye et al. 2005). The data was
then reanalysed using controls matched for length of stay for each case group.
RESULTS. Between April 2007 and March 2008 there were 552 eligible admissions. 30
patients were identified with 3GC sensitive isolates, 11 with 3GC resistant isolates (all 11 of
these produced at least one beta-lactamase, only one did not produce an ESBL). With ran-
domly selected controls the CPI was a significant risk factor for isolation of sensitive bacteria
(OR 1.127). There was a significant correlation between the CPI and unit LOS (rs = 0.443,
p = 0.000). Length of stay and age were significant risk factors for isolation of resistant
bacteria (OR 1.195 and 0.932, respectively). With controls matched for length of stay 3GC
use had a protective effect for isolation of sensitive bacteria (OR 0.318). No significant risk
factors were found for isolation of resistant bacteria.
CONCLUSION. When length of stay was controlled for, cross infection was not a significant
risk factor for isolation of E. coli or K. pneumoniae. A protective effect of 3GCs against the
subsequent isolation of 3GC sensitive E. coli or K. pneumoniae was found. This may have
implications at the population level (Lipsitch and Samore, 2002).
REFERENCES. 1. Kaye KS, Harris AD, Samore M, Carmeli Y (2005) The case-case-control
study design: addressing the limitations of risk factor studies for antimicrobial resistance.
Infect Cont Hosp Epid 26:346–335.
2. Lipsitch M, Samore MH (2002) Antimicrobial use and antimicrobial resistance: a popu-
lation perspective. Emerg Infect Dis 8(4):347–354.
GRANT ACKNOWLEDGEMENT. None.
0766
PREDICTORS FOR BLOODSTREAM INFECTIONS AMONG ICU PATIENTS
CAUSED BY CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE ISO-
LATES PRODUCING DIFFERENT CARBAPENEMASES AND EFFECT OF
ACQUISITION ON MORTALITY. A PROSPECTIVE OBSERVATIONAL STUDY
E. Mouloudi1, E. Protonotariou2, A. Zagorianou2, E. Iosifidis2, K. Katsanoulas1, A. Kara-
panagiotou1, T. Giasnetsova1, D. Sofianou2, N. Gritsi-Gerogianni1
1Hippokrateion Hospital, Intensive Care Unit, Thessaloniki, Greece, 2Hippokrateion Hospital,
Microbiology, Thessaloniki, Greece
INTRODUCTION. Carbapenem resistance of Klebsiella pneumoniae (KP) in our hospital
has increased from 1.75% in 2005 to 37% in 2008.
OBJECTIVES. The aim of our study was the evaluation of molecular epidemiology, risk
factors, treatment and outcome of patients with bloodstream infections (BSI) due to KP in the
ICU of a 1,200-bed tertiary Greek hospital.
METHODS. We prospectively studied all patients with BSI due to KP in our ICU from 1/1/
2007 to 1/1/2009 and we divided them in three groups: Patients with BSI due to carbapenem-
susceptible KP (control group), patients with BSI due to VIM-type producing KP (VIM
group) and patients with BSI due to KPC-type producing KP (KPC group). Risk factors,
treatment and outcome of VIM and KPC group were compared with the control group in order
to identify risk factors and mortality rates of BSI due to VIM or KPC producing KP.
RESULTS. A total of 59 patients were included in the analysis, 22 in control group (37.2%,
17 male, age 49 ± 18.6 years, admission APACHE II score 19 ± 6.9 and SOFA score on the
first day of infection 10.8 ± 3.2), 18 in VIM group (30.6%, 13 male, age 56 ± 17.4 years,
APACHE II score 20 ± 7 and SOFA score 10.8 ± 3.5) and 19 in KPC group (32.2%, 15
male, age 48.6 ± 15 years, APACHE II score 24.5 ± 6.8 and SOFA score 11.8 ± 4.8). BSI
occurred 12 (range 5–37) days after admission in control, 13 (range 7–36) days in VIM and 18
(range 6–30) days in KPC group. The patients’ ICU LOS was 25 (range 13–90) days in
control, 26 (range 12–60) days in VIM and 28 (range 8–51) days in KPC group. VIM group
isolates were susceptible to gentamycin (100%) and colistin (100%). KPC group isolates were
susceptible to gentamycin (80%) and colistin (100%). All patients in control and VIM group
and 18/19 (94.7%) in KPC group received appropriate empiric therapy. Age, gender,
APACHE II and SOFA score, recent organ transplantation and any kind of prior antibiotic
therapy did not affect the prevalence of BSI due to VIM or KPC producing KP (p [ 0.05).
The ICU mortality rates were 41% for the control group, 44% for the VIM and 63% for the
KPC group.
CONCLUSIONS. The emergence of carbapenem resistance of KP has important implica-
tions to the future ability to treat these infections meaning that patients with BSI due to KPC
producing KP are more likely to die. No specific predictors may discriminate the prevalence
of this kind of infection.
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THROMBOCYTOSIS IN RESPIRATORY TRACT INFECTIONS CAUSED BY
ACINETOBACTER
E. Curiel Balsera1, M. J. Chaparro Sa´nchez1, M. D. Arias Verdu´1, I. Macias Guarasa1,
J. Mun˜oz Bono1, J. L. Mun˜oz Mun˜oz1
1Hospital Regional Universitario Carlos Haya, Unidad de Cuidados Intensivos, Ma´laga, Spain
INTRODUCTION. In recent years we have been noting that Acinetobacter infections are
often accompanied by thrombocytosis. We have not found any reference in medical publi-
cations before.
MATERIAL AND METHODS. Case-control study of patients admitted in ICU who
developed an acinetobacter infection since October 2007 to December 2008. For the control
group we used a random group of patients for any reason, who developed infections for any
other microorganisms and were admitted in the same period of time.
We analyzed clinical and demographic data y both groups. Presence of thrombocytosis
([400.000 l/mL) and clinical types of infections (respiratory, bloodstream, urinary or central
nerve system) were studied.
Qualitative variables are expressed as percentage and absolute value, while mean and stan-
dard deviation are provided for quantitative variables.
RESULTS. We analyzed 66 patients in the acinetobacter group and 61 in control group.
Mean age was 50.24 ± 17.51 years for acinetobacter group and 54.77 ± 18.34 years in
control group. We did not find differences in previous clinical data in both groups, except
increased male sex in acinetobacter group (74.2% vs. 57.37%, p = 0.045).
We detected higher percentage of patients in the group of acinetobacter than in control group
(p = 0.0001). After analyzed clinical forms of infections, only respiratory tract infections by
acinetobacter were related with thrombocytosis (p = 0.014). In the group of acinetobacter in-
fectios, the presence of thrombocytosis were associated with lower rate of mortality (p = 0.036).
CONCLUSIONS. In our patients, the presence of thrombocytosis was associated with
respiratory tract infections by acinetobacter, and with less severe forms of infections, with
lower rate of mortality in this sub-group of patients.
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CLINICAL AND MICROBIOLOGICAL PROFILE OF PATIENTS INFECTED WITH
ACINETOBACTER IN ICU
I. Macias Guarasa1, J. Mun˜oz Bono1, J. L. Mun˜oz Mun˜oz1, E. Curiel Balsera1, M. D. Arias
Verdu´1, M. J. Chaparro Sa´nchez1
1Hospital Regional Universitario Carlos Haya, Unidad de Cuidados Intensivos, Ma´laga, Spain
INTRODUCTION. We aim to describe what kind of patients actually develops an Acine-
tobacter infection and how far since admission in ICU the infection develops. We have also
analysed the antibiotic resistance profile and the antibiotic treatment used.
MATERIAL AND METHODS. This is a prospective-retrospective observational study of
patients admitted in ICU, with at least, one positive culture for Acinetobacter.
We collected clinical and demographic data. We analysed previous infections and germs
during admission and length of stay in ICU. We also reviewed the resistance profile of
acinetobacter and the treatment used.
Qualitative variables are expressed as percentage and absolute value, while mean and stan-
dard deviation are provided for quantitative variables (except for skewed variables, for which
median and interquartile range are used).
RESULTS. 91 clinical histories for patients with documented infection by Acinetobacter
have been collected from September 2007 through February 2009. Table 1 shows some
clinical and demographic characteristics of the collected data.
Age 51.07 ± 17 years
Male 71.4% (65)
Personal history
• COPD 8.9% (8)
• Inmuno-deficiency 11.1% (10)
• Diabetes 13.1% (12)
• Cirrosis 6.7% (6)
• Used pre-steroids 11.1% (10)
• Solid tumor 10% (9)
• Congestive heart failure 5.6% (5)
• Chronic renal failure 4.4% (4)
The length of stay was 34.48 ± 23.9 days. Isolation of Acinetobacter occurred most fre-
quently in the second week from admission (13.14 ± 8 days). The reasons for admission
were medical causes in 48.4%, major trauma in 38.5% and surgical patients in 13.2% patients.
Only 13.2% of patients were re-admissions from other services, primarily from internal
medicine (11%) and neurosurgery (9%).
Up to 40.4% of patients had isolated acinetobacter in multiple sites. Respiratory infection was
the most frequently developed (89%), followed by bacteraemia (12.4%) or urinary tract
infection (12.4%). Acinetobacter was isolated in cerebral spinal fluid in three patients.
The resistance profile has modified during the study period, but globally we have 83.8% of
resistance to carbapenem and 74.4% to ampicillin-sulbactam. The drugs tested with less
resistance were amikacin (9.3%), colistin (7.6%), and tigecycline (4.2%). The most used anti-
biotic was intravenous (65.2%) and inhaled (50.6%) colistin. In more than half of the cases, more
than two antibiotics were used to eradicate the infection. The mortality rate was 30.3%.
CONCLUSIONS. Acinetobacter infection occurs more frequently in medical or trauma patients
during the second or third week from admission to ICU. The therapeutical arsenal is limited, and
the combination of antibiotics is essential to prevent the development of new resistances. Length of
stay in the ICU for these patients is prolonged, and the mortality rate is also high.
S198 22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009
0769
CEFOPERAZONE - SULBACTAM FOR TREATMENT OF INFECTIONS BY PAN—
RESISTANT ACINETOBACTER BAUMANNII IN THE ICU
A. Gurnani1
1Kailash Hospital and Heart Institute, Noida, Critical Care, DELHI, India
INTRODUCTION. Acinetobacter baumannii has a relevant clinical implication in ICUs due
to elevated number of infections caused by this microorganism; the prevalence of CRAB
(Cerbapenem Resistant Acinetobacter) and pan-resistant A. baumannii is on the increase
leaving few therapeutic options and high mortality (40–70%). Various antimicrobial regimes
have been tried including Colistin, Rifampin etc. with high incidence of adverse effects. The
present study was done to evaluate the safety and therapeutic efficacy of cefoperazone plus
sulbactam in treating nosocomial infections caused by this strain in an Indian ICU.
METHODS. This open-label prospective study was done in 50 adult patients admitted to the
ICU over a period of 12 months. Upon admission to ICU, besides standard investigations,
cultures were sent from Blood, Urine, drains, surgical site and BAL (Bronchoalveolar
Lavage) and repeated after 48 h, on day5, day7 and on clinical cure. Upon isolation of A.
baumanni, cefoperazone (2 g)—sulbactam (2 g) (Magnex Pfizer, India) was initiated as
intravenous infusion over 60 minutes every 6–8 h and was continued till resolution of
pathology requiring admission to ICU.
The parameters studied included clinical, microbiological and radiological cure and complete
blood count, liver and kidney functions and Prothombin Time.
RESULTS. 31 males and 19 females, mean (SD) age 43.9 ± 2.4, were studied. The patient
population comprised of Head Injury (22%), Chest trauma (8%), Polytrauma (18%), COPD
(22%), Post-operative (18%), Pneumonia (6%) and Sepsis syndrome (6%). A. baumannii was
isolated from 88% specimen of BAL, 8% from surgical site, 2% from drain and 2% of blood
cultures. Microbiological cure was obtained in all the 50 patients while 44 and 46 patients had
radiological and clinical cure, respectively (p \ 0.001, significant). Mild increase in liver
enzymes was observed in 7 patients which was not significant (p [ 0.05); Sulbactam had to
be discontinued in one patient (p [ 0.05) due to increased S. Bilirubin and liver enzymes. 47
patients were discharged from the ICU (p \ 0.001), one with residual paresis while antibiotic
intervention (change of therapy) was required in 4 patients (p [ 0.05). Mean length of stay in
ICU was 10.4 ± 2.5 days, mean number of days on ventilator was 7.3 ± 2.4 while mean
number of days on cefoperezone–sulbactam was 8.4 ± 1.1 days.
CONCLUSIONS. Data from this study suggest that cefoperazone (2 g) plus sulbactam (2 g)
in a dose of 6–8 g/day is safe and effective in the treatment of nosocomial infections in the
ICU caused by pan-resistant Acinetobacter baumannii.
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A STEP-BASED STRATEGY TO CONTROL MULTI-DRUG RESISTANT A. BAU-
MANNII OUTBREAK IN ITALIAN ICUS
D. Orazi1, G. Nardi2, A. Menichetti2, E. Cingolani2, L. Riccioni2, A. Lappa2, C. Serafini1,
V. Mondillo1
1St. Camillo Hospital, Emergency-Hygiene, Rome, Italy, 2St. Camillo Hospital, Emergency,
Rome, Italy
AIMS. Acinetobacter baumannii has emerged as an important nosocomial pathogen. St.
Camillo Hospital is a tertiary care 950-bed Institution with 6 ICUs. Since July 2007 a
continuous monitoring system of the alert organisms (as A.baumannii) was implemented in
the hospital ICUs. Surveillance cultures (twice a week) were implemented. The monitoring
system has been able to identify outbreaks by MDR A baumannii in at least two of them:
Cardio-Surgical ICU and Shock and Trauma ICU, in which MDR A.baumannii isolates
reached a peak in June 2008. This was associated to severe infections caused by this bug,
raising a great concern. A specific strategy was therefore endorsed in the attempt to control
and reduce the spread of MDR A. baumannii strains. The full strategy was introduced in the
clinical practice starting on September 1, 2008.
METHODS. Different alert levels were defined and for each level specific interventions were
planned and implemented in a step wise manner. Step 1 was defined as the presence in the
ICU of a single patient carrying A. baumannii, while step 2 and 3 were defined by A.
baumannii isolation from 2 or more patients. In each corresponding step the operative
measures have been activated to limit or to eradicate the diffusion of the micro organism. The
principal procedures adopted have been: the integrated work-team of physicians, nurses and
epidemiologists, the patient isolation, the standard and contact precautions of health care
providers and visitors, the hands decontamination, strengthening environmental cleaning and
the antibiotic resistance monitoring. The level of awareness was further reinforced as one of
the ICU was enrolled into the MOSAR-ICU study project. Clinical and surveillance cultures
were collected as usual. Data of the alert organisms monitoring database were analysed to
understand whether the adopted strategy was effective in reducing the spread of MDR A
baumannii strains.
RESULTS. From April 2008 to March 2009, 1302 patients were admitted to the ICUs. A.
baumannii was cultured from 239 specimens in 152 patients. The trend in MDR A.baumannii
isolation progressively decreased after the introduction of the step based control system and
the adoption of hands hydroalcholic decontamination. Since September 2008 we observed no
new epidemic outbreaks and the number of the overall isolations of A.baumannii showed a
30% reduction from 8 versus 5% of the positive samples.
CONCLUSIONS. After the adoption of the step based control strategy there has been a trend
towards a progressive reduction in A. baumannii isolations. The observational time is too
short to allow any sound conclusion about the efficacy of the adopted strategy, nevertheless
the introduction of the step-based control strategy there were no more epidemic outbreaks.
The step response seems to improve health care provider adherence to recommendations and
might improve the level of efficiency in the use of resources.
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PREVALENCE OF BACTEREMIA DUE TO PAN-RESISTANT ACINETOBACTER
IN TERTIARY INTENSIVE CARE UNIT
K. A. Dalal1, S. Bindroo1, I. Raut1, S. Tandan1, M. Patel1, J. Sunavala1
1Jaslok Hospital and Research Centre, Critical Care Medicine, Mumbai, India
INTRODUCTION. Pan-resistant bacteremia is frequently a life-threatening complication in
critically ill patients admitted to intensive care units
OBJECTIVES. To determine prevalence, risk factor; outcome of Pan-resistant Acinetobacter
in tertiary care hospital open ICU
METHODS. A 3-year retrospective observational study conducted in the open ICU of a
tertiary care hospital at Mumbai, India. Patients whose blood cultures were positive for
Acinetobacter were included in the study. We defined multi-drug resistant (MDR) acineto-
bacter as those resistant to Cephalosproin, Aminoglycosides and Beta-Lactams puls Beta
Lactamase inhibitors and susceptible to Carbapenems, Tigecycline and Polymyxin group. We
defined pan-drug resistant (PDR) acinetobacter as those sesitive to only Tigecylcine and
Polymyxin group.
The incidence, risk factors and mortality were assessed from the data.
RESULTS. From February 2006 to March 2009, Acinetobacter spp. was isolated from blood
in 52 critically ill patients. The mean incidence of isolation was 17/1,000 admissions.
Out of 52, 28 was multi-drug resistant bacteria while 24 was pan-drug resistant bacteria. The
main risk factors for isolation of acinetobecter were malignancy (32.5%), prolonged venti-
lation (17.88%), Catheter related blood stream infection (15%). Crude mortality was 80%
with pan-drug resistant acinetobacter while 40% with susceptible bacteria.
CONCLUSIONS. Acinteobacter is a common nosocomial cause of infection in critically ill
patients admitted to Intensive Care Unit of our hospital. Pan-resistant Acinetobacter is
common in our ICU (Table 1)
TABLE 1 RISK FACTOR FOR PAN-RESISTANT ACINETOBACTER
Risk Factors No. Of patients Percentage
Prolonged Antibiotics 20 38.5
Malignancy 17 32.5
Prolonged Ventilation 10 17.88
CRBSI 08 15
REFERENCE(S). 1. Marchaim D, Navon-Venezia S, Schwartz D et al (2007) Surveillance
cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin
Microbiol 45:1551–1555.
2. Falagas ME, Bliziotis IA, Siempos II (2006) Attributable mortality of Acinetobacter
baumannii infections in critically ill patients: a systematic review of matched cohort and case-
control studies. Crit Care 10:R48.
GRANT ACKNOWLEDGEMENT. We are very thankful to the Jaslok Hospital for the
providing data for our study. We are also helpful to Ms Vijeta Kamat for helping us for
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LONGITUDINAL TRENDS OF PSEUDOMONAS AERUGINOSA RESISTANCE IN
SPUTUM ISOLATES FROM CHRONICALLY VENTILATED PATIENTS
E.-L. Marcus1, S. Benenson2, L. Altmark3, A. E. Moses2
1Herzog Hospital, Chronic Ventilation Unit, Jerusalem, Israel, 2Hadassah-Hebrew University
Medical Center, Department of Clinical Microbiology and Infectious Diseases, Jerusalem,
Israel, 3Herzog Hospital, Microbiology Laboratory, Jerusalem, Israel
AIMS. The carriage and infection rates by resistant bacteria in chronic ventilation units are
high and lead to elevated morbidity, mortality and cost of care. The fact that some patients are
ventilated for lengthy periods provides us a unique opportunity to examine trends in the
prevalence of antimicrobial resistance over time.
METHODS. In the chronic ventilation units in Herzog Hospital, sputum cultures are obtained
routinely every 3–4 weeks and as needed for evaluation of fever. Pseudomonas aeruginosa is
the most prevalent isolate. We analyzed the change in its antimicrobial susceptibility pattern
over time. Included in the study were only patients with at least seven separate sputum
isolations isolates of P. aeruginosa. We calculated in each patient, and for each antimicrobial
agent, the number of times the resistance status remained the same, increased, or decreased
between two consecutive cultures. For all patients, the proportions for either event (no change
in resistance status, increase, or decrease) was calculated for each antibiotic.
RESULTS. From May 2005 to August 2007, P.aeruginosa was isolated from the sputum of
181 patients. Ninety-six patients, in whom there were at least seven separate isolations, were
included in the analysis. The average number of isolates per patient was 18 (range 7–60). The
average time of follow up was 407 days (range 47–793). The proportion of resistance to the
antimicrobial agents was: piperacillin–tazobactam 25%, amikacin 35%, piperacillin 37%,
imipenem 45%, ceftazidime 55%, gentamicin 63%, and ciprofloxacin 76%. The pattern of
resistance with time varied between patients; in some, it was stable over time, in some it
decreased or increased once, and in others decreased and increased several times. The overall
incidence of no change, increase, or decrease in antimicrobial resistance between two con-
secutive cultures for the various antimicrobial agents was, respectively: amikacin 62.9, 19.1.
18.0%; ceftazidime 63.7, 18.7, 17.6%; imipenem 65.0, 17.7, 17.3%; gentamicin 70.8, 15.3,
13.9%; piperacillin 70.6, 14.6, 14.8%; ciprofloxacin 77.5, 11.9, 10.6%; piperacillin–tazo-
bactam 78.1, 10.7, 11.2%. The distribution of events was statistically significantly different
between three groups of antimicrobials (p \ 0.001). The first group included: amikacin,
ceftazidime and imipenem; the second group gentamicin and piperacillin and the third cip-
rofloxacin and piperacillin–tazobactam.
CONCLUSIONS. Contrary to our expectation, the trends in antimicrobial resistance over
time were found to be complex and unpredictable. Further analysis is needed to define
whether factors such as patient characteristics, infection control policies and patterns of
antimicrobial administration also influence this pattern.
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ACINETOBACTER INFECTION VERSUS OTHER NOSOCOMIAL PATHOGENS
IN AN INTENSIVE CARE UNIT
M. J. Chaparro Sa´nchez1, M. D. Arias Verdu´1, E. Curiel Balsera1, I. Macı´as1, J. L. Mun˜oz
Mun˜oz1, J. Mun˜oz Bono1
1Carlos Haya Hospital, Intensive Care Unit, Ma´laga, Spain
INTRODUCTION. Acinetobacter is a serious nosocomial problem in the intensive care unit
(ICU) setting, due to its persistence in the hospital environment and its broad antimicrobial
resistance patterns, with important clinical and economic consequences. In Spain, Acineto-
bacter is the third leading pathogen after Pseudomonas, and Staphylococcus. Although this
pathogen can be associated with an elevated crude mortality, it only contributes to this
mortality in a subset of high-risk patients. Adequate empirical antimicrobial therapy is a
protective factor, even though the therapeutic options are often limited. We compare epide-
miological, clinical and microbiological data in two groups of patients infected with and
without Acinetobacter.
METHODS. A case-control study from October 2007 to December 2008. Information was
collected on 121 patients hospitalised in our ICU setting with different reason for admission.
All patients with microbiologically documented infection due to Acinetobacter were defined
as cases (AG: 66). The control group (NoAG: 61) were infected due to other pathogens.
Demographic, clinical and microbiological data, mortality rate and length of stay were
evaluated. The data were expressed in mean ± standard deviation and percentages. Student t
test and chi-square test were used.
RESULTS. Table 1 expresses some of the data. No differences in underline diseases were
observed between the two groups. There were more central venous cathetheres in AG (AG
95% vs. NoA group 88.5%; p = 0,024). The infection developed later in AG (AG 2th-3rd
week vs. NoAG 1st week; p = 0.0001). Thrombocytosis was higher in AG (AG
311,109,4 ± 216,842,4; NoAG 185,137,9 ± 97,866; p = 0.0001). There were not statistical
significant differences in mortality (AG 31.2% vs. NoAG 36%; p = 0.56) but in length of
stay (AG 31.8 ± 18.14 days vs. NoAG 12.31 ± 9.4 days; p = 0.0001).
TABLE 1
AG (n = 66) NoAG (n = 61) p
Age 50.2 ± 17.5 54.7 ± 18.3 NS
APACHE II 22.9 ± 7.1 20.6 ± 7.8 NS
Male 74.2% 57.3% 0.045
Reason for admission
Medical 48.4% 60.6% 0.02
Surgical 10.6% 24.5% 0.02
Traumatism 40.9% 14.7% 0.02
CONCLUSIONS. In our setting, Acinetobacter infection occurs more frequently around 2–3
week of stay in ICU and is associated with longer length of stay, however, mortality seems not
to be affected. Thrombocytosis, that frecuently appears in this kind of infections, could be a
useful tool to predict Acinetobacter infections and iniciate prompt and adequate therapy.
More trials must be conducted to assess this point.
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NOSOCOMIAL STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS IN
A PEDIATRIC INTENSIVE CARE UNIT: EPIDEMIOLOGY AND IMPACT OF
METHICILLIN RESISTANCE ON OUTCOME
A. Chakroun Bouziri1, A. Khaldi1, S. Bel Hadj1, A. Hamdi1, K. Menif1, N. Ben Jaballah1
1Children’s Hospital of Tunis, Tunis, Tunisia
OBJECTIVE. The incidence of nosocomial methicillin-resistant Staphylococcus aureus
(MRSA) infections is increasing and constitutes a serious problem in the intensive care units.
The aim of this study was to describe the epidemiological profile of nosocomial S. aureus
bloodstream infections (BSI) in a pediatric intensive care unit (PICU) and to assess the impact
of methicillin resistance on outcome.
METHODS. Data were collected as a part of an epidemiological surveillance program of
nosocomial infections conducted in a PICU between January 2004 and March 2008. All
patients who remained in the PICU for more than 48 h were included. Centers for Disease
Control and Prevention criteria were applied for the diagnosis of nosocomial BSI. Nosocomial
infections rates were calculated as incidence and density incidence rates (per 1000 patient-
days). The outcome of patients developing S. aureus BSI was studied in terms of mortality
and length of stay.
RESULTS. During the study period, 1,245 patients (mean age = 5.5 ± 20.6 months; mean
length of stay = 11 ± 19 days) were included. Twenty-two patients (mean
age = 3.4 ± 9.8 months; mean length of stay = 22.5 ± 13.8 days) developed 23 episodes of
nosocomial S. aureus BSI accounting for 20.2% of nosocomial BSI and 57.5% of nosocomial
BSI caused by gram-positive rods; with an incidence rate of 1.8% and a density incidence rate
of 1.6 per 1,000 patient-days. The mean time of onset of these infections was 7.4 ± 3.6 days.
Seventeen episodes of S. aureus BSI (73.9%) occurred in patients with central venous catheter
and 5 episodes (21.7%) were associated with nosocomial S. aureus pneumonia and/or lar-
yngotracheitis. The overall mortality rate of nosocomial S. aureus BSI was 34.8%.
S. aureus was methicillin resistant in 8 episodes (34.8%) with a density incidence rate of
MRSA nosocomial BSI of 0.58 per 1,000 patient-days. Compared with patients developing
nosocomial BSI due to methicillin-susceptible S. aureus, those with MRSA BSI had a sig-
nificantly higher rate of mortality (75 vs. 13.3%; p = 0.006).
CONCLUSIONS. The density incidence rate of S. aureus BSI was of 1.6 per 1000 patient-
days in our unit. S. aureus was methicillin resistant in 34.8% of episodes with a density
incidence rate of MRSA nosocomial BSI of 0.58 per 1,000 patient-days. Methicillin resistance
seems to increase the mortality rate in patients developing nosocomial S. aureus BSI.
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METHICILIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) RESPIRA-
TORY TRACT INFECTIONS IN ICU PATIENTS: LACK OF INFLUENCE OF
REDUCED SUSCEPTIBILITY TO VANCOMYCIN (VA) AND LINEZOLID (LZD)
ON OUTCOME
M. J. Tolo´n Herrera1, L. Riesco de Vega2, M. J. Jimenez Martı´n2, S. Domingo Marin2,
L. Parro Herrero2, M. A. De la Torre Ramos2, R. Fernandez Mun˜oz2, M. Sanchez Garcia2,
I. Bonilla Hernandez3, R. Andrade4
1H. U. Clı´nico San Carlos, Intensive Care Unit, Madrid, Spain, 2H. U. Clinico San Carlos,
Intensive Care Unit, Madrid, Spain, 3H. U. Clinico San Carlos, Microbiology, Madrid, Spain,
4H. U. Clinico San Carlos, Preventive Medicine, Madrid, Spain
INTRODUCTION. MRSA is an important cause of ventilator associated pneumonia (VAP).
Emergence of MRSA strains with reduced susceptibility to VA has prompted an increase of
empirical use of LZD in this setting.
OBJECTIVES. To describe the epidemiology of MRSA respiratory tract infections in crit-
ically ill patients and evaluate the influence of VA and LZD minimum inhibitory
concentration (MIC) on clinical resolution and mortality.
METHODS. 6,882 patients were admitted from June 2006 to June 2008. The 40 (0.58%)
mechanically ventilated patients with positive cultures for MRSA in respiratory secretions
were retrospectively studied. MICs for VA and LZD were determined by E-test. Clinical
variables were recorded, including APACHE II, SOFA, and clinical pulmonary infection
(CPIS) scores, and previous MRSA colonization. VAP was defined as [1 SIRS criterium.
And new radiological infiltrates. Antimicrobial treatment, whether empirical, delayed[1 day,
or inappropriate, need for change, length of stay (LOS) and mortality were registered.
Qualitative variables are expressed as totals and percentages and quantitative variables as
mean or median and interquartile range. Univariate and multivariate analyses were performed.
RESULTS. Median age was 69 (49–76), 31 (77%) were male, urgent admission 31 (77%),
sepsis 15 (37.5%), surgical (27.5%). COPD 14 (35%), prior antimicrobials 40 (100%), cor-
ticosteroids 10 (25%), APACHE II 18 (10–22), SOFA 4 (3–7). CPIS 6 (5–9). Previous MRSA
colonization 21 (52%), VAP 25 (67.5%), tracheobronchitis 7 (17%), lower respiratory tract
colonization 3 (7.5%). Empirical therapy 19 (47.5%), VA 14 (35%), LZD 17 (42%), VA
MIC = 1 lg/ml 13 (43.3%) and MIC = 2 lg/ml 17 (56.7%), VA resistant strains 0, LZD
MIC \ 4 lg/ml 15 (37.5%), linezolid resistant strains (MIC [ 4 lg/ml) 4 (10%), inappro-
priate treatment 8 (20%), need for change 9 (22%), treatment delay 9 (25%), treatment failure
10 (25%), clinical resolution 27 (67.5%), Hospital LOS 60 (36–92), ICU LOS 34 (10–54).
ICU mortality 32%, hospital 45%. The variables associated significatively with mortality in
univariate analysis were: fever p 0.04, OR 0.2 (0.06–0.9), Leucocytosis p 0.004, OR 15.4
(1.7–138), clinical resolution p 0.003, OR 0.005 (0.006–0.5) and comorbidity (oncologic
patients) p 0.015, OR 6.3 (1.37–29). In the multivariate analysis no variables were inde-
pendently associated with mortality.
CONCLUSION. Incidence of MRSA in respiratory tract secretions in our patients was low.
67% developed VAP. Antibiotic choice, treatment delay and VA and LZD MICs were not
related to outcome.
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STUDY OF INCIDENCE AND RISK FACTORS OF METHICILLIN-RESISTANT
STAPHYLOCOCCUS AUREUS (MRSA) INFECTION AMONG ALEXANDRIA
UNIVERSITY PEDIATRIC INTENSIVE CARE ADMISSIONS
A. A. El-Nawawy1, S. S. E.-D. Barakat1, M. M. Abdel-Fattah1, R. M. El-Haddad1
1Alexandria University, Pediatrics, Alexandria, Egypt
OBJECTIVE. To assess the incidence and risk factors of MRSA among Pediatric Intensive
Care (PICU) admitted patients.
METHODS. An 18 months prospective study (June2007–December 2008) included all
admitted patients (n = 480). All demographic and clinical data, exposure to possible risk
factors during last 12 months, the length of hospital stay (LOS), and fate were recorded.
Blood, urine, stool and throat swab cultures and whenever indicated cerebrospinal fluid (CSF)
and empyema cultures were performed on admission. The tip of the IV cannula and endo-
tracheal tube (ET) (if present) were cultured 48 h after admission. Cases suspected of
nosocomial infection were subjected to re-culture according to the affected system. Suculture
on ORSAB media were performed for MRSA detection for positive Staphylococcus aureus
(SA) cultures. MRSA infection were classified as community acquired (CA-MRSA) if
detected on admission and hospital acquired (HA-MRSA) if acquired[48 h from admission.
RESULTS. SA infection represented 15% of admissions (72/480), divided into three groups:
methicillin-sensitive SA (MSSA) (4.2%), CA-MRSA (7.5%) and HA-MRSA (3.3%). Study of
risk factors among CA-MRSA compared to HA-MRSA cases, showed higher percent of
patients referred from wards (p \ 0.001), hospitalized within the last 12 months
(p = 0.0005), having surgery within last 12 months (p = 0.0102), having an outpatient visit
within last 12 months (p \ 0.001), having a chronic disease (p = 0.0009), previous use of
injectable drugs (p = 0.0009); while it was statistically less as regards PRISM III score[12
on admission (p = 0.0475), less LOS [ 5 days (p = 0.0001). There was a higher incidence
of mortality among MRSA cases compared to MSSA cases (p \ 0.001). A multiple logistic
regression analysis for predicting MRSA infection showed that the risk factors for HA-MRSA
were PRIM III score [12 on admission (p = 0.013, OR 15.735 with 95% CI 1.78–138),
LOS [ 5 days (p = 0.018, OR 20.68 with 95% CI 1.69–252), hospital admission within last
12 months (p = 0.048, OR 271.7 with 95% CI 18–4,092); with the model success to diagnose
97.1% of total cases; and for CA-MRSA risk factors: residence in rural areas (p \ 0.001, OR
0.007 with 95% CI 0.000–0.116), hospital admission within last 12 months (p \ 0.001 OR
64.7 with 95% CI 6.88–608), having an outpatient visit within last 12 months (p = 0.001 OR
39 with 95% CI 4.19–363) and use of antibiotics within last 12 months (p \ 0.001 OR 571
with 95% CI 33.7–9676); with the model success to diagnose 97.4% of total cases.
CONCLUSION. There is a high incidence of MRSA in Alexandria University PICU, with
CA-MRSA stated to be an alarming community organism. Minimizing risk factors, early
diagnosis and judicious use of antibiotics are the cornerstone for MRSA reduction in the
community.
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CIPROFLOXACIN AND COLONIZATION/INFECTION WITH STAPHYLOCOCCUS
SPP. IN CRITICALLY ILL PATIENTS
I. Grigoras1, O. Chelarescu2, C. Caramidaru2, D. Rusu2
1‘Gr.T. Popa’ University of Medicine and Pharmacy, School of Medicine, Anesthesia and
Intensive Care Department, University Hospital ‘‘St. Spiridon ‘‘, Iasi, Romania, 2University
Hospital ‘‘St. Spiridon’’, Anesthesia and Intensive Care Department, Iasi, Romania
INTRODUCTION. Staphylococcus spp continues to be a major concern. The rate of
staphylococcal colonization/infection in critically ill patients is influenced by several factors
one of the the most important being the policy of antibiotic use. Previous studies have shown
a strong correlation between ciprofloxacin use and rate of Staphylococcus aureus infection.
Our study investigated changes in Staphylococcus spp. rate of colonization/infection and their
antibiotic susceptibility in relation with changes in antibiotic use in ICU patients.
METHODS. A prospective study was performed in a 19 beds mixed ICU on a tertiary care
university hospital. Blood, catheters, urine, respiratory tract, peritoneal fluid, pleural fluid, and
wound specimens were cultured any time when infection was present or every 4–5 days in
case of patients with ICU LOS (length of stay) [5 days (microbiological surveillance).
Positive cultures for Staphylococci spp. [Staphylococcus aureus and coagulaso-negative (CN)
staphylococci] were counted disregarding the infection or colonization status. Antibiotic use
was recorded as daily drug doses/100 beds (DDDs). The study included two periods: January–
June 2007 (P1—839 admitted pts) and January–June 2008 (P2—779 admitted pts). Com-
parison between these two periods included overall and site specific rate of positive cultures
with Staphylococi spp, patterns of antibiotic susceptibility and antibiotic usage.
RESULTS. The overall number of positive cultures with Staphylococcus aureus decreased
from 127 (15%) in P1 to 85 (11%) in P2 (p = 0.02). CNstaphylococci decreased from 61
(7%) in P1 to 35 (4%) in P2 (p = 0.01). Antibiotic usage decreased by half in P2 versus P1
(68.7 DDDs vs. 113.8 DDDs, p = 0.01), with the most significant drop in fluoroquinolones.
Ciprofloxacin use dropped from 1st (P1; 16.72 DDDs) to 7th position (P2; 2.15 DDDs) (75%
decrease). From 127 clinical isolates of Staphylococcus aureus in P1, 94% were ciprofloxacin
resistant compared to 46% rate of resistance from 85 positive cultures in P2 (p \ 0.01). There
was a correlation between ciprofloxacin use and Staphylococcus aureus colonization/infection
rate (r = 0.70; 95% confidence interval -0.01–0.94; p = 0.05). There was no statistical
difference in ciprofloxacin resistance of CN staphylococci in P1 (48%) versus P2(50%).
CONCLUSIONS. The drop in ciprofloxacin usage resulted in decreased number of Staph-
ylococcus spp. colonised/infected patients and in increased ciprofloxacin sensitivity in
Staphylococcus aureus isolated in ICU patients.
REFERENCES. 1. European Antimicrobial Resistance Surveillance System (2005) Sus-
ceptibility Results for S. aureus isolates. http://www.rivm.nl/earss/database/.
2. Stvers D et al (2006) Laboratory-based surveillance of current antimicrobial resistance
patterns and trends among Staphylococcus aureus: 2005 status in the USA. Ann Clin
Microbiol Antimicrob 5:2
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EARLY VERSUS LATE PERCUTANEOUS DILATATIONAL TRACHEOSTOMY
(PDT): ARE THERE RELIABLE PREDICTIVE FACTORS?
K. Tra¨ger1, L. K. Eberhardt2, M. Georgieff1, H. Suger-Wiedeck1, W. Stahl1
1University Hospital Ulm, Department of Anaesthesiology, Ulm, Germany, 2Ostalbklinikum
Aalen, Department of Anaesthesiology, Aalen, Germany
INTRODUCTION. There is still a debate, if in patients on mechanical ventilation PDT
should preferentially be performed early (i.e. B7 days) or late (i.e. [7 days) and in partic-
ularly which subsets of patients are prone to have PDT for airway management purposes. In
daily clinical practice indication for PDT is mainly based on empirical decision. It would be
helpful to have predictive factors to decide which patient should undergo PDT and when. We
retrospectively analysed our database of patients having PDT from 2003 through 2006 in
order to rule out factors that resulted in early or late PDT.
OBJECTIVES. The objective of the analysis was to find out if there are specific patient
related factors associated with early or late PDT. These factors should be implemented in a
list that should help to reliably predict need and optimum time of potential PDT.
METHODS. The retrospective study was performed in a mixed surgical and trauma ICU in a
university hospital. Patient charts were reviewed for demographic data and time of PDT (days
after admission). Reasons of admission, comorbidities and severity of illness were evaluated.
Patients were assigned to an ‘‘early’’ (B7 days) and ‘‘late’’ ([7 days) PDT group. According
to these groups coexisting factors and patient characteristics were evaluated. Statistical
analysis was performed using a chi square test or a Mann–Whitney U test where appropriate.
P \ 0.05 was regarded as significant.
RESULTS. From 2003 through 2006 PDT was performed in 248 patients; 139 patients
underwent early and 109 patients late PDT (Table 1)
TABLE 1
Early PDT Late PDT P
Age 69 [56–74] 63 [51–72] 0.052
BMI (kg/m2) 25 [23–28] 25 [23–28] n.s.
COPD 24% 14% 0.07
Elective surgery 26% 34% n.s.
Emergency surgery 65% 60% n.s.
Neurosurgical admission 28% 12% 0.003
Abdominal surgery 24% 41% 0.007
Trauma surgery 13% 20% n.s.
SAPS II 45 [32–54] 50 [36–59] 0.03
Data are given as median [interquartile range] or as percent. n.s. not significant
CONCLUSIONS. Neither demographic characteristics nor comorbidity factors were clearly
associated with early or late PDT. Whereas neurosurgical admission was clearly related to the
early PDT group, abdominal surgery was in contrast more often represented in the late PDT
group. In general, we could not find a unique profile that would assign a patient to early or late
PDT.
REFERENCES. 1. Goettler CE (2006) J Trauma 60:991–996.
2. Mo¨ller MG (2005) Am J Surg 189:293–296
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PATIENT OUTCOME PARAMETERS AFTER EARLY VERSUS LATE PERCUTA-
NEOUS DILATATIONAL TRACHEOSTOMY (PDT). A RETROSPECTIVE
ANALYSIS
W. Stahl1, L. K. Eberhardt2, E. Calzia1, H. Bracht1, M. Georgieff1, K. Tra¨ger1
1University Hospital Ulm, Dept. of Anaesthesiology, Ulm, Germany, 2Ostalbklinikum Aalen,
Dept. of Anaesthesiology, Aalen, Germany
INTRODUCTION. Albeit PDT has become a routinely performed procedure in ICU
patients, its effectiveness regarding morbidity, mortality and ICU length of stay (LOS) still
needs to be more clarified [1].
OBJECTIVES. The aim of our study was to compare outcome parameters as mortality,
morbidity and the ICU LOS in two subgroups of mechanically ventilated surgical patients
undergoing either early (\7 days, n = 139) versus late ([7 days, n = 109) PDT.
METHODS. From 2003 through 2006 patients were included to the study (adult, non-cardiac
surgical and trauma patients) undergoing a PDT during the course of their ICU stay due to the
need for prolonged mechanical ventilation. The timing for tracheostomy was set by the
responsible physicians depending from the patient’s conditions and based on a common
consense. PDT was performed exclusively by experienced physicians using the PercuTwist
technique (Ru¨sch AG, Germany). The main outcome measure of our study were mortality,
morbidity and the ICU length of stay. Statistical analysis of the data was performed by means
of the Mann–Whitney test. Statistical significance was assumed at p \ 0.05. Data are pre-
sented as median and [25–75%] interquartile range.
RESULTS. 248 patients were included in the study. Early PDT was performed on day 5 [4–6]
after admission in 139 patients, whereas late PDT was performed on day 10 [9–12] after
admission in 109 patients. Mortality in the early PDT group (32/139, 23%) did not differ from
the late PDT group (29/109, 27%) [p = 0.62]. Procedure related morbidity was not statisti-
cally different between the groups (early PDT group 22/139, 16% vs. late PDT group 8/109,
7% [p = 0.07]).
The results of the ICU LOS are presented in Fig. 1. The ICU length of stay significantly
differed between the two groups and was roughly half as long in the early PDT group.
Fig. 1
CONCLUSIONS. Our data clearly indicate tht early PDT results in shorter ICU length of
stay. Moreover, the results are encouraging in view of further large-scale studies attempting
to demonstrate the benfits of early PDT.
REFERENCE. 1. Griffiths J et al (2005) BMJ 330:1243–1248.
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PERCUTANEOUS DILATATIONAL TRACHEOSTOMY (PDT) AND WEANING
FORM SEDATION AND VASOPRESSORS
W. Stahl1, L. K. Eberhardt2, M. Georgieff1, H. Suger-Wiedeck1, K. Tra¨ger1
1University Hospital Ulm, Dept. of Anaesthesiology, Ulm, Germany, 2Ostalbklinikum Aalen,
Dept. of Anaesthesiology, Aalen, Germany
INTRODUCTION. PDT is an established safe measure for airway management in critically
ill patients. But beyond airway management PDT enables to process with reduction in
sedation and often also vasopressor administration. We retrospectively analysed our database
of patients having PDT from 2003 through 2006 in order to evaluate the time course of
sedation and vasopressor administration before and after PDT.
OBJECTIVES. The objective was to describe the effectiveness and time course of reduction
in sedation and vasopressor dosage before and after PDT.
METHODS. The retrospective study was performed in a mixed surgical and trauma ICU in a
university hospital. Patient charts were reviewed for weight adjusted daily doses of sedatives
(propofol, sufentanil and midazolam) as well as vasopressors (noradrenaline) in patients
undergoing PDT. The time interval reviewed was 3 days before and 3 days after PDT. Sta-
tistical analysis was performed using Wilcoxon signed rank test. P \ 0,05 was regarded as
significant.
RESULTS. From 2003 through 2006 PDT was performed in 248 patients.
Data are given as median values.
CONCLUSIONS. PDT was associated with clear changes in sedation management and
probably as a consequence resulted in consecutive reduction of vasopressor need. After
performance of PDT a majority of patients could be weaned from sedatives over the next
3 days. This might give a potential role of PDT in strategies pursuing weaning from sedation,
that otherwise might have failed (Table 1)
TABLE 1
3 days before PDT 3 days after PDT P
Propofol
Median (mg/kg/d) 37.2 3.3 \0.001
Midazolam
Median (mg/kg/d) 0.76 0.48 \0.001
Sufentanil
Median (lg/kg/d) 3.1 1.4 \0.001
Noradrenaline
Median (mg/kg/d) 0.061 0.009 \0.001
REFERENCES. 1. Nieskowska A (2005) Crit Care Med 33:2527–2533.
2. Veelo DP (2006) Crit Care 10:R99.
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EARLY EXPERIENCE WITH A SINGLE-STAGE BALLOON-DILATATIONAL
PERCUTANEOUS TRACHEOSTOMY DEVICE
I. Bouras1, A. K. Krishnamurthy2, J. A. J. Phillips2
1University College Hospital, London, UK, 2Princess Alexandra Hospital NHS Trust, Harlow,
UK
INTRODUCTION. Percutaneous dilatational tracheostomy (PDT) is one of the commonest
invasive procedures performed in mechanically ventilated patients. There is increasing evi-
dence to show that PDT is associated with fewer complications than surgical tracheostomies
(Delaney 2006; Freeman 2000). The ideal PDT technique should reduce bleeding by pre-
venting damage to local blood vessels and tamponade bleeding, eliminate posterior tracheal
wall trauma and minimise time from dilation to tracheal tube insertion. Cook recently
launched the Ciaglia Blue Dolphin PDT set which involves single stage dilation with a radial
balloon dilator allowing the insertion of a pre-loaded tracheostomy tube.
METHODS. The procedure was performed in accordance with the manufacturer’s recom-
mendations. However, we used a blunt dissection technique to visualise the trachea, and in
order to secure the balloon position during inflation, the operator held the balloon steady with
one hand and inflated the balloon by using their abdomen to depress the plunger of the
syringe. This allowed the procedure to be performed by a single operator. After the first five
cases, subsequent procedures used a balloon inflation time of at least 10 s. All PDTs were
performed under bronchoscopic guidance.
RESULTS. 31 CBD tracheostomies were performed of which 30 were successful. The failed
insertion was attributed to an initial incision which was too small; there were no clinical
repercussions. In one case the stoma had to be dilated twice because the CBD device slipped
on the lubricant gel. There was no clinically significant bleeding or desaturation.
As the CBD was used for teaching we did not formally time the procedure. However, we
noted that the operators who had inserted several CBD tracheostomies did so in 4–6 min from
skin incision.
The operators felt that the balloon dilatation does reduce the downward pressure onto the
trachea as asserted by the manufacturers.
CONCLUSIONS. We found the CBD to be a safe and straightforward device. Minimal force
is required to insert the CBD dilator, which theoretically should result in less damage to the
posterior tracheal wall and tracheal rings. The single stage insertion should minimse the risk
of creating a false passage. Our current experience of the CBD would lead us to recommend
at least a 2 cm incision, blunt dissection, at least 10 seconds of dilation and a firm grip on the
balloon during inflation to prevent slippage. A multicentre database could confirm our clinical
suspicions.
REFERENCES. 1 .Delaney A, Bagshaw M, Nalos M (2006) Percutaneous dilatational tra-
cheostomy versus surgical tracheostomy in critically ill patients: a systematic review and
meta-analysis. Critical Care 10:R55.
2. Freeman B, Isabella K, Lin N et al (2000) A meta-analysis of prospective trials comparing
percutaneous and surgical tracheostomy in critically ill patients. Chest 118:1412–1418.
0782
EVALUATION OF PREDICTORS INDEXES OF SUCCESS OR FAILURE IN THE
WEANING FROM INVASIVE MECHANICAL VENTILATION
J. A. Arau´jo Neto1, G. F. Amaral1, S. C. G. Bernardes1, A. C. Gouveia1, F. B. Lima1, M. O.
Maia1, F. Viegas1
1Hospital Santa Luzia, Fisioterapia, Brası´lia, Brazil
OBJECTIVE. To verify and analyze the predictors indexes of success or failure of ventilator
weaning in the Intensive Care Unit of Hospital Santa Luzia, Brasilia-DF.
METHODS. The study was carried out from November 1, 2008 to March 31, 2009. There
were included in the study adult patients with indication for weaning from mechanical
ventilation (MV). The use of protocols with evidence based criteria can reduce the failure of
weaning from MV. We evaluated the correlation between success and failure with the pre-
dictors indexes of maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP)
and Index of rapid and superficial respiration (IRSR).
RESULTS. There were studied 58 patients, 34 (58.62%) males and 24 (41.38%) female.
Medium APACHE II index of 13.82 ± 8.90 and mean SAPS II 36.82 ± 15.79. The success
index of ventilator weaning from was 86.20% (50 patients) and failure index of 13.80% (8
patients). The MIP success’ group was 48 ± 10.30 cmH2O and the failure’s group was
48.13 ± 6.51 cmH2O (p = 0.48). It was also not observed significant difference in the group
of IRSR between success and failure, 45.96 ± 20.68 and 47.41 ± 20.40 (p = 0.42),
respectively. In relation to the MEP, there was statistical difference (p = 0.02) between the
group of success and failure, 71.80 ± 31.72 cmH2O and 53.13 ± 20.86 cmH2O,
respectively.
CONCLUSION. We conclude that there is a correlation between success and failure of
weaning from mechanical ventilation and the measurement of maximal expiratory pressure.
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WHAT CRITERIA DO NURSES PERCEIVE IMPORTANT AND USE TO IDENTIFY
THE ABILITY OF A COPD PATIENT TO WEAN OFF THE VENTILATOR?
K. Kydonaki1
1The University of Edinburgh, School of Health in Social Science, Edinburgh, UK
AIM. The process of weaning from mechanical ventilation is fundamental to the management
of patients with Chronic Obstructive Pulmonary Disease (COPD) and their outcome. The
literature does not support methodologically rigid techniques of measuring a parameter to
continue or discontinue ventilatory support and there are no objective criteria to determine the
patient’s tolerance of spontaneous breathing. Careful clinical assessment is required from the
clinician to identify the patient’s readiness for subsequent discontinuation of ventilatory
support and ultimately extubation. The purpose of this paper is to present the criteria that
nurses use to decide on the weaning of long-term ventilated patients.
METHODS. Ten COPD patients were selected during a 5-month period in a 12-bedded
Intensive Care Unit in Greece. Observation of the nurses looking after those patients while
weaning, and 24-h chart and medical notes review to follow the patient’s progress from a pre-
weaning stage to their discontinuation from the ventilator, extracted information on which
criteria the nurses used to make decisions on the patients’ weaning process. The nurses were
then interviewed to investigate their perceptions of the patients’ ability to wean. Data was
analysed thematically using the qualitative analysis software NVivo (version 8).
RESULTS. An important theme of decision-making identified was nurse’s assessment of the
patient’s ability to wean. The patient’s clinical appearance and the clinical indexes (tidal
volume, respiratory rate, oxygen saturation) guided nurses’ decision-making. The criteria
used to define a Spontaneous Breathing Trial (SBT) tolerance were not single parameters but
integrated indexes which included several physiologic parameters as well as clinical judg-
ment, incorporating such difficult-to-quantify factors as ‘anxiety’, ‘discomfort’, and ‘clinical
appearance’. Significant criteria considered were a reversal underlying cause of respiratory
failure, adequate oxygenation and ability to initiate a breath, the level of consciousness after
reducing the sedation and cardiovascular stability. Blood gases and oxygen requirements were
deemed when making the decision to reduce the support from the ventilator, while the
consciousness level and cough reflex where considered for extubation.
CONCLUSIONS. In difficult to wean patients, such as the COPD, nurses’ supervision of the
patient can influence the decisions made during the weaning process. Nurses perceived their
role crucial because they knew the patient’s behavior better than the doctor and influenced the
decisions about weaning.
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EFFECTS OF MECHANICAL INSUFFLATION-EXSUFFLATION IN PREVENTING
RESPIRATORY FAILURE AFTER EXTUBATION: A RANDOMIZED CON-
TROLLED TRIAL
M. Gonc¸alves1, T. Honrado2, J. C. Winck3, J. A. Paiva2
1University Hospital of S. Joa˜o, Faculty of Medicine, University of Porto, Pulmonology
Department; Intensive Care and Emergency Department, Porto, Portugal, 2University Hos-
pital of S. Joa˜o, Faculty of Medicine, University of Porto, Intensive Care and Emergency
Department, Porto, Portugal, 3University Hospital of S. Joa˜o, Faculty of Medicine, University
of Porto, Pulmonology Department, Porto, Portugal
BACKGROUND. Emphasis on early extubation, coupled with the use of noninvasive ven-
tilation (NIV), decreases the incidence of re-intubation, ventilator-associated pneumonia,
mortality and ICU length of stay. However, secretion encumbrance and impaired airway
clearance are associated with NIV failure. Mechanical Insufflation-Exsufflation (MI-E) is an
assisted coughing technique that has been proven to be very effective in patients under NIV.
AIMS. To assess the efficacy of MI-E for airway clearance, as part of a weaning protocol for
patients at risk of respiratory failure after extubation.
METHODS. Patients under mechanical ventilation (MV) for more than 48 h with specific
inclusion criteria for a weaning protocol were enrolled and randomized in two groups: Group
A patients were put on a weaning protocol that included standard medical therapy (including
NIV, if necessary) and Group B patients were submitted to the same weaning protocol with
the application (minimum 3 times a day) of MI-E sessions. Re-intubation rates, ICU length of
stay and NIV failure rates were analyzed as outcome variables.
RESULTS. Forty-nine patients (18 females) with a mean age of 62.2 ± 18.7 years old were
randomized in Group A (control group, n = 26, mean SAPS II 48.3 ± 18.9, mean age of
62.5 ± 21.2) and Group B (study group, n = 23, mean SAPS II 45.1 ± 12.1, mean age of
62.6 ± 13.7).MV time before enrollment was 10.8 ± 6.2 days for Group A and
12.3 ± 9.4 days for Group B patients. In the first 48 h after extubation, NIV for respiratory
failure was used in 55% of Group A and 40% of Group B patients. We found significant
differences (p \ 0.05) in re-intubation rates (50% for Group A vs. 14% for Group B). Reasons
for re-intubation for group A and B patients, respectively were: severe hypoxemia (25 vs.
55%), respiratory distress with severe acidosis (40 vs. 30%), hemodynamic instability (12 vs.
8%), decreasing level of consciousness (10 vs. 4%) and high risk of cardio-respiratory arrest
(13 vs. 3%).Considering only the sub-group of patients that used NIV, the re-intubation rates
were significantly different (p \ 0.05): 80% for Group A and 6% for Group B. All re-
intubations in this sub-group were related to NIV failure. Mean of total ICU length of stay
was lower in Group B (16.8 ± 15.6 days) than in Group A (18.2 ± 8.3 days). We also found
that mean ICU length of stay po´s-extubation was significantly lower in Group B than in group
A (3.1 ± 2.1 vs. 7.1 ± 7.4 days, p \ 0.05).
CONCLUSIONS. Inclusion of MI-E in a weaning protocol has a positive impact in out-
comes, namely reducing re-intubation rates and ICU length of stay. This technique seems to
be more efficient in improving the efficacy of NIV in patients with respiratory failure after
extubation.
S202 22nd ESICM Annual Congress – Vienna, Austria – 11–14 October 2009
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EFFECTS OF PERIODIC HYPERINSUFFLATION ON REGIONAL LUNG VENTI-
LATION IN PATIENTS WITH NEUROMUSCULAR DISEASE
C. Gue´rin1, B. Vincent1, T. Petitjean1, P. Lecam1, C. Luizet1, M. Rabilloud2, J.-C. Richard1
1Croix Rousse Hospital, Re´animation Me´dicale, Lyon, France, 2Hospices Civils, Service de
Biostatistiques, Lyon, France
BACKGROUND. The effects of intermittent positive pressure breathing (IPPB) and
abdominal belt on regional lung ventilation in neuromuscular patients are unknown.We
underwent a prospective crossover physiologic short-term study in stable neuromuscular
patients to determine the effects of IPBB with or without abdominal belt on regional lung
ventilation.
METHODS. IPPB was performed as 30 consecutive deep breaths up to 30 cmH2O face mask
pressure each: 10 in supine, 10 in left lateral and 10 in right lateral position. Each patient
received IPPB sessions with or without an abdominal belt in a random order at 1 day
intervals. Patients were then followed-up to 3 h after the end of IPPB sessions. Lung venti-
lation was measured using electrical impedance tomography (VTEIT expressed in arbitrary
units a.u.) in four lung quadrants. Baseline tidal volume (VT) and exhaled lung volume (VTE)
after each deep breath were also measured.
RESULTS. Fourteen patients with neuromuscular disease were analyzed in the follow-up
part of the study and 12 in the IPPB part of the study. With IPPB, baseline [median (inter-
quartile range)] VT was 0.25 (0.10) increased to VTE amounting to 1.48 (0.81) L
(P \ 0.0001). With IPPB, baseline global VTEIT increased from 14 (28) up to 126 (98) a.u.
(P \ 0.00001). In supine position, VTEIT was significantly greater in the anterior than in the
posterior lung regions (P \ 0.0001). The abdominal belt was not significant during IPPB.
Within the 3 h period following IPPB, global VTEIT was greater than baseline and greater with
than without the abdominal belt. The regional ventilation did not change significantly over
time.
CONCLUSIONS. In patients with neuromuscular disease, IPPB in the supine position
increased ventilation to the anterior parts of the lung. The abdominal belt during IPPB
maintained the ventilation higher than baseline for 3 h.
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INTENSIVE CARE NURSES0 KNOWLEDGE AND MANAGEMENT OF TRA-
CHEAL TUBE CUFFS
S. Labeau1,2, M. Bleiman3, J. Rello4,5, D. Vandijck2, B. Claes6, S. Blot1,2,7, the EVIDENCE
Study Group
1University College Ghent, Faculty of Healthcare, Ghent, Belgium, 2Ghent University, Fac-
ulty of Medicine and Health Sciences, Ghent, Belgium, 3Covidien Belgium BVBA/SPRL,
Mechelen, Belgium, 4Joan XXIII Hospital, ICU, Tarragona, Spain, 5University Rovira i
Virgili, IISPV, CIBER Enfermedades Respiratorias (CIBERES), Tarragona, Spain, 6Antwerp
University Hospital, ICU, Antwerp, Belgium, 7Ghent University Hospital, Internal Medicine
and Infectious Diseases, Ghent, Belgium
INTRODUCTION. High volume low pressure cuffs are used to seal the extraluminal airway.
In this study, knowledge and management of cuffs were investigated in Flemish Intensive
Care Unit (ICU) nurses.
METHODS. Survey at the Flemish Society for Critical Care Nurses’ annual congress (Nov
2008), using a questionnaire about current practice and a 10-item knowledge test.
RESULTS. We collected 591 questionnaires (response rate 82%); 75% of respondents were
female, 50% had[10 years ICU experience, and 82% had a specialized ICU nursing degree;
43% worked in a hospital with[15 ICU beds. Mean nurse:patient ratio was 1:2.2. As targeted
cuff pressure in the own ICU, a median of 25 cmH2O (IQR 10) was reported by 36% and of
30 mmHg (IQR 7.5) by 32%; 36% indicated not to know. Pressure is measured by auditive
determination of the minimal occlusive volume in 10%, by manometer in 76%, by finger
palpation of the balloon in 41%, and continuously in 0.3% only. Audibly leakage was the
most reported indication (79%) for pressure check. In the absence of indications, 53% checks
pressure every 8 h. In 46% there is no registration at all in the patient’s charts. The median
score on the knowledge test was 6/10 (IQR 2). Correct pressure is known to range between 20
and 30 cmH2O by 52%, and 84% is aware that cuff pressure is measured most accurately by
means of a calibrated manometer. It is well known that the purpose of the cuff is to seal the
extraluminal airway (95%), that subinflation can lead to aspiration (94%) and overinflation to
tracheal injury (98%). Only 15%, however, knew that overinflation can also cause alterations
in swallowing, and barely 7% that it is allowed to fill cuffs with sterile water. Linear
regression analysis showed male gender (p = 0.01), longer working experience (p \ 0.001)
and a larger number of ICU beds (p = 0.01) to be independently associated with higher test
scores.
CONCLUSIONS. Some aspects of current practice and lack of specific knowledge indicate
that Flemish ICU nurses are not fully aware of the importance of strict cuff pressure moni-
toring. Educational initiatives may be the first step in enhancing their knowledge and
management of tracheal cuffs.
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ROLE-RESPONSIBILITIES FOR MECHANICAL VENTILATION AND WEANING
IN THE NETHERLANDS
A. Kanitz1, J. G. Hofhuis1, J. H. Rommes1, M. J. Schultz2,3, L. Rose4, P. E. Spronk1,2,3
1Gelre Hospitals, Intensive Care Medicine, Apeldoorn, Netherlands, 2Academic Medical
Center at the University of Amsterdam, Intensive Care Medicine, Amsterdam, Netherlands,
3HERMES Critical Care Group, Amsterdam, Netherlands, 4University of Toronto, Lawrence
S. Bloomberg Faculty of Nursing, Toronto, Canada
INTRODUCTION. Responsibility for mechanical ventilation and weaning may differ
locally, nationally and internationally due to differences such as intensive care unit (ICU)
organizational structure, staffing, skill-mix and leadership models. Nurses in Australia and
New Zealand participate actively in ventilation and weaning decisions [1]. Little data
describes European nurses’ role for ventilation management.
OBJECTIVES. To describe role-responsibilities for mechanical ventilation and weaning in
adult ICUs in the Netherlands.
METHODS. We conducted a multi-centre, self-administered exploratory survey sent to nurse
managers of all adult ICUs in the Netherlands. The survey was translated and contextually
adapted from a survey previously used to describe the profile of role responsibility and
nursing scope of practice for key ventilation and weaning decisions in Australia/New Zealand
[1]. Surveys were distributed via mail with subsequent phone reminders.
RESULTS. Survey response rate was 69% (72/104), 47/72 (65%) from teaching hospitals,
25/72 (35%) from rural community hospitals. The nurse-patient ratio for mechanically ven-
tilated patients was most often 1:2 (60%) and less frequently 1:1 (13%) or 1:3 (1%). In the
remaining 26% of ICUs the nurse-patient ratio varied according to shift. Selection of initial
ventilator settings was performed only by physicians in all ICUs (100%). Seniority of medical
staff selecting initial ventilator settings was at consultant level for 43/72 (59%) ICUs; 29/72
(41%) ICUs at registrar level or above. Subsequent titration of ventilator settings was per-
formed independently by nurses in most ICUs (67/72, 93%). Only experienced nurses titrated
ventilator settings in 41% of ICUs. Weaning readiness was independently determined by
nurses in 59/72(82%) ICUs; weaning method was selected by nurses in 62% of ICUs, by
physicians in 25% and by others, e.g. ventilation practitioners in 13% of ICUs. Responsibility
for determining extubation readiness was mixed (nurses 46% of ICUs, physicians 49%, both
5%). In the majority of ICUs weaning failure was identified by nurses (55/72, 76%). In other
units weaning failure was identified by physicians in 8/72 (11%) or by both nurses and
physicians 9/72 (13%). Nursing autonomy for ventilation practices (rated on a 10-point
numerical scale) was judged as moderate (median 7, IQR 6–8). In most ICUs nurses often
(51–75% of required adjustments) independently increased or decreased FiO2 and frequently
(26–50%) independently changed ventilation mode, titrated respiratory rate, tidal volume and
inspiratory pressure; independent PEEP adjustment seldom (\25%) occurred.
CONCLUSIONS. In the Netherlands the initial ventilator settings were selected by physi-
cians. Titration of ventilator settings (except changes in PEEP levels), recognition of
readiness for weaning and weaning failure were mostly performed by nurses.
REFERENCES. 1. Rose et al (2008) J Clin Nurs 17:1035–1043.
GRANT ACKNOWLEDGEMENT. None.
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ROLE OF PHYSIOTHERAPISTS IN THE IMPLEMENTATION OF NON-INVASIVE
VENTILATION (NIV)
M. Norrenberg1, F. Vermeulen1, F. X. Leroux1, J. L. Vincent1
1Erasme, ICU, Brussels, Belgium
INTRODUCTION. Physiotherapists are now available 24 h/day in our university hospital,
including for application of continuous positive airway pressure (CPAP) or non-invasive
ventilation (NIV). We evaluated the potential benefit of this activity over the 24 h period.
MATERIALS. During a 4 month period (November 6, 2007–March 6, 2008), we prospec-
tively collected data on the number of NIV sessions and their duration in all patients requiring
NIV or CPAP in the ICU or in the emergency room as well as arterial blood gases (ABG)
before and after the treatment.
RESULTS. Initial settings for CPAP were PEEP 7.8 ± 1.1 cmH2O and FiO2 63 ± 22%, and
for NIV, PEEP 6.0 ± 1.3 cmH2O, FiO2 52 ± 25%, and pressure support 11.1 ± 5.3 cmH2O.
In the NIV group, pH increased from 7.27 to 7.35 (p \ 0.01) and PCO2 decreased from
61 ± 20 to 56 ± 25 mmHg (p = 0.06), while PaO2/FiO2 increased from 159 ± 76 to
194 ± 70 (p \ 0.02).
Failure of the technique (as defined by need for endotracheal intubation within 6 h) occurred
in 34 of 81 patients (42%); these patients had a higher respiratory rate before the initiation of
the treatment (37 ± 12 vs. 27 ± 8, p \ 0.01) and a longer ICU stay (29 ± 28 vs.
13 ± 12 days, p \ 0.01) than successfully treated patients.
CONCLUSION. Our results show that CPAP/NIV is often implemented during the night,
justifying the presence of a physiotherapist 24 h a day in our university hospital. Successful
intervention is associated with a shorter length of ICU stay (Table 1)
TABLE 1 RESULTS
CPAP (n = 35) NIV (n = 46)
Number of treatments/patient 3.4 2.4
Duration of each treatment 89 ± 78 min 124 ± 174 min
% of CPAP/NIV at night
(21H30–08H00)
24% 40%
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EFFECT OF AN EDUCATIONAL INTERVENTION ON THE TRACHEOBRON-
CHIAL ASPIRATION TECHNIQUE
E. Dall’Agnol1, S. R. Vieira1, C. S. Fleck1, M. Granja1
1Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
The tracheobronchial aspiration is a used technique in the Intensive Care Unit (ICU), with the
purpose of removing secretions. Despite the existing recommendations worldwide for the
tracheobronchial aspiration procedure to properly prevent hospital infections, many times
they are not appropriately followed by health professionals. For this reason, educational
programs for the medical team have been adopted as a measure to prevent of respiratory
infections in ICU.
Evaluate the effectiveness of an educational intervention in the adhesion by health profes-
sionals, the technical recommendations for tracheobronchial aspiration in patients
hospitalized in the ICU.
It is a quasi-experimental study with evaluation of pre and post theoretical educational
intervention, using interactivity and practical educational intervention with demonstration of
the aspiration technique steps to participants. The trainings were divided into: 2 h in the
evening for the employees that work in the afternoon and at night B, and 2 h in the afternoon
for the employees that work in the morning and at night A. The technical recommendations
for the tracheobronchial aspiration were addressed in patients hospitalized in the ICU. At the
end of the educational intervention, each employee received didactic material on the tra-
cheobronchial aspiration technique. In order to evaluate the adhesion to the technical
recommendations for the tracheobronchial aspiration, after the application of the educational
intervention, the procedures observed pre and post intervention were compared. The results
were presented as absolute values and percentages and comparisons were performed using the
qui-square test with significance level of p \ 0.05.
A low adhesion of health professionals regarding preventive measures was verified when
observing 124 procedures. When comparing pre and post intervention, a significant increase
in the adhesion in the following aspiration recommendations was verified: use of individual
protection equipment (50% pre and 66.1% post, p = 0.01), care when opening the catheter
package (67.7% pre and 96.8% post, p \ 0.001), use of sterile gloves in the dominant hand
for catheter removal (79.8% pre and 92.7% post, p = 0.003), contact of gloves with the
catheter only (53.2% pre and 78.2% post, p \ 0.001), execution of circular movements during
catheter removal (14.5% pre and 45.2% post, p \ 0.001), wrapping the catheter with the
sterile gloves at the end of the procedure (63.7% pre and 80.6% post, p = 0.003), water tap to
wash the connection latex in the beginning of the procedure (62.1% pre and 79.8% post,
p = 0.002) and disposed of at the end (70.2% pre and 87.9% post, p \ 0.001), execution of
all aspiration technique procedures (0.8% pre and 14.5% post, p \ 0.001).
The results of this study showed low adhesion of health professionals to preventive measures
of hospital infection, indicating that the implementation of educational strategies is required.
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APPARATUS PROPOSAL OF A SIMPLE METHOD TO OBTAIN OPTIMAL CUFF
PRESSURE IN THE CLASSIC LARYNGEAL MASK AIRWAY
J. L. Scally1, A. M. Eusuf2
1Royal Blackburn Hospital, Orthopaedics, Blackburn, UK, 2Royal Bolton Hospital, Anaes-
thesia, Bolton, UK
Laryngeal Mask Airways are often over-inflated by anaesthetists and operating department
practitioners (ODPs), despite several papers advocating inflation of the cuff with volumes less
than the manufacturer0s recommended maximum. It is in our best interest to review current
practice not only because of the reported Laryngopharyngeal morbidity associated with high
cuff pressures but also due to the potential legal implications that misuse of the laryngeal
mask airway may have.
OBJECTIVE. To investigate whether the cuff pressure applied to the Laryngeal Mask
Airway Classic follows manufacturers’ recommendations and to review the effectiveness of a
novel technique in reducing the intra-cuff pressure to within manufacturers recommendations.
DESIGN. Observational Cohort Study Setting - Anaesthetic rooms in the operating theatres
at the Royal Bolton Hospital from May to July 2008
PARICIPANTS. 192 adult and paediatric patients undergoing general anaesthesia where the
Laryngeal Mask Airway Classic was used as airway management.
MAIN OUTCOME MEASURE. Comparison of intra-cuff pressure after induction of
anaesthesia before and after application of a 20 ml syringe.
RESULTS. 93% (179/192) of samples initially demonstrated intra-cuff pressures of greater
than 60 cmH2O and so failed to meet the manufacturers recommendations (30–60 cm H2O).
In 122 of those samples, the pressure was grossly elevated to beyond 120 cmH2O. The initial
mean cuff pressure was 106.54 ± 21.10 cmH2O. After initial passive removal of air with a
20 ml syringe the number of samples where the intra-cuff pressure met the manufacturers
recommended limits increased to 73% (52/192), with the mean pressure being
59.60 ± 16.22 cmH2O. Following a second passive removal of air only 3% (5/192) of
samples sustained intracuff pressures that were outside the recommendations. The mean intra-
cuff pressure had fallen to 51.2 cmH2O ± 7.94. After the third application of the syringe all
192 samples had an optimal intra-cuff pressure as recommended by the manufacturer. There
was no significant difference between males or females, size of laryngeal mask or age with
regard to intra-cuff pressures.
CONCLUSIONS. Considerably higher volumes of air are routinely being used to inflate the
LMA than is deemed necessary by the manufacturer. It is possible that by applying a 20 ml
syringe onto the pilot balloon of an overinflated cuff a more optimal pressure can be achieved.
There is significant morbidity as a consequence of misuse of the LMA. All anaesthetists seem
to be working outside the manufactures recommendations and therefore, theoretically, ille-
gally. We can assume that this is both a national and international problem which needs
addressing, whether in ICU, resuscitation or elective anaesthesia.
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AN ASSESSMENT OF THE INTERVECTM ENDOTRACHEAL TUBE INTRO-
DUCER AS ADJUNCT TO AIRWAY SCOPETM IN A MANIKIN-SIMULATED
DIFFICULT AIRWAY
T. Iizuka1, A. Notoya1, Y. Yokokawa1, T. Satake1
1National Cancer Center Hospital, Anesthesia, Chuo, Japan
INTRODUCTION. The Airway ScopeTM video laryngoscope provides an enhanced view of
the glottis, and increases the likelihood of tracheal intubation compared with direct laryn-
goscopy in patients with a difficult airway. However, it has been well demonstrated that
providing a good view of the glottis dose not always correlate with successful airway
instrumentation. The limitation of the Airway ScopeTM in advancing the endotracheal tube
through the vocal cords into the trachea has been well described.
We evaluate the effectiveness of a new endotracheal tube introducer, INTERVECTM as an
adjunct to Airway ScopeTM video laryngoscope in facilitating simulated difficult tracheal
intubation in a manikin.
METHODS. In experienced laryngoscopists were recruited for this study. After brief train-
ing, participants were use the INTERVECTM as an adjunct to Airway ScopeTM for attempted
tracheal intubation of a manikin-simulated difficult airway. Primary outcomes were successful
endotracheal tube placement.
RESULTS. 10 study participants performed a total of 100 tracheal intubation for evaluation,
and correct placement of the endotracheal tube was achieved in 10 (100%).
CONCLUSION. THE INTERVECTM was effective adjunct to Airway ScopeTM in facili-
tating tracheal intubation of a manikin-simulated difficult airway.
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